,index,pmid,rpsid,pmidlink,components_type,rna_id,rna_id_interface,rnas,rna_length,rna_sequence,rna_classification,source,protein_sequence,protein_name,protein_region,protein_modification,protein_sequence_length,Uniprot ID,mark,link,IDR,low complexity domain,In_vitrovivo,solute_concentration,salt_concentration,buffer,temperature,incubation_time,other_requirement,detection_method,morphology,description,rna_length_num
0,26,PMID: 26474065,RNAPS0000014,https://pubmed.ncbi.nlm.nih.gov/26474065,RNA + protein,NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/1201,CLN3,1879nt(1-1879),GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA,Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,370-7400nM [Whi3];|0.5-134 nM CLN3,150 mM NaCl,"50 mM Tris pH8, 1 mM DTT",RT,> 12 h,-,Fluorescence microscopy,"solute, liquid","Remarkably, CLN3 RNA can promote detectable formation of droplets at Whi3 concentrations as low as 200 nM. This is in the same order of magnitude of soluble Whi3 in Ashbya cytosol that we have measured by fluorescence correlation spectroscopy (57±14 nM).",1879
1,27,PMID: 26474065,RNAPS0000014,https://pubmed.ncbi.nlm.nih.gov/26474065,RNA + protein,NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/1201,CLN3,1879nt(1-1879),GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA,Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,9 µM [Whi3];|50 nM CLN3,150 mM NaCl,"50 mM Tris pH8, 1 mM DTT",RT,-,-,Confocal microscopy,liquid,"We see that BNI1 mRNA can drive Whi3 phase separation at 150 mM salt in a similar fashion as CLN3 RNA, in that for a given protein concentration, the apparent droplet volume fraction increases then decreases with increasing RNA concentration. We also found that BNI1 droplets fuse faster than CLN3 droplets.",1879
2,28,PMID: 26474065,RNAPS0000014,https://pubmed.ncbi.nlm.nih.gov/26474065,RNA + protein,NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/1201,CLN3,1879nt(1-1879),GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA,Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,3.7 µM [Whi3];|53 nM CLN3,150 mM NaCl,"50 mM Tris pH8, 1 mM DTT",RT,-,-,Fluorescence microscopy,liquid,"We found that droplets consisting of Whi3 and RNA were indeed readily formed. In contrast, adding the same amount of DNA, yeast total RNA or heparin did not promote Whi3 droplets. This indicates that CLN3 mRNA can shift the phase boundary to lower protein concentration and high salt concentration, enabling Whi3 phase separation in physiological conditions.",1879
3,29,PMID: 26474065,RNAPS0000014,https://pubmed.ncbi.nlm.nih.gov/26474065,RNA + protein,NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/1201,CLN3,1879nt(1-1879),GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA,Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,7.4 µM [Whi3];|53 nM CLN3,150 mM NaCl,"50 mM Tris pH8, 1 mM DTT",RT,> 4 h,-,Fluorescence microscopy,liquid,"Individual single-point mutations showed minimal effect on droplet formation with or without mRNA. However, the RRM double mutant demonstrates a marked reduction in mRNA-mediated assembly. Thus, direct binding of the RRM domain with CLN3 mRNA is necessary for mRNA-mediated assembly of droplets. Purified individual RRM domain, polyQ domain, and RRM-polyQ domains are also not able to form droplets, neither by lowering salt nor by adding CLN3 mRNA.",1879
4,30,PMID: 26474065,RNAPS0000014,https://pubmed.ncbi.nlm.nih.gov/26474065,RNA + protein,NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/1201,CLN3,1879nt(1-1879),GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA,Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729|mutation=F653A
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCAVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,protein_mutation:F653A,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[654-676],[698-718],[728-729]",-,In vitro,7.4 µM [Whi3];|53 nM CLN3,150 mM NaCl,"50 mM Tris pH8, 1 mM DTT",RT,> 4 h,-,Fluorescence microscopy,liquid,"Individual single-point mutations showed minimal effect on droplet formation with or without mRNA. However, the RRM double mutant demonstrates a marked reduction in mRNA-mediated assembly. Thus, direct binding of the RRM domain with CLN3 mRNA is necessary for mRNA-mediated assembly of droplets. Purified individual RRM domain, polyQ domain, and RRM-polyQ domains are also not able to form droplets, neither by lowering salt nor by adding CLN3 mRNA.",1879
5,31,PMID: 26474065,RNAPS0000014,https://pubmed.ncbi.nlm.nih.gov/26474065,RNA + protein,NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/1201,CLN3,1879nt(1-1879),GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA,Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729|mutation=Y610A
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLAVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,protein_mutation:Y610A,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,7.4 µM [Whi3];|53 nM CLN3,150 mM NaCl,"50 mM Tris pH8, 1 mM DTT",RT,> 4 h,-,Fluorescence microscopy,liquid,"Individual single-point mutations showed minimal effect on droplet formation with or without mRNA. However, the RRM double mutant demonstrates a marked reduction in mRNA-mediated assembly. Thus, direct binding of the RRM domain with CLN3 mRNA is necessary for mRNA-mediated assembly of droplets. Purified individual RRM domain, polyQ domain, and RRM-polyQ domains are also not able to form droplets, neither by lowering salt nor by adding CLN3 mRNA.",1879
6,32,PMID: 26474065,RNAPS0000014,https://pubmed.ncbi.nlm.nih.gov/26474065,RNA + protein,NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/1201,CLN3,1879nt(1-1879),GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA,Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729|mutation=Y610A,F653A
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLAVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCAVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,"protein_mutation:Y610A,F653A",729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[654-676],[698-718],[728-729]",-,In vitro,7.4 µM [Whi3];|53 nM CLN3,150 mM NaCl,"50 mM Tris pH8, 1 mM DTT",RT,> 4 h,-,Fluorescence microscopy,liquid,"Individual single-point mutations showed minimal effect on droplet formation with or without mRNA. However, the RRM double mutant demonstrates a marked reduction in mRNA-mediated assembly. Thus, direct binding of the RRM domain with CLN3 mRNA is necessary for mRNA-mediated assembly of droplets. Purified individual RRM domain, polyQ domain, and RRM-polyQ domains are also not able to form droplets, neither by lowering salt nor by adding CLN3 mRNA.",1879
7,33,PMID: 26474065,RNAPS0000014,https://pubmed.ncbi.nlm.nih.gov/26474065,RNA + protein,NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/1201,CLN3,1879nt(1-1879),GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA,Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=640aa|residues=1-605,695-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPPLGVRGPNSRRGGATNNTSNAGTTNYSYAAAFGKS",Whi3,△RRM,-,"640aa(1-605,695-729)",Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-605],[695-718],[728]-[729]      ",-,In vitro,7.4 µM [Whi3△RRM];|53 nM CLN3,150 mM NaCl,"50 mM Tris pH8, 1 mM DTT",RT,> 4 h,-,Fluorescence microscopy,solute,"Individual single-point mutations showed minimal effect on droplet formation with or without mRNA. However, the RRM double mutant demonstrates a marked reduction in mRNA-mediated assembly. Thus, direct binding of the RRM domain with CLN3 mRNA is necessary for mRNA-mediated assembly of droplets. Purified individual RRM domain, polyQ domain, and RRM-polyQ domains are also not able to form droplets, neither by lowering salt nor by adding CLN3 mRNA.",1879
8,34,PMID: 26474065,RNAPS0000014,https://pubmed.ncbi.nlm.nih.gov/26474065,RNA + protein,NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/1201,CLN3,1879nt(1-1879),GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA,Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=636aa|residues=1-460,554-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHGSSRNSISKTLQVNGPKNAA
AALQNTNGISQVDLSLLAKVPPPANPADQNPPCNTLYVGNLPPDATEQELRQLFSSQKGF
RRLSFRNKNNNGNGHGPMCFVEFEDVAHATRALAELYGSQLARTSGTHNNKGGIRLSFSK
NPLGVRGPNSRRGGATNNTSNAGTTNYSYAAAFGKS",Whi3,△polyQ,-,"636aa(1-460,554-729)",Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-460],[554-623],[668-676],[698-718],[728-729]",-,In vitro,7.4 µM [whi3△polyQ];|53 nM CLN3,150 mM NaCl,"50 mM Tris pH8, 1 mM DTT",RT,> 4 h,-,Fluorescence microscopy,liquid,"Individual single-point mutations showed minimal effect on droplet formation with or without mRNA. However, the RRM double mutant demonstrates a marked reduction in mRNA-mediated assembly. Thus, direct binding of the RRM domain with CLN3 mRNA is necessary for mRNA-mediated assembly of droplets. Purified individual RRM domain, polyQ domain, and RRM-polyQ domains are also not able to form droplets, neither by lowering salt nor by adding CLN3 mRNA.",1879
9,35,PMID: 26474065,RNAPS0000014,https://pubmed.ncbi.nlm.nih.gov/26474065,RNA + protein,NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/1201,CLN3,1879nt(1-1879),GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA,Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,5 µM [Whi3];|53 nM CLN3,60 mM NaCl,"50 mM Tris pH8, 1 mM DTT",RT,≤ 15 min,-,Fluorescence microscopy,liquid,"The first indication that mRNA can promote droplets is clear when an endogenous Whi3-interacting mRNA, CLN3, is added to Whi3-protein droplets. Before adding RNA, the bulk concentration outside the protein droplet is the saturation concentration in these conditions. Shortly after adding CLN3 mRNA, new droplets consisting of Whi3 and RNA start to form and enlarge. Meanwhile, old protein-only droplets begin shrinking and eventually dissolve completely as Whi3 leaves the protein-only droplets and goes into the new protein-RNA droplets. Notably, the new droplets do not fuse with the preformed Whi3-only droplets.",1879
10,36,PMID: 26474065,RNAPS0000015,https://pubmed.ncbi.nlm.nih.gov/26474065,RNA + protein,NCBI ID:855450,https://www.ncbi.nlm.nih.gov/gene/855450,BNI1,5862nt(1-5862),AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA,mRNA,Saccharomyces cerevisiae,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,9 µM [Whi3];|50 nM BNI1,150 mM NaCl,"50 mM Tris pH8, 1 mM DTT",RT,-,-,Confocal microscopy,liquid,"We see that BNI1 mRNA can drive Whi3 phase separation at 150 mM salt in a similar fashion as CLN3 RNA, in that for a given protein concentration, the apparent droplet volume fraction increases then decreases with increasing RNA concentration. We also found that BNI1 droplets fuse faster than CLN3 droplets.",5862
11,37,PMID: 26474065,RNAPS0000015,https://pubmed.ncbi.nlm.nih.gov/26474065,RNA + protein,NCBI ID:855450,https://www.ncbi.nlm.nih.gov/gene/855450,BNI1,5862nt(1-5862),AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA,mRNA,Saccharomyces cerevisiae,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,1850-7400nM [Whi3];|5/27/53/134/268nM BNI1,150 mM NaCl,"50 mM Tris pH8, 1 mM DTT",RT,> 4 h,-,Fluorescence microscopy,liquid,"We see that BNI1 mRNA can drive Whi3 phase separation at 150 mM salt in a similar fashion as CLN3 RNA, in that for a given protein concentration, the apparent droplet volume fraction increases then decreases with increasing RNA concentration. We also found that BNI1 droplets fuse faster than CLN3 droplets.",5862
12,84,PMID: 27594427,RNAPS0000171,https://pubmed.ncbi.nlm.nih.gov/27594427,RNAs + protein,-,-,18S,1754nt(1-1754),AUACCUGAUUGAUUCUGUCAGCGCGAUAUGCUCAAGUAAAAGAUUAAGCCAUGCAUGCUUUGAUUCAUCAAUGAAAUUGCGUACGGCUCAUUAGAGCAGAUAUCACCUUAUCCGGGAUCCUCAUAUGGAUAACUGCGGAAAUACUGGAGCUAAUACAUGCAACUAUACCCCAACGCAAGGCGGGGUGCAAUUAUUAGAACAGACCAAACGUUUUCGGACGUUGUUUGUUGACUCUGAAUAAAGCAGUUUACUGUCAGUUUCGACUGACUCUAUCCGGAAAGGGUGUCUGCCCUUUCAACUAGAUGGUAGUUUAUUGGACUACCAUGGUUGUUACGGGUAACGGAGAAUAAGGGUUCGACUCCGGAGAGGGAGCCUUAGAAACGGCUACCACGUCCAAGGAAGGCAGCAGGCGCGAAACUUAUCCACUGUUGAGUAUGAGAUAGUGACUAAAAAUAUAAAGACUCAUCCUUUUGGAUGAGUUAUUUCAAUGAGUUGAAUACAAAUGAUUCUUCGAGUAGCAAGGAGAGGGCAAGUCUGGUGCCAGCAGCCGCGGUAAUUCCAGCUCUCCUAGUGUAUCUCGUUAUUGCUGCGGUUAAAAAGCUCGUAGUUGGAUCUAGGUUACGUGCCGCAGUUCGCAAUUUGCGUCAACUGUGGUCGUGACUUCUAAUUUGCUGGUUUGAGGUUGGGUUCGCCCUUCAACUGCCAGCAGGUUUACCUUGAAUAAAUCAGAGUGCUCAAUACAAGCGCUUGCUUGAAUAGCUCAUCAUGGAAUAAUGAAACAGGACUUCGGUUCUUUUUGUUGGUUCUAGAACUGAUUUAAUGGUUAAGAGGGACAAACCGGGGGCAUUCGUAUCAUUACGCGAGAGGUGAAAUUCGUGGACCGUAGUGAGACGCCCAACAGCGAAAGCAUUUGCCAAGAAUGUCUUCAUUAAUCAAGAACGAAAGUCAGAGGUUCGAAGGCGAUUAGAUACCGCCCUAGUUCUGACCGUAAACGAUGCCAUCUCGCGAUUCGGAGGGUUUUUGCCCUGCCGAGGAGCUAUCCGGAAACGAAAGUCUUUCGGUUCCGGGGGUAGUAUGGUUGCAAAGCUGAAACUUAAAGAAAUUGACGGAAGGGCACCACAAGGCGUGGAGCUUGCGGCUUAAUUUGACUCAACACGGGAAAACUCACCCGGUCCGGACACCAUUAGGACUGACAGAUUGAAAGCUCUUUCUCGAUUUGGUGGUUGGUGGUGCAUGGCCGUUCUUAGUUGGUGGAGUGAUUUGUCUGGUUUAUUCCGAUAACGAGCGAGACUCUAGCCUGCUAAAUAGUUGGCGAAUCUUCGGGUUCGUAUAACUUCUUAGAGGGAUAAGCGGUGUUUAGCCGCACGAGAUUGAGCGAUAACAGGUCUGUGAUGCCCUUAGAUGUCCGGGGCUGCACGCGUGCUACACUGGUGGAGUCAGCGGGUUUUUCCUAUGCCGAAAGGUAUCGGUAAACCGUUGAAAUUCUUCCAUGUCCGGGAUAGGGUAUUGUAAUUAUUGCCCUUAAACGAGGAAUGCCUAGUAAGUGUGAGUCAUCAGCUCACGUUGAUUACGUCCCUGCCCUUUGUACACACCGCCCGUCGCUAUCCGGGACUGAACUGAUUCGAGAAGAGUGGGGACUGUCGCUUCGAGGUUUAACGACUUCGUUGUUGCGGAAACCAUUUUUAUCGCAUUGGUUUGAACCGGGUAAAAGUCGUAACAAGGUAGCUGUAGGUGAACCUGCAGCUGGAUCAUCG,rRNA,Caenorhabditis elegans,"sp|G5EBV6|PGL3_CAEEL Guanyl-specific ribonuclease pgl-3 OS=Caenorhabditis elegans OX=6239 GN=pgl-3 PE=1 SV=1|length=693aa|residues=1-693
MEANKRQIVEVDGIKSYFFPHLAHYLASNDELLVNNIAQANKLAAFVLGATDKRPSNEEI
AEMILPNDSSAYVLAAGMDVCLILGDDFRPKFDSGAEKLSQLGQAHDLAPIIDDEKKISM
LARKTKLKKSNDAKILQVLLKVLGAEEAEEKFVELSELSSALDLDFDVYVLAKLLGFASE
ELQEEIEIIRDNVTDAFEACKPLLKKLMIEGPKIDSVDPFTQLLLTPQEESIEKAVSHIV
ARFEEASAVEDDESLVLKSQLGYQLIFLVVRSLADGKRDASRTIQSLMPSSVRAEVFPGL
QRSVFKSAVFLASHIIQVFLGSMKSFEDWAFVGLAEDLESTWRRRAIAELLKKFRISVLE
QCFSQPIPLLPQSELNNETVIENVNNALQFALWITEFYGSESEKKSLNQLQFLSPKSKNL
LVDSFKKFAQGLDSKDHVNRIIESLEKSSSSEPSATAKQTTTSNGPTTVSTAAQVVTVEK
MPFSRQTIPCEGTDLANVLNSAKIIGESVTVAAHDVIPEKLNAEKNDNTPSTASPVQFSS
DGWDSPTKSVALPPKISTLEEEQEEDTTITKVSPQPQERTGTAWGSGDATPVPLATPVNE
YKVSGFGAAPVASGFGQFASSNGTSGRGSYGGGRGGDRGGRGAYGGDRGRGGSGDGSRGY
RGGDRGGRGSYGEGSRGYQGGRAGFFGGSRGGS",pgl-3,-,-,693aa(1-693),G5EBV6,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/G5EBV6,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2109,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0049,http://db.phasep.pro/browse/","[445-468],[523-591],[620-693]","[154-165],[443-454],[460-478],[625-692]",In vitro,10-100 ng/µl rRNA;|0.6 µM [pgl-3],150 mM KCl,"25 mM HEPES pH 7.5, 1 mM DTT",RT,≤ 30-40 min,-,Microscopy,solute,"In-vitro-transcribed 18S rRNA did not promote assembly of PGL-3 drops over a broad range of concentrations (10–100 ng/ml). Heating the rRNA made it assembly competent, which suggests that the complex structures of rRNA attenuate its ability to promote PGL-3 drops.",1754
13,85,PMID: 27594427,RNAPS0000171,https://pubmed.ncbi.nlm.nih.gov/27594427,RNAs + protein,-,-,18S,1754nt(1-1754),AUACCUGAUUGAUUCUGUCAGCGCGAUAUGCUCAAGUAAAAGAUUAAGCCAUGCAUGCUUUGAUUCAUCAAUGAAAUUGCGUACGGCUCAUUAGAGCAGAUAUCACCUUAUCCGGGAUCCUCAUAUGGAUAACUGCGGAAAUACUGGAGCUAAUACAUGCAACUAUACCCCAACGCAAGGCGGGGUGCAAUUAUUAGAACAGACCAAACGUUUUCGGACGUUGUUUGUUGACUCUGAAUAAAGCAGUUUACUGUCAGUUUCGACUGACUCUAUCCGGAAAGGGUGUCUGCCCUUUCAACUAGAUGGUAGUUUAUUGGACUACCAUGGUUGUUACGGGUAACGGAGAAUAAGGGUUCGACUCCGGAGAGGGAGCCUUAGAAACGGCUACCACGUCCAAGGAAGGCAGCAGGCGCGAAACUUAUCCACUGUUGAGUAUGAGAUAGUGACUAAAAAUAUAAAGACUCAUCCUUUUGGAUGAGUUAUUUCAAUGAGUUGAAUACAAAUGAUUCUUCGAGUAGCAAGGAGAGGGCAAGUCUGGUGCCAGCAGCCGCGGUAAUUCCAGCUCUCCUAGUGUAUCUCGUUAUUGCUGCGGUUAAAAAGCUCGUAGUUGGAUCUAGGUUACGUGCCGCAGUUCGCAAUUUGCGUCAACUGUGGUCGUGACUUCUAAUUUGCUGGUUUGAGGUUGGGUUCGCCCUUCAACUGCCAGCAGGUUUACCUUGAAUAAAUCAGAGUGCUCAAUACAAGCGCUUGCUUGAAUAGCUCAUCAUGGAAUAAUGAAACAGGACUUCGGUUCUUUUUGUUGGUUCUAGAACUGAUUUAAUGGUUAAGAGGGACAAACCGGGGGCAUUCGUAUCAUUACGCGAGAGGUGAAAUUCGUGGACCGUAGUGAGACGCCCAACAGCGAAAGCAUUUGCCAAGAAUGUCUUCAUUAAUCAAGAACGAAAGUCAGAGGUUCGAAGGCGAUUAGAUACCGCCCUAGUUCUGACCGUAAACGAUGCCAUCUCGCGAUUCGGAGGGUUUUUGCCCUGCCGAGGAGCUAUCCGGAAACGAAAGUCUUUCGGUUCCGGGGGUAGUAUGGUUGCAAAGCUGAAACUUAAAGAAAUUGACGGAAGGGCACCACAAGGCGUGGAGCUUGCGGCUUAAUUUGACUCAACACGGGAAAACUCACCCGGUCCGGACACCAUUAGGACUGACAGAUUGAAAGCUCUUUCUCGAUUUGGUGGUUGGUGGUGCAUGGCCGUUCUUAGUUGGUGGAGUGAUUUGUCUGGUUUAUUCCGAUAACGAGCGAGACUCUAGCCUGCUAAAUAGUUGGCGAAUCUUCGGGUUCGUAUAACUUCUUAGAGGGAUAAGCGGUGUUUAGCCGCACGAGAUUGAGCGAUAACAGGUCUGUGAUGCCCUUAGAUGUCCGGGGCUGCACGCGUGCUACACUGGUGGAGUCAGCGGGUUUUUCCUAUGCCGAAAGGUAUCGGUAAACCGUUGAAAUUCUUCCAUGUCCGGGAUAGGGUAUUGUAAUUAUUGCCCUUAAACGAGGAAUGCCUAGUAAGUGUGAGUCAUCAGCUCACGUUGAUUACGUCCCUGCCCUUUGUACACACCGCCCGUCGCUAUCCGGGACUGAACUGAUUCGAGAAGAGUGGGGACUGUCGCUUCGAGGUUUAACGACUUCGUUGUUGCGGAAACCAUUUUUAUCGCAUUGGUUUGAACCGGGUAAAAGUCGUAACAAGGUAGCUGUAGGUGAACCUGCAGCUGGAUCAUCG,rRNA,Caenorhabditis elegans,"sp|G5EBV6|PGL3_CAEEL Guanyl-specific ribonuclease pgl-3 OS=Caenorhabditis elegans OX=6239 GN=pgl-3 PE=1 SV=1|length=693aa|residues=1-693
MEANKRQIVEVDGIKSYFFPHLAHYLASNDELLVNNIAQANKLAAFVLGATDKRPSNEEI
AEMILPNDSSAYVLAAGMDVCLILGDDFRPKFDSGAEKLSQLGQAHDLAPIIDDEKKISM
LARKTKLKKSNDAKILQVLLKVLGAEEAEEKFVELSELSSALDLDFDVYVLAKLLGFASE
ELQEEIEIIRDNVTDAFEACKPLLKKLMIEGPKIDSVDPFTQLLLTPQEESIEKAVSHIV
ARFEEASAVEDDESLVLKSQLGYQLIFLVVRSLADGKRDASRTIQSLMPSSVRAEVFPGL
QRSVFKSAVFLASHIIQVFLGSMKSFEDWAFVGLAEDLESTWRRRAIAELLKKFRISVLE
QCFSQPIPLLPQSELNNETVIENVNNALQFALWITEFYGSESEKKSLNQLQFLSPKSKNL
LVDSFKKFAQGLDSKDHVNRIIESLEKSSSSEPSATAKQTTTSNGPTTVSTAAQVVTVEK
MPFSRQTIPCEGTDLANVLNSAKIIGESVTVAAHDVIPEKLNAEKNDNTPSTASPVQFSS
DGWDSPTKSVALPPKISTLEEEQEEDTTITKVSPQPQERTGTAWGSGDATPVPLATPVNE
YKVSGFGAAPVASGFGQFASSNGTSGRGSYGGGRGGDRGGRGAYGGDRGRGGSGDGSRGY
RGGDRGGRGSYGEGSRGYQGGRAGFFGGSRGGS",pgl-3,-,-,693aa(1-693),G5EBV6,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/G5EBV6,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2109,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0049,http://db.phasep.pro/browse/","[445-468],[523-591],[620-693]","[154-165],[443-454],[460-478],[625-692]",In vitro,＞100 ng/µl rRNA;|0.6 µM [pgl-3],150 mM KCl,"25 mM HEPES pH 7.5, 1 mM DTT",RT,≤ 30-40 min,-,Microscopy,liquid,"In-vitro-transcribed 18S rRNA did not promote assembly of PGL-3 drops over a broad range of concentrations (10–100 ng/ml). Heating the rRNA made it assembly competent, which suggests that the complex structures of rRNA attenuate its ability to promote PGL-3 drops.",1754
14,88,PMID: 29932899,RNAPS0000032,https://pubmed.ncbi.nlm.nih.gov/29932899,RNA + protein,NCBI ID:283131,https://www.ncbi.nlm.nih.gov/gene/283131,NEAT1_antisense,1531nt(9.7-11.1k),GGGCGAAUUGGGCCCUCUAGAUGCAUGCUCGAGCGGCCGCCAGUGUGAUGGAUAUCUGCAGAAUUCGCCCUUGGGUGGCAGGAGGCGGCAGGGGAGGCGGGUGGUGUGGGACCACAUAAGUGGAAGGUGUAGUAAAAUCUCAGACUUCACUACUGUAGAACUCAUAUAUAUGACCAAAAGCCAUUUGUACCCCAAAAGCCAUUGAAAUUAAAUAUAUAUAUAUACACACACACACACACACAUAAAGAAAAAAAAAGAAAAUUAUAAGAAGUUAAUAUUGACAGACCUGGAACAAAAAAUCAAAGACAGUAUUUAGUCAUUAAAAUUUUGCUAUUUCAAUUUCAUCAGUGUAAAUAAUUAAUUUAAGUGGAGAGGAGUGUUCAUUGUAACCAUAGGAGUUACUGUCUGUAUUGUCCUAGUUUUUGUAUUGGAUAGGAGAUUCAGAAAUGCUUACCACAUUAUUAAAAAACAAUUAAAGAAAGCAAGUAAAAGAGAGCCAUGUUGUGUCCUGAAUCAAAGAUUAAGAUUGAGAUUUACCCAGUUCUGUGUAUUUGAGUUCCAACAGAGAGAAUAUUCUUGCCUUACAGGAGUGUUCUAGCCUCCAUUUACCAGAUUUUAAAGCAUAAUGAAAAGUGAUGAUCAUUACAUUCCAUUGCAUUUUAUUAACAACAACAACAAAAACUGGAGCCUAAAAUUUCCAGAAAUAGAUCCAGAGAGAAAAUGUUAAGAACCAUUUGAUCUAGCAAUCCCACUCCUGGGUAUCUACCCAAAGGAAAAGAAGUCAUUAUACCAGAAAGACACUUGAUGGCAGUACAAGUCACAAUUGCAAAGAUGUGGAACCAACCCAUCAACCAGUGAGUGGAUAAAUAAAAUGUGGUAUCUCUACACCAUGGAAUAUGACUUAGCAAUAAAAAAGAACAAAAUAAUGUUUGUGGUUUUUUUUUUUUUUGCAGCAAUUUUGGAUGGAGCUGGAGGAUAUUAUUCUAAGUGAAGCAACUCAGGAAUGGAAAACCAAAUACUGUGUGUUCUCACUUAUAAGUGAGAGCUAACUUAUGGGUACAAAAAGGUAUACAGAGUGACAUAAUGGACACUAGAGACUCAAAGUGGGGAGGGUAAGAGGGGGGCAAGGUAUAAAAAACCACAUAUUGGGUACAAUGUACACUACUCAGGUGACCGGUGCAGUAAAAUCUCAGACUUCACUACUGUAGAAUUCAUCUAUAUGACCAAAAGCCAUUUGUACCCCAAAAGCCAUUGAAAUUAAAAAAAAAAAAAUACACACACACACACACAUAAAGAAAAAAAAGAAAAUUAUAAGAAGUUAAUAUUGACUGACCUGGAACGAAAAAACCAAGACAGUAUUUAGUCAUUAACAUUUUGCUAUUUCAUCAAUGUAAAUAAUUAAUUUAAAUGGAGAGGAGUGUUCAUUGUAAUCAUAGGAGUACAUACAUGUUUAGCUACUAAAGAAAAAGUAAUCAGAAGCAAAUUCAAUGGACAAGGGCGAAUUCCAGCACACUGGCGGCCGUUACUAGUG,lncRNA,Homo sapiens,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-,-,526aa(1-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[1-507],[508-512]","[17-104],[106-261],[371-425],[450-507]",In vitro,-,-,-,-,-,-,Immunoblotting,liquid,"Immunoblotting analysis revealed that three essential PSPs (NONO, SFPQ, and RBM14) were specifically precipitated with the sense RNA. Interestingly, FUS nonspecifically bound both to the sense and antisense RNAs (Figure 7B).",1531
15,93,PMID: 27791212,RNAPS0000015,https://pubmed.ncbi.nlm.nih.gov/27791212,RNA + protein,NCBI ID:855450,https://www.ncbi.nlm.nih.gov/gene/855450,BNI1,5862nt(1-5862),AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA,mRNA,Saccharomyces cerevisiae,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,53 nM [BNI1];|-,150 mM KCl,-,RT,≤ 2 h,-,Confocal microscopy,liquid,"The MSD versus lag time for LAF-1 at high salt (250 mM NaCl), Whi3 at physiological salt (150 mM KCl) in the presence of 53 nM BNI1 mRNA, LAF-1 at low salt (125 mM NaCl), GAR-1DN at low salt (150 mM NaCl), and the noise floor is shown in Fig. 2c.",5862
16,94,PMID: 27791212,RNAPS0000015,https://pubmed.ncbi.nlm.nih.gov/27791212,RNA + protein,NCBI ID:855450,https://www.ncbi.nlm.nih.gov/gene/855450,BNI1,5862nt(1-5862),AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA,mRNA,Saccharomyces cerevisiae,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,9 µM [Whi3];|50 nM BNI1,150 mM KCl,"20 mM Tris, pH 7.4, 1 mM DTT",RT,-,-,Confocal microscopy,liquid,"In the case of Whi3, specific mRNA binding partners (i.e., cyclin transcripts, CLN3, and formin transcripts, BNI1) shifts the droplet phase boundary down, approaching physiological protein concentrations at physiological salt concentration. Such protein droplets appear to be liquid-like, exhibiting round morphologies after coalescence.",5862
17,103,PMID: 28556382,RNAPS0000103,https://pubmed.ncbi.nlm.nih.gov/28556382,RNA + protein,-,-,polyU,2400-3100nt,-,poly RNA,-,RRxxxRRxxxRRxxx,RP3,-,-,15aa,-,-,-,-,-,In vitro,200 µM[RP3];|400µM[polyU],50 mM NaCl,"10mM Tris-HCl,pH 7.9",RT,≤ 60 min,other_molecular:1 µM T7 RNA polymerase,Confocal fluorescence microscopy,liquid,"RNA transcription by T7 RNA polymerase in presence of RLMs leads to the formation of phase-separated RLM/RNA droplets, while further increase in [RNA] by transcription leads to a subsequent mixing phase transition and dissolves the RLM/RNA droplets",3100
18,104,PMID: 28556382,RNAPS0000103,https://pubmed.ncbi.nlm.nih.gov/28556382,RNA + protein,-,-,polyU,2400-3100nt,-,poly RNA,-,RRxxxRRxxxRRxxx,RP3,-,-,15aa,-,-,-,-,-,In vitro,2~2000µM [RNA];|200 µM [RP3],25-225 nm NACl,"10mM Tris-HCl,pH 7.9",RT,-,-,Confocal fluorescence microscopy,"solute, liquid","We observe that RP3 and SR8 undergo sequential demixing and mixing phase transitions in response to increasing RNA concentration. These data suggest a window-like behavior for immiscibility, which is a hallmark for a reentrant phase transition. Within this window, the peptide/RNA microdroplets display liquid-like properties such as circular appearance (aspect ratio = 0.97±0.04; n =15), facile fusion, and rapid recovery of fluorescence after photobleaching.",3100
19,105,PMID: 28556382,RNAPS0000104,https://pubmed.ncbi.nlm.nih.gov/28556382,RNA + protein,-,-,polyU,2400-3100nt,-,poly RNA,-,sRsRsRsRxxxxxsRsRsRsR,SR8,-,-,21aa,-,-,-,-,-,In vitro,200µM[polyU];|200 µM[SR8],50 mM NaCl,"10mM Tris-HCl,pH 7.9",RT,-,-,Confocal fluorescence microscopy,liquid,"We observe that RP3 and SR8 undergo sequential demixing and mixing phase transitions in response to increasing RNA concentration. These data suggest a window-like behavior for immiscibility, which is a hallmark for a reentrant phase transition. Within this window, the peptide/RNA microdroplets display liquid-like properties such as circular appearance (aspect ratio = 0.97±0.04; n =15), facile fusion, and rapid recovery of fluorescence after photobleaching.",3100
20,106,PMID: 28556382,RNAPS0000105,https://pubmed.ncbi.nlm.nih.gov/28556382,RNA + protein,-,-,polyU,2400-3100nt,-,poly RNA,-,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-,-,526aa(1-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[1-507],[508-512]","[17-104],[106-261],[371-425],[450-507]",In vitro,0.3 µM[polyU];|10 µM[FUS],50 mM NaCl,"10mM Tris-HCl,pH 7.9",RT,-,-,Confocal fluorescence microscopy,liquid,"Below the threshold concentration for homologous LLPS, FUS titrated with RNA not only triggers a demixing transition into liquid droplets but also leads to droplet dissolution, which is analogous to the phase behavior of RP3 and SR8 peptides.",3100
21,132,PMID: 29064502,RNAPS0000015,https://pubmed.ncbi.nlm.nih.gov/29064502,RNA + protein,NCBI ID:855450,https://www.ncbi.nlm.nih.gov/gene/855450,BNI1,5862nt(1-5862),AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA,mRNA,Saccharomyces cerevisiae,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,9 µM [Whi3];|50 nM BNI1,150 mM KCl,"20 mM Tris, pH 7.4, 1 mM DTT",RT,-,crowding agent:0.01-0.07 mg/ml dextran 10-155 kD,Confocal microscopy,liquid,"The smaller 10 kDa dextranpartitions favourably into P granules, while the larger 155 kDa dextran is significantly excluded; similar in vivo results have beenreported for P granules and for nucleoli. Moreover, we see similar size-dependent exclusionin vitro for two other well-known droplet forming proteins, WHI3 and NPM1. These results suggest that the semidilute, void-rich nature of droplets is likely a feature of many liquid-phase organelles that are driven by the sequence encoded conformational fluctuations of IDRs.",5862
22,133,PMID: 29064502,RNAPS0000123,https://pubmed.ncbi.nlm.nih.gov/29064502,RNA + protein,-,-,polyA(3000),3000nt,AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,poly RNA,-,"sp|D0PV95|DDX3_CAEEL ATP-dependent RNA helicase laf-1 OS=Caenorhabditis elegans OX=6239 GN=laf-1 PE=1 SV=1|length=708aa|residues=1-708
MESNQSNNGGSGNAALNRGGRYVPPHLRGGDGGAAAAASAGGDDRRGGAGGGGYRRGGGN
SGGGGGGGYDRGYNDNRDDRDNRGGSGGYGRDRNYEDRGYNGGGGGGGNRGYNNNRGGGG
GGYNRQDRGDGGSSNFSRGGYNNRDEGSDNRGSGRSYNNDRRDNGGDGQNTRWNNLDAPP
SRGTSKWENRGARDERIEQELFSGQLSGINFDKYEEIPVEATGDDVPQPISLFSDLSLHE
WIEENIKTAGYDRPTPVQKYSIPALQGGRDLMSCAQTGSGKTAAFLVPLVNAILQDGPDA
VHRSVTSSGGRKKQYPSALVLSPTRELSLQIFNESRKFAYRTPITSALLYGGRENYKDQI
HKLRLGCHILIATPGRLIDVMDQGLIGMEGCRYLVLDEADRMLDMGFEPQIRQIVECNRM
PSKEERITAMFSATFPKEIQLLAQDFLKENYVFLAVGRVGSTSENIMQKIVWVEEDEKRS
YLMDLLDATGDSSLTLVFVETKRGASDLAYYLNRQNYEVVTIHGDLKQFEREKHLDLFRT
GTAPILVATAVAARGLDIPNVKHVINYDLPSDVDEYVHRIGRTGRVGNVGLATSFFNDKN
RNIARELMDLIVEANQELPDWLEGMSGDMRSGGGYRGRGGRGNGQRFGGRDHRYQGGSGN
GGGGNGGGGGFGGGGQRSGGGGGFQSGGGGGRQQQQQQRAQPQQDWWS",laf-1,-,-,708aa(1-708),D0PV95,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/D0PV95,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-0337,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0001,http://db.phasep.pro/browse/",-,-,In vitro,0-9 mg/ml [laf-1];|75 nM polyA,0-500 mM NaCl,"20 mM Tris, pH 7.4, 1 mM DTT",RT,-,-,Confocal microscopy,"solute, liquid","In the presence of polyadenylate RNA (poly-rA) of various lengths, the low-concentration arm of the LAF-1 binodal and the concentrations corresponding to the critical region remain essentially invariant. However, upon addition of RNA we observe a marked shift of the high-concentration arm of the LAF-1 binodal, toward lower values of dense phase concentration.",3000
23,153,PMID: 29650702,RNAPS0000151,https://pubmed.ncbi.nlm.nih.gov/29650702,RNA + protein,NCBI ID:283131,https://www.ncbi.nlm.nih.gov/gene/283131,NEAT1,3756nt(1-3756),GGAGUUAGCGACAGGGAGGGAUGCGCGCCUGGGUGUAGUUGUGGGGGAGGAAGUGGCUAGCUCAGGGCUUCAGGGGACAGACAGGGAGAGAUGACUGAGUUAGAUGAGACGAGGGGGCGGGCUGGGGGUGCGAGAAGGAAGCUUGGCAAGGAGACUAGGUCUAGGGGGACCACAGUGGGGCAGGCUGCAUGGAAAAUAUCCGCAGGGUCCCCCAGGCAGAACAGCCACGCUCCAGGCCAGGCUGUCCCUACUGCCUGGUGGAGGGGGAACUUGACCUCUGGGAGGGCGCCGCUCUUGCAUAGCUGAGCGAGCCCGGGUGCGCUGGUCUGUGUGGAAGGAGGAAGGCAGGGAGAGGUAGAAGGGGUGGAGGAGUCAGGAGGAAUAGGCCGCAGCAGCCCUGGAAAUGAUCAGGAAGGCAGGCAGUGGGUGCAGGGCUGCAGGAGGGCCGGGAGGGCUAAUCUUCAACUUGUCCAUGCCAGCAGCCCCUUUUUUUCCAGACCAAGGGCUGUGAACCCGCCUGGGGAUGAGGCCUGGUCUUGUGGAACUGAACUUAGCUCGACGGGGCUGACCGCUCUGGCCCAGGGUGGUAUGUAAUUUUCGCUCGGCCUGGGACGGGGCCCAGGCCGGGCCCAGCCUGGUGGAGCGUCCAGGUCUGGGUGCGAAGCCAGGCCCCUGGGCGGAGGUGAGGGGUGGUCUGAGGAGUGAUGUGGAGUUAAGGCGCCAUCCUCACCGGUGACUGGUGCGGCACCUAGCAUGUUUGACAGGCGGGGACUGCGAGGCACGCUGCUCGGGUGUUGGGGACAACAUUGACCAACGCUUUAUUUUCCAGGUGGCAGUGCUCCUUUUGGACUUUUCUCUAGGUUUGGCGCUAAACUCUUCUUGUGAGCUCACUCCACCCCUUCUUCCUCCCUUUAACUUAUCCAUUCACUUAAAACAUUACCUGGUCAUCUGGUAAGCCCGGGACAGUAAGCCGAGUGGCUGUUGGAGUCGGUAUUGUUGGUAAUGGUGGAGGAAGAGAGGCCUUCCCGCUGAGGCUGGGGUGGGGCGGAUCGGUGUUGCUUGCCUGCAGAGAGGGUGGGGAGUGAAUGUGCACCCUUGGGUGGGCCUGCAGCCAUCCAGCUGAAAGUUACAAAAAUGCUUCAUGGACCGUGGUUUGUUACUAUAGUGUUCCUCAUGGCGAGCAGAUGGAACCGGGAGACAUGGAGUCCCUGGCCAGUGUGAGUCCUAGCAUUGCAGGAGGGGAGACCCUGGAGGAGAGAGCCCGCCUCAAUUGAUGCCUGCAGAUUGAAUUUCCAGAGGCUUAGGAGGAGGAAGUUCUCCAAUGUUCUGUUUCCAGGCCUUGCUCAGGAAGCCCUGUAUUCAGGAGGCUACCAUUUAAAGUUUGCAGAUGAGCUUAUGGGGGGCAAUCUUAAAAAGUCCACAGCAGAUGCAUCCGGCUCGAGGGGCCAUCAGCUUUGAAUAAAUGCUUGUUCCAGAGCCCAUGAAUGCCAGCAGGCACCCCUCCUUUCCUGGGGUAAAGGUUUUCAGAUGCUGCAUCUUCUAAAUUGAGCCUCCGGUCAUACUAGUUUUGUGCUUGGAACCUUGCUUCAAGAAGAUCCCUAAGCUGUAGAACAUUUUAACGUUGAUGCCACAACGCAGAUUGAUGCCUUGUAGAUGGAGCUUGCAGAUGGAGCCCCGUGACCUCUCACCUACCCACCUGUUUGCCUGCCUUCUUGUGCGUUUCUCGGAGAAGUUCUUAGCCUGAUGAAAUAACUUGGGGCGUUGAAGAGCUGUUUAAUUUUAAAUGCCUUAGACUGGGGAUAUAUUAGAGGAAGCAGAUUGUCAAAUUAAGGGUGUCAUUGUGUUGUGCUAAACGCUGGGAGGGUACAAGUUGGUCAUUCCUAAAUCUGUGUGUGAGAAAUGGCAGGUCUAGUUUGGGCAUUGUGAUUGCAUUGCAGAUUACUAGGAGAAGGGAAUGGUGGGUACACCGGUAGUGCUCUUUUGUUCUUGCUUCGUUUUUUUAAACUUGAACUUUACUUCGUUAGAUUUCAUAAUACUUUCUUGGCAUUCUAGUAAGAGGACCCUGAGGUGGGAGUUGUGGGGGACGGGGAGAAGGGGACAGCUUGGCACCGGUCCCGUGGGCGUUGCAGUGUGGGGGAUGGGGGUAUGCAGCUUGGCACUGGUACUGGGAGGGAUGAGGGUGAAGAAGGGGAGAGGGUUGGUUAGAGAUACAGUGUGGGUGGUGGGGGUGGUAGGAAAUGCAGGUUGAAGGGAAUUCUCUGGGGCUUUGGGGAAUUUAGUGCGUGGGUGAGCCAAGAAAAUACUAAUUAAUAAUAGUAAGUUGUUAGUGUUGGUUAAGUUGUUGCUUGGAAGUGAGAAGUUGCUUAGAAACUUUCCAAAGUGCUUAGAACUUUAAGUGCAAACAGACAAACUAACAAACAAAAAUUGUUUUGCUUUGCUACAAGGUGGGGAAGACUGAAGAAGUGUUAACUGAAAACAGGUGACACAGAGUCACCAGUUUUCCGAGAACCAAAGGGAGGGGUGUGUGAUGCCAUCUCACAGGCAGGGGAAAUGUCUUUACCAGCUUCCUCCUGGUGGCCAAGACAGCCUGUUUCAGAGGGUUGUUUUGUUUGGGGUGUGGGUGUUAUCAAGUGAAUUAGUCACUUGAAAGAUGGGCGUCAGACUUGCAUACGCAGCAGAUCAGCAUCCUUCGCUGCCCCUUAGCAACUUAGGUGGUUGAUUUGAAACUGUGAAGGUGUGAUUUUUUCAGGAGCUGGAAGUCUUAGAAAAGCCUUGUAAAUGCCUAUAUUGUGGGCUUUUAACGUAUUUAAGGGACCACUUAAGACGAGAUUAGAUGGGCUCUUCUGGAUUUGUUCCUCAUUUGUCACAGGUGUCUUGUGAUUGAAAAUCAUGAGCGAAGUGAAAUUGCAUUGAAUUUCAAGGGAAUUUAGUAUGUAAAUCGUGCCUUAGAAACACAUCUGUUGUCUUUUCUGUGUUUGGUCGAUAUUAAUAAUGGCAAAAUUUUUGCCUAUCUAGUAUCUUCAAAUUGUAGUCUUUGUAACAACCAAAUAACCUUUUGUGGUCACUGUAAAAUUAAUAUUUGGUAGACAGAAUCCAUGUACCUUUGCUAAGGUUAGAAUGAAUAAUUUAUUGUAUUUUUAAUUUGAAUGUUUGUGCUUUUUAAAUGAGCCAAGACUAGAGGGGAAACUAUCACCUAAAAUCAGUUUGGAAAACAAGACCUAAAAAGGGAAGGGGAUGGGGAUUGUGGGGAGAGAGUGGGCGAGGUGCCUUUACUACAUGUGUGAUCUGAAAACCCUGCUUGGUUCUGAGCUGCGUCUAUUGAAUUGGUAAAGUAAUACCAAUGGCUUUUUAUCAUUUCCUUCUUCCCUUUAAGUUUCACUUGAAAUUUUAAAAAUCAUGGUUAUUUUUAUCGUUGGGAUCUUUCUGUCUUCUGGGUUCCAUUUUUUAAAUGUUUAAAAAUAUGUUGACAUGGUAGUUCAGUUCUUAACCAAUGACUUGGGGAUGAUGCAAACAAUUACUGUCGUUGGGAUUUAGAGUGUAUUAGUCACGCAUGUAUGGGGAAGUAGUCUCGGGUAUGCUGUUGUGAAAUUGAAACUGUAAAAGUAGAUGGUUGAAAGUACUGGUAUGUUGCUCUGUAUGGUAAGAACUAAUUCUGUUACGUCAUGUACAUAAUUACUAAUCACUUUUCUUCCCCUUUACAGCACAAAUAAAGUUUGAGUUCUAAACUCAUUAGAAAAAAAAAAAAAAAAAAAAAAA,lncRNA,Homo sapiens,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=526aa|residues=1-526
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-,-,526aa(1-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[1-507],[508-512]","[17-104],[106-261],[371-425],[450-507]",In vitro,5 µM [FUS];|0-800 ng/µl Neat1 ,"75 mM KCl, 1 mM MgCl2","25 mM Tris/HCl buffer (pH 7.4), 1 mM TCEP",RT,-,-,Confocal Laser scanning microscopy,liquid,"rRNA, tRNA, and a noncoding RNA that is known to bind to FUS (Neat1) were all able to solubilize FUS droplets, suggesting a general effect, but smaller RNAs were more potent than larger ones. The FUS droplets re-appear after RNase A induced RNA degradation.",3756
24,154,PMID: 29650702,RNAPS0000151,https://pubmed.ncbi.nlm.nih.gov/29650702,RNA + protein,NCBI ID:283131,https://www.ncbi.nlm.nih.gov/gene/283131,NEAT1,3756nt(1-3756),GGAGUUAGCGACAGGGAGGGAUGCGCGCCUGGGUGUAGUUGUGGGGGAGGAAGUGGCUAGCUCAGGGCUUCAGGGGACAGACAGGGAGAGAUGACUGAGUUAGAUGAGACGAGGGGGCGGGCUGGGGGUGCGAGAAGGAAGCUUGGCAAGGAGACUAGGUCUAGGGGGACCACAGUGGGGCAGGCUGCAUGGAAAAUAUCCGCAGGGUCCCCCAGGCAGAACAGCCACGCUCCAGGCCAGGCUGUCCCUACUGCCUGGUGGAGGGGGAACUUGACCUCUGGGAGGGCGCCGCUCUUGCAUAGCUGAGCGAGCCCGGGUGCGCUGGUCUGUGUGGAAGGAGGAAGGCAGGGAGAGGUAGAAGGGGUGGAGGAGUCAGGAGGAAUAGGCCGCAGCAGCCCUGGAAAUGAUCAGGAAGGCAGGCAGUGGGUGCAGGGCUGCAGGAGGGCCGGGAGGGCUAAUCUUCAACUUGUCCAUGCCAGCAGCCCCUUUUUUUCCAGACCAAGGGCUGUGAACCCGCCUGGGGAUGAGGCCUGGUCUUGUGGAACUGAACUUAGCUCGACGGGGCUGACCGCUCUGGCCCAGGGUGGUAUGUAAUUUUCGCUCGGCCUGGGACGGGGCCCAGGCCGGGCCCAGCCUGGUGGAGCGUCCAGGUCUGGGUGCGAAGCCAGGCCCCUGGGCGGAGGUGAGGGGUGGUCUGAGGAGUGAUGUGGAGUUAAGGCGCCAUCCUCACCGGUGACUGGUGCGGCACCUAGCAUGUUUGACAGGCGGGGACUGCGAGGCACGCUGCUCGGGUGUUGGGGACAACAUUGACCAACGCUUUAUUUUCCAGGUGGCAGUGCUCCUUUUGGACUUUUCUCUAGGUUUGGCGCUAAACUCUUCUUGUGAGCUCACUCCACCCCUUCUUCCUCCCUUUAACUUAUCCAUUCACUUAAAACAUUACCUGGUCAUCUGGUAAGCCCGGGACAGUAAGCCGAGUGGCUGUUGGAGUCGGUAUUGUUGGUAAUGGUGGAGGAAGAGAGGCCUUCCCGCUGAGGCUGGGGUGGGGCGGAUCGGUGUUGCUUGCCUGCAGAGAGGGUGGGGAGUGAAUGUGCACCCUUGGGUGGGCCUGCAGCCAUCCAGCUGAAAGUUACAAAAAUGCUUCAUGGACCGUGGUUUGUUACUAUAGUGUUCCUCAUGGCGAGCAGAUGGAACCGGGAGACAUGGAGUCCCUGGCCAGUGUGAGUCCUAGCAUUGCAGGAGGGGAGACCCUGGAGGAGAGAGCCCGCCUCAAUUGAUGCCUGCAGAUUGAAUUUCCAGAGGCUUAGGAGGAGGAAGUUCUCCAAUGUUCUGUUUCCAGGCCUUGCUCAGGAAGCCCUGUAUUCAGGAGGCUACCAUUUAAAGUUUGCAGAUGAGCUUAUGGGGGGCAAUCUUAAAAAGUCCACAGCAGAUGCAUCCGGCUCGAGGGGCCAUCAGCUUUGAAUAAAUGCUUGUUCCAGAGCCCAUGAAUGCCAGCAGGCACCCCUCCUUUCCUGGGGUAAAGGUUUUCAGAUGCUGCAUCUUCUAAAUUGAGCCUCCGGUCAUACUAGUUUUGUGCUUGGAACCUUGCUUCAAGAAGAUCCCUAAGCUGUAGAACAUUUUAACGUUGAUGCCACAACGCAGAUUGAUGCCUUGUAGAUGGAGCUUGCAGAUGGAGCCCCGUGACCUCUCACCUACCCACCUGUUUGCCUGCCUUCUUGUGCGUUUCUCGGAGAAGUUCUUAGCCUGAUGAAAUAACUUGGGGCGUUGAAGAGCUGUUUAAUUUUAAAUGCCUUAGACUGGGGAUAUAUUAGAGGAAGCAGAUUGUCAAAUUAAGGGUGUCAUUGUGUUGUGCUAAACGCUGGGAGGGUACAAGUUGGUCAUUCCUAAAUCUGUGUGUGAGAAAUGGCAGGUCUAGUUUGGGCAUUGUGAUUGCAUUGCAGAUUACUAGGAGAAGGGAAUGGUGGGUACACCGGUAGUGCUCUUUUGUUCUUGCUUCGUUUUUUUAAACUUGAACUUUACUUCGUUAGAUUUCAUAAUACUUUCUUGGCAUUCUAGUAAGAGGACCCUGAGGUGGGAGUUGUGGGGGACGGGGAGAAGGGGACAGCUUGGCACCGGUCCCGUGGGCGUUGCAGUGUGGGGGAUGGGGGUAUGCAGCUUGGCACUGGUACUGGGAGGGAUGAGGGUGAAGAAGGGGAGAGGGUUGGUUAGAGAUACAGUGUGGGUGGUGGGGGUGGUAGGAAAUGCAGGUUGAAGGGAAUUCUCUGGGGCUUUGGGGAAUUUAGUGCGUGGGUGAGCCAAGAAAAUACUAAUUAAUAAUAGUAAGUUGUUAGUGUUGGUUAAGUUGUUGCUUGGAAGUGAGAAGUUGCUUAGAAACUUUCCAAAGUGCUUAGAACUUUAAGUGCAAACAGACAAACUAACAAACAAAAAUUGUUUUGCUUUGCUACAAGGUGGGGAAGACUGAAGAAGUGUUAACUGAAAACAGGUGACACAGAGUCACCAGUUUUCCGAGAACCAAAGGGAGGGGUGUGUGAUGCCAUCUCACAGGCAGGGGAAAUGUCUUUACCAGCUUCCUCCUGGUGGCCAAGACAGCCUGUUUCAGAGGGUUGUUUUGUUUGGGGUGUGGGUGUUAUCAAGUGAAUUAGUCACUUGAAAGAUGGGCGUCAGACUUGCAUACGCAGCAGAUCAGCAUCCUUCGCUGCCCCUUAGCAACUUAGGUGGUUGAUUUGAAACUGUGAAGGUGUGAUUUUUUCAGGAGCUGGAAGUCUUAGAAAAGCCUUGUAAAUGCCUAUAUUGUGGGCUUUUAACGUAUUUAAGGGACCACUUAAGACGAGAUUAGAUGGGCUCUUCUGGAUUUGUUCCUCAUUUGUCACAGGUGUCUUGUGAUUGAAAAUCAUGAGCGAAGUGAAAUUGCAUUGAAUUUCAAGGGAAUUUAGUAUGUAAAUCGUGCCUUAGAAACACAUCUGUUGUCUUUUCUGUGUUUGGUCGAUAUUAAUAAUGGCAAAAUUUUUGCCUAUCUAGUAUCUUCAAAUUGUAGUCUUUGUAACAACCAAAUAACCUUUUGUGGUCACUGUAAAAUUAAUAUUUGGUAGACAGAAUCCAUGUACCUUUGCUAAGGUUAGAAUGAAUAAUUUAUUGUAUUUUUAAUUUGAAUGUUUGUGCUUUUUAAAUGAGCCAAGACUAGAGGGGAAACUAUCACCUAAAAUCAGUUUGGAAAACAAGACCUAAAAAGGGAAGGGGAUGGGGAUUGUGGGGAGAGAGUGGGCGAGGUGCCUUUACUACAUGUGUGAUCUGAAAACCCUGCUUGGUUCUGAGCUGCGUCUAUUGAAUUGGUAAAGUAAUACCAAUGGCUUUUUAUCAUUUCCUUCUUCCCUUUAAGUUUCACUUGAAAUUUUAAAAAUCAUGGUUAUUUUUAUCGUUGGGAUCUUUCUGUCUUCUGGGUUCCAUUUUUUAAAUGUUUAAAAAUAUGUUGACAUGGUAGUUCAGUUCUUAACCAAUGACUUGGGGAUGAUGCAAACAAUUACUGUCGUUGGGAUUUAGAGUGUAUUAGUCACGCAUGUAUGGGGAAGUAGUCUCGGGUAUGCUGUUGUGAAAUUGAAACUGUAAAAGUAGAUGGUUGAAAGUACUGGUAUGUUGCUCUGUAUGGUAAGAACUAAUUCUGUUACGUCAUGUACAUAAUUACUAAUCACUUUUCUUCCCCUUUACAGCACAAAUAAAGUUUGAGUUCUAAACUCAUUAGAAAAAAAAAAAAAAAAAAAAAAA,lncRNA,Homo sapiens,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=526aa|residues=1-526
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-,-,526aa(1-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[1-507],[508-512]","[17-104],[106-261],[371-425],[450-507]",In vitro,5 µM [FUS];|1200-2500 ng/µl Neat1 ,"75 mM KCl, 1 mM MgCl2","25 mM Tris/HCl buffer (pH 7.4), 1 mM TCEP",RT,-,-,Confocal Laser scanning microscopy,solute,"rRNA, tRNA, and a noncoding RNA that is known to bind to FUS (Neat1) were all able to solubilize FUS droplets, suggesting a general effect, but smaller RNAs were more potent than larger ones. The FUS droplets re-appear after RNase A induced RNA degradation.",3756
25,155,PMID: 29650702,RNAPS0000151,https://pubmed.ncbi.nlm.nih.gov/29650702,RNA + protein,NCBI ID:283131,https://www.ncbi.nlm.nih.gov/gene/283131,NEAT1,3756nt(1-3756),GGAGUUAGCGACAGGGAGGGAUGCGCGCCUGGGUGUAGUUGUGGGGGAGGAAGUGGCUAGCUCAGGGCUUCAGGGGACAGACAGGGAGAGAUGACUGAGUUAGAUGAGACGAGGGGGCGGGCUGGGGGUGCGAGAAGGAAGCUUGGCAAGGAGACUAGGUCUAGGGGGACCACAGUGGGGCAGGCUGCAUGGAAAAUAUCCGCAGGGUCCCCCAGGCAGAACAGCCACGCUCCAGGCCAGGCUGUCCCUACUGCCUGGUGGAGGGGGAACUUGACCUCUGGGAGGGCGCCGCUCUUGCAUAGCUGAGCGAGCCCGGGUGCGCUGGUCUGUGUGGAAGGAGGAAGGCAGGGAGAGGUAGAAGGGGUGGAGGAGUCAGGAGGAAUAGGCCGCAGCAGCCCUGGAAAUGAUCAGGAAGGCAGGCAGUGGGUGCAGGGCUGCAGGAGGGCCGGGAGGGCUAAUCUUCAACUUGUCCAUGCCAGCAGCCCCUUUUUUUCCAGACCAAGGGCUGUGAACCCGCCUGGGGAUGAGGCCUGGUCUUGUGGAACUGAACUUAGCUCGACGGGGCUGACCGCUCUGGCCCAGGGUGGUAUGUAAUUUUCGCUCGGCCUGGGACGGGGCCCAGGCCGGGCCCAGCCUGGUGGAGCGUCCAGGUCUGGGUGCGAAGCCAGGCCCCUGGGCGGAGGUGAGGGGUGGUCUGAGGAGUGAUGUGGAGUUAAGGCGCCAUCCUCACCGGUGACUGGUGCGGCACCUAGCAUGUUUGACAGGCGGGGACUGCGAGGCACGCUGCUCGGGUGUUGGGGACAACAUUGACCAACGCUUUAUUUUCCAGGUGGCAGUGCUCCUUUUGGACUUUUCUCUAGGUUUGGCGCUAAACUCUUCUUGUGAGCUCACUCCACCCCUUCUUCCUCCCUUUAACUUAUCCAUUCACUUAAAACAUUACCUGGUCAUCUGGUAAGCCCGGGACAGUAAGCCGAGUGGCUGUUGGAGUCGGUAUUGUUGGUAAUGGUGGAGGAAGAGAGGCCUUCCCGCUGAGGCUGGGGUGGGGCGGAUCGGUGUUGCUUGCCUGCAGAGAGGGUGGGGAGUGAAUGUGCACCCUUGGGUGGGCCUGCAGCCAUCCAGCUGAAAGUUACAAAAAUGCUUCAUGGACCGUGGUUUGUUACUAUAGUGUUCCUCAUGGCGAGCAGAUGGAACCGGGAGACAUGGAGUCCCUGGCCAGUGUGAGUCCUAGCAUUGCAGGAGGGGAGACCCUGGAGGAGAGAGCCCGCCUCAAUUGAUGCCUGCAGAUUGAAUUUCCAGAGGCUUAGGAGGAGGAAGUUCUCCAAUGUUCUGUUUCCAGGCCUUGCUCAGGAAGCCCUGUAUUCAGGAGGCUACCAUUUAAAGUUUGCAGAUGAGCUUAUGGGGGGCAAUCUUAAAAAGUCCACAGCAGAUGCAUCCGGCUCGAGGGGCCAUCAGCUUUGAAUAAAUGCUUGUUCCAGAGCCCAUGAAUGCCAGCAGGCACCCCUCCUUUCCUGGGGUAAAGGUUUUCAGAUGCUGCAUCUUCUAAAUUGAGCCUCCGGUCAUACUAGUUUUGUGCUUGGAACCUUGCUUCAAGAAGAUCCCUAAGCUGUAGAACAUUUUAACGUUGAUGCCACAACGCAGAUUGAUGCCUUGUAGAUGGAGCUUGCAGAUGGAGCCCCGUGACCUCUCACCUACCCACCUGUUUGCCUGCCUUCUUGUGCGUUUCUCGGAGAAGUUCUUAGCCUGAUGAAAUAACUUGGGGCGUUGAAGAGCUGUUUAAUUUUAAAUGCCUUAGACUGGGGAUAUAUUAGAGGAAGCAGAUUGUCAAAUUAAGGGUGUCAUUGUGUUGUGCUAAACGCUGGGAGGGUACAAGUUGGUCAUUCCUAAAUCUGUGUGUGAGAAAUGGCAGGUCUAGUUUGGGCAUUGUGAUUGCAUUGCAGAUUACUAGGAGAAGGGAAUGGUGGGUACACCGGUAGUGCUCUUUUGUUCUUGCUUCGUUUUUUUAAACUUGAACUUUACUUCGUUAGAUUUCAUAAUACUUUCUUGGCAUUCUAGUAAGAGGACCCUGAGGUGGGAGUUGUGGGGGACGGGGAGAAGGGGACAGCUUGGCACCGGUCCCGUGGGCGUUGCAGUGUGGGGGAUGGGGGUAUGCAGCUUGGCACUGGUACUGGGAGGGAUGAGGGUGAAGAAGGGGAGAGGGUUGGUUAGAGAUACAGUGUGGGUGGUGGGGGUGGUAGGAAAUGCAGGUUGAAGGGAAUUCUCUGGGGCUUUGGGGAAUUUAGUGCGUGGGUGAGCCAAGAAAAUACUAAUUAAUAAUAGUAAGUUGUUAGUGUUGGUUAAGUUGUUGCUUGGAAGUGAGAAGUUGCUUAGAAACUUUCCAAAGUGCUUAGAACUUUAAGUGCAAACAGACAAACUAACAAACAAAAAUUGUUUUGCUUUGCUACAAGGUGGGGAAGACUGAAGAAGUGUUAACUGAAAACAGGUGACACAGAGUCACCAGUUUUCCGAGAACCAAAGGGAGGGGUGUGUGAUGCCAUCUCACAGGCAGGGGAAAUGUCUUUACCAGCUUCCUCCUGGUGGCCAAGACAGCCUGUUUCAGAGGGUUGUUUUGUUUGGGGUGUGGGUGUUAUCAAGUGAAUUAGUCACUUGAAAGAUGGGCGUCAGACUUGCAUACGCAGCAGAUCAGCAUCCUUCGCUGCCCCUUAGCAACUUAGGUGGUUGAUUUGAAACUGUGAAGGUGUGAUUUUUUCAGGAGCUGGAAGUCUUAGAAAAGCCUUGUAAAUGCCUAUAUUGUGGGCUUUUAACGUAUUUAAGGGACCACUUAAGACGAGAUUAGAUGGGCUCUUCUGGAUUUGUUCCUCAUUUGUCACAGGUGUCUUGUGAUUGAAAAUCAUGAGCGAAGUGAAAUUGCAUUGAAUUUCAAGGGAAUUUAGUAUGUAAAUCGUGCCUUAGAAACACAUCUGUUGUCUUUUCUGUGUUUGGUCGAUAUUAAUAAUGGCAAAAUUUUUGCCUAUCUAGUAUCUUCAAAUUGUAGUCUUUGUAACAACCAAAUAACCUUUUGUGGUCACUGUAAAAUUAAUAUUUGGUAGACAGAAUCCAUGUACCUUUGCUAAGGUUAGAAUGAAUAAUUUAUUGUAUUUUUAAUUUGAAUGUUUGUGCUUUUUAAAUGAGCCAAGACUAGAGGGGAAACUAUCACCUAAAAUCAGUUUGGAAAACAAGACCUAAAAAGGGAAGGGGAUGGGGAUUGUGGGGAGAGAGUGGGCGAGGUGCCUUUACUACAUGUGUGAUCUGAAAACCCUGCUUGGUUCUGAGCUGCGUCUAUUGAAUUGGUAAAGUAAUACCAAUGGCUUUUUAUCAUUUCCUUCUUCCCUUUAAGUUUCACUUGAAAUUUUAAAAAUCAUGGUUAUUUUUAUCGUUGGGAUCUUUCUGUCUUCUGGGUUCCAUUUUUUAAAUGUUUAAAAAUAUGUUGACAUGGUAGUUCAGUUCUUAACCAAUGACUUGGGGAUGAUGCAAACAAUUACUGUCGUUGGGAUUUAGAGUGUAUUAGUCACGCAUGUAUGGGGAAGUAGUCUCGGGUAUGCUGUUGUGAAAUUGAAACUGUAAAAGUAGAUGGUUGAAAGUACUGGUAUGUUGCUCUGUAUGGUAAGAACUAAUUCUGUUACGUCAUGUACAUAAUUACUAAUCACUUUUCUUCCCCUUUACAGCACAAAUAAAGUUUGAGUUCUAAACUCAUUAGAAAAAAAAAAAAAAAAAAAAAAA,lncRNA,Homo sapiens,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=526aa|residues=1-526
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-,-,526aa(1-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[1-507],[508-512]","[17-104],[106-261],[371-425],[450-507]",In vitro,5 µM [FUS];|2500 ng/µl Neat1 ,"75 mM KCl, 1 mM MgCl2","25 mM Tris/HCl buffer (pH 7.4), 1 mM TCEP",RT,-,other_molecular:5 ng/µl RNase A,Confocal Laser scanning microscopy,liquid,"rRNA, tRNA, and a noncoding RNA that is known to bind to FUS (Neat1) were all able to solubilize FUS droplets, suggesting a general effect, but smaller RNAs were more potent than larger ones. The FUS droplets re-appear after RNase A induced RNA degradation.",3756
26,174,PMID: 29650703,RNAPS0000015,https://pubmed.ncbi.nlm.nih.gov/29650703,RNA + protein,NCBI ID:855450,https://www.ncbi.nlm.nih.gov/gene/855450,BNI1,5862nt(1-5862),AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA,mRNA,Saccharomyces cerevisiae,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,2 µM [Whi3];|2.5 nM BNI1,150 mM KCl,"50 mM Tris pH 8.0, 1 mM DTT",RT,> 30 min,-,Fluorescence microscopy,liquid,"CLN3 mRNA is not efficiently recruited, but BNI1 or SPA2 mRNA are recruited into preformed Whi3-BNI1 droplets based on fluorescence microscopy.",5862
27,175,PMID: 29650703,RNAPS0000028,https://pubmed.ncbi.nlm.nih.gov/29650703,RNA + protein,NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/1201,CLN3_scr,1879nt(1-1879),GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA,Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,8 µM [Whi3];|5 nM CLN3 scr,150 mM KCl,"50 mM Tris pH 8.0, 1 mM DTT",RT,-,-,Fluorescence microscopy,liquid,"An mRNA with scrambled CLN3 coding sequence (cln3 scr) with intact Whi3-binding sites formed Whi3 droplets, but no longer showed specificity. Fluorescence microscopy images showing the recruitment of cln3 scrambled mRNA into droplets with Whi3.",1879
28,176,PMID: 29650703,RNAPS0000055,https://pubmed.ncbi.nlm.nih.gov/29650703,RNAs + protein,NCBI ID:855450;|NCBI ID:850639,https://www.ncbi.nlm.nih.gov/gene/855450;|https://www.ncbi.nlm.nih.gov/gene/850639,BNI1;|SPA2,5862nt(1-5862);|4401nt(1-4401),AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA;|AUGGGUACGUCAAGCGAGGUUUCUCUCGCACAUCAUAGAGAUAUCUUCCAUUACUACGUCUCACUGAAGACUUUUUUCGAGGUGACUGGCGAAAAUCGUGACAGGUCAAAUUCGACACGAGCUCAAAAGGCCAGAGCCAAGCUGUUGAAGCUAUCUUCUUCGCAAUUUUACGAGCUGAGUACAGACGUGUCCGAUGAGCUGCAGAGGAGAAUCGGUGAAGAUGCUAACCAACCAGAUUACCUUUUGCCGAAGGCAAAUUUCCACAUGAAAAGGAACCAGGCUAGACAGAAACUGGCCAAUCUAUCACAAACUCGAUUUAAUGAUUUGUUGGACGAUAUCCUUUUUGAGAUCAAGAGAAGAGGGUUCGACAAGGAUUUGGAUGCUCCACGGCCCCCAUUACCGCAGCCGAUGAAACAAGAGGUCAGCAAAGACAGCGAUGAUACUGCAAGAACAUCCACAAAUUCUUCCUCUGUGACUCAAGUAGCUCCAAACGUCUCCGUACAACCUUCUUUGGUCAUUCCUAAGAUGGCAUCUAUCGAUUGGUCUUCUGAGGAAGAAGAAGAGGAGCAAGUAAAGGAGAAGCCAAAUGAACCGGAGGGAAAACAAACAAGCAUGGAUGAAAAGAAAGAGGCUAAACCUGCUCUAAACCCCAUAGUUACAGAUUCUGAUCUGCCUGACUCCCAAGUGCUCGCUCGUGAUAUCACAUCAAUGGCAAGGACUCCAACAACGACGCAUAAAAAUUACUGGGACGUUAAUGAUUCUCCAAUUAUCAAGGUAGAUAAAGAUAUCGAUAACGAAAAGGGUCCCGAACAGUUGAAGAGCCCUGAAGUACAACGGGCUGAGAACAAUAACCCUAACUCAGAGAUGGAAGACAAGGUUAAAGAACUGACUGAUUUAAACAGCGACUUACAUUUGCAAAUUGAAGAUUUGAAUGCUAAGUUAGCAUCUUUAACCAGCGAGAAGGAAAAGGAGAAGAAGGAAGAGAAGGAGGAAAAAGAAAAGGAAAAGAACUUAAAGAUUAACUACACCAUUGAUGAAAGUUUUCAGAAAGAAUUGCUGUCAUUAAACUCUCAAAUCGGUGAAUUAUCAAUUGAGAAUGAAAAUUUGAAGCAGAAAAUUUCAGAAUUCGAACUGCAUCAAAAAAAGAAUGACAACCAUAAUGAUUUGAAAAUCACUGACGGUUUUAUUAGCAAGUACUCUUCUGCCGAUGGGCUCAUUCCAGCUCAAUACAUCUUAAACGCUAACAACUUGAUAAUUCAAUUUACUACUAGGCUUUCCGCAGUACCCAUAGGCGACUCCACGGCAAUUUCCCAUCAAAUUGGCGAAGAGUUAUUUCAAAUAUUAUCCCAGUUAUCGAACCUAAUCUCCCAGCUAUUACUAUCGGCCGACCUAUUACAGUACAAAGAUCAGGUCAUUUUACUGAAGGCAUCAUUAUCGCAUGCGAUCACAUCGAUAAGAUAUUUCUCUGUUUACGGUCCCGUAUUAAUUCCGAAAAUAACUGUGCAAGCUGCUGUUUCAGAGGUUUGUUUUGCCAUGUGUAAUCUAAUUGAUUCAGCGAAAAUAAAAUCCGAUUCAAAUGGUGAGAGCACCACCUCUAAUGAAGGUAACCGACAGGUAUUAGAAUAUUCUUCACCAACUGCUACCACCCCAAUGACGCCAACUUUCCCCUCGACUUCUGGAAUAAAUAUGAAGAAGGGGUUUAUAAACCCAAGAAAACCAGCAUCUUUCUUGAAUGAUGUGGAGGAAGAAGAAUCUCCAGUCAAGCCAUUGAAAAUUACACAAAAGGCAAUUAACAGUCCGAUCAUAAGACCGUCAUCGUCUAAUGGAGUUCCAACAACCUCAAGAAAACCUUCAGGAACGGGGCUAUUUAGUUUAAUGAUUGAUUCAUCAAUUGCUAAGAAUAGCUCCCAUAAAGAGGAUAAUGAUAAAUAUGUCUCGCCCAUAAAGGCAGUAACAUCGGCCUCCAAUUCUGCAAGUAGCAAUAUUUCCGAAAUUCCUAAACUAACACUACCUCCACAAGCCAAAAUCGGUACUGUUAUUCCACCGUCAGAGAAUCAAGUUCCCAAUAUUAAAAUCGAGAAUACAGAAGAGGAUAAUAAAAGGAGUGACAUAACAAAUGAAAUCUCUGUUAAACCAACUUCUAGCAUUGCUGAUAAACUGAAACAAUUUGAGCAAAGUUCCGAAAAGAAAUCAUCACCAAAGGAAAAUCCUAUAGCAAAAGAAGAAAUGGAUUCAAAACCAAAACUAUCCAAUAAAUUUAUCACUUCAAUGAAUGAUGUGUCCACAGAUGAUUCAAGCUCUGAUGGUAACGAAAAUGACGAUGCAGACGAUGAUGAUGAUUUUACCUAUAUGGCAUUGAAACAAACAAUGAAGAGAGAAGGUUCAAAAAUUGAAAAAAAUAAUGACAGCAAACUACCUGCAAAUAUAGUGGAACUUGAUUUACAUGAGUCACCGGAGUCCGUGAAGAUUGAAUCUCCUGAAUCGAUAAAGGAAAUCACGUCAUCUGAAAUGUCUUCAGAAAUGCCAAGUAGUUCGCUGCCUAAGAGAUUAGUAGAGGAUGUUGAGCCUUCAGAAAUGCCAGAGAAGGGCGCAUCUGUAGAAUCAGUCAGGAAGAAAAAUUUUCAAGAACCACUUGGUAAUGUCGAAUCUCCGGAUAUGACGCAGAAGGUCAAGUCUUUGGGUAUGACAGGAAAGGCUGUAGGCCCAGAAUCAGAUAGUAGGGUCGAAUCUCCGGGCAUGACAGGACAGAUUAAAUCUUUGAAUAUGGCAGGAAAAGUUGUAGGCCCAGAAGCAGAUAGUAGGGUCGAAUCUCCGGGCAUGAAAGAGCAGAUUAAGUCUUUGGGUAUGACAGGAAAAAUUACAGCUCAAGAAUCAAUCAAGUCCCCGGAAGCGGCUAGGAAGUUGGCGUCAUCAGGAGAAGUUGACAAAAUUGAAUCUCCAAGAAUGGUAAGGGAAAGCGAGUCCUUGGAGGCAGUAGGCAAUACUAUCCCCUCAAACAUGACAGUGAAAAUGGAAUCCCCAAAUUUAAAGGGAAAUACUGUGUCUGAACCUCAAGAAAUAAGGAGAGACAUUGCCUCCUCAGAGCCGAUAGAGAAUGUUGACCCCCCAAAAGUACUAAAAAAGAUUGUCUUUCCAAAGGCUGUUAAUAGAACUGGAUCACCAAAAUCAGUCGAAAAGACUCCAUCUUCAGCUACACUGAAAAAGAGCGGGCUCCCAGAACCGAAUAGCCAAAUUGUUUCUCCUGAAUUGGCAAAAAAUUCACCUCUAGCACCGAUAAAGAAAAAUGUCGAGUUACGAGAAACUAAUAAACCACAUACUGAGACUAUCACUUCUGUGGAACCAACAAACAAGGAUGCCAAUACUUCUUGGAGAGACGCCGACUUAAACCGUACGAUCAAACGAGAGGAGGAGGACGAAGAUUUUGAUAGAGUGAACCACAAUAUCCAGAUCACUGGUGCAUAUACGAAAACUGGAAAAAUUGAUUAUCAUAAAAUACCUGUUGAUCGUAAAGCAAAAAGCGAAGCAGAAGUGCAUACUUCCGAGGAAGAUAUUGAUGAAUCAAAUAAUGUUAAUGGAAAAAGAGCUGAUGCCCAAAUACACAUCACUGAAAGAAAGCAUGCUUUCGUAAAUCCAACUGAAAAUUCACAGGUAAAAAAGACGAGCCACUCACCAUUUUUAAACAGUAAACCGGUUCAAUACGAGAACUCAGAGUCGAACGGCGGCAUUAACAACCACAUAAAGAUAAAAAAUACUGGAGAAACUACGGCACAUGACGAGAAACAUUAUAGUGAUGAUGAUGAUUCUAGCUAUCAAUUUGUUCCCAUGAAACAUGAAGAACAAGAACAAGAACAAAACAGAAGUGAGGAAGAGGAAAGUGAAGAUGACGAUGAAGAGGAAGAAGACAGUGAUUUUGAUGUGGAUACAUUUGACAUUGAAAAUCCGGAUAAUACACUAUCAGAGUUACUAUUGUAUUUAGAACAUCAAACAAUGGACGUCAUAUCCACGAUUCAAUCGCUUUUGACAUCGAUCAAGAAACCACAGGUGACGAAGGGUAAUUUGAGGGGAGAAUCGAAUGCAAUCAACCAAGUCAUAGGUCAAAUGGUGGACGCUACUAGCAUAUCAAUGGAGCAAAGCAGAAAUGCCAAUUUGAAGAAACACGGUGAUUGGGUGGUGCAAAGUCUAAGAGACUGUUCGCGUAGAAUGACAAUUUUGUGCCAAUUAACUGGCGAUGGAAUACUAGCGAAGGAAAAGAGCGAUCAAGAUUAUGCUGACAAAAACUUCAAACAGCGGUUGGCAGGGAUUGCGUUUGAUGUUGCCAAAUGUACAAAGGAGCUGGUAAAAACUGUAGAAGAGGCAAGUUUGAAGGACGAAAUAAAUUAUUUGAAUUCGAAGUUGAAGUAA,mRNA;|mRNA,Saccharomyces cerevisiae;|Saccharomyces cerevisiae,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,2 µM [Whi3];|1.25 nM BNI1;|1.25 nM SPA2,150 mM KCl,"50 mM Tris pH 8.0, 1 mM DTT",RT,> 30 min,-,Fluorescence microscopy,liquid,"Fluorescence microscopy images and quantification show SPA2 mRNA incubated with oligos to target the complement nucleotide regions of BNI1 (5 nM) is less recruited into preformed Whi3-BNI1 droplets (8 µM Whi3, 5 nM BNI1) compared to native SPA2 alone.",5862
29,177,PMID: 29650703,RNAPS0000055,https://pubmed.ncbi.nlm.nih.gov/29650703,RNAs + protein,NCBI ID:855450;|NCBI ID:850639,https://www.ncbi.nlm.nih.gov/gene/855450;|https://www.ncbi.nlm.nih.gov/gene/850639,BNI1;|SPA2,5862nt(1-5862);|4401nt(1-4401),AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA;|AUGGGUACGUCAAGCGAGGUUUCUCUCGCACAUCAUAGAGAUAUCUUCCAUUACUACGUCUCACUGAAGACUUUUUUCGAGGUGACUGGCGAAAAUCGUGACAGGUCAAAUUCGACACGAGCUCAAAAGGCCAGAGCCAAGCUGUUGAAGCUAUCUUCUUCGCAAUUUUACGAGCUGAGUACAGACGUGUCCGAUGAGCUGCAGAGGAGAAUCGGUGAAGAUGCUAACCAACCAGAUUACCUUUUGCCGAAGGCAAAUUUCCACAUGAAAAGGAACCAGGCUAGACAGAAACUGGCCAAUCUAUCACAAACUCGAUUUAAUGAUUUGUUGGACGAUAUCCUUUUUGAGAUCAAGAGAAGAGGGUUCGACAAGGAUUUGGAUGCUCCACGGCCCCCAUUACCGCAGCCGAUGAAACAAGAGGUCAGCAAAGACAGCGAUGAUACUGCAAGAACAUCCACAAAUUCUUCCUCUGUGACUCAAGUAGCUCCAAACGUCUCCGUACAACCUUCUUUGGUCAUUCCUAAGAUGGCAUCUAUCGAUUGGUCUUCUGAGGAAGAAGAAGAGGAGCAAGUAAAGGAGAAGCCAAAUGAACCGGAGGGAAAACAAACAAGCAUGGAUGAAAAGAAAGAGGCUAAACCUGCUCUAAACCCCAUAGUUACAGAUUCUGAUCUGCCUGACUCCCAAGUGCUCGCUCGUGAUAUCACAUCAAUGGCAAGGACUCCAACAACGACGCAUAAAAAUUACUGGGACGUUAAUGAUUCUCCAAUUAUCAAGGUAGAUAAAGAUAUCGAUAACGAAAAGGGUCCCGAACAGUUGAAGAGCCCUGAAGUACAACGGGCUGAGAACAAUAACCCUAACUCAGAGAUGGAAGACAAGGUUAAAGAACUGACUGAUUUAAACAGCGACUUACAUUUGCAAAUUGAAGAUUUGAAUGCUAAGUUAGCAUCUUUAACCAGCGAGAAGGAAAAGGAGAAGAAGGAAGAGAAGGAGGAAAAAGAAAAGGAAAAGAACUUAAAGAUUAACUACACCAUUGAUGAAAGUUUUCAGAAAGAAUUGCUGUCAUUAAACUCUCAAAUCGGUGAAUUAUCAAUUGAGAAUGAAAAUUUGAAGCAGAAAAUUUCAGAAUUCGAACUGCAUCAAAAAAAGAAUGACAACCAUAAUGAUUUGAAAAUCACUGACGGUUUUAUUAGCAAGUACUCUUCUGCCGAUGGGCUCAUUCCAGCUCAAUACAUCUUAAACGCUAACAACUUGAUAAUUCAAUUUACUACUAGGCUUUCCGCAGUACCCAUAGGCGACUCCACGGCAAUUUCCCAUCAAAUUGGCGAAGAGUUAUUUCAAAUAUUAUCCCAGUUAUCGAACCUAAUCUCCCAGCUAUUACUAUCGGCCGACCUAUUACAGUACAAAGAUCAGGUCAUUUUACUGAAGGCAUCAUUAUCGCAUGCGAUCACAUCGAUAAGAUAUUUCUCUGUUUACGGUCCCGUAUUAAUUCCGAAAAUAACUGUGCAAGCUGCUGUUUCAGAGGUUUGUUUUGCCAUGUGUAAUCUAAUUGAUUCAGCGAAAAUAAAAUCCGAUUCAAAUGGUGAGAGCACCACCUCUAAUGAAGGUAACCGACAGGUAUUAGAAUAUUCUUCACCAACUGCUACCACCCCAAUGACGCCAACUUUCCCCUCGACUUCUGGAAUAAAUAUGAAGAAGGGGUUUAUAAACCCAAGAAAACCAGCAUCUUUCUUGAAUGAUGUGGAGGAAGAAGAAUCUCCAGUCAAGCCAUUGAAAAUUACACAAAAGGCAAUUAACAGUCCGAUCAUAAGACCGUCAUCGUCUAAUGGAGUUCCAACAACCUCAAGAAAACCUUCAGGAACGGGGCUAUUUAGUUUAAUGAUUGAUUCAUCAAUUGCUAAGAAUAGCUCCCAUAAAGAGGAUAAUGAUAAAUAUGUCUCGCCCAUAAAGGCAGUAACAUCGGCCUCCAAUUCUGCAAGUAGCAAUAUUUCCGAAAUUCCUAAACUAACACUACCUCCACAAGCCAAAAUCGGUACUGUUAUUCCACCGUCAGAGAAUCAAGUUCCCAAUAUUAAAAUCGAGAAUACAGAAGAGGAUAAUAAAAGGAGUGACAUAACAAAUGAAAUCUCUGUUAAACCAACUUCUAGCAUUGCUGAUAAACUGAAACAAUUUGAGCAAAGUUCCGAAAAGAAAUCAUCACCAAAGGAAAAUCCUAUAGCAAAAGAAGAAAUGGAUUCAAAACCAAAACUAUCCAAUAAAUUUAUCACUUCAAUGAAUGAUGUGUCCACAGAUGAUUCAAGCUCUGAUGGUAACGAAAAUGACGAUGCAGACGAUGAUGAUGAUUUUACCUAUAUGGCAUUGAAACAAACAAUGAAGAGAGAAGGUUCAAAAAUUGAAAAAAAUAAUGACAGCAAACUACCUGCAAAUAUAGUGGAACUUGAUUUACAUGAGUCACCGGAGUCCGUGAAGAUUGAAUCUCCUGAAUCGAUAAAGGAAAUCACGUCAUCUGAAAUGUCUUCAGAAAUGCCAAGUAGUUCGCUGCCUAAGAGAUUAGUAGAGGAUGUUGAGCCUUCAGAAAUGCCAGAGAAGGGCGCAUCUGUAGAAUCAGUCAGGAAGAAAAAUUUUCAAGAACCACUUGGUAAUGUCGAAUCUCCGGAUAUGACGCAGAAGGUCAAGUCUUUGGGUAUGACAGGAAAGGCUGUAGGCCCAGAAUCAGAUAGUAGGGUCGAAUCUCCGGGCAUGACAGGACAGAUUAAAUCUUUGAAUAUGGCAGGAAAAGUUGUAGGCCCAGAAGCAGAUAGUAGGGUCGAAUCUCCGGGCAUGAAAGAGCAGAUUAAGUCUUUGGGUAUGACAGGAAAAAUUACAGCUCAAGAAUCAAUCAAGUCCCCGGAAGCGGCUAGGAAGUUGGCGUCAUCAGGAGAAGUUGACAAAAUUGAAUCUCCAAGAAUGGUAAGGGAAAGCGAGUCCUUGGAGGCAGUAGGCAAUACUAUCCCCUCAAACAUGACAGUGAAAAUGGAAUCCCCAAAUUUAAAGGGAAAUACUGUGUCUGAACCUCAAGAAAUAAGGAGAGACAUUGCCUCCUCAGAGCCGAUAGAGAAUGUUGACCCCCCAAAAGUACUAAAAAAGAUUGUCUUUCCAAAGGCUGUUAAUAGAACUGGAUCACCAAAAUCAGUCGAAAAGACUCCAUCUUCAGCUACACUGAAAAAGAGCGGGCUCCCAGAACCGAAUAGCCAAAUUGUUUCUCCUGAAUUGGCAAAAAAUUCACCUCUAGCACCGAUAAAGAAAAAUGUCGAGUUACGAGAAACUAAUAAACCACAUACUGAGACUAUCACUUCUGUGGAACCAACAAACAAGGAUGCCAAUACUUCUUGGAGAGACGCCGACUUAAACCGUACGAUCAAACGAGAGGAGGAGGACGAAGAUUUUGAUAGAGUGAACCACAAUAUCCAGAUCACUGGUGCAUAUACGAAAACUGGAAAAAUUGAUUAUCAUAAAAUACCUGUUGAUCGUAAAGCAAAAAGCGAAGCAGAAGUGCAUACUUCCGAGGAAGAUAUUGAUGAAUCAAAUAAUGUUAAUGGAAAAAGAGCUGAUGCCCAAAUACACAUCACUGAAAGAAAGCAUGCUUUCGUAAAUCCAACUGAAAAUUCACAGGUAAAAAAGACGAGCCACUCACCAUUUUUAAACAGUAAACCGGUUCAAUACGAGAACUCAGAGUCGAACGGCGGCAUUAACAACCACAUAAAGAUAAAAAAUACUGGAGAAACUACGGCACAUGACGAGAAACAUUAUAGUGAUGAUGAUGAUUCUAGCUAUCAAUUUGUUCCCAUGAAACAUGAAGAACAAGAACAAGAACAAAACAGAAGUGAGGAAGAGGAAAGUGAAGAUGACGAUGAAGAGGAAGAAGACAGUGAUUUUGAUGUGGAUACAUUUGACAUUGAAAAUCCGGAUAAUACACUAUCAGAGUUACUAUUGUAUUUAGAACAUCAAACAAUGGACGUCAUAUCCACGAUUCAAUCGCUUUUGACAUCGAUCAAGAAACCACAGGUGACGAAGGGUAAUUUGAGGGGAGAAUCGAAUGCAAUCAACCAAGUCAUAGGUCAAAUGGUGGACGCUACUAGCAUAUCAAUGGAGCAAAGCAGAAAUGCCAAUUUGAAGAAACACGGUGAUUGGGUGGUGCAAAGUCUAAGAGACUGUUCGCGUAGAAUGACAAUUUUGUGCCAAUUAACUGGCGAUGGAAUACUAGCGAAGGAAAAGAGCGAUCAAGAUUAUGCUGACAAAAACUUCAAACAGCGGUUGGCAGGGAUUGCGUUUGAUGUUGCCAAAUGUACAAAGGAGCUGGUAAAAACUGUAGAAGAGGCAAGUUUGAAGGACGAAAUAAAUUAUUUGAAUUCGAAGUUGAAGUAA,mRNA;|mRNA,Saccharomyces cerevisiae;|Saccharomyces cerevisiae,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,20 µM [Whi3];|5 nM BNI1;|5 nM SPA2,150 mM KCl,"50 mM Tris pH 8.0, 1 mM DTT",RT,-,-,Fluorescence microscopy,liquid,"Fluorescence microscopy images and quantification show SPA2 mRNA incubated with oligos to target the complement nucleotide regions of BNI1 (5 nM) is less recruited into preformed Whi3-BNI1 droplets (8 µM Whi3, 5 nM BNI1) compared to native SPA2 alone.",5862
30,178,PMID: 29650703,RNAPS0000056,https://pubmed.ncbi.nlm.nih.gov/29650703,RNAs + protein,NCBI ID:855450;|NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/855450;|https://www.ncbi.nlm.nih.gov/gene/1201,BNI1;|CLN3_refold,5862nt(1-5862);|1879nt(1-1879),AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA;|GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA;|mRNA,Saccharomyces cerevisiae;|Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,8 µM [Whi3];|5 nM BNI1;|5 nM CLN3 refold,150 mM KCl,"50 mM Tris pH 8.0, 1 mM DTT",RT,-,-,Fluorescence microscopy,liquid,"Melted CLN3 mRNA that was slowly refolded (CLN3 refold) showed significantly less recruitment than melted, but more than native CLN3 (Fig. 3A and C). Mixing between melted CLN3 and melted BNI1 occurred in the presence of Whi3 and in RNA-only reactions, suggesting mixing is initiated by RNA-RNA interactions.",5862
31,179,PMID: 29650703,RNAPS0000057,https://pubmed.ncbi.nlm.nih.gov/29650703,RNAs + protein,NCBI ID:855450;|NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/855450;|https://www.ncbi.nlm.nih.gov/gene/1201,BNI1;|CLN3_scr,5862nt(1-5862);|1879nt(1-1879),AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA;|GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA;|mRNA,Saccharomyces cerevisiae;|Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,8 µM [Whi3];|5 nM BNI1;|5 nM CLN3 scr,150 mM KCl,"50 mM Tris pH 8.0, 1 mM DTT",RT,-,-,Fluorescence microscopy,liquid,"CLN3 mRNA heated to 95°C to disrupt secondary structure also readily incorporated into Whi3-BNI1 droplets (Fig. 3, A and C). Melted CLN3 mRNA that was slowly refolded (CLN3 refold) showed significantly less recruitment than melted, but more than native CLN3.",5862
32,180,PMID: 29650703,RNAPS0000059,https://pubmed.ncbi.nlm.nih.gov/29650703,RNAs + protein,NCBI ID:855450;|NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/855450;|https://www.ncbi.nlm.nih.gov/gene/1201,BNI1;|CLN3_ml,5862nt(1-5862);|1879nt(1-1879),AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA;|GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA;|mRNA,Saccharomyces cerevisiae;|Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,8 µM [Whi3];|5 nM BNI1;|5 nM CLN3 ml,150 mM KCl,"50 mM Tris pH 8.0, 1 mM DTT",RT,-,-,Fluorescence microscopy,liquid,We next investigated which features of the mRNA sequence generate specificity. An mRNA with scrambled CLN3 coding sequence (cln3 scr) with intact Whi3-binding sites formed Whi3 droplets.,5862
33,181,PMID: 29650703,RNAPS0000060,https://pubmed.ncbi.nlm.nih.gov/29650703,RNAs + protein,NCBI ID:855450;|NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/855450;|https://www.ncbi.nlm.nih.gov/gene/1201,BNI1;|CLN3_sm,5862nt(1-5862);|1879nt(1-1879),AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA;|GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA;|mRNA,Saccharomyces cerevisiae;|Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,8 µM [Whi3];|5 nM BNI1;|5 nM CLN3 sm,150 mM KCl,"50 mM Tris pH 8.0, 1 mM DTT",RT,-,-,Fluorescence microscopy,liquid,"Additionally, cln3sm, a mutant perturbing structure and exposing complementarity, co-localized with BNI1 transcripts in vitro and at polarity sites in cells (Fig. 3F, S5, >60% tips co-localized). Thus, secondary structure can regulate RNA sorting into distinct droplets through altering the capacity to form intermolecular interactions.",5862
34,182,PMID: 29650703,RNAPS0000061,https://pubmed.ncbi.nlm.nih.gov/29650703,RNAs + protein,NCBI ID:855450;|NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/855450;|https://www.ncbi.nlm.nih.gov/gene/1201,BNI1;|CLN3,5862nt(1-5862);|1879nt(1-1879),AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA;|GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA;|mRNA,Saccharomyces cerevisiae;|Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,2 µM [Whi3];|1.25 nM BNI1;|1.25 nM CLN3,150 mM KCl,"50 mM Tris pH 8.0, 1 mM DTT",RT,> 30 min,-,Fluorescence microscopy,liquid,Fluorescence microscopy images showing CLN3 is excluded from Whi3-BNI1 droplets in a variety of protein and RNA concentrations.,5862
35,183,PMID: 29650703,RNAPS0000061,https://pubmed.ncbi.nlm.nih.gov/29650703,RNAs + protein,NCBI ID:855450;|NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/855450;|https://www.ncbi.nlm.nih.gov/gene/1201,BNI1;|CLN3,5862nt(1-5862);|1879nt(1-1879),AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA;|GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA;|mRNA,Saccharomyces cerevisiae;|Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,20 µM [Whi3];|5 nM BNI1;|5 nM CLN3,150 mM KCl,"50 mM Tris pH 8.0, 1 mM DTT",RT,> 30 min,-,Fluorescence microscopy,liquid,Fluorescence microscopy images showing CLN3 is excluded from Whi3-BNI1 droplets in a variety of protein and RNA concentrations.,5862
36,184,PMID: 29650703,RNAPS0000063,https://pubmed.ncbi.nlm.nih.gov/29650703,RNAs + protein,NCBI ID:850639;|NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/850639;|https://www.ncbi.nlm.nih.gov/gene/1201,SPA2;|CLN3,4401nt(1-4401);|1879nt(1-1879),AUGGGUACGUCAAGCGAGGUUUCUCUCGCACAUCAUAGAGAUAUCUUCCAUUACUACGUCUCACUGAAGACUUUUUUCGAGGUGACUGGCGAAAAUCGUGACAGGUCAAAUUCGACACGAGCUCAAAAGGCCAGAGCCAAGCUGUUGAAGCUAUCUUCUUCGCAAUUUUACGAGCUGAGUACAGACGUGUCCGAUGAGCUGCAGAGGAGAAUCGGUGAAGAUGCUAACCAACCAGAUUACCUUUUGCCGAAGGCAAAUUUCCACAUGAAAAGGAACCAGGCUAGACAGAAACUGGCCAAUCUAUCACAAACUCGAUUUAAUGAUUUGUUGGACGAUAUCCUUUUUGAGAUCAAGAGAAGAGGGUUCGACAAGGAUUUGGAUGCUCCACGGCCCCCAUUACCGCAGCCGAUGAAACAAGAGGUCAGCAAAGACAGCGAUGAUACUGCAAGAACAUCCACAAAUUCUUCCUCUGUGACUCAAGUAGCUCCAAACGUCUCCGUACAACCUUCUUUGGUCAUUCCUAAGAUGGCAUCUAUCGAUUGGUCUUCUGAGGAAGAAGAAGAGGAGCAAGUAAAGGAGAAGCCAAAUGAACCGGAGGGAAAACAAACAAGCAUGGAUGAAAAGAAAGAGGCUAAACCUGCUCUAAACCCCAUAGUUACAGAUUCUGAUCUGCCUGACUCCCAAGUGCUCGCUCGUGAUAUCACAUCAAUGGCAAGGACUCCAACAACGACGCAUAAAAAUUACUGGGACGUUAAUGAUUCUCCAAUUAUCAAGGUAGAUAAAGAUAUCGAUAACGAAAAGGGUCCCGAACAGUUGAAGAGCCCUGAAGUACAACGGGCUGAGAACAAUAACCCUAACUCAGAGAUGGAAGACAAGGUUAAAGAACUGACUGAUUUAAACAGCGACUUACAUUUGCAAAUUGAAGAUUUGAAUGCUAAGUUAGCAUCUUUAACCAGCGAGAAGGAAAAGGAGAAGAAGGAAGAGAAGGAGGAAAAAGAAAAGGAAAAGAACUUAAAGAUUAACUACACCAUUGAUGAAAGUUUUCAGAAAGAAUUGCUGUCAUUAAACUCUCAAAUCGGUGAAUUAUCAAUUGAGAAUGAAAAUUUGAAGCAGAAAAUUUCAGAAUUCGAACUGCAUCAAAAAAAGAAUGACAACCAUAAUGAUUUGAAAAUCACUGACGGUUUUAUUAGCAAGUACUCUUCUGCCGAUGGGCUCAUUCCAGCUCAAUACAUCUUAAACGCUAACAACUUGAUAAUUCAAUUUACUACUAGGCUUUCCGCAGUACCCAUAGGCGACUCCACGGCAAUUUCCCAUCAAAUUGGCGAAGAGUUAUUUCAAAUAUUAUCCCAGUUAUCGAACCUAAUCUCCCAGCUAUUACUAUCGGCCGACCUAUUACAGUACAAAGAUCAGGUCAUUUUACUGAAGGCAUCAUUAUCGCAUGCGAUCACAUCGAUAAGAUAUUUCUCUGUUUACGGUCCCGUAUUAAUUCCGAAAAUAACUGUGCAAGCUGCUGUUUCAGAGGUUUGUUUUGCCAUGUGUAAUCUAAUUGAUUCAGCGAAAAUAAAAUCCGAUUCAAAUGGUGAGAGCACCACCUCUAAUGAAGGUAACCGACAGGUAUUAGAAUAUUCUUCACCAACUGCUACCACCCCAAUGACGCCAACUUUCCCCUCGACUUCUGGAAUAAAUAUGAAGAAGGGGUUUAUAAACCCAAGAAAACCAGCAUCUUUCUUGAAUGAUGUGGAGGAAGAAGAAUCUCCAGUCAAGCCAUUGAAAAUUACACAAAAGGCAAUUAACAGUCCGAUCAUAAGACCGUCAUCGUCUAAUGGAGUUCCAACAACCUCAAGAAAACCUUCAGGAACGGGGCUAUUUAGUUUAAUGAUUGAUUCAUCAAUUGCUAAGAAUAGCUCCCAUAAAGAGGAUAAUGAUAAAUAUGUCUCGCCCAUAAAGGCAGUAACAUCGGCCUCCAAUUCUGCAAGUAGCAAUAUUUCCGAAAUUCCUAAACUAACACUACCUCCACAAGCCAAAAUCGGUACUGUUAUUCCACCGUCAGAGAAUCAAGUUCCCAAUAUUAAAAUCGAGAAUACAGAAGAGGAUAAUAAAAGGAGUGACAUAACAAAUGAAAUCUCUGUUAAACCAACUUCUAGCAUUGCUGAUAAACUGAAACAAUUUGAGCAAAGUUCCGAAAAGAAAUCAUCACCAAAGGAAAAUCCUAUAGCAAAAGAAGAAAUGGAUUCAAAACCAAAACUAUCCAAUAAAUUUAUCACUUCAAUGAAUGAUGUGUCCACAGAUGAUUCAAGCUCUGAUGGUAACGAAAAUGACGAUGCAGACGAUGAUGAUGAUUUUACCUAUAUGGCAUUGAAACAAACAAUGAAGAGAGAAGGUUCAAAAAUUGAAAAAAAUAAUGACAGCAAACUACCUGCAAAUAUAGUGGAACUUGAUUUACAUGAGUCACCGGAGUCCGUGAAGAUUGAAUCUCCUGAAUCGAUAAAGGAAAUCACGUCAUCUGAAAUGUCUUCAGAAAUGCCAAGUAGUUCGCUGCCUAAGAGAUUAGUAGAGGAUGUUGAGCCUUCAGAAAUGCCAGAGAAGGGCGCAUCUGUAGAAUCAGUCAGGAAGAAAAAUUUUCAAGAACCACUUGGUAAUGUCGAAUCUCCGGAUAUGACGCAGAAGGUCAAGUCUUUGGGUAUGACAGGAAAGGCUGUAGGCCCAGAAUCAGAUAGUAGGGUCGAAUCUCCGGGCAUGACAGGACAGAUUAAAUCUUUGAAUAUGGCAGGAAAAGUUGUAGGCCCAGAAGCAGAUAGUAGGGUCGAAUCUCCGGGCAUGAAAGAGCAGAUUAAGUCUUUGGGUAUGACAGGAAAAAUUACAGCUCAAGAAUCAAUCAAGUCCCCGGAAGCGGCUAGGAAGUUGGCGUCAUCAGGAGAAGUUGACAAAAUUGAAUCUCCAAGAAUGGUAAGGGAAAGCGAGUCCUUGGAGGCAGUAGGCAAUACUAUCCCCUCAAACAUGACAGUGAAAAUGGAAUCCCCAAAUUUAAAGGGAAAUACUGUGUCUGAACCUCAAGAAAUAAGGAGAGACAUUGCCUCCUCAGAGCCGAUAGAGAAUGUUGACCCCCCAAAAGUACUAAAAAAGAUUGUCUUUCCAAAGGCUGUUAAUAGAACUGGAUCACCAAAAUCAGUCGAAAAGACUCCAUCUUCAGCUACACUGAAAAAGAGCGGGCUCCCAGAACCGAAUAGCCAAAUUGUUUCUCCUGAAUUGGCAAAAAAUUCACCUCUAGCACCGAUAAAGAAAAAUGUCGAGUUACGAGAAACUAAUAAACCACAUACUGAGACUAUCACUUCUGUGGAACCAACAAACAAGGAUGCCAAUACUUCUUGGAGAGACGCCGACUUAAACCGUACGAUCAAACGAGAGGAGGAGGACGAAGAUUUUGAUAGAGUGAACCACAAUAUCCAGAUCACUGGUGCAUAUACGAAAACUGGAAAAAUUGAUUAUCAUAAAAUACCUGUUGAUCGUAAAGCAAAAAGCGAAGCAGAAGUGCAUACUUCCGAGGAAGAUAUUGAUGAAUCAAAUAAUGUUAAUGGAAAAAGAGCUGAUGCCCAAAUACACAUCACUGAAAGAAAGCAUGCUUUCGUAAAUCCAACUGAAAAUUCACAGGUAAAAAAGACGAGCCACUCACCAUUUUUAAACAGUAAACCGGUUCAAUACGAGAACUCAGAGUCGAACGGCGGCAUUAACAACCACAUAAAGAUAAAAAAUACUGGAGAAACUACGGCACAUGACGAGAAACAUUAUAGUGAUGAUGAUGAUUCUAGCUAUCAAUUUGUUCCCAUGAAACAUGAAGAACAAGAACAAGAACAAAACAGAAGUGAGGAAGAGGAAAGUGAAGAUGACGAUGAAGAGGAAGAAGACAGUGAUUUUGAUGUGGAUACAUUUGACAUUGAAAAUCCGGAUAAUACACUAUCAGAGUUACUAUUGUAUUUAGAACAUCAAACAAUGGACGUCAUAUCCACGAUUCAAUCGCUUUUGACAUCGAUCAAGAAACCACAGGUGACGAAGGGUAAUUUGAGGGGAGAAUCGAAUGCAAUCAACCAAGUCAUAGGUCAAAUGGUGGACGCUACUAGCAUAUCAAUGGAGCAAAGCAGAAAUGCCAAUUUGAAGAAACACGGUGAUUGGGUGGUGCAAAGUCUAAGAGACUGUUCGCGUAGAAUGACAAUUUUGUGCCAAUUAACUGGCGAUGGAAUACUAGCGAAGGAAAAGAGCGAUCAAGAUUAUGCUGACAAAAACUUCAAACAGCGGUUGGCAGGGAUUGCGUUUGAUGUUGCCAAAUGUACAAAGGAGCUGGUAAAAACUGUAGAAGAGGCAAGUUUGAAGGACGAAAUAAAUUAUUUGAAUUCGAAGUUGAAGUAA;|GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA;|mRNA,Saccharomyces cerevisiae;|Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,8 µM [Whi3];|5 nM SPA2;|5 nM CLN3,150 mM KCl,"50 mM Tris pH 8.0, 1 mM DTT",RT,> 30 min,-,Fluorescence microscopy,liquid,Fluorescence microscopy images show cy3 labeled cln3 mRNA is not efficiently recruited into whi3-spa2 droplets.,4401
37,185,PMID: 29650703,RNAPS0000064,https://pubmed.ncbi.nlm.nih.gov/29650703,RNAs + protein,NCBI ID:855450;|NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/855450;|https://www.ncbi.nlm.nih.gov/gene/1201,BNI1_ml;|CLN3,5862nt(1-5862);|1879nt(1-1879),AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA;|GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA;|mRNA,Saccharomyces cerevisiae;|Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,8 µM [Whi3];|5 nM BNI1 ml;|5 nM CLN3,150 mM KCl,"50 mM Tris pH 8.0, 1 mM DTT",RT,-,-,Fluorescence microscopy,liquid,"Fluorescence microscopy images and recruitment coefficients show CLN3 mRNA (5 nM) is modestly recruited into preformed Whi3 droplets made with melted BNI1 (8 µM Whi3, 5 nM BNI1) unless complement regions of CLN3 are also exposed through melting (CLN3ml).In contrast, recruitment of CLN3 ml is lost when the mRNA is mixed with oligos targeting the sequence on CLN3 with complementarity to BNI1 mRNA (CLN3 ml + oligos). Outliers are indicated with (•) marks.",5862
38,186,PMID: 29650703,RNAPS0000065,https://pubmed.ncbi.nlm.nih.gov/29650703,RNAs + protein,NCBI ID:855450;|NCBI ID:1201,https://www.ncbi.nlm.nih.gov/gene/855450;|https://www.ncbi.nlm.nih.gov/gene/1201,BNI1_ml;|CLN3_ml,5862nt(1-5862);|1879nt(1-1879),AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA;|GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA,mRNA;|mRNA,Saccharomyces cerevisiae;|Homo sapiens,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,8 µM [Whi3];|5 nM BNI1 ml;|5 nM CLN3 ml,150 mM KCl,"50 mM Tris pH 8.0, 1 mM DTT",RT,-,-,Fluorescence microscopy,liquid,"Fluorescence microscopy images and recruitment coefficients show CLN3 mRNA (5 nM) is modestly recruited into preformed Whi3 droplets made with melted BNI1 (8 µM Whi3, 5 nM BNI1) unless complement regions of CLN3 are also exposed through melting (CLN3ml).In contrast, recruitment of CLN3 ml is lost when the mRNA is mixed with oligos targeting the sequence on CLN3 with complementarity to BNI1 mRNA (CLN3 ml + oligos). Outliers are indicated with (•) marks.",5862
39,187,PMID: 29650703,RNAPS0000066,https://pubmed.ncbi.nlm.nih.gov/29650703,RNAs + protein,NCBI ID:855450;|NCBI ID:1201;|-,https://www.ncbi.nlm.nih.gov/gene/855450;|https://www.ncbi.nlm.nih.gov/gene/1201;|-,BNI1;|CLN3_ml;|Oligos_Blend,5862nt(1-5862);|1879nt(1-1879);|-,AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA;|GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA;|-,mRNA;|mRNA;|-,Saccharomyces cerevisiae;|Homo sapiens;|-,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,8 µM [Whi3];|5 nM BNI1;|5 nM CLN3;|100 nM Oligos,150 mM KCl,"50 mM Tris pH 8.0, 1 mM DTT",RT,-,-,Fluorescence microscopy,liquid,"Oligonucleotides (i.e., oligos) complementary to these regions were added to melted CLN3 and significantly decreased the coassembly with BNI1, restoring the formation of distinct CLN3 droplets.",5862
40,188,PMID: 29650703,RNAPS0000069,https://pubmed.ncbi.nlm.nih.gov/29650703,RNAs + protein,NCBI ID:855450;|NCBI ID:1201;|-,https://www.ncbi.nlm.nih.gov/gene/855450;|https://www.ncbi.nlm.nih.gov/gene/1201;|-,BNI1;|CLN3;|Oligos_Blend,5862nt(1-5862);|1879nt(1-1879);|-,AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA;|GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA;|-,mRNA;|mRNA;|-,Saccharomyces cerevisiae;|Homo sapiens;|-,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,20 µM [Whi3];|5 nM BNI1;|5 nM SPA2;|100 nM Oligos,150 mM KCl,"50 mM Tris pH 8.0, 1 mM DTT",RT,-,-,Fluorescence microscopy,liquid,"Fluorescence microscopy images and quantification show SPA2 mRNA incubated with oligos to target the complement nucleotide regions of BNI1 (5 nM) is less recruited into preformed Whi3-BNI1 droplets (8 µM Whi3, 5 nM BNI1) compared to native SPA2 alone.",5862
41,189,PMID: 29650703,RNAPS0000070,https://pubmed.ncbi.nlm.nih.gov/29650703,RNAs + protein,NCBI ID:855450;|NCBI ID:1201;|-,https://www.ncbi.nlm.nih.gov/gene/855450;|https://www.ncbi.nlm.nih.gov/gene/1201;|-,BNI1;|CLN3;|Oligos,5862nt(1-5862);|1879nt(1-1879);|-,AUGUUGAAGAAUUCAGGCUCCAAACAUUCGAACUCAAAGGAAAGUCAUUCGAAUUCGAGUUCUGGUAUAUUCCAAAAUUUGAAGCGUUUGGCUAACUCAAAUGCAACGAAUAGCAAUACGGGUUCUCCGACCUAUGCAUCCCAACAACAGCACUCUCCAGUGGGAAACGAAGUGUCCACUUCACCUGCAUCUUCGUCAUCUUUUAGAAAACUGAAUGCACCUUCUAGGUCUACAUCUACUGAGGCGAGGCCGUUGAAUAAAAAAUCGACAUUAAACACACAAAACUUGUCUCAAUAUAUGAAUGGUAAAUUAAGUGGAGAUGUUCCCGUAUCCUCACAGCACGCAAGGUCGCAUUCAAUGCAAUCGAAAUAUUCGUAUUCCAAGAGGAAUUCUUCACAGGCGUCCAAUAAGCUAACAAGGCAGCAUACCGGGCAAAGUCACUCCGCAUCAAGUCUUCUCUCUCAAGGUUCGCUAACUAACUUGAGCAAAUUCACUACACCCGAUGGUAAAAUUUAUUUAGAAAUGCCGUCGGACCCAUACGAGGUGGAAGUUUUGUUUGAAGAUAUUAUGUAUAAAAGAAAUAUUUUUCAGUCUUUAUCAGAGGACAAACAAGAAGCUCUGAUGGGCUACAGCAUUGAGAAGAAAUGGCUGAUUGUUAAGCAGGAUUUACAAAAUGAGCUAAAAAAAAUGCGAGCAAACACUACAUCUUCUUCCACUGCCUCCAGAACUUCGAUGGCGUCGGACCAUCAUCCUAUCCUUACGGCUAAUUCAUCUCUUUCGUCUCCCAAAUCUGUUUUGAUGACAAGCGCCUCUUCUCCCACCUCAACUGUAUACAGCAACAGUUUAAAUCAUUCUACUACUCUUUCAUCGGUAGGUACGUCAACCUCGAAGGGGAAAAAAUUAGUGAGCGGGAGUUUGAAAAAGCAGCCAUCUCUAAACAAUAUUUAUAGAGGUGGGGCUGAGAACAAUACGAGUGCAUCUACUCUUCCAGGAGACAGAACAAACAGACCACCGAUACAUUAUGUGCAACGAAUCCUGGCAGACAAACUUACUAGCGAUGAGAUGAAAGAUUUAUGGGUAACUUUAAGAACUGAACAGUUAGACUGGGUAGACGCUUUUAUAGACCAUCAGGGUCACAUUGCUAUGGCUAAUGUACUAAUGAACUCUAUUUAUAAGACUGCACCCCGAGAAAACUUGACUAAAGAAUUAUUAGAGAAAGAAAAUUCAUUUUUUAAAUGCUUCAGAGUCUUAUCAAUGCUCUCACAAGGUUUGUAUGAGUUCAGUACACAUAGGUUAAUGACUGAUACUGUUGCAGAAGGUUUAUUCUCUACGAAACUGGCCACAAGGAAAAUGGCCACUGAAAUUUUUGUUUGUAUGCUAGAAAAAAAAAAUAAAAGCAGAUUCGAAGCAGUUCUUACCUCACUAGAUAAAAAGUUUAGGAUAGGGCAAAAUCUUCAUAUGAUUCAAAACUUCAAAAAAAUGCCCCAGUAUUUCUCUCAUUUAACCUUGGAAAGUCAUUUGAAAAUUAUUCAAGCCUGGUUAUUUGCCGUUGAACAAACUUUAGAUGGAAGAGGAAAAAUGGGUUCCUUAGUAGGCGCGUCGGAUGAAUUUAAAAAUGGUGGGGGUGAAAAUGCGAUUCUAGAAUACUGCCAAUGGACAAUGGUUUUUAUCAAUCAUUUAUGCUCUUGCUCUGAUAACAUAAAUCAAAGAAUGCUAUUAAGGACGAAACUAGAAAAUUGUGGAAUUUUACGAAUUAUGAACAAAAUAAAACUGCUAGAUUACGACAAGGUAAUUGACCAAAUUGAGUUAUAUGACAAUAAUAAACUUGACGAUUUUAACGUUAAAUUAGAGGCCAACAAUAAGGCUUUUAAUGUAGAUUUACACGAUCCACUAUCAUUAUUAAAAAACCUUUGGGAUAUAUGUAAAGGUACCGAGAAUGAAAAGCUUUUAGUAUCUUUAGUUCAACAUCUUUUCCUUUCUAGUUCAAAGUUAAUAGAAGAAAACCAAAAUUCCUCUAAACUUACUAAGCAAUUGAAACUUAUGGAUUCUUUGGUGACUAAUGUUAGUGUUGCCUCAACUUCUGAUGAAGAAACUAAUAUGAAUAUGGCUAUCCAGCGGCUUUACGAUGCCAUGCAGACUGAUGAAGUUGCACGUCGAGCUAUAUUAGAAAGUAGAGCUCUAACGAAGAAAUUGGAAGAAAUUCAGGCAGAAAGGGAUUCUUUAAGUGAAAAGUUAAGCAAGGCGGAGCACGGACUCGUUGGACAGUUAGAAGAUGAGUUGCAUGAGAGAGAUCGUAUUUUAGCUAAGAAUCAGAGAGUUAUGCAGCAGCUGGAAGCUGAGUUAGAAGAGUUGAAAAAGAAGCAUCUUUUGGAAAAGCAUCAGCAAGAGGUAGAAUUGAGAAAAAUGUUGACUAUAUUGAAUUCGAGGCCUGAAGAAAGCUUCAAUAAGAAUGAAGGCACCAGAGGUAUGAACUCGAGCCUAAAUUCUUCAGAGAAAGCGAAUAUCCAAAAGGUGUUACAGGACGGAUUAUCAAGAGCAAAAAAGGAUUACAAGGAUGAUUCAAAAAAAUUCGGCAUGACACUUCAACCUAAUAAGAGAUUAAAAAUGUUAAGAAUGCAAAUGGAAAAUAUUGAAAAUGAAGCCAGGCAACUAGAGAUGACAAAUUUUGCUGAAUUUGAGAAAGAUCGUCUUGAACCUCCAAUACAUAUUAAGAAGCCCAAAGUGAAGAAGAUGAAAAAUAAGGAUAGGAAACCUUUAGUCAAGCCUCAAGAGGCGGACGUAAAUAAACUAAAUGACCUAAGGCGGGCUUUGGCUGAAAUCCAAAUGGAAAGUAAUGAUAUUUCCAAAUUUAACGUCGAAGAACGUGUUAAUGAGCUAUUUAAUGAAAAGAAAUCUCUGGCUUUAAAGAGACUGAAAGAACUAGAAACAAAAUACAAAGGAUUUGGUAUUGACUUUAAUGUCGACGAGAUUAUGGACAGUCCAAAGAAAAAUACUGGGGACGUGGAAACGGAAGAAGACGCUAACUAUGCCAGUCUUGACCCUAAGACAUAUCAGAAAAAGUUAGACGAGAUUAAUAGAAUAACGGACCAGUUGUUAGAUAUUCAGACUCAAACCGAACACGAAAUACAAGUAGAAGAAGAUGGGGAAAGCGAUCUUUCCUCUUCAAGUUCUGAUGAUGAAAGUGAGGAAAUAUACCAAGACGCAUCUCCAACUCAAGAACUAAGGAGCGAACACUCAGAGCUAUCUUCAGGAUCAGGUCCUGGGUCUUUUCUCGAUGCCUUAUCUCAAAAAUAUGGUACUGGUCAAAAUGUUACUGCAUCGGCUGCUUUUGGAGAGAACAAUAACGGUUCGGGUAUUGGACCUCUACAUAGUAAAGUUGAAAAGACCUUUAUGAACAGACUCAGAAAAUCCACCGUGUCUUCUGCUCCAUAUUUAGAGGAGUUAACACAGAAGGUAAAUAAAGUUGAACCAUAUGAACAAAAUGAAGAUGAAGGUCUAGAUAAAAAAUCUUUACCGGAAAACAGCACGGCAAGUGCAGCUUCCGCCUUUGACAAAGCUGAGAAAGACAUGAGACAACAUGUGGAAAACGGAAAGCAAGGGCGUGUGGUAAAUCAUGAAGAAGAUAAAACAGCGGAUUUCAGCGCUGUGAGUAAACUGAAUAAUACAGAUGGCGCAGAAGAUCUCUCUACUCAAUCAUCUGUACUCUCCUCACAGCCGCCACCGCCUCCUCCUCCUCCUCCUCCAGUUCCCGCCAAAUUGUUCGGUGAAUCGUUGGAGAAAGAGAAAAAGUCGGAAGACGACACUGUCAAGCAAGAAACUACUGGGGAUUCUCCUGCUCCUCCCCCUCCACCACCACCACCUCCUCCUCCACCCAUGGCAUUGUUCGGCAAACCCAAGGGAGAAACACCACCACCGCCGCCGCUACCAUCUGUAUUAUCUUCAUCUACUGAUGGCGUCAUUCCGCCAGCUCCACCUAUGAUGCCGGCAUCGCAAAUCAAAUCAGCUGUAACAUCACCAUUACUUCCUCAAUCGCCCUCAUUAUUUGAAAAGUAUCCUCGUCCACACAAGAAAUUAAAGCAACUGCAUUGGGAAAAAUUAGAUUGUACUGAUAAUUCUAUUUGGGGUACAGGUAAAGCUGAGAAGUUCGCAGAUGACUUAUACGAAAAGGGUGUUCUUGCUGAUUUAGAAAAGGCCUUUGCCGCUAGGGAAAUUAAAUCAUUAGCAAGCAAGCGCAAGGAAGAUCUGCAGAAAAUUACAUUUUUAUCCAGGGAUAUUUCUCAACAGUUUGGUAUCAAUUUGCAUAUGUAUUCAUCACUUUCGGUUGCCGAUCUGGUGAAAAAGAUUCUAAACUGCGAUAGGGAUUUUUUGCAAACACCGAGUGUUGUUGAGUUUUUGUCAAAAUCUGAAAUAAUUGAAGUUUCUGUUAAUUUAGCUAGGAAUUACGCCCCGUAUUCGACAGACUGGGAGGGCGUGAGGAAUCUCGAAGAUGCCAAGCCCCCUGAAAAAGAUCCAAACGAUUUACAGAGGGCUGACCAAAUUUAUUUGCAAUUGAUGGUUAAUCUAGAAUCAUACUGGGGUUCACGUAUGAGAGCUCUCACAGUGGUUACUUCGUAUGAAAGAGAAUAUAAUGAGUUAUUGGCAAAGUUAAGAAAAGUCGACAAAGCUGUUAGCGCGCUUCAAGAAUCAGAUAACUUGCGCAAUGUCUUUAAUGUUAUCUUAGCAGUUGGUAAUUUCAUGAACGACACUUCUAAGCAGGCACAAGGUUUCAAACUUUCAACCUUGCAGAGGUUGACGUUUAUCAAGGAUACUACCAAUAGCAUGACCUUUCUAAAUUACGUCGAAAAAAUUGUCAGGUUAAAUUAUCCAAGCUUCAAUGACUUUCUAAGUGAAUUAGAACCUGUAUUGGAUGUCGUGAAAGUUUCCAUUGAGCAGUUAGUUAACGACUGUAAGGACUUUAGCCAAUCGAUUGUAAACGUAGAGCGUUCAGUUGAAAUUGGUAAUUUAAGCGAUUCCUCAAAGUUUCAUCCAUUAGAUAAAGUUUUGAUAAAAACAUUGCCCGUGUUACCGGAAGCCAGAAAAAAGGGGGACUUGUUAGAAGACGAAGUUAAGCUGACUAUCAUGGAAUUUGAAAGUCUGAUGCAUACGUACGGUGAAGAUUCUGGUGAUAAGUUUGCAAAAAUCUCAUUCUUUAAGAAAUUUGCAGAUUUUAUAAAUGAAUACAAAAAAGCUCAAGCGCAAAAUCUAGCCGCGGAAGAAGAAGAAAGACUUUAUAUAAAGCAUAAGAAAAUAGUGGAAGAACAGCAAAAAAGGGCACAAGAAAAGGAAAAACAAAAAGAGAACAGCAAUUCGCCUUCAUCUGAAGGAAAUGAAGAGGAUGAAGCAGAAGAUAGGCGCGCUGUUAUGGAUAAACUAUUAGAACAGUUGAAAAAUGCAGGUCCUGCUAAAAGUGACCCAUCUUCCGCCAGAAAGAGAGCCCUAGUGAGGAAAAAAUAUCUUUCUGAAAAAGACAACGCUCCACAAUUACUCAACGAUUUGGAUACUGAAGAAGGGUCUAUUCUUUAUUCUCCAGAAGCUAUGGACCCUACUGCCGAUACAGUGAUUCACGCUGAAUCACCCACUCCGCUUGCCACAAGGGGUGUUAUGAAUACCUCUGAAGAUUUACCAUCGCCAUCCAAGACAUCUGCGCUGGAAGAUCAAGAGGAAAUUAGUGACAGAGCUAGAAUGUUAUUAAAGGAGCUAAGAGGCUCUGACACACCAGUAAAGCAAAAUUCCAUACUCGAUGAACAUCUAGAAAAAUUGAGGGCCCGCAAGGAAAGAUCCAUAGGUGAGGCUAGCACAGGUAACAGGCUAAGUUUCAAAUAA;|GUGCUGUCACGUGAUCCGACAAACGGCCUCUGCAUAGUGCAGAACAUUCUGCUGCUCUUAAAGGUACAGGCCUCAGGGUCCCUGCUGUAGACGGGGCGGGGGAGAGUACGAUGGGUGGGGCGUGGUGGGUCGUAGGGCGCUCGAGAUGGAGCCCCCAGCUUCCUUGAUGGAUCGCGGGGCGCGAGUGCCCUAGACAAGCCGGAGCUGGGACCGGCAAUCGGGCGUUGAUCCUUGUCACCUGUCGCAGACCCUCAUCCCUCCCGUGGGAGCCCCCUUUGGACACUCUAUGACCCUGGACCCUCGGGGGACCUGAACUUGAUGCGAUGGGAGGCUGUGCAGGCUCGCGGCGGCGCUUUUCGGAUUCCGAGGGGGAGGAGACCGUCCCGGAGCCCCGGCUCCCUCUGUUGGACCAUCAGGGCGCGCAUUGGAAGAACGCGGUGGGCUUCUGGCUGCUGGGCCUUUGCAACAACUUCUCUUAUGUGGUGAUGCUGAGUGCCGCCCACGACAUCCUUAGCCACAAGAGGACAUCGGGAAACCAGAGCCAUGUGGACCCAGGCCCAACGCCGAUCCCCCACAACAGCUCAUCACGAUUUGACUGCAACUCUGUCUCUACGGCUGCUGUGCUCCUGGCGGACAUCCUCCCCACACUCGUCAUCAAAUUGUUGGCUCCUCUUGGCCUUCACCUGCUGCCCUACAGCCCCCGGGUUCUCGUCAGUGGGAUUUGUGCUGCUGGAAGCUUCGUCCUGGUUGCCUUUUCUCAUUCUGUGGGGACCAGCCUGUGUGGUGUGGUCUUCGCUAGCAUCUCAUCAGGCCUUGGGGAGGUCACCUUCCUCUCCCUCACUGCCUUCUACCCCAGGGCCGUGAUCUCCUGGUGGUCCUCAGGGACUGGGGGAGCUGGGCUGCUGGGGGCCCUGUCCUACCUGGGCCUCACCCAGGCCGGCCUCUCCCCUCAGCAGACCCUGCUGUCCAUGCUGGGUAUCCCUGCCCUGCUGCUGGCCAGCUAUUUCUUGUUGCUCACAUCUCCUGAGGCCCAGGACCCUGGAGGGGAAGAAGAAGCAGAGAGCGCAGCCCGGCAGCCCCUCAUAAGAACCGAGGCCCCGGAGUCGAAGCCAGGCUCCAGCUCCAGCCUCUCCCUUCGGGAAAGGUGGACAGUGUUCAAGGGUCUGCUGUGGUACAUUGUUCCCUUGGUCGUAGUUUACUUUGCCGAGUAUUUCAUUAACCAGGGACUUUUUGAACUCCUCUUUUUCUGGAACACUUCCCUGAGUCACGCUCAGCAAUACCGCUGGUACCAGAUGCUGUACCAGGCUGGCGUCUUUGCCUCCCGCUCUUCUCUCCGCUGCUGUCGCAUCCGUUUCACCUGGGCCCUGGCCCUGCUGCAGUGCCUCAACCUGGUGUUCCUGCUGGCAGACGUGUGGUUCGGCUUUCUGCCAAGCAUCUACCUCGUCUUCCUGAUCAUUCUGUAUGAGGGGCUCCUGGGAGGCGCAGCCUACGUGAACACCUUCCACAACAUCGCCCUGGAGACCAGUGAUGAGCACCGGGAGUUUGCAAUGGCGGCCACCUGCAUCUCUGACACACUGGGGAUCUCCCUGUCGGGGCUCCUGGCUUUGCCUCUGCAUGACUUCCUCUGCCAGCUCUCCUGAUACUCGGGAUCCUCAGGACGCAGGUCACAUUCACCUGUGGGCAGAGGGACAGGUCAGACACCCAGGCCCACCCCAGAGACCCUCCAUGAACUGUGCUCCCAGCCUUCCCGGCAGGUCUGGGAGUAGGGAAGGGCUGAAGCCUUGUUUCCCUUGCAGGGGGGCCAGCCAUUGUCUCCCACUUGGGGAGUUUCUUCCUGGCAUCAUGCCUUCUGAAUAAAUGCCGAUUUUAUCCAUGGAAA;|-,mRNA;|mRNA;|-,Saccharomyces cerevisiae;|Homo sapiens;|-,"tr|Q75E28|Q75E28_ASHGO ABL158Cp OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=AGOS_ABL158C PE=4 SV=1|length=729aa|residues=1-729
MSLVNSHSSASVENAAYNLHRAFSSSTENVGHMTPSNSSPLHHSTVVAMGAESQGGGASN
NNNNPANPGSTANNNSNNVNMNSIGGGASLGAGSGATGSISGTKGMNNSHSPLHIATMLN
TLSMNSNPPSQQQSNVQGPYLVRLQNVPKDTTLRECHALFALAHGVLSIELSSFQQYAER
SQTSGQESTNYIVAKFDSLHLACQYATILDEKAQIFGPSFPFKTYVEVVDELTQQQIPFQ
TQMQMHQGSPPAPTHVTAYQQPLLSASGVVSPPQSASSVKRPSLLVQRSRFSFTDPFSSE
QTNMGSQQPDLITTPLKGHQDTGKSFLLMESDEINDSIWGNGTGIPSSISGLTTSQPPTP
HLEWGTTGRRQSSTFYPSQSNTEIPPMHLTGQVQSSQLATGLQQPLPQPQRQSLSYNLVT
PLSSDMNLPPQSSQGGILPHQAPAQTQPQSQALQHHQHLHHQQQQLQQQQHHLQQQQHQQ
QQQSLSQQPQQQQSQQSQAHSQQHQQQHQQQQQQQQPQQQQPQQHPPQQPQQQNSQQAIV
GQSQQQVTSGQQKGSSRNSISKTLQVNGPKNAAAALQNTNGISQVDLSLLAKVPPPANPA
DQNPPCNTLYVGNLPPDATEQELRQLFSSQKGFRRLSFRNKNNNGNGHGPMCFVEFEDVA
HATRALAELYGSQLARTSGTHNNKGGIRLSFSKNPLGVRGPNSRRGGATNNTSNAGTTNY
SYAAAFGKS",Whi3,-,-,729aa(1-729),Q75E28,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q75E28,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0003,http://db.phasep.pro/browse/","[19-20],[29-144],[173-186],[237-282],[302-314],[337-364],[376-459],[469-623],[668-676],[698-718],[728-729]",-,In vitro,8 µM [Whi3];|5 nM BNI1 ml;|5 nM CLN3 ml;|100 nM Oligos,150 mM KCl,"50 mM Tris pH 8.0, 1 mM DTT",RT,-,-,Fluorescence microscopy,liquid,"Fluorescence microscopy images and recruitment coefficients show CLN3 mRNA (5 nM) is modestly recruited into preformed Whi3 droplets made with melted BNI1 (8 µM Whi3, 5 nM BNI1) unless complement regions of CLN3 are also exposed through melting (CLN3ml). In contrast, recruitment of CLN3 ml is lost when the mRNA is mixed with oligos targeting the sequence on CLN3 with complementarity to BNI1 mRNA (CLN3 ml + oligos). Outliers are indicated with (•) marks.",5862
42,190,PMID: 29677514,RNAPS0000029,https://pubmed.ncbi.nlm.nih.gov/29677514,RNA + protein,NCBI ID:4137,https://www.ncbi.nlm.nih.gov/gene/4137,MAPT,6644nt(1-6644),GCAGUCACCGCCACCCACCAGCUCCGGCACCAACAGCAGCGCCGCUGCCACCGCCCACCUUCUGCCGCCGCCACCACAGCCACCUUCUCCUCCUCCGCUGUCCUCUCCCGUCCUCGCCUCUGUCGACUAUCAGGUGAACUUUGAACCAGGAUGGCUGAGCCCCGCCAGGAGUUCGAAGUGAUGGAAGAUCACGCUGGGACGUACGGGUUGGGGGACAGGAAAGAUCAGGGGGGCUACACCAUGCACCAAGACCAAGAGGGUGACACGGACGCUGGCCUGAAAGAAUCUCCCCUGCAGACCCCCACUGAGGACGGAUCUGAGGAACCGGGCUCUGAAACCUCUGAUGCUAAGAGCACUCCAACAGCGGAAGAUGUGACAGCACCCUUAGUGGAUGAGGGAGCUCCCGGCAAGCAGGCUGCCGCGCAGCCCCACACGGAGAUCCCAGAAGGAACCACAGCUGAAGAAGCAGGCAUUGGAGACACCCCCAGCCUGGAAGACGAAGCUGCUGGUCACGUGACCCAAGAGCCUGAAAGUGGUAAGGUGGUCCAGGAAGGCUUCCUCCGAGAGCCAGGCCCCCCAGGUCUGAGCCACCAGCUCAUGUCCGGCAUGCCUGGGGCUCCCCUCCUGCCUGAGGGCCCCAGAGAGGCCACACGCCAACCUUCGGGGACAGGACCUGAGGACACAGAGGGCGGCCGCCACGCCCCUGAGCUGCUCAAGCACCAGCUUCUAGGAGACCUGCACCAGGAGGGGCCGCCGCUGAAGGGGGCAGGGGGCAAAGAGAGGCCGGGGAGCAAGGAGGAGGUGGAUGAAGACCGCGACGUCGAUGAGUCCUCCCCCCAAGACUCCCCUCCCUCCAAGGCCUCCCCAGCCCAAGAUGGGCGGCCUCCCCAGACAGCCGCCAGAGAAGCCACCAGCAUCCCAGGCUUCCCAGCGGAGGGUGCCAUCCCCCUCCCUGUGGAUUUCCUCUCCAAAGUUUCCACAGAGAUCCCAGCCUCAGAGCCCGACGGGCCCAGUGUAGGGCGGGCCAAAGGGCAGGAUGCCCCCCUGGAGUUCACGUUUCACGUGGAAAUCACACCCAACGUGCAGAAGGAGCAGGCGCACUCGGAGGAGCAUUUGGGAAGGGCUGCAUUUCCAGGGGCCCCUGGAGAGGGGCCAGAGGCCCGGGGCCCCUCUUUGGGAGAGGACACAAAAGAGGCUGACCUUCCAGAGCCCUCUGAAAAGCAGCCUGCUGCUGCUCCGCGGGGGAAGCCCGUCAGCCGGGUCCCUCAACUCAAAGCUCGCAUGGUCAGUAAAAGCAAAGACGGGACUGGAAGCGAUGACAAAAAAGCCAAGACAUCCACACGUUCCUCUGCUAAAACCUUGAAAAAUAGGCCUUGCCUUAGCCCCAAACACCCCACUCCUGGUAGCUCAGACCCUCUGAUCCAACCCUCCAGCCCUGCUGUGUGCCCAGAGCCACCUUCCUCUCCUAAAUACGUCUCUUCUGUCACUUCCCGAACUGGCAGUUCUGGAGCAAAGGAGAUGAAACUCAAGGGGGCUGAUGGUAAAACGAAGAUCGCCACACCGCGGGGAGCAGCCCCUCCAGGCCAGAAGGGCCAGGCCAACGCCACCAGGAUUCCAGCAAAAACCCCGCCCGCUCCAAAGACACCACCCAGCUCUGCGACUAAGCAAGUCCAGAGAAGACCACCCCCUGCAGGGCCCAGAUCUGAGAGAGGUGAACCUCCAAAAUCAGGGGAUCGCAGCGGCUACAGCAGCCCCGGCUCCCCAGGCACUCCCGGCAGCCGCUCCCGCACCCCGUCCCUUCCAACCCCACCCACCCGGGAGCCCAAGAAGGUGGCAGUGGUCCGUACUCCACCCAAGUCGCCGUCUUCCGCCAAGAGCCGCCUGCAGACAGCCCCCGUGCCCAUGCCAGACCUGAAGAAUGUCAAGUCCAAGAUCGGCUCCACUGAGAACCUGAAGCACCAGCCGGGAGGCGGGAAGGUGCAGAUAAUUAAUAAGAAGCUGGAUCUUAGCAACGUCCAGUCCAAGUGUGGCUCAAAGGAUAAUAUCAAACACGUCCCGGGAGGCGGCAGUGUGCAAAUAGUCUACAAACCAGUUGACCUGAGCAAGGUGACCUCCAAGUGUGGCUCAUUAGGCAACAUCCAUCAUAAACCAGGAGGUGGCCAGGUGGAAGUAAAAUCUGAGAAGCUUGACUUCAAGGACAGAGUCCAGUCGAAGAUUGGGUCCCUGGACAAUAUCACCCACGUCCCUGGCGGAGGAAAUAAAAAGAUUGAAACCCACAAGCUGACCUUCCGCGAGAACGCCAAAGCCAAGACAGACCACGGGGCGGAGAUCGUGUACAAGUCGCCAGUGGUGUCUGGGGACACGUCUCCACGGCAUCUCAGCAAUGUCUCCUCCACCGGCAGCAUCGACAUGGUAGACUCGCCCCAGCUCGCCACGCUAGCUGACGAGGUGUCUGCCUCCCUGGCCAAGCAGGGUUUGUGAUCAGGCCCCUGGGGCGGUCAAUAAUUGUGGAGAGGAGAGAAUGAGAGAGUGUGGAAAAAAAAAGAAUAAUGACCCGGCCCCCGCCCUCUGCCCCCAGCUGCUCCUCGCAGUUCGGUUAAUUGGUUAAUCACUUAACCUGCUUUUGUCACUCGGCUUUGGCUCGGGACUUCAAAAUCAGUGAUGGGAGUAAGAGCAAAUUUCAUCUUUCCAAAUUGAUGGGUGGGCUAGUAAUAAAAUAUUUAAAAAAAAACAUUCAAAAACAUGGCCACAUCCAACAUUUCCUCAGGCAAUUCCUUUUGAUUCUUUUUUCUUCCCCCUCCAUGUAGAAGAGGGAGAAGGAGAGGCUCUGAAAGCUGCUUCUGGGGGAUUUCAAGGGACUGGGGGUGCCAACCACCUCUGGCCCUGUUGUGGGGGUGUCACAGAGGCAGUGGCAGCAACAAAGGAUUUGAAACUUGGUGUGUUCGUGGAGCCACAGGCAGACGAUGUCAACCUUGUGUGAGUGUGACGGGGGUUGGGGUGGGGCGGGAGGCCACGGGGGAGGCCGAGGCAGGGGCUGGGCAGAGGGGAGAGGAAGCACAAGAAGUGGGAGUGGGAGAGGAAGCCACGUGCUGGAGAGUAGACAUCCCCCUCCUUGCCGCUGGGAGAGCCAAGGCCUAUGCCACCUGCAGCGUCUGAGCGGCCGCCUGUCCUUGGUGGCCGGGGGUGGGGGCCUGCUGUGGGUCAGUGUGCCACCCUCUGCAGGGCAGCCUGUGGGAGAAGGGACAGCGGGUAAAAAGAGAAGGCAAGCUGGCAGGAGGGUGGCACUUCGUGGAUGACCUCCUUAGAAAAGACUGACCUUGAUGUCUUGAGAGCGCUGGCCUCUUCCUCCCUCCCUGCAGGGUAGGGGGCCUGAGUUGAGGGGCUUCCCUCUGCUCCACAGAAACCCUGUUUUAUUGAGUUCUGAAGGUUGGAACUGCUGCCAUGAUUUUGGCCACUUUGCAGACCUGGGACUUUAGGGCUAACCAGUUCUCUUUGUAAGGACUUGUGCCUCUUGGGAGACGUCCACCCGUUUCCAAGCCUGGGCCACUGGCAUCUCUGGAGUGUGUGGGGGUCUGGGAGGCAGGUCCCGAGCCCCCUGUCCUUCCCACGGCCACUGCAGUCACCCCGUCUGCGCCGCUGUGCUGUUGUCUGCCGUGAGAGCCCAAUCACUGCCUAUACCCCUCAUCACACGUCACAAUGUCCCGAAUUCCCAGCCUCACCACCCCUUCUCAGUAAUGACCCUGGUUGGUUGCAGGAGGUACCUACUCCAUACUGAGGGUGAAAUUAAGGGAAGGCAAAGUCCAGGCACAAGAGUGGGACCCCAGCCUCUCACUCUCAGUUCCACUCAUCCAACUGGGACCCUCACCACGAAUCUCAUGAUCUGAUUCGGUUCCCUGUCUCCUCCUCCCGUCACAGAUGUGAGCCAGGGCACUGCUCAGCUGUGACCCUAGGUGUUUCUGCCUUGUUGACAUGGAGAGAGCCCUUUCCCCUGAGAAGGCCUGGCCCCUUCCUGUGCUGAGCCCACAGCAGCAGGCUGGGUGUCUUGGUUGUCAGUGGUGGCACCAGGAUGGAAGGGCAAGGCACCCAGGGCAGGCCCACAGUCCCGCUGUCCCCCACUUGCACCCUAGCUUGUAGCUGCCAACCUCCCAGACAGCCCAGCCCGCUGCUCAGCUCCACAUGCAUAGUAUCAGCCCUCCACACCCGACAAAGGGGAACACACCCCCUUGGAAAUGGUUCUUUUCCCCCAGUCCCAGCUGGAAGCCAUGCUGUCUGUUCUGCUGGAGCAGCUGAACAUAUACAUAGAUGUUGCCCUGCCCUCCCCAUCUGCACCCUGUUGAGUUGUAGUUGGAUUUGUCUGUUUAUGCUUGGAUUCACCAGAGUGACUAUGAUAGUGAAAAGAAAAAAAAAAAAAAAAAAGGACGCAUGUAUCUUGAAAUGCUUGUAAAGAGGUUUCUAACCCACCCUCACGAGGUGUCUCUCACCCCCACACUGGGACUCGUGUGGCCUGUGUGGUGCCACCCUGCUGGGGCCUCCCAAGUUUUGAAAGGCUUUCCUCAGCACCUGGGACCCAACAGAGACCAGCUUCUAGCAGCUAAGGAGGCCGUUCAGCUGUGACGAAGGCCUGAAGCACAGGAUUAGGACUGAAGCGAUGAUGUCCCCUUCCCUACUUCCCCUUGGGGCUCCCUGUGUCAGGGCACAGACUAGGUCUUGUGGCUGGUCUGGCUUGCGGCGCGAGGAUGGUUCUCUCUGGUCAUAGCCCGAAGUCUCAUGGCAGUCCCAAAGGAGGCUUACAACUCCUGCAUCACAAGAAAAAGGAAGCCACUGCCAGCUGGGGGGAUCUGCAGCUCCCAGAAGCUCCGUGAGCCUCAGCCACCCCUCAGACUGGGUUCCUCUCCAAGCUCGCCCUCUGGAGGGGCAGCGCAGCCUCCCACCAAGGGCCCUGCGACCACAGCAGGGAUUGGGAUGAAUUGCCUGUCCUGGAUCUGCUCUAGAGGCCCAAGCUGCCUGCCUGAGGAAGGAUGACUUGACAAGUCAGGAGACACUGUUCCCAAAGCCUUGACCAGAGCACCUCAGCCCGCUGACCUUGCACAAACUCCAUCUGCUGCCAUGAGAAAAGGGAAGCCGCCUUUGCAAAACAUUGCUGCCUAAAGAAACUCAGCAGCCUCAGGCCCAAUUCUGCCACUUCUGGUUUGGGUACAGUUAAAGGCAACCCUGAGGGACUUGGCAGUAGAAAUCCAGGGCCUCCCCUGGGGCUGGCAGCUUCGUGUGCAGCUAGAGCUUUACCUGAAAGGAAGUCUCUGGGCCCAGAACUCUCCACCAAGAGCCUCCCUGCCGUUCGCUGAGUCCCAGCAAUUCUCCUAAGUUGAAGGGAUCUGAGAAGGAGAAGGAAAUGUGGGGUAGAUUUGGUGGUGGUUAGAGAUAUGCCCCCCUCAUUACUGCCAACAGUUUCGGCUGCAUUUCUUCACGCACCUCGGUUCCUCUUCCUGAAGUUCUUGUGCCCUGCUCUUCAGCACCAUGGGCCUUCUUAUACGGAAGGCUCUGGGAUCUCCCCCUUGUGGGGCAGGCUCUUGGGGCCAGCCUAAGAUCAUGGUUUAGGGUGAUCAGUGCUGGCAGAUAAAUUGAAAAGGCACGCUGGCUUGUGAUCUUAAAUGAGGACAAUCCCCCCAGGGCUGGGCACUCCUCCCCUCCCCUCACUUCUCCCACCUGCAGAGCCAGUGUCCUUGGGUGGGCUAGAUAGGAUAUACUGUAUGCCGGCUCCUUCAAGCUGCUGACUCACUUUAUCAAUAGUUCCAUUUAAAUUGACUUCAGUGGUGAGACUGUAUCCUGUUUGCUAUUGCUUGUUGUGCUAUGGGGGGAGGGGGGAGGAAUGUGUAAGAUAGUUAACAUGGGCAAAGGGAGAUCUUGGGGUGCAGCACUUAAACUGCCUCGUAACCCUUUUCAUGAUUUCAACCACAUUUGCUAGAGGGAGGGAGCAGCCACGGAGUUAGAGGCCCUUGGGGUUUCUCUUUUCCACUGACAGGCUUUCCCAGGCAGCUGGCUAGUUCAUUCCCUCCCCAGCCAGGUGCAGGCGUAGGAAUAUGGACAUCUGGUUGCUUUGGCCUGCUGCCCUCUUUCAGGGGUCCUAAGCCCACAAUCAUGCCUCCCUAAGACCUUGGCAUCCUUCCCUCUAAGCCGUUGGCACCUCUGUGCCACCUCUCACACUGGCUCCAGACACACAGCCUGUGCUUUUGGAGCUGAGAUCACUCGCUUCACCCUCCUCAUCUUUGUUCUCCAAGUAAAGCCACGAGGUCGGGGCGAGGGCAGAGGUGAUCACCUGCGUGUCCCAUCUACAGACCUGCAGCUUCAUAAAACUUCUGAUUUCUCUUCAGCUUUGAAAAGGGUUACCCUGGGCACUGGCCUAGAGCCUCACCUCCUAAUAGACUUAGCCCCAUGAGUUUGCCAUGUUGAGCAGGACUAUUUCUGGCACUUGCAAGUCCCAUGAUUUCUUCGGUAAUUCUGAGGGUGGGGGGAGGGACAUGAAAUCAUCUUAGCUUAGCUUUCUGUCUGUGAAUGUCUAUAUAGUGUAUUGUGUGUUUUAACAAAUGAUUUACACUGACUGUUGCUGUAAAAGUGAAUUUGGAAAUAAAGUUAUUACUCUGAUUAAA,mRNA,Homo sapiens,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=73aa|residues=454-526
GPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDS
RGEHRQDRRERPY",FUS,RGG3-PY,-,73aa(454-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[454-507],[508-512]",[454-507],In vitro,15-90 µM [FUS RGG3-PY];|add MAPT at a molar ratio of 1:50,75-300 µM NaCl ,"20 mM Na2HPO4/NaH2PO4, pH 7.5, 2.5% glycerol, 1 mM DTT",25˚C,-,-,Microscopy,"liquid, solute","In the presence of substoichiometric amounts of RNA, RGG3-PY formed liquid droplets in a concentration- and temperature-dependent manner, similar to the N-terminal SYGQ-rich domain (Burke et al., 2015). Formation of RGG3-PY droplets was enhanced at lower salt concentrations, suggesting that electrostatic interactions involving RGG/RG motifs drive LLPS of this domain.",6644
43,191,PMID: 29677514,RNAPS0000029,https://pubmed.ncbi.nlm.nih.gov/29677514,RNA + protein,NCBI ID:4137,https://www.ncbi.nlm.nih.gov/gene/4137,MAPT,6644nt(1-6644),GCAGUCACCGCCACCCACCAGCUCCGGCACCAACAGCAGCGCCGCUGCCACCGCCCACCUUCUGCCGCCGCCACCACAGCCACCUUCUCCUCCUCCGCUGUCCUCUCCCGUCCUCGCCUCUGUCGACUAUCAGGUGAACUUUGAACCAGGAUGGCUGAGCCCCGCCAGGAGUUCGAAGUGAUGGAAGAUCACGCUGGGACGUACGGGUUGGGGGACAGGAAAGAUCAGGGGGGCUACACCAUGCACCAAGACCAAGAGGGUGACACGGACGCUGGCCUGAAAGAAUCUCCCCUGCAGACCCCCACUGAGGACGGAUCUGAGGAACCGGGCUCUGAAACCUCUGAUGCUAAGAGCACUCCAACAGCGGAAGAUGUGACAGCACCCUUAGUGGAUGAGGGAGCUCCCGGCAAGCAGGCUGCCGCGCAGCCCCACACGGAGAUCCCAGAAGGAACCACAGCUGAAGAAGCAGGCAUUGGAGACACCCCCAGCCUGGAAGACGAAGCUGCUGGUCACGUGACCCAAGAGCCUGAAAGUGGUAAGGUGGUCCAGGAAGGCUUCCUCCGAGAGCCAGGCCCCCCAGGUCUGAGCCACCAGCUCAUGUCCGGCAUGCCUGGGGCUCCCCUCCUGCCUGAGGGCCCCAGAGAGGCCACACGCCAACCUUCGGGGACAGGACCUGAGGACACAGAGGGCGGCCGCCACGCCCCUGAGCUGCUCAAGCACCAGCUUCUAGGAGACCUGCACCAGGAGGGGCCGCCGCUGAAGGGGGCAGGGGGCAAAGAGAGGCCGGGGAGCAAGGAGGAGGUGGAUGAAGACCGCGACGUCGAUGAGUCCUCCCCCCAAGACUCCCCUCCCUCCAAGGCCUCCCCAGCCCAAGAUGGGCGGCCUCCCCAGACAGCCGCCAGAGAAGCCACCAGCAUCCCAGGCUUCCCAGCGGAGGGUGCCAUCCCCCUCCCUGUGGAUUUCCUCUCCAAAGUUUCCACAGAGAUCCCAGCCUCAGAGCCCGACGGGCCCAGUGUAGGGCGGGCCAAAGGGCAGGAUGCCCCCCUGGAGUUCACGUUUCACGUGGAAAUCACACCCAACGUGCAGAAGGAGCAGGCGCACUCGGAGGAGCAUUUGGGAAGGGCUGCAUUUCCAGGGGCCCCUGGAGAGGGGCCAGAGGCCCGGGGCCCCUCUUUGGGAGAGGACACAAAAGAGGCUGACCUUCCAGAGCCCUCUGAAAAGCAGCCUGCUGCUGCUCCGCGGGGGAAGCCCGUCAGCCGGGUCCCUCAACUCAAAGCUCGCAUGGUCAGUAAAAGCAAAGACGGGACUGGAAGCGAUGACAAAAAAGCCAAGACAUCCACACGUUCCUCUGCUAAAACCUUGAAAAAUAGGCCUUGCCUUAGCCCCAAACACCCCACUCCUGGUAGCUCAGACCCUCUGAUCCAACCCUCCAGCCCUGCUGUGUGCCCAGAGCCACCUUCCUCUCCUAAAUACGUCUCUUCUGUCACUUCCCGAACUGGCAGUUCUGGAGCAAAGGAGAUGAAACUCAAGGGGGCUGAUGGUAAAACGAAGAUCGCCACACCGCGGGGAGCAGCCCCUCCAGGCCAGAAGGGCCAGGCCAACGCCACCAGGAUUCCAGCAAAAACCCCGCCCGCUCCAAAGACACCACCCAGCUCUGCGACUAAGCAAGUCCAGAGAAGACCACCCCCUGCAGGGCCCAGAUCUGAGAGAGGUGAACCUCCAAAAUCAGGGGAUCGCAGCGGCUACAGCAGCCCCGGCUCCCCAGGCACUCCCGGCAGCCGCUCCCGCACCCCGUCCCUUCCAACCCCACCCACCCGGGAGCCCAAGAAGGUGGCAGUGGUCCGUACUCCACCCAAGUCGCCGUCUUCCGCCAAGAGCCGCCUGCAGACAGCCCCCGUGCCCAUGCCAGACCUGAAGAAUGUCAAGUCCAAGAUCGGCUCCACUGAGAACCUGAAGCACCAGCCGGGAGGCGGGAAGGUGCAGAUAAUUAAUAAGAAGCUGGAUCUUAGCAACGUCCAGUCCAAGUGUGGCUCAAAGGAUAAUAUCAAACACGUCCCGGGAGGCGGCAGUGUGCAAAUAGUCUACAAACCAGUUGACCUGAGCAAGGUGACCUCCAAGUGUGGCUCAUUAGGCAACAUCCAUCAUAAACCAGGAGGUGGCCAGGUGGAAGUAAAAUCUGAGAAGCUUGACUUCAAGGACAGAGUCCAGUCGAAGAUUGGGUCCCUGGACAAUAUCACCCACGUCCCUGGCGGAGGAAAUAAAAAGAUUGAAACCCACAAGCUGACCUUCCGCGAGAACGCCAAAGCCAAGACAGACCACGGGGCGGAGAUCGUGUACAAGUCGCCAGUGGUGUCUGGGGACACGUCUCCACGGCAUCUCAGCAAUGUCUCCUCCACCGGCAGCAUCGACAUGGUAGACUCGCCCCAGCUCGCCACGCUAGCUGACGAGGUGUCUGCCUCCCUGGCCAAGCAGGGUUUGUGAUCAGGCCCCUGGGGCGGUCAAUAAUUGUGGAGAGGAGAGAAUGAGAGAGUGUGGAAAAAAAAAGAAUAAUGACCCGGCCCCCGCCCUCUGCCCCCAGCUGCUCCUCGCAGUUCGGUUAAUUGGUUAAUCACUUAACCUGCUUUUGUCACUCGGCUUUGGCUCGGGACUUCAAAAUCAGUGAUGGGAGUAAGAGCAAAUUUCAUCUUUCCAAAUUGAUGGGUGGGCUAGUAAUAAAAUAUUUAAAAAAAAACAUUCAAAAACAUGGCCACAUCCAACAUUUCCUCAGGCAAUUCCUUUUGAUUCUUUUUUCUUCCCCCUCCAUGUAGAAGAGGGAGAAGGAGAGGCUCUGAAAGCUGCUUCUGGGGGAUUUCAAGGGACUGGGGGUGCCAACCACCUCUGGCCCUGUUGUGGGGGUGUCACAGAGGCAGUGGCAGCAACAAAGGAUUUGAAACUUGGUGUGUUCGUGGAGCCACAGGCAGACGAUGUCAACCUUGUGUGAGUGUGACGGGGGUUGGGGUGGGGCGGGAGGCCACGGGGGAGGCCGAGGCAGGGGCUGGGCAGAGGGGAGAGGAAGCACAAGAAGUGGGAGUGGGAGAGGAAGCCACGUGCUGGAGAGUAGACAUCCCCCUCCUUGCCGCUGGGAGAGCCAAGGCCUAUGCCACCUGCAGCGUCUGAGCGGCCGCCUGUCCUUGGUGGCCGGGGGUGGGGGCCUGCUGUGGGUCAGUGUGCCACCCUCUGCAGGGCAGCCUGUGGGAGAAGGGACAGCGGGUAAAAAGAGAAGGCAAGCUGGCAGGAGGGUGGCACUUCGUGGAUGACCUCCUUAGAAAAGACUGACCUUGAUGUCUUGAGAGCGCUGGCCUCUUCCUCCCUCCCUGCAGGGUAGGGGGCCUGAGUUGAGGGGCUUCCCUCUGCUCCACAGAAACCCUGUUUUAUUGAGUUCUGAAGGUUGGAACUGCUGCCAUGAUUUUGGCCACUUUGCAGACCUGGGACUUUAGGGCUAACCAGUUCUCUUUGUAAGGACUUGUGCCUCUUGGGAGACGUCCACCCGUUUCCAAGCCUGGGCCACUGGCAUCUCUGGAGUGUGUGGGGGUCUGGGAGGCAGGUCCCGAGCCCCCUGUCCUUCCCACGGCCACUGCAGUCACCCCGUCUGCGCCGCUGUGCUGUUGUCUGCCGUGAGAGCCCAAUCACUGCCUAUACCCCUCAUCACACGUCACAAUGUCCCGAAUUCCCAGCCUCACCACCCCUUCUCAGUAAUGACCCUGGUUGGUUGCAGGAGGUACCUACUCCAUACUGAGGGUGAAAUUAAGGGAAGGCAAAGUCCAGGCACAAGAGUGGGACCCCAGCCUCUCACUCUCAGUUCCACUCAUCCAACUGGGACCCUCACCACGAAUCUCAUGAUCUGAUUCGGUUCCCUGUCUCCUCCUCCCGUCACAGAUGUGAGCCAGGGCACUGCUCAGCUGUGACCCUAGGUGUUUCUGCCUUGUUGACAUGGAGAGAGCCCUUUCCCCUGAGAAGGCCUGGCCCCUUCCUGUGCUGAGCCCACAGCAGCAGGCUGGGUGUCUUGGUUGUCAGUGGUGGCACCAGGAUGGAAGGGCAAGGCACCCAGGGCAGGCCCACAGUCCCGCUGUCCCCCACUUGCACCCUAGCUUGUAGCUGCCAACCUCCCAGACAGCCCAGCCCGCUGCUCAGCUCCACAUGCAUAGUAUCAGCCCUCCACACCCGACAAAGGGGAACACACCCCCUUGGAAAUGGUUCUUUUCCCCCAGUCCCAGCUGGAAGCCAUGCUGUCUGUUCUGCUGGAGCAGCUGAACAUAUACAUAGAUGUUGCCCUGCCCUCCCCAUCUGCACCCUGUUGAGUUGUAGUUGGAUUUGUCUGUUUAUGCUUGGAUUCACCAGAGUGACUAUGAUAGUGAAAAGAAAAAAAAAAAAAAAAAAGGACGCAUGUAUCUUGAAAUGCUUGUAAAGAGGUUUCUAACCCACCCUCACGAGGUGUCUCUCACCCCCACACUGGGACUCGUGUGGCCUGUGUGGUGCCACCCUGCUGGGGCCUCCCAAGUUUUGAAAGGCUUUCCUCAGCACCUGGGACCCAACAGAGACCAGCUUCUAGCAGCUAAGGAGGCCGUUCAGCUGUGACGAAGGCCUGAAGCACAGGAUUAGGACUGAAGCGAUGAUGUCCCCUUCCCUACUUCCCCUUGGGGCUCCCUGUGUCAGGGCACAGACUAGGUCUUGUGGCUGGUCUGGCUUGCGGCGCGAGGAUGGUUCUCUCUGGUCAUAGCCCGAAGUCUCAUGGCAGUCCCAAAGGAGGCUUACAACUCCUGCAUCACAAGAAAAAGGAAGCCACUGCCAGCUGGGGGGAUCUGCAGCUCCCAGAAGCUCCGUGAGCCUCAGCCACCCCUCAGACUGGGUUCCUCUCCAAGCUCGCCCUCUGGAGGGGCAGCGCAGCCUCCCACCAAGGGCCCUGCGACCACAGCAGGGAUUGGGAUGAAUUGCCUGUCCUGGAUCUGCUCUAGAGGCCCAAGCUGCCUGCCUGAGGAAGGAUGACUUGACAAGUCAGGAGACACUGUUCCCAAAGCCUUGACCAGAGCACCUCAGCCCGCUGACCUUGCACAAACUCCAUCUGCUGCCAUGAGAAAAGGGAAGCCGCCUUUGCAAAACAUUGCUGCCUAAAGAAACUCAGCAGCCUCAGGCCCAAUUCUGCCACUUCUGGUUUGGGUACAGUUAAAGGCAACCCUGAGGGACUUGGCAGUAGAAAUCCAGGGCCUCCCCUGGGGCUGGCAGCUUCGUGUGCAGCUAGAGCUUUACCUGAAAGGAAGUCUCUGGGCCCAGAACUCUCCACCAAGAGCCUCCCUGCCGUUCGCUGAGUCCCAGCAAUUCUCCUAAGUUGAAGGGAUCUGAGAAGGAGAAGGAAAUGUGGGGUAGAUUUGGUGGUGGUUAGAGAUAUGCCCCCCUCAUUACUGCCAACAGUUUCGGCUGCAUUUCUUCACGCACCUCGGUUCCUCUUCCUGAAGUUCUUGUGCCCUGCUCUUCAGCACCAUGGGCCUUCUUAUACGGAAGGCUCUGGGAUCUCCCCCUUGUGGGGCAGGCUCUUGGGGCCAGCCUAAGAUCAUGGUUUAGGGUGAUCAGUGCUGGCAGAUAAAUUGAAAAGGCACGCUGGCUUGUGAUCUUAAAUGAGGACAAUCCCCCCAGGGCUGGGCACUCCUCCCCUCCCCUCACUUCUCCCACCUGCAGAGCCAGUGUCCUUGGGUGGGCUAGAUAGGAUAUACUGUAUGCCGGCUCCUUCAAGCUGCUGACUCACUUUAUCAAUAGUUCCAUUUAAAUUGACUUCAGUGGUGAGACUGUAUCCUGUUUGCUAUUGCUUGUUGUGCUAUGGGGGGAGGGGGGAGGAAUGUGUAAGAUAGUUAACAUGGGCAAAGGGAGAUCUUGGGGUGCAGCACUUAAACUGCCUCGUAACCCUUUUCAUGAUUUCAACCACAUUUGCUAGAGGGAGGGAGCAGCCACGGAGUUAGAGGCCCUUGGGGUUUCUCUUUUCCACUGACAGGCUUUCCCAGGCAGCUGGCUAGUUCAUUCCCUCCCCAGCCAGGUGCAGGCGUAGGAAUAUGGACAUCUGGUUGCUUUGGCCUGCUGCCCUCUUUCAGGGGUCCUAAGCCCACAAUCAUGCCUCCCUAAGACCUUGGCAUCCUUCCCUCUAAGCCGUUGGCACCUCUGUGCCACCUCUCACACUGGCUCCAGACACACAGCCUGUGCUUUUGGAGCUGAGAUCACUCGCUUCACCCUCCUCAUCUUUGUUCUCCAAGUAAAGCCACGAGGUCGGGGCGAGGGCAGAGGUGAUCACCUGCGUGUCCCAUCUACAGACCUGCAGCUUCAUAAAACUUCUGAUUUCUCUUCAGCUUUGAAAAGGGUUACCCUGGGCACUGGCCUAGAGCCUCACCUCCUAAUAGACUUAGCCCCAUGAGUUUGCCAUGUUGAGCAGGACUAUUUCUGGCACUUGCAAGUCCCAUGAUUUCUUCGGUAAUUCUGAGGGUGGGGGGAGGGACAUGAAAUCAUCUUAGCUUAGCUUUCUGUCUGUGAAUGUCUAUAUAGUGUAUUGUGUGUUUUAACAAAUGAUUUACACUGACUGUUGCUGUAAAAGUGAAUUUGGAAAUAAAGUUAUUACUCUGAUUAAA,mRNA,Homo sapiens,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=73aa|residues=454-526
GPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDS
RGEHRQDRRERPY",FUS,RGG3-PY,-,73aa(454-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[454-507],[508-512]",[454-507],In vitro,30 µM [FUS RGG3-PY];|in presence of different amounts(0:1/1:100/1:75/1:50/1:25/1:10) of MAPT RNA,75 mM NaCl,"20 mM Na2HPO4/NaH2PO4, pH 7.5, 2.5% glycerol, 1 mM DTT",RT,-,-,Turbidity measurement,liquid,"Enhanced phase separation was also observed for the unmethylated RGG3-PY domain, which reached higher turbidity values than methylated RGG3-PY upon addition of RNA. This difference was not due to altered RNA binding, as filter binding experiments demonstrated equal affinity of unmethylated and methylated RGG3-PY for RNA.",6644
44,192,PMID: 29677514,RNAPS0000029,https://pubmed.ncbi.nlm.nih.gov/29677514,RNA + protein,NCBI ID:4137,https://www.ncbi.nlm.nih.gov/gene/4137,MAPT,6644nt(1-6644),GCAGUCACCGCCACCCACCAGCUCCGGCACCAACAGCAGCGCCGCUGCCACCGCCCACCUUCUGCCGCCGCCACCACAGCCACCUUCUCCUCCUCCGCUGUCCUCUCCCGUCCUCGCCUCUGUCGACUAUCAGGUGAACUUUGAACCAGGAUGGCUGAGCCCCGCCAGGAGUUCGAAGUGAUGGAAGAUCACGCUGGGACGUACGGGUUGGGGGACAGGAAAGAUCAGGGGGGCUACACCAUGCACCAAGACCAAGAGGGUGACACGGACGCUGGCCUGAAAGAAUCUCCCCUGCAGACCCCCACUGAGGACGGAUCUGAGGAACCGGGCUCUGAAACCUCUGAUGCUAAGAGCACUCCAACAGCGGAAGAUGUGACAGCACCCUUAGUGGAUGAGGGAGCUCCCGGCAAGCAGGCUGCCGCGCAGCCCCACACGGAGAUCCCAGAAGGAACCACAGCUGAAGAAGCAGGCAUUGGAGACACCCCCAGCCUGGAAGACGAAGCUGCUGGUCACGUGACCCAAGAGCCUGAAAGUGGUAAGGUGGUCCAGGAAGGCUUCCUCCGAGAGCCAGGCCCCCCAGGUCUGAGCCACCAGCUCAUGUCCGGCAUGCCUGGGGCUCCCCUCCUGCCUGAGGGCCCCAGAGAGGCCACACGCCAACCUUCGGGGACAGGACCUGAGGACACAGAGGGCGGCCGCCACGCCCCUGAGCUGCUCAAGCACCAGCUUCUAGGAGACCUGCACCAGGAGGGGCCGCCGCUGAAGGGGGCAGGGGGCAAAGAGAGGCCGGGGAGCAAGGAGGAGGUGGAUGAAGACCGCGACGUCGAUGAGUCCUCCCCCCAAGACUCCCCUCCCUCCAAGGCCUCCCCAGCCCAAGAUGGGCGGCCUCCCCAGACAGCCGCCAGAGAAGCCACCAGCAUCCCAGGCUUCCCAGCGGAGGGUGCCAUCCCCCUCCCUGUGGAUUUCCUCUCCAAAGUUUCCACAGAGAUCCCAGCCUCAGAGCCCGACGGGCCCAGUGUAGGGCGGGCCAAAGGGCAGGAUGCCCCCCUGGAGUUCACGUUUCACGUGGAAAUCACACCCAACGUGCAGAAGGAGCAGGCGCACUCGGAGGAGCAUUUGGGAAGGGCUGCAUUUCCAGGGGCCCCUGGAGAGGGGCCAGAGGCCCGGGGCCCCUCUUUGGGAGAGGACACAAAAGAGGCUGACCUUCCAGAGCCCUCUGAAAAGCAGCCUGCUGCUGCUCCGCGGGGGAAGCCCGUCAGCCGGGUCCCUCAACUCAAAGCUCGCAUGGUCAGUAAAAGCAAAGACGGGACUGGAAGCGAUGACAAAAAAGCCAAGACAUCCACACGUUCCUCUGCUAAAACCUUGAAAAAUAGGCCUUGCCUUAGCCCCAAACACCCCACUCCUGGUAGCUCAGACCCUCUGAUCCAACCCUCCAGCCCUGCUGUGUGCCCAGAGCCACCUUCCUCUCCUAAAUACGUCUCUUCUGUCACUUCCCGAACUGGCAGUUCUGGAGCAAAGGAGAUGAAACUCAAGGGGGCUGAUGGUAAAACGAAGAUCGCCACACCGCGGGGAGCAGCCCCUCCAGGCCAGAAGGGCCAGGCCAACGCCACCAGGAUUCCAGCAAAAACCCCGCCCGCUCCAAAGACACCACCCAGCUCUGCGACUAAGCAAGUCCAGAGAAGACCACCCCCUGCAGGGCCCAGAUCUGAGAGAGGUGAACCUCCAAAAUCAGGGGAUCGCAGCGGCUACAGCAGCCCCGGCUCCCCAGGCACUCCCGGCAGCCGCUCCCGCACCCCGUCCCUUCCAACCCCACCCACCCGGGAGCCCAAGAAGGUGGCAGUGGUCCGUACUCCACCCAAGUCGCCGUCUUCCGCCAAGAGCCGCCUGCAGACAGCCCCCGUGCCCAUGCCAGACCUGAAGAAUGUCAAGUCCAAGAUCGGCUCCACUGAGAACCUGAAGCACCAGCCGGGAGGCGGGAAGGUGCAGAUAAUUAAUAAGAAGCUGGAUCUUAGCAACGUCCAGUCCAAGUGUGGCUCAAAGGAUAAUAUCAAACACGUCCCGGGAGGCGGCAGUGUGCAAAUAGUCUACAAACCAGUUGACCUGAGCAAGGUGACCUCCAAGUGUGGCUCAUUAGGCAACAUCCAUCAUAAACCAGGAGGUGGCCAGGUGGAAGUAAAAUCUGAGAAGCUUGACUUCAAGGACAGAGUCCAGUCGAAGAUUGGGUCCCUGGACAAUAUCACCCACGUCCCUGGCGGAGGAAAUAAAAAGAUUGAAACCCACAAGCUGACCUUCCGCGAGAACGCCAAAGCCAAGACAGACCACGGGGCGGAGAUCGUGUACAAGUCGCCAGUGGUGUCUGGGGACACGUCUCCACGGCAUCUCAGCAAUGUCUCCUCCACCGGCAGCAUCGACAUGGUAGACUCGCCCCAGCUCGCCACGCUAGCUGACGAGGUGUCUGCCUCCCUGGCCAAGCAGGGUUUGUGAUCAGGCCCCUGGGGCGGUCAAUAAUUGUGGAGAGGAGAGAAUGAGAGAGUGUGGAAAAAAAAAGAAUAAUGACCCGGCCCCCGCCCUCUGCCCCCAGCUGCUCCUCGCAGUUCGGUUAAUUGGUUAAUCACUUAACCUGCUUUUGUCACUCGGCUUUGGCUCGGGACUUCAAAAUCAGUGAUGGGAGUAAGAGCAAAUUUCAUCUUUCCAAAUUGAUGGGUGGGCUAGUAAUAAAAUAUUUAAAAAAAAACAUUCAAAAACAUGGCCACAUCCAACAUUUCCUCAGGCAAUUCCUUUUGAUUCUUUUUUCUUCCCCCUCCAUGUAGAAGAGGGAGAAGGAGAGGCUCUGAAAGCUGCUUCUGGGGGAUUUCAAGGGACUGGGGGUGCCAACCACCUCUGGCCCUGUUGUGGGGGUGUCACAGAGGCAGUGGCAGCAACAAAGGAUUUGAAACUUGGUGUGUUCGUGGAGCCACAGGCAGACGAUGUCAACCUUGUGUGAGUGUGACGGGGGUUGGGGUGGGGCGGGAGGCCACGGGGGAGGCCGAGGCAGGGGCUGGGCAGAGGGGAGAGGAAGCACAAGAAGUGGGAGUGGGAGAGGAAGCCACGUGCUGGAGAGUAGACAUCCCCCUCCUUGCCGCUGGGAGAGCCAAGGCCUAUGCCACCUGCAGCGUCUGAGCGGCCGCCUGUCCUUGGUGGCCGGGGGUGGGGGCCUGCUGUGGGUCAGUGUGCCACCCUCUGCAGGGCAGCCUGUGGGAGAAGGGACAGCGGGUAAAAAGAGAAGGCAAGCUGGCAGGAGGGUGGCACUUCGUGGAUGACCUCCUUAGAAAAGACUGACCUUGAUGUCUUGAGAGCGCUGGCCUCUUCCUCCCUCCCUGCAGGGUAGGGGGCCUGAGUUGAGGGGCUUCCCUCUGCUCCACAGAAACCCUGUUUUAUUGAGUUCUGAAGGUUGGAACUGCUGCCAUGAUUUUGGCCACUUUGCAGACCUGGGACUUUAGGGCUAACCAGUUCUCUUUGUAAGGACUUGUGCCUCUUGGGAGACGUCCACCCGUUUCCAAGCCUGGGCCACUGGCAUCUCUGGAGUGUGUGGGGGUCUGGGAGGCAGGUCCCGAGCCCCCUGUCCUUCCCACGGCCACUGCAGUCACCCCGUCUGCGCCGCUGUGCUGUUGUCUGCCGUGAGAGCCCAAUCACUGCCUAUACCCCUCAUCACACGUCACAAUGUCCCGAAUUCCCAGCCUCACCACCCCUUCUCAGUAAUGACCCUGGUUGGUUGCAGGAGGUACCUACUCCAUACUGAGGGUGAAAUUAAGGGAAGGCAAAGUCCAGGCACAAGAGUGGGACCCCAGCCUCUCACUCUCAGUUCCACUCAUCCAACUGGGACCCUCACCACGAAUCUCAUGAUCUGAUUCGGUUCCCUGUCUCCUCCUCCCGUCACAGAUGUGAGCCAGGGCACUGCUCAGCUGUGACCCUAGGUGUUUCUGCCUUGUUGACAUGGAGAGAGCCCUUUCCCCUGAGAAGGCCUGGCCCCUUCCUGUGCUGAGCCCACAGCAGCAGGCUGGGUGUCUUGGUUGUCAGUGGUGGCACCAGGAUGGAAGGGCAAGGCACCCAGGGCAGGCCCACAGUCCCGCUGUCCCCCACUUGCACCCUAGCUUGUAGCUGCCAACCUCCCAGACAGCCCAGCCCGCUGCUCAGCUCCACAUGCAUAGUAUCAGCCCUCCACACCCGACAAAGGGGAACACACCCCCUUGGAAAUGGUUCUUUUCCCCCAGUCCCAGCUGGAAGCCAUGCUGUCUGUUCUGCUGGAGCAGCUGAACAUAUACAUAGAUGUUGCCCUGCCCUCCCCAUCUGCACCCUGUUGAGUUGUAGUUGGAUUUGUCUGUUUAUGCUUGGAUUCACCAGAGUGACUAUGAUAGUGAAAAGAAAAAAAAAAAAAAAAAAGGACGCAUGUAUCUUGAAAUGCUUGUAAAGAGGUUUCUAACCCACCCUCACGAGGUGUCUCUCACCCCCACACUGGGACUCGUGUGGCCUGUGUGGUGCCACCCUGCUGGGGCCUCCCAAGUUUUGAAAGGCUUUCCUCAGCACCUGGGACCCAACAGAGACCAGCUUCUAGCAGCUAAGGAGGCCGUUCAGCUGUGACGAAGGCCUGAAGCACAGGAUUAGGACUGAAGCGAUGAUGUCCCCUUCCCUACUUCCCCUUGGGGCUCCCUGUGUCAGGGCACAGACUAGGUCUUGUGGCUGGUCUGGCUUGCGGCGCGAGGAUGGUUCUCUCUGGUCAUAGCCCGAAGUCUCAUGGCAGUCCCAAAGGAGGCUUACAACUCCUGCAUCACAAGAAAAAGGAAGCCACUGCCAGCUGGGGGGAUCUGCAGCUCCCAGAAGCUCCGUGAGCCUCAGCCACCCCUCAGACUGGGUUCCUCUCCAAGCUCGCCCUCUGGAGGGGCAGCGCAGCCUCCCACCAAGGGCCCUGCGACCACAGCAGGGAUUGGGAUGAAUUGCCUGUCCUGGAUCUGCUCUAGAGGCCCAAGCUGCCUGCCUGAGGAAGGAUGACUUGACAAGUCAGGAGACACUGUUCCCAAAGCCUUGACCAGAGCACCUCAGCCCGCUGACCUUGCACAAACUCCAUCUGCUGCCAUGAGAAAAGGGAAGCCGCCUUUGCAAAACAUUGCUGCCUAAAGAAACUCAGCAGCCUCAGGCCCAAUUCUGCCACUUCUGGUUUGGGUACAGUUAAAGGCAACCCUGAGGGACUUGGCAGUAGAAAUCCAGGGCCUCCCCUGGGGCUGGCAGCUUCGUGUGCAGCUAGAGCUUUACCUGAAAGGAAGUCUCUGGGCCCAGAACUCUCCACCAAGAGCCUCCCUGCCGUUCGCUGAGUCCCAGCAAUUCUCCUAAGUUGAAGGGAUCUGAGAAGGAGAAGGAAAUGUGGGGUAGAUUUGGUGGUGGUUAGAGAUAUGCCCCCCUCAUUACUGCCAACAGUUUCGGCUGCAUUUCUUCACGCACCUCGGUUCCUCUUCCUGAAGUUCUUGUGCCCUGCUCUUCAGCACCAUGGGCCUUCUUAUACGGAAGGCUCUGGGAUCUCCCCCUUGUGGGGCAGGCUCUUGGGGCCAGCCUAAGAUCAUGGUUUAGGGUGAUCAGUGCUGGCAGAUAAAUUGAAAAGGCACGCUGGCUUGUGAUCUUAAAUGAGGACAAUCCCCCCAGGGCUGGGCACUCCUCCCCUCCCCUCACUUCUCCCACCUGCAGAGCCAGUGUCCUUGGGUGGGCUAGAUAGGAUAUACUGUAUGCCGGCUCCUUCAAGCUGCUGACUCACUUUAUCAAUAGUUCCAUUUAAAUUGACUUCAGUGGUGAGACUGUAUCCUGUUUGCUAUUGCUUGUUGUGCUAUGGGGGGAGGGGGGAGGAAUGUGUAAGAUAGUUAACAUGGGCAAAGGGAGAUCUUGGGGUGCAGCACUUAAACUGCCUCGUAACCCUUUUCAUGAUUUCAACCACAUUUGCUAGAGGGAGGGAGCAGCCACGGAGUUAGAGGCCCUUGGGGUUUCUCUUUUCCACUGACAGGCUUUCCCAGGCAGCUGGCUAGUUCAUUCCCUCCCCAGCCAGGUGCAGGCGUAGGAAUAUGGACAUCUGGUUGCUUUGGCCUGCUGCCCUCUUUCAGGGGUCCUAAGCCCACAAUCAUGCCUCCCUAAGACCUUGGCAUCCUUCCCUCUAAGCCGUUGGCACCUCUGUGCCACCUCUCACACUGGCUCCAGACACACAGCCUGUGCUUUUGGAGCUGAGAUCACUCGCUUCACCCUCCUCAUCUUUGUUCUCCAAGUAAAGCCACGAGGUCGGGGCGAGGGCAGAGGUGAUCACCUGCGUGUCCCAUCUACAGACCUGCAGCUUCAUAAAACUUCUGAUUUCUCUUCAGCUUUGAAAAGGGUUACCCUGGGCACUGGCCUAGAGCCUCACCUCCUAAUAGACUUAGCCCCAUGAGUUUGCCAUGUUGAGCAGGACUAUUUCUGGCACUUGCAAGUCCCAUGAUUUCUUCGGUAAUUCUGAGGGUGGGGGGAGGGACAUGAAAUCAUCUUAGCUUAGCUUUCUGUCUGUGAAUGUCUAUAUAGUGUAUUGUGUGUUUUAACAAAUGAUUUACACUGACUGUUGCUGUAAAAGUGAAUUUGGAAAUAAAGUUAUUACUCUGAUUAAA,mRNA,Homo sapiens,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=73aa|residues=454-526
GPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDS
RGEHRQDRRERPY",FUS,RGG3-PY,protein_ptm:Methylation,73aa(454-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[454-507],[508-512]",[454-507],In vitro,30 µM [FUS RGG3-PY];|in presence of different amounts(0:1/1:100/1:75/1:50/1:25/1:10) of MAPT RNA,75 mM NaCl,"20 mM Na2HPO4/NaH2PO4, pH 7.5, 2.5% glycerol, 1 mM DTT",RT,-,-,Turbidity measurement,liquid,"Enhanced phase separation was also observed for the unmethylated RGG3-PY domain, which reached higher turbidity values than methylated RGG3-PY upon addition of RNA. This difference was not due to altered RNA binding, as filter binding experiments demonstrated equal affinity of unmethylated and methylated RGG3-PY for RNA.",6644
45,193,PMID: 29677514,RNAPS0000029,https://pubmed.ncbi.nlm.nih.gov/29677514,RNA + protein,NCBI ID:4137,https://www.ncbi.nlm.nih.gov/gene/4137,MAPT,6644nt(1-6644),GCAGUCACCGCCACCCACCAGCUCCGGCACCAACAGCAGCGCCGCUGCCACCGCCCACCUUCUGCCGCCGCCACCACAGCCACCUUCUCCUCCUCCGCUGUCCUCUCCCGUCCUCGCCUCUGUCGACUAUCAGGUGAACUUUGAACCAGGAUGGCUGAGCCCCGCCAGGAGUUCGAAGUGAUGGAAGAUCACGCUGGGACGUACGGGUUGGGGGACAGGAAAGAUCAGGGGGGCUACACCAUGCACCAAGACCAAGAGGGUGACACGGACGCUGGCCUGAAAGAAUCUCCCCUGCAGACCCCCACUGAGGACGGAUCUGAGGAACCGGGCUCUGAAACCUCUGAUGCUAAGAGCACUCCAACAGCGGAAGAUGUGACAGCACCCUUAGUGGAUGAGGGAGCUCCCGGCAAGCAGGCUGCCGCGCAGCCCCACACGGAGAUCCCAGAAGGAACCACAGCUGAAGAAGCAGGCAUUGGAGACACCCCCAGCCUGGAAGACGAAGCUGCUGGUCACGUGACCCAAGAGCCUGAAAGUGGUAAGGUGGUCCAGGAAGGCUUCCUCCGAGAGCCAGGCCCCCCAGGUCUGAGCCACCAGCUCAUGUCCGGCAUGCCUGGGGCUCCCCUCCUGCCUGAGGGCCCCAGAGAGGCCACACGCCAACCUUCGGGGACAGGACCUGAGGACACAGAGGGCGGCCGCCACGCCCCUGAGCUGCUCAAGCACCAGCUUCUAGGAGACCUGCACCAGGAGGGGCCGCCGCUGAAGGGGGCAGGGGGCAAAGAGAGGCCGGGGAGCAAGGAGGAGGUGGAUGAAGACCGCGACGUCGAUGAGUCCUCCCCCCAAGACUCCCCUCCCUCCAAGGCCUCCCCAGCCCAAGAUGGGCGGCCUCCCCAGACAGCCGCCAGAGAAGCCACCAGCAUCCCAGGCUUCCCAGCGGAGGGUGCCAUCCCCCUCCCUGUGGAUUUCCUCUCCAAAGUUUCCACAGAGAUCCCAGCCUCAGAGCCCGACGGGCCCAGUGUAGGGCGGGCCAAAGGGCAGGAUGCCCCCCUGGAGUUCACGUUUCACGUGGAAAUCACACCCAACGUGCAGAAGGAGCAGGCGCACUCGGAGGAGCAUUUGGGAAGGGCUGCAUUUCCAGGGGCCCCUGGAGAGGGGCCAGAGGCCCGGGGCCCCUCUUUGGGAGAGGACACAAAAGAGGCUGACCUUCCAGAGCCCUCUGAAAAGCAGCCUGCUGCUGCUCCGCGGGGGAAGCCCGUCAGCCGGGUCCCUCAACUCAAAGCUCGCAUGGUCAGUAAAAGCAAAGACGGGACUGGAAGCGAUGACAAAAAAGCCAAGACAUCCACACGUUCCUCUGCUAAAACCUUGAAAAAUAGGCCUUGCCUUAGCCCCAAACACCCCACUCCUGGUAGCUCAGACCCUCUGAUCCAACCCUCCAGCCCUGCUGUGUGCCCAGAGCCACCUUCCUCUCCUAAAUACGUCUCUUCUGUCACUUCCCGAACUGGCAGUUCUGGAGCAAAGGAGAUGAAACUCAAGGGGGCUGAUGGUAAAACGAAGAUCGCCACACCGCGGGGAGCAGCCCCUCCAGGCCAGAAGGGCCAGGCCAACGCCACCAGGAUUCCAGCAAAAACCCCGCCCGCUCCAAAGACACCACCCAGCUCUGCGACUAAGCAAGUCCAGAGAAGACCACCCCCUGCAGGGCCCAGAUCUGAGAGAGGUGAACCUCCAAAAUCAGGGGAUCGCAGCGGCUACAGCAGCCCCGGCUCCCCAGGCACUCCCGGCAGCCGCUCCCGCACCCCGUCCCUUCCAACCCCACCCACCCGGGAGCCCAAGAAGGUGGCAGUGGUCCGUACUCCACCCAAGUCGCCGUCUUCCGCCAAGAGCCGCCUGCAGACAGCCCCCGUGCCCAUGCCAGACCUGAAGAAUGUCAAGUCCAAGAUCGGCUCCACUGAGAACCUGAAGCACCAGCCGGGAGGCGGGAAGGUGCAGAUAAUUAAUAAGAAGCUGGAUCUUAGCAACGUCCAGUCCAAGUGUGGCUCAAAGGAUAAUAUCAAACACGUCCCGGGAGGCGGCAGUGUGCAAAUAGUCUACAAACCAGUUGACCUGAGCAAGGUGACCUCCAAGUGUGGCUCAUUAGGCAACAUCCAUCAUAAACCAGGAGGUGGCCAGGUGGAAGUAAAAUCUGAGAAGCUUGACUUCAAGGACAGAGUCCAGUCGAAGAUUGGGUCCCUGGACAAUAUCACCCACGUCCCUGGCGGAGGAAAUAAAAAGAUUGAAACCCACAAGCUGACCUUCCGCGAGAACGCCAAAGCCAAGACAGACCACGGGGCGGAGAUCGUGUACAAGUCGCCAGUGGUGUCUGGGGACACGUCUCCACGGCAUCUCAGCAAUGUCUCCUCCACCGGCAGCAUCGACAUGGUAGACUCGCCCCAGCUCGCCACGCUAGCUGACGAGGUGUCUGCCUCCCUGGCCAAGCAGGGUUUGUGAUCAGGCCCCUGGGGCGGUCAAUAAUUGUGGAGAGGAGAGAAUGAGAGAGUGUGGAAAAAAAAAGAAUAAUGACCCGGCCCCCGCCCUCUGCCCCCAGCUGCUCCUCGCAGUUCGGUUAAUUGGUUAAUCACUUAACCUGCUUUUGUCACUCGGCUUUGGCUCGGGACUUCAAAAUCAGUGAUGGGAGUAAGAGCAAAUUUCAUCUUUCCAAAUUGAUGGGUGGGCUAGUAAUAAAAUAUUUAAAAAAAAACAUUCAAAAACAUGGCCACAUCCAACAUUUCCUCAGGCAAUUCCUUUUGAUUCUUUUUUCUUCCCCCUCCAUGUAGAAGAGGGAGAAGGAGAGGCUCUGAAAGCUGCUUCUGGGGGAUUUCAAGGGACUGGGGGUGCCAACCACCUCUGGCCCUGUUGUGGGGGUGUCACAGAGGCAGUGGCAGCAACAAAGGAUUUGAAACUUGGUGUGUUCGUGGAGCCACAGGCAGACGAUGUCAACCUUGUGUGAGUGUGACGGGGGUUGGGGUGGGGCGGGAGGCCACGGGGGAGGCCGAGGCAGGGGCUGGGCAGAGGGGAGAGGAAGCACAAGAAGUGGGAGUGGGAGAGGAAGCCACGUGCUGGAGAGUAGACAUCCCCCUCCUUGCCGCUGGGAGAGCCAAGGCCUAUGCCACCUGCAGCGUCUGAGCGGCCGCCUGUCCUUGGUGGCCGGGGGUGGGGGCCUGCUGUGGGUCAGUGUGCCACCCUCUGCAGGGCAGCCUGUGGGAGAAGGGACAGCGGGUAAAAAGAGAAGGCAAGCUGGCAGGAGGGUGGCACUUCGUGGAUGACCUCCUUAGAAAAGACUGACCUUGAUGUCUUGAGAGCGCUGGCCUCUUCCUCCCUCCCUGCAGGGUAGGGGGCCUGAGUUGAGGGGCUUCCCUCUGCUCCACAGAAACCCUGUUUUAUUGAGUUCUGAAGGUUGGAACUGCUGCCAUGAUUUUGGCCACUUUGCAGACCUGGGACUUUAGGGCUAACCAGUUCUCUUUGUAAGGACUUGUGCCUCUUGGGAGACGUCCACCCGUUUCCAAGCCUGGGCCACUGGCAUCUCUGGAGUGUGUGGGGGUCUGGGAGGCAGGUCCCGAGCCCCCUGUCCUUCCCACGGCCACUGCAGUCACCCCGUCUGCGCCGCUGUGCUGUUGUCUGCCGUGAGAGCCCAAUCACUGCCUAUACCCCUCAUCACACGUCACAAUGUCCCGAAUUCCCAGCCUCACCACCCCUUCUCAGUAAUGACCCUGGUUGGUUGCAGGAGGUACCUACUCCAUACUGAGGGUGAAAUUAAGGGAAGGCAAAGUCCAGGCACAAGAGUGGGACCCCAGCCUCUCACUCUCAGUUCCACUCAUCCAACUGGGACCCUCACCACGAAUCUCAUGAUCUGAUUCGGUUCCCUGUCUCCUCCUCCCGUCACAGAUGUGAGCCAGGGCACUGCUCAGCUGUGACCCUAGGUGUUUCUGCCUUGUUGACAUGGAGAGAGCCCUUUCCCCUGAGAAGGCCUGGCCCCUUCCUGUGCUGAGCCCACAGCAGCAGGCUGGGUGUCUUGGUUGUCAGUGGUGGCACCAGGAUGGAAGGGCAAGGCACCCAGGGCAGGCCCACAGUCCCGCUGUCCCCCACUUGCACCCUAGCUUGUAGCUGCCAACCUCCCAGACAGCCCAGCCCGCUGCUCAGCUCCACAUGCAUAGUAUCAGCCCUCCACACCCGACAAAGGGGAACACACCCCCUUGGAAAUGGUUCUUUUCCCCCAGUCCCAGCUGGAAGCCAUGCUGUCUGUUCUGCUGGAGCAGCUGAACAUAUACAUAGAUGUUGCCCUGCCCUCCCCAUCUGCACCCUGUUGAGUUGUAGUUGGAUUUGUCUGUUUAUGCUUGGAUUCACCAGAGUGACUAUGAUAGUGAAAAGAAAAAAAAAAAAAAAAAAGGACGCAUGUAUCUUGAAAUGCUUGUAAAGAGGUUUCUAACCCACCCUCACGAGGUGUCUCUCACCCCCACACUGGGACUCGUGUGGCCUGUGUGGUGCCACCCUGCUGGGGCCUCCCAAGUUUUGAAAGGCUUUCCUCAGCACCUGGGACCCAACAGAGACCAGCUUCUAGCAGCUAAGGAGGCCGUUCAGCUGUGACGAAGGCCUGAAGCACAGGAUUAGGACUGAAGCGAUGAUGUCCCCUUCCCUACUUCCCCUUGGGGCUCCCUGUGUCAGGGCACAGACUAGGUCUUGUGGCUGGUCUGGCUUGCGGCGCGAGGAUGGUUCUCUCUGGUCAUAGCCCGAAGUCUCAUGGCAGUCCCAAAGGAGGCUUACAACUCCUGCAUCACAAGAAAAAGGAAGCCACUGCCAGCUGGGGGGAUCUGCAGCUCCCAGAAGCUCCGUGAGCCUCAGCCACCCCUCAGACUGGGUUCCUCUCCAAGCUCGCCCUCUGGAGGGGCAGCGCAGCCUCCCACCAAGGGCCCUGCGACCACAGCAGGGAUUGGGAUGAAUUGCCUGUCCUGGAUCUGCUCUAGAGGCCCAAGCUGCCUGCCUGAGGAAGGAUGACUUGACAAGUCAGGAGACACUGUUCCCAAAGCCUUGACCAGAGCACCUCAGCCCGCUGACCUUGCACAAACUCCAUCUGCUGCCAUGAGAAAAGGGAAGCCGCCUUUGCAAAACAUUGCUGCCUAAAGAAACUCAGCAGCCUCAGGCCCAAUUCUGCCACUUCUGGUUUGGGUACAGUUAAAGGCAACCCUGAGGGACUUGGCAGUAGAAAUCCAGGGCCUCCCCUGGGGCUGGCAGCUUCGUGUGCAGCUAGAGCUUUACCUGAAAGGAAGUCUCUGGGCCCAGAACUCUCCACCAAGAGCCUCCCUGCCGUUCGCUGAGUCCCAGCAAUUCUCCUAAGUUGAAGGGAUCUGAGAAGGAGAAGGAAAUGUGGGGUAGAUUUGGUGGUGGUUAGAGAUAUGCCCCCCUCAUUACUGCCAACAGUUUCGGCUGCAUUUCUUCACGCACCUCGGUUCCUCUUCCUGAAGUUCUUGUGCCCUGCUCUUCAGCACCAUGGGCCUUCUUAUACGGAAGGCUCUGGGAUCUCCCCCUUGUGGGGCAGGCUCUUGGGGCCAGCCUAAGAUCAUGGUUUAGGGUGAUCAGUGCUGGCAGAUAAAUUGAAAAGGCACGCUGGCUUGUGAUCUUAAAUGAGGACAAUCCCCCCAGGGCUGGGCACUCCUCCCCUCCCCUCACUUCUCCCACCUGCAGAGCCAGUGUCCUUGGGUGGGCUAGAUAGGAUAUACUGUAUGCCGGCUCCUUCAAGCUGCUGACUCACUUUAUCAAUAGUUCCAUUUAAAUUGACUUCAGUGGUGAGACUGUAUCCUGUUUGCUAUUGCUUGUUGUGCUAUGGGGGGAGGGGGGAGGAAUGUGUAAGAUAGUUAACAUGGGCAAAGGGAGAUCUUGGGGUGCAGCACUUAAACUGCCUCGUAACCCUUUUCAUGAUUUCAACCACAUUUGCUAGAGGGAGGGAGCAGCCACGGAGUUAGAGGCCCUUGGGGUUUCUCUUUUCCACUGACAGGCUUUCCCAGGCAGCUGGCUAGUUCAUUCCCUCCCCAGCCAGGUGCAGGCGUAGGAAUAUGGACAUCUGGUUGCUUUGGCCUGCUGCCCUCUUUCAGGGGUCCUAAGCCCACAAUCAUGCCUCCCUAAGACCUUGGCAUCCUUCCCUCUAAGCCGUUGGCACCUCUGUGCCACCUCUCACACUGGCUCCAGACACACAGCCUGUGCUUUUGGAGCUGAGAUCACUCGCUUCACCCUCCUCAUCUUUGUUCUCCAAGUAAAGCCACGAGGUCGGGGCGAGGGCAGAGGUGAUCACCUGCGUGUCCCAUCUACAGACCUGCAGCUUCAUAAAACUUCUGAUUUCUCUUCAGCUUUGAAAAGGGUUACCCUGGGCACUGGCCUAGAGCCUCACCUCCUAAUAGACUUAGCCCCAUGAGUUUGCCAUGUUGAGCAGGACUAUUUCUGGCACUUGCAAGUCCCAUGAUUUCUUCGGUAAUUCUGAGGGUGGGGGGAGGGACAUGAAAUCAUCUUAGCUUAGCUUUCUGUCUGUGAAUGUCUAUAUAGUGUAUUGUGUGUUUUAACAAAUGAUUUACACUGACUGUUGCUGUAAAAGUGAAUUUGGAAAUAAAGUUAUUACUCUGAUUAAA,mRNA,Homo sapiens,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=73aa|residues=454-526
GPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDS
RGEHRQDRRERPY",FUS,RGG3-PY,-,73aa(454-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[454-507],[508-512]",[454-507],In vitro,15-60 µM [FUS RGG3-PY];|add MAPT at a molar ratio of 1:50,75 mM NaCl,"20 mM Na2HPO4/NaH2PO4, pH 7.5, 2.5% glycerol, 1 mM DTT",25˚C,-,-,Confocal microscopy,liquid,"In the presence of substoichiometric amounts of RNA, RGG3-PY formed liquid droplets in a concentration- and temperature-dependent manner. KGG3-PY remained completely dispersed and did not form any visible droplets under conditions that induced large RGG3-PY droplets. This demonstrates that arginines in RGG motifs are crucial for LLPS of the RGG3-PY domain.",6644
46,194,PMID: 29677514,RNAPS0000029,https://pubmed.ncbi.nlm.nih.gov/29677514,RNA + protein,NCBI ID:4137,https://www.ncbi.nlm.nih.gov/gene/4137,MAPT,6644nt(1-6644),GCAGUCACCGCCACCCACCAGCUCCGGCACCAACAGCAGCGCCGCUGCCACCGCCCACCUUCUGCCGCCGCCACCACAGCCACCUUCUCCUCCUCCGCUGUCCUCUCCCGUCCUCGCCUCUGUCGACUAUCAGGUGAACUUUGAACCAGGAUGGCUGAGCCCCGCCAGGAGUUCGAAGUGAUGGAAGAUCACGCUGGGACGUACGGGUUGGGGGACAGGAAAGAUCAGGGGGGCUACACCAUGCACCAAGACCAAGAGGGUGACACGGACGCUGGCCUGAAAGAAUCUCCCCUGCAGACCCCCACUGAGGACGGAUCUGAGGAACCGGGCUCUGAAACCUCUGAUGCUAAGAGCACUCCAACAGCGGAAGAUGUGACAGCACCCUUAGUGGAUGAGGGAGCUCCCGGCAAGCAGGCUGCCGCGCAGCCCCACACGGAGAUCCCAGAAGGAACCACAGCUGAAGAAGCAGGCAUUGGAGACACCCCCAGCCUGGAAGACGAAGCUGCUGGUCACGUGACCCAAGAGCCUGAAAGUGGUAAGGUGGUCCAGGAAGGCUUCCUCCGAGAGCCAGGCCCCCCAGGUCUGAGCCACCAGCUCAUGUCCGGCAUGCCUGGGGCUCCCCUCCUGCCUGAGGGCCCCAGAGAGGCCACACGCCAACCUUCGGGGACAGGACCUGAGGACACAGAGGGCGGCCGCCACGCCCCUGAGCUGCUCAAGCACCAGCUUCUAGGAGACCUGCACCAGGAGGGGCCGCCGCUGAAGGGGGCAGGGGGCAAAGAGAGGCCGGGGAGCAAGGAGGAGGUGGAUGAAGACCGCGACGUCGAUGAGUCCUCCCCCCAAGACUCCCCUCCCUCCAAGGCCUCCCCAGCCCAAGAUGGGCGGCCUCCCCAGACAGCCGCCAGAGAAGCCACCAGCAUCCCAGGCUUCCCAGCGGAGGGUGCCAUCCCCCUCCCUGUGGAUUUCCUCUCCAAAGUUUCCACAGAGAUCCCAGCCUCAGAGCCCGACGGGCCCAGUGUAGGGCGGGCCAAAGGGCAGGAUGCCCCCCUGGAGUUCACGUUUCACGUGGAAAUCACACCCAACGUGCAGAAGGAGCAGGCGCACUCGGAGGAGCAUUUGGGAAGGGCUGCAUUUCCAGGGGCCCCUGGAGAGGGGCCAGAGGCCCGGGGCCCCUCUUUGGGAGAGGACACAAAAGAGGCUGACCUUCCAGAGCCCUCUGAAAAGCAGCCUGCUGCUGCUCCGCGGGGGAAGCCCGUCAGCCGGGUCCCUCAACUCAAAGCUCGCAUGGUCAGUAAAAGCAAAGACGGGACUGGAAGCGAUGACAAAAAAGCCAAGACAUCCACACGUUCCUCUGCUAAAACCUUGAAAAAUAGGCCUUGCCUUAGCCCCAAACACCCCACUCCUGGUAGCUCAGACCCUCUGAUCCAACCCUCCAGCCCUGCUGUGUGCCCAGAGCCACCUUCCUCUCCUAAAUACGUCUCUUCUGUCACUUCCCGAACUGGCAGUUCUGGAGCAAAGGAGAUGAAACUCAAGGGGGCUGAUGGUAAAACGAAGAUCGCCACACCGCGGGGAGCAGCCCCUCCAGGCCAGAAGGGCCAGGCCAACGCCACCAGGAUUCCAGCAAAAACCCCGCCCGCUCCAAAGACACCACCCAGCUCUGCGACUAAGCAAGUCCAGAGAAGACCACCCCCUGCAGGGCCCAGAUCUGAGAGAGGUGAACCUCCAAAAUCAGGGGAUCGCAGCGGCUACAGCAGCCCCGGCUCCCCAGGCACUCCCGGCAGCCGCUCCCGCACCCCGUCCCUUCCAACCCCACCCACCCGGGAGCCCAAGAAGGUGGCAGUGGUCCGUACUCCACCCAAGUCGCCGUCUUCCGCCAAGAGCCGCCUGCAGACAGCCCCCGUGCCCAUGCCAGACCUGAAGAAUGUCAAGUCCAAGAUCGGCUCCACUGAGAACCUGAAGCACCAGCCGGGAGGCGGGAAGGUGCAGAUAAUUAAUAAGAAGCUGGAUCUUAGCAACGUCCAGUCCAAGUGUGGCUCAAAGGAUAAUAUCAAACACGUCCCGGGAGGCGGCAGUGUGCAAAUAGUCUACAAACCAGUUGACCUGAGCAAGGUGACCUCCAAGUGUGGCUCAUUAGGCAACAUCCAUCAUAAACCAGGAGGUGGCCAGGUGGAAGUAAAAUCUGAGAAGCUUGACUUCAAGGACAGAGUCCAGUCGAAGAUUGGGUCCCUGGACAAUAUCACCCACGUCCCUGGCGGAGGAAAUAAAAAGAUUGAAACCCACAAGCUGACCUUCCGCGAGAACGCCAAAGCCAAGACAGACCACGGGGCGGAGAUCGUGUACAAGUCGCCAGUGGUGUCUGGGGACACGUCUCCACGGCAUCUCAGCAAUGUCUCCUCCACCGGCAGCAUCGACAUGGUAGACUCGCCCCAGCUCGCCACGCUAGCUGACGAGGUGUCUGCCUCCCUGGCCAAGCAGGGUUUGUGAUCAGGCCCCUGGGGCGGUCAAUAAUUGUGGAGAGGAGAGAAUGAGAGAGUGUGGAAAAAAAAAGAAUAAUGACCCGGCCCCCGCCCUCUGCCCCCAGCUGCUCCUCGCAGUUCGGUUAAUUGGUUAAUCACUUAACCUGCUUUUGUCACUCGGCUUUGGCUCGGGACUUCAAAAUCAGUGAUGGGAGUAAGAGCAAAUUUCAUCUUUCCAAAUUGAUGGGUGGGCUAGUAAUAAAAUAUUUAAAAAAAAACAUUCAAAAACAUGGCCACAUCCAACAUUUCCUCAGGCAAUUCCUUUUGAUUCUUUUUUCUUCCCCCUCCAUGUAGAAGAGGGAGAAGGAGAGGCUCUGAAAGCUGCUUCUGGGGGAUUUCAAGGGACUGGGGGUGCCAACCACCUCUGGCCCUGUUGUGGGGGUGUCACAGAGGCAGUGGCAGCAACAAAGGAUUUGAAACUUGGUGUGUUCGUGGAGCCACAGGCAGACGAUGUCAACCUUGUGUGAGUGUGACGGGGGUUGGGGUGGGGCGGGAGGCCACGGGGGAGGCCGAGGCAGGGGCUGGGCAGAGGGGAGAGGAAGCACAAGAAGUGGGAGUGGGAGAGGAAGCCACGUGCUGGAGAGUAGACAUCCCCCUCCUUGCCGCUGGGAGAGCCAAGGCCUAUGCCACCUGCAGCGUCUGAGCGGCCGCCUGUCCUUGGUGGCCGGGGGUGGGGGCCUGCUGUGGGUCAGUGUGCCACCCUCUGCAGGGCAGCCUGUGGGAGAAGGGACAGCGGGUAAAAAGAGAAGGCAAGCUGGCAGGAGGGUGGCACUUCGUGGAUGACCUCCUUAGAAAAGACUGACCUUGAUGUCUUGAGAGCGCUGGCCUCUUCCUCCCUCCCUGCAGGGUAGGGGGCCUGAGUUGAGGGGCUUCCCUCUGCUCCACAGAAACCCUGUUUUAUUGAGUUCUGAAGGUUGGAACUGCUGCCAUGAUUUUGGCCACUUUGCAGACCUGGGACUUUAGGGCUAACCAGUUCUCUUUGUAAGGACUUGUGCCUCUUGGGAGACGUCCACCCGUUUCCAAGCCUGGGCCACUGGCAUCUCUGGAGUGUGUGGGGGUCUGGGAGGCAGGUCCCGAGCCCCCUGUCCUUCCCACGGCCACUGCAGUCACCCCGUCUGCGCCGCUGUGCUGUUGUCUGCCGUGAGAGCCCAAUCACUGCCUAUACCCCUCAUCACACGUCACAAUGUCCCGAAUUCCCAGCCUCACCACCCCUUCUCAGUAAUGACCCUGGUUGGUUGCAGGAGGUACCUACUCCAUACUGAGGGUGAAAUUAAGGGAAGGCAAAGUCCAGGCACAAGAGUGGGACCCCAGCCUCUCACUCUCAGUUCCACUCAUCCAACUGGGACCCUCACCACGAAUCUCAUGAUCUGAUUCGGUUCCCUGUCUCCUCCUCCCGUCACAGAUGUGAGCCAGGGCACUGCUCAGCUGUGACCCUAGGUGUUUCUGCCUUGUUGACAUGGAGAGAGCCCUUUCCCCUGAGAAGGCCUGGCCCCUUCCUGUGCUGAGCCCACAGCAGCAGGCUGGGUGUCUUGGUUGUCAGUGGUGGCACCAGGAUGGAAGGGCAAGGCACCCAGGGCAGGCCCACAGUCCCGCUGUCCCCCACUUGCACCCUAGCUUGUAGCUGCCAACCUCCCAGACAGCCCAGCCCGCUGCUCAGCUCCACAUGCAUAGUAUCAGCCCUCCACACCCGACAAAGGGGAACACACCCCCUUGGAAAUGGUUCUUUUCCCCCAGUCCCAGCUGGAAGCCAUGCUGUCUGUUCUGCUGGAGCAGCUGAACAUAUACAUAGAUGUUGCCCUGCCCUCCCCAUCUGCACCCUGUUGAGUUGUAGUUGGAUUUGUCUGUUUAUGCUUGGAUUCACCAGAGUGACUAUGAUAGUGAAAAGAAAAAAAAAAAAAAAAAAGGACGCAUGUAUCUUGAAAUGCUUGUAAAGAGGUUUCUAACCCACCCUCACGAGGUGUCUCUCACCCCCACACUGGGACUCGUGUGGCCUGUGUGGUGCCACCCUGCUGGGGCCUCCCAAGUUUUGAAAGGCUUUCCUCAGCACCUGGGACCCAACAGAGACCAGCUUCUAGCAGCUAAGGAGGCCGUUCAGCUGUGACGAAGGCCUGAAGCACAGGAUUAGGACUGAAGCGAUGAUGUCCCCUUCCCUACUUCCCCUUGGGGCUCCCUGUGUCAGGGCACAGACUAGGUCUUGUGGCUGGUCUGGCUUGCGGCGCGAGGAUGGUUCUCUCUGGUCAUAGCCCGAAGUCUCAUGGCAGUCCCAAAGGAGGCUUACAACUCCUGCAUCACAAGAAAAAGGAAGCCACUGCCAGCUGGGGGGAUCUGCAGCUCCCAGAAGCUCCGUGAGCCUCAGCCACCCCUCAGACUGGGUUCCUCUCCAAGCUCGCCCUCUGGAGGGGCAGCGCAGCCUCCCACCAAGGGCCCUGCGACCACAGCAGGGAUUGGGAUGAAUUGCCUGUCCUGGAUCUGCUCUAGAGGCCCAAGCUGCCUGCCUGAGGAAGGAUGACUUGACAAGUCAGGAGACACUGUUCCCAAAGCCUUGACCAGAGCACCUCAGCCCGCUGACCUUGCACAAACUCCAUCUGCUGCCAUGAGAAAAGGGAAGCCGCCUUUGCAAAACAUUGCUGCCUAAAGAAACUCAGCAGCCUCAGGCCCAAUUCUGCCACUUCUGGUUUGGGUACAGUUAAAGGCAACCCUGAGGGACUUGGCAGUAGAAAUCCAGGGCCUCCCCUGGGGCUGGCAGCUUCGUGUGCAGCUAGAGCUUUACCUGAAAGGAAGUCUCUGGGCCCAGAACUCUCCACCAAGAGCCUCCCUGCCGUUCGCUGAGUCCCAGCAAUUCUCCUAAGUUGAAGGGAUCUGAGAAGGAGAAGGAAAUGUGGGGUAGAUUUGGUGGUGGUUAGAGAUAUGCCCCCCUCAUUACUGCCAACAGUUUCGGCUGCAUUUCUUCACGCACCUCGGUUCCUCUUCCUGAAGUUCUUGUGCCCUGCUCUUCAGCACCAUGGGCCUUCUUAUACGGAAGGCUCUGGGAUCUCCCCCUUGUGGGGCAGGCUCUUGGGGCCAGCCUAAGAUCAUGGUUUAGGGUGAUCAGUGCUGGCAGAUAAAUUGAAAAGGCACGCUGGCUUGUGAUCUUAAAUGAGGACAAUCCCCCCAGGGCUGGGCACUCCUCCCCUCCCCUCACUUCUCCCACCUGCAGAGCCAGUGUCCUUGGGUGGGCUAGAUAGGAUAUACUGUAUGCCGGCUCCUUCAAGCUGCUGACUCACUUUAUCAAUAGUUCCAUUUAAAUUGACUUCAGUGGUGAGACUGUAUCCUGUUUGCUAUUGCUUGUUGUGCUAUGGGGGGAGGGGGGAGGAAUGUGUAAGAUAGUUAACAUGGGCAAAGGGAGAUCUUGGGGUGCAGCACUUAAACUGCCUCGUAACCCUUUUCAUGAUUUCAACCACAUUUGCUAGAGGGAGGGAGCAGCCACGGAGUUAGAGGCCCUUGGGGUUUCUCUUUUCCACUGACAGGCUUUCCCAGGCAGCUGGCUAGUUCAUUCCCUCCCCAGCCAGGUGCAGGCGUAGGAAUAUGGACAUCUGGUUGCUUUGGCCUGCUGCCCUCUUUCAGGGGUCCUAAGCCCACAAUCAUGCCUCCCUAAGACCUUGGCAUCCUUCCCUCUAAGCCGUUGGCACCUCUGUGCCACCUCUCACACUGGCUCCAGACACACAGCCUGUGCUUUUGGAGCUGAGAUCACUCGCUUCACCCUCCUCAUCUUUGUUCUCCAAGUAAAGCCACGAGGUCGGGGCGAGGGCAGAGGUGAUCACCUGCGUGUCCCAUCUACAGACCUGCAGCUUCAUAAAACUUCUGAUUUCUCUUCAGCUUUGAAAAGGGUUACCCUGGGCACUGGCCUAGAGCCUCACCUCCUAAUAGACUUAGCCCCAUGAGUUUGCCAUGUUGAGCAGGACUAUUUCUGGCACUUGCAAGUCCCAUGAUUUCUUCGGUAAUUCUGAGGGUGGGGGGAGGGACAUGAAAUCAUCUUAGCUUAGCUUUCUGUCUGUGAAUGUCUAUAUAGUGUAUUGUGUGUUUUAACAAAUGAUUUACACUGACUGUUGCUGUAAAAGUGAAUUUGGAAAUAAAGUUAUUACUCUGAUUAAA,mRNA,Homo sapiens,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=73aa|residues=454-526
GPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDS
RGEHRQDRRERPY",FUS,RGG3-PY,-,73aa(454-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[454-507],[508-512]",[454-507],In vitro,2.5-30 µM [FUS RGG3-PY];|add MAPT at a molar ratio of 1:50,75 mM NaCl,"20 mM Na2HPO4/NaH2PO4, pH 7.5, 2.5% glycerol, 1 mM DTT",0-40˚C,-,-,Microscopy,"liquid, solute","In the presence of substoichiometric amounts of RNA, RGG3-PY formed liquid droplets in a concentration- and temperature-dependent manner. KGG3-PY remained completely dispersed and did not form any visible droplets under conditions that induced large RGG3-PY droplets. This demonstrates that arginines in RGG motifs are crucial for LLPS of the RGG3-PY domain.",6644
47,195,PMID: 29677514,RNAPS0000029,https://pubmed.ncbi.nlm.nih.gov/29677514,RNA + protein,NCBI ID:4137,https://www.ncbi.nlm.nih.gov/gene/4137,MAPT,6644nt(1-6644),GCAGUCACCGCCACCCACCAGCUCCGGCACCAACAGCAGCGCCGCUGCCACCGCCCACCUUCUGCCGCCGCCACCACAGCCACCUUCUCCUCCUCCGCUGUCCUCUCCCGUCCUCGCCUCUGUCGACUAUCAGGUGAACUUUGAACCAGGAUGGCUGAGCCCCGCCAGGAGUUCGAAGUGAUGGAAGAUCACGCUGGGACGUACGGGUUGGGGGACAGGAAAGAUCAGGGGGGCUACACCAUGCACCAAGACCAAGAGGGUGACACGGACGCUGGCCUGAAAGAAUCUCCCCUGCAGACCCCCACUGAGGACGGAUCUGAGGAACCGGGCUCUGAAACCUCUGAUGCUAAGAGCACUCCAACAGCGGAAGAUGUGACAGCACCCUUAGUGGAUGAGGGAGCUCCCGGCAAGCAGGCUGCCGCGCAGCCCCACACGGAGAUCCCAGAAGGAACCACAGCUGAAGAAGCAGGCAUUGGAGACACCCCCAGCCUGGAAGACGAAGCUGCUGGUCACGUGACCCAAGAGCCUGAAAGUGGUAAGGUGGUCCAGGAAGGCUUCCUCCGAGAGCCAGGCCCCCCAGGUCUGAGCCACCAGCUCAUGUCCGGCAUGCCUGGGGCUCCCCUCCUGCCUGAGGGCCCCAGAGAGGCCACACGCCAACCUUCGGGGACAGGACCUGAGGACACAGAGGGCGGCCGCCACGCCCCUGAGCUGCUCAAGCACCAGCUUCUAGGAGACCUGCACCAGGAGGGGCCGCCGCUGAAGGGGGCAGGGGGCAAAGAGAGGCCGGGGAGCAAGGAGGAGGUGGAUGAAGACCGCGACGUCGAUGAGUCCUCCCCCCAAGACUCCCCUCCCUCCAAGGCCUCCCCAGCCCAAGAUGGGCGGCCUCCCCAGACAGCCGCCAGAGAAGCCACCAGCAUCCCAGGCUUCCCAGCGGAGGGUGCCAUCCCCCUCCCUGUGGAUUUCCUCUCCAAAGUUUCCACAGAGAUCCCAGCCUCAGAGCCCGACGGGCCCAGUGUAGGGCGGGCCAAAGGGCAGGAUGCCCCCCUGGAGUUCACGUUUCACGUGGAAAUCACACCCAACGUGCAGAAGGAGCAGGCGCACUCGGAGGAGCAUUUGGGAAGGGCUGCAUUUCCAGGGGCCCCUGGAGAGGGGCCAGAGGCCCGGGGCCCCUCUUUGGGAGAGGACACAAAAGAGGCUGACCUUCCAGAGCCCUCUGAAAAGCAGCCUGCUGCUGCUCCGCGGGGGAAGCCCGUCAGCCGGGUCCCUCAACUCAAAGCUCGCAUGGUCAGUAAAAGCAAAGACGGGACUGGAAGCGAUGACAAAAAAGCCAAGACAUCCACACGUUCCUCUGCUAAAACCUUGAAAAAUAGGCCUUGCCUUAGCCCCAAACACCCCACUCCUGGUAGCUCAGACCCUCUGAUCCAACCCUCCAGCCCUGCUGUGUGCCCAGAGCCACCUUCCUCUCCUAAAUACGUCUCUUCUGUCACUUCCCGAACUGGCAGUUCUGGAGCAAAGGAGAUGAAACUCAAGGGGGCUGAUGGUAAAACGAAGAUCGCCACACCGCGGGGAGCAGCCCCUCCAGGCCAGAAGGGCCAGGCCAACGCCACCAGGAUUCCAGCAAAAACCCCGCCCGCUCCAAAGACACCACCCAGCUCUGCGACUAAGCAAGUCCAGAGAAGACCACCCCCUGCAGGGCCCAGAUCUGAGAGAGGUGAACCUCCAAAAUCAGGGGAUCGCAGCGGCUACAGCAGCCCCGGCUCCCCAGGCACUCCCGGCAGCCGCUCCCGCACCCCGUCCCUUCCAACCCCACCCACCCGGGAGCCCAAGAAGGUGGCAGUGGUCCGUACUCCACCCAAGUCGCCGUCUUCCGCCAAGAGCCGCCUGCAGACAGCCCCCGUGCCCAUGCCAGACCUGAAGAAUGUCAAGUCCAAGAUCGGCUCCACUGAGAACCUGAAGCACCAGCCGGGAGGCGGGAAGGUGCAGAUAAUUAAUAAGAAGCUGGAUCUUAGCAACGUCCAGUCCAAGUGUGGCUCAAAGGAUAAUAUCAAACACGUCCCGGGAGGCGGCAGUGUGCAAAUAGUCUACAAACCAGUUGACCUGAGCAAGGUGACCUCCAAGUGUGGCUCAUUAGGCAACAUCCAUCAUAAACCAGGAGGUGGCCAGGUGGAAGUAAAAUCUGAGAAGCUUGACUUCAAGGACAGAGUCCAGUCGAAGAUUGGGUCCCUGGACAAUAUCACCCACGUCCCUGGCGGAGGAAAUAAAAAGAUUGAAACCCACAAGCUGACCUUCCGCGAGAACGCCAAAGCCAAGACAGACCACGGGGCGGAGAUCGUGUACAAGUCGCCAGUGGUGUCUGGGGACACGUCUCCACGGCAUCUCAGCAAUGUCUCCUCCACCGGCAGCAUCGACAUGGUAGACUCGCCCCAGCUCGCCACGCUAGCUGACGAGGUGUCUGCCUCCCUGGCCAAGCAGGGUUUGUGAUCAGGCCCCUGGGGCGGUCAAUAAUUGUGGAGAGGAGAGAAUGAGAGAGUGUGGAAAAAAAAAGAAUAAUGACCCGGCCCCCGCCCUCUGCCCCCAGCUGCUCCUCGCAGUUCGGUUAAUUGGUUAAUCACUUAACCUGCUUUUGUCACUCGGCUUUGGCUCGGGACUUCAAAAUCAGUGAUGGGAGUAAGAGCAAAUUUCAUCUUUCCAAAUUGAUGGGUGGGCUAGUAAUAAAAUAUUUAAAAAAAAACAUUCAAAAACAUGGCCACAUCCAACAUUUCCUCAGGCAAUUCCUUUUGAUUCUUUUUUCUUCCCCCUCCAUGUAGAAGAGGGAGAAGGAGAGGCUCUGAAAGCUGCUUCUGGGGGAUUUCAAGGGACUGGGGGUGCCAACCACCUCUGGCCCUGUUGUGGGGGUGUCACAGAGGCAGUGGCAGCAACAAAGGAUUUGAAACUUGGUGUGUUCGUGGAGCCACAGGCAGACGAUGUCAACCUUGUGUGAGUGUGACGGGGGUUGGGGUGGGGCGGGAGGCCACGGGGGAGGCCGAGGCAGGGGCUGGGCAGAGGGGAGAGGAAGCACAAGAAGUGGGAGUGGGAGAGGAAGCCACGUGCUGGAGAGUAGACAUCCCCCUCCUUGCCGCUGGGAGAGCCAAGGCCUAUGCCACCUGCAGCGUCUGAGCGGCCGCCUGUCCUUGGUGGCCGGGGGUGGGGGCCUGCUGUGGGUCAGUGUGCCACCCUCUGCAGGGCAGCCUGUGGGAGAAGGGACAGCGGGUAAAAAGAGAAGGCAAGCUGGCAGGAGGGUGGCACUUCGUGGAUGACCUCCUUAGAAAAGACUGACCUUGAUGUCUUGAGAGCGCUGGCCUCUUCCUCCCUCCCUGCAGGGUAGGGGGCCUGAGUUGAGGGGCUUCCCUCUGCUCCACAGAAACCCUGUUUUAUUGAGUUCUGAAGGUUGGAACUGCUGCCAUGAUUUUGGCCACUUUGCAGACCUGGGACUUUAGGGCUAACCAGUUCUCUUUGUAAGGACUUGUGCCUCUUGGGAGACGUCCACCCGUUUCCAAGCCUGGGCCACUGGCAUCUCUGGAGUGUGUGGGGGUCUGGGAGGCAGGUCCCGAGCCCCCUGUCCUUCCCACGGCCACUGCAGUCACCCCGUCUGCGCCGCUGUGCUGUUGUCUGCCGUGAGAGCCCAAUCACUGCCUAUACCCCUCAUCACACGUCACAAUGUCCCGAAUUCCCAGCCUCACCACCCCUUCUCAGUAAUGACCCUGGUUGGUUGCAGGAGGUACCUACUCCAUACUGAGGGUGAAAUUAAGGGAAGGCAAAGUCCAGGCACAAGAGUGGGACCCCAGCCUCUCACUCUCAGUUCCACUCAUCCAACUGGGACCCUCACCACGAAUCUCAUGAUCUGAUUCGGUUCCCUGUCUCCUCCUCCCGUCACAGAUGUGAGCCAGGGCACUGCUCAGCUGUGACCCUAGGUGUUUCUGCCUUGUUGACAUGGAGAGAGCCCUUUCCCCUGAGAAGGCCUGGCCCCUUCCUGUGCUGAGCCCACAGCAGCAGGCUGGGUGUCUUGGUUGUCAGUGGUGGCACCAGGAUGGAAGGGCAAGGCACCCAGGGCAGGCCCACAGUCCCGCUGUCCCCCACUUGCACCCUAGCUUGUAGCUGCCAACCUCCCAGACAGCCCAGCCCGCUGCUCAGCUCCACAUGCAUAGUAUCAGCCCUCCACACCCGACAAAGGGGAACACACCCCCUUGGAAAUGGUUCUUUUCCCCCAGUCCCAGCUGGAAGCCAUGCUGUCUGUUCUGCUGGAGCAGCUGAACAUAUACAUAGAUGUUGCCCUGCCCUCCCCAUCUGCACCCUGUUGAGUUGUAGUUGGAUUUGUCUGUUUAUGCUUGGAUUCACCAGAGUGACUAUGAUAGUGAAAAGAAAAAAAAAAAAAAAAAAGGACGCAUGUAUCUUGAAAUGCUUGUAAAGAGGUUUCUAACCCACCCUCACGAGGUGUCUCUCACCCCCACACUGGGACUCGUGUGGCCUGUGUGGUGCCACCCUGCUGGGGCCUCCCAAGUUUUGAAAGGCUUUCCUCAGCACCUGGGACCCAACAGAGACCAGCUUCUAGCAGCUAAGGAGGCCGUUCAGCUGUGACGAAGGCCUGAAGCACAGGAUUAGGACUGAAGCGAUGAUGUCCCCUUCCCUACUUCCCCUUGGGGCUCCCUGUGUCAGGGCACAGACUAGGUCUUGUGGCUGGUCUGGCUUGCGGCGCGAGGAUGGUUCUCUCUGGUCAUAGCCCGAAGUCUCAUGGCAGUCCCAAAGGAGGCUUACAACUCCUGCAUCACAAGAAAAAGGAAGCCACUGCCAGCUGGGGGGAUCUGCAGCUCCCAGAAGCUCCGUGAGCCUCAGCCACCCCUCAGACUGGGUUCCUCUCCAAGCUCGCCCUCUGGAGGGGCAGCGCAGCCUCCCACCAAGGGCCCUGCGACCACAGCAGGGAUUGGGAUGAAUUGCCUGUCCUGGAUCUGCUCUAGAGGCCCAAGCUGCCUGCCUGAGGAAGGAUGACUUGACAAGUCAGGAGACACUGUUCCCAAAGCCUUGACCAGAGCACCUCAGCCCGCUGACCUUGCACAAACUCCAUCUGCUGCCAUGAGAAAAGGGAAGCCGCCUUUGCAAAACAUUGCUGCCUAAAGAAACUCAGCAGCCUCAGGCCCAAUUCUGCCACUUCUGGUUUGGGUACAGUUAAAGGCAACCCUGAGGGACUUGGCAGUAGAAAUCCAGGGCCUCCCCUGGGGCUGGCAGCUUCGUGUGCAGCUAGAGCUUUACCUGAAAGGAAGUCUCUGGGCCCAGAACUCUCCACCAAGAGCCUCCCUGCCGUUCGCUGAGUCCCAGCAAUUCUCCUAAGUUGAAGGGAUCUGAGAAGGAGAAGGAAAUGUGGGGUAGAUUUGGUGGUGGUUAGAGAUAUGCCCCCCUCAUUACUGCCAACAGUUUCGGCUGCAUUUCUUCACGCACCUCGGUUCCUCUUCCUGAAGUUCUUGUGCCCUGCUCUUCAGCACCAUGGGCCUUCUUAUACGGAAGGCUCUGGGAUCUCCCCCUUGUGGGGCAGGCUCUUGGGGCCAGCCUAAGAUCAUGGUUUAGGGUGAUCAGUGCUGGCAGAUAAAUUGAAAAGGCACGCUGGCUUGUGAUCUUAAAUGAGGACAAUCCCCCCAGGGCUGGGCACUCCUCCCCUCCCCUCACUUCUCCCACCUGCAGAGCCAGUGUCCUUGGGUGGGCUAGAUAGGAUAUACUGUAUGCCGGCUCCUUCAAGCUGCUGACUCACUUUAUCAAUAGUUCCAUUUAAAUUGACUUCAGUGGUGAGACUGUAUCCUGUUUGCUAUUGCUUGUUGUGCUAUGGGGGGAGGGGGGAGGAAUGUGUAAGAUAGUUAACAUGGGCAAAGGGAGAUCUUGGGGUGCAGCACUUAAACUGCCUCGUAACCCUUUUCAUGAUUUCAACCACAUUUGCUAGAGGGAGGGAGCAGCCACGGAGUUAGAGGCCCUUGGGGUUUCUCUUUUCCACUGACAGGCUUUCCCAGGCAGCUGGCUAGUUCAUUCCCUCCCCAGCCAGGUGCAGGCGUAGGAAUAUGGACAUCUGGUUGCUUUGGCCUGCUGCCCUCUUUCAGGGGUCCUAAGCCCACAAUCAUGCCUCCCUAAGACCUUGGCAUCCUUCCCUCUAAGCCGUUGGCACCUCUGUGCCACCUCUCACACUGGCUCCAGACACACAGCCUGUGCUUUUGGAGCUGAGAUCACUCGCUUCACCCUCCUCAUCUUUGUUCUCCAAGUAAAGCCACGAGGUCGGGGCGAGGGCAGAGGUGAUCACCUGCGUGUCCCAUCUACAGACCUGCAGCUUCAUAAAACUUCUGAUUUCUCUUCAGCUUUGAAAAGGGUUACCCUGGGCACUGGCCUAGAGCCUCACCUCCUAAUAGACUUAGCCCCAUGAGUUUGCCAUGUUGAGCAGGACUAUUUCUGGCACUUGCAAGUCCCAUGAUUUCUUCGGUAAUUCUGAGGGUGGGGGGAGGGACAUGAAAUCAUCUUAGCUUAGCUUUCUGUCUGUGAAUGUCUAUAUAGUGUAUUGUGUGUUUUAACAAAUGAUUUACACUGACUGUUGCUGUAAAAGUGAAUUUGGAAAUAAAGUUAUUACUCUGAUUAAA,mRNA,Homo sapiens,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=73aa|residues=454-526|mutation=R473,476,481,487,491,495,498,503K
GPGGGPGGSHMGGNYGDDRKGGKGGYDKGGYRGKGGDKGGFKGGKGGGDKGGFGPGKMDS
RGEHRQDRRERPY",FUS,RGG3-PY,"protein_mutation:R473,476,481,487,491,495,498,503K",73aa(454-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[454-470],[475-485],[491-492],[505-526]",-,In vitro,60 µM [FUS KGG3-PY];|add MAPT at a molar ratio of 1:50,75 mM NaCl,"20 mM Na2HPO4/NaH2PO4, pH 7.5, 2.5% glycerol, 1 mM DTT",25˚C,-,-,Confocal microscopy,solute,"In the presence of substoichiometric amounts of RNA, RGG3-PY formed liquid droplets in a concentration- and temperature-dependent manner. KGG3-PY remained completely dispersed and did not form any visible droplets under conditions that induced large RGG3-PY droplets. This demonstrates that arginines in RGG motifs are crucial for LLPS of the RGG3-PY domain.",6644
48,201,PMID: 29932899,RNAPS0000034,https://pubmed.ncbi.nlm.nih.gov/29932899,RNA + protein,NCBI ID:283131,https://www.ncbi.nlm.nih.gov/gene/283131,NEAT1_antisense,1079nt(12-13k),AGAAUACUCAAGCUAUGCAUCAAGCUUGGUACCGAGGUAACGGCCGCCAGUGUGCUGGAAUUCGCCCUUUUCCGGUAUGGACAGGCAGCUGCAGCCACUACGCAGUUUUACCCCAGUUCCACGGCACAUGAGGAGAGGACCAACAUUAUUCUAUUUUGGCAGCACGUGCUUUCAACCCAUCUCACAAAACAGUGUCACCAACCAGAUGUGCCAAGAGCCAGAGCAGGUGAAGACACCUACAGAUGCUGCCUCCUCUGGACACUGCCUCUGGGUGCCUCAGCUCUGCACCCAGAGGGAUGCAAAAGAGAUCCCCGCAGCACACUUUGAGAUGGCUAGGAAACUGCAAAUAACCUCAAAGCCAUCACUAGAAAAAUGGUUAAAAUGACCAUACCAACACGUACAAUAUGACAUGUUAUAGAGCCAUAAAAAUAACAGUACACCUUGUAUGAUUCCAUUUUAGGGCAGAGAAUAAUAGGAUACAUUUUAGUACAUCCACAGCCAGAAAAUGUCUGAAGGAAUAUAAAUGAAGUUGUCAUUAGUAGUUAUCUUAGGGGUCCGGGAUUAUAGAGGAACUUUUAUCUUCUACAUGGCCUUUUUCUAUAGUGUUUGAAUUUUAAUUACAAGACCAGUGAUUUAUAAAUUCAUACACUCCACAGCCCCAUCCAUUACAAUAGCACAUAAUAUAAUAACAUUAGCCAUGGACUUACCUAAAUCUGCAUAAUUUUGGUCUCUUCAGGACAGUUGCUGCAAUGCAGGCAUAAGCAGAGGACAAAGCCACAGUGUGACCUGGGUGCAGAGCACUGGGUUGGGCAUCACCAGCAGACACAUGACAAAAGCAAUUUAAAAAAUUAUACCUUGACAAAAUUAUACAUGAUUAUAUGUCUUGGACCCUGGGGGCCUUGUCAGCAUUAAGCCCAUGAAUGCUAAAUUCACACACAGAUGACAAGAAUCUACUGUACCAAUUACAGUCUUAGUAGGUCACUGCAUACAUGAUAGAUCAAAGAUGGCAACUAGCAGAAACUUAAGUUUCAUAUAUGGAGCGUCGAAGGGCGAAUUCUGCAGAUAUCCAUCACACUGGC,lncRNA,Homo sapiens,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-,-,526aa(1-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[1-507],[508-512]","[17-104],[106-261],[371-425],[450-507]",In vitro,-,-,-,-,-,-,Immunoblotting,liquid,"Immunoblotting analysis revealed that three essential PSPs (NONO, SFPQ, and RBM14) were specifically precipitated with the sense RNA. Interestingly, FUS nonspecifically bound both to the sense and antisense RNAs (Figure 7B).",1079
49,235,PMID: 30765518,RNAPS0000036,https://pubmed.ncbi.nlm.nih.gov/30765518,RNA + protein,NCBI ID:4609,https://www.ncbi.nlm.nih.gov/gene/4609,MYC,4515nt(1-4515),GGAGUUUAUUCAUAACGCGCUCUCCAAGUAUACGUGGCAAUGCGUUGCUGGGUUAUUUUAAUCAUUCUAGGCAUCGUUUUCCUCCUUAUGCCUCUAUCAUUCCUCCCUAUCUACACUAACAUCCCACGCUCUGAACGCGCGCCCAUUAAUACCCUUCUUUCCUCCACUCUCCCUGGGACUCUUGAUCAAAGCGCGGCCCUUUCCCCAGCCUUAGCGAGGCGCCCUGCAGCCUGGUACGCGCGUGGCGUGGCGGUGGGCGCGCAGUGCGUUCUCGGUGUGGAGGGCAGCUGUUCCGCCUGCGAUGAUUUAUACUCACAGGACAAGGAUGCGGUUUGUCAAACAGUACUGCUACGGAGGAGCAGCAGAGAAAGGGAGAGGGUUUGAGAGGGAGCAAAAGAAAAUGGUAGGCGCGCGUAGUUAAUUCAUGCGGCUCUCUUACUCUGUUUACAUCCUAGAGCUAGAGUGCUCGGCUGCCCGGCUGAGUCUCCUCCCCACCUUCCCCACCCUCCCCACCCUCCCCAUAAGCGCCCCUCCCGGGUUCCCAAAGCAGAGGGCGUGGGGGAAAAGAAAAAAGAUCCUCUCUCGCUAAUCUCCGCCCACCGGCCCUUUAUAAUGCGAGGGUCUGGACGGCUGAGGACCCCCGAGCUGUGCUGCUCGCGGCCGCCACCGCCGGGCCCCGGCCGUCCCUGGCUCCCCUCCUGCCUCGAGAAGGGCAGGGCUUCUCAGAGGCUUGGCGGGAAAAAGAACGGAGGGAGGGAUCGCGCUGAGUAUAAAAGCCGGUUUUCGGGGCUUUAUCUAACUCGCUGUAGUAAUUCCAGCGAGAGGCAGAGGGAGCGAGCGGGCGGCCGGCUAGGGUGGAAGAGCCGGGCGAGCAGAGCUGCGCUGCGGGCGUCCUGGGAAGGGAGAUCCGGAGCGAAUAGGGGGCUUCGCCUCUGGCCCAGCCCUCCCGCUGAUCCCCCAGCCAGCGGUCCGCAACCCUUGCCGCAUCCACGAAACUUUGCCCAUAGCAGCGGGCGGGCACUUUGCACUGGAACUUACAACACCCGAGCAAGGACGCGACUCUCCCGACGCGGGGAGGCUAUUCUGCCCAUUUGGGGACACUUCCCCGCCGCUGCCAGGACCCGCUUCUCUGAAAGGCUCUCCUUGCAGCUGCUUAGACGCUGGAUUUUUUUCGGGUAGUGGAAAACCAGCCUCCCGCGACGAUGCCCCUCAACGUUAGCUUCACCAACAGGAACUAUGACCUCGACUACGACUCGGUGCAGCCGUAUUUCUACUGCGACGAGGAGGAGAACUUCUACCAGCAGCAGCAGCAGAGCGAGCUGCAGCCCCCGGCGCCCAGCGAGGAUAUCUGGAAGAAAUUCGAGCUGCUGCCCACCCCGCCCCUGUCCCCUAGCCGCCGCUCCGGGCUCUGCUCGCCCUCCUACGUUGCGGUCACACCCUUCUCCCUUCGGGGAGACAACGACGGCGGUGGCGGGAGCUUCUCCACGGCCGACCAGCUGGAGAUGGUGACCGAGCUGCUGGGAGGAGACAUGGUGAACCAGAGUUUCAUCUGCGACCCGGACGACGAGACCUUCAUCAAAAACAUCAUCAUCCAGGACUGUAUGUGGAGCGGCUUCUCGGCCGCCGCCAAGCUCGUCUCAGAGAAGCUGGCCUCCUACCAGGCUGCGCGCAAAGACAGCGGCAGCCCGAACCCCGCCCGCGGCCACAGCGUCUGCUCCACCUCCAGCUUGUACCUGCAGGAUCUGAGCGCCGCCGCCUCAGAGUGCAUCGACCCCUCGGUGGUCUUCCCCUACCCUCUCAACGACAGCAGCUCGCCCAAGUCCUGCGCCUCGCAAGACUCCAGCGCCUUCUCUCCGUCCUCGGAUUCUCUGCUCUCCUCGACGGAGUCCUCCCCGCAGGGCAGCCCCGAGCCCCUGGUGCUCCAUGAGGAGACACCGCCCACCACCAGCAGCGACUCUGAGGAGGAACAAGAAGAUGAGGAAGAAAUCGAUGUUGUUUCUGUGGAAAAGAGGCAGGCUCCUGGCAAAAGGUCAGAGUCUGGAUCACCUUCUGCUGGAGGCCACAGCAAACCUCCUCACAGCCCACUGGUCCUCAAGAGGUGCCACGUCUCCACACAUCAGCACAACUACGCAGCGCCUCCCUCCACUCGGAAGGACUAUCCUGCUGCCAAGAGGGUCAAGUUGGACAGUGUCAGAGUCCUGAGACAGAUCAGCAACAACCGAAAAUGCACCAGCCCCAGGUCCUCGGACACCGAGGAGAAUGUCAAGAGGCGAACACACAACGUCUUGGAGCGCCAGAGGAGGAACGAGCUAAAACGGAGCUUUUUUGCCCUGCGUGACCAGAUCCCGGAGUUGGAAAACAAUGAAAAGGCCCCCAAGGUAGUUAUCCUUAAAAAAGCCACAGCAUACAUCCUGUCCGUCCAAGCAGAGGAGCAAAAGCUCAUUUCUGAAGAGGACUUGUUGCGGAAACGACGAGAACAGUUGAAACACAAACUUGAACAGCUACGGAACUCUUGUGCGUAAGGAAAAGUAAGGAAAACGAUUCCUUCUAACAGAAAUGUCCUGAGCAAUCACCUAUGAACUUGUUUCAAAUGCAUGAUCAAAUGCAACCUCACAACCUUGGCUGAGUCUUGAGACUGAAAGAUUUAGCCAUAAUGUAAACUGCCUCAAAUUGGACUUUGGGCAUAAAAGAACUUUUUUAUGCUUACCAUCUUUUUUUUUUCUUUAACAGAUUUGUAUUUAAGAAUUGUUUUUAAAAAAUUUUAAGAUUUACACAAUGUUUCUCUGUAAAUAUUGCCAUUAAAUGUAAAUAACUUUAAUAAAACGUUUAUAGCAGUUACACAGAAUUUCAAUCCUAGUAUAUAGUACCUAGUAUUAUAGGUACUAUAAACCCUAAUUUUUUUUAUUUAAGUACAUUUUGCUUUUUAAAGUUGAUUUUUUUCUAUUGUUUUUAGAAAAAAUAAAAUAACUGGCAAAUAUAUCAUUGAGCCAAAUCUUAAGUUGUGAAUGUUUUGUUUCGUUUCUUCCCCCUCCCAACCACCACCAUCCCUGUUUGUUUUCAUCAAUUGCCCCUUCAGAGGGUGGUCUUAAGAAAGGCAAGAGUUUUCCUCUGUUGAAAUGGGUCUGGGGGCCUUAAGGUCUUUAAGUUCUUGGAGGUUCUAAGAUGCUUCCUGGAGACUAUGAUAACAGCCAGAGUUGACAGUUAGAAGGAAUGGCAGAAGGCAGGUGAGAAGGUGAGAGGUAGGCAAAGGAGAUACAAGAGGUCAAAGGUAGCAGUUAAGUACACAAAGAGGCAUAAGGACUGGGGAGUUGGGAGGAAGGUGAGGAAGAAACUCCUGUUACUUUAGUUAACCAGUGCCAGUCCCCUGCUCACUCCAAACCCAGGAAUUCUGCCCAGUUGAUGGGGACACGGUGGGAACCAGCUUCUGCUGCCUUCACAACCAGGCGCCAGUCCUGUCCAUGGGUUAUCUCGCAAACCCCAGAGGAUCUCUGGGAGGAAUGCUACUAUUAACCCUAUUUCACAAACAAGGAAAUAGAAGAGCUCAAAGAGGUUAUGUAACUUAUCUGUAGCCACGCAGAUAAUACAAAGCAGCAAUCUGGACCCAUUCUGUUCAAAACACUUAACCCUUCGCUAUCAUGCCUUGGUUCAUCUGGGUCUAAUGUGCUGAGAUCAAGAAGGUUUAGGACCUAAUGGACAGACUCAAGUCAUAACAAUGCUAAGCUCUAUUUGUGUCCCAAGCACUCCUAAGCAUUUUAUCCCUAACUCUACAUCAACCCCAUGAAGGAGAUACUGUUGAUUUCCCCAUAUUAGAAGUAGAGAGGGAAGCUGAGGCACACAAAGACUCAUCCACAUGCCCAAGAUUCACUGAUAGGGAAAAGUGGAAGCGAGAUUUGAACCCAGGCUGUUUACUCCUAACCUGUCCAAGCCACCUCUCAGACGACGGUAGGAAUCAGCUGGCUGCUUGUGAGUACAGGAGUUACAGUCCAGUGGGUUAUGUUUUUUAAGUCUCAACAUCUAAGCCUGGUCAGGCAUCAGUUCCCCUUUUUUUGUGAUUUAUUUUGUUUUUAUUUUGUUGUUCAUUGUUUAAUUUUUCCUUUUACAAUGAGAAGGUCACCAUCUUGACUCCUACCUUAGCCAUUUGUUGAAUCAGACUCAUGACGGCUCCUGGGAAGAAGCCAGUUCAGAUCAUAAAAUAAAACAUAUUUAUUCUUUGUCAUGGGAGUCAUUAUUUUAGAAACUACAAACUCUCCUUGCUUCCAUCCUUUUUUACAUACUCAUGACACAUGCUCAUCCUGAGUCCUUGAAAAGGUAUUUUUGAACAUGUGUAUUAAUUAUAAGCCUCUGAAAACCUAUGGCCCAAACCAGAAAUGAUGUUGAUUAUAUAGGUAAAUGAAGGAUGCUAUUGCUGUUCUAAUUACCUCAUUGUCUCAGUCUCAAAGUAGGUCUUCAGCUCCCUGUACUUUGGGAUUUUAAUCUACCACCACCCAUAAAUCAAUAAAUAAUUACUUUCUUUGA,mRNA,Homo sapiens,"sp|Q06787|FMR1_HUMAN Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1|length=188aa|residues=445-632
GASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRGHGRRGPGYTSGTNSEASNASETES
DHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRGQGGRGRGGGFKGNDDHSRTDNRPR
NPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSSEGSRLRTGKDRNQKKEKPDSVDGQ
QPLVNGVP",FMR1,LCR,-,188aa(445-632),Q06787,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q06787,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2426,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0024,http://db.phasep.pro/browse/","[445-515],[516-632]","[492-504],[527-549]",In vitro,125 µM [FMR1 LCR];|0.05 mg/mL c-Myc RNA,30 mM NaCl,"25 mM Na2PO4, pH 7.4, 2 mM DTT",4˚C,> 5 min,-,Microscopy,liquid,"By mixing different RNA sequences with FMRP LCR, we showed that FMRP LCR-RNA phase separation is not sequence-specific and does not require sequences capable of G-quadruplex formation. FMRPLCR:RNA phase separation is not dependent on RNA sequence or structure but is likely driven by protein:RNA electrostatic and pi-pi interactions.",4515
50,236,PMID: 30765518,RNAPS0000260,https://pubmed.ncbi.nlm.nih.gov/30765518,RNA + protein,-,-,luciferase RNA,1857nt(1-1857),UCCGUUUAGUUACCUAUACCUGAUUUUAUUAUUCGUUAAAAUAGUACAGUGACCCACAAUUACAAAAUUACCAUUCAUCAAUUUGCAUAUAAUAUUACAAUAGCUAAGAAUUUCGUCAUCGCUGAAUACAGUUACAUUUUACAAUUUGGACUUUCCGCCCUUCUUGGCCUUUAUGAGGAUCUCUCUGAUUUUUCUUGCGUCGAGUUUUCCGGUAAGACCUUUCGGUACUUCGUCCACAAACACAACUCCUCCGCGCAACUUUUUCGCGGUUGUUACUUGACUGGCGACGUAAUCCACGAUCUCUUUUUCCGUCAUCGUCUUUCCGUGCUCCAAAACAACAACGGCGGCGGGAAGUUCACCGGCGUCAUCGUCGGGAAGACCUGCCACGCCCGCGUCGAAGAUGUUGGGGUGUUGUAACAAUAUCGAUUCCAAUUCAGCGGGGGCCACCUGAUAUCCUUUGUAUUUAAUUAAAGACUUCAAGCGGUCAACUAUGAAGAAGUGUUCGUCUUCGUCCCAGUAAGCUAUGUCUCCAGAAUGUAGCCAUCCAUCCUUGUCAAUCAAGGCGUUGGUCGCUUCCGGAUUGUUUACAUAACCGGACAUAAUCAUAGGUCCUCUGACACAUAAUUCGCCUCUCUGAUUAACGCCCAGCGUUUUCCCGGUAUCCAGAUCCACAACCUUCGCUUCAAAAAAUGGAACAACUUUACCGACCGCGCCCGGUUUAUCAUCCCCCUCGGGUGUAAUCAGAAUAGCUGAUGUAGUCUCAGUGAGCCCAUAUCCUUGUCGUAUCCCUGGAAGAUGGAAGCGUUUUGCAACCGCUUCCCCGACUUCUUUCGAAAGAGGUGCGCCCCCAGAAGCAAUUUCGUGUAAAUUAGAUAAAUCGUAUUUGUCAAUCAGAGUGCUUUUGGCGAAGAAUGAAAAUAGGGUUGGUACUAGCAACGCACUUUGAAUUUUGUAAUCCUGAAGGGAUCGUAAAAACAGCUCUUCUUCAAAUCUAUACAUUAAGACGACUCGAAAUCCACAUAUCAAAUAUCCGAGUGUAGUAAACAUUCCAAAACCGUGAUGGAAUGGAACAACACUUAAAAUCGCAGUAUCCGGAAUGAUUUGAUUGCCAAAAAUAGGAUCUCUGGCAUGCGAGAAUCUGACGCAGGCAGUUCUAUGCGGAAGGGCCACACCCUUAGGUAACCCAGUAGAUCCAGAGGAAUUCAUUAUCAGUGCAAUUGUUUUGUCACGAUCAAAGGACUCUGGUACAAAAUCGUAUUCAUUAAAACCGGGAGGUAGAUGAGAUGUGACGAACGUGUACAUCGACUGAAAUCCCUGGUAAUCCGUUUUAGAAUCCAUGAUAAUAAUUUUCUGGAUUAUUGGUAAUUUUUUUUGCACGUUCAAAAUUUUUUGCAACCCCUUUUUGGAAACAAACACUACGGUAGGCUGCGAAAUGUUCAUACUGUUGAGCAAUUCACGUUCAUUAUAAAUGUCGUUCGCGGGCGCAACUGCAACUCCGAUAAAUAACGCGCCCAACACCGGCAUAAAGAAUUGAAGAGAGUUUUCACUGCAUACGACGAUUCUGUGAUUUGUAUUCAGCCCAUAUCGUUUCAUAGCUUCUGCCAACCGAACGGACAUUUCGAAGUAUUCCGCGUACGUGAUGUUCACCUCGAUAUGUGCAUCUGUAAAAGCAAUUGUUCCAGGAACCAGGGCGUAUCUCUUCAUAGCCUUAUGCAGUUGCUCUCCAGCGGUUCCAUCCUCUAGAGGAUAGAAUGGCGCCGGGCCUUUCUUUAUGUUUUUGGCGUCUUCCAUUUUACCAACAGUACCGGAAUGCUAAUGUCACUGCGAGCGACAUUCAAGAAUGUAACACAAAGGAAU,mRNA,Photinus pyralis,"sp|Q06787|FMR1_HUMAN Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1|length=188aa|residues=445-632
GASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRGHGRRGPGYTSGTNSEASNASETES
DHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRGQGGRGRGGGFKGNDDHSRTDNRPR
NPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSSEGSRLRTGKDRNQKKEKPDSVDGQ
QPLVNGVP",FMR1,LCR,-,188aa(445-632),Q06787,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q06787,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2426,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0024,http://db.phasep.pro/browse/","[445-515],[516-632]","[492-504],[527-549]",In vitro,125 µM [FMR1 LCR];|0.05 mg/mL luciferase RNA,30 mM NaCl,"25 mM Na2PO4, pH 7.4, 2 mM DTT",4˚C,> 5 min,-,Microscopy,liquid,"By mixing different RNA sequences with FMRP LCR, we showed that FMRP LCR-RNA phase separation is not sequence-specific and does not require sequences capable of G-quadruplex formation. FMRPLCR:RNA phase separation is not dependent on RNA sequence or structure but is likely driven by protein:RNA electrostatic and pi-pi interactions.",1857
51,309,PMID: 32901111,RNAPS0000294,https://pubmed.ncbi.nlm.nih.gov/32901111,RNA + protein,-,-,SARS-CoV-2 N1541 RNA,1541nt,GGGGAAUUGUGAGCGGAUAACAAUUCCCCUCUAGAAAUAAUUUUGUUUAACUUUAAGAAGGAGAUAUACCAUGGGCAGCAGCCAUCAUCAUCAUCAUCACCACCACCACCAUAGCAGCGGCCUGGUGCCGCGCGGCAGCGCUAGCAUGUCUGAUAAUGGACCCCAAAAUCAGCGAAAUGCACCCCGCAUUACGUUUGGUGGACCCUCAGAUUCAACUGGCAGUAACCAGAAUGGAGAACGCAGUGGGGCGCGAUCAAAACAACGUCGGCCCCAAGGUUUACCCAAUAAUACUGCGUCUUGGUUCACCGCUCUCACUCAACAUGGCAAGGAAGACCUUAAAUUCCCUCGAGGACAAGGCGUUCCAAUUAACACCAAUAGCAGUCCAGAUGACCAAAUUGGCUACUACCGAAGAGCUACCAGACGAAUUCGUGGUGGUGACGGUAAAAUGAAAGAUCUCAGUCCAAGAUGGUAUUUCUACUACCUAGGAACUGGGCCAGAAGCUGGACUUCCCUAUGGUGCUAACAAAGACGGCAUCAUAUGGGUUGCAACUGAGGGAGCCUUGAAUACACCAAAAGAUCACAUUGGCACCCGCAAUCCUGCUAACAAUGCUGCAAUCGUGCUACAACUUCCUCAAGGAACAACAUUGCCAAAAGGCUUCUACGCAGAAGGGAGCAGAGGCGGCAGUCAAGCCUCUUCUCGUUCCUCAUCACGUAGUCGCAACAGUUCAAGAAAUUCAACUCCAGGCAGCAGUAGGGGAACUUCUCCUGCUAGAAUGGCUGGCAAUGGCGGUGAUGCUGCUCUUGCUUUGCUGCUGCUUGACAGAUUGAACCAGCUUGAGAGCAAAAUGUCUGGUAAAGGCCAACAACAACAAGGCCAAACUGUCACUAAGAAAUCUGCUGCUGAGGCUUCUAAGAAGCCUCGGCAAAAACGUACUGCCACUAAAGCAUACAAUGUAACACAAGCUUUCGGCAGACGUGGUCCAGAACAAACCCAAGGAAAUUUUGGGGACCAGGAACUAAUCAGACAAGGAACUGAUUACAAACAUUGGCCGCAAAUUGCACAAUUUGCCCCCAGCGCUUCAGCGUUCUUCGGAAUGUCGCGCAUUGGCAUGGAAGUCACACCUUCGGGAACGUGGUUGACCUACACAGGUGCCAUCAAAUUGGAUGACAAAGAUCCAAAUUUCAAAGAUCAAGUCAUUUUGCUGAAUAAGCAUAUUGACGCAUACAAAACAUUCCCACCAACAGAGCCUAAAAAGGACAAAAAGAAGAAGGCUGAUGAAACUCAAGCCUUACCGCAGAGACAGAAGAAACAGCAAACUGUGACUCUUCUUCCUGCUGCAGAUUUGGAUGAUUUCUCCAAACAAUUGCAACAAUCCAUGAGCAGUGCUGACUCAACUCAGGCCUGUUGAGGAUCCUGUGAAUUCGAGCUCCGUCGACAAGCUUGCGGCCGCACUCGAGCACCACCACCACCACCACUGAGAUCCGGCUGCUAACAAAGCCCGAAAGGAAGCUGAGUUGGCUGCUGCCACCGCUGAGCAAUAA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,0.1-5µM [A85];|20µM [N protein],-,"1× PBS, pH 7.4",RT,> 1 h,crowding agent:2.5% PEG8000,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"Representative fluorescence and DIC images of LLPS formed by N protein (green) with 85-nt RNA A85 at the indicated concentrations. Representative fluorescence and DIC images of LLPS formed by N protein (red) with the positive strand RNA of N protein (N1541, 1541 nt) at the indicated concentrations.",1541
52,319,PMID: 31266957,RNAPS0000301,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKASLKKASLKKASL,K3,-,-,15aa,-,-,-,-,-,In vitro,0.5 mg/ml [polyU RNA];|1 mM.[K3],-,"25 mM HEPES,pH 7.4",RT,-,-,Differential interference contrast microscopy,liquid,DIC image of a pair of K3/RNA liquid droplets undergoing fusion. The concentration of polyU RNA was 0.5 mg ml−1 and K3 was 1 mM.,3300
53,320,PMID: 31266957,RNAPS0000301,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKASLKKASLKKASL,K3,-,-,15aa,-,-,-,-,-,In vitro,1 mg/ml[polyU RNA];|1 mM[K3],-,"25 mM HEPES,PH 5.4 or 7.4 or 9.4",RT,5 min-20 min,-,Fluorescence microscopy,"solute, liquid",Distribution of droplet diameters after 5 and 20 min with the corresponding fluorescence images.The K3 droplets grew in time at the expense of smaller droplets,3300
54,321,PMID: 31266957,RNAPS0000301,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKASLKKASLKKASL,K3,-,-,15aa,-,-,-,-,-,In vitro,0.5 mg/ml[polyU RNA];|1 mM[K3],-,"25 mM HEPES,pH 7.4",RT,≤ 90 min,other_molecular:CREB/p300,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
55,322,PMID: 31266957,RNAPS0000301,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKASLKKASLKKASL,K3,-,-,15aa,-,-,-,-,-,In vitro,0.5 mg/ml[polyU RNA];|1 mM[K3],-,"25 mM HEPES,pH 7.4",RT,≤ 90 min,other_molecular:AcCoA,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
56,323,PMID: 31266957,RNAPS0000301,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKASLKKASLKKASL,K3,-,-,15aa,-,-,-,-,-,In vitro,0.5 mg/ml[polyU RNA];|1 mM[K3],-,"25 mM HEPES,pH 7.4",RT,≤ 90 min,other_molecular:both the enzyme and AcCoA.,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
57,324,PMID: 31266957,RNAPS0000302,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKASLKKASLRRASL,K2R1,-,-,15aa,-,-,-,-,-,In vitro,1 mg/ml[polyU RNA ];|1 mM[K2R1R3],-,"25 mM HEPES,pH 7.4",RT,≤ 25 min,-,"FRAP,Differential interference contrast microscopy,Fluorescence microscopy",-,"The concentration of K3, K2R1, R3, and polyU RNA in DIC, fluorescence imaging, and FRAP were identical and equal to 1 mM K3/K2R1/ R3 and 1 mg ml−1 polyU RNA, in 50 mM HEPES, pH 7.4.",3300
58,325,PMID: 31266957,RNAPS0000303,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKKKKKKKKKKKKKKKKKKKR,K18,-,-,21aa,-,-,-,-,-,In vitro,50 µM[K18];|125 µg/ml[polyU RNA],-,-,RT,≤ 20 min,-,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 50 μM.",3300
59,326,PMID: 31266957,RNAPS0000303,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKKKKKKKKKKKKKKKKKKKR,K18,-,-,21aa,-,-,-,-,-,In vitro,50 µM[K18];|125 µg/ml[polyU RNA],-,"25 mM HEPES,pH 7.4",RT,≤ 20 min,-,"Differential interference contrast microscopy,Fluorescence microscopy",solute,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 50 μM.",3300
60,327,PMID: 31266957,RNAPS0000303,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKKKKKKKKKKKKKKKKKKKR,K18,-,-,21aa,-,-,-,-,-,In vitro,50 µM[K18];|125 µg/ml[polyU RNA],-,-,RT,≤ 20 min,crowding agent:10% dextran,"Differential interference contrast microscopy,Fluorescence microscopy",solute,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 50 μM.",3300
61,328,PMID: 31266957,RNAPS0000303,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKKKKKKKKKKKKKKKKKKKR,K18,-,-,21aa,-,-,-,-,-,In vitro,125 µg/ml[RNA];|50 µM[K18],-,"25 mM HEPES,pH 7.4",RT,≤ 1 h,other_molecular:CREB/p300,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
62,329,PMID: 31266957,RNAPS0000303,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKKKKKKKKKKKKKKKKKKKR,K18,-,-,21aa,-,-,-,-,-,In vitro,125 µg/ml[RNA];|50 µM[K18],-,"25 mM HEPES,pH 7.4",RT,≤ 1 h,other_molecular:AcCoA,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
63,330,PMID: 31266957,RNAPS0000303,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKKKKKKKKKKKKKKKKKKKR,K18,-,-,21aa,-,-,-,-,-,In vitro,125 µg/ml[RNA];|50 µM[K18],-,"25 mM HEPES,pH 7.4",RT,≤ 1 h,other_molecular:both the enzyme and AcCoA.,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
64,331,PMID: 31266957,RNAPS0000304,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,"SKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",K25,-,-,184aa,-,-,-,"[1-10],[23-25],[27-29],[34-42],[83-93],[139-179]",-,In vitro,50 µM[K25];|100 µg/ml[polyU RNA],-,-,RT,≤ 20 min,-,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 50μM.",3300
65,332,PMID: 31266957,RNAPS0000304,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,"SKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",K25,-,-,184aa,-,-,-,"[1-10],[23-25],[27-29],[34-42],[83-93],[139-179]",-,In vitro,50 µM[K25];|100 µg/ml[polyU RNA],-,"25 mM HEPES,pH 7.4",RT,≤ 20 min,-,"Differential interference contrast microscopy,Fluorescence microscopy",solute,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 50μM.",3300
66,333,PMID: 31266957,RNAPS0000304,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,"SKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",K25,-,-,184aa,-,-,-,"[1-10],[23-25],[27-29],[34-42],[83-93],[139-179]",-,In vitro,50 µM[K25];|100 µg/ml[polyU RNA],-,-,RT,≤ 20 min,crowding agent:10% dextran,"Differential interference contrast microscopy,Fluorescence microscopy",solute,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 50μM.",3300
67,334,PMID: 31266957,RNAPS0000305,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT
MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPG
SETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAG
HVTQARMVSKSKDGTGSDDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPK
TPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAK
SRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHV
PGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNI
THVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMV
DSPQLATLADEVSASLAKQGL",MAPT,-,-,441aa(1-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[125-375],[395-441]","[216-226],[323-340],[380-403]",In vitro,50 µM[hTau40];|40 µg/ml[polyU RNA],-,-,RT,≤ 20 min,-,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 52 μM.",3300
68,335,PMID: 31266957,RNAPS0000305,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT
MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPG
SETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAG
HVTQARMVSKSKDGTGSDDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPK
TPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAK
SRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHV
PGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNI
THVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMV
DSPQLATLADEVSASLAKQGL",MAPT,-,-,441aa(1-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[125-375],[395-441]","[216-226],[323-340],[380-403]",In vitro,50 µM[hTau40];|40 µg/ml[polyU RNA],-,"25 mM HEPES,pH 7.4",RT,≤ 20 min,-,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 52 μM.",3300
69,336,PMID: 31266957,RNAPS0000305,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT
MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPG
SETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAG
HVTQARMVSKSKDGTGSDDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPK
TPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAK
SRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHV
PGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNI
THVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMV
DSPQLATLADEVSASLAKQGL",MAPT,-,-,441aa(1-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[125-375],[395-441]","[216-226],[323-340],[380-403]",In vitro,50 µM[hTau40];|40 µg/ml[polyU RNA],-,-,RT,≤ 20 min,crowding agent:10% dextran,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 52 μM.",3300
70,337,PMID: 31266957,RNAPS0000306,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,RRASLRRASLRRASL,R3,-,-,15aa,-,-,-,-,-,In vitro,0.5 mg/ml[polyU RNA];|1 mM[R3],-,"25 mM HEPES,pH 7.4",RT,≤ 90 min,other_molecular:CREB/p300,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
71,338,PMID: 31266957,RNAPS0000306,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,RRASLRRASLRRASL,R3,-,-,15aa,-,-,-,-,-,In vitro,0.5 mg/ml[polyU RNA];|1 mM[R3],-,"25 mM HEPES,pH 7.4",RT,≤ 90 min,other_molecular:AcCoA,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
72,339,PMID: 31266957,RNAPS0000306,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,RRASLRRASLRRASL,R3,-,-,15aa,-,-,-,-,-,In vitro,0.5 mg/ml[polyU RNA];|1 mM[R3],-,"25 mM HEPES,pH 7.4",RT,≤ 90 min,other_molecular:both the enzyme and AcCoA.,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
73,344,PMID: 31271494,RNAPS0000037,https://pubmed.ncbi.nlm.nih.gov/31271494,RNA + protein,NCBI ID:7082,https://www.ncbi.nlm.nih.gov/gene/7082,TJP1,8024nt(1-8024),GCCGCCGGGCCACGGCCUGCAGGGGUGGAAGGGGCGGCGGCGGCGGGAGCUGCGGGCCACGCACGGCGGCGGCGGCGGGAGCGGCCGGGCACGCACGGCGACGGCGGCGGCGGGAGCGGGAGCCCGGGCCACGCACGGCCGCAGCUGCGGGUGCGGCGGGCGCGGGAGCGGUGGGAGCUGUGGUGGCGGCGGAUGGCCCAGAGCUGAUCUAUGCGGCGCCUGGAGGGGCUGUGUCUGCGGCGGCGGCGGAGGCGGCGGGGCCCUGCCCGCGAGCGGAGCGGGGACAAGAUGAAGUACCAGAAAUACCUGACGGUGCUGCAGAUGGCCAUCGGCGUCACCCCCUCCAACCGCGGCAGCCUCCUGCCGCUCAAGAGGAAGCUGUGGGUAACGCCAUCCUCUGAAAAUCCUAAUGGUGCUACUUCUAGUGUCAGCCAAGGAAAACCCUCUUUAAGACGAAUUAAAGGGAGAUUACACAGAAGCAAAAGCCUUGAUAGCAUGGAUUUCUGUGAGCUCACUAGCACAGCAAUGGAGGAAACAGCUAUAUGGGAACAACAUACAGUGACGCUUCACAGGGCUCCUGGAUUUGGAUUUGGAAUUGCAAUAUCUGGUGGACGAGAUAAUCCUCAUUUUCAGAGUGGGGAAACGUCAAUAGUGAUUUCAGAUGUGCUGAAAGGAGGACCAGCUGAAGGACAGCUACAGGAAAAUGACCGAGUUGCAAUGGUUAACGGAGUUUCAAUGGAUAAUGUUGAACAUGCUUUUGCUGUUCAGCAACUAAGGAAAAGUGGGAAAAAUGCAAAAAUUACAAUUAGAAGGAAGAAGAAAGUUCAAAUACCAGUAAGUCGUCCUGAUCCUGAACCAGUAUCUGAUAAUGAAGAAGAUAGUUAUGAUGAGGAAAUACAUGAUCCAAGAAGUGGCCGGAGUGGUGUGGUUAACAGAAGGAGUGAGAAGAUUUGGCCGAGGGAUAGAAGUGCAAGUAGAGAGAGGAGCUUGUCCCCGCGGUCAGACAGGCGGUCAGUGGCUUCCAGCCAGCCUGCUAAACCUACUAAAGUCACACUGGUGAAAUCCCGGAAAAAUGAAGAAUAUGGUCUUCGAUUGGCAAGCCAUAUAUUUGUUAAGGAAAUUUCACAAGAUAGUUUGGCAGCAAGAGAUGGCAAUAUUCAAGAAGGUGAUGUUGUAUUGAAGAUAAAUGGUACUGUGACAGAAAAUAUGUCAUUGACAGAUGCAAAGACAUUGAUAGAAAGGUCUAAAGGCAAAUUAAAAAUGGUAGUUCAAAGAGAUGAACGGGCUACGCUAUUGAAUGUCCCUGAUCUUUCUGACAGCAUCCACUCUGCUAAUGCCUCUGAGAGAGACGACAUUUCAGAAAUUCAGUCACUGGCAUCAGAUCAUUCUGGUCGAUCACACGAUAGGCCUCCCCGCCGCAGCCGGUCACGAUCUCCUGACCAGCGGUCAGAGCCUUCUGAUCAUUCCAGGCACUCGCCGCAGCAGCCAAGCAAUGGCAGUCUCCGGAGUAGAGAUGAAGAGAGAAUUUCUAAACCUGGGGCUGUCUCAACUCCUGUAAAGCAUGCUGAUGAUCACACACCUAAAACAGUGGAAGAAGUUACAGUUGAAAGAAAUGAGAAACAAACACCUUCUCUUCCAGAACCAAAGCCUGUGUAUGCCCAAGUUGGGCAACCAGAUGUGGAUUUACCUGUCAGUCCAUCUGAUGGUGUCCUACCUAAUUCAACUCAUGAAGAUGGGAUUCUUCGGCCCAGCAUGAAAUUGGUAAAAUUCAGAAAAGGAGAUAGUGUGGGUUUGCGGCUGGCUGGUGGAAAUGAUGUUGGAAUAUUUGUAGCUGGCGUUCUAGAAGAUAGCCCUGCAGCCAAGGAAGGCUUAGAGGAAGGUGAUCAAAUUCUCAGGGUAAACAACGUAGAUUUUACAAAUAUCAUAAGAGAAGAAGCCGUCCUUUUCCUGCUUGACCUCCCUAAAGGAGAAGAAGUGACCAUAUUGGCUCAGAAGAAGAAGGAUGUUUAUCGUCGCAUUGUAGAAUCAGAUGUAGGAGAUUCUUUCUAUAUUAGAACCCAUUUUGAAUAUGAAAAGGAAUCUCCCUAUGGACUUAGUUUUAACAAAGGAGAGGUGUUCCGUGUUGUGGAUACCUUGUACAAUGGAAAACUGGGCUCUUGGCUUGCUAUUCGAAUUGGUAAAAAUCAUAAGGAGGUAGAACGAGGCAUCAUCCCUAAUAAGAACAGAGCUGAGCAGCUAGCCAGUGUACAGUAUACACUUCCAAAAACAGCAGGCGGAGACCGUGCUGACUUCUGGAGAUUCAGAGGUCUUCGCAGCUCCAAGAGAAAUCUUCGAAAAAGCAGAGAGGAUUUGUCCGCUCAGCCUGUUCAAACAAAGUUUCCAGCUUAUGAAAGAGUGGUUCUUCGAGAAGCUGGAUUUCUGAGGCCUGUAACCAUUUUUGGACCAAUAGCUGAUGUUGCCAGAGAAAAGCUGGCAAGAGAAGAACCAGAUAUUUAUCAAAUUGCAAAGAGUGAACCACGAGACGCUGGAACUGACCAACGUAGCUCUGGCAUUAUUCGCCUGCAUACAAUAAAGCAAAUCAUAGAUCAAGACAAACAUGCUUUAUUAGAUGUAACACCAAAUGCAGUUGAUCGUCUUAACUAUGCCCAGUGGUAUCCAAUUGUUGUAUUUCUUAACCCUGAUUCUAAGCAAGGAGUAAAAACAAUGAGAAUGAGGUUAUGUCCAGAAUCUCGGAAAAGUGCCAGGAAGUUAUACGAGCGAUCUCAUAAACUUCGUAAAAAUAAUCACCAUCUUUUUACAACUACAAUUAACUUAAAUUCAAUGAAUGAUGGUUGGUAUGGUGCGCUGAAAGAAGCAAUUCAACAACAGCAAAACCAGCUGGUAUGGGUUUCCGAGGGAAAGGCGGAUGGUGCUACAAGUGAUGACCUUGAUUUGCAUGAUGAUCGUCUGUCCUACCUGUCAGCUCCAGGUAGUGAAUACUCAAUGUAUAGCACGGACAGUAGACACACUUCUGACUAUGAAGACACAGACACAGAAGGCGGGGCCUACACUGAUCAAGAACUAGAUGAAACUCUUAAUGAUGAGGUUGGGACUCCACCGGAGUCUGCCAUUACACGGUCCUCUGAGCCUGUAAGAGAGGACUCCUCUGGAAUGCAUCAUGAAAACCAAACAUAUCCUCCUUACUCACCACAAGCGCAGCCACAACCAAUUCAUAGAAUAGACUCCCCUGGAUUUAAGCCAGCCUCUCAACAGAAAGCAGAAGCUUCAUCUCCAGUCCCUUACCUUUCGCCUGAAACAAACCCAGCAUCAUCAACCUCUGCUGUUAAUCAUAAUGUAAAUUUAACUAAUGUCAGACUGGAGGAGCCCACCCCAGCUCCUUCCACCUCUUACUCACCACAAGCUGAUUCUUUAAGAACACCAAGUACUGAGGCAGCUCACAUAAUGCUAAGAGAUCAAGAACCAUCAUUGUCGUCGCAUGUAGAUCCAACAAAGGUGUAUAGAAAGGAUCCAUAUCCCGAGGAAAUGAUGAGGCAGAACCAUGUUUUGAAACAGCCAGCCGUUAGUCACCCAGGGCACAGGCCAGACAAAGAGCCUAAUCUGACCUAUGAACCCCAACUCCCAUACGUAGAGAAACAAGCCAGCAGAGACCUCGAGCAGCCCACAUACAGAUACGAGUCCUCAAGCUAUACGGACCAGUUUUCUCGAAACUAUGAACAUCGUCUGCGAUACGAAGAUCGCGUCCCCAUGUAUGAAGAACAGUGGUCAUAUUAUGAUGACAAACAGCCCUACCCAUCUCGGCCACCUUUUGAUAAUCAGCACUCUCAAGACCUUGACUCCAGACAGCAUCCCGAAGAGUCCUCAGAACGAGGGUACUUUCCACGUUUUGAAGAGCCAGCCCCUCUGUCUUACGACAGCAGACCACGUUACGAACAGGCACCUAGAGCAUCCGCCCUGCGGCACGAAGAGCAGCCAGCUCCUGGGUAUGACACACAUGGUAGACUCAGACCGGAAGCCCAGCCCCACCCUUCAGCAGGGCCCAAGCCUGCAGAGUCCAAGCAGUAUUUUGAGCAAUAUUCACGCAGUUACGAGCAAGUACCACCCCAAGGAUUUACCUCUAGAGCAGGUCAUUUUGAGCCUCUCCAUGGUGCUGCAGCUGUCCCUCCGCUGAUACCUUCAUCUCAGCAUAAGCCAGAAGCUCUGCCUUCAAACACCAAACCACUGCCUCCACCCCCAACUCAAACCGAAGAAGAGGAAGAUCCAGCAAUGAAGCCACAGUCUGUACUCACCAGAGUUAAGAUGUUUGAAAACAAAAGAUCUGCAUCCUUAGAGACCAAGAAGGAUGUAAAUGACACUGGCAGUUUUAAGCCUCCAGAAGUAGCAUCUAAACCUUCAGGUGCUCCCAUCAUUGGUCCCAAACCCACUUCUCAGAAUCAAUUCAGUGAACAUGACAAAACUCUGUACAGGAUCCCAGAACCUCAAAAACCUCAACUGAAGCCACCUGAAGAUAUUGUUCGGUCCAAUCAUUAUGACCCUGAAGAAGAUGAAGAAUAUUAUCGAAAACAGCUGUCAUACUUUGACCGAAGAAGUUUUGAGAAUAAGCCUCCUGCACACAUUGCCGCCAGCCAUCUCUCCGAGCCUGCAAAGCCAGCGCAUUCUCAGAAUCAAUCAAAUUUUUCUAGUUAUUCUUCAAAGGGAAAGCCUCCUGAAGCUGAUGGUGUGGAUAGAUCAUUUGGCGAGAAACGCUAUGAACCCAUCCAGGCCACUCCCCCUCCUCCUCCAUUGCCCUCGCAGUAUGCCCAGCCAUCUCAGCCUGUCACCAGCGCGUCUCUCCACAUACAUUCUAAGGGAGCACAUGGUGAAGGUAAUUCAGUGUCAUUGGAUUUUCAGAAUUCCUUAGUGUCCAAACCAGACCCACCUCCAUCUCAGAAUAAGCCAGCAACUUUCAGACCACCAAACCGAGAAGAUACUGCUCAGGCAGCUUUCUAUCCCCAGAAAAGUUUUCCAGAUAAAGCCCCAGUUAAUGGAACUGAACAGACUCAGAAAACAGUCACUCCAGCAUACAAUCGAUUCACACCAAAACCAUAUACAAGUUCUGCCCGACCAUUUGAACGCAAGUUUGAAAGUCCUAAAUUCAAUCACAAUCUUCUGCCAAGUGAAACUGCACAUAAACCUGACUUGUCUUCAAAAACUCCCACUUCUCCAAAAACUCUUGUGAAAUCGCACAGUUUGGCACAGCCUCCUGAGUUUGACAGUGGAGUUGAAACUUUCUCUAUCCAUGCAGAGAAGCCUAAAUAUCAAAUAAAUAAUAUCAGCACAGUGCCUAAAGCUAUUCCUGUGAGUCCUUCAGCUGUGGAAGAGGAUGAAGAUGAAGAUGGUCAUACUGUGGUGGCCACAGCCCGAGGCAUAUUUAACAGCAAUGGGGGCGUGCUGAGUUCCAUAGAAACUGGUGUUAGUAUAAUUAUCCCUCAAGGAGCCAUUCCCGAAGGAGUUGAGCAGGAAAUCUAUUUCAAGGUCUGCCGGGACAACAGCAUCCUUCCACCUUUAGAUAAAGAGAAAGGUGAAACACUGCUGAGUCCUUUGGUGAUGUGUGGUCCCCAUGGCCUCAAGUUCCUGAAGCCUGUGGAGCUGCGCUUACCACACUGUGCGUCCAUGACUCCUGACGGUUGGUCUUUUGCUCUAAAAUCAUCCGACUCCUCGUCGGGUGAUCCUAAAACCUGGCAAAACAAGUGUCUUCCCGGAGAUCCAAAUUAUCUCGUUGGAGCAAACUGUGUUUCUGUCCUUAUUGACCACUUUUAACUCUUGAAAUAUAGGAACUUAAAUAAUGUGAAACUGGAUUAAACUUAAUCUAAAUGGAACCACUCUAUCAAGUAUUAUACCUUUUUUAGAGUUGAUACUACAGUUUGUUAGUAUGAGGCAUUUGUUUGAACUGAUAAAGAUGAGUGAGCAUGCCCCUGAACCAUGGUCGGAAAACAUGCUACACACUGCAUGUUUGUGAUUGACGGGACUGUUGGUAUUGGCUAGAGGUUCAAAGAUAUUUUGCUUUGUGAUUUUUGUAAUUUUUUUAUCGUCACUGCUUAACUUCACAUAUUGAUUUCCGUUAAAAUACCAGCCAGUAAAUGGGGGUGCAUUUGAGGUCUGUUCUUUCCAAAGUACACUGUUUCAAACUUUACUAUGGCCCUGGCCUAGCAUACGUACACAUUUUAUUUUAUUAUGCAUGAAGUAAUAUGCACACAUUUUUUAAAUGCACCUGGAAUAUAUAACCAGUGUUGUGGAUUUAACAGAAAUGUACAGCAAGGAGAUUUACAACUGGGGGAGGGUGAAGUGAAGACAAUGACUUACUGUACAUGAAAACACAUUUUUCUUAGGGAAGGAUACAAAAGCAUGUGAGACUGGUUCCAUGGCCUCUUCAGAUCUCUAACUUCACCAUAUUACCACAGACAUACUAACCAGCAGAAAUGCCUUACCCUCAUGUUCUUAAUUCUUAGCUCAUUCUCCUUGUGUUACUAAGUUUUUAUGGCUUUUGUGCAUUAUCUAGAUACUGUAUCAUGACAAAGACUGAGUACGUUGUGCAUUUGGUGGUUUCAGAAAUGUGUUAUCACCCAGAAGAAAAUAGUGGUGUGAUUUGGGGAUAUUUUUUUCUUUUCUUUUCUUUUCUUUUUUUUUUUUUUUGACAAGGGGCAGUGGUGGUUUUCUGUUCUUUCUGGCUAUGCAUUUGAAAAUUUUGAUGUUUUAAGGAUGCUUGUACAUAAUGCGUGCAUACCACUUUUGUUCUUGGUUUGUAAAUUAACUUUUAUAAACUUUACCUUUUUUAUACAUAAACAAGACCACGUUUCUAAAGGCUACCUUUGUAUUCUCUCCUGUACCUCUUGAGCCUUGAACUUUGACCUCUGCAGCAAUAAAGCAGCGUUUCUAUGACACAUGCAAGGUCAUUUUUUUUAAGAAAAAGGAUGCACAGAGUUGUUACAUUUUUAAGUGCUGCAUUUAAAAGAUACAGUUACUCAGAAUUCUCUAGUUUGAUUAAAUUCUUGCAAAGUAUCCCUACUGUAAUUUGUGAUACAAUGCUGUGCCCUAAAGUGUAUUUUUUUACUAAUAGACAAUUUAUUAUGGCACAUCAGCACGAUUUCUGUUUAGAUAAUACACCACUACAUUCUGUUAAUCAUUAGGUGUGACUGAAUUUCUUUUGCCGUUAUUAAAAAUCUCAAAUUUCUAAAUCUCCAAAAUAAAACUUUUUAAAAUAAAGUGCUGGCUUGGUCUGUUUGCCCACUGUUUUCUAGUUUCAUGCAGCUUUAUAAUCCUGUUUUAAAAUCCUGCACACAAAUCCCUAUCACCCAGCGUCACCUACCACCUCGUCGUCUGGUGUUGCAUGCAGAAUUUCUCCCCUUGGCCAGCAUGUACAGAUGGGUGGGCAGUGCUCAUCUGAAGGGCUCAGACUGAAGUGGGGCAGAAGGACCUGGAGACAGAGUGGGAGAAGGCAGCAGGCCGACUUCCCCCUGUGGGUAAACACACACCCCUGCGUGGAGAAACACCCCUGCAUGGGGACACACGUGCGUUUGUGUGUGUGCGUGUAACCAUUUGUAUAUGGUUUUAUUCCCCAGAUAAAUAGCACGGGCAUUGUUUAAUGUCACCCACAUUUGGGGGAAGAAAAUGGGUUUAGUGAGCAUAAAUAUUCCAUUGUGGACAUCCUACUUACUUAACUGCCACCCCUGUUGACAUUUGGAUUAUUGCUAUAGUGUUUCAGUAAACACCUUUGUGGACUGAAUCCAUCUAUGUGGAUUUUAUUUUUUUCAUCUUUGUUAAGGUAUAAUUUACAUAGAGUAAGUUACUGUUUUUAAAAUGUAUAGUUCAAAUUUUGACAAACACAUACUGUUUAUUUACCACGGUUAAUACAUACAACAGUUUCUUUAUCUUCUCUAAUCAUUUGUACCCCUUUAUACUCAACCCUUCUUCCAGCCCCUGGCAGGAUGAUCUCUUCUGUUUCUAUAGUUGCCUUUUUGACAGUGUCAUAUAAAUGGAAUCAUACAAUA,mRNA,Homo sapiens,"sp|P26368|U2AF2_HUMAN Splicing factor U2AF 65 kDa subunit OS=Homo sapiens OX=9606 GN=U2AF2 PE=1 SV=4
MSDFDEFERQLNENKQERDKENRHRKRSHSRSRSRDRKRRSRSRDRRNRDQRSASRDRRR
RSKPLTRGAKEEHGGLIRSPRHEKKKKVRKYWDVPPPGFEHITPMQYKAMQAAGQIPATA
LLPTMTPDGLAVTPTPVPVVGSQMTRQARRLYVGNIPFGITEEAMMDFFNAQMRLGGLTQ
APGNPVLAVQINQDKNFAFLEFRSVDETTQAMAFDGIIFQGQSLKIRRPHDYQPLPGMSE
NPSVYVPGVVSTVVPDSAHKLFIGGLPNYLNDDQVKELLTSFGPLKAFNLVKDSATGLSK
GYAFCEYVDINVTDQAIAGLNGMQLGDKKLLVQRASVGAKNATLVSPPSTINQTPVTLQV
PGLMSSQVQMGGHPTEVLCLMNMVLPEELLDDEEYEEIVEDVRDECSKYGLVKSIEIPRP
VDGVEVPGCGKIFVEFTSVFDCQKAMQGLTGRKFANRVVVTKYCDPDSYHRRDFW",U2AF65,-,-,475aa(1-475),P26368,"PhaSePro,DrLLPS","https://phasepro.elte.hu/entry/P26368,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0481",-,"[157-178],[248-259],[365-376]",In vitro,1 µg [TJP1];|2µM [U2AF65],150 mM NaCl,Hepes 20 mM pH 7.5,RT,-,-,Sedimentation assay,-,"Furthermore, this SPY-rich RNA partly cosedimented with U2AF65 assemblies (Fig 5C, compare lanes 3 and 4 with lanes 5 and 6). Analyses of four additional RNAs confirmed the correlation between SPY content and the ability of an RNA to exacerbate U2AF65 sedimentation.",8024
74,345,PMID: 31271494,RNAPS0000365,https://pubmed.ncbi.nlm.nih.gov/31271494,RNA + protein,NCBI ID:1785,https://www.ncbi.nlm.nih.gov/gene/1785,DNM2,3633nt(1-3633),GAGAACCGGAUGAGGCGGCGACCGUGAGGCCGAGCCGGGAGCGGGCGUCUUGCCGAGGCCCGGGCGGGCGGGGAGCAACGGCUACAGACGCCGCGGGGCCAGGUCGUUGAGGGUCGGCGGCGGGCGAGGAGCGCAGGGCGCUCGGGCCGGGGGCCGCCGGCGCCAUGGGCAACCGCGGGAUGGAAGAGCUGAUCCCGCUGGUCAACAAACUGCAGGACGCCUUCAGCUCCAUCGGCCAGAGCUGCCACCUGGACCUGCCGCAGAUCGCUGUAGUGGGCGGCCAGAGCGCCGGCAAGAGCUCGGUGCUGGAGAACUUCGUGGGCCGGGACUUCCUUCCCCGCGGUUCAGGAAUCGUCACCCGGCGGCCUCUCAUUCUGCAGCUCAUCUUCUCAAAAACAGAACAUGCCGAGUUUUUGCACUGCAAGUCCAAAAAGUUUACAGACUUUGAUGAAGUCCGGCAGGAGAUUGAAGCAGAGACCGACAGGGUCACGGGGACCAACAAAGGCAUCUCCCCAGUGCCCAUCAACCUUCGAGUCUACUCGCCACACGUGUUGAACUUGACCCUCAUCGACCUCCCGGGUAUCACCAAGGUGCCUGUGGGCGACCAGCCUCCAGACAUCGAGUACCAGAUCAAGGACAUGAUCCUGCAGUUCAUCAGCCGGGAGAGCAGCCUCAUUCUGGCUGUCACGCCCGCCAACAUGGACCUGGCCAACUCCGACGCCCUCAAGCUGGCCAAGGAAGUCGAUCCCCAAGGCCUACGGACCAUCGGUGUCAUCACCAAGCUUGACCUGAUGGACGAGGGCACCGACGCCAGGGACGUCUUGGAGAACAAGUUGCUCCCGUUGAGAAGAGGCUACAUUGGCGUGGUGAACCGCAGCCAGAAGGAUAUUGAGGGCAAGAAGGACAUCCGUGCAGCACUGGCAGCUGAGAGGAAGUUCUUCCUCUCCCACCCGGCCUACCGGCACAUGGCCGACCGCAUGGGCACGCCACAUCUGCAGAAGACGCUGAAUCAGCAACUGACCAACCACAUCCGGGAGUCGCUGCCGGCCCUACGUAGCAAACUACAGAGCCAGCUGCUGUCCCUGGAGAAGGAGGUGGAGGAGUACAAGAACUUUCGGCCCGACGACCCCACCCGCAAAACCAAAGCCCUGCUGCAGAUGGUCCAGCAGUUUGGGGUGGAUUUUGAGAAGAGGAUCGAGGGCUCAGGAGAUCAGGUGGACACUCUGGAGCUCUCCGGGGGCGCCCGAAUCAAUCGCAUCUUCCACGAGCGGUUCCCAUUUGAGCUGGUGAAGAUGGAGUUUGACGAGAAGGACUUACGACGGGAGAUCAGCUAUGCCAUUAAGAACAUCCAUGGAGUCAGGACCGGGCUUUUCACCCCGGACUUGGCAUUCGAGGCCAUUGUGAAAAAGCAGGUCGUCAAGCUGAAAGAGCCCUGUCUGAAAUGUGUCGACCUGGUUAUCCAGGAGCUAAUCAAUACAGUUAGGCAGUGUACCAGUAAGCUCAGUUCCUACCCCCGGUUGCGAGAGGAGACAGAGCGAAUCGUCACCACUUACAUCCGGGAACGGGAGGGGAGAACGAAGGACCAGAUUCUUCUGCUGAUCGACAUUGAGCAGUCCUACAUCAACACGAACCAUGAGGACUUCAUCGGGUUUGCCAAUGCCCAGCAGAGGAGCACGCAGCUGAACAAGAAGAGAGCCAUCCCCAAUCAGGGGGAGAUCCUGGUGAUCCGCAGGGGCUGGCUGACCAUCAACAACAUCAGCCUGAUGAAAGGCGGCUCCAAGGAGUACUGGUUUGUGCUGACUGCCGAGUCACUGUCCUGGUACAAGGAUGAGGAGGAGAAAGAGAAGAAGUACAUGCUGCCUCUGGACAACCUCAAGAUCCGUGAUGUGGAGAAGGGCUUCAUGUCCAACAAGCACGUCUUCGCCAUCUUCAACACGGAGCAGAGAAACGUCUACAAGGACCUGCGGCAGAUCGAGCUGGCCUGUGACUCCCAGGAAGACGUGGACAGCUGGAAGGCCUCGUUCCUCCGAGCUGGCGUCUACCCCGAGAAGGACCAGGCAGAAAACGAGGAUGGGGCCCAGGAGAACACCUUCUCCAUGGACCCCCAACUGGAGCGGCAGGUGGAGACCAUUCGCAACCUGGUGGACUCAUACGUGGCCAUCAUCAACAAGUCCAUCCGCGACCUCAUGCCAAAGACCAUCAUGCACCUCAUGAUCAACAAUACGAAGGCCUUCAUCCACCACGAGCUGCUGGCCUACCUAUACUCCUCGGCAGACCAGAGCAGCCUCAUGGAGGAGUCGGCUGACCAGGCACAGCGGCGGGACGACAUGCUGCGCAUGUACCAUGCCCUCAAGGAGGCGCUCAACAUCAUCGGUGACAUCAGCACCAGCACUGUGUCCACGCCUGUACCCCCGCCUGUCGAUGACACCUGGCUCCAGAGCGCCAGCAGCCACAGCCCCACUCCACAGCGCCGACCGGUGUCCAGCAUACACCCCCCUGGCCGGCCCCCAGCAGUGAGGGGCCCCACUCCAGGGCCCCCCCUGAUUCCUGUUCCCGUGGGGGCAGCAGCCUCCUUCUCGGCGCCCCCAAUCCCAUCCCGGCCUGGACCCCAGAGCGUGUUUGCCAACAGUGACCUCUUCCCAGCCCCGCCUCAGAUCCCAUCUCGGCCAGUUCGGAUCCCCCCAGGGAUUCCCCCAGGAGUGCCCAGCAGAAGACCCCCUGCUGCGCCCAGCCGGCCCACCAUUAUCCGCCCAGCCGAGCCAUCCCUGCUCGACUAGGCCUCGAGGGGGGCGUGCUCUCGGGGGGGCCUCACGCACCCGCGGCGCAGGAGCUUCAGUGGUCUGGGGCCCUCCGCCGCCCCUAUGCUGGGACCAGGCUCCCAGUGGGCAGCCCUGGCCUCUUCCUUAACGCUGGCCCCGGUCCAGGGCCGGCCCCUGUGCCUGGCUGGACACCGCACUGCGCAAAGGGGCCCUGGAGCUCCAGGCAGGGGGCGCUGGGGUGUUGCACUUUGGGGGAUGGAGUCUCAGGGUGGCAGAGGGGGGACCAGAACCCUUGACACCAUCCUGAAUGAGGGGUCCAGCCUGGGGGGGACUCUACCAAGGUCUUCUUGGGCUGGGAAAGCCCAUGUAGGGCAGGCCUUCUAUAAGUGCGGGCACCAAGGGCGCCUACAUCCCCAGGCCUUGCUGGGGUGCAGGGGUAUAUCAACUUCCCAUUAGCAGGAGCUCCCCAGCGGCAAGCCUGGCCCAGUGGGCUCGGUAGUGCCCAGCUGGCAGGCCUGAGGUGUACAUAGUCCUUCCCGGCCAUAUUAACCACACAGCCUGAGCCUGGCCCAGCCUCGGCUGCCAGAGGUGCCUUUGCUAGGCCCGGAGCCGUUGGCCCGGGCCGGCCUUGCCCUAUUCCUCUCCUCCUCCUCCUCCUGGGUCCCCCAGGGUGGCUGGGCUUGGGCUAUGUGGGUGGUGGUGGCGGGGGGUCUUGGGGGCCUCUCAGCUCCCGCCCAUGCCUCCCUGAUGGGUGGGCCCAGGGCGGCCUCUCUCUGAGGAGACCUCACCCACUCCUCGCUCAGUUUGACCACUGUAAGUGCCUGCACUCUGUAUUCUAUUAAUAAACUAAAAUAAAGGGAAGACGCUGCUGGUG,mRNA,Homo sapiens,"sp|P26368|U2AF2_HUMAN Splicing factor U2AF 65 kDa subunit OS=Homo sapiens OX=9606 GN=U2AF2 PE=1 SV=4
MSDFDEFERQLNENKQERDKENRHRKRSHSRSRSRDRKRRSRSRDRRNRDQRSASRDRRR
RSKPLTRGAKEEHGGLIRSPRHEKKKKVRKYWDVPPPGFEHITPMQYKAMQAAGQIPATA
LLPTMTPDGLAVTPTPVPVVGSQMTRQARRLYVGNIPFGITEEAMMDFFNAQMRLGGLTQ
APGNPVLAVQINQDKNFAFLEFRSVDETTQAMAFDGIIFQGQSLKIRRPHDYQPLPGMSE
NPSVYVPGVVSTVVPDSAHKLFIGGLPNYLNDDQVKELLTSFGPLKAFNLVKDSATGLSK
GYAFCEYVDINVTDQAIAGLNGMQLGDKKLLVQRASVGAKNATLVSPPSTINQTPVTLQV
PGLMSSQVQMGGHPTEVLCLMNMVLPEELLDDEEYEEIVEDVRDECSKYGLVKSIEIPRP
VDGVEVPGCGKIFVEFTSVFDCQKAMQGLTGRKFANRVVVTKYCDPDSYHRRDFW",U2AF65,-,-,475aa(1-475),P26368,"PhaSePro,DrLLPS","https://phasepro.elte.hu/entry/P26368,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0481",-,"[157-178],[248-259],[365-376]",In vitro,1 µg [DNM2];|2µM [U2AF65],150 mM NaCl,Hepes 20 mM pH 7.5,RT,-,-,Sedimentation assay,-,"Furthermore, this SPY-rich RNA partly cosedimented with U2AF65 assemblies (Fig 5C, compare lanes 3 and 4 with lanes 5 and 6). Analyses of four additional RNAs confirmed the correlation between SPY content and the ability of an RNA to exacerbate U2AF65 sedimentation.",3633
75,372,PMID: 31975687,RNAPS0000038,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,NCBI ID:245998,https://www.ncbi.nlm.nih.gov/gene/245998,Y51F10.2,1073nt(1-1073),UUCCUGUUCUCUGUGGACAAAAAUGUACAGUUUCAAAAGCAGCACCGACGUGAAGACUUAUAUCAGCACCCCGUCGUGCCGGAUAUGUCUUGAGCCAUUUGACGAAGGACAACAUCUUCCGAAAAUCCUGCAAUGUGCCCACACGGUCUGCGAGAGAUGCAUCGGUUUGCUCGACGAGCAGAGCCGAAUCAACCACAAUCGGCCGCCGAUCGACCGCUCGUUUGUGCACAUUAGAUGUCCAGUUUGCAGGGCAGUCACCCAGACUCCACGCAACUACAUUCGAUCCAACUACCAGCUAAUCGAAUUGAUGGAUUCGAUGCGUGGAGAAGCCGAUCAUAAUAUUUCAUUCCUCGCGUGUGUCGGCUGUAAUGGCGUUUAUCACGAGAAAGACACCAAUAUUUGCACUACAUGCUCCCCAAUCAUCAAGGAUGCUCAUCCCACUGAACUCAUCGAGCAAGGAGUAAUUCUGAAUCAGUACGCGUUGUGUUCGACGUGUCUCCUCAGAGAUCACAUCAAAAAGAACCACGUGUCGAUCAGUCUGCAGCCUCUUCGCGUCGAAAUGCAACGCCAGGAGAAUCAGCGGCGGAUAGUCGGCUUGCAGGACAAUUUGCACAAAGUGCAACGCGAUUUUCGUGAGCAGCUUAACGCGACUAUGGAGCGAUGGGCCGGAUGGAAUGGGAGCCACGAUUUGUCGAUGGAUAAAUUCCGUGAGCUUGGUGAUACGUACAAUCAGAAGAAGGUUUAUGAUGCGUUCGUGCAUCAGCUGAGAGGCAAGACCGCUAAGAUUGAGAAGCUCGCCGAGCACGUUUUGCGAUGGAAUGAUGAGCUGGACAGGGAGAUGGAAAGACCACCAGCUCAUCGUUUGCCACGUAGCUCAACUCCAGCGCCAGCACCACCAUUCGACAACUCCGUCGCCUACUAUUUUGAGCACCAAUUUUGAGCUUUUAUAUUUUUUUUUCUCAUCCCACCACCACAUUAAAACAGAGUUUUUAUAUAUACAGUACCCAUUAUUCGAACACAAUUUGUUCUAAAAGAGCCCCCAAGAAUCAGAUUUAAUAAAGAAUGCUCUCACC,mRNA,Caenorhabditis elegans,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [polyU(30)];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To determine whether RNA length affects MEG-3 condensation behavior, we tested RNAs of varying sizes in the condensation assay. We found that short RNAs (30 and 100 nt) were not as efficient as longer RNAs at stimulating MEG-3 condensation.",1073
76,374,PMID: 31975687,RNAPS0000039,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,NCBI ID:174158,https://www.ncbi.nlm.nih.gov/gene/174158,nos-2,1242nt(1-1242),CACAGACGACGGAAAGGGGAAAUUCAAGCCAUUUGAGUUUUUGUUCUUCUUGAAAGAUGUCUCUGGGUACUCCAAGUGAACCGACUUCGACUCUCGAAUCAGACAUUUUUGACGAUCUUUCGUUGUAUUAUCUAGAGGAUGUAUUCCUUUCCGCCACAACGCCGUCGCCAACAUUUGAUUUGAGUGAUCCAUCGGAUCCAUCACUUUCGGAUUCGUUUGACAGUGAAUGGUCACCAAUGACUCCAUGCUCAAUAGAAAGACCGGAGACCUCAACAUCAUCAAUCUUCUCGUUUGAAGCUAGACCCAUCAAAACGCCGCCACCUGCCGAAUAUCUUCGACUUCCGACAUUCCUGUCAACGAAUAAUUCCGGAUUUUUCGAUUCAGUUGUCGCUUCGGAUUUCAAUUUGUACGGGAAGUUCAAUGAUUGGUUGAAUGACAGCAAGCCUCGCAGUGGAUCGUUUGCGAUUGAAUCUGCUGAAGAGCUCGCGAGGAAUCCAAGAGAAACUCGCUCCGAGCCCGAAGUGCCAUCAUUGUUCAAAAGGCGUGAAUAUGGAUGUGGAUACUGUCGUUCCGUUGGAUAUAUGCGAUGGGAAACGCAUACACGUAAGAAAUGCGACAAGCUCAGCUCAUUGGCUCCAUGUAAAAUUUGUGGAGCUCGCGGUGAAAUGAAUCACACCGAGACGUACUGCCCAAUGAAGCCGUCGAGCCAGUUGUUCUUCAAUGAGGAUUUCAGCCGAGACUUCGAAAACCGACGAUUCCAGCGCAGUCGUUAUCAAUUUUACAAGCAUUCCUCAUUAAUUCAGAAGAUCUACGCAUCAUCCGAAGAUUCUUUCUAGAAGAUCCAAUUUCUCAAUACUUUUUUAUAUCGGGUCCAACCCGUUUAUUUUCUACAAGCUUUCACAAACAGAUAGUUUAUUGAGUUACCCGUUCAUAGCCUUUAUUGAUUCCAAAUUUCCCAUCUCACACUUUUCUACGGUAUACCAUUUACUUUUUCUGCUAAUAAUCAAUUAUUAAUACCGUAUAAUGGUCCUCUAUAUUGUCCACGUAACAACUUGUGCUUUUUCGUCGAAUUUUCAUCAGUUUGUGGAAGAAAGUGAUAACUGAAAGAAAGAAGUUUUGAAAGGAAUAGUUGUAGAAGUAAAUCACUUGUCAAUUGCAUUUGAAUAGUUGGCGAGAGCCGCAAUAUCGAGAAAAUGUGUAGCCAGGAAGGUAUAGCUCUGAAAAUAAAAAUUUACAAUUCGU,mRNA,Caenorhabditis elegans,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [nos-2];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To investigate whether MEG-3 shows any bias when presented with specific sequences, we synthesized nine fluorescently labeled RNAs (800-1300nt size range) corresponding to embryonic transcripts with strong, minimal, or no localization to P granules in vivo under normal culture conditions. Each transcript (20 ng/mL) was combined with recombinant His-tagged MEG-3 (500 nM; ) in condensation buffer containing 150 mM salt. In the absence of RNA, MEG-3 formed irregular assemblies with a broad size range.",1242
77,375,PMID: 31975687,RNAPS0000040,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,NCBI ID:172773,https://www.ncbi.nlm.nih.gov/gene/172773,skr-2,758nt(1-758),CGUUAGUGACCCUGUCACAACUAAUUUUAAUUCCAGUCAACUACAACACGAUGGCUGACCAAAAGGAAGCAUCCGAAGCAGCAAAGAACCGCGAAAUCAAGAUCUCGUCUUCGGAUGAUGAAAUCUUCUUGGUCCCACGCAAUGUGAUCCGUCUCUCAAACACUCUCAACACUCUUCUUGUGGACCUCGGGCUCGACGACGAUGAAGGAACCAACGCUGAGCCAAUUCCAGUGCAAAACGUCACUGCCUCGAUUUUGAAGAAGGUUAUCAACUGGUGCACCAAACACCAGUCCGACCCAAUUCCAACUGAAGACAGUGAGAAGAAAACGGAUGGUUCCAUCCAAGACUGGGACAAAAAAUUUCUCGAUAUUGACCAAGGAACCCUUUUCGAGCUCAUUUUGGCUGCCAACUAUUUGGACAUCAAAGGACUUCUUGAUGUCGCCUGCCAGUCUGUCGCCAACAUGAUCAAGGGAAAAUCUCCAGAUGAAAUUCGUCGUGCUUUCAACAUCAAGGACGACUUCACUGCAGAGGAGAGAGAGCAAAUCCGUAAGGAAAACGCCUGGUGCGAUGAUUAAAUCUCCAUCUUUUCCCCUGUUAAACUUUCAAUUACCUUGUUUUCUAAAUGUUUCACAUCAUCCACCAUAUCUUUCCCCUUAUUAAACGCACUUUUUAAUUGUUAACAAAUUUCUUCACUGCCAGCUGACACAACUGUGUACAGUUCUGUUUUUCAUUCAAUAAAGUUGAUGUGAACAUGAAAA,mRNA,Caenorhabditis elegans,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [skr-2];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To investigate whether MEG-3 shows any bias when presented with specific sequences, we synthesized nine fluorescently labeled RNAs (800-1300nt size range) corresponding to embryonic transcripts with strong, minimal, or no localization to P granules in vivo under normal culture conditions. Each transcript (20 ng/mL) was combined with recombinant His-tagged MEG-3 (500 nM; ) in condensation buffer containing 150 mM salt. In the absence of RNA, MEG-3 formed irregular assemblies with a broad size range.",758
78,376,PMID: 31975687,RNAPS0000041,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,NCBI ID:181451,https://www.ncbi.nlm.nih.gov/gene/181451,R04D3.2,951nt(1-951),CUAAAGUCUGAAUGUUCUAUUUGUCUUUGCUUUUCUUGAUGGCGUGUGUCUUCUCGUCAUUGUUGGUGGUGCAGUUGGUGUGGAUGGAUUUUCAUUCUUAUCUGCAUCGAAUGUCUCCGUCUCCUUUUGCUUUUCCUCUUUCUUUUUGGCAGAAGUACGACGAGAGGUCGAUAGUUUCUCGAUGCGAACUGAUGUUCCUCGUUUUCUUCCGCGUGUUUUCUUUGUACUUUGUACCGGCUCUUUGAAAACAAUUUCGCCACCAUCUCCAAGCUCAGAUUUGGUCUUUUCAUCUGUCUCUUGGUCAUUUUCAAUCGGAUCAUUUGUGGGAGACUUAUCUUUUCUGAAAAUCCAAUCACCGGAAGCUUGAUUUCUCUCAUUUACAUCAAUGUCUCCGGCAAUAGUUGUAUUGAAGAGUACGGUAGUGUCAUCAAAAGAAGAGAAAAACAGUGGGAAAUCUCUAUUUUUCGGCGACUCUGUUAUUUGUGAUGUUCCUUCUCCAUGGUUACGAUGGUCAAUACGGAAUGUUGAGUUAAGUAGAUCUCCAGAACCUGCAUCGCGAGGAUAGUCAGUGUCGAAAAGCCAAUUGAGUCCCAAUGUCUCGUCACAAUCUACCACUGGUUCUCCUGUUUUGAUCAUCACUUCAGUGUCAUUUCUCUGAAAUUUUCUUCGUCUUUCAGAUAAUUGAAUUUUUGGCGUUUUUGCUGGAGUUGCGGUUUCAAGAACAGUGGACGAGCGUCUUUUUGCAACUUUCAGGAACGUCGGAAGAUCAACAAGCUGAUCGGAAAUAUCAAUGAUAGACGAUUGUGAAGGCGUAUGAAACACCGACACUGGGGUCGUUGGGACUGAUUCUUGAACUUCAAUACUGUGACCGUCGACCAUGUCGUAAUCUGAACUUUCAUCAGCUUCUUCUUCGGGGCCAACACCCAACAUCCACCAAGGAAGCGGCAACAU,mRNA,Caenorhabditis elegans,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [RO4D3.2];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To investigate whether MEG-3 shows any bias when presented with specific sequences, we synthesized nine fluorescently labeled RNAs (800-1300nt size range) corresponding to embryonic transcripts with strong, minimal, or no localization to P granules in vivo under normal culture conditions. Each transcript (20 ng/mL) was combined with recombinant His-tagged MEG-3 (500 nM; ) in condensation buffer containing 150 mM salt. In the absence of RNA, MEG-3 formed irregular assemblies with a broad size range.",951
79,377,PMID: 31975687,RNAPS0000042,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,NCBI ID:183500,https://www.ncbi.nlm.nih.gov/gene/183500,C46A5.6,1084nt(1-1084),GGUAAAAUGUUGCCGCUUCCUUGGUGGAUGUUGGGUGUUGGCCCCGAAGAAGAAGCUGAUGAAAGUUCAGAUUACGACAUGGUCGACGGUCACAGUAUUGAAGUUCAAGAAUCAGUCCCAACGACCCCAGUGUCGGUGUUUCAUACGCCUUCACAAUCGUCUAUCAUUGAUAUUUCCGAUCAGCUUGUUGAUCUUCCGACGUUCCUGAAAGUUGCAAAAAGACGCUCGUCCACUGUUCUUGAAACCGCAACUCCAGCAAAAACGCCAAAAAUUCAAUUAUCUGAAAGACGAAGAAAAUUUCAGAGAAAUGACACUGAAGUGAUGAUCAAAACAGGAGAACCAGUGGUAGAUUGUGACGAGACAUUGGGACUCAAUUGGCUUUUCGACACUGACUAUCCUCGCGAUGCAGGUUCUGGAGAUCUACUUAACUCAACAUUCCGUAUUGACCAUCGUAACCAUGGAGAAGGAACAUCACAAAUAACAGAGUCGCCGAAAAAUAGAGAUUUCCCACUGUUUUUCUCUUCUUUUGAUGACACUACCGUACUCUUCAAUACAACUAUUGCCGGAGACAUUGAUGUAAAUGAGAGAAAUCAAGCUUCCGGUGAUUGGAUUUUCAGAAAAGAUAAGUCUCCCACAAAUGAUCCGAUUGAAAAUGACCAAGAGACAGAUGAAAAGACCAAAUCUGAGCUUGGAGAUGGUGGCGAAAUUGUUUUCAAAGAGCCGGUACAAAGUACAAAGAAAACACGCGGAAGAAAACGAGGAACAUCAGUUCGCAUCGAGAAACUAUCGACCUCUCGUCGUACUUCUGCCAAAAAGAAAGAGGAAAAGCAAAAGGAGACGGAGACAUUCGAUGCAGAUAAGAAUGAAAAUCCAUCCACACCAACUGCACCACCAACAAUGACGAGAAGACACACGCCAUCAAGAAAAGCAAAGACAAAUAGAACAUUCAGACUUUAGAUUUGUUCUGUAAAAUUGUUAAUCCUCUGUUAGUUUUUCUUCAACGUUGUAGUUGUUUCUGUUAAAUUUGACUGUCUAUUUAAAGUUUUUUGUUGUUGUUCUUUUUUGCAUAAAAUGCUUAGUAUUA,mRNA,Caenorhabditis elegans,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [C46A5.6];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To investigate whether MEG-3 shows any bias when presented with specific sequences, we synthesized nine fluorescently labeled RNAs (800-1300nt size range) corresponding to embryonic transcripts with strong, minimal, or no localization to P granules in vivo under normal culture conditions. Each transcript (20 ng/mL) was combined with recombinant His-tagged MEG-3 (500 nM; ) in condensation buffer containing 150 mM salt. In the absence of RNA, MEG-3 formed irregular assemblies with a broad size range.",1084
80,378,PMID: 31975687,RNAPS0000043,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,NCBI ID:172674,https://www.ncbi.nlm.nih.gov/gene/172674,pbs-7,878nt(1-878),AGAACCAAAAUGAAUGCUCACGACGAAGUCCAGCGCACACUGAAUCCUACUUGUACCGGAACAUCGGUUAUCGCUCUCCAGUAUAAAACUGGGGUUGUUGUCCUUACUGAUCGAGUUGUUUCCUAUGGAAAAAUGGCUCGUUACAAGAAUGUUUCUCGUCAAUACAAGGUCAAUGAUAAUGUUCUCAUUGCCUUCGGAGGAGAUCACGCUGACUUCCACUGGCUUCAAAAUGUGAUCGAGCGUCAGGUUCUUCUCUGGAAGCGCUUCGAUCAGGAUAUUGGACCAAAAGCUCUCCACGGAUACCUCACAAGCCUUCUCUACGCCAAACGUUGCAAGAUGAACCCAGUGUGGAACACACUUGUUGUCGCCGGAGUCGAAGAGGAGGAGAAGAACAACAAGGAGACUAGCACACCUUUCAUCGGUGUCAUUACUCAGAAGGGAUGCGCAUAUCAAGUGAAGCACAUUGCAACUGGACUUGGAGCGUUCCUCCUCAACCAAGCUGUUGAAGAUGAGUGGAGAAAGAAGGGAGAAGACCUCUCCCGUGAAGAGGCAGAAGCCGUGCUUCGCAAAUCGCUUGAACUUACUCUCUACCACGACUGCGUCGCUGACAAUGAGUUCGAAAUCGGACGUGUUGAUGCGACAGAAGGUGUCGUUUUGGGUAAAGAAGAGAAGAUUAUUGGUGACUGGUCGAUUGCCGAGACUAACUGUCAAUAUGAAUAAGUUUUCCCCGGUGUGCAGGAUGCGUUUCAGUAUCUCCAUGUUUAACUUAUUUGUAUCCUUCUUUUCAAAACAUUUUACUCUCUCCAACCCACGUUUUCGGUGUAAAUUUUAUUUAUUUUCGCGUGAAGUCGAUAAAUAAACUUCCAUUUAAUCCUUCU,mRNA,Caenorhabditis elegans,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [pbs-7];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To investigate whether MEG-3 shows any bias when presented with specific sequences, we synthesized nine fluorescently labeled RNAs (800-1300nt size range) corresponding to embryonic transcripts with strong, minimal, or no localization to P granules in vivo under normal culture conditions. Each transcript (20 ng/mL) was combined with recombinant His-tagged MEG-3 (500 nM; ) in condensation buffer containing 150 mM salt. In the absence of RNA, MEG-3 formed irregular assemblies with a broad size range.",878
81,379,PMID: 31975687,RNAPS0000044,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,NCBI ID:178881,https://www.ncbi.nlm.nih.gov/gene/178881,T19H12.2,891nt(1-891),ACCAGCUCACGAAACUAACAAUGCCGUCGAUGGAGGAAGUCUACGCCAGCGAGCUCAGAGGACGUGAGCCGGAAACCGUCGACACACUUUUCCUCGACAACACCCAAGGAGGAGUGAUCGGAGGAAUCAACGAAAAACUCACCAAACUGGAGUUGCUGAGCAUGGUCAAGUGCGGGUUGACCACUCUCAAAGGGAUGCCGGUUCUCCCAGCGCUCAACUACUUGGAUCUCAGCGACAACGAGCUUGGAGACGAUGCUUCGUUUGACGUCCUCAUCAAAUGUGCUCCGGAGAUCAAGAAAAUCACGCUUUCCGGAAACCGCCUCACUCUGGACAACGUUCGGACGCUGAAGAUGCUCCCCAAUCUCAUGGAGCUCGACCUGUCGAACAAUUCAAGCCUCGGACUUCUCGACGACUAUCGUGUCAAGAUGUUCGAGAUGAUCCCGUCGCUGAAGAUUCUCGAUGGAUGCGACGUCGAUGGAGAGGAGGUUGAGGAGGAGUUCGCCGCCGGCGAGGGAGCCGAGGACAGCGACGAGGGAGACAGCGAUGAAGAUGGCCCAGGGCUCAGCUACCUCAACAAGAGCCAGUUCUCAGAUGACGAGACCGACGACUACGUCGUUCCAGAAGCGGGAGAUGCUGAGACUCGUGGAGCCAAGAGAGCCGCUUCUGCUGACUGCGACGAGCCGGAGGCCAAGAAGUCGGCCGAGUAACAAGGGAUGCUCCACUGCUCCACGCCACCACCAUCGUCAAUUUCUCCCGUCUAUUUUUCAAUUCAACUUUCUUAUAUUUUCAAUACUCAAUCAUUCCCUUCCACGUGUGUGCCCAAUAUUUAAAUUUCACCCAAGCGAUCUCGGCGAAAAACGCCUCCUGUAAAAUAAAAUUUCUUUCGCUUUC,mRNA,Caenorhabditis elegans,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [T19H12.2];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To investigate whether MEG-3 shows any bias when presented with specific sequences, we synthesized nine fluorescently labeled RNAs (800-1300nt size range) corresponding to embryonic transcripts with strong, minimal, or no localization to P granules in vivo under normal culture conditions. Each transcript (20 ng/mL) was combined with recombinant His-tagged MEG-3 (500 nM; ) in condensation buffer containing 150 mM salt. In the absence of RNA, MEG-3 formed irregular assemblies with a broad size range.",891
82,380,PMID: 31975687,RNAPS0000373,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,NCBI ID:172242,https://www.ncbi.nlm.nih.gov/gene/172242,hil-5,867nt(1-867),ACUAUCACUUUUCAAGUGUUUGUUCAUCGUUUAACAAUGUCCGACGUCGCCGUUGCCGAGACUCCAGCAGUCAAGACCCCAACCAAAGCUUCAAAAGCCACGAAGGCCAAGGCUACCAAGAUUCCGAAGGUGAAGGUCGUUGCCGCCCAUCCGCCAUUCAUCAACAUGAUCACCGAAGCCGUCAGCAACCUCAAGGACCGCAAGGGAUCAUCCAGGGUCGCCAUUUUCAAGUUCAUCACUGCCAAAUACACGCUUGGAGAUCAAGUUAACAAGACCAACGCUCACCUUCGCUCUGCACUUAAAAAAGGAGUCGUCAGCAAGGUCCUCGUCCAGACUAACGGAAUCGGAGCCAACGGACGAUUCCGUCUUGCCGUUGCCGAGAAGCCACCAGCAGUGAAGAAGGCUGCCACUGGAGAGCAAAAGGUUAUGAAGACCGUCGCCAAGAAGGCUGUCAGCGGAGACAAGGCUAAGAAAACUGUCGCCAAAAAGACCGGAGACAAGGUGAAGAAGGUCAAGUCACCGAAGAGGAUCGCUAAGCCAGCUGUCAAGAAGGUCACUAAGAAAGCCGCCGCUCCAACGAAGUCUGCUGCCAAUGAAACCGCUCCAAAGAAGGCUGCUGCCACUGAAGCCGCUCCAAAGAAGGCUGCUGUCACGAAAGCUGCUACAAAGAAGACUCCUGCCAGGAAGGCCGUUGGUACUGCCCCAAAAGCCUAAUAACACUGUGUGAAAUUCAAAUUUAAUUCGAUCUCACCAUUGUAAUAUACCUCCUCCUUGAAGGUGUCCCGGGUACCGGUUUUUUCUUCCCAUUUAAUCAUAAUUUGUUCCAUUUUAACAAAUAUACCUUCCAAUAAACCAUUAAUAGAUUCU,mRNA,Caenorhabditis elegans,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [hil-5];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To investigate whether MEG-3 shows any bias when presented with specific sequences, we synthesized nine fluorescently labeled RNAs (800-1300nt size range) corre sponding to embryonic transcripts with strong, minimal, or no localization to P granules in vivo under normal culture conditions. Each transcript (20 ng/mL) was combined with recombinant His-tagged MEG-3 (500 nM; ) in condensation buffer containing 150 mM salt. In the absence of RNA, MEG-3 formed irregular assemblies with a broad size range .",867
83,381,PMID: 31975687,RNAPS0000045,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,NCBI ID:266845,https://www.ncbi.nlm.nih.gov/gene/266845,dao-5,3158nt(1-3158),GGUACCCCUGAUCGCUAUGAGUUCCGACUUGUAUGCGAAUGCUGUUCUCUACAGCGAAAUUUCACAAAGAAACCCGGAGUUGGUAUCGAAAAUGUUCAAUGAAGCAACACGGAAAAAGUUGGAUGCGUUUUUAAAAGACAAUGAAGCGCCAAAGCUCAAAGACAUCGUCACCGACAAUGUAUUCAAGAAGAGAAAGCGUAUAGCUUCUUCUUCCGGAAACGAGCCACCUGUUAAAAAAAUGGCAGCAAAGGACUCGUCUGACUCAGAUUCUUCAGACGAUGGAGCUGUGAAGAAGAAUGGUGUGCAAAAACCUGUCAAUGUUGCGGCCAAAAAAUCGGCGACUCCUGUUCAAAAGAAGGCUGAAUCUAGCAGCAGUUCGGAUAGUGAUGCUCCUGCCAAGAAAUUGACUCCAGUUAAGAAACCGGCCCAAACUCCUGCACAGAAGAAAGCUGCGUCAAGCUCUGAUAGCGAUAGCGAUGAUGAACCUCCGAAGAAAGCUCCAGCUGUUACAACCAAAGUUGCUCCAAAGCCAAUGGCAAAGAAGCAGGAUACCAGUGAUUCCGACAGUGAUAGCGAGGAUAGCGACGAUGGCAAAAGCAAGAAAGCAAAUCCAGUAAAGGUUACUCCAGUUGCGAAUGUUCUCCAGAAAGUUGUUGCCAAGAAAGCCGCUUCUUCAUCUUCCGAUUCCUCUGACGACGAAAAGAAGCCAGCUGCCAAACCAACUCCAGCUAAACCUACUCCAAAGCCUGUUGUCAAGAAGGCCGAGUCCUCUUCGGAUUCAAGCGAUGACGAGAAGAAGCCAGUUGCCAAGCCAGCACCAGCUAAAGCAACUCCAAAGCCUGCUGCCAAGAAGGCCGAUUCAUCUUCUGAUUCUUCUGAUGAUGAAGCUCCAGCGAAAAAGACUCCAGCUAAAGCUGCUCCAAAGCCUGUUGCCAAGAAGGCCGAGUCCUCUUCGGAUUCAAGCGAUGACGAGAAGAAGCCAGCUGCCAAGCCAACGCCGGCUAAAGCUACUCCAAAGCCUGUUGCAAAGAAGGCCGAAUCCUCUUCGGAUUCAUCCGAUGACGAGAAGAAACCAGUUGCCAAGCCAGCACCAGCUAAAGCUACUCCAAAGCCUGUUGCCAAGAAGGCCGAGUCCUCUUCGGAUUCAAGCGAUGACGAGAAGAAGCCAGCUGCCAAGCCAACGCCGGCUAAAGCUACUCCAAAGCCUGUUGCAAAGAAGGCCGAAUCCUCUUCGGAUUCAUCCGAUGACGAGAAGAAACCAGUUGCCAAGCCAACAUCAGCUAAAGCAACUCCAAAGCCUGCUGCCAAGAAGGCCGAUUCAUCUUCUGAUUCUUCUGAUGAUGAAGCUCCAGCGAAAAAGACUCCAGCUAAAGCUGCUCCAAAGCCUGCUUCCAAGAAGGCCGAAUCCUCUUCGGAUUCAUCCGAUGACGAGAAGCCAGCUGCCAAGUCAACACCGGCUAAGAUCACUCCAAAGCCUACUGCCAAGAAGGUCGCCUCCUCAUCUUCUGAUUCCUCCGACGACGAGAAAAAACCAGCUGCCAAGCCAACUCCAGCCAACGCUACUCCAAAGCCUGUUGCCAAGAAGGCCGAGUCCUCUUCGGAUUCAAGCGAUGACGAGAAGAAACCAGUUGCCAAGCCAACAUCAGCUAAAGCAACUCCAAAGCCUGCUGCCAAGAAGGCCGAUUUAUCUUCUGAUUUUUCUGAUGAUGAAGCUCCAGCGAAAAAGACUCCAGCUAAAGCUGCUCCAAAGCCUGCUUCCAAGAAGGCCGAAUCCUCUUCGGAUUCAUCCGAUGACGAGAAGCCAGCUGCCAAGUCAACACCGGCUAAGACCACUCCAAAGCCUACUGCCAAGAAGGCCGCCUCCUCAUCUUCUGAUUCCUCCGACGACGAGAAGAAACCAGUUGCCAAGCCAACAUCAGCUAAAGCAACUCCAAAGCCUGCUGCCAAGAAGGCCGAUUCAUCUUCUGAUUCUUCUGAUGAUGAGGCUCCAGCGAAAAAGACUCCAGUUAAGCCAACUCCAGUCAAGAUUGUAGCGAAGAAAGUUGAUUCGUCUUCUGAUUCAUCCGAUGAUGAGAAGAAGCCUACAAAGGCAACUCCUGUCAAAGUCACCCCGAAGUCAGUUACAAAGAAAGCAGCAGCAUCGUCUUCGGACUCAUCCGAUGAUGAAAAGAAACCAGUGGUGAAACAAACUCCUAACGUUGUCCCGAAAAAAGAGAAAGCGGCUUCAAGUUCAGAUGAUUCUUCUGACGAUGAAAAGAAGCCGACUGCCAAGCCAACACCAAAAGCUACUCCUAAGCAAUCUGCCAAAAAAGCUGAUUCAUCCGAUGAUUCUUCUGAUGACGAGGCACCGGCUAAGAAGACACCAGCCAAGUCAACACCUGCAAAAACCGCUGUGAAAAAAGAAGCCUCUUCAUCGUCAGACGAUUCUUCGGAUGAUGAGAAAACGAAAAAGAAGUCUGCCACCACACCAGCAAAAUCAACUCCAAAGACUGCACUAAAGAAAGCUGAAUCUUCUGAUUCCUCUGAUGACGACGAAGAUCUUCCAAAACCAUCUAAGGCUGUCACUCCAAGACCACAACGUGCUGACUCUGAAGAAUCCGCCGAGACCGAGGAGAGCAGUUCAAGAACACCGGCUUUGAAGGCAAAACCAUUGGCUACCUCGACUGAAAAGGCGGUCUAUGAAAACCGAAAAAGAAAGUCUUCACCAUUCCGACGCGUGCAAAUGACAAAGGAUAGCGUUUCUGAAAAAUUUAGAAACAACCAGCAUGAUUCGCACUUCGAUCAAUGGGGACAGCGUGCCAAUGAAAGCCUAGGAAAAGUUGUUGGAAAAGCAUUCCGUCAUGAGAAAACUAAGAAGAAGAAGGGAAGCUACGGAGGUGGUCCAAUCAACCAAUCUAUUAAUUCUAUCAAGUUCUCUGACUCUGACGAUUAGUUUCUUAACUUUAUCCUUAAGUUAAUUUGUUUCCAAAAUUGUUUCUCACCCCCGUCUACACUUCGUUUUUUAUCUGUUGUCUGUUGCUUUCCUUUUUGUUUCCCCUUUAAAUUUAUAAUCCUGAGUUGAUCCAAAACAAAUGUUUUGUAUACUUUUGUUACUUCAAAUAUAACUUGUUAUGUUUCCGUUUUUCUCCCUCUUGUCUCAUCCAUAAAAUGUUUGGUCC,mRNA,Caenorhabditis elegans,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [dao-5];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To investigate whether MEG-3 shows any bias when presented with specific sequences, we synthesized nine fluorescently labeled RNAs (800-1300nt size range) corresponding to embryonic transcripts with strong, minimal, or no localization to P granules in vivo under normal culture conditions. Each transcript (20 ng/mL) was combined with recombinant His-tagged MEG-3 (500 nM; ) in condensation buffer containing 150 mM salt. In the absence of RNA, MEG-3 formed irregular assemblies with a broad size range.",3158
84,386,PMID: 31975687,RNAPS0000380,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,-,-,polyU(600),600nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [U600];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To determine whether RNA length affects MEG-3 condensation behavior, we tested RNAs of varying sizes in the condensation assay. We found that short RNAs (30 and 100 nt) were not as effi cient as longer RNAs at stimulating MEG-3 condensation",600
85,410,PMID: 32637943,RNAPS0000404,https://pubmed.ncbi.nlm.nih.gov/32637943,RNA + protein,-,-,luciferase RNA,1857nt(1-1857),UCCGUUUAGUUACCUAUACCUGAUUUUAUUAUUCGUUAAAAUAGUACAGUGACCCACAAUUACAAAAUUACCAUUCAUCAAUUUGCAUAUAAUAUUACAAUAGCUAAGAAUUUCGUCAUCGCUGAAUACAGUUACAUUUUACAAUUUGGACUUUCCGCCCUUCUUGGCCUUUAUGAGGAUCUCUCUGAUUUUUCUUGCGUCGAGUUUUCCGGUAAGACCUUUCGGUACUUCGUCCACAAACACAACUCCUCCGCGCAACUUUUUCGCGGUUGUUACUUGACUGGCGACGUAAUCCACGAUCUCUUUUUCCGUCAUCGUCUUUCCGUGCUCCAAAACAACAACGGCGGCGGGAAGUUCACCGGCGUCAUCGUCGGGAAGACCUGCCACGCCCGCGUCGAAGAUGUUGGGGUGUUGUAACAAUAUCGAUUCCAAUUCAGCGGGGGCCACCUGAUAUCCUUUGUAUUUAAUUAAAGACUUCAAGCGGUCAACUAUGAAGAAGUGUUCGUCUUCGUCCCAGUAAGCUAUGUCUCCAGAAUGUAGCCAUCCAUCCUUGUCAAUCAAGGCGUUGGUCGCUUCCGGAUUGUUUACAUAACCGGACAUAAUCAUAGGUCCUCUGACACAUAAUUCGCCUCUCUGAUUAACGCCCAGCGUUUUCCCGGUAUCCAGAUCCACAACCUUCGCUUCAAAAAAUGGAACAACUUUACCGACCGCGCCCGGUUUAUCAUCCCCCUCGGGUGUAAUCAGAAUAGCUGAUGUAGUCUCAGUGAGCCCAUAUCCUUGUCGUAUCCCUGGAAGAUGGAAGCGUUUUGCAACCGCUUCCCCGACUUCUUUCGAAAGAGGUGCGCCCCCAGAAGCAAUUUCGUGUAAAUUAGAUAAAUCGUAUUUGUCAAUCAGAGUGCUUUUGGCGAAGAAUGAAAAUAGGGUUGGUACUAGCAACGCACUUUGAAUUUUGUAAUCCUGAAGGGAUCGUAAAAACAGCUCUUCUUCAAAUCUAUACAUUAAGACGACUCGAAAUCCACAUAUCAAAUAUCCGAGUGUAGUAAACAUUCCAAAACCGUGAUGGAAUGGAACAACACUUAAAAUCGCAGUAUCCGGAAUGAUUUGAUUGCCAAAAAUAGGAUCUCUGGCAUGCGAGAAUCUGACGCAGGCAGUUCUAUGCGGAAGGGCCACACCCUUAGGUAACCCAGUAGAUCCAGAGGAAUUCAUUAUCAGUGCAAUUGUUUUGUCACGAUCAAAGGACUCUGGUACAAAAUCGUAUUCAUUAAAACCGGGAGGUAGAUGAGAUGUGACGAACGUGUACAUCGACUGAAAUCCCUGGUAAUCCGUUUUAGAAUCCAUGAUAAUAAUUUUCUGGAUUAUUGGUAAUUUUUUUUGCACGUUCAAAAUUUUUUGCAACCCCUUUUUGGAAACAAACACUACGGUAGGCUGCGAAAUGUUCAUACUGUUGAGCAAUUCACGUUCAUUAUAAAUGUCGUUCGCGGGCGCAACUGCAACUCCGAUAAAUAACGCGCCCAACACCGGCAUAAAGAAUUGAAGAGAGUUUUCACUGCAUACGACGAUUCUGUGAUUUGUAUUCAGCCCAUAUCGUUUCAUAGCUUCUGCCAACCGAACGGACAUUUCGAAGUAUUCCGCGUACGUGAUGUUCACCUCGAUAUGUGCAUCUGUAAAAGCAAUUGUUCCAGGAACCAGGGCGUAUCUCUUCAUAGCCUUAUGCAGUUGCUCUCCAGCGGUUCCAUCCUCUAGAGGAUAGAAUGGCGCCGGGCCUUUCUUUAUGUUUUUGGCGUCUUCCAUUUUACCAACAGUACCGGAAUGCUAAUGUCACUGCGAGCGACAUUCAAGAAUGUAACACAAAGGAAU,mRNA,Photinus pyralis,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,100 nM [Luc];|5-25 µM [SARS-CoV-2 N protein],70 mM KCl,25 mM Hepes pH 7.5,RT,30 min,-,Microscopy,"liquid, solid","We first analyzed the effects of three mid-sized viral RNA fragments: (1) 5’-400, containing the 400 nt at the 5’ end of the SARS-CoV-2 genome, which is thought to include multiple secondary  structure elements and the leader TRS; (2) PS-318, a sequence near the end of ORF1b in  SARS-CoV, proposed as a packaging sequence but of unknown function; and (3) N- 1260, containing the open reading frame of the N gene near the 3’ end of the SARS-CoV-2  genome. RNA encoding firefly luciferase (Luc-1710) was a nonviral control. N protein structures were analyzed by microscopy 30 minutes after addition of RNA at room temperature",1857
86,422,PMID: 32637943,RNAPS0000407,https://pubmed.ncbi.nlm.nih.gov/32637943,RNA + protein,-,-,SARS-CoV-2 N1260 RNA,1260nt,UGUCGACGGAGCUCGAAUUCUUAGGCCUGAGUUGAGUCAGCACUGCUCAUGGAUUGUUGCAAUUGUUUGGAGAAAUCAUCCAAAUCUGCAGCAGGAAGAAGAGUCACAGUUUGCUGUUUCUUCUGUCUCUGCGGUAAGGCUUGAGUUUCAUCAGCCUUCUUCUUUUUGUCCUUUUUAGGCUCUGUUGGUGGGAAUGUUUUGUAUGCGUCAAUAUGCUUAUUCAGCAAAAUGACUUGAUCUUUGAAAUUUGGAUCUUUGUCAUCCAAUUUGAUGGCACCUGUGUAGGUCAACCACGUUCCCGAAGGUGUGACUUCCAUGCCAAUGCGCGACAUUCCGAAGAACGCUGAAGCGCUGGGGGCAAAUUGUGCAAUUUGCGGCCAAUGUUUGUAAUCAGUUCCUUGUCUGAUUAGUUCCUGGUCCCCAAAAUUUCCUUGGGUUUGUUCUGGACCACGUCUGCCGAAAGCUUGUGUUACAUUGUAUGCUUUAGUGGCAGUACGUUUUUGCCGAGGCUUCUUAGAAGCCUCAGCAGCAGAUUUCUUAGUGACAGUUUGGCCUUGUUGUUGUUGGCCUUUACCAGACAUUUUGCUCUCAAGCUGGUUCAAUCUGUCAAGCAGCAGCAAAGCAAGAGCAGCAUCACCGCCAUUGCCAGCCAUUCUAGCAGGAGAAGUUCCCCUACUGCUGCCUGGAGUUGAAUUUCUUGAACUGUUGCGACUACGUGAUGAGGAACGAGAAGAGGCUUGACUGCCGCCUCUGCUCCCUUCUGCGUAGAAGCCUUUUGGCAAUGUUGUUCCUUGAGGAAGUUGUAGCACGAUUGCAGCAUUGUUAGCAGGAUUGCGGGUGCCAAUGUGAUCUUUUGGUGUAUUCAAGGCUCCCUCAGUUGCAACCCAUAUGAUGCCGUCUUUGUUAGCACCAUAGGGAAGUCCAGCUUCUGGCCCAGUUCCUAGGUAGUAGAAAUACCAUCUUGGACUGAGAUCUUUCAUUUUACCGUCACCACCACGAAUUCGUCUGGUAGCUCUUCGGUAGUAGCCAAUUUGGUCAUCUGGACUGCUAUUGGUGUUAAUUGGAACGCCUUGUCCUCGAGGGAAUUUAAGGUCUUCCUUGCCAUGUUGAGUGAGAGCGGUGAACCAAGACGCAGUAUUAUUGGGUAAACCUUGGGGCCGACGUUGUUUUGAUCGCGCCCCACUGCGUUCUCCAUUCUGGUUACUGCCAGUUGAAUCUGAGGGUCCACCAAACGUAAUGCGGGGUGCAUUUCGCUGAUUUUGGGGUCCAUUAUCAGACAUGGAUCCCUGAAAAUACAGGUUUUCCGUGGUACCGCGCGGCACCAGGCCGCUGCUGUGAUGAUGAUGAUGAUGGCUGCUGCCCAUGGUAUAUCUCCUUCUUAAAGUUAAACAAAAUUAUUUCUAGAGGGGAAUUGUUAUCCGCUCACAAUUCCC,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,200 nM [SARS-CoV-2];|5-25 µM [SARS-CoV-2 N protein],70 mM KCl,25 mM Hepes pH 7.5,RT,30 min,-,Microscopy,liquid,"We first analyzed the effects of three mid-sized viral RNA fragments: (1) 5’-400, containing the 400 nt at the 5’ end of the SARS-CoV-2 genome, which is thought to include multiple secondary  structure elements and the leader TRS51-53; (2) PS-318, a sequence near the end of ORF1b in  SARS-CoV, proposed as a packaging sequence54,55 but of unknown function51,56; and (3) N- 1260, containing the open reading frame of the N gene near the 3’ end of the SARS-CoV-2  genome. RNA encoding firefly luciferase (Luc-1710) was a nonviral control. N protein structures were analyzed by microscopy 30 minutes after addition of RNA at room temperature",1260
87,434,PMID: 32649883,RNAPS0000409,https://pubmed.ncbi.nlm.nih.gov/32649883,RNA + protein,NCBI ID:283131,https://www.ncbi.nlm.nih.gov/gene/283131,NEAT1,3756nt(1-3756),GGAGUUAGCGACAGGGAGGGAUGCGCGCCUGGGUGUAGUUGUGGGGGAGGAAGUGGCUAGCUCAGGGCUUCAGGGGACAGACAGGGAGAGAUGACUGAGUUAGAUGAGACGAGGGGGCGGGCUGGGGGUGCGAGAAGGAAGCUUGGCAAGGAGACUAGGUCUAGGGGGACCACAGUGGGGCAGGCUGCAUGGAAAAUAUCCGCAGGGUCCCCCAGGCAGAACAGCCACGCUCCAGGCCAGGCUGUCCCUACUGCCUGGUGGAGGGGGAACUUGACCUCUGGGAGGGCGCCGCUCUUGCAUAGCUGAGCGAGCCCGGGUGCGCUGGUCUGUGUGGAAGGAGGAAGGCAGGGAGAGGUAGAAGGGGUGGAGGAGUCAGGAGGAAUAGGCCGCAGCAGCCCUGGAAAUGAUCAGGAAGGCAGGCAGUGGGUGCAGGGCUGCAGGAGGGCCGGGAGGGCUAAUCUUCAACUUGUCCAUGCCAGCAGCCCCUUUUUUUCCAGACCAAGGGCUGUGAACCCGCCUGGGGAUGAGGCCUGGUCUUGUGGAACUGAACUUAGCUCGACGGGGCUGACCGCUCUGGCCCAGGGUGGUAUGUAAUUUUCGCUCGGCCUGGGACGGGGCCCAGGCCGGGCCCAGCCUGGUGGAGCGUCCAGGUCUGGGUGCGAAGCCAGGCCCCUGGGCGGAGGUGAGGGGUGGUCUGAGGAGUGAUGUGGAGUUAAGGCGCCAUCCUCACCGGUGACUGGUGCGGCACCUAGCAUGUUUGACAGGCGGGGACUGCGAGGCACGCUGCUCGGGUGUUGGGGACAACAUUGACCAACGCUUUAUUUUCCAGGUGGCAGUGCUCCUUUUGGACUUUUCUCUAGGUUUGGCGCUAAACUCUUCUUGUGAGCUCACUCCACCCCUUCUUCCUCCCUUUAACUUAUCCAUUCACUUAAAACAUUACCUGGUCAUCUGGUAAGCCCGGGACAGUAAGCCGAGUGGCUGUUGGAGUCGGUAUUGUUGGUAAUGGUGGAGGAAGAGAGGCCUUCCCGCUGAGGCUGGGGUGGGGCGGAUCGGUGUUGCUUGCCUGCAGAGAGGGUGGGGAGUGAAUGUGCACCCUUGGGUGGGCCUGCAGCCAUCCAGCUGAAAGUUACAAAAAUGCUUCAUGGACCGUGGUUUGUUACUAUAGUGUUCCUCAUGGCGAGCAGAUGGAACCGGGAGACAUGGAGUCCCUGGCCAGUGUGAGUCCUAGCAUUGCAGGAGGGGAGACCCUGGAGGAGAGAGCCCGCCUCAAUUGAUGCCUGCAGAUUGAAUUUCCAGAGGCUUAGGAGGAGGAAGUUCUCCAAUGUUCUGUUUCCAGGCCUUGCUCAGGAAGCCCUGUAUUCAGGAGGCUACCAUUUAAAGUUUGCAGAUGAGCUUAUGGGGGGCAAUCUUAAAAAGUCCACAGCAGAUGCAUCCGGCUCGAGGGGCCAUCAGCUUUGAAUAAAUGCUUGUUCCAGAGCCCAUGAAUGCCAGCAGGCACCCCUCCUUUCCUGGGGUAAAGGUUUUCAGAUGCUGCAUCUUCUAAAUUGAGCCUCCGGUCAUACUAGUUUUGUGCUUGGAACCUUGCUUCAAGAAGAUCCCUAAGCUGUAGAACAUUUUAACGUUGAUGCCACAACGCAGAUUGAUGCCUUGUAGAUGGAGCUUGCAGAUGGAGCCCCGUGACCUCUCACCUACCCACCUGUUUGCCUGCCUUCUUGUGCGUUUCUCGGAGAAGUUCUUAGCCUGAUGAAAUAACUUGGGGCGUUGAAGAGCUGUUUAAUUUUAAAUGCCUUAGACUGGGGAUAUAUUAGAGGAAGCAGAUUGUCAAAUUAAGGGUGUCAUUGUGUUGUGCUAAACGCUGGGAGGGUACAAGUUGGUCAUUCCUAAAUCUGUGUGUGAGAAAUGGCAGGUCUAGUUUGGGCAUUGUGAUUGCAUUGCAGAUUACUAGGAGAAGGGAAUGGUGGGUACACCGGUAGUGCUCUUUUGUUCUUGCUUCGUUUUUUUAAACUUGAACUUUACUUCGUUAGAUUUCAUAAUACUUUCUUGGCAUUCUAGUAAGAGGACCCUGAGGUGGGAGUUGUGGGGGACGGGGAGAAGGGGACAGCUUGGCACCGGUCCCGUGGGCGUUGCAGUGUGGGGGAUGGGGGUAUGCAGCUUGGCACUGGUACUGGGAGGGAUGAGGGUGAAGAAGGGGAGAGGGUUGGUUAGAGAUACAGUGUGGGUGGUGGGGGUGGUAGGAAAUGCAGGUUGAAGGGAAUUCUCUGGGGCUUUGGGGAAUUUAGUGCGUGGGUGAGCCAAGAAAAUACUAAUUAAUAAUAGUAAGUUGUUAGUGUUGGUUAAGUUGUUGCUUGGAAGUGAGAAGUUGCUUAGAAACUUUCCAAAGUGCUUAGAACUUUAAGUGCAAACAGACAAACUAACAAACAAAAAUUGUUUUGCUUUGCUACAAGGUGGGGAAGACUGAAGAAGUGUUAACUGAAAACAGGUGACACAGAGUCACCAGUUUUCCGAGAACCAAAGGGAGGGGUGUGUGAUGCCAUCUCACAGGCAGGGGAAAUGUCUUUACCAGCUUCCUCCUGGUGGCCAAGACAGCCUGUUUCAGAGGGUUGUUUUGUUUGGGGUGUGGGUGUUAUCAAGUGAAUUAGUCACUUGAAAGAUGGGCGUCAGACUUGCAUACGCAGCAGAUCAGCAUCCUUCGCUGCCCCUUAGCAACUUAGGUGGUUGAUUUGAAACUGUGAAGGUGUGAUUUUUUCAGGAGCUGGAAGUCUUAGAAAAGCCUUGUAAAUGCCUAUAUUGUGGGCUUUUAACGUAUUUAAGGGACCACUUAAGACGAGAUUAGAUGGGCUCUUCUGGAUUUGUUCCUCAUUUGUCACAGGUGUCUUGUGAUUGAAAAUCAUGAGCGAAGUGAAAUUGCAUUGAAUUUCAAGGGAAUUUAGUAUGUAAAUCGUGCCUUAGAAACACAUCUGUUGUCUUUUCUGUGUUUGGUCGAUAUUAAUAAUGGCAAAAUUUUUGCCUAUCUAGUAUCUUCAAAUUGUAGUCUUUGUAACAACCAAAUAACCUUUUGUGGUCACUGUAAAAUUAAUAUUUGGUAGACAGAAUCCAUGUACCUUUGCUAAGGUUAGAAUGAAUAAUUUAUUGUAUUUUUAAUUUGAAUGUUUGUGCUUUUUAAAUGAGCCAAGACUAGAGGGGAAACUAUCACCUAAAAUCAGUUUGGAAAACAAGACCUAAAAAGGGAAGGGGAUGGGGAUUGUGGGGAGAGAGUGGGCGAGGUGCCUUUACUACAUGUGUGAUCUGAAAACCCUGCUUGGUUCUGAGCUGCGUCUAUUGAAUUGGUAAAGUAAUACCAAUGGCUUUUUAUCAUUUCCUUCUUCCCUUUAAGUUUCACUUGAAAUUUUAAAAAUCAUGGUUAUUUUUAUCGUUGGGAUCUUUCUGUCUUCUGGGUUCCAUUUUUUAAAUGUUUAAAAAUAUGUUGACAUGGUAGUUCAGUUCUUAACCAAUGACUUGGGGAUGAUGCAAACAAUUACUGUCGUUGGGAUUUAGAGUGUAUUAGUCACGCAUGUAUGGGGAAGUAGUCUCGGGUAUGCUGUUGUGAAAUUGAAACUGUAAAAGUAGAUGGUUGAAAGUACUGGUAUGUUGCUCUGUAUGGUAAGAACUAAUUCUGUUACGUCAUGUACAUAAUUACUAAUCACUUUUCUUCCCCUUUACAGCACAAAUAAAGUUUGAGUUCUAAACUCAUUAGAAAAAAAAAAAAAAAAAAAAAAA;|-,lncRNA,Homo sapiens,"sp|Q13148|TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens OX=9606 GN=TARDBP PE=1 SV=1|length=274aa|residues=1-274|mutation=D169G
MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGI
LHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDL
KEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIGGRWCDCKLPNS
KQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIA
QSLCGEDLIIKGISVHISNAEPKHNSNRQLERSG",TDP-43,-,protein_mutation:D169G,274aa(1-274),Q13148,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q13148,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2689,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0023,http://db.phasep.pro/browse/","[9-28],[84-104],[180-194],[261-274]",-,In vitro,0-500ng/µl siNEAT1;|50 µM TDP-43,100 mM NaCl,"50 mM Tris-HCl, pH 7.5",RT,1 min,-,Differential interference contrast microscopy,"solute, liquid","Suppression of TDP-43 LLPS by total RNAs showed no marked difference between D169G and WT TDP-431-274 (Figures 7C and 7D). In contrast, the induction of TDP-43 LLPS by NEAT1 RNA was drastically reduced by D169G (Figures 7E and 7F).",3756
88,435,PMID: 32649883,RNAPS0000409,https://pubmed.ncbi.nlm.nih.gov/32649883,RNA + protein,NCBI ID:283131,https://www.ncbi.nlm.nih.gov/gene/283131,NEAT1,3756nt(1-3756),GGAGUUAGCGACAGGGAGGGAUGCGCGCCUGGGUGUAGUUGUGGGGGAGGAAGUGGCUAGCUCAGGGCUUCAGGGGACAGACAGGGAGAGAUGACUGAGUUAGAUGAGACGAGGGGGCGGGCUGGGGGUGCGAGAAGGAAGCUUGGCAAGGAGACUAGGUCUAGGGGGACCACAGUGGGGCAGGCUGCAUGGAAAAUAUCCGCAGGGUCCCCCAGGCAGAACAGCCACGCUCCAGGCCAGGCUGUCCCUACUGCCUGGUGGAGGGGGAACUUGACCUCUGGGAGGGCGCCGCUCUUGCAUAGCUGAGCGAGCCCGGGUGCGCUGGUCUGUGUGGAAGGAGGAAGGCAGGGAGAGGUAGAAGGGGUGGAGGAGUCAGGAGGAAUAGGCCGCAGCAGCCCUGGAAAUGAUCAGGAAGGCAGGCAGUGGGUGCAGGGCUGCAGGAGGGCCGGGAGGGCUAAUCUUCAACUUGUCCAUGCCAGCAGCCCCUUUUUUUCCAGACCAAGGGCUGUGAACCCGCCUGGGGAUGAGGCCUGGUCUUGUGGAACUGAACUUAGCUCGACGGGGCUGACCGCUCUGGCCCAGGGUGGUAUGUAAUUUUCGCUCGGCCUGGGACGGGGCCCAGGCCGGGCCCAGCCUGGUGGAGCGUCCAGGUCUGGGUGCGAAGCCAGGCCCCUGGGCGGAGGUGAGGGGUGGUCUGAGGAGUGAUGUGGAGUUAAGGCGCCAUCCUCACCGGUGACUGGUGCGGCACCUAGCAUGUUUGACAGGCGGGGACUGCGAGGCACGCUGCUCGGGUGUUGGGGACAACAUUGACCAACGCUUUAUUUUCCAGGUGGCAGUGCUCCUUUUGGACUUUUCUCUAGGUUUGGCGCUAAACUCUUCUUGUGAGCUCACUCCACCCCUUCUUCCUCCCUUUAACUUAUCCAUUCACUUAAAACAUUACCUGGUCAUCUGGUAAGCCCGGGACAGUAAGCCGAGUGGCUGUUGGAGUCGGUAUUGUUGGUAAUGGUGGAGGAAGAGAGGCCUUCCCGCUGAGGCUGGGGUGGGGCGGAUCGGUGUUGCUUGCCUGCAGAGAGGGUGGGGAGUGAAUGUGCACCCUUGGGUGGGCCUGCAGCCAUCCAGCUGAAAGUUACAAAAAUGCUUCAUGGACCGUGGUUUGUUACUAUAGUGUUCCUCAUGGCGAGCAGAUGGAACCGGGAGACAUGGAGUCCCUGGCCAGUGUGAGUCCUAGCAUUGCAGGAGGGGAGACCCUGGAGGAGAGAGCCCGCCUCAAUUGAUGCCUGCAGAUUGAAUUUCCAGAGGCUUAGGAGGAGGAAGUUCUCCAAUGUUCUGUUUCCAGGCCUUGCUCAGGAAGCCCUGUAUUCAGGAGGCUACCAUUUAAAGUUUGCAGAUGAGCUUAUGGGGGGCAAUCUUAAAAAGUCCACAGCAGAUGCAUCCGGCUCGAGGGGCCAUCAGCUUUGAAUAAAUGCUUGUUCCAGAGCCCAUGAAUGCCAGCAGGCACCCCUCCUUUCCUGGGGUAAAGGUUUUCAGAUGCUGCAUCUUCUAAAUUGAGCCUCCGGUCAUACUAGUUUUGUGCUUGGAACCUUGCUUCAAGAAGAUCCCUAAGCUGUAGAACAUUUUAACGUUGAUGCCACAACGCAGAUUGAUGCCUUGUAGAUGGAGCUUGCAGAUGGAGCCCCGUGACCUCUCACCUACCCACCUGUUUGCCUGCCUUCUUGUGCGUUUCUCGGAGAAGUUCUUAGCCUGAUGAAAUAACUUGGGGCGUUGAAGAGCUGUUUAAUUUUAAAUGCCUUAGACUGGGGAUAUAUUAGAGGAAGCAGAUUGUCAAAUUAAGGGUGUCAUUGUGUUGUGCUAAACGCUGGGAGGGUACAAGUUGGUCAUUCCUAAAUCUGUGUGUGAGAAAUGGCAGGUCUAGUUUGGGCAUUGUGAUUGCAUUGCAGAUUACUAGGAGAAGGGAAUGGUGGGUACACCGGUAGUGCUCUUUUGUUCUUGCUUCGUUUUUUUAAACUUGAACUUUACUUCGUUAGAUUUCAUAAUACUUUCUUGGCAUUCUAGUAAGAGGACCCUGAGGUGGGAGUUGUGGGGGACGGGGAGAAGGGGACAGCUUGGCACCGGUCCCGUGGGCGUUGCAGUGUGGGGGAUGGGGGUAUGCAGCUUGGCACUGGUACUGGGAGGGAUGAGGGUGAAGAAGGGGAGAGGGUUGGUUAGAGAUACAGUGUGGGUGGUGGGGGUGGUAGGAAAUGCAGGUUGAAGGGAAUUCUCUGGGGCUUUGGGGAAUUUAGUGCGUGGGUGAGCCAAGAAAAUACUAAUUAAUAAUAGUAAGUUGUUAGUGUUGGUUAAGUUGUUGCUUGGAAGUGAGAAGUUGCUUAGAAACUUUCCAAAGUGCUUAGAACUUUAAGUGCAAACAGACAAACUAACAAACAAAAAUUGUUUUGCUUUGCUACAAGGUGGGGAAGACUGAAGAAGUGUUAACUGAAAACAGGUGACACAGAGUCACCAGUUUUCCGAGAACCAAAGGGAGGGGUGUGUGAUGCCAUCUCACAGGCAGGGGAAAUGUCUUUACCAGCUUCCUCCUGGUGGCCAAGACAGCCUGUUUCAGAGGGUUGUUUUGUUUGGGGUGUGGGUGUUAUCAAGUGAAUUAGUCACUUGAAAGAUGGGCGUCAGACUUGCAUACGCAGCAGAUCAGCAUCCUUCGCUGCCCCUUAGCAACUUAGGUGGUUGAUUUGAAACUGUGAAGGUGUGAUUUUUUCAGGAGCUGGAAGUCUUAGAAAAGCCUUGUAAAUGCCUAUAUUGUGGGCUUUUAACGUAUUUAAGGGACCACUUAAGACGAGAUUAGAUGGGCUCUUCUGGAUUUGUUCCUCAUUUGUCACAGGUGUCUUGUGAUUGAAAAUCAUGAGCGAAGUGAAAUUGCAUUGAAUUUCAAGGGAAUUUAGUAUGUAAAUCGUGCCUUAGAAACACAUCUGUUGUCUUUUCUGUGUUUGGUCGAUAUUAAUAAUGGCAAAAUUUUUGCCUAUCUAGUAUCUUCAAAUUGUAGUCUUUGUAACAACCAAAUAACCUUUUGUGGUCACUGUAAAAUUAAUAUUUGGUAGACAGAAUCCAUGUACCUUUGCUAAGGUUAGAAUGAAUAAUUUAUUGUAUUUUUAAUUUGAAUGUUUGUGCUUUUUAAAUGAGCCAAGACUAGAGGGGAAACUAUCACCUAAAAUCAGUUUGGAAAACAAGACCUAAAAAGGGAAGGGGAUGGGGAUUGUGGGGAGAGAGUGGGCGAGGUGCCUUUACUACAUGUGUGAUCUGAAAACCCUGCUUGGUUCUGAGCUGCGUCUAUUGAAUUGGUAAAGUAAUACCAAUGGCUUUUUAUCAUUUCCUUCUUCCCUUUAAGUUUCACUUGAAAUUUUAAAAAUCAUGGUUAUUUUUAUCGUUGGGAUCUUUCUGUCUUCUGGGUUCCAUUUUUUAAAUGUUUAAAAAUAUGUUGACAUGGUAGUUCAGUUCUUAACCAAUGACUUGGGGAUGAUGCAAACAAUUACUGUCGUUGGGAUUUAGAGUGUAUUAGUCACGCAUGUAUGGGGAAGUAGUCUCGGGUAUGCUGUUGUGAAAUUGAAACUGUAAAAGUAGAUGGUUGAAAGUACUGGUAUGUUGCUCUGUAUGGUAAGAACUAAUUCUGUUACGUCAUGUACAUAAUUACUAAUCACUUUUCUUCCCCUUUACAGCACAAAUAAAGUUUGAGUUCUAAACUCAUUAGAAAAAAAAAAAAAAAAAAAAAAA;|-,lncRNA,Homo sapiens,"sp|Q13148|TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens OX=9606 GN=TARDBP PE=1 SV=1|residues=1-274
MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGI
LHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDL
KEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNS
KQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIA
QSLCGEDLIIKGISVHISNAEPKHNSNRQLERSG",TDP-43,-,-,274aa(1-274),Q13148,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q13148,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2689,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0023,http://db.phasep.pro/browse/",[266-274],[272-274],In vitro,0-500ng/µl siNEAT1;|50 µM TDP-43,100 mM NaCl,"50 mM Tris-HCl, pH 7.5",RT,1 min,-,Differential interference contrast microscopy,"solute, liquid","We found that the PS scaffolding RNA NEAT1 promoted TDP-43 de-mixing in a dose-dependent manner (Figure 5I), which involved both RRM1 and RRM2 (Figures 5J and 5K). Furthermore, we demonstrated that increasing concentrations of NEAT1 antagonized the suppressive environment generated by tRNA in the in vitro LLPS assay of TDP-43 (Figure 5L), which was markedly reduced by DRRM1 but enhanced by DRRM2 (Figures 5M and 5N).",3756
89,436,PMID: 32649883,RNAPS0000409,https://pubmed.ncbi.nlm.nih.gov/32649883,RNA + protein,NCBI ID:283131,https://www.ncbi.nlm.nih.gov/gene/283131,NEAT1,3756nt(1-3756),GGAGUUAGCGACAGGGAGGGAUGCGCGCCUGGGUGUAGUUGUGGGGGAGGAAGUGGCUAGCUCAGGGCUUCAGGGGACAGACAGGGAGAGAUGACUGAGUUAGAUGAGACGAGGGGGCGGGCUGGGGGUGCGAGAAGGAAGCUUGGCAAGGAGACUAGGUCUAGGGGGACCACAGUGGGGCAGGCUGCAUGGAAAAUAUCCGCAGGGUCCCCCAGGCAGAACAGCCACGCUCCAGGCCAGGCUGUCCCUACUGCCUGGUGGAGGGGGAACUUGACCUCUGGGAGGGCGCCGCUCUUGCAUAGCUGAGCGAGCCCGGGUGCGCUGGUCUGUGUGGAAGGAGGAAGGCAGGGAGAGGUAGAAGGGGUGGAGGAGUCAGGAGGAAUAGGCCGCAGCAGCCCUGGAAAUGAUCAGGAAGGCAGGCAGUGGGUGCAGGGCUGCAGGAGGGCCGGGAGGGCUAAUCUUCAACUUGUCCAUGCCAGCAGCCCCUUUUUUUCCAGACCAAGGGCUGUGAACCCGCCUGGGGAUGAGGCCUGGUCUUGUGGAACUGAACUUAGCUCGACGGGGCUGACCGCUCUGGCCCAGGGUGGUAUGUAAUUUUCGCUCGGCCUGGGACGGGGCCCAGGCCGGGCCCAGCCUGGUGGAGCGUCCAGGUCUGGGUGCGAAGCCAGGCCCCUGGGCGGAGGUGAGGGGUGGUCUGAGGAGUGAUGUGGAGUUAAGGCGCCAUCCUCACCGGUGACUGGUGCGGCACCUAGCAUGUUUGACAGGCGGGGACUGCGAGGCACGCUGCUCGGGUGUUGGGGACAACAUUGACCAACGCUUUAUUUUCCAGGUGGCAGUGCUCCUUUUGGACUUUUCUCUAGGUUUGGCGCUAAACUCUUCUUGUGAGCUCACUCCACCCCUUCUUCCUCCCUUUAACUUAUCCAUUCACUUAAAACAUUACCUGGUCAUCUGGUAAGCCCGGGACAGUAAGCCGAGUGGCUGUUGGAGUCGGUAUUGUUGGUAAUGGUGGAGGAAGAGAGGCCUUCCCGCUGAGGCUGGGGUGGGGCGGAUCGGUGUUGCUUGCCUGCAGAGAGGGUGGGGAGUGAAUGUGCACCCUUGGGUGGGCCUGCAGCCAUCCAGCUGAAAGUUACAAAAAUGCUUCAUGGACCGUGGUUUGUUACUAUAGUGUUCCUCAUGGCGAGCAGAUGGAACCGGGAGACAUGGAGUCCCUGGCCAGUGUGAGUCCUAGCAUUGCAGGAGGGGAGACCCUGGAGGAGAGAGCCCGCCUCAAUUGAUGCCUGCAGAUUGAAUUUCCAGAGGCUUAGGAGGAGGAAGUUCUCCAAUGUUCUGUUUCCAGGCCUUGCUCAGGAAGCCCUGUAUUCAGGAGGCUACCAUUUAAAGUUUGCAGAUGAGCUUAUGGGGGGCAAUCUUAAAAAGUCCACAGCAGAUGCAUCCGGCUCGAGGGGCCAUCAGCUUUGAAUAAAUGCUUGUUCCAGAGCCCAUGAAUGCCAGCAGGCACCCCUCCUUUCCUGGGGUAAAGGUUUUCAGAUGCUGCAUCUUCUAAAUUGAGCCUCCGGUCAUACUAGUUUUGUGCUUGGAACCUUGCUUCAAGAAGAUCCCUAAGCUGUAGAACAUUUUAACGUUGAUGCCACAACGCAGAUUGAUGCCUUGUAGAUGGAGCUUGCAGAUGGAGCCCCGUGACCUCUCACCUACCCACCUGUUUGCCUGCCUUCUUGUGCGUUUCUCGGAGAAGUUCUUAGCCUGAUGAAAUAACUUGGGGCGUUGAAGAGCUGUUUAAUUUUAAAUGCCUUAGACUGGGGAUAUAUUAGAGGAAGCAGAUUGUCAAAUUAAGGGUGUCAUUGUGUUGUGCUAAACGCUGGGAGGGUACAAGUUGGUCAUUCCUAAAUCUGUGUGUGAGAAAUGGCAGGUCUAGUUUGGGCAUUGUGAUUGCAUUGCAGAUUACUAGGAGAAGGGAAUGGUGGGUACACCGGUAGUGCUCUUUUGUUCUUGCUUCGUUUUUUUAAACUUGAACUUUACUUCGUUAGAUUUCAUAAUACUUUCUUGGCAUUCUAGUAAGAGGACCCUGAGGUGGGAGUUGUGGGGGACGGGGAGAAGGGGACAGCUUGGCACCGGUCCCGUGGGCGUUGCAGUGUGGGGGAUGGGGGUAUGCAGCUUGGCACUGGUACUGGGAGGGAUGAGGGUGAAGAAGGGGAGAGGGUUGGUUAGAGAUACAGUGUGGGUGGUGGGGGUGGUAGGAAAUGCAGGUUGAAGGGAAUUCUCUGGGGCUUUGGGGAAUUUAGUGCGUGGGUGAGCCAAGAAAAUACUAAUUAAUAAUAGUAAGUUGUUAGUGUUGGUUAAGUUGUUGCUUGGAAGUGAGAAGUUGCUUAGAAACUUUCCAAAGUGCUUAGAACUUUAAGUGCAAACAGACAAACUAACAAACAAAAAUUGUUUUGCUUUGCUACAAGGUGGGGAAGACUGAAGAAGUGUUAACUGAAAACAGGUGACACAGAGUCACCAGUUUUCCGAGAACCAAAGGGAGGGGUGUGUGAUGCCAUCUCACAGGCAGGGGAAAUGUCUUUACCAGCUUCCUCCUGGUGGCCAAGACAGCCUGUUUCAGAGGGUUGUUUUGUUUGGGGUGUGGGUGUUAUCAAGUGAAUUAGUCACUUGAAAGAUGGGCGUCAGACUUGCAUACGCAGCAGAUCAGCAUCCUUCGCUGCCCCUUAGCAACUUAGGUGGUUGAUUUGAAACUGUGAAGGUGUGAUUUUUUCAGGAGCUGGAAGUCUUAGAAAAGCCUUGUAAAUGCCUAUAUUGUGGGCUUUUAACGUAUUUAAGGGACCACUUAAGACGAGAUUAGAUGGGCUCUUCUGGAUUUGUUCCUCAUUUGUCACAGGUGUCUUGUGAUUGAAAAUCAUGAGCGAAGUGAAAUUGCAUUGAAUUUCAAGGGAAUUUAGUAUGUAAAUCGUGCCUUAGAAACACAUCUGUUGUCUUUUCUGUGUUUGGUCGAUAUUAAUAAUGGCAAAAUUUUUGCCUAUCUAGUAUCUUCAAAUUGUAGUCUUUGUAACAACCAAAUAACCUUUUGUGGUCACUGUAAAAUUAAUAUUUGGUAGACAGAAUCCAUGUACCUUUGCUAAGGUUAGAAUGAAUAAUUUAUUGUAUUUUUAAUUUGAAUGUUUGUGCUUUUUAAAUGAGCCAAGACUAGAGGGGAAACUAUCACCUAAAAUCAGUUUGGAAAACAAGACCUAAAAAGGGAAGGGGAUGGGGAUUGUGGGGAGAGAGUGGGCGAGGUGCCUUUACUACAUGUGUGAUCUGAAAACCCUGCUUGGUUCUGAGCUGCGUCUAUUGAAUUGGUAAAGUAAUACCAAUGGCUUUUUAUCAUUUCCUUCUUCCCUUUAAGUUUCACUUGAAAUUUUAAAAAUCAUGGUUAUUUUUAUCGUUGGGAUCUUUCUGUCUUCUGGGUUCCAUUUUUUAAAUGUUUAAAAAUAUGUUGACAUGGUAGUUCAGUUCUUAACCAAUGACUUGGGGAUGAUGCAAACAAUUACUGUCGUUGGGAUUUAGAGUGUAUUAGUCACGCAUGUAUGGGGAAGUAGUCUCGGGUAUGCUGUUGUGAAAUUGAAACUGUAAAAGUAGAUGGUUGAAAGUACUGGUAUGUUGCUCUGUAUGGUAAGAACUAAUUCUGUUACGUCAUGUACAUAAUUACUAAUCACUUUUCUUCCCCUUUACAGCACAAAUAAAGUUUGAGUUCUAAACUCAUUAGAAAAAAAAAAAAAAAAAAAAAAA;|-,lncRNA,Homo sapiens,"sp|Q13148|TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens OX=9606 GN=TARDBP PE=1 SV=1|residues=1-103,201-274
MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGI
LHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTDMTEDELREFFSQ
YGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSG",TDP-43,△RRM1,-,"317aa(1-103,201-274)",Q13148,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q13148,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2689,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0023,http://db.phasep.pro/browse/",[266-274],[272-274],In vitro,0-500ng/µl siNEAT1;|50 µM TDP-43,100 mM NaCl,"50 mM Tris-HCl, pH 7.5",RT,1 min,-,Differential interference contrast microscopy,"liquid, solute","We found that the PS scaffolding RNA NEAT1 promoted TDP-43 de-mixing in a dose-dependent manner (Figure 5I), which involved both RRM1 and RRM2 (Figures 5J and 5K). Furthermore, we demonstrated that increasing concentrations of NEAT1 antagonized the suppressive environment generated by tRNA in the in vitro LLPS assay of TDP-43 (Figure 5L), which was markedly reduced by DRRM1 but enhanced by DRRM2 (Figures 5M and 5N).",3756
90,437,PMID: 32649883,RNAPS0000409,https://pubmed.ncbi.nlm.nih.gov/32649883,RNA + protein,NCBI ID:283131,https://www.ncbi.nlm.nih.gov/gene/283131,NEAT1,3756nt(1-3756),GGAGUUAGCGACAGGGAGGGAUGCGCGCCUGGGUGUAGUUGUGGGGGAGGAAGUGGCUAGCUCAGGGCUUCAGGGGACAGACAGGGAGAGAUGACUGAGUUAGAUGAGACGAGGGGGCGGGCUGGGGGUGCGAGAAGGAAGCUUGGCAAGGAGACUAGGUCUAGGGGGACCACAGUGGGGCAGGCUGCAUGGAAAAUAUCCGCAGGGUCCCCCAGGCAGAACAGCCACGCUCCAGGCCAGGCUGUCCCUACUGCCUGGUGGAGGGGGAACUUGACCUCUGGGAGGGCGCCGCUCUUGCAUAGCUGAGCGAGCCCGGGUGCGCUGGUCUGUGUGGAAGGAGGAAGGCAGGGAGAGGUAGAAGGGGUGGAGGAGUCAGGAGGAAUAGGCCGCAGCAGCCCUGGAAAUGAUCAGGAAGGCAGGCAGUGGGUGCAGGGCUGCAGGAGGGCCGGGAGGGCUAAUCUUCAACUUGUCCAUGCCAGCAGCCCCUUUUUUUCCAGACCAAGGGCUGUGAACCCGCCUGGGGAUGAGGCCUGGUCUUGUGGAACUGAACUUAGCUCGACGGGGCUGACCGCUCUGGCCCAGGGUGGUAUGUAAUUUUCGCUCGGCCUGGGACGGGGCCCAGGCCGGGCCCAGCCUGGUGGAGCGUCCAGGUCUGGGUGCGAAGCCAGGCCCCUGGGCGGAGGUGAGGGGUGGUCUGAGGAGUGAUGUGGAGUUAAGGCGCCAUCCUCACCGGUGACUGGUGCGGCACCUAGCAUGUUUGACAGGCGGGGACUGCGAGGCACGCUGCUCGGGUGUUGGGGACAACAUUGACCAACGCUUUAUUUUCCAGGUGGCAGUGCUCCUUUUGGACUUUUCUCUAGGUUUGGCGCUAAACUCUUCUUGUGAGCUCACUCCACCCCUUCUUCCUCCCUUUAACUUAUCCAUUCACUUAAAACAUUACCUGGUCAUCUGGUAAGCCCGGGACAGUAAGCCGAGUGGCUGUUGGAGUCGGUAUUGUUGGUAAUGGUGGAGGAAGAGAGGCCUUCCCGCUGAGGCUGGGGUGGGGCGGAUCGGUGUUGCUUGCCUGCAGAGAGGGUGGGGAGUGAAUGUGCACCCUUGGGUGGGCCUGCAGCCAUCCAGCUGAAAGUUACAAAAAUGCUUCAUGGACCGUGGUUUGUUACUAUAGUGUUCCUCAUGGCGAGCAGAUGGAACCGGGAGACAUGGAGUCCCUGGCCAGUGUGAGUCCUAGCAUUGCAGGAGGGGAGACCCUGGAGGAGAGAGCCCGCCUCAAUUGAUGCCUGCAGAUUGAAUUUCCAGAGGCUUAGGAGGAGGAAGUUCUCCAAUGUUCUGUUUCCAGGCCUUGCUCAGGAAGCCCUGUAUUCAGGAGGCUACCAUUUAAAGUUUGCAGAUGAGCUUAUGGGGGGCAAUCUUAAAAAGUCCACAGCAGAUGCAUCCGGCUCGAGGGGCCAUCAGCUUUGAAUAAAUGCUUGUUCCAGAGCCCAUGAAUGCCAGCAGGCACCCCUCCUUUCCUGGGGUAAAGGUUUUCAGAUGCUGCAUCUUCUAAAUUGAGCCUCCGGUCAUACUAGUUUUGUGCUUGGAACCUUGCUUCAAGAAGAUCCCUAAGCUGUAGAACAUUUUAACGUUGAUGCCACAACGCAGAUUGAUGCCUUGUAGAUGGAGCUUGCAGAUGGAGCCCCGUGACCUCUCACCUACCCACCUGUUUGCCUGCCUUCUUGUGCGUUUCUCGGAGAAGUUCUUAGCCUGAUGAAAUAACUUGGGGCGUUGAAGAGCUGUUUAAUUUUAAAUGCCUUAGACUGGGGAUAUAUUAGAGGAAGCAGAUUGUCAAAUUAAGGGUGUCAUUGUGUUGUGCUAAACGCUGGGAGGGUACAAGUUGGUCAUUCCUAAAUCUGUGUGUGAGAAAUGGCAGGUCUAGUUUGGGCAUUGUGAUUGCAUUGCAGAUUACUAGGAGAAGGGAAUGGUGGGUACACCGGUAGUGCUCUUUUGUUCUUGCUUCGUUUUUUUAAACUUGAACUUUACUUCGUUAGAUUUCAUAAUACUUUCUUGGCAUUCUAGUAAGAGGACCCUGAGGUGGGAGUUGUGGGGGACGGGGAGAAGGGGACAGCUUGGCACCGGUCCCGUGGGCGUUGCAGUGUGGGGGAUGGGGGUAUGCAGCUUGGCACUGGUACUGGGAGGGAUGAGGGUGAAGAAGGGGAGAGGGUUGGUUAGAGAUACAGUGUGGGUGGUGGGGGUGGUAGGAAAUGCAGGUUGAAGGGAAUUCUCUGGGGCUUUGGGGAAUUUAGUGCGUGGGUGAGCCAAGAAAAUACUAAUUAAUAAUAGUAAGUUGUUAGUGUUGGUUAAGUUGUUGCUUGGAAGUGAGAAGUUGCUUAGAAACUUUCCAAAGUGCUUAGAACUUUAAGUGCAAACAGACAAACUAACAAACAAAAAUUGUUUUGCUUUGCUACAAGGUGGGGAAGACUGAAGAAGUGUUAACUGAAAACAGGUGACACAGAGUCACCAGUUUUCCGAGAACCAAAGGGAGGGGUGUGUGAUGCCAUCUCACAGGCAGGGGAAAUGUCUUUACCAGCUUCCUCCUGGUGGCCAAGACAGCCUGUUUCAGAGGGUUGUUUUGUUUGGGGUGUGGGUGUUAUCAAGUGAAUUAGUCACUUGAAAGAUGGGCGUCAGACUUGCAUACGCAGCAGAUCAGCAUCCUUCGCUGCCCCUUAGCAACUUAGGUGGUUGAUUUGAAACUGUGAAGGUGUGAUUUUUUCAGGAGCUGGAAGUCUUAGAAAAGCCUUGUAAAUGCCUAUAUUGUGGGCUUUUAACGUAUUUAAGGGACCACUUAAGACGAGAUUAGAUGGGCUCUUCUGGAUUUGUUCCUCAUUUGUCACAGGUGUCUUGUGAUUGAAAAUCAUGAGCGAAGUGAAAUUGCAUUGAAUUUCAAGGGAAUUUAGUAUGUAAAUCGUGCCUUAGAAACACAUCUGUUGUCUUUUCUGUGUUUGGUCGAUAUUAAUAAUGGCAAAAUUUUUGCCUAUCUAGUAUCUUCAAAUUGUAGUCUUUGUAACAACCAAAUAACCUUUUGUGGUCACUGUAAAAUUAAUAUUUGGUAGACAGAAUCCAUGUACCUUUGCUAAGGUUAGAAUGAAUAAUUUAUUGUAUUUUUAAUUUGAAUGUUUGUGCUUUUUAAAUGAGCCAAGACUAGAGGGGAAACUAUCACCUAAAAUCAGUUUGGAAAACAAGACCUAAAAAGGGAAGGGGAUGGGGAUUGUGGGGAGAGAGUGGGCGAGGUGCCUUUACUACAUGUGUGAUCUGAAAACCCUGCUUGGUUCUGAGCUGCGUCUAUUGAAUUGGUAAAGUAAUACCAAUGGCUUUUUAUCAUUUCCUUCUUCCCUUUAAGUUUCACUUGAAAUUUUAAAAAUCAUGGUUAUUUUUAUCGUUGGGAUCUUUCUGUCUUCUGGGUUCCAUUUUUUAAAUGUUUAAAAAUAUGUUGACAUGGUAGUUCAGUUCUUAACCAAUGACUUGGGGAUGAUGCAAACAAUUACUGUCGUUGGGAUUUAGAGUGUAUUAGUCACGCAUGUAUGGGGAAGUAGUCUCGGGUAUGCUGUUGUGAAAUUGAAACUGUAAAAGUAGAUGGUUGAAAGUACUGGUAUGUUGCUCUGUAUGGUAAGAACUAAUUCUGUUACGUCAUGUACAUAAUUACUAAUCACUUUUCUUCCCCUUUACAGCACAAAUAAAGUUUGAGUUCUAAACUCAUUAGAAAAAAAAAAAAAAAAAAAAAAA;|-,lncRNA,Homo sapiens,"sp|Q13148|TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens OX=9606 GN=TARDBP PE=1 SV=1|residues=1-190,263-274
MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGI
LHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDL
KEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNS
KQSQDEPLRSKHNSNRQLERSG",TDP-43,△RRM2,-,"202aa(1-190,263-274)",Q13148,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q13148,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2689,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0023,http://db.phasep.pro/browse/",[266-274],[272-274],In vitro,0-500ng/µl siNEAT1;|50 µM TDP-43,100 mM NaCl,"50 mM Tris-HCl, pH 7.5",RT,1 min,-,Differential interference contrast microscopy,"liquid, solute","We found that the PS scaffolding RNA NEAT1 promoted TDP-43 de-mixing in a dose-dependent manner (Figure 5I), which involved both RRM1 and RRM2 (Figures 5J and 5K). Furthermore, we demonstrated that increasing concentrations of NEAT1 antagonized the suppressive environment generated by tRNA in the in vitro LLPS assay of TDP-43 (Figure 5L), which was markedly reduced by DRRM1 but enhanced by DRRM2 (Figures 5M and 5N).",3756
91,438,PMID: 32649883,RNAPS0000129,https://pubmed.ncbi.nlm.nih.gov/32649883,RNAs + protein,NCBI ID:283131;|-,https://www.ncbi.nlm.nih.gov/gene/283131;|-,NEAT1;|yeast tRNA,3756nt(1-3756);|-,GGAGUUAGCGACAGGGAGGGAUGCGCGCCUGGGUGUAGUUGUGGGGGAGGAAGUGGCUAGCUCAGGGCUUCAGGGGACAGACAGGGAGAGAUGACUGAGUUAGAUGAGACGAGGGGGCGGGCUGGGGGUGCGAGAAGGAAGCUUGGCAAGGAGACUAGGUCUAGGGGGACCACAGUGGGGCAGGCUGCAUGGAAAAUAUCCGCAGGGUCCCCCAGGCAGAACAGCCACGCUCCAGGCCAGGCUGUCCCUACUGCCUGGUGGAGGGGGAACUUGACCUCUGGGAGGGCGCCGCUCUUGCAUAGCUGAGCGAGCCCGGGUGCGCUGGUCUGUGUGGAAGGAGGAAGGCAGGGAGAGGUAGAAGGGGUGGAGGAGUCAGGAGGAAUAGGCCGCAGCAGCCCUGGAAAUGAUCAGGAAGGCAGGCAGUGGGUGCAGGGCUGCAGGAGGGCCGGGAGGGCUAAUCUUCAACUUGUCCAUGCCAGCAGCCCCUUUUUUUCCAGACCAAGGGCUGUGAACCCGCCUGGGGAUGAGGCCUGGUCUUGUGGAACUGAACUUAGCUCGACGGGGCUGACCGCUCUGGCCCAGGGUGGUAUGUAAUUUUCGCUCGGCCUGGGACGGGGCCCAGGCCGGGCCCAGCCUGGUGGAGCGUCCAGGUCUGGGUGCGAAGCCAGGCCCCUGGGCGGAGGUGAGGGGUGGUCUGAGGAGUGAUGUGGAGUUAAGGCGCCAUCCUCACCGGUGACUGGUGCGGCACCUAGCAUGUUUGACAGGCGGGGACUGCGAGGCACGCUGCUCGGGUGUUGGGGACAACAUUGACCAACGCUUUAUUUUCCAGGUGGCAGUGCUCCUUUUGGACUUUUCUCUAGGUUUGGCGCUAAACUCUUCUUGUGAGCUCACUCCACCCCUUCUUCCUCCCUUUAACUUAUCCAUUCACUUAAAACAUUACCUGGUCAUCUGGUAAGCCCGGGACAGUAAGCCGAGUGGCUGUUGGAGUCGGUAUUGUUGGUAAUGGUGGAGGAAGAGAGGCCUUCCCGCUGAGGCUGGGGUGGGGCGGAUCGGUGUUGCUUGCCUGCAGAGAGGGUGGGGAGUGAAUGUGCACCCUUGGGUGGGCCUGCAGCCAUCCAGCUGAAAGUUACAAAAAUGCUUCAUGGACCGUGGUUUGUUACUAUAGUGUUCCUCAUGGCGAGCAGAUGGAACCGGGAGACAUGGAGUCCCUGGCCAGUGUGAGUCCUAGCAUUGCAGGAGGGGAGACCCUGGAGGAGAGAGCCCGCCUCAAUUGAUGCCUGCAGAUUGAAUUUCCAGAGGCUUAGGAGGAGGAAGUUCUCCAAUGUUCUGUUUCCAGGCCUUGCUCAGGAAGCCCUGUAUUCAGGAGGCUACCAUUUAAAGUUUGCAGAUGAGCUUAUGGGGGGCAAUCUUAAAAAGUCCACAGCAGAUGCAUCCGGCUCGAGGGGCCAUCAGCUUUGAAUAAAUGCUUGUUCCAGAGCCCAUGAAUGCCAGCAGGCACCCCUCCUUUCCUGGGGUAAAGGUUUUCAGAUGCUGCAUCUUCUAAAUUGAGCCUCCGGUCAUACUAGUUUUGUGCUUGGAACCUUGCUUCAAGAAGAUCCCUAAGCUGUAGAACAUUUUAACGUUGAUGCCACAACGCAGAUUGAUGCCUUGUAGAUGGAGCUUGCAGAUGGAGCCCCGUGACCUCUCACCUACCCACCUGUUUGCCUGCCUUCUUGUGCGUUUCUCGGAGAAGUUCUUAGCCUGAUGAAAUAACUUGGGGCGUUGAAGAGCUGUUUAAUUUUAAAUGCCUUAGACUGGGGAUAUAUUAGAGGAAGCAGAUUGUCAAAUUAAGGGUGUCAUUGUGUUGUGCUAAACGCUGGGAGGGUACAAGUUGGUCAUUCCUAAAUCUGUGUGUGAGAAAUGGCAGGUCUAGUUUGGGCAUUGUGAUUGCAUUGCAGAUUACUAGGAGAAGGGAAUGGUGGGUACACCGGUAGUGCUCUUUUGUUCUUGCUUCGUUUUUUUAAACUUGAACUUUACUUCGUUAGAUUUCAUAAUACUUUCUUGGCAUUCUAGUAAGAGGACCCUGAGGUGGGAGUUGUGGGGGACGGGGAGAAGGGGACAGCUUGGCACCGGUCCCGUGGGCGUUGCAGUGUGGGGGAUGGGGGUAUGCAGCUUGGCACUGGUACUGGGAGGGAUGAGGGUGAAGAAGGGGAGAGGGUUGGUUAGAGAUACAGUGUGGGUGGUGGGGGUGGUAGGAAAUGCAGGUUGAAGGGAAUUCUCUGGGGCUUUGGGGAAUUUAGUGCGUGGGUGAGCCAAGAAAAUACUAAUUAAUAAUAGUAAGUUGUUAGUGUUGGUUAAGUUGUUGCUUGGAAGUGAGAAGUUGCUUAGAAACUUUCCAAAGUGCUUAGAACUUUAAGUGCAAACAGACAAACUAACAAACAAAAAUUGUUUUGCUUUGCUACAAGGUGGGGAAGACUGAAGAAGUGUUAACUGAAAACAGGUGACACAGAGUCACCAGUUUUCCGAGAACCAAAGGGAGGGGUGUGUGAUGCCAUCUCACAGGCAGGGGAAAUGUCUUUACCAGCUUCCUCCUGGUGGCCAAGACAGCCUGUUUCAGAGGGUUGUUUUGUUUGGGGUGUGGGUGUUAUCAAGUGAAUUAGUCACUUGAAAGAUGGGCGUCAGACUUGCAUACGCAGCAGAUCAGCAUCCUUCGCUGCCCCUUAGCAACUUAGGUGGUUGAUUUGAAACUGUGAAGGUGUGAUUUUUUCAGGAGCUGGAAGUCUUAGAAAAGCCUUGUAAAUGCCUAUAUUGUGGGCUUUUAACGUAUUUAAGGGACCACUUAAGACGAGAUUAGAUGGGCUCUUCUGGAUUUGUUCCUCAUUUGUCACAGGUGUCUUGUGAUUGAAAAUCAUGAGCGAAGUGAAAUUGCAUUGAAUUUCAAGGGAAUUUAGUAUGUAAAUCGUGCCUUAGAAACACAUCUGUUGUCUUUUCUGUGUUUGGUCGAUAUUAAUAAUGGCAAAAUUUUUGCCUAUCUAGUAUCUUCAAAUUGUAGUCUUUGUAACAACCAAAUAACCUUUUGUGGUCACUGUAAAAUUAAUAUUUGGUAGACAGAAUCCAUGUACCUUUGCUAAGGUUAGAAUGAAUAAUUUAUUGUAUUUUUAAUUUGAAUGUUUGUGCUUUUUAAAUGAGCCAAGACUAGAGGGGAAACUAUCACCUAAAAUCAGUUUGGAAAACAAGACCUAAAAAGGGAAGGGGAUGGGGAUUGUGGGGAGAGAGUGGGCGAGGUGCCUUUACUACAUGUGUGAUCUGAAAACCCUGCUUGGUUCUGAGCUGCGUCUAUUGAAUUGGUAAAGUAAUACCAAUGGCUUUUUAUCAUUUCCUUCUUCCCUUUAAGUUUCACUUGAAAUUUUAAAAAUCAUGGUUAUUUUUAUCGUUGGGAUCUUUCUGUCUUCUGGGUUCCAUUUUUUAAAUGUUUAAAAAUAUGUUGACAUGGUAGUUCAGUUCUUAACCAAUGACUUGGGGAUGAUGCAAACAAUUACUGUCGUUGGGAUUUAGAGUGUAUUAGUCACGCAUGUAUGGGGAAGUAGUCUCGGGUAUGCUGUUGUGAAAUUGAAACUGUAAAAGUAGAUGGUUGAAAGUACUGGUAUGUUGCUCUGUAUGGUAAGAACUAAUUCUGUUACGUCAUGUACAUAAUUACUAAUCACUUUUCUUCCCCUUUACAGCACAAAUAAAGUUUGAGUUCUAAACUCAUUAGAAAAAAAAAAAAAAAAAAAAAAA;|-,lncRNA;|tRNA,Homo sapiens;|yeast,"sp|Q13148|TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens OX=9606 GN=TARDBP PE=1 SV=1|residues=1-274
MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGI
LHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDL
KEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNS
KQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIA
QSLCGEDLIIKGISVHISNAEPKHNSNRQLERSG",TDP-43,-,-,274aa(1-274),Q13148,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q13148,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2689,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0023,http://db.phasep.pro/browse/",[266-274],[272-274],In vitro,1.25µg/µl tRNA;|0-400ng/µl siNEAT1;|50 µM TDP-43,100 mM NaCl,"50 mM Tris-HCl, pH 7.5",RT,1 min,crowding agent:5%PEG8000,Differential interference contrast microscopy,"liquid, solute","We found that the PS scaffolding RNA NEAT1 promoted TDP-43 de-mixing in a dose-dependent manner (Figure 5I), which involved both RRM1 and RRM2 (Figures 5J and 5K). Furthermore, we demonstrated that increasing concentrations of NEAT1 antagonized the suppressive environment generated by tRNA in the in vitro LLPS assay of TDP-43 (Figure 5L), which was markedly reduced by DRRM1 but enhanced by DRRM2 (Figures 5M and 5N).",3756
92,439,PMID: 32649883,RNAPS0000129,https://pubmed.ncbi.nlm.nih.gov/32649883,RNAs + protein,NCBI ID:283131;|-,https://www.ncbi.nlm.nih.gov/gene/283131;|-,NEAT1;|yeast tRNA,3756nt(1-3756);|-,GGAGUUAGCGACAGGGAGGGAUGCGCGCCUGGGUGUAGUUGUGGGGGAGGAAGUGGCUAGCUCAGGGCUUCAGGGGACAGACAGGGAGAGAUGACUGAGUUAGAUGAGACGAGGGGGCGGGCUGGGGGUGCGAGAAGGAAGCUUGGCAAGGAGACUAGGUCUAGGGGGACCACAGUGGGGCAGGCUGCAUGGAAAAUAUCCGCAGGGUCCCCCAGGCAGAACAGCCACGCUCCAGGCCAGGCUGUCCCUACUGCCUGGUGGAGGGGGAACUUGACCUCUGGGAGGGCGCCGCUCUUGCAUAGCUGAGCGAGCCCGGGUGCGCUGGUCUGUGUGGAAGGAGGAAGGCAGGGAGAGGUAGAAGGGGUGGAGGAGUCAGGAGGAAUAGGCCGCAGCAGCCCUGGAAAUGAUCAGGAAGGCAGGCAGUGGGUGCAGGGCUGCAGGAGGGCCGGGAGGGCUAAUCUUCAACUUGUCCAUGCCAGCAGCCCCUUUUUUUCCAGACCAAGGGCUGUGAACCCGCCUGGGGAUGAGGCCUGGUCUUGUGGAACUGAACUUAGCUCGACGGGGCUGACCGCUCUGGCCCAGGGUGGUAUGUAAUUUUCGCUCGGCCUGGGACGGGGCCCAGGCCGGGCCCAGCCUGGUGGAGCGUCCAGGUCUGGGUGCGAAGCCAGGCCCCUGGGCGGAGGUGAGGGGUGGUCUGAGGAGUGAUGUGGAGUUAAGGCGCCAUCCUCACCGGUGACUGGUGCGGCACCUAGCAUGUUUGACAGGCGGGGACUGCGAGGCACGCUGCUCGGGUGUUGGGGACAACAUUGACCAACGCUUUAUUUUCCAGGUGGCAGUGCUCCUUUUGGACUUUUCUCUAGGUUUGGCGCUAAACUCUUCUUGUGAGCUCACUCCACCCCUUCUUCCUCCCUUUAACUUAUCCAUUCACUUAAAACAUUACCUGGUCAUCUGGUAAGCCCGGGACAGUAAGCCGAGUGGCUGUUGGAGUCGGUAUUGUUGGUAAUGGUGGAGGAAGAGAGGCCUUCCCGCUGAGGCUGGGGUGGGGCGGAUCGGUGUUGCUUGCCUGCAGAGAGGGUGGGGAGUGAAUGUGCACCCUUGGGUGGGCCUGCAGCCAUCCAGCUGAAAGUUACAAAAAUGCUUCAUGGACCGUGGUUUGUUACUAUAGUGUUCCUCAUGGCGAGCAGAUGGAACCGGGAGACAUGGAGUCCCUGGCCAGUGUGAGUCCUAGCAUUGCAGGAGGGGAGACCCUGGAGGAGAGAGCCCGCCUCAAUUGAUGCCUGCAGAUUGAAUUUCCAGAGGCUUAGGAGGAGGAAGUUCUCCAAUGUUCUGUUUCCAGGCCUUGCUCAGGAAGCCCUGUAUUCAGGAGGCUACCAUUUAAAGUUUGCAGAUGAGCUUAUGGGGGGCAAUCUUAAAAAGUCCACAGCAGAUGCAUCCGGCUCGAGGGGCCAUCAGCUUUGAAUAAAUGCUUGUUCCAGAGCCCAUGAAUGCCAGCAGGCACCCCUCCUUUCCUGGGGUAAAGGUUUUCAGAUGCUGCAUCUUCUAAAUUGAGCCUCCGGUCAUACUAGUUUUGUGCUUGGAACCUUGCUUCAAGAAGAUCCCUAAGCUGUAGAACAUUUUAACGUUGAUGCCACAACGCAGAUUGAUGCCUUGUAGAUGGAGCUUGCAGAUGGAGCCCCGUGACCUCUCACCUACCCACCUGUUUGCCUGCCUUCUUGUGCGUUUCUCGGAGAAGUUCUUAGCCUGAUGAAAUAACUUGGGGCGUUGAAGAGCUGUUUAAUUUUAAAUGCCUUAGACUGGGGAUAUAUUAGAGGAAGCAGAUUGUCAAAUUAAGGGUGUCAUUGUGUUGUGCUAAACGCUGGGAGGGUACAAGUUGGUCAUUCCUAAAUCUGUGUGUGAGAAAUGGCAGGUCUAGUUUGGGCAUUGUGAUUGCAUUGCAGAUUACUAGGAGAAGGGAAUGGUGGGUACACCGGUAGUGCUCUUUUGUUCUUGCUUCGUUUUUUUAAACUUGAACUUUACUUCGUUAGAUUUCAUAAUACUUUCUUGGCAUUCUAGUAAGAGGACCCUGAGGUGGGAGUUGUGGGGGACGGGGAGAAGGGGACAGCUUGGCACCGGUCCCGUGGGCGUUGCAGUGUGGGGGAUGGGGGUAUGCAGCUUGGCACUGGUACUGGGAGGGAUGAGGGUGAAGAAGGGGAGAGGGUUGGUUAGAGAUACAGUGUGGGUGGUGGGGGUGGUAGGAAAUGCAGGUUGAAGGGAAUUCUCUGGGGCUUUGGGGAAUUUAGUGCGUGGGUGAGCCAAGAAAAUACUAAUUAAUAAUAGUAAGUUGUUAGUGUUGGUUAAGUUGUUGCUUGGAAGUGAGAAGUUGCUUAGAAACUUUCCAAAGUGCUUAGAACUUUAAGUGCAAACAGACAAACUAACAAACAAAAAUUGUUUUGCUUUGCUACAAGGUGGGGAAGACUGAAGAAGUGUUAACUGAAAACAGGUGACACAGAGUCACCAGUUUUCCGAGAACCAAAGGGAGGGGUGUGUGAUGCCAUCUCACAGGCAGGGGAAAUGUCUUUACCAGCUUCCUCCUGGUGGCCAAGACAGCCUGUUUCAGAGGGUUGUUUUGUUUGGGGUGUGGGUGUUAUCAAGUGAAUUAGUCACUUGAAAGAUGGGCGUCAGACUUGCAUACGCAGCAGAUCAGCAUCCUUCGCUGCCCCUUAGCAACUUAGGUGGUUGAUUUGAAACUGUGAAGGUGUGAUUUUUUCAGGAGCUGGAAGUCUUAGAAAAGCCUUGUAAAUGCCUAUAUUGUGGGCUUUUAACGUAUUUAAGGGACCACUUAAGACGAGAUUAGAUGGGCUCUUCUGGAUUUGUUCCUCAUUUGUCACAGGUGUCUUGUGAUUGAAAAUCAUGAGCGAAGUGAAAUUGCAUUGAAUUUCAAGGGAAUUUAGUAUGUAAAUCGUGCCUUAGAAACACAUCUGUUGUCUUUUCUGUGUUUGGUCGAUAUUAAUAAUGGCAAAAUUUUUGCCUAUCUAGUAUCUUCAAAUUGUAGUCUUUGUAACAACCAAAUAACCUUUUGUGGUCACUGUAAAAUUAAUAUUUGGUAGACAGAAUCCAUGUACCUUUGCUAAGGUUAGAAUGAAUAAUUUAUUGUAUUUUUAAUUUGAAUGUUUGUGCUUUUUAAAUGAGCCAAGACUAGAGGGGAAACUAUCACCUAAAAUCAGUUUGGAAAACAAGACCUAAAAAGGGAAGGGGAUGGGGAUUGUGGGGAGAGAGUGGGCGAGGUGCCUUUACUACAUGUGUGAUCUGAAAACCCUGCUUGGUUCUGAGCUGCGUCUAUUGAAUUGGUAAAGUAAUACCAAUGGCUUUUUAUCAUUUCCUUCUUCCCUUUAAGUUUCACUUGAAAUUUUAAAAAUCAUGGUUAUUUUUAUCGUUGGGAUCUUUCUGUCUUCUGGGUUCCAUUUUUUAAAUGUUUAAAAAUAUGUUGACAUGGUAGUUCAGUUCUUAACCAAUGACUUGGGGAUGAUGCAAACAAUUACUGUCGUUGGGAUUUAGAGUGUAUUAGUCACGCAUGUAUGGGGAAGUAGUCUCGGGUAUGCUGUUGUGAAAUUGAAACUGUAAAAGUAGAUGGUUGAAAGUACUGGUAUGUUGCUCUGUAUGGUAAGAACUAAUUCUGUUACGUCAUGUACAUAAUUACUAAUCACUUUUCUUCCCCUUUACAGCACAAAUAAAGUUUGAGUUCUAAACUCAUUAGAAAAAAAAAAAAAAAAAAAAAAA;|-,lncRNA;|tRNA,Homo sapiens;|yeast,"sp|Q13148|TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens OX=9606 GN=TARDBP PE=1 SV=1|residues=1-103,201-274
MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGI
LHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTDMTEDELREFFSQ
YGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSG",TDP-43,△RRM1,-,"317aa(1-103,201-274)",Q13148,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q13148,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2689,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0023,http://db.phasep.pro/browse/",[266-274],[272-274],In vitro,1.25µg/µl tRNA;|0-400ng/µl siNEAT1;|50 µM TDP-43,100 mM NaCl,"50 mM Tris-HCl, pH 7.5",RT,1 min,crowding agent:5%PEG8000,Differential interference contrast microscopy,"liquid, solute","We found that the PS scaffolding RNA NEAT1 promoted TDP-43 de-mixing in a dose-dependent manner (Figure 5I), which involved both RRM1 and RRM2 (Figures 5J and 5K). Furthermore, we demonstrated that increasing concentrations of NEAT1 antagonized the suppressive environment generated by tRNA in the in vitro LLPS assay of TDP-43 (Figure 5L), which was markedly reduced by DRRM1 but enhanced by DRRM2 (Figures 5M and 5N).",3756
93,440,PMID: 32649883,RNAPS0000129,https://pubmed.ncbi.nlm.nih.gov/32649883,RNAs + protein,NCBI ID:283131;|-,https://www.ncbi.nlm.nih.gov/gene/283131;|-,NEAT1;|yeast tRNA,3756nt(1-3756);|-,GGAGUUAGCGACAGGGAGGGAUGCGCGCCUGGGUGUAGUUGUGGGGGAGGAAGUGGCUAGCUCAGGGCUUCAGGGGACAGACAGGGAGAGAUGACUGAGUUAGAUGAGACGAGGGGGCGGGCUGGGGGUGCGAGAAGGAAGCUUGGCAAGGAGACUAGGUCUAGGGGGACCACAGUGGGGCAGGCUGCAUGGAAAAUAUCCGCAGGGUCCCCCAGGCAGAACAGCCACGCUCCAGGCCAGGCUGUCCCUACUGCCUGGUGGAGGGGGAACUUGACCUCUGGGAGGGCGCCGCUCUUGCAUAGCUGAGCGAGCCCGGGUGCGCUGGUCUGUGUGGAAGGAGGAAGGCAGGGAGAGGUAGAAGGGGUGGAGGAGUCAGGAGGAAUAGGCCGCAGCAGCCCUGGAAAUGAUCAGGAAGGCAGGCAGUGGGUGCAGGGCUGCAGGAGGGCCGGGAGGGCUAAUCUUCAACUUGUCCAUGCCAGCAGCCCCUUUUUUUCCAGACCAAGGGCUGUGAACCCGCCUGGGGAUGAGGCCUGGUCUUGUGGAACUGAACUUAGCUCGACGGGGCUGACCGCUCUGGCCCAGGGUGGUAUGUAAUUUUCGCUCGGCCUGGGACGGGGCCCAGGCCGGGCCCAGCCUGGUGGAGCGUCCAGGUCUGGGUGCGAAGCCAGGCCCCUGGGCGGAGGUGAGGGGUGGUCUGAGGAGUGAUGUGGAGUUAAGGCGCCAUCCUCACCGGUGACUGGUGCGGCACCUAGCAUGUUUGACAGGCGGGGACUGCGAGGCACGCUGCUCGGGUGUUGGGGACAACAUUGACCAACGCUUUAUUUUCCAGGUGGCAGUGCUCCUUUUGGACUUUUCUCUAGGUUUGGCGCUAAACUCUUCUUGUGAGCUCACUCCACCCCUUCUUCCUCCCUUUAACUUAUCCAUUCACUUAAAACAUUACCUGGUCAUCUGGUAAGCCCGGGACAGUAAGCCGAGUGGCUGUUGGAGUCGGUAUUGUUGGUAAUGGUGGAGGAAGAGAGGCCUUCCCGCUGAGGCUGGGGUGGGGCGGAUCGGUGUUGCUUGCCUGCAGAGAGGGUGGGGAGUGAAUGUGCACCCUUGGGUGGGCCUGCAGCCAUCCAGCUGAAAGUUACAAAAAUGCUUCAUGGACCGUGGUUUGUUACUAUAGUGUUCCUCAUGGCGAGCAGAUGGAACCGGGAGACAUGGAGUCCCUGGCCAGUGUGAGUCCUAGCAUUGCAGGAGGGGAGACCCUGGAGGAGAGAGCCCGCCUCAAUUGAUGCCUGCAGAUUGAAUUUCCAGAGGCUUAGGAGGAGGAAGUUCUCCAAUGUUCUGUUUCCAGGCCUUGCUCAGGAAGCCCUGUAUUCAGGAGGCUACCAUUUAAAGUUUGCAGAUGAGCUUAUGGGGGGCAAUCUUAAAAAGUCCACAGCAGAUGCAUCCGGCUCGAGGGGCCAUCAGCUUUGAAUAAAUGCUUGUUCCAGAGCCCAUGAAUGCCAGCAGGCACCCCUCCUUUCCUGGGGUAAAGGUUUUCAGAUGCUGCAUCUUCUAAAUUGAGCCUCCGGUCAUACUAGUUUUGUGCUUGGAACCUUGCUUCAAGAAGAUCCCUAAGCUGUAGAACAUUUUAACGUUGAUGCCACAACGCAGAUUGAUGCCUUGUAGAUGGAGCUUGCAGAUGGAGCCCCGUGACCUCUCACCUACCCACCUGUUUGCCUGCCUUCUUGUGCGUUUCUCGGAGAAGUUCUUAGCCUGAUGAAAUAACUUGGGGCGUUGAAGAGCUGUUUAAUUUUAAAUGCCUUAGACUGGGGAUAUAUUAGAGGAAGCAGAUUGUCAAAUUAAGGGUGUCAUUGUGUUGUGCUAAACGCUGGGAGGGUACAAGUUGGUCAUUCCUAAAUCUGUGUGUGAGAAAUGGCAGGUCUAGUUUGGGCAUUGUGAUUGCAUUGCAGAUUACUAGGAGAAGGGAAUGGUGGGUACACCGGUAGUGCUCUUUUGUUCUUGCUUCGUUUUUUUAAACUUGAACUUUACUUCGUUAGAUUUCAUAAUACUUUCUUGGCAUUCUAGUAAGAGGACCCUGAGGUGGGAGUUGUGGGGGACGGGGAGAAGGGGACAGCUUGGCACCGGUCCCGUGGGCGUUGCAGUGUGGGGGAUGGGGGUAUGCAGCUUGGCACUGGUACUGGGAGGGAUGAGGGUGAAGAAGGGGAGAGGGUUGGUUAGAGAUACAGUGUGGGUGGUGGGGGUGGUAGGAAAUGCAGGUUGAAGGGAAUUCUCUGGGGCUUUGGGGAAUUUAGUGCGUGGGUGAGCCAAGAAAAUACUAAUUAAUAAUAGUAAGUUGUUAGUGUUGGUUAAGUUGUUGCUUGGAAGUGAGAAGUUGCUUAGAAACUUUCCAAAGUGCUUAGAACUUUAAGUGCAAACAGACAAACUAACAAACAAAAAUUGUUUUGCUUUGCUACAAGGUGGGGAAGACUGAAGAAGUGUUAACUGAAAACAGGUGACACAGAGUCACCAGUUUUCCGAGAACCAAAGGGAGGGGUGUGUGAUGCCAUCUCACAGGCAGGGGAAAUGUCUUUACCAGCUUCCUCCUGGUGGCCAAGACAGCCUGUUUCAGAGGGUUGUUUUGUUUGGGGUGUGGGUGUUAUCAAGUGAAUUAGUCACUUGAAAGAUGGGCGUCAGACUUGCAUACGCAGCAGAUCAGCAUCCUUCGCUGCCCCUUAGCAACUUAGGUGGUUGAUUUGAAACUGUGAAGGUGUGAUUUUUUCAGGAGCUGGAAGUCUUAGAAAAGCCUUGUAAAUGCCUAUAUUGUGGGCUUUUAACGUAUUUAAGGGACCACUUAAGACGAGAUUAGAUGGGCUCUUCUGGAUUUGUUCCUCAUUUGUCACAGGUGUCUUGUGAUUGAAAAUCAUGAGCGAAGUGAAAUUGCAUUGAAUUUCAAGGGAAUUUAGUAUGUAAAUCGUGCCUUAGAAACACAUCUGUUGUCUUUUCUGUGUUUGGUCGAUAUUAAUAAUGGCAAAAUUUUUGCCUAUCUAGUAUCUUCAAAUUGUAGUCUUUGUAACAACCAAAUAACCUUUUGUGGUCACUGUAAAAUUAAUAUUUGGUAGACAGAAUCCAUGUACCUUUGCUAAGGUUAGAAUGAAUAAUUUAUUGUAUUUUUAAUUUGAAUGUUUGUGCUUUUUAAAUGAGCCAAGACUAGAGGGGAAACUAUCACCUAAAAUCAGUUUGGAAAACAAGACCUAAAAAGGGAAGGGGAUGGGGAUUGUGGGGAGAGAGUGGGCGAGGUGCCUUUACUACAUGUGUGAUCUGAAAACCCUGCUUGGUUCUGAGCUGCGUCUAUUGAAUUGGUAAAGUAAUACCAAUGGCUUUUUAUCAUUUCCUUCUUCCCUUUAAGUUUCACUUGAAAUUUUAAAAAUCAUGGUUAUUUUUAUCGUUGGGAUCUUUCUGUCUUCUGGGUUCCAUUUUUUAAAUGUUUAAAAAUAUGUUGACAUGGUAGUUCAGUUCUUAACCAAUGACUUGGGGAUGAUGCAAACAAUUACUGUCGUUGGGAUUUAGAGUGUAUUAGUCACGCAUGUAUGGGGAAGUAGUCUCGGGUAUGCUGUUGUGAAAUUGAAACUGUAAAAGUAGAUGGUUGAAAGUACUGGUAUGUUGCUCUGUAUGGUAAGAACUAAUUCUGUUACGUCAUGUACAUAAUUACUAAUCACUUUUCUUCCCCUUUACAGCACAAAUAAAGUUUGAGUUCUAAACUCAUUAGAAAAAAAAAAAAAAAAAAAAAAA;|-,lncRNA;|tRNA,Homo sapiens;|yeast,"sp|Q13148|TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens OX=9606 GN=TARDBP PE=1 SV=1|residues=1-190,263-274
MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGI
LHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDL
KEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNS
KQSQDEPLRSKHNSNRQLERSG",TDP-43,△RRM2,-,"202aa(1-190,263-274)",Q13148,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q13148,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2689,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0023,http://db.phasep.pro/browse/",[266-274],[272-274],In vitro,1.25µg/µl tRNA;|0-400ng/µl siNEAT1;|50 µM TDP-43,100 mM NaCl,"50 mM Tris-HCl, pH 7.5",RT,1 min,crowding agent:5%PEG8000,Differential interference contrast microscopy,liquid,"We found that the PS scaffolding RNA NEAT1 promoted TDP-43 de-mixing in a dose-dependent manner (Figure 5I), which involved both RRM1 and RRM2 (Figures 5J and 5K). Furthermore, we demonstrated that increasing concentrations of NEAT1 antagonized the suppressive environment generated by tRNA in the in vitro LLPS assay of TDP-43 (Figure 5L), which was markedly reduced by DRRM1 but enhanced by DRRM2 (Figures 5M and 5N).",3756
94,466,PMID: 32895492,RNAPS0000416,https://pubmed.ncbi.nlm.nih.gov/32895492,RNA + protein,NCBI ID:108868751,https://www.ncbi.nlm.nih.gov/gene/108868751,DIGIT,2226nt(1-2226),AAAUUCAUUGUGGACGAUUUUACUUUGGGGCUACUUUUUUCCCCCUUUCGGAAUUGGUUUUGUUUUAGAAAAUGUGAGGGGCUGCAUCCCCUCUCAAGCAGGAUUGAAAAUUCCACCACUCCUCCGCGCCCCCACGUACUCACCGCCUGAUUUACCUCUUUUUUAAAUCUUGAGUUUCUCUCCCGAAUGGAACUUGUUAACCCCCCCAAAAAACUUUUGGUUUUGUAAAAUCCAAAUUUUGUAAAGGCAAAAACGACUAAAGGAGGGGUGCAUCGUGCUUCUUAAAAAGAUUUUUUUUUCCAGCCACUCUGGGUCUGAAAACUACCAUGGCAGUCCCUAGGUCCUACACAGCGAAGACCAAAUUCAGCCGCUCUUUAAAAUUCGCCACCAAGAGUUGCAGUCUGAAGCGGUGCUUCUAGCUGCUCCCAGCGUGGGUGUCGGUAGUUUUUGUGCUUUUAAAAAAUUAGUUUUGGAAAUGUGGUGCCUUCUCUCCCAAACUAUUUUUUUGAUUUUCAAUCCAGAUGGGGUCUUUGGGACUUCCCUAUCUUCUUCCCCAAUAAUUGGGUCGCAUUUUUCCUUACGACCUGCUGGCUGCCGGUAGGCCUGCCCUUCCGCCUGGCAGGCCCAGAGUGGAUUCCCUGGGCCGCAGUGGCCUGGACGAUGGCCGGGUCUGAUAGCGGCAGGCGGCCGCGAUGAUUUGCGGGAUUCUCGGCAUGGCACGGCCAGCCUGCCCGAGCCACGGGAGGCGCAGCCAGCCCACCACUCACGGCAAGCAGGCGGCCGAGCGCCCUUCGAGAAGAGACUUAAGUCACCAUGCUCCAGGGCAGAUACUCCCCCACCAAUCUUUCCCAGGUUUAAAGCUACAGGGCAGUUGAUGGACGACAACUAGAGGCUGCAACUUAUCAGUGACUGCCUGCGUUUGUGUUGGAGGCUGGGUGUGCGCUGCGGUGCGCGUGUGAGUGGAUCUUUUAAGACCUUUGUCUGAGCCGGGCAGAGGCACAAGUGCCACCUGACGCUUGGGGCAGAUUCCUCGUCCUGUUCUUGCAAAGAUGCCAAAUCAGGAGAGUGUCAAGAUUUCAACCGCAGACCUAAAAAAAGUGUCUCCAUGUUUUUAAAAGUAUCAGACAACCACCUCCACACACCCCUCCGUCUCCCCUUCCACCUGGAACAUUGUUCUUUUUAAUAACCAGGUUUAGCAAACUGCUAUACUGCGCCUGUGCUUUCCUGCAGCCCUCCGCUGUACCAGCUGAGCCCUGUACAGAAUCUGAGCGUCAGAGUUGCAGACCCAACCUUGCCACCUUGCAAAUCAUCCCUUCUCUGGAGGCCUCAGGAUUUUAGUUGAUCAAACCAACACCAACAUUCAUUGGGUCCCUUUGCAACCCUAACAUUUAAUGAGACUUGGUAAUUGUCAUCCGUUCGCCAAGGAGGUUGGGGAUGAACUUGGGGGCAUUUUCUUGUUUAUUUUUCAUUGAGACAAAGGAGUGUGCUGUCCCCACCUCCGCCCCCAGACAAGGACAGGGUUCCUACAUCAGCUGGGUCUAAAAUAAGGAAAAGCGAGUGCUGCCGCAGAGGGGACUUUCCGGGAAGGGGGUCACAGGAACCCCAAGGCCACACAGCUCCAGACACUCUGCCGGAGCUCUAGGGGAGCUCACCCCUGCGCGGCGGGACCUCCCCCAUCGGGUUGCCCCUUCAAUCUGCAGCCGCGCGGAGGCAGGCCCCGGGAAAGGCAGUCGGCGCUCGGUGCUCGCACUGCGCCUCGGCGGGCGGAAACUCACAAGUGUCCUCAACGUGCUAAACAAACCAUCAGGGCCCCGCAUCGCCUGGCGCAAUUGGAAUAACAAAUGCGACGCACGCAAAUUGUCCACCUCGUGUUGCUAAGCGAUUGUUUGUCGGCCCCGCACGCACAGCUCAGCAUGGGAGGACCGCGAGCGUCCAGAGGCAGCCGGCGAGCGCUUAGGUCGGAAAUGCAGUAAACAUGCCGCUGAUUUUCCCUAUUAUCACCCAAACACGAUUUCACACAAAGCAAUCACCACGCAGAAGUCUAUGAAAAUGUGUUUGUUGAGGAGUCACUCGCCCCAGUAAUAGUCCUCAUUUUUAAGAUAUUAAAGAAUAGCUCAGCGGAUUCCACAUGCAUAAGGUCUAUUUGCCGUUCGGCAUCUGUCACGGCGCUUUUGCACUGCGGUCAUCACUAAAUUGAUUCAUAGAGUGUAGAUUAAAUUGCUUCUC,lncRNA,Homo sapiens,"sp|Q15059|BRD3_HUMAN Bromodomain-containing protein 3 OS=Homo sapiens OX=9606 GN=BRD3 PE=1 SV=1
MSTATTVAPAGIPATPGPVNPPPPEVSNPSKPGRKTNQLQYMQNVVVKTLWKHQFAWPFY
QPVDAIKLNLPDYHKIIKNPMDMGTIKKRLENNYYWSASECMQDFNTMFTNCYIYNKPTD
DIVLMAQALEKIFLQKVAQMPQEEVELLPPAPKGKGRKPAAGAQSAGTQQVAAVSSVSPA
TPFQSVPPTVSQTPVIAATPVPTITANVTSVPVPPAAAPPPPATPIVPVVPPTPPVVKKK
GVKRKADTTTPTTSAITASRSESPPPLSDPKQAKVVARRESGGRPIKPPKKDLEDGEVPQ
HAGKKGKLSEHLRYCDSILREMLSKKHAAYAWPFYKPVDAEALELHDYHDIIKHPMDLST
VKRKMDGREYPDAQGFAADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMPDEPV
EAPALPAPAAPMVSKGAESSRSSEESSSDSGSSDSEEERATRLAELQEQLKAVHEQLAAL
SQAPVNKPKKKKEKKEKEKKKKDKEKEKEKHKVKAEEEKKAKVAPPAKQAQQKKAPAKKA
NSTTTAGRQLKKGGKQASASYDSEEEEEGLPMSYDEKRQLSLDINRLPGEKLGRVVHIIQ
SREPSLRDSNPDEIEIDFETLKPTTLRELERYVKSCLQKKQRKPFSASGKKQAAKSKEEL
AQEKKKELEKRLQDVSGQLSSSKKPARKEKPGSAPSGGPSRLSSSSSSESGSSSSSGSSS
DSSDSE",BRD3,-,-,726aa(1-726),Q15059,PhaSepDB,http://db.phasep.pro/browse/,"[1-35],[156-169],[237-244],[251-251],[254-305],[421-462],[478-556],[645-726]","[16-33],[149-163],[208-261],[419-431],[436-460],[463-540],[564-568],[646-678],[692-725]",In vitro,100nM [DIGIT];|0.5-2µM [BRD3],200mM NaCl,"50mM Tris-HCl pH7.5, 10% glycerol and 1mM DTT",RT,-,crowding agent:1.5% PEG-6000,Fluorescence microscopy,liquid,"Droplet assay showing the formation of mEGFP–BRD3 droplets in the presence of 100 nM DIGIT (top), 100 nM scrambled DIGIT (SCRM; middle) or no RNA (bottom). The NaCl concentration is  200 mM. PEG-6000 (1.5%) was added to each reaction.",2226
95,467,PMID: 32895492,RNAPS0000417,https://pubmed.ncbi.nlm.nih.gov/32895492,RNA + protein,NCBI ID:108868751,https://www.ncbi.nlm.nih.gov/gene/108868751,DIGIT_scr,2226nt(1-2226),AAAUUCAUUGUGGACGAUUUUACUUUGGGGCUACUUUUUUCCCCCUUUCGGAAUUGGUUUUGUUUUAGAAAAUGUGAGGGGCUGCAUCCCCUCUCAAGCAGGAUUGAAAAUUCCACCACUCCUCCGCGCCCCCACGUACUCACCGCCUGAUUUACCUCUUUUUUAAAUCUUGAGUUUCUCUCCCGAAUGGAACUUGUUAACCCCCCCAAAAAACUUUUGGUUUUGUAAAAUCCAAAUUUUGUAAAGGCAAAAACGACUAAAGGAGGGGUGCAUCGUGCUUCUUAAAAAGAUUUUUUUUUCCAGCCACUCUGGGUCUGAAAACUACCAUGGCAGUCCCUAGGUCCUACACAGCGAAGACCAAAUUCAGCCGCUCUUUAAAAUUCGCCACCAAGAGUUGCAGUCUGAAGCGGUGCUUCUAGCUGCUCCCAGCGUGGGUGUCGGUAGUUUUUGUGCUUUUAAAAAAUUAGUUUUGGAAAUGUGGUGCCUUCUCUCCCAAACUAUUUUUUUGAUUUUCAAUCCAGAUGGGGUCUUUGGGACUUCCCUAUCUUCUUCCCCAAUAAUUGGGUCGCAUUUUUCCUUACGACCUGCUGGCUGCCGGUAGGCCUGCCCUUCCGCCUGGCAGGCCCAGAGUGGAUUCCCUGGGCCGCAGUGGCCUGGACGAUGGCCGGGUCUGAUAGCGGCAGGCGGCCGCGAUGAUUUGCGGGAUUCUCGGCAUGGCACGGCCAGCCUGCCCGAGCCACGGGAGGCGCAGCCAGCCCACCACUCACGGCAAGCAGGCGGCCGAGCGCCCUUCGAGAAGAGACUUAAGUCACCAUGCUCCAGGGCAGAUACUCCCCCACCAAUCUUUCCCAGGUUUAAAGCUACAGGGCAGUUGAUGGACGACAACUAGAGGCUGCAACUUAUCAGUGACUGCCUGCGUUUGUGUUGGAGGCUGGGUGUGCGCUGCGGUGCGCGUGUGAGUGGAUCUUUUAAGACCUUUGUCUGAGCCGGGCAGAGGCACAAGUGCCACCUGACGCUUGGGGCAGAUUCCUCGUCCUGUUCUUGCAAAGAUGCCAAAUCAGGAGAGUGUCAAGAUUUCAACCGCAGACCUAAAAAAAGUGUCUCCAUGUUUUUAAAAGUAUCAGACAACCACCUCCACACACCCCUCCGUCUCCCCUUCCACCUGGAACAUUGUUCUUUUUAAUAACCAGGUUUAGCAAACUGCUAUACUGCGCCUGUGCUUUCCUGCAGCCCUCCGCUGUACCAGCUGAGCCCUGUACAGAAUCUGAGCGUCAGAGUUGCAGACCCAACCUUGCCACCUUGCAAAUCAUCCCUUCUCUGGAGGCCUCAGGAUUUUAGUUGAUCAAACCAACACCAACAUUCAUUGGGUCCCUUUGCAACCCUAACAUUUAAUGAGACUUGGUAAUUGUCAUCCGUUCGCCAAGGAGGUUGGGGAUGAACUUGGGGGCAUUUUCUUGUUUAUUUUUCAUUGAGACAAAGGAGUGUGCUGUCCCCACCUCCGCCCCCAGACAAGGACAGGGUUCCUACAUCAGCUGGGUCUAAAAUAAGGAAAAGCGAGUGCUGCCGCAGAGGGGACUUUCCGGGAAGGGGGUCACAGGAACCCCAAGGCCACACAGCUCCAGACACUCUGCCGGAGCUCUAGGGGAGCUCACCCCUGCGCGGCGGGACCUCCCCCAUCGGGUUGCCCCUUCAAUCUGCAGCCGCGCGGAGGCAGGCCCCGGGAAAGGCAGUCGGCGCUCGGUGCUCGCACUGCGCCUCGGCGGGCGGAAACUCACAAGUGUCCUCAACGUGCUAAACAAACCAUCAGGGCCCCGCAUCGCCUGGCGCAAUUGGAAUAACAAAUGCGACGCACGCAAAUUGUCCACCUCGUGUUGCUAAGCGAUUGUUUGUCGGCCCCGCACGCACAGCUCAGCAUGGGAGGACCGCGAGCGUCCAGAGGCAGCCGGCGAGCGCUUAGGUCGGAAAUGCAGUAAACAUGCCGCUGAUUUUCCCUAUUAUCACCCAAACACGAUUUCACACAAAGCAAUCACCACGCAGAAGUCUAUGAAAAUGUGUUUGUUGAGGAGUCACUCGCCCCAGUAAUAGUCCUCAUUUUUAAGAUAUUAAAGAAUAGCUCAGCGGAUUCCACAUGCAUAAGGUCUAUUUGCCGUUCGGCAUCUGUCACGGCGCUUUUGCACUGCGGUCAUCACUAAAUUGAUUCAUAGAGUGUAGAUUAAAUUGCUUCUC,lncRNA,Homo sapiens,"sp|Q15059|BRD3_HUMAN Bromodomain-containing protein 3 OS=Homo sapiens OX=9606 GN=BRD3 PE=1 SV=1
MSTATTVAPAGIPATPGPVNPPPPEVSNPSKPGRKTNQLQYMQNVVVKTLWKHQFAWPFY
QPVDAIKLNLPDYHKIIKNPMDMGTIKKRLENNYYWSASECMQDFNTMFTNCYIYNKPTD
DIVLMAQALEKIFLQKVAQMPQEEVELLPPAPKGKGRKPAAGAQSAGTQQVAAVSSVSPA
TPFQSVPPTVSQTPVIAATPVPTITANVTSVPVPPAAAPPPPATPIVPVVPPTPPVVKKK
GVKRKADTTTPTTSAITASRSESPPPLSDPKQAKVVARRESGGRPIKPPKKDLEDGEVPQ
HAGKKGKLSEHLRYCDSILREMLSKKHAAYAWPFYKPVDAEALELHDYHDIIKHPMDLST
VKRKMDGREYPDAQGFAADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMPDEPV
EAPALPAPAAPMVSKGAESSRSSEESSSDSGSSDSEEERATRLAELQEQLKAVHEQLAAL
SQAPVNKPKKKKEKKEKEKKKKDKEKEKEKHKVKAEEEKKAKVAPPAKQAQQKKAPAKKA
NSTTTAGRQLKKGGKQASASYDSEEEEEGLPMSYDEKRQLSLDINRLPGEKLGRVVHIIQ
SREPSLRDSNPDEIEIDFETLKPTTLRELERYVKSCLQKKQRKPFSASGKKQAAKSKEEL
AQEKKKELEKRLQDVSGQLSSSKKPARKEKPGSAPSGGPSRLSSSSSSESGSSSSSGSSS
DSSDSE",BRD3,-,-,726aa(1-726),Q15059,PhaSepDB,http://db.phasep.pro/browse/,"[1-35],[156-169],[237-244],[251-251],[254-305],[421-462],[478-556],[645-726]","[16-33],[149-163],[208-261],[419-431],[436-460],[463-540],[564-568],[646-678],[692-725]",In vitro,100nM [scrambled DIGIT (SCRM)];|1-2µM [BRD3],200mM NaCl,"50mM Tris-HCl pH7.5, 10% glycerol and 1mM DTT",RT,-,crowding agent:1.5% PEG-6000,Fluorescence microscopy,liquid,"Droplet assay showing the formation of mEGFP–BRD3 droplets in the presence of 100 nM DIGIT (top), 100 nM scrambled DIGIT (SCRM; middle) or no RNA (bottom). The NaCl concentration is  200 mM. PEG-6000 (1.5%) was added to each reaction.",2226
96,468,PMID: 32901111,RNAPS0000294,https://pubmed.ncbi.nlm.nih.gov/32901111,RNA + protein,-,-,SARS-CoV-2 N1541 RNA,1541nt,GGGGAAUUGUGAGCGGAUAACAAUUCCCCUCUAGAAAUAAUUUUGUUUAACUUUAAGAAGGAGAUAUACCAUGGGCAGCAGCCAUCAUCAUCAUCAUCACCACCACCACCAUAGCAGCGGCCUGGUGCCGCGCGGCAGCGCUAGCAUGUCUGAUAAUGGACCCCAAAAUCAGCGAAAUGCACCCCGCAUUACGUUUGGUGGACCCUCAGAUUCAACUGGCAGUAACCAGAAUGGAGAACGCAGUGGGGCGCGAUCAAAACAACGUCGGCCCCAAGGUUUACCCAAUAAUACUGCGUCUUGGUUCACCGCUCUCACUCAACAUGGCAAGGAAGACCUUAAAUUCCCUCGAGGACAAGGCGUUCCAAUUAACACCAAUAGCAGUCCAGAUGACCAAAUUGGCUACUACCGAAGAGCUACCAGACGAAUUCGUGGUGGUGACGGUAAAAUGAAAGAUCUCAGUCCAAGAUGGUAUUUCUACUACCUAGGAACUGGGCCAGAAGCUGGACUUCCCUAUGGUGCUAACAAAGACGGCAUCAUAUGGGUUGCAACUGAGGGAGCCUUGAAUACACCAAAAGAUCACAUUGGCACCCGCAAUCCUGCUAACAAUGCUGCAAUCGUGCUACAACUUCCUCAAGGAACAACAUUGCCAAAAGGCUUCUACGCAGAAGGGAGCAGAGGCGGCAGUCAAGCCUCUUCUCGUUCCUCAUCACGUAGUCGCAACAGUUCAAGAAAUUCAACUCCAGGCAGCAGUAGGGGAACUUCUCCUGCUAGAAUGGCUGGCAAUGGCGGUGAUGCUGCUCUUGCUUUGCUGCUGCUUGACAGAUUGAACCAGCUUGAGAGCAAAAUGUCUGGUAAAGGCCAACAACAACAAGGCCAAACUGUCACUAAGAAAUCUGCUGCUGAGGCUUCUAAGAAGCCUCGGCAAAAACGUACUGCCACUAAAGCAUACAAUGUAACACAAGCUUUCGGCAGACGUGGUCCAGAACAAACCCAAGGAAAUUUUGGGGACCAGGAACUAAUCAGACAAGGAACUGAUUACAAACAUUGGCCGCAAAUUGCACAAUUUGCCCCCAGCGCUUCAGCGUUCUUCGGAAUGUCGCGCAUUGGCAUGGAAGUCACACCUUCGGGAACGUGGUUGACCUACACAGGUGCCAUCAAAUUGGAUGACAAAGAUCCAAAUUUCAAAGAUCAAGUCAUUUUGCUGAAUAAGCAUAUUGACGCAUACAAAACAUUCCCACCAACAGAGCCUAAAAAGGACAAAAAGAAGAAGGCUGAUGAAACUCAAGCCUUACCGCAGAGACAGAAGAAACAGCAAACUGUGACUCUUCUUCCUGCUGCAGAUUUGGAUGAUUUCUCCAAACAAUUGCAACAAUCCAUGAGCAGUGCUGACUCAACUCAGGCCUGUUGAGGAUCCUGUGAAUUCGAGCUCCGUCGACAAGCUUGCGGCCGCACUCGAGCACCACCACCACCACCACUGAGAUCCGGCUGCUAACAAAGCCCGAAAGGAAGCUGAGUUGGCUGCUGCCACCGCUGAGCAAUAA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,0.05-0.5µM [N1541];|20µM [N protein],-,"1× PBS, pH 7.4",RT,> 1 h,crowding agent:2.5% PEG8000,"Differential interference contrast microscopy,Fluorescence microscopy","liquid, solid","Representative fluorescence and DIC images of LLPS formed by N protein (green) with 85-nt RNA A85 at the indicated concentrations. Representative fluorescence and DIC images of LLPS formed by N protein (red) with the positive strand RNA of N protein (N1541, 1541 nt) at the indicated concentrations.",1541
97,478,PMID: 32995779,RNAPS0000428,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,SARS-CoV-2 virus RNA,5000nt(1-5000),GGUUAAUGUUGUCUACUGUUGUAAACACCUUAAUAGUCCUCACUUCUCUCAAAGAAAGAAGUGUCUUAAGAUUGUCAAAGGUGAUAACUUCACCAUCUAGGUGGAAUGUGGUAGGAUUACUAGUGUAAUAUACACUUUUAUCACCUCUCUUAAGAAAUUCUAUACCUAGUUGUGUAGAUUGUCCAGAAUAGGACCAAUCUUUAUAGGAACCAGCAAGUGAGAUGGUUUCAAUAAAAUGUUCUUCAGGUGUUUUAGAAGAAGAAGUAAGAUAACCAUUAUACGCUGUAACAGCAUCAGGUGAAGAAACAGAAACUGUAGCUGGCACUUUGAGAGAUCUCAUAUACCGAGCAGCUUCUUCCAAAUUUAAGCCAUGUGUUACAUAGCCAAGUGGCAUUGUAACAAGAGUUUCAUUUAGAUCGUUAAGUGUGUUGAUAAGUGACGCUACAGUUGUUUUACUGGUGUAAAAGUAAAAUCUAGCACCAUAAUCAACCACACCCUCUUGUAUUUUAAUACCCUUAUAUUUACGCUGUAUAGUUGAAACUAUGGCUUUAGUUUCCACACAGACAGGCAUUAAUUUGCGUGUUUCUUCUGCAUGUGCAAGCAUUUCUCGCAAAUUCCAAGAAACAGUUCCAAGAAUUUCUUGCUUCUCAUUAGAGAUAAUAGAUGGUAGAAUGUAAAAGGCACUUUUACACUUUUUAAGCACUGUCUUUGCCUCCUCUACAGUGUAACCAUUUAAACCCUGACCCGGGUAAGUGGUUAUAUAAUUGUCUGUUGGCACUUUUCUCAAAGCUUUCGCUAGCAUUUCAGUAGUGCCACCAGCCUUUUUAGUAGGUAUAACCACAGCAGUUAAAACACCCUCUUGAACAACAUCACCCACUAUAUAUGGAGCAUCUUUCUUUAAGAAAGUGAUGUCAAUGUCACUAACAAGAGUGGCAGAAUCUGGAUGAAGAUUGCCAUUAAUGUCAAUAUAAAGUAACAAGUUUUCUGUGAGGAACUUAGUUUCUUCCAGAGUUGUUGUAACUUCUUCAACACAAGCUUUGAUUUUCUUAUCAUCUUGUUUUCUCUGUUCAACUGAAGGUUUACUUUCAGUUAUAAAUGGCUUAACUUCCUCUUUAGGAAUCUCAGCGAUCUUUUGUUCAACUUGCUUUUCACUCUUCAUUUCCAAAAAGCUUGAAACAAGUUUGUCAUAGAGAUUUUUAUCAAAGACAGCUAAGUAGACAUUUGUGCGAACAGUAUCUACACAAACUCUUAAAGAAUGUAUAGGGUCAGCACCAAAAAUACCAGCUGAUAAUAAUGGUGCAAGUAGAACUUCGUGCUGAUUAAAAUUUUCAUAAGCACUCUUAAGAAGUUGAAUGUCUUCACCUUUGUUAACAUUUGGGCCGACAACAUGAAGACAGUGUUUAGCAAGAUUGUGUCCGCUUAAAACACAACUACCACCCACUUUAAGUGGUCCAUUAGUAGCUAUGUAAUCAUCAGAUUCAACUUGCAUGGCAUUGUUAGUAGCCUUAUUUAAGGCUCCUGCAACACCUCCUCCAUGUUUAAGGUAAACAUUGGCUGCAUUAACAACCACUGUUGGUUUUACCUUUUUAGCUUCUUCCACAAUGUCUGCAUUUUUAAUGUAUACAUUGUCAGUAAGUUUUAAAUAACCACUAAAACUAUUCACUUCAAUAGUCUGAACAACUGGUGUAAGUUCCAUCUCUAAUUGAGGUUGAACCUCAACAAUUGUUUGAAUAGUAGUUGUCUGAUUGUCCUCACUGCCGUCUUGUUGACCAACAGUUUGUUGACUAUCAUCAUCUAACCAAUCUUCUUCUUGCUCUUCUUCAGGUUGAAGAGCAGCAGAAGUGGCACCAAAUUCCAAAGGUUUACCUUGGUAAUCAUCUUCAGUACCAUACUCAUAUUGAGUUGAUGGCUCAAACUCUUCUUCUUCACAAUCACCUUCUUCUUCAUCCUCAUCUGGAGGGUAGAAAGAACAAUACAUAUGUGAAGCCAAUUUAAACUCACCAGACUCAUCAAAUAAGUAGUAUGUAGCCAUACUCCACUCAUCUAAAUCAAUGCCCAGUGGUGUAAGUAAUUCAGAUACUGGUUGCAAAGUUUUUAUGACAGCAUCUGCCACAACACAGGCGAACUCAUUUACUUCUGUACCGAGUUCAACUGUAUAGGCAGAGCACUUCUCAUUAAGUACUUUAUCAAUCCUUUCAUCAAGUUCAAAAGUGAUAUUCACACUCUUGUAACCUUGCACUUCUAUCACAGUGUCAUCACCAAAAGUAACCUUUGUUGGUGCACCGCCUUUGAGUGUGAAGGUAUUGUUUGUUACCAUCAUAUUAGGUGCAAGGGCACAGUACUUUUCUGUGUCUUUGAUUUCGAGCAACAUAAGCCCGUUAAUACAAACUGGUGUACCAACCAAUGGAGCUUCAACAGCUUCACUAGUAGGUUGUUCUAAUGGUUGUAAAUCACCAGUUUUCAAGACAACUUCCUCUGUUAACACUUCUGUGGGAAGUGUUUCUCCCUCUAAGAAGAUAAUUUCUUUUGGGGCUUUUAGAGGCAUGAGUAGGCCAGUUUCUUCUCUGGAUUUAACACACUUUCUGUACAAUCCCUUUGAGUGCGUGACAAAUGUUUCACCUAAAUUCAAGGCUUUAAGUUUAGCUCCACCAAUAAUGAUAGAGUCAGCACACAAAGCCAAAAAUUUAUUUACAAGCUUAAAGAAUGUCUGAACACUCUCCUUAAUUUCCUUUGCACAGGUGACAAUUUGUCCACCGACAAUUUCACAAGCACAGGUUGAGAUAAAUUUAACAAUUUCCCAACCGUCUCUAAGAAACUCUACACCUUCCUUAAACUUCUCUUCAAGCCAAUCAAGGACGGGUUUGAGUUUUUCAUAAACAGUGCCAAAGAUGUUAGUUAGCCACUGCGAAGUCAACUGAACAACACCACCUGUAAUGUAGGCCAUUACAACUAGAUUGUUAGUAGCCAAAUCAGAUGUGAACAUCAUAGCAUCAAUGAGUCUCAGUGAAUACUGUGAAAUUCCAUCUAGUAUUGUUAUAGCGGCCUUCUGUAAAACACGCACAGAAUUUUGAGCAGUUUCAAGAGUGCGGGAGAAAAUUGAUCGUACAACACGAGCAGCCUCUGAUGCAAAUGCAUAAAGAGGACUCAGUAUUGAUUUCUGUUCACCAAUAUUCCAGGCACCUUUUUUAGCUUUUCCUUUUGUAACUUUAAAAUUACCACAGGAUUCAACAAUUUGUUUGAAUGCUUUAUAAUCCAAACCUUUCACAGUUUCCACAAAAGCACUUGUGGAAGCAGAAAAAGAUGCCAAAAUAAUGGCGAUCUCUUCAUUAAGUUUAAAGUCACCAACAAUAUUGAUGUUGACUUUCUCUUUUUGGAGUAUUUCAAGAAGGUUGUCAUUAAGACCUUCGGAACCUUCUCCAACAACACCUGUAUGGUUACAACCUAUGUUAGCGCUAGCACGUGGAACCCAAUAGGCACACUUGUUAUGGCAACCAACAUAAGAGAACACACAGCCUCCAAAGGCAAUAGUGCGACCACCCUUACGAAGAAUGGUUUUCAAGCCAGAUUCAUUAUGGUAUUCGGCAAGACUAUGCUCAGGUCCUACUUCUGAAUUGUGACAUGCUGGACAAUAAAUUUUAACAACAGCAUUUUGGGGUAAGUAACCACAAGUAGUGGCACCUUCUUUAGUCAAAUUCUCAGUGCCACAAAAUUCGCAAGUGGCUUUAACAAAAUCGCCCGUCUGCCAUGAAGUUUCACCACAAUGAUCACACUUCAUGAGAGUUGAAAGGCACAUUUGGUUGCAUUCAUUUGGUGACGCAACUGGAUAGACAGAUCGAAUUCUACCCAUAAAGCCAUCAAGCUUUUUCUUUUCAACCCUUGGUUGAAUAGUCUUGAUUAUGGAAUUUAAGGGAAAUACAAAAUUUGGACAUUCCCCAUUGAAGGUGUCAAAUUUCUUUGCCAAUUUAAUUUCAAAAGGUGUCUGCAAUUCAUAGCUCUUUUCAGAACGUUCCGUGUACCAAGCAAUUUCAUGCUCAUGUUCACGGCAGCAGUAUACACCCCUCUUAGUGUCAAUAAAGUCCAGUUGUUCGGACAAAGUGCAUGAAGCUUUACCAGCACGUGCUAGAAGGUCUUUAAUGCACUCAAGAGGGUAGCCAUCAGGGCCACAGAAGUUGUUAUCGACAUAGCGAGUGUAUGCCCCUCCGUUAAGCUCACGCAUGAGUUCACGGGUAACACCACUGCUAUGUUUAGUGUUCCAGUUUUCUUGAAAAUCUUCAUAAGGAUCAGUGCCAAGCUCGUCGCCUAAGUCAAAUGACUUUAGAUCGGCGCCGUAACUAUGGCCACCAGCUCCUUUAUUACCGUUCUUACGAAGAAGAACCUUGCGGUAAGCCACUGGUAUUUCGCCCACAUGAGGGACAAGGACACCAAGUGUCUCACCACUACGACCGUACUGAAUGCCUUCGAGUUCUGCUACCAGCUCAACCAUAACAUGACCAUGAGGUGCAGUUCGAGCAUCCGAACGUUUGAUGAACACAUAGGGCUGUUCAAGUUGAGGCAAAACGCCUUUUUCAACUUCUACUAAGCCACAAGUGCCAUCUUUAAGAUGUUGACGUGCCUCUGAUAAGACCUCCUCCACGGAGUCUCCAAAGCCACGUACGAGCACGUCGCGAACCUGUAAAACAGGCAAACUGAGUUGGACGUGUGUUUUCUCGUUGAAACCAGGGACAAGGCUCUCCAUCUUACCUUUCGGUCACACCCGGACGAAACCUAGAUGUGCUGAUGAUCGGCUGCAACACGGACGAAACCGUAAGCAGCCUGCAGAAGAUAGACGAGUUACUCGUGUCCUGUCAACGACAGUAAUUAGUUAUUAAUUAUACUGCGUGAGUGCACUAAGCAUGCAGCCGAGUGACAGCCACACAGAUUUUAAAGUUCGUUUAGAGAACAGAUCUACAAGAGAUCGAAAGUUGGUUGGUUUGUUACCUGGGAAGGUAUAAACCUUUAAU,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,"1.7,17,170 nM[SARS-CoV-2];|18.5 µM [N protein]","150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,solid,"Unlike polyC, in silico methods predict that these RNA fragments can form intra- and inter-molecular base-pairing interactions and contain extensive secondary structure elements. Similar to synthetic RNA substrates that form base-pair interactions, the N protein formed non-spherical condensates with viral RNA fragments in vitro.",5000
98,479,PMID: 32995779,RNAPS0000428,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,SARS-CoV-2 virus RNA,5000nt(1-5000),GGUUAAUGUUGUCUACUGUUGUAAACACCUUAAUAGUCCUCACUUCUCUCAAAGAAAGAAGUGUCUUAAGAUUGUCAAAGGUGAUAACUUCACCAUCUAGGUGGAAUGUGGUAGGAUUACUAGUGUAAUAUACACUUUUAUCACCUCUCUUAAGAAAUUCUAUACCUAGUUGUGUAGAUUGUCCAGAAUAGGACCAAUCUUUAUAGGAACCAGCAAGUGAGAUGGUUUCAAUAAAAUGUUCUUCAGGUGUUUUAGAAGAAGAAGUAAGAUAACCAUUAUACGCUGUAACAGCAUCAGGUGAAGAAACAGAAACUGUAGCUGGCACUUUGAGAGAUCUCAUAUACCGAGCAGCUUCUUCCAAAUUUAAGCCAUGUGUUACAUAGCCAAGUGGCAUUGUAACAAGAGUUUCAUUUAGAUCGUUAAGUGUGUUGAUAAGUGACGCUACAGUUGUUUUACUGGUGUAAAAGUAAAAUCUAGCACCAUAAUCAACCACACCCUCUUGUAUUUUAAUACCCUUAUAUUUACGCUGUAUAGUUGAAACUAUGGCUUUAGUUUCCACACAGACAGGCAUUAAUUUGCGUGUUUCUUCUGCAUGUGCAAGCAUUUCUCGCAAAUUCCAAGAAACAGUUCCAAGAAUUUCUUGCUUCUCAUUAGAGAUAAUAGAUGGUAGAAUGUAAAAGGCACUUUUACACUUUUUAAGCACUGUCUUUGCCUCCUCUACAGUGUAACCAUUUAAACCCUGACCCGGGUAAGUGGUUAUAUAAUUGUCUGUUGGCACUUUUCUCAAAGCUUUCGCUAGCAUUUCAGUAGUGCCACCAGCCUUUUUAGUAGGUAUAACCACAGCAGUUAAAACACCCUCUUGAACAACAUCACCCACUAUAUAUGGAGCAUCUUUCUUUAAGAAAGUGAUGUCAAUGUCACUAACAAGAGUGGCAGAAUCUGGAUGAAGAUUGCCAUUAAUGUCAAUAUAAAGUAACAAGUUUUCUGUGAGGAACUUAGUUUCUUCCAGAGUUGUUGUAACUUCUUCAACACAAGCUUUGAUUUUCUUAUCAUCUUGUUUUCUCUGUUCAACUGAAGGUUUACUUUCAGUUAUAAAUGGCUUAACUUCCUCUUUAGGAAUCUCAGCGAUCUUUUGUUCAACUUGCUUUUCACUCUUCAUUUCCAAAAAGCUUGAAACAAGUUUGUCAUAGAGAUUUUUAUCAAAGACAGCUAAGUAGACAUUUGUGCGAACAGUAUCUACACAAACUCUUAAAGAAUGUAUAGGGUCAGCACCAAAAAUACCAGCUGAUAAUAAUGGUGCAAGUAGAACUUCGUGCUGAUUAAAAUUUUCAUAAGCACUCUUAAGAAGUUGAAUGUCUUCACCUUUGUUAACAUUUGGGCCGACAACAUGAAGACAGUGUUUAGCAAGAUUGUGUCCGCUUAAAACACAACUACCACCCACUUUAAGUGGUCCAUUAGUAGCUAUGUAAUCAUCAGAUUCAACUUGCAUGGCAUUGUUAGUAGCCUUAUUUAAGGCUCCUGCAACACCUCCUCCAUGUUUAAGGUAAACAUUGGCUGCAUUAACAACCACUGUUGGUUUUACCUUUUUAGCUUCUUCCACAAUGUCUGCAUUUUUAAUGUAUACAUUGUCAGUAAGUUUUAAAUAACCACUAAAACUAUUCACUUCAAUAGUCUGAACAACUGGUGUAAGUUCCAUCUCUAAUUGAGGUUGAACCUCAACAAUUGUUUGAAUAGUAGUUGUCUGAUUGUCCUCACUGCCGUCUUGUUGACCAACAGUUUGUUGACUAUCAUCAUCUAACCAAUCUUCUUCUUGCUCUUCUUCAGGUUGAAGAGCAGCAGAAGUGGCACCAAAUUCCAAAGGUUUACCUUGGUAAUCAUCUUCAGUACCAUACUCAUAUUGAGUUGAUGGCUCAAACUCUUCUUCUUCACAAUCACCUUCUUCUUCAUCCUCAUCUGGAGGGUAGAAAGAACAAUACAUAUGUGAAGCCAAUUUAAACUCACCAGACUCAUCAAAUAAGUAGUAUGUAGCCAUACUCCACUCAUCUAAAUCAAUGCCCAGUGGUGUAAGUAAUUCAGAUACUGGUUGCAAAGUUUUUAUGACAGCAUCUGCCACAACACAGGCGAACUCAUUUACUUCUGUACCGAGUUCAACUGUAUAGGCAGAGCACUUCUCAUUAAGUACUUUAUCAAUCCUUUCAUCAAGUUCAAAAGUGAUAUUCACACUCUUGUAACCUUGCACUUCUAUCACAGUGUCAUCACCAAAAGUAACCUUUGUUGGUGCACCGCCUUUGAGUGUGAAGGUAUUGUUUGUUACCAUCAUAUUAGGUGCAAGGGCACAGUACUUUUCUGUGUCUUUGAUUUCGAGCAACAUAAGCCCGUUAAUACAAACUGGUGUACCAACCAAUGGAGCUUCAACAGCUUCACUAGUAGGUUGUUCUAAUGGUUGUAAAUCACCAGUUUUCAAGACAACUUCCUCUGUUAACACUUCUGUGGGAAGUGUUUCUCCCUCUAAGAAGAUAAUUUCUUUUGGGGCUUUUAGAGGCAUGAGUAGGCCAGUUUCUUCUCUGGAUUUAACACACUUUCUGUACAAUCCCUUUGAGUGCGUGACAAAUGUUUCACCUAAAUUCAAGGCUUUAAGUUUAGCUCCACCAAUAAUGAUAGAGUCAGCACACAAAGCCAAAAAUUUAUUUACAAGCUUAAAGAAUGUCUGAACACUCUCCUUAAUUUCCUUUGCACAGGUGACAAUUUGUCCACCGACAAUUUCACAAGCACAGGUUGAGAUAAAUUUAACAAUUUCCCAACCGUCUCUAAGAAACUCUACACCUUCCUUAAACUUCUCUUCAAGCCAAUCAAGGACGGGUUUGAGUUUUUCAUAAACAGUGCCAAAGAUGUUAGUUAGCCACUGCGAAGUCAACUGAACAACACCACCUGUAAUGUAGGCCAUUACAACUAGAUUGUUAGUAGCCAAAUCAGAUGUGAACAUCAUAGCAUCAAUGAGUCUCAGUGAAUACUGUGAAAUUCCAUCUAGUAUUGUUAUAGCGGCCUUCUGUAAAACACGCACAGAAUUUUGAGCAGUUUCAAGAGUGCGGGAGAAAAUUGAUCGUACAACACGAGCAGCCUCUGAUGCAAAUGCAUAAAGAGGACUCAGUAUUGAUUUCUGUUCACCAAUAUUCCAGGCACCUUUUUUAGCUUUUCCUUUUGUAACUUUAAAAUUACCACAGGAUUCAACAAUUUGUUUGAAUGCUUUAUAAUCCAAACCUUUCACAGUUUCCACAAAAGCACUUGUGGAAGCAGAAAAAGAUGCCAAAAUAAUGGCGAUCUCUUCAUUAAGUUUAAAGUCACCAACAAUAUUGAUGUUGACUUUCUCUUUUUGGAGUAUUUCAAGAAGGUUGUCAUUAAGACCUUCGGAACCUUCUCCAACAACACCUGUAUGGUUACAACCUAUGUUAGCGCUAGCACGUGGAACCCAAUAGGCACACUUGUUAUGGCAACCAACAUAAGAGAACACACAGCCUCCAAAGGCAAUAGUGCGACCACCCUUACGAAGAAUGGUUUUCAAGCCAGAUUCAUUAUGGUAUUCGGCAAGACUAUGCUCAGGUCCUACUUCUGAAUUGUGACAUGCUGGACAAUAAAUUUUAACAACAGCAUUUUGGGGUAAGUAACCACAAGUAGUGGCACCUUCUUUAGUCAAAUUCUCAGUGCCACAAAAUUCGCAAGUGGCUUUAACAAAAUCGCCCGUCUGCCAUGAAGUUUCACCACAAUGAUCACACUUCAUGAGAGUUGAAAGGCACAUUUGGUUGCAUUCAUUUGGUGACGCAACUGGAUAGACAGAUCGAAUUCUACCCAUAAAGCCAUCAAGCUUUUUCUUUUCAACCCUUGGUUGAAUAGUCUUGAUUAUGGAAUUUAAGGGAAAUACAAAAUUUGGACAUUCCCCAUUGAAGGUGUCAAAUUUCUUUGCCAAUUUAAUUUCAAAAGGUGUCUGCAAUUCAUAGCUCUUUUCAGAACGUUCCGUGUACCAAGCAAUUUCAUGCUCAUGUUCACGGCAGCAGUAUACACCCCUCUUAGUGUCAAUAAAGUCCAGUUGUUCGGACAAAGUGCAUGAAGCUUUACCAGCACGUGCUAGAAGGUCUUUAAUGCACUCAAGAGGGUAGCCAUCAGGGCCACAGAAGUUGUUAUCGACAUAGCGAGUGUAUGCCCCUCCGUUAAGCUCACGCAUGAGUUCACGGGUAACACCACUGCUAUGUUUAGUGUUCCAGUUUUCUUGAAAAUCUUCAUAAGGAUCAGUGCCAAGCUCGUCGCCUAAGUCAAAUGACUUUAGAUCGGCGCCGUAACUAUGGCCACCAGCUCCUUUAUUACCGUUCUUACGAAGAAGAACCUUGCGGUAAGCCACUGGUAUUUCGCCCACAUGAGGGACAAGGACACCAAGUGUCUCACCACUACGACCGUACUGAAUGCCUUCGAGUUCUGCUACCAGCUCAACCAUAACAUGACCAUGAGGUGCAGUUCGAGCAUCCGAACGUUUGAUGAACACAUAGGGCUGUUCAAGUUGAGGCAAAACGCCUUUUUCAACUUCUACUAAGCCACAAGUGCCAUCUUUAAGAUGUUGACGUGCCUCUGAUAAGACCUCCUCCACGGAGUCUCCAAAGCCACGUACGAGCACGUCGCGAACCUGUAAAACAGGCAAACUGAGUUGGACGUGUGUUUUCUCGUUGAAACCAGGGACAAGGCUCUCCAUCUUACCUUUCGGUCACACCCGGACGAAACCUAGAUGUGCUGAUGAUCGGCUGCAACACGGACGAAACCGUAAGCAGCCUGCAGAAGAUAGACGAGUUACUCGUGUCCUGUCAACGACAGUAAUUAGUUAUUAAUUAUACUGCGUGAGUGCACUAAGCAUGCAGCCGAGUGACAGCCACACAGAUUUUAAAGUUCGUUUAGAGAACAGAUCUACAAGAGAUCGAAAGUUGGUUGGUUUGUUACCUGGGAAGGUAUAAACCUUUAAU,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,18 nM[SARS-CoV-2 virus Sec1];|7.8 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,"other_molecular:0,10 mM lipoic acid",Electron microscopy,solid,"The  condensates formed by the N protein in the absence or presence of polyC or viral RNA dissolve with the  addition of 10% 1,6 hexanediol, indicating that phase separation is driven, at least partially, by hydrophobic  interactions (Figure 5A). In comparison, lipoic acid that increases the liquidity of stress granules did  not affect phase separation",5000
99,480,PMID: 32995779,RNAPS0000428,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,SARS-CoV-2 virus RNA,5000nt(1-5000),GGUUAAUGUUGUCUACUGUUGUAAACACCUUAAUAGUCCUCACUUCUCUCAAAGAAAGAAGUGUCUUAAGAUUGUCAAAGGUGAUAACUUCACCAUCUAGGUGGAAUGUGGUAGGAUUACUAGUGUAAUAUACACUUUUAUCACCUCUCUUAAGAAAUUCUAUACCUAGUUGUGUAGAUUGUCCAGAAUAGGACCAAUCUUUAUAGGAACCAGCAAGUGAGAUGGUUUCAAUAAAAUGUUCUUCAGGUGUUUUAGAAGAAGAAGUAAGAUAACCAUUAUACGCUGUAACAGCAUCAGGUGAAGAAACAGAAACUGUAGCUGGCACUUUGAGAGAUCUCAUAUACCGAGCAGCUUCUUCCAAAUUUAAGCCAUGUGUUACAUAGCCAAGUGGCAUUGUAACAAGAGUUUCAUUUAGAUCGUUAAGUGUGUUGAUAAGUGACGCUACAGUUGUUUUACUGGUGUAAAAGUAAAAUCUAGCACCAUAAUCAACCACACCCUCUUGUAUUUUAAUACCCUUAUAUUUACGCUGUAUAGUUGAAACUAUGGCUUUAGUUUCCACACAGACAGGCAUUAAUUUGCGUGUUUCUUCUGCAUGUGCAAGCAUUUCUCGCAAAUUCCAAGAAACAGUUCCAAGAAUUUCUUGCUUCUCAUUAGAGAUAAUAGAUGGUAGAAUGUAAAAGGCACUUUUACACUUUUUAAGCACUGUCUUUGCCUCCUCUACAGUGUAACCAUUUAAACCCUGACCCGGGUAAGUGGUUAUAUAAUUGUCUGUUGGCACUUUUCUCAAAGCUUUCGCUAGCAUUUCAGUAGUGCCACCAGCCUUUUUAGUAGGUAUAACCACAGCAGUUAAAACACCCUCUUGAACAACAUCACCCACUAUAUAUGGAGCAUCUUUCUUUAAGAAAGUGAUGUCAAUGUCACUAACAAGAGUGGCAGAAUCUGGAUGAAGAUUGCCAUUAAUGUCAAUAUAAAGUAACAAGUUUUCUGUGAGGAACUUAGUUUCUUCCAGAGUUGUUGUAACUUCUUCAACACAAGCUUUGAUUUUCUUAUCAUCUUGUUUUCUCUGUUCAACUGAAGGUUUACUUUCAGUUAUAAAUGGCUUAACUUCCUCUUUAGGAAUCUCAGCGAUCUUUUGUUCAACUUGCUUUUCACUCUUCAUUUCCAAAAAGCUUGAAACAAGUUUGUCAUAGAGAUUUUUAUCAAAGACAGCUAAGUAGACAUUUGUGCGAACAGUAUCUACACAAACUCUUAAAGAAUGUAUAGGGUCAGCACCAAAAAUACCAGCUGAUAAUAAUGGUGCAAGUAGAACUUCGUGCUGAUUAAAAUUUUCAUAAGCACUCUUAAGAAGUUGAAUGUCUUCACCUUUGUUAACAUUUGGGCCGACAACAUGAAGACAGUGUUUAGCAAGAUUGUGUCCGCUUAAAACACAACUACCACCCACUUUAAGUGGUCCAUUAGUAGCUAUGUAAUCAUCAGAUUCAACUUGCAUGGCAUUGUUAGUAGCCUUAUUUAAGGCUCCUGCAACACCUCCUCCAUGUUUAAGGUAAACAUUGGCUGCAUUAACAACCACUGUUGGUUUUACCUUUUUAGCUUCUUCCACAAUGUCUGCAUUUUUAAUGUAUACAUUGUCAGUAAGUUUUAAAUAACCACUAAAACUAUUCACUUCAAUAGUCUGAACAACUGGUGUAAGUUCCAUCUCUAAUUGAGGUUGAACCUCAACAAUUGUUUGAAUAGUAGUUGUCUGAUUGUCCUCACUGCCGUCUUGUUGACCAACAGUUUGUUGACUAUCAUCAUCUAACCAAUCUUCUUCUUGCUCUUCUUCAGGUUGAAGAGCAGCAGAAGUGGCACCAAAUUCCAAAGGUUUACCUUGGUAAUCAUCUUCAGUACCAUACUCAUAUUGAGUUGAUGGCUCAAACUCUUCUUCUUCACAAUCACCUUCUUCUUCAUCCUCAUCUGGAGGGUAGAAAGAACAAUACAUAUGUGAAGCCAAUUUAAACUCACCAGACUCAUCAAAUAAGUAGUAUGUAGCCAUACUCCACUCAUCUAAAUCAAUGCCCAGUGGUGUAAGUAAUUCAGAUACUGGUUGCAAAGUUUUUAUGACAGCAUCUGCCACAACACAGGCGAACUCAUUUACUUCUGUACCGAGUUCAACUGUAUAGGCAGAGCACUUCUCAUUAAGUACUUUAUCAAUCCUUUCAUCAAGUUCAAAAGUGAUAUUCACACUCUUGUAACCUUGCACUUCUAUCACAGUGUCAUCACCAAAAGUAACCUUUGUUGGUGCACCGCCUUUGAGUGUGAAGGUAUUGUUUGUUACCAUCAUAUUAGGUGCAAGGGCACAGUACUUUUCUGUGUCUUUGAUUUCGAGCAACAUAAGCCCGUUAAUACAAACUGGUGUACCAACCAAUGGAGCUUCAACAGCUUCACUAGUAGGUUGUUCUAAUGGUUGUAAAUCACCAGUUUUCAAGACAACUUCCUCUGUUAACACUUCUGUGGGAAGUGUUUCUCCCUCUAAGAAGAUAAUUUCUUUUGGGGCUUUUAGAGGCAUGAGUAGGCCAGUUUCUUCUCUGGAUUUAACACACUUUCUGUACAAUCCCUUUGAGUGCGUGACAAAUGUUUCACCUAAAUUCAAGGCUUUAAGUUUAGCUCCACCAAUAAUGAUAGAGUCAGCACACAAAGCCAAAAAUUUAUUUACAAGCUUAAAGAAUGUCUGAACACUCUCCUUAAUUUCCUUUGCACAGGUGACAAUUUGUCCACCGACAAUUUCACAAGCACAGGUUGAGAUAAAUUUAACAAUUUCCCAACCGUCUCUAAGAAACUCUACACCUUCCUUAAACUUCUCUUCAAGCCAAUCAAGGACGGGUUUGAGUUUUUCAUAAACAGUGCCAAAGAUGUUAGUUAGCCACUGCGAAGUCAACUGAACAACACCACCUGUAAUGUAGGCCAUUACAACUAGAUUGUUAGUAGCCAAAUCAGAUGUGAACAUCAUAGCAUCAAUGAGUCUCAGUGAAUACUGUGAAAUUCCAUCUAGUAUUGUUAUAGCGGCCUUCUGUAAAACACGCACAGAAUUUUGAGCAGUUUCAAGAGUGCGGGAGAAAAUUGAUCGUACAACACGAGCAGCCUCUGAUGCAAAUGCAUAAAGAGGACUCAGUAUUGAUUUCUGUUCACCAAUAUUCCAGGCACCUUUUUUAGCUUUUCCUUUUGUAACUUUAAAAUUACCACAGGAUUCAACAAUUUGUUUGAAUGCUUUAUAAUCCAAACCUUUCACAGUUUCCACAAAAGCACUUGUGGAAGCAGAAAAAGAUGCCAAAAUAAUGGCGAUCUCUUCAUUAAGUUUAAAGUCACCAACAAUAUUGAUGUUGACUUUCUCUUUUUGGAGUAUUUCAAGAAGGUUGUCAUUAAGACCUUCGGAACCUUCUCCAACAACACCUGUAUGGUUACAACCUAUGUUAGCGCUAGCACGUGGAACCCAAUAGGCACACUUGUUAUGGCAACCAACAUAAGAGAACACACAGCCUCCAAAGGCAAUAGUGCGACCACCCUUACGAAGAAUGGUUUUCAAGCCAGAUUCAUUAUGGUAUUCGGCAAGACUAUGCUCAGGUCCUACUUCUGAAUUGUGACAUGCUGGACAAUAAAUUUUAACAACAGCAUUUUGGGGUAAGUAACCACAAGUAGUGGCACCUUCUUUAGUCAAAUUCUCAGUGCCACAAAAUUCGCAAGUGGCUUUAACAAAAUCGCCCGUCUGCCAUGAAGUUUCACCACAAUGAUCACACUUCAUGAGAGUUGAAAGGCACAUUUGGUUGCAUUCAUUUGGUGACGCAACUGGAUAGACAGAUCGAAUUCUACCCAUAAAGCCAUCAAGCUUUUUCUUUUCAACCCUUGGUUGAAUAGUCUUGAUUAUGGAAUUUAAGGGAAAUACAAAAUUUGGACAUUCCCCAUUGAAGGUGUCAAAUUUCUUUGCCAAUUUAAUUUCAAAAGGUGUCUGCAAUUCAUAGCUCUUUUCAGAACGUUCCGUGUACCAAGCAAUUUCAUGCUCAUGUUCACGGCAGCAGUAUACACCCCUCUUAGUGUCAAUAAAGUCCAGUUGUUCGGACAAAGUGCAUGAAGCUUUACCAGCACGUGCUAGAAGGUCUUUAAUGCACUCAAGAGGGUAGCCAUCAGGGCCACAGAAGUUGUUAUCGACAUAGCGAGUGUAUGCCCCUCCGUUAAGCUCACGCAUGAGUUCACGGGUAACACCACUGCUAUGUUUAGUGUUCCAGUUUUCUUGAAAAUCUUCAUAAGGAUCAGUGCCAAGCUCGUCGCCUAAGUCAAAUGACUUUAGAUCGGCGCCGUAACUAUGGCCACCAGCUCCUUUAUUACCGUUCUUACGAAGAAGAACCUUGCGGUAAGCCACUGGUAUUUCGCCCACAUGAGGGACAAGGACACCAAGUGUCUCACCACUACGACCGUACUGAAUGCCUUCGAGUUCUGCUACCAGCUCAACCAUAACAUGACCAUGAGGUGCAGUUCGAGCAUCCGAACGUUUGAUGAACACAUAGGGCUGUUCAAGUUGAGGCAAAACGCCUUUUUCAACUUCUACUAAGCCACAAGUGCCAUCUUUAAGAUGUUGACGUGCCUCUGAUAAGACCUCCUCCACGGAGUCUCCAAAGCCACGUACGAGCACGUCGCGAACCUGUAAAACAGGCAAACUGAGUUGGACGUGUGUUUUCUCGUUGAAACCAGGGACAAGGCUCUCCAUCUUACCUUUCGGUCACACCCGGACGAAACCUAGAUGUGCUGAUGAUCGGCUGCAACACGGACGAAACCGUAAGCAGCCUGCAGAAGAUAGACGAGUUACUCGUGUCCUGUCAACGACAGUAAUUAGUUAUUAAUUAUACUGCGUGAGUGCACUAAGCAUGCAGCCGAGUGACAGCCACACAGAUUUUAAAGUUCGUUUAGAGAACAGAUCUACAAGAGAUCGAAAGUUGGUUGGUUUGUUACCUGGGAAGGUAUAAACCUUUAAU,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,18 nM[SARS-CoV-2 virus Sec1];|7.8 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,"other_molecular:10% 1,6-hexanediol",Electron microscopy,liquid,"The  condensates formed by the N protein in the absence or presence of polyC or viral RNA dissolve with the  addition of 10% 1,6 hexanediol, indicating that phase separation is driven, at least partially, by hydrophobic  interactions (Figure 5A). In comparison, lipoic acid that increases the liquidity of stress granules did  not affect phase separation",5000
100,481,PMID: 32995779,RNAPS0000429,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,SARS-CoV-2 virus RNA,5000nt(5001-10000),ACCUGAGUUACUGAAGUCAUUGAGAGCCUUUGCGAGAUGACAACAAGCAGCUUCUCUGUAGCUAGUUGUAUCCAUUGCUCCACUAAAAUACUUGUACUUAUUAUAAAGAGCUAAGUAUCUAUUAUAUUGCGUAAGAGGUAAUAGCACAUCACUACGCAACUUUAGAUACAUUUCUUUAUUUAACAAAAAGGUGCACAGCGCAGCUUCUUCAAAAGUACUAAAGGAAACACCAUUAAAGACUACACGUCUCUUUAGGUAAUUACUAAAGAACCAAUAGAAAUGCUUUGUGGAAAUACAAAUGAUAUAAGCAAUUGUUAUCCAGAAAGGUACUAAAGGUGUGAACAUAACCAUCCACUGAAUAUGUGCUAAAAAAGAAACAUCAUUAGUAAGAUAAAAUGUCAAGUACAAGUAAAUAACAGAAUAAACACCAGGUAAGAAUGAGUAAACUGGUGUUAAACAGAGUACAGUGAAUGACAUAAGGAAUAGUAAAGUAUUAAAGGCAACUACAUGACUGUAUUCACCAAAAGCUCUUCUAAACCUCAUAAAAUAGUAGGCAAGGCAUGUUACUACGAUAGCUACAAUACCACCAGCUACUAUAGAUGCUGAUAUGUCCAAAGCACCAAUAGGUUGAAUUAGUGGUGUAAACAUAUUAGUAAGUAAAUUUACAGCAUCUACACCACAGAAAACUCCUGGUAAAGAUCUGUAAUAAUCAUUGUUAAGUACCCAUCUACCACUAGUAGAUACACAAACACCAGCUUCUGAUCUUUCACAAGUGCCGUGCCUACAGUACUCAGAAUCAAAAGUUGUUACCACUCUAACAGAACCUUCAAGGUAGGUGUUAGGAAAUUGAAUAAUAGAGCCAUCCAUGAGCACAUAACGUGUGUCAGGGCGUAAACUUUCAUAAGCAACAGAACCUUCUAGUACAUUGGUAUCAUAACAAUAUGGUACUGGCUUACCAGAAGCAUCUUUAAAAAUUGUACAUUCAGCAGCCAAAACACAAGCUGAUGUUGCAAAGUCAGUGUACUCUAUAAGUUUUGAUGGUGUGUAACAGAUGUUACCAACUGCACUAAAAACUCUAGGUAAGAAAUGCAAAAAGUCACCAUUAGUUGUGCGUAAUAUCGUGCCAGGCAAACCAGGCACGACAAAACCCACUUCUCUUGUUAUGACUGCAGCAAUCAAUGGGCAAGCUUUGUCAUUAGUAUAACUACCACCACGCUGGCUAAACCAUGUGUCAAAAUCAGCAUGUUUGUUAGCAAAACAAGUAUCUGUAGAUGCUAUGUCACGAGUGACACCACCAUCAAUAGCCUUGUAUCCUAUGAUUUCACUUGAAAAGUCAGUAUGUUUAGACAUGACAUGAACAGGUGUUAUUAAAUAGAAAAUAGCAGCAACAAAAAGGAACACAAGUGUAACUUUAAUUAACUGCUUCAACCAAUUAUUAACAAUUUUACCACCCUUAAGUGCUAUCUUUGUUGUUACAACAUUAACAACUUGUCUAGUAGUUGCACAUGUCAACUUAAAAGGUAAGUUAUUCUUUUUAGCAGCACUACGUAUUUGUUUUCGUAGUUGUUCAGACAAUGACAUGAAAUCUUUAACGUUCCAUAUCAAAGCAAUGUUGUGACUUUUUGCUACCUGCGCAUUAAUAUGACGCGCACUACAGUCAAUACAAGCACCAAGGUCACGGGGUGUCAUGUUUUCAACUUUGUUAUAGGUGAGCAUAUAGUUAUUACAACUAUCGCCAGUAACUUCUAUGUCAGAUUGAUGUGACAAUUUAAGACAUUCAACAACAUCUUUAGUUUCUACAUCUGAAUCAACAAACCCUUGCCGAGCUGCUGAAAUAAAAGUAGAUAAGACAUUGUCUAAGGACACAUUCUUUGCAAGUUCAGCUUCUGCAGUUGCAACUAGUGUUUUGAGUUUUUCCAUUGGUACGUUAAAAGUUGAUGAAAACGUAUUAACGUAAGCAUCAAACAUUUUAACUGCAACUUCCGCACUAUCACCAACAUCAGACACUAAUGCCUGAUCUAGUAACAGUAUAGGUUGACACAUAAGCUGACUGUAGUAAACAGACGCUGAUUUUGCAGAUGAUUCUUCACAUUUUGAUUUACCAUCAAAAACUAUAACAUUAAUAGGCAAUGAACCUUUAGUGUUAUUAGCUCUCAGGUUGUCUAAGUUAACAAAAUGAGAGAGAGAAUGUCUUUCAUAAGUCUUUUGACCAGCUUUAUCAAAGUAAAGAUGGAUGGAACCAUUCUUCACUGUAACACUAUCAACGAUGUAAGAAGACUGGUCAGUAGGAUUUAUUGGUCUUUUAAACUGUAGUGACAAGUCUCUCGCAACUUCAUCACUAAUAAAUGUACUACCAGCACAGAAUGUAUCACAAUUAACACAAUUCCAAUUGUGUAGUUUGCAAAAGCCUUUACCUCCAUUAGCAUAGACAUAAAAGGACCUUCUAACACCAUUAACAAUAGUUGUACAUUCGACUCUUGUUGCUCUAUUACGUUUGUAACACAUCAUACAAGUUGAUGAAUUACAACCGUCUACAACAUGCACAUAACUUUUCCAUACAUAAUAAAAUGAUGCAAAGAAGAUGUACAUUCUAACCAUAGCUGAAAUCGGGGCCAUUUGUACAAGAUUAAUUAUUAACCACAUAAGCCAAGAAUUACUAAUAAAAUGUACUGCAAAAUAGCUGAAAAACAAUUGCAUGAUUGCAGCCAAUCCAAGUACAUAGAAAAACCUAGUGAAAAGAAUAUAUGCCAAAAACCACUCUGCAACUAAGCCAAAAGCAGUUAAAUCCCAUUUAAAAGAUGAAAUGGUAAUUUGUAUAGUUUCUAAAGAAGGAUAGGUGUCUAAAGAAUCUAAACCACUAAGACAAACACUACAAGGUAUAGAACCAGUACAGUAGGUUGCAAUAGUGACAUUAGUAGAGUUCAAAUAGCCUUCUCUGUAACCAGUACAGUAAGAAGGCAUGCCUAAAUUAGACAUUAAAACACCUAAAGCAGCGGUUGAGUAGAUUAAAGAACCUAGGCAAACACUUAAUAGUAAAAACCAAAUUAUAAUAUUUAUCAGUUUAGAAAAAUUAGGUGACUUCAAAUAAUUAAAUGAAGCCUCUAGACAAAAUUUACCGACACUCUUAACAGUAUUCUUUGCUAUAGUAGUCGGCAUAGAUGCUUUAAUUCUAGAAUUUGUACUUCUAGUAAAAGUACACAAUUGUAGCAAUAAAGUAAAGAAAUAAGGCAUAUAAUUAGUACAAACACGGUUUAAACACCGUGUAACUAUGUUAGUAGUUGUACUAACAACUUUGUUAAGAAAAGGCUUAGCAUAAUUAGCUAUAGUAUCCCAAGGGACACUAUUAACAGCAGCUAAACCAUGAGUAGCAAGGGUUUUCAAACCUAAUACUCUAGAUAAUUCAUUAGGUUUCUUAAUAGUAAGACUAGAAUUGUCUACAUAAGCAGCCAUUAGAUCUGUGUGGCCAACCUCUUCUGUAAUUUUUAAACUAUUAUUUGCUGGUUUAAGUAUAAUGUCUCCUACAACUUCGGUAGUUUUCACAUUACACUCAAGAACGUCUUUCUGUAUGGUAGGAUUUUCCACUACUUCUUCAGAGACUGGUUUUAGAUCUUCGCAGGCAAGAUUAUCCAUUCCCUGCGCGUCCUCUGACUUCAGUACAUCAAACGAAUUUGAUGUUUCAACUGGUUUUGUGCUCCAAAGACAACGUAUACACCAGGUAUUUGGUUUAUACGUGGCUUUAUUAGUUGCAUUGUUAACAUGCCAAACAAUAGGUUUAUGUAACAAUUUAGCUCCUUUCUUAAAAGAGGGUGUGUAGUGUUUAUAAUCAAUAGCCACCACAUCACCAUUUAAGUCAGGGAAAAAUGUAACUUUAAGCUCUCUUGAAGCAGGUUUCUUAUAACCAGUUAACUGGUUUAAAUCAUCAGCAAAUUUGAUAUUAUCACAUACAAACUUAAAAUUAUCGAAGCUUGCGUUUGGAUAUGGUUGGUUUGGUACAAGAUCAAUUGGUUGCUCUGUGAAAUAAGAAUUGUCUUUCUUAUAAUAAUUGUCCAACUUAGGGUCAAUUUCUGUACAAACAACACCAUCCAAUUUAUAAGUAACUGGUUUUAUGGUUGUUGUGUAACUGUUUUCUUUGUAGAAAACAUCCGUAAUAGGACCUUUGUAUUCUGAGGACUUUGUAAGUAAAGCACCGUCUAUGCAAUACAAAGUUUCUUUAGAAGUUAUAUGUUUAUAGUGACCACACUGGUAAUUACCAGUGUACUCACUAGCACAAGUAAAUGUACCAUGCUUAAGUUCAUACUGAGCAGGUGGUGCUGACAUCAUAACAAAAGGUGACUCCUGUUGUACUAGAUAUUUUGUAGCUUGUUUACCACACGUACAAGGUAUCUGAACACCUUUCUUAAAUUGUUCAUAAGAAAGUGUGCCCAUGUACAUAACAGCUUCUACACCCUUAAGGGUUGUCUGCUGUUGUCCACAAGUUUUACACACCACGUUCAAGACUCUUUUGCAAGAAUCUAAAUUGGCAUGUUGAAACAAGUAACUCAUUGUUUCUCUAACAUCACCUAACUCACCUACUGUCUUAUUACAGUAGGCUAAGAUAAGUGCACAAAAGUUAGCAGCUUCACCAGCCCUUGCUCUGUAAUAAGCAUCUUGUAGAGCAGGUGGAUUAAACUUCAACUCUAUUUGUUGGAGUGUUAACAAUGCAGUGGCAAGAUAACAGUUGUUAUCUGCCCAUUUAAUAGAAGUUAAACCAUUAACUUGUGGGUAUUUCCACUUUUUAGUGUGAUUUAAUGCUGACAUGUACCUACCCAGAAAACUAGGAUCAGUUGUGUGGUAGUACUCAAAAGCCUCAACACGUAGAGUGUCAUCAUUAGGUAAAACAUAAAAUGUUUUACCUUCAUGUGAAUUAUGAGGUUUUAUUUUAGUAACAUCAGCUCCAUCCAAAUAAGUUGGACCAAACUGUUGUCCAUAUGUCAUUGACAUGUCCACAACUUGCGUGUGGA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,"1.9,18,190 nM[SARS-CoV-2];|18.5 µM [N protein]","150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,solid,"Unlike polyC, in silico methods predict that these RNA fragments can form intra- and inter-molecular base-pairing interactions and contain extensive secondary structure elements. Similar to synthetic RNA substrates that form base-pair interactions, the N protein formed non-spherical condensates with viral RNA fragments in vitro.",5000
101,482,PMID: 32995779,RNAPS0000430,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,SARS-CoV-2 virus RNA,5000nt(10001-15000),ACUCAUUGAAUCAUAAUAAAGUCUAGCCUUACCCCAUUUAUUAAAUGGAAAACCAGCUGAUUUGUCUAGGUUGUUGACGAUGACUUGGUUAGCAUUAAUACAGCCACCAUCGUAACAAUCAAAGUACUUAUCAACAACUUCAACUACAAAUAGUAGUUGUCUGAUAUCACACAUUGUUGGUAGAUUAUAACGAUAGUAGUCAUAAUCGCUGAUAGCAGCAUUACCAUCCUGAGCAAAGAAGAAGUGUUUUAAUUCAACAGAACUUCCUUCCUUAAAGAAACCCUUAGACACAGCAAAGUCAUAGAAGUCUUUGUUAAAAUUACCGGGUUUGACAGUUUGAAAAGCAACAUUGUUAGUAAGUGCAGCUACUGAAAAGCACGUAGUGCGUUUAUCUAGUAAUAGAUUACCAGAAGCAGCGUGCAUAGCAGGGUCAGCAGCAUACACAAGUAAUUCCUUAAAACUAAGUCUAGAGCUAUGUAAGUUUACAUCCUGAUUAUGUACAACACCUAGCUCUCUGAAGUGGUAUCCAGUUGAAACUACAAAUGGAACACCAUCAACAAAUAUUUUUCUCACUAGUGGUCCAAAACUUGUAGGUGGGAACACUGUAGAGAAUAAAACAUUAAAGUUUGCACAAUGCAGAAUGCAUCUGUCAUCCAAACAGUUAACACAAUUUGGGUGGUAUGUCUGAUCCCAAUAUUUAAAAUAACGGUCAAAGAGUUUUAACCUCUCUUCCGUGAAGUCAUAUUUUAACAAAUCCCACUUAAUGUAAGGCUUUGUUAAGUCAGUGUCAACAUGUGACUCUGCAGUUAAAGCCCUGGUCAAGGUUAAUAUAGGCAUUAACAAUGAAUAAUAAGAAUCUACAACAGGAACUCCACUACCUGGCGUGGUUUGUAUGAAAUCACCGAAAUCAUACCAGUUACCAUUGAGAUCUUGAUUAUCUAAUGUCAGUACACCAACAAUACCAGCAUUUCGCAUGGCAUCACAGAAUUGUACUGUUUUUAACAAAGCUUGGCGUACACGUUCACCUAAGUUGGCGUAUACGCGUAAUAUAUCUGGGUUUUCUACAAAAUCAUACCAGUCCUUUUUAUUGAAAUAAUCAUCAUCACAACAAUUGUAUGUGACAAGUAUUUCUUUUAAUGUGUCACAAUUACCUUCAUCAAAAUGCCUUAAAGCAUAGACGAGGUCUGCCAUUGUGUAUUUAGUAAGACGUUGACGUGAUAUAUGUGGUACCAUGUCACCGUCUAUUCUAAACUUAAAGAAGUCAUGUUUAGCAACAGCUGGACAAUCCUUAAGUAAAUUAUAAAUUGUUUCUUCAUGUUGGUAGUUAGAGAAAGUGUGUCUCUUAACUACAAAGUAAGAAUCAAUUAAAUUGUCAUCUUCGUCCUUUUCUUGGAAGCGACAACAAUUAGUUUUUAGGAAUUUAGCAAAACCAGCUACUUUAUCAUUGUAGAUGUCAAAAGCCCUGUAUACGACAUCAGUACUAGUGCCUGUGCCGCACGGUGUAAGACGGGCUGCACUUACACCGCAAACCCGUUUAAAAACGAUUGUGCAUCAGCUGACUGAAGCAUGGGUUCGCGGAGUUGAUCACAACUACAGCCAUAACCUUUCCACAUACCGCAGACGGUACAGACUGUGUUUUUAAGUGUAAAACCCACAGGGUCAUUAGCACAAGUUGUAGGUAUUUGUACAUACUUACCUUUUAAGUCACAAAAUCCUUUAGGAUUUGGAUGAUCUAUGUGGCAACGGCAGUACAGACAACACGAUGCACCACCAAAGGAUUCUUGAUCCAUAUUGGCUUCCGGUGUAACUGUUAUUGCCUGACCAGUACCAGUGUGUGUACACAACAUCUUAACACAAUUAGUGAUUGGUUGUCCCCCACUAGCUAGAUAAUCUUUGUAAGCUUUAGCAGCAUCUACAGCAAAAGCACAGAAAGAUAAUACAGUUGAAUUGGCAGGCACUUCUGUUGCAUUACCAGCUUGUAGACGUACUGUGGCAGCUAAACUACCAAGUACCAUACCUCUAUUUAGGUUGUUUAAUCCUUUAAUAAAGUAUAAAUACUUCACUUUAGGACCUUUAGGUGUGUCUGUAACAAACCUACAAGGUGGUUCCAGUUCUGUAUAGAUAGUACCAGUUCCAUCACUCUUAGGGAAUCUAGCCCAUUUCAAAUCCUGUAAAUCGGAUAACAGUGCAAGUACAAACCUACCUCCCUUUGUUGUGUUGUAGUAAGCUAACGCAUUGUCAUCAGUGCAAGCAGUUUGUGUAGUACCGGCAGCACAAGACAUCUGUCGUAGUGCAACAGGACUAAGCUCAUUAUUCUGUAAUUUGACAGCAGAAUUGGCCCUUAAAGCUGUUACAAUAAGAGGCCAUGCUAAAUUAGGUGAAUUGUCCAUACUAAUUUCACUAAGUUGAACAAUUUUACUAUCUGCAUCUACAACCUGUUGGAUUUCCCACAAUGCUGAUGCAUAAGUAAAUGUUGUACCAUCACACGUAUUUUUAUAUGUGUUAUAGUCUGGUAUGACAACCAUUAGUUUGGCUGCUGUUGUAAGAGGUAUUAUGUUCAAGGGAACACAACCAUCUCUUGCAUUGUUGAUAAUGUUGUUGAGUGCAUCAUUAUCCAACUUUCUAAGCAUAGUGAAAAGCAUUGUCUGCAUAGCACUAGUAACUUUUGCCCUCUUGUCCUCAGAUCUAGCCUGUUUAUACAUUUGGGUCAUAGCUUGAUCAGCCAUCUUUUCCAACUUACGUUGCAUGGCUGCAUCACGGUCAAAUUCAGAUUUAGCCACAUUCAAAGACUUCUUCAACUUUUUAAGAACAACUUCAGAAUCACCAUUAGCAACAGCCUGCUCAUAAGCUUCUUGAGCAGUAGCAAAAGCUGCAUAUGAUGGAAGGGAACUAAACUCUGAGGCUAUAGCUUGUAAGGUUGCCCUGUUGUCCAGCAUUUCUUCACAAAGCUUGUUUAUGUCUACAGCACCCUGCAUGGAAAGCAAAACAGAAAGUAGUGAAACCAUUUUUUCAAAGGCUUCAGUAGUAUCUUUAGCUAAGAGAAUGUCAUUGUGUAACUGGACACAUUGAGCCCACAAUUUAGAUGAUGAUUCUACUCUGAGUUGUUGCAAAACUGAGAGUAAGACUACUGAUGUGCACUUUACAUCUGACAUUUUAGACUGUACAGUGGCUACUUUGAUACAAGGUUUGCCACCAACACCCAACAAUUUAAUGUUGAGUUUGAAGGCAUCUAUGCUAUUCUUGGGUGGGAGUAGUCCCUGUGAAUUCAUAUAUCUAAACUCCUGUGUAGAAACUAAGUAAUCAUAAACACCAAGAGUCAGUCUAAAGUAGCGGUUGAGUAAACAAAAGAGGCCAAAGUAACAAGUACAAAAAUAGCCUAAGAAACAAUAAACUAGCAUUAUACACUGAAGUGUAUUACCAGUUAUGAAGAAAAUAGGGCAAUACUCAACACACAUAAAAACAAUACCUCUGGCCAAAAACAUGACAGUUGUAACUACACCUGAGUAGUUAGAAGUAACAGAGAUUAUAAGAGCCCACAUGGAAAUGGCUUGAUCUAAAGCAUUACCAUAAUAAACUUUAUAAACGAGUGUCAAGACAUUCAUAAGUGUCCACACUCUCCUAGCACCAUCAUCAUACACAGUUCUUGCUGUCAUAAGGAUUAGUAACACUACAGCUGAUGCAUACAUAACACAGUCUUUUAGCUUAAAACCAGACAAACUAGUAUCAACCAUAUCCAACCAUGUCAUAAUACGCAUCACCCAACUAGCAGGCAUAUAGACCAUAUUAAAAUAAGCUACAGUGGCAAGAGAAGGUAACAAAAACAAACAGAGAAAUGCAUGCUUAUGUUUGACAAACAUCAUUGCAAAAGCAGACAUAGCAAUAAUACCCAUAGCAAAAGGUAAAAAGGCAUUUUCAUACAAAAAAAAGAACAAAGACCAUUGAGUACUCUGGACUAAAACUAAAAGUGAAGUCAAAAUUGUGAGUAACAACCAGUGGUGUGUACCCUUGAUUGUUCUUUUCACUGCACUUUGGAAAGUAACACCUGAGCAUUGUCUAACAACAUCAAAAGGUGUAAAUUCAUCUUCUAAUAAAGCACUACCCAAUAUGGUACGUCCAUUCAUACCAUUUUGCAGUAAUUCUUUUAAUGAAGCACACAUAUCUAAAACGGCAAUUCCAGUUUGAGCAGAAAGAGGUCCUAGUAUGUCAACAUGGUCUUGUGUUAGAGGUUCAUAAUUGUACUUCAUAGCCACAAGGUUAAAGUCAUUAAGAGUUGUGGUAAAUCGAUUGAGAAACCACCUGUCUCCAUUUAUAACAGCAGCGUACAACCAAGCUAAAACAUUAACUGUAAUAGUUGUGUCCGUACCAGCUGCUUGUGCUGUUUGCCUGUCAACAAAAGGUCCAUAAAAGUUACCUUCUAAGUCUGUGCCAGCAUGAACUCCAGUUGGUAAUUCCAUAUGGUGCAUGUAACAAAAAGAGACACAGUCAUAAUCUAUGUUAAAACCAACACUACCACAUGAACCAUUAAGGAAUGAACCCUUAAUAGUGAAAUUGGGCCUCAUAGCACAUUGGUAAACACCAGAUGGUGAACCAUUGUAACAAGCUAACACUGAAAAAGUCUGUCCUGGUUGAAUGCGAACAAACUUAUACUUAGGUGUCUUAGGAUUGGCUGUAUCAACCUUAAGCUUAAGUACACAAUUUUGCAUAGAAUGUCCAAUAACCCUGAGUUGAACAUUACCAGCCUGUACCAAGAAAUUAUGAUUAGACUUACGAAUGAGUAAAUCUUCAUAAUUAGGGUUAAGCAUGUCUUCAGAGGUGCAGAUCACAUGUCUUGGACAGUAAACUACGUCAUCAAGCCAAAGACCGUUAAGUGUAGUUGUACCACAAGUUACUUGUACCAUACAACCCUCAACUUUACCAGAUGGGAAUGCCAUUUUUCUAAAACCACUCUGCAAAACAGCUGAGGUGAUAGAGGUUUGUGGUGGUUGGUAAAGAACAUCAGA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,"1.8,18,180 nM[SARS-CoV-2];|18.5 µM [N protein]","150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,solid,"Unlike polyC, in silico methods predict that these RNA fragments can form intra- and inter-molecular base-pairing interactions and contain extensive secondary structure elements. Similar to synthetic RNA substrates that form base-pair interactions, the N protein formed non-spherical condensates with viral RNA fragments in vitro.",5000
102,483,PMID: 32995779,RNAPS0000431,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,SARS-CoV-2 virus RNA,5000nt(15001-20000),ACUCUACCAUCAAAAAAGACAGUGAGUGGUGCACAAAUCGUUUCAGUUGGUUUCUUGGCUAUGUCAGUCAUAGAACAAACACCAAUAGUAGAUAUAUGUGCUGGAGCAUCUCUUUUGUAGUCCCAGAUCACAGUAUUAGCAGCAAUGUCCACACCCAAAUUAUUGAGUAUUUUCACCUCUGGUACUGGUUUAAUGUUGCGCUUAGCCCAAAGCUCAAAUGCUACAUUAACAGGUAAUGUUGUUUUAUUUUCAAACAAUUCUACAUCAACACCAUCAACUUUUGUGUAAACAGUGUUAUUAAUGAUAGAAACUGGUACUUCACCCUGUUGUCCAUCAAAGUGUCCCUUAUUUACAACAUUAAAAGCCACAUUUUCUAAACUCUGAAGUCUUGUAAAAGUGUUCCAGAGGUUAUAAGUAUCAAAUUGUUUGUAAACCCACAAGCUAAAGCCAGCUGAGAUCAUCAUGUUAUAAGCAUCGAGAUACAAUCUGUACUCAUUAGCAUGAUGUCUACAGACAGCACCACCUAAAUUGCAACGUGUUAUACACGUAGCAGACUUUAGUGGUACAUAAUCUAUAUCUGACACUACUUGUUUUCCAUGAGACUCACAUGGACUGUCAGAGUAAUAGAAAAAUGGUAAUUGUUUUAAAUUAACAAAAGCACUUUUAUCAAAAGCUGGUGUGUGGAAUGCAUGUUUAUUUACAUACAAACUGCCACCAUCACAACCAGGCAAGUUAAGGUUAGAUAGCACUCUAGUGUCAAAUCUACAAACAAUGGAAUUAGCAGGAUAUCUAUCGACAUUGCAAUUCCAAAAUAGGCAUACACCAUCUGUGAAUUUGUCAGAAUGUGUGGCAUAAGAAUAGAAUAAUUCUUCUAUUUUAUAAGCUUUGUCACUACAAGGCUGUGCAUCAUAGAACUUCCAUUCUACAUCAGCUUGAGGUACACACUUAAUAGCUUUAGGGUUACCAAUGUCGUGAAGAACUGGGAAUUUGUCUGCUAAUAAUGCAGCUUUAACAACCAUGUGUUGAACCUUUCUACAAGCCGCAUUAAUCUUCAGUUCAUCACCAAUUAUAGGAUAUUCAAUAGUCCAGUCAACACGCUUAACAAAGCACUCGUGGACAGCUAGACACCUAGUCAUGAUUGCAUCACAACUAGCUACAUGUGCAUUACCAUGGACUUGACAAUACAGAUCAUGGUUGCUUUGUAGGUUACCUGUAAAACCCCAUUGUUGAACAUCAAUCAUAAACGGAUUAUAGACGUAAUCAAAUCCAAUAGAAUGAUGCCAACAGGCAUAAGUGUCUGAAGCAGUGGAAAAGCAUGUGGCACGUCUAUCACAUAGACAACAGGUGCGCUCAGGUCCUAUUUUCACAAAAUACUUCAUAGAUGUCAACUCAAAGCCAUGUGCCCAUAAGACAAAUACGACUCUGUCAGAGAGAUUUUUAAGUGUGUCACUUAACAUUUGUACAAUCUUUAUACGCACUACAUUCCAAGGAAGUCCUUUGUACAUAAGUGGUAUGAGGUGUUUAAAUUGAUCUCCAGGCGGUGGUUUAGCACUAACUCUGGAAAAAUCUGUAUUAUUAGGUGUAUCAACAUAACCUGUAGGUACAGCAACUAGGUUAACACCUGUAGAAAAACCUAGCUGUAAAGGUAAAUUGGUACCAACAGCUUCUCUAGUAGCAUGACACCCCUCGACAUCGAAGCCAAUCCAUGCACGUACAUGUCUUAUAGCUUCUUCGCGGGUGAUAAACAUGUUAGGGUAACCAUUAACUUGAUAAUUCAUUUUAAAACCCAUCAUAGAGAUGAGUCUUCUAUAGGUCAUGUCCUUAGGUAUGCCAGGUAUGUCAACACAUAAACCUUCAGUUUUGAAUUUAGUGUCAACACUGAGGUGUGUAGGUGCCUGUGUAGGAUGUAACCCAGUGAUUACCUUACUACAAUCUUUAAAGAGUCCUGUUACAUUUUCAGCUUGUAAAGUUGCCACAUUCCUACGUGGAAUUUCAAGACUUGUAAAUUGCAACUUGUCAUAAAGGUCUCUAUCAGACAUUAUGCAAAGUAUGCCUACUUUUGCUCUGGUAAUAGCAACAUUAAAUCUGUUUACAUUACAAGAGUGAGCUGUUUCAGUGGUUUGAGUGAAUAUGACAUAGUCAUAUUCUGAGCCCUGUGAUGAAUCAACAGUUUGAGUUGGUAGUCCCAAAAUCUUUGAGGCUACAGCAUUCUGUGAAUUAUAAGGUGAAAUAAAGACAGCUUUUCUCCAAGCAGGGUUACGUGUAAGGAAUUCUCUUACCACGCCUAUUUGUGGCCUGUUAAUUGCAGAUGAAACAUCAUGCGUGAUAACACCCUUAUAAAACAUUUUAAAGCAUUGAGCUGAUUUGUCUUUAUGUGCUUUAAGCUUAUUAUCAUAAACCAAAGCACUCACAGUGUCAACAAUUUCAGCAGGACAACGCCGACAAGUUCCGAGGAACAUGUCUGGACCUAUAGUUUUCAUAAGUCUACACACUGAAUUGAAAUAUUCUGGUUCUAGUGUGCCCUUAGUUAGCAAUGUGCGUGGUGCAGGUAAUUGAGCAGGGUCGCCAAUGUACACAUAGUGCUUAGCACGUAAUCUGGCAUUGACAACACUCAAAUCAUAAUUUGUGGCCAUUGAAAUUUCAUCAAAGACAACUAUAUCUGCUGUCGUCUCAGGCAAUGCAUUUACAGUACAAAAGACAUACUGUUCUAAUGUUGAAUUCACUUUGAAUUUAUCAAAACACUCUACACGAGCACGUGCAGGUAUAAUUCUACUACAUUUAUCUAUAGGCAAAUAUUUUAAUGCCUUCUCACAUAGUGCAUCAACAGCGGCAUGAGAGCAAGCUGUAUACACUAUGCGAGCAGAAGGGUAGUAGAGAGCUAGGCCAAUAGCAAAAUGACUCUUACCAGUACCAGGUGGUCCCUGGAGUGUAGAAUACUUUUGCAUACCAACCUUUUGAUAAUUUGCAACAUUGCUAGAAAACUCAUCUGAGAUAUUGAGUGUUGGGUAUAAGCCAGUAAUUCUAACAUAGUGCUCUUGUGGCACUAGUGUAGGUGCACUUAAUGGCAUUACUGUAUGUGAUGUCAGCACAAAAUAAUCACCAACAUUUAAUUUGUAAGUUGUUGUACCUCGGUAAACAACAGCAUCACCAUAGUCACCUUUUUCAAAGGUGUACUCUCCUAUUUGUACUUUACUGUUUUUAGUUACACGAUAACCAGUAAAGACAUAAUUUCGGUUAAGUGGUGGUCUAGGUUUACCAACUUCCCAUGAAAGAUGUAAUUCUCUGUCAGACAGCACUUCACGUACAGUAGCAAUACCAUAAGACAGUUUAAAUGUCUCCUCAGUAGCUUUGAGCGUUUCUGCUGCAAAAAGCUUGAGUCUUUCAGUACAGGUGUUAGCUAAAAUGUAAUCACCAGCAUUUGUCCAGUCACAUGUUGCAAUUGCAUUAAAGUCAGUAACAUUAUCGCUACCAACACAUGUAUUUUUAUAUAAACCAAAAACUUGUCCAUUAGCACACAAUGGAAAACUAAUGGGUGGUUUAUGUGAUUUACAAUAAUAGCUCAUACCUCCUAAGUAAAGUUGAGUCACAUCUGUGACAUCACAACCUGGAGCAUUGCAAACAUACGGAUUAACAGACAAGACUAAUUUAUGUGAUGUUGAUAUGACAUGGUCGUAACAGCAUUUACAACAUAAGAAUGGUCUACGUAUGCAAGCACCACAUCUUAAUGAAGUCUGUGAAUUGCAAAGAACACAAGCCCCAACAGCCUGUAAGACUGUAUGCGGUGUGUACAUAGCCUCAUAAAACUCAGGUUCCCAAUACCUUGAAGUGUUAUCAUUAGUAAGCAUAACAGAAUACAUGUCUAACAUGUGUCCUGUUAACUCAUCAUGUAGCUUUCUUAUGUAUUGUAAGUACAAAUGAAAGACAUCAGCAUACUCCUGAUUAGGAUGUUUAGUAAGUGGGUAAGCAUCUAUAGCUAAAGACACGAACCGUUCAAUCAUAAGUGUACCAUCUGUUUUUACGAUAUCAUCUACAAAACAGCCGGCCCCUAGGAUUCUUGAUGGAUCUGGGUAAGGAAGGUACACAUAAUCAUCACCCUGUUUAACUAGCAUUGUAUGUUGAGAGCAAAAUUCAUGAGGUCCUUUAGUAAGGUCAGUCUCAGUCCAACAUUUUGCUUCAGACAUAAAAACAUUGUUUUGAUAAUAAAGAACUGACUUAAAGUUCUUUAUGCUAGCCACUAGACCUUGAGAUGCAUAAGUGCUAUUGAAACACACAACAGCAUCGUCAGAGAGUAUCAUCAUUGAGAAAUGUUUACGCAAAUAUGCGUAAAACUCAUUCACAAAGUCUGUGUCAACAUCUCUAUUUCUAUAGAGACACUCAUAAAGUCUGUGUUGUAAAUUGCGGACAUACUUAUCGGCAAUUUUGUUACCAUCAGUAGAUAAAAGUGCAUUAACAUUGGCCGUGACAGCUUGACAAAUGUUAAAAACACUAUUAGCAUAAGCAGUUGUGGCAUCUCCUGAUGAGGUUCCACCUGGUUUAACAUAUAGUGAACCGCCACACAUGACCAUUUCACUCAAUACUUGAGCACACUCAUUAGCUAAUCUAUAGAAACGGUGUGACAAGCUACAACACGUUGUAUGUUUGCGAGCAAGAACAAGUGAGGCCAUAAUUCUAAGCAUGUUAGGCAUGGCUCUAUCACAUUUAGGAUAAUCCCAACCCAUAAGGUGAGGGUUUUCUACAUCACUAUAAACAGUUUUUAACAUGUUGUGCCAACCACCAUAGAAUUUGCUUGUUCCAAUUACUACAGUAGCUCCUCUAGUGGCGGCUAUUGAUUUCAAUAAUUUUUGAUGAAACUGUCUAUUGGUCAUAGUACUACAGAUAGAGACACCAGCUACGGUGCGAGCUCUAUUCUUUGCACUAAUGGCAUACUUAAGAUUCAUUUGAGUUAUAGUAGGGAUGACAUUACGUUUUGUAUAUGCGAAAAGUGCAUCUUGAUCCUCAUA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,"1.8,18,52 nM[SARS-CoV-2];|18.5 µM [N protein]","150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,solid,"Unlike polyC, in silico methods predict that these RNA fragments can form intra- and inter-molecular base-pairing interactions and contain extensive secondary structure elements. Similar to synthetic RNA substrates that form base-pair interactions, the N protein formed non-spherical condensates with viral RNA fragments in vitro.",5000
103,484,PMID: 32995779,RNAPS0000432,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,SARS-CoV-2 virus RNA,5000nt(20001-25000),GUCUAAUUCAGGUUGCAAAGGAUCAUAAACUGUGUUGUUGACAAUUCCUAUUACAACAUCACAGUUACCAGACACAAAUGUGUUGUCUGUAGUAAUGAUUUGUGGUUCAUAAAAAUUCCUUUGUGUUACAAACCAGUGUGUGCCAUUUGAAACAAAGACACCUUCACGAGGAAAGUGUGCUUUUCCAUCAUGACAAAUGGCAGGAGCAGUUGUGAAGUUCUUUUCUUGUGCAGGGACAUAAGUCACAUGCAAGAAGACUACACCAUGAGGUGCUGACUGAGGGAAGGACAUAAGAUGAUAGCCCUUUCCACAAAAAUCAACUCUUUUUGAUUGUCCAAGUACACACUCUGACAUUUUAGUAGCAGCAAGAUUAGCAGAAGCUCUGAUUUCUGCAGCUCUAAUUAAUUGUUGAGUCACAUAUGUCUGCAAACUUUGAAGUCUGCCUGUGAUCAACCUAUCAAUUUGCACUUCAGCCUCAACUUUGUCAAGACGUGAAAGGAUAUCAUUUAAAACACUUGAAAUUGCACCAAAAUUGGAGCUAAGUUGUUUAACAAGCGUGUUUAAAGCUUGUGCAUUUUGGUUGACCACAUCUUGAAGUUUUCCAAGUGCACUUGCUGUGGAAGAAAGUGAGUCUUGAAUUUUGCCAAUAGCACUAUUAAAUUGGUUGGCAAUCAAUUUUUGGUUCUCAUAGAGAACAUUCUGUGUAACUCCAAUACCAUUAAACCUAUAAGCCAUUUGCAUAGCAAAUGGUAUUUGUAAUGCAGCACCUGCACCAAAGGUCCAACCAGAAGUGAUUGUACCCGCUAACAGUGCAGAAGUGUAUUGAGCAAUCAUUUCAUCUGUGAGCAAAGGUGGCAAAACAGUAAGGCCGUUAAACUUUUGUGCACAAAUGAGGUCUCUAGCAGCAAUAUCACCAAGGCAAUCACCAUAUUGUUUGAUGAAGCCAGCAUCUGCAAGUGUCACUUUGUUGAAAAGUAGAUCUUCAAUAAAUGACCUCUUGCUUGGUUUUGAUGGAUCUGGUAAUAUUUGUGAAAAAUUAAAACCACCAAAAUCUUUAAUUGGUGGUGUUUUGUAAAUUUGUUUGACUUGUGCAAAAACUUCUUGGGUGUUUUUGUCUUGUUCAACAGCUAUUCCAGUUAAAGCACGGUUUAAUUGUGUACAAAAACUGCCAUAUUGCAACAAAAGAUUGCUGCAUUCAGUUGAAUCACCACAAAUGUACAUUGUACAAUCUACUGAUGUCUUGGUCAUAGACACUGGUAGAAUUUCUGUGGUAACACUAAUAGUAAAAUUUGUGGGUAUGGCAAUAGAGUUAUUAGAGUAAGCAACUGAAUUUUCUGCACCAAGUGACAUAGUGUAGGCAAUGAUGGAUUGACUAGCUACACUACGUGCCCGCCGAGGAGAAUUAGUCUGAGUCUGAUAACUAGCGCAUAUACCUGCACCAAUGGGUAUGUCACACUCAUAUGAGUUGUUGACAUGUUCAGCCCCUAUUAAACAGCCUGCACGUGUUUGAAAAACAUUAGAACCUGUAGAAUAAACACGCCAAGUAGGAGUAAGUUGAUCUGCAUGAAUAGCAACAGGGACUUCUGUGCAGUUAACAUCCUGAUAAAGAACAGCAACCUGGUUAGAAGUAUUUGUUCCUGGUGUUAUAACACUGACACCACCAAAAGAACAUGGUGUAAUGUCAAGAAUCUCAAGUGUCUGUGGAUCACGGACAGCAUCAGUAGUGUCAGCAAUGUCUCUGCCAAAUUGUUGGAAAGGCAGAAACUUUUUGUUAGACUCAGUAAGAACACCUGUGCCUGUUAAACCAUUGAAGUUGAAAUUGACACAUUUGUUUUUAACCAAAUUAGUAGACUUUUUAGGUCCACAAACAGUUGCUGGUGCAUGUAGAAGUUCAAAAGAAAGUACUACUACUCUGUAUGGUUGGUAACCAACACCAUUAGUGGGUUGGAAACCAUAUGAUUGUAAAGGAAAGUAACAAUUAAAACCUUCAACACCAUUACAAGGUGUGCUACCGGCCUGAUAGAUUUCAGUUGAAAUAUCUCUCUCAAAAGGUUUGAGAUUAGACUUCCUAAACAAUCUAUACAGGUAAUUAUAAUUACCACCAACCUUAGAAUCAAGAUUGUUAGAAUUCCAAGCUAUAACGCAGCCUGUAAAAUCAUCUGGUAAUUUAUAAUUAUAAUCAGCAAUCUUUCCAGUUUGCCCUGGAGCGAUUUGUCUGACUUCAUCACCUCUAAUUACAAAUGAAUCUGCAUAGACAUUAGUAAAGCAGAGAUCAUUUAAUUUAGUAGGAGACACUCCAUAACACUUAAAAGUGGAAAAUGAUGCGGAAUUAUAUAGGACAGAAUAAUCAGCAACACAGUUGCUGAUUCUCUUCCUGUUCCAAGCAUAAACAGAUGCAAAUCUGGUGGCGUUAAAAACUUCACCAAAAGGGCACAAGUUUGUAAUAUUAGGAAAUCUAACAAUAGAUUCUGUUGGUUGGACUCUAAAGUUAGAAGUUUGAUAGAUUCCUUUUUCUACAGUGAAGGAUUUCAACGUACACUUUGUUUCUGAGAGAGGGUCAAGUGCACAGUCUACAGCAUCUGUAAUGGUUCCAUUUUCAUUAUAUUUUAAUAGAAAAGUCCUAGGUUGAAGAUAACCCACAUAAUAAGCUGCAGCACCAGCUGUCCAACCUGAAGAAGAAUCACCAGGAGUCAAAUAACUUCUAUGUAAAGCAAGUAAAGUUUGAAACCUAGUGAUGUUAAUACCUAUUGGCAAAUCUACCAAUGGUUCUAAAGCCGAAAAACCCUGAGGGAGAUCACGCACUAAAUUAAUAGGCGUGUGCUUAGAAUAUAUUUUAAAAUAACCAUCAAUAUUCUUAAACACAAAUUCCCUAAGAUUUUUGAAAUUACCCUGUUUUCCUUCAAGGUCCAUAAGAAAAGGCUGAGAGACAUAUUCAAAAGUGCAAUUAUUCGCACUAGAAUAAACUCUGAACUCACUUUCCAUCCAACUUUUGUUGUUUUUGUGGUAAUAAACACCCAAAAAUGGAUCAUUACAAAAUUGAAAUUCACAGACUUUAAUAACAACAUUAGUAGCGUUAUUAACAAUAAGUAGGGACUGGGUCUUCGAAUCUAAAGUAGUACCAAAAAUCCAGCCUCUUAUUAUGUUAGACUUCUCAGUGGAAGCAAAAUAAACACCAUCAUUAAAUGGUAGGACAGGGUUAUCAAACCUCUUAGUACCAUUGGUCCCAGAGACAUGUAUAGCAUGGAACCAAGUAACAUUGGAAAAGAAAGGUAAGAACAAGUCCUGAGUUGAAUGUAAAACUGAGGAUCUGAAAACUUUGUCAGGGUAAUAAACACCACGUGUGAAAGAAUUAGUGUAUGCAGGGGGUAAUUGAGUUCUGGUUGUAAGAUUAACACACUGACUAGAGACUAGUGGCAAUAAAACAAGAAAAACAAACAUUGUUCGUUUAGUUGUUAACAAGAACAUCACUAGAAAUAACAACUCUGUUGUUUUCUCUAAUUAUAAGUCUACCUUUACUAAGAAGAGAUAAAAUCAUAUCAUUGAUUUGACCUUCUUUUAAAGACAUAACAGCAGUACCCCUUAAUUUAAGGGGAAAUUUACUCAUGUCAAAUAAAGAAUAGGAAGACAACUGAAUUGGAUUUGUAUUCCUCCAAAAUAUGUAAUUUGCAUGCAUGACAUAACCAUCUAUUUGUUCGCGUGGUUUGCCAAGAUAAUUACAUCCAAUUAAAAAUGCUUCAGAUGAUGACGCAUUCACAUUAGUAACAAAGGCUGUCCACCAUGCGAAGUGUCCCAUGAGCUUAUAAAGAUCAGCAUUCCAAGAAUGUUCUGUUAUCUUUAUAGCCACGGAACCUCCAAGAGCUAGCUUUUGUUGUAUAAACCCACAAAUGUAAGUGAAAAAACCCUCUUUAGAGUCAUUUUCUUUUGUAACAUUUUUAGUCUUAGGGUCGUACAUAUCACUAAUAAUGAGAUCCCAUUUAUUAGCUGUAUGUACAGUUGCACAAUCACCAAUCAAAGUUGAAUCUGCAUCAGAGACAAAGUCAUUAAGAUCUGAAUCGACAAGCAGCGUACCCGUAGGCAACCACUGUCUUAAAACAGCUGUACCUGGUGCAACUCCUUUAUCAGAACCAGCACCAAAAUGUAUAACUCUCAUAUUAUAGGGUACAGCUAAUGUUAAUGUGUUUAAAUAUUGACACAGUUGAGUAUAUUUUGCGACAUUCAUCAUUAUGCCUUUAGGUAAUGUUGCACUAUCACCAUAAUUUUGAAGGUCACACUUUUCUAAUAGCAUUCUUUGCAUUUUGUAAAGAUUAGGCAUAGCAACACCCGGUUGCCACGCUUGACUAGAUUGUAAUUUUGGGUAAAAUGUUUCUACAUGGCCAUCUUUACACCAAAGCAUAAAUGAAAUUUCUGUAUAGUCAAUAGUCACUUUGACAACCUUAGAAACUACAGAUAAAUCUUGGGAUUUUAUUAUUUCAACAAAAUCAUCAAGUAAUAAAUCAAUAACAGAACACACACACUUAGAUGAACCUGUUUGCGCAUCUGUUAUGAAAUAGUUUUUAACUGUACUGUCCAUAGGAAUAAAAUCUUCUAAUUCAAAAGGUGAUUCCUUAAAACGUUUAGCUAGUCCAAUCAGUAGAUGUAAACCACCUAACUGACUAUGACUAAAAUCUCCAUAAACGAUAUGUUCGAAGGCAUAGCCUUCUAAUUUAUACCGUUCAAUGAAUUCAUCCAUAGCUAAUUCUAAGAAAUCAAUUUCCAUUUGACUCCUGGGUUUAAAUUCUUGUAAAUUUCUACUCUGAGUAAAGUAAGUUUCAGGUAAUUGUUGGACAACACCAUCAACUUUCUUAUAAUAAUUGAACUGUGUUUUUACGGCUUCUCCAAUUAAUGUGACUCCAUUAAGACUAGCUUGUUUGGGACCUACAGAUGGUUGUAAACCUUUAACACUACCUUCUGUAAUAAGAACACCAUUACGGGCAUUUCUAAAUAAGUCUACUUGACCAUCA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,"1.8,18,265 nM[SARS-CoV-2];|18.5 µM [N protein]","150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,solid,"Unlike polyC, in silico methods predict that these RNA fragments can form intra- and inter-molecular base-pairing interactions and contain extensive secondary structure elements. Similar to synthetic RNA substrates that form base-pair interactions, the N protein formed non-spherical condensates with viral RNA fragments in vitro.",5000
104,485,PMID: 32995779,RNAPS0000433,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,SARS-CoV-2 virus RNA,4903nt(25001-29903),UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUGUCAUUCUCCUAAGAAGCUAUUAAAAUCACAUGGGGAUAGCACUACUAAAAUUAAUUUUACACAUUAGGGCUCUUCCAUAUAGGCAGCUCUCCCUAGCAUUGUUCACUGUACACUCGAUCGUACUCCGCGUGGCCUCGGUGAAAAUGUGGUGGCUCUUUCAAGUCCUCCCUAAUGUUACACACUGAUUAAAGAUUGCUAUGUGAGAUUAAAGUUAACUACAUCUACUUGUGCUAUGUAGUUACGAGAAUUCAUUCUGCACAAGAGUAGACUAUAUAUCGUAAACGGAAAAGCGAAAACGUUUAUAUAGCCCAUCUGCCUUGUGUGGUCUGCAUGAGUUUAGGCCUGAGUUGAGUCAGCACUGCUCAUGGAUUGUUGCAAUUGUUUGGAGAAAUCAUCCAAAUCUGCAGCAGGAAGAAGAGUCACAGUUUGCUGUUUCUUCUGUCUCUGCGGUAAGGCUUGAGUUUCAUCAGCCUUCUUCUUUUUGUCCUUUUUAGGCUCUGUUGGUGGGAAUGUUUUGUAUGCGUCAAUAUGCUUAUUCAGCAAAAUGACUUGAUCUUUGAAAUUUGGAUCUUUGUCAUCCAAUUUGAUGGCACCUGUGUAGGUCAACCACGUUCCCGAAGGUGUGACUUCCAUGCCAAUGCGCGACAUUCCGAAGAACGCUGAAGCGCUGGGGGCAAAUUGUGCAAUUUGCGGCCAAUGUUUGUAAUCAGUUCCUUGUCUGAUUAGUUCCUGGUCCCCAAAAUUUCCUUGGGUUUGUUCUGGACCACGUCUGCCGAAAGCUUGUGUUACAUUGUAUGCUUUAGUGGCAGUACGUUUUUGCCGAGGCUUCUUAGAAGCCUCAGCAGCAGAUUUCUUAGUGACAGUUUGGCCUUGUUGUUGUUGGCCUUUACCAGACAUUUUGCUCUCAAGCUGGUUCAAUCUGUCAAGCAGCAGCAAAGCAAGAGCAGCAUCACCGCCAUUGCCAGCCAUUCUAGCAGGAGAAGUUCCCCUACUGCUGCCUGGAGUUGAAUUUCUUGAACUGUUGCGACUACGUGAUGAGGAACGAGAAGAGGCUUGACUGCCGCCUCUGCUCCCUUCUGCGUAGAAGCCUUUUGGCAAUGUUGUUCCUUGAGGAAGUUGUAGCACGAUUGCAGCAUUGUUAGCAGGAUUGCGGGUGCCAAUGUGAUCUUUUGGUGUAUUCAAGGCUCCCUCAGUUGCAACCCAUAUGAUGCCGUCUUUGUUAGCACCAUAGGGAAGUCCAGCUUCUGGCCCAGUUCCUAGGUAGUAGAAAUACCAUCUUGGACUGAGAUCUUUCAUUUUACCGUCACCACCACGAAUUCGUCUGGUAGCUCUUCGGUAGUAGCCAAUUUGGUCAUCUGGACUGCUAUUGGUGUUAAUUGGAACGCCUUGUCCUCGAGGGAAUUUAAGGUCUUCCUUGCCAUGUUGAGUGAGAGCGGUGAACCAAGACGCAGUAUUAUUGGGUAAACCUUGGGGCCGACGUUGUUUUGAUCGCGCCCCACUGCGUUCUCCAUUCUGGUUACUGCCAGUUGAAUCUGAGGGUCCACCAAACGUAAUGCGGGGUGCAUUUCGCUGAUUUUGGGGUCCAUUAUCAGACAUUUUAGUUUGUUCGUUUAGAUGAAAUCUAAAACAACACGAACGUCAUGAUACUCUAAAAAGUCUUCAUAGAACGAACAACGCACUACAAGACUACCCAAUUUAGGUUCCUGGCAAUUAAUUGUAAAAGGUAAACAGGAAACUGUAUAAUUACCGAUAUCGAUGUACUGAAUGGGUGAUUUAGAACCAGCCUCAUCCACGCACAAUUCAAUUAAAGGUGCUGAUUUUCUAGCUCCUACUCUAAUAUACCAUUUAGAAUAGAAGUGAAUAGGACACGGGUCAUCAACUACAUAUGGUUGAUGUUGAGUACAUGACUGUAAACUACAUUCUUGGUGAAAUGCAGCUACAGUUGUGAUGAUUCCUAAGAAAACAAGAAAUUUCAUGUUCGUUUAGGCGUGACAAGUUUCAUUAUGAUCUUGCAGUUCAAGUGAGAACCAAAAGAUAAUAAGCAUAAUUAAAACAAGGAAUAGCAGAAAGGCUAAAAAGCACAAAUAGAAGUCAAUUAAUGAAAGUUCAAUCAUUCUGUCUUUCUUUUGAGUGUGAAGCAAAGUGUUAUAAACACUAUUGCCGCAACAAUAAGAAAAAUUGGAGAGUAAAGUUCUUGAACUUCCUCUUGUCUGAUGAACAGUUUAGGUGAAACUGAUCUGGCACGUAACUGAUAGACGUGUUUUACGCCGUCAGGACAAGCAAAAGCAAAUUGAGUGCUAAAGCAAGUCAGUGCAAAUUUGUUAUCAGCUAGAGGAUGAAAUGGUGAAUUGCCCUCGUAUGUUCCAGAAGAGCAAGGUUCUUUUAAAAGUACUGUUGUACCUCUAACACACUCUUGGUAGUGAUAAAGCUCACAAGUAGCGAGUGUUAUCAGUGCCAAGAAAAGAAUAAUUUUCAUGUUCGUUUAAUCAAUCUCCAUUGGUUGCUCUUCAUCUAAUUGAGAAUAUUUAUUCUCAGUUAGUGACUUAGAUAAAUUUUUAAUUAUGAGGUUUAUGAUGUAAUCAAGAUUCCAAAUGGAAACUUUAAAAGUCCUCAUAAUAAUUAGUAAUAUCUCUGCUAUAGUAACCUGAAAGUCAACGAGAUGAAACAUCUGUUGUCACUUACUGUACAAGCAAAGCAAUAUUGUCACUGCUACUGGAAUGGUCUGUGUUUAAUUUAUAGUUGCCAAUCCUGUAGCGACUGUAUGCAGCAAAACCUGAGUCACCUGCUACACGCUGCGAAGCUCCCAAUUUGUAAUAAGAAAGCGUUCGUGAUGUAGCAACAGUGAUUUCUUUAGGCAGGUCCUUGAUGUCACAGCGUCCUAGAUGGUGUCCAGCAAUACGAAGAUGUCCACGAAGGAUCACAGCUCCGAUUACGAGUUCACUUUCUAGAAGCGGUCUGGUCAGAAUAGUGCCAUGGAGUGGCACGUUGAGAAGAAUGUUAGUUUCUGGAUUGAAUGACCACAUGGAACGCGUACGCGCAAACAGUCUGAAAGAAGCAAUGAAGUAGCUGAGCCACAUCAAGCCUACAAGACAAGCCAUUGCGAUAGCAAUUCCACCGGUGAUCCAAUUUAUUCUGUAAACAGCAGCAAGCACAAAACAAGCUAAAGUUACUGGCCAUAACAGCCAGAGGAAAAUUAACUUAAUUAUAUACAAAAACCUAUUCCUGUUGGCAUAGGCAAAUUGUAGAAGACAAAUCCAUGUAAGGAAUAGGAAACCUAUUACUAGGUUCCAUUGUUCAAGGAGCUUUUUAAGCUCUUCAACGGUAAUAGUACCGUUGGAAUCUGCCAUGGCUAAAAUUAAAGUUCCAAACAGAAAAACUAAUAUAAUAUUUAGUUCGUUUAGACCAGAAGAUCAGGAACUCUAGAAGAAUUCAGAUUUUUAACACGAGAGUAAACGUAAAAAGAAGGUUUUACAAGACUCACGUUAACAAUAUUGCAGCAGUACGCACACAAUCGAAGCGCAGUAAGGAUGGCUAGUGUAACUAGCAAGAAUACCACGAAAGCAAGAAAAAGAAGUACGCUAUUAACUAUUAACGUACCUGUCUCUUCCGAAACGAAUGAGUACAUAAGUUCGUACUCAUCAGCUUGUGCUUACAAAGGCACGCUAGUAGUCGUCGUCGGUUCAUCAUAAAUUGGUUCCAUUACUGGAUUAACAACUCCGGAUGAACCGUCGAUUGUGUGAAUUUGGACAUGUUCUUCAGGCUCAUCAACAAUUUUAUUGUAGAUGAAGAAGGUAACAUGUUCAACACCAGUGUCUGUACUCAAUUGAGUUGAGUACAGCUGGUAAUAGUCUGAAGUGAAGUAACUGUGUAAUACAACACAGUCUUUUACUCCAGAUUCCCAUUUUUCAGUAUAACCACCAAUCUGGUAGUCAUGUUCAGAAAUAGGACUUGUUGUGCCAUCACCUGAAGUAAUGACAAUUGAAGAAGUUACACUAUUGUAAGGUAUACAAUAGUCGUAACAAUUAGUAUGCCAGCAAAGAAAAUAGUUGGCAUCAUAAAGUAAUGGGUUUUUGGAACGGCAUUUCCAGCAAAGCCAAAGCCUCAUUAUUAUUCUUACAAAGUUUAUACUCUGCAAGAAGUAGACUAAAGCAUAAAGAUAGAGAAAAGGGGCUUCAAGGCCAGCAGCAACGAGCAAAAGGUGUGAGUAAACUGUUACAAACAACAACAGCAAGUUGCAAACAAAGUGAACACCCUUGGAGAGUGCUAGUUGCCAUCUCUUUUUGAGGGUUAUGAUUUUGGAAGCGCUCUGAAAAACAGCAAGAAGUGCAACGCCAACAAUAAGCCAUCCGAAAGGGAGUGAGGCUUGUAUCGGUAUCGUUGCAGUAGCGCGAACAAAAUCUGAAGGAGUAGCAUCCUUGAUUUCACCUUGCUUCAAAGUUACAGUUCCAAUUGUGAAGAUUCUCAUAAACAAAUCCAUAAGUUCGUUUAUGUGUAAUGUAAUUUGACUCCUUUGAGCACUGGCUCAGAGUCGUCUUCAUCAAAUUUGCAGCAGGAUCCACAAGAACAACAGCCCUUGAGACAACUACAGCAACUGGUCAUACAGCAAAGCAUAAUUGUCACCAUUACUAUGGCAAUCAAGCCAGCUAUAAAACCUAGCCAAAUGUACCAUGGCCAUUUUAUAUACUGCUCAUACUUUCCAAGUUCUUGGAGAUCGAUGAGAGAUUCAUUUAAAUUCUUGGCAACCUCAUUGAGGCGGUCAAUUUCUUUUUGAAUGUUUACAACUGAAGCAUUAAUGCCAGAGAUGUCACCUAAAUCAACAUCUGGUGAUGUAUGAUUCUUAAAAUAUUUAUCUAACUCCUCCUUGAAUGA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,"1.8,18,103 nM[SARS-CoV-2];|18.5 µM [N protein]","150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,solid,"Unlike polyC, in silico methods predict that these RNA fragments can form intra- and inter-molecular base-pairing interactions and contain extensive secondary structure elements. Similar to synthetic RNA substrates that form base-pair interactions, the N protein formed non-spherical condensates with viral RNA fragments in vitro.",4903
105,486,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 ng/µL [polyC];|2.3-18 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,≤ 25 min,-,Electron microscopy,"liquid, solute","Mixing of 50 ng/µL polyC RNA and the N protein resulted in the formation of condensates in 150 mM NaCl. The analysis of the condensates settled on the coverslip revealed a saturation concentration (csat) of 3.3 ± 1.3 µM for N protein in the presence of 50 ng/µL polyC RNA (± s.e.), consistent with the abundance of N protein in infected cells (43). The partition coefficient of N protein into condensates was 13 ± 2 (±s.d.).",2000
106,487,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|residues=1,31-419
MERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,△PLD,-,"390aa(1,31-419)",P0DTC9,-,-,"[1-1],[31-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,0.5-5000 ng/µL[polyC];|18 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,"liquid, solute","Phase separation was only moderately reduced in the ΔSR, ΔPLD, and ΔR1 mutants, suggesting that these regions are not essential for phase separation. In comparison, deletion of the R2 sequence fully abolished the formation of condensates with polyC RNA.",2000
107,488,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,△R1,-,"397aa(1-234,257-419)",P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-234],[365-391]","[175-208],[211-230],[361-379]",In vitro,0.5-5000 ng/µL[polyC];|18 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,"liquid, solute","Phase separation was only moderately reduced in the ΔSR, ΔPLD, and ΔR1 mutants, suggesting that these regions are not essential for phase separation. In comparison, deletion of the R2 sequence fully abolished the formation of condensates with polyC RNA.",2000
108,489,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|residues=1-368,391-419
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,△R2,-,"397aa(1-368,391-419)",P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-368],[391-391]","[175-208],[211-230],[236-249],[361-368]",In vitro,0.5-5000 ng/µL[polyC];|18 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,"solute, liquid","Phase separation was only moderately reduced in the ΔSR, ΔPLD, and ΔR1 mutants, suggesting that these regions are not essential for phase separation. In comparison, deletion of the R2 sequence fully abolished the formation of condensates with polyC RNA.",2000
109,490,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,protein_ptm:phosphorylated or dePhosphorylated,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 ng/µL[polyC];|1.9-60 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,"liquid, solute","Phase separation was only moderately reduced in the ΔSR, ΔPLD, and ΔR1 mutants, suggesting that these regions are not essential for phase separation. In comparison, deletion of the R2 sequence fully abolished the formation of condensates with polyC RNA.",2000
110,491,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|residues=1-182,196-419
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,△SR,-,"406aa(1-182,196-419)",P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-182],[196-212],[233-247],[249-256],[365-391]","[175-182],[196-208],[211-230],[236-249],[361-379]",In vitro,0.5-5000 ng/µL[polyC];|18 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,"liquid, solute","Phase separation was only moderately reduced in the ΔSR, ΔPLD, and ΔR1 mutants, suggesting that these regions are not essential for phase separation. In comparison, deletion of the R2 sequence fully abolished the formation of condensates with polyC RNA.",2000
111,492,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|residues=1-368,391-419
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,△R2,protein_ptm:dePhosphorylated,"397aa(1-368,391-419)",P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-368],[391-391]","[175-208],[211-230],[236-249],[361-368]",In vitro,50 ng/µL[polyC];|1.9-60 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,"liquid, solute","Phase separation was only moderately reduced in the ΔSR, ΔPLD, and ΔR1 mutants, suggesting that these regions are not essential for phase separation. In comparison, deletion of the R2 sequence fully abolished the formation of condensates with polyC RNA.",2000
112,493,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 ng/µL [polyC];|24 µM [N protein],"50-200 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,"solute, liquid","Although N protein is unable to phase separate without RNA in 150 mM salt, 24 µM N protein efficiently formed condensates at lower salt with a half-maximal inhibition constant (IC50) of 90 ± 1 µM NaCl (±s.e.). The addition of 50 ng/µL polyC RNA increased IC50 to 152 ± 6 mM NaCl.",2000
113,494,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 ng/µL [polyC];|7.8 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,"other_molecular:0,10 mM lipoic acid",Electron microscopy,liquid,"The condensates formed by the N protein in the absence or presence of polyC or viral RNA dissolve with the  addition of 10% 1,6 hexanediol, indicating that phase separation is driven, at least partially, by hydrophobic  interactions (Figure 5A). In comparison, lipoic acid that increases the liquidity of stress granules  did  not affect phase separation",2000
114,495,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 ng/µL [polyC];|7.8 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,"other_molecular:10% 1,6-hexanediol",Electron microscopy,"solute, liquid","The condensates formed by the N protein in the absence or presence of polyC or viral RNA dissolve with the  addition of 10% 1,6 hexanediol, indicating that phase separation is driven, at least partially, by hydrophobic  interactions (Figure 5A). In comparison, lipoic acid that increases the liquidity of stress granules  did  not affect phase separation",2000
115,496,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,0.5-5000 ng/µL [polyC];|18.5 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,"liquid, solute","Condensate formation of N protein and RNA was dependent on protein-RNA stoichiometry. At 18 µM N  protein, condensate formation was not observed in the presence of 0-5 ng/µL polyC RNA. Increasing the RNA  concentration promoted phase separation with an optimal RNA concentration of 100-500 ng/µL, in which  charge neutralization occurs with the positively-charged N protein",2000
116,497,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 µg/µL[polyC];|7.8 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,"drug:2.5,40 µM Nelfinavir Mesylate",Electron microscopy,liquid,"Nelfinavir mesylate and LDK378 produced larger but  fewer condensates, whereas crystal violet, tolcapone, and chlorhexidine enhanced phase separation by  increasing the number and size of the condensates (Figure 5B, Figure 5_figure supplement 1A-B). Nilotinib  resulted in a 50% increase in condensate volume and altered the shape of the condensates (Figure 5B), which  may be due to changes in condensate fusion or maturation",2000
117,498,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 µg/µL[polyC];|7.8 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,"drug:2.5,40 µM Tolcapone",Electron microscopy,liquid,"Nelfinavir mesylate and LDK378 produced larger but  fewer condensates, whereas crystal violet, tolcapone, and chlorhexidine enhanced phase separation by  increasing the number and size of the condensates (Figure 5B, Figure 5_figure supplement 1A-B). Nilotinib  resulted in a 50% increase in condensate volume and altered the shape of the condensates (Figure 5B), which  may be due to changes in condensate fusion or maturation",2000
118,499,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 µg/µL[polyC];|7.8 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,"drug:2.5,40 µM Nilotinib",Electron microscopy,liquid,"Nelfinavir mesylate and LDK378 produced larger but  fewer condensates, whereas crystal violet, tolcapone, and chlorhexidine enhanced phase separation by  increasing the number and size of the condensates (Figure 5B, Figure 5_figure supplement 1A-B). Nilotinib  resulted in a 50% increase in condensate volume and altered the shape of the condensates (Figure 5B), which  may be due to changes in condensate fusion or maturation",2000
119,504,PMID: 33056997,RNAPS0000439,https://pubmed.ncbi.nlm.nih.gov/33056997,RNA + protein,-,-,polyU(2200),2200nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,FRGRGRGD,Ac-FRGRGRGD-OH (precursor),-,-,8aa,-,-,-,-,-,In vitro,4.1 mM [polyU];|23 mM[Ac-FRGRGRGD-OH],-,MES buffer (500-1000 mM),25˚C,≤ 40 min,other_molecular:0-100 mM EDC,Turbidity measurement,"liquid, solute",We dissolved 23 mM of the peptide precursor in an aqueous 200 mM MES buffer solution at pH 5.3 with 4.1 mM RNA (expressed in [Uracil nucleotides]).We performed the same experiments with various fuel concentrations to make a phase diagram,2200
120,505,PMID: 33056997,RNAPS0000439,https://pubmed.ncbi.nlm.nih.gov/33056997,RNA + protein,-,-,polyU(2200),2200nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,FRGRGRGD,Ac-FRGRGRGD-OH (precursor),-,-,8aa,-,-,-,-,-,In vitro,0-5 mM [polyU];|23 mM[Ac-FRGRGRGD-OH],-,MES buffer (500-1000 mM),25˚C,≤ 40 min,other_molecular:0-60 mM EDC,Turbidity measurement,"liquid, solute","We found that more than 7.5 mM fuel was required to induce an increase in turbidity, which corresponds to 0.9 mM product. This result suggests a critical coacervation concentration of 0.9 mM anhydride product. Between 7.5 mM and 40 mM fuel, we found dynamic droplets. Above 40 mM of fuel, the droplets were metastable. We tested the effect of the RNA concentration on the droplet’s behavior",2200
121,523,PMID: 33290746,RNAPS0000445,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,1000nt(1-1000),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCU,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,25 nM[SARS-CoV-2 frameshifting];|4 µM[N protein],150 mM NaCl,20 mM Tris pH 7.5,22-40˚C,20 min,-,Fluorescence microscopy,liquid,"N-protein alone demixed into droplets in a temperature-dependent manner, highly pronounced at fever temperature (40℃) and above (45℃). Addition of the 50 end RNA lowered the most effficient condensation temper_x0002atures to 37℃and 33℃(which correspond to the exterior lung and upper airway temperatures, respectively) (McFadden et al., 1985).",1000
122,524,PMID: 33290746,RNAPS0000445,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,1000nt(1-1000),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCU,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,0-15 nM[SARS-CoV-2 frameshifting];|0.5-2 µM[N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,"liquid, solute","The 5'end and frameshifting region, which have the same length, displayed consistent near-opposing behaviors across a range of RNA and protein concentrations. The 5'end generally drives N-protein condensation, whereas the frameshifting region solubilized condensates and promoted LLPS only within a narrow protein and RNA concentration range.",1000
123,525,PMID: 33290746,RNAPS0000445,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,1000nt(1-1000),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCU,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5 nM[SARS-CoV-2];|1 µM[N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,liquid,"N-protein LLPS varied as a function of the specific RNA co component (Figure 1E). The 5’ end and the nucleocapsid RNAs promoted LLPS. In contrast, at the same concentration, the fra meshifting region and the PS region RNAs reduced LLPS relative to N-protein alone",1000
124,526,PMID: 33290746,RNAPS0000445,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,1000nt(1-1000),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCU,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5 nM[SARS-CoV-2 frameshifting];|2 µM[N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,liquid,"Addition of 0.3 kb or 2.4 kb of non-viral sequence to the 1 kb 5’ end or frameshifting re gion RNAs resulted in progressive increase in condensate size/ number, with the 5’ end driving enhanced condensates relative to the frameshifting region at all lengths tested",1000
125,527,PMID: 33290746,RNAPS0000445,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,1000nt(1-1000),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCU,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|mutation:Y109A
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWAFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,protein_mutation:Y109A,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5-50 nM [SARS-CoV-2];|,150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,liquid,"Y109A mutation eliminates 5’ end RNA-driven condensation (Fig ure 5A) and interactions between N-pro tein Y109A and the 5’ end are diminished relative to the WT sequence, in both 203 (40% average binding decrease in N binding intensity) and 1603 (50% N bind ing decrease) conditions",1000
126,528,PMID: 33290746,RNAPS0000445,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,1000nt(1-1000),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCU,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 nM [SARS-CoV-2 5‘end];|50 nM [SARS-CoV-2 N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,liquid,"We mixed frameshifting re gion RNA with either 5’ end or nucleocapsid RNA. Mixtures con taining the 5’ end and frameshifting region produced droplets of intermediate properties, including smaller size and more numerous assemblies. Similarly, frameshifting region RNA made nucleocapsid RNA condensates less flocculated and smaller",1000
127,529,PMID: 33290746,RNAPS0000445,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,1000nt(1-1000),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCU,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,7.5-50 nM[SARS-CoV-2 frameshifting];|4µM[N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,liquid,"The 5‘ end and frameshifting region, which have the same length, displayed consistent near-opposing behaviors across a range of RNA and protein concentrations. The 5’ end generally drives N-protein condensation, whereas the frameshifting region solubilized condensates and promoted LLPS only within a narrow protein and RNA concentration range",1000
128,530,PMID: 33290746,RNAPS0000446,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,996nt(13404-14400),GCUGUAGUUGUGAUCAACUCCGCGAACCCAUGCUUCAGUCAGCUGAUGCACAAUCGUUUUUAAACGGGUUUGCGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGGCACUAGUACUGAUGUCGUAUACAGGGCUUUUGACAUCUACAAUGAUAAAGUAGCUGGUUUUGCUAAAUUCCUAAAAACUAAUUGUUGUCGCUUCCAAGAAAAGGACGAAGAUGACAAUUUAAUUGAUUCUUACUUUGUAGUUAAGAGACACACUUUCUCUAACUACCAACAUGAAGAAACAAUUUAUAAUUUACUUAAGGAUUGUCCAGCUGUUGCUAAACAUGACUUCUUUAAGUUUAGAAUAGACGGUGACAUGGUACCACAUAUAUCACGUCAACGUCUUACUAAAUACACAAUGGCAGACCUCGUCUAUGCUUUAAGGCAUUUUGAUGAAGGUAAUUGUGACACAUUAAAAGAAAUACUUGUCACAUACAAUUGUUGUGAUGAUGAUUAUUUCAAUAAAAAGGACUGGUAUGAUUUUGUAGAAAACCCAGAUAUAUUACGCGUAUACGCCAACUUAGGUGAACGUGUACGCCAAGCUUUGUUAAAAACAGUACAAUUCUGUGAUGCCAUGCGAAAUGCUGGUAUUGUUGGUGUACUGACAUUAGAUAAUCAAGAUCUCAAUGGUAACUGGUAUGAUUUCGGUGAUUUCAUACAAACCACGCCAGGUAGUGGAGUUCCUGUUGUAGAUUCUUAUUAUUCAUUGUUAAUGCCUAUAUUAACCUUGACCAGGGCUUUAACUGCAGAGUCACAUGUUGACACUGACUUAACAAAGCCUUACAUUAAGUGGGAUUUGUUAAAAUAUGACUUCACGGAAGAGAGGUUAAAACUCUUUGACCGUUAUUUUAAAUAUUGGGAUCAGACAUACCACCCAAAUUGUGUUAACUGUUUGGAUGACAGAUGCAUUCUGCAUUGUGCAAACUUUAAUGUUUUAUUCUCUACAGUG,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 nM [SARS-CoV-2 frameshifting];|50 nM [SARS-CoV-2 N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,solute,"We mixed frameshifting re gion RNA with either 5’ end or nucleocapsid RNA. Mixtures con taining the 5’ end and frameshifting region produced droplets of intermediate properties, including smaller size and more numerous assemblies. Similarly, frameshifting region RNA made nucleocapsid RNA condensates less flocculated and smaller",996
129,531,PMID: 33290746,RNAPS0000446,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,1000nt(1-1000),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCU,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 nM [SARS-CoV-2 frameshifting];|50 nM [SARS-CoV-2 frameshifting],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,solute,"We mixed frameshifting re gion RNA with either 5’ end or nucleocapsid RNA. Mixtures con taining the 5’ end and frameshifting region produced droplets of intermediate properties, including smaller size and more numerous assemblies. Similarly, frameshifting region RNA made nucleocapsid RNA condensates less flocculated and smaller",1000
130,532,PMID: 33290746,RNAPS0000446,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,996nt(13404-14400),GCUGUAGUUGUGAUCAACUCCGCGAACCCAUGCUUCAGUCAGCUGAUGCACAAUCGUUUUUAAACGGGUUUGCGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGGCACUAGUACUGAUGUCGUAUACAGGGCUUUUGACAUCUACAAUGAUAAAGUAGCUGGUUUUGCUAAAUUCCUAAAAACUAAUUGUUGUCGCUUCCAAGAAAAGGACGAAGAUGACAAUUUAAUUGAUUCUUACUUUGUAGUUAAGAGACACACUUUCUCUAACUACCAACAUGAAGAAACAAUUUAUAAUUUACUUAAGGAUUGUCCAGCUGUUGCUAAACAUGACUUCUUUAAGUUUAGAAUAGACGGUGACAUGGUACCACAUAUAUCACGUCAACGUCUUACUAAAUACACAAUGGCAGACCUCGUCUAUGCUUUAAGGCAUUUUGAUGAAGGUAAUUGUGACACAUUAAAAGAAAUACUUGUCACAUACAAUUGUUGUGAUGAUGAUUAUUUCAAUAAAAAGGACUGGUAUGAUUUUGUAGAAAACCCAGAUAUAUUACGCGUAUACGCCAACUUAGGUGAACGUGUACGCCAAGCUUUGUUAAAAACAGUACAAUUCUGUGAUGCCAUGCGAAAUGCUGGUAUUGUUGGUGUACUGACAUUAGAUAAUCAAGAUCUCAAUGGUAACUGGUAUGAUUUCGGUGAUUUCAUACAAACCACGCCAGGUAGUGGAGUUCCUGUUGUAGAUUCUUAUUAUUCAUUGUUAAUGCCUAUAUUAACCUUGACCAGGGCUUUAACUGCAGAGUCACAUGUUGACACUGACUUAACAAAGCCUUACAUUAAGUGGGAUUUGUUAAAAUAUGACUUCACGGAAGAGAGGUUAAAACUCUUUGACCGUUAUUUUAAAUAUUGGGAUCAGACAUACCACCCAAAUUGUGUUAACUGUUUGGAUGACAGAUGCAUUCUGCAUUGUGCAAACUUUAAUGUUUUAUUCUCUACAGUG,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,7.5-50 nM[SARS-CoV-2 5'end];|4µM[N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,"solute, liquid","The 5‘ end and frameshifting region, which have the same length, displayed consistent near-opposing behaviors across a range of RNA and protein concentrations. The 5’ end generally drives N-protein condensation, whereas the frameshifting region solubilized condensates and promoted LLPS only within a narrow protein and RNA concentration range",996
131,533,PMID: 33290746,RNAPS0000446,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,996nt(13404-14400),GCUGUAGUUGUGAUCAACUCCGCGAACCCAUGCUUCAGUCAGCUGAUGCACAAUCGUUUUUAAACGGGUUUGCGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGGCACUAGUACUGAUGUCGUAUACAGGGCUUUUGACAUCUACAAUGAUAAAGUAGCUGGUUUUGCUAAAUUCCUAAAAACUAAUUGUUGUCGCUUCCAAGAAAAGGACGAAGAUGACAAUUUAAUUGAUUCUUACUUUGUAGUUAAGAGACACACUUUCUCUAACUACCAACAUGAAGAAACAAUUUAUAAUUUACUUAAGGAUUGUCCAGCUGUUGCUAAACAUGACUUCUUUAAGUUUAGAAUAGACGGUGACAUGGUACCACAUAUAUCACGUCAACGUCUUACUAAAUACACAAUGGCAGACCUCGUCUAUGCUUUAAGGCAUUUUGAUGAAGGUAAUUGUGACACAUUAAAAGAAAUACUUGUCACAUACAAUUGUUGUGAUGAUGAUUAUUUCAAUAAAAAGGACUGGUAUGAUUUUGUAGAAAACCCAGAUAUAUUACGCGUAUACGCCAACUUAGGUGAACGUGUACGCCAAGCUUUGUUAAAAACAGUACAAUUCUGUGAUGCCAUGCGAAAUGCUGGUAUUGUUGGUGUACUGACAUUAGAUAAUCAAGAUCUCAAUGGUAACUGGUAUGAUUUCGGUGAUUUCAUACAAACCACGCCAGGUAGUGGAGUUCCUGUUGUAGAUUCUUAUUAUUCAUUGUUAAUGCCUAUAUUAACCUUGACCAGGGCUUUAACUGCAGAGUCACAUGUUGACACUGACUUAACAAAGCCUUACAUUAAGUGGGAUUUGUUAAAAUAUGACUUCACGGAAGAGAGGUUAAAACUCUUUGACCGUUAUUUUAAAUAUUGGGAUCAGACAUACCACCCAAAUUGUGUUAACUGUUUGGAUGACAGAUGCAUUCUGCAUUGUGCAAACUUUAAUGUUUUAUUCUCUACAGUG,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,0-15 nM[SARS-CoV-2 5'end];|0.5-2 µM[N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,"liquid, solute","The 5'end and frameshifting region, which have the same length, displayed consistent near-opposing behaviors across a range of RNA and protein concentrations. The 5'end generally drives N-protein condensation, whereas the frameshifting region solubilized condensates and promoted LLPS only within a narrow protein and RNA concentration range.",996
132,534,PMID: 33290746,RNAPS0000446,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,996nt(13404-14400),GCUGUAGUUGUGAUCAACUCCGCGAACCCAUGCUUCAGUCAGCUGAUGCACAAUCGUUUUUAAACGGGUUUGCGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGGCACUAGUACUGAUGUCGUAUACAGGGCUUUUGACAUCUACAAUGAUAAAGUAGCUGGUUUUGCUAAAUUCCUAAAAACUAAUUGUUGUCGCUUCCAAGAAAAGGACGAAGAUGACAAUUUAAUUGAUUCUUACUUUGUAGUUAAGAGACACACUUUCUCUAACUACCAACAUGAAGAAACAAUUUAUAAUUUACUUAAGGAUUGUCCAGCUGUUGCUAAACAUGACUUCUUUAAGUUUAGAAUAGACGGUGACAUGGUACCACAUAUAUCACGUCAACGUCUUACUAAAUACACAAUGGCAGACCUCGUCUAUGCUUUAAGGCAUUUUGAUGAAGGUAAUUGUGACACAUUAAAAGAAAUACUUGUCACAUACAAUUGUUGUGAUGAUGAUUAUUUCAAUAAAAAGGACUGGUAUGAUUUUGUAGAAAACCCAGAUAUAUUACGCGUAUACGCCAACUUAGGUGAACGUGUACGCCAAGCUUUGUUAAAAACAGUACAAUUCUGUGAUGCCAUGCGAAAUGCUGGUAUUGUUGGUGUACUGACAUUAGAUAAUCAAGAUCUCAAUGGUAACUGGUAUGAUUUCGGUGAUUUCAUACAAACCACGCCAGGUAGUGGAGUUCCUGUUGUAGAUUCUUAUUAUUCAUUGUUAAUGCCUAUAUUAACCUUGACCAGGGCUUUAACUGCAGAGUCACAUGUUGACACUGACUUAACAAAGCCUUACAUUAAGUGGGAUUUGUUAAAAUAUGACUUCACGGAAGAGAGGUUAAAACUCUUUGACCGUUAUUUUAAAUAUUGGGAUCAGACAUACCACCCAAAUUGUGUUAACUGUUUGGAUGACAGAUGCAUUCUGCAUUGUGCAAACUUUAAUGUUUUAUUCUCUACAGUG,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5 nM[SARS-CoV-2];|1 µM[N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,liquid,"N-protein LLPS varied as a function of the specific RNA co component (Figure 1E). The 5’ end and the nucleocapsid RNAs promoted LLPS. In contrast, at the same concentration, the fra meshifting region and the PS region RNAs reduced LLPS relative to N-protein alone",996
133,535,PMID: 33290746,RNAPS0000446,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,996nt(13404-14400),GCUGUAGUUGUGAUCAACUCCGCGAACCCAUGCUUCAGUCAGCUGAUGCACAAUCGUUUUUAAACGGGUUUGCGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGGCACUAGUACUGAUGUCGUAUACAGGGCUUUUGACAUCUACAAUGAUAAAGUAGCUGGUUUUGCUAAAUUCCUAAAAACUAAUUGUUGUCGCUUCCAAGAAAAGGACGAAGAUGACAAUUUAAUUGAUUCUUACUUUGUAGUUAAGAGACACACUUUCUCUAACUACCAACAUGAAGAAACAAUUUAUAAUUUACUUAAGGAUUGUCCAGCUGUUGCUAAACAUGACUUCUUUAAGUUUAGAAUAGACGGUGACAUGGUACCACAUAUAUCACGUCAACGUCUUACUAAAUACACAAUGGCAGACCUCGUCUAUGCUUUAAGGCAUUUUGAUGAAGGUAAUUGUGACACAUUAAAAGAAAUACUUGUCACAUACAAUUGUUGUGAUGAUGAUUAUUUCAAUAAAAAGGACUGGUAUGAUUUUGUAGAAAACCCAGAUAUAUUACGCGUAUACGCCAACUUAGGUGAACGUGUACGCCAAGCUUUGUUAAAAACAGUACAAUUCUGUGAUGCCAUGCGAAAUGCUGGUAUUGUUGGUGUACUGACAUUAGAUAAUCAAGAUCUCAAUGGUAACUGGUAUGAUUUCGGUGAUUUCAUACAAACCACGCCAGGUAGUGGAGUUCCUGUUGUAGAUUCUUAUUAUUCAUUGUUAAUGCCUAUAUUAACCUUGACCAGGGCUUUAACUGCAGAGUCACAUGUUGACACUGACUUAACAAAGCCUUACAUUAAGUGGGAUUUGUUAAAAUAUGACUUCACGGAAGAGAGGUUAAAACUCUUUGACCGUUAUUUUAAAUAUUGGGAUCAGACAUACCACCCAAAUUGUGUUAACUGUUUGGAUGACAGAUGCAUUCUGCAUUGUGCAAACUUUAAUGUUUUAUUCUCUACAGUG,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5 nM[SARS-CoV-2 5'end];|2 µM[N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,liquid,"Addition of 0.3 kb or 2.4 kb of non-viral sequence to the 1 kb 5’ end or frameshifting re gion RNAs resulted in progressive increase in condensate size/ number, with the 5’ end driving enhanced condensates relative to the frameshifting region at all lengths tested",996
134,536,PMID: 33290746,RNAPS0000447,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,1300nt(5' end region),-,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5 nM[SARS-CoV-2 5'end];|2 µM[N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,liquid,"Addition of 0.3 kb or 2.4 kb of non-viral sequence to the 1 kb 5’ end or frameshifting re gion RNAs resulted in progressive increase in condensate size/ number, with the 5’ end driving enhanced condensates relative to the frameshifting region at all lengths tested",1300
135,537,PMID: 33290746,RNAPS0000447,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,1300nt(frameshift region),-,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5 nM[SARS-CoV-2 frameshifting];|2 µM[N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,liquid,"Addition of 0.3 kb or 2.4 kb of non-viral sequence to the 1 kb 5’ end or frameshifting re gion RNAs resulted in progressive increase in condensate size/ number, with the 5’ end driving enhanced condensates relative to the frameshifting region at all lengths tested",1300
136,538,PMID: 33290746,RNAPS0000448,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,582nt(19782–20363),AUUUGAGCUUUGGGCUAAGCGCAACAUUAAACCAGUACCAGAGGUGAAAAUACUCAAUAAUUUGGGUGUGGACAUUGCUGCUAAUACUGUGAUCUGGGACUACAAAAGAGAUGCUCCAGCACAUAUAUCUACUAUUGGUGUUUGUUCUAUGACUGACAUAGCCAAGAAACCAACUGAAACGAUUUGUGCACCACUCACUGUCUUUUUUGAUGGUAGAGUUGAUGGUCAAGUAGACUUAUUUAGAAAUGCCCGUAAUGGUGUUCUUAUUACAGAAGGUAGUGUUAAAGGUUUACAACCAUCUGUAGGUCCCAAACAAGCUAGUCUUAAUGGAGUCACAUUAAUUGGAGAAGCCGUAAAAACACAGUUCAAUUAUUAUAAGAAAGUUGAUGGUGUUGUCCAACAAUUACCUGAAACUUACUUUACUCAGAGUAGAAAUUUACAAGAAUUUAAACCCAGGAGUCAAAUGGAAAUUGAUUUCUUAGAAUUAGCUAUGGAUGAAUUCAUUGAACGGUAUAAAUUAGAAGGCUAUGCCUUCGAACAUAUCGUUUAUGGAGAUUUUAGUCAUAGUCAGUUAGGUGGUUU,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5 nM[SARS-CoV-2];|1 µM[N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,liquid,"N-protein LLPS varied as a function of the specific RNA co component (Figure 1E). The 5’ end and the nucleocapsid RNAs promoted LLPS. In contrast, at the same concentration, the fra meshifting region and the PS region RNAs reduced LLPS relative to N-protein alone",582
137,539,PMID: 33290746,RNAPS0000449,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,1336nt(1–75 + 28273–29533),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACGGUGCUAACAAAGACGGCAUCAUAUGGGUUGCAACUGAGGGAGCCUUGAAUACACCAAAAGAUCACAUUGGCACCCGCAAUCCUGCUAACAAUGCUGCAAUCGUGCUACAACUUCCUCAAGGAACAACAUUGCCAAAAGGCUUCUACGCAGAAGGGAGCAGAGGCGGCAGUCAAGCCUCUUCUCGUUCCUCAUCACGUAGUCGCAACAGUUCAAGAAAUUCAACUCCAGGCAGCAGUAGGGGAACUUCUCCUGCUAGAAUGGCUGGCAAUGGCGGUGAUGCUGCUCUUGCUUUGCUGCUGCUUGACAGAUUGAACCAGCUUGAGAGCAAAAUGUCUGGUAAAGGCCAACAACAACAAGGCCAAACUGUCACUAAGAAAUCUGCUGCUGAGGCUUCUAAGAAGCCUCGGCAAAAACGUACUGCCACUAAAGCAUACAAUGUAACACAAGCUUUCGGCAGACGUGGUCCAGAACAAACCCAAGGAAAUUUUGGGGACCAGGAACUAAUCAGACAAGGAACUGAUUACAAACAUUGGCCGCAAAUUGCACAAUUUGCCCCCAGCGCUUCAGCGUUCUUCGGAAUGUCGCGCAUUGGCAUGGAAGUCACACCUUCGGGAACGUGGUUGACCUACACAGGUGCCAUCAAAUUGGAUGACAAAGAUCCAAAUUUCAAAGAUCAAGUCAUUUUGCUGAAUAAGCAUAUUGACGCAUACAAAACAUUCCCACCAACAGAGCCUAAAAAGGACAAAAAGAAGAAGGCUGAUGAAACUCAAGCCUUACCGCAGAGACAGAAGAAACAGCAAACUGUGACUCUUCUUCCUGCUGCAGAUUUGGAUGAUUUCUCCAAACAAUUGCAACAAUCCAUGAGCAGUGCUGACUCAACUCAGGCCUAAACUCAUGCAGACCACACAAGGCAGAUGGGCUAUAUAAACGUUUUCGCUUUUCCGUUUACGAUAUAUAGUCUACUCUUGUGCAGAAUGAAUUCUCGUAACUACAUAGCACAAGUAGAUGUAGUUAACUUUAAUCUCACAUAGCAAUCUUUAAUCAGUGUGUAACAUUAGGGAGGACUUGAAAGAGCCACCACAUUUUCACCGAGGCCACGCGGAGUACGAUCGAGUGUACAGUGAACAAUGCUAGGGAGAGCUGCCUAUAUGGAAGAGCCCUAAUGUGUAAAAUUAAUUUUAGUAGUGCUAUCCCCAUGUGAUUUUAAUAGCUUCUUAGGAGAAUGACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5 nM[SARS-CoV-2];|1 µM[N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,liquid,"N-protein LLPS varied as a function of the specific RNA co component (Figure 1E). The 5’ end and the nucleocapsid RNAs promoted LLPS. In contrast, at the same concentration, the fra meshifting region and the PS region RNAs reduced LLPS relative to N-protein alone",1336
138,540,PMID: 33290746,RNAPS0000450,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,29903nt(1-29903),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCUGAAAAGAGCUAUGAAUUGCAGACACCUUUUGAAAUUAAAUUGGCAAAGAAAUUUGACACCUUCAAUGGGGAAUGUCCAAAUUUUGUAUUUCCCUUAAAUUCCAUAAUCAAGACUAUUCAACCAAGGGUUGAAAAGAAAAAGCUUGAUGGCUUUAUGGGUAGAAUUCGAUCUGUCUAUCCAGUUGCGUCACCAAAUGAAUGCAACCAAAUGUGCCUUUCAACUCUCAUGAAGUGUGAUCAUUGUGGUGAAACUUCAUGGCAGACGGGCGAUUUUGUUAAAGCCACUUGCGAAUUUUGUGGCACUGAGAAUUUGACUAAAGAAGGUGCCACUACUUGUGGUUACUUACCCCAAAAUGCUGUUGUUAAAAUUUAUUGUCCAGCAUGUCACAAUUCAGAAGUAGGACCUGAGCAUAGUCUUGCCGAAUACCAUAAUGAAUCUGGCUUGAAAACCAUUCUUCGUAAGGGUGGUCGCACUAUUGCCUUUGGAGGCUGUGUGUUCUCUUAUGUUGGUUGCCAUAACAAGUGUGCCUAUUGGGUUCCACGUGCUAGCGCUAACAUAGGUUGUAACCAUACAGGUGUUGUUGGAGAAGGUUCCGAAGGUCUUAAUGACAACCUUCUUGAAAUACUCCAAAAAGAGAAAGUCAACAUCAAUAUUGUUGGUGACUUUAAACUUAAUGAAGAGAUCGCCAUUAUUUUGGCAUCUUUUUCUGCUUCCACAAGUGCUUUUGUGGAAACUGUGAAAGGUUUGGAUUAUAAAGCAUUCAAACAAAUUGUUGAAUCCUGUGGUAAUUUUAAAGUUACAAAAGGAAAAGCUAAAAAAGGUGCCUGGAAUAUUGGUGAACAGAAAUCAAUACUGAGUCCUCUUUAUGCAUUUGCAUCAGAGGCUGCUCGUGUUGUACGAUCAAUUUUCUCCCGCACUCUUGAAACUGCUCAAAAUUCUGUGCGUGUUUUACAGAAGGCCGCUAUAACAAUACUAGAUGGAAUUUCACAGUAUUCACUGAGACUCAUUGAUGCUAUGAUGUUCACAUCUGAUUUGGCUACUAACAAUCUAGUUGUAAUGGCCUACAUUACAGGUGGUGUUGUUCAGUUGACUUCGCAGUGGCUAACUAACAUCUUUGGCACUGUUUAUGAAAAACUCAAACCCGUCCUUGAUUGGCUUGAAGAGAAGUUUAAGGAAGGUGUAGAGUUUCUUAGAGACGGUUGGGAAAUUGUUAAAUUUAUCUCAACCUGUGCUUGUGAAAUUGUCGGUGGACAAAUUGUCACCUGUGCAAAGGAAAUUAAGGAGAGUGUUCAGACAUUCUUUAAGCUUGUAAAUAAAUUUUUGGCUUUGUGUGCUGACUCUAUCAUUAUUGGUGGAGCUAAACUUAAAGCCUUGAAUUUAGGUGAAACAUUUGUCACGCACUCAAAGGGAUUGUACAGAAAGUGUGUUAAAUCCAGAGAAGAAACUGGCCUACUCAUGCCUCUAAAAGCCCCAAAAGAAAUUAUCUUCUUAGAGGGAGAAACACUUCCCACAGAAGUGUUAACAGAGGAAGUUGUCUUGAAAACUGGUGAUUUACAACCAUUAGAACAACCUACUAGUGAAGCUGUUGAAGCUCCAUUGGUUGGUACACCAGUUUGUAUUAACGGGCUUAUGUUGCUCGAAAUCAAAGACACAGAAAAGUACUGUGCCCUUGCACCUAAUAUGAUGGUAACAAACAAUACCUUCACACUCAAAGGCGGUGCACCAACAAAGGUUACUUUUGGUGAUGACACUGUGAUAGAAGUGCAAGGUUACAAGAGUGUGAAUAUCACUUUUGAACUUGAUGAAAGGAUUGAUAAAGUACUUAAUGAGAAGUGCUCUGCCUAUACAGUUGAACUCGGUACAGAAGUAAAUGAGUUCGCCUGUGUUGUGGCAGAUGCUGUCAUAAAAACUUUGCAACCAGUAUCUGAAUUACUUACACCACUGGGCAUUGAUUUAGAUGAGUGGAGUAUGGCUACAUACUACUUAUUUGAUGAGUCUGGUGAGUUUAAAUUGGCUUCACAUAUGUAUUGUUCUUUCUACCCUCCAGAUGAGGAUGAAGAAGAAGGUGAUUGUGAAGAAGAAGAGUUUGAGCCAUCAACUCAAUAUGAGUAUGGUACUGAAGAUGAUUACCAAGGUAAACCUUUGGAAUUUGGUGCCACUUCUGCUGCUCUUCAACCUGAAGAAGAGCAAGAAGAAGAUUGGUUAGAUGAUGAUAGUCAACAAACUGUUGGUCAACAAGACGGCAGUGAGGACAAUCAGACAACUACUAUUCAAACAAUUGUUGAGGUUCAACCUCAAUUAGAGAUGGAACUUACACCAGUUGUUCAGACUAUUGAAGUGAAUAGUUUUAGUGGUUAUUUAAAACUUACUGACAAUGUAUACAUUAAAAAUGCAGACAUUGUGGAAGAAGCUAAAAAGGUAAAACCAACAGUGGUUGUUAAUGCAGCCAAUGUUUACCUUAAACAUGGAGGAGGUGUUGCAGGAGCCUUAAAUAAGGCUACUAACAAUGCCAUGCAAGUUGAAUCUGAUGAUUACAUAGCUACUAAUGGACCACUUAAAGUGGGUGGUAGUUGUGUUUUAAGCGGACACAAUCUUGCUAAACACUGUCUUCAUGUUGUCGGCCCAAAUGUUAACAAAGGUGAAGACAUUCAACUUCUUAAGAGUGCUUAUGAAAAUUUUAAUCAGCACGAAGUUCUACUUGCACCAUUAUUAUCAGCUGGUAUUUUUGGUGCUGACCCUAUACAUUCUUUAAGAGUUUGUGUAGAUACUGUUCGCACAAAUGUCUACUUAGCUGUCUUUGAUAAAAAUCUCUAUGACAAACUUGUUUCAAGCUUUUUGGAAAUGAAGAGUGAAAAGCAAGUUGAACAAAAGAUCGCUGAGAUUCCUAAAGAGGAAGUUAAGCCAUUUAUAACUGAAAGUAAACCUUCAGUUGAACAGAGAAAACAAGAUGAUAAGAAAAUCAAAGCUUGUGUUGAAGAAGUUACAACAACUCUGGAAGAAACUAAGUUCCUCACAGAAAACUUGUUACUUUAUAUUGACAUUAAUGGCAAUCUUCAUCCAGAUUCUGCCACUCUUGUUAGUGACAUUGACAUCACUUUCUUAAAGAAAGAUGCUCCAUAUAUAGUGGGUGAUGUUGUUCAAGAGGGUGUUUUAACUGCUGUGGUUAUACCUACUAAAAAGGCUGGUGGCACUACUGAAAUGCUAGCGAAAGCUUUGAGAAAAGUGCCAACAGACAAUUAUAUAACCACUUACCCGGGUCAGGGUUUAAAUGGUUACACUGUAGAGGAGGCAAAGACAGUGCUUAAAAAGUGUAAAAGUGCCUUUUACAUUCUACCAUCUAUUAUCUCUAAUGAGAAGCAAGAAAUUCUUGGAACUGUUUCUUGGAAUUUGCGAGAAAUGCUUGCACAUGCAGAAGAAACACGCAAAUUAAUGCCUGUCUGUGUGGAAACUAAAGCCAUAGUUUCAACUAUACAGCGUAAAUAUAAGGGUAUUAAAAUACAAGAGGGUGUGGUUGAUUAUGGUGCUAGAUUUUACUUUUACACCAGUAAAACAACUGUAGCGUCACUUAUCAACACACUUAACGAUCUAAAUGAAACUCUUGUUACAAUGCCACUUGGCUAUGUAACACAUGGCUUAAAUUUGGAAGAAGCUGCUCGGUAUAUGAGAUCUCUCAAAGUGCCAGCUACAGUUUCUGUUUCUUCACCUGAUGCUGUUACAGCGUAUAAUGGUUAUCUUACUUCUUCUUCUAAAACACCUGAAGAACAUUUUAUUGAAACCAUCUCACUUGCUGGUUCCUAUAAAGAUUGGUCCUAUUCUGGACAAUCUACACAACUAGGUAUAGAAUUUCUUAAGAGAGGUGAUAAAAGUGUAUAUUACACUAGUAAUCCUACCACAUUCCACCUAGAUGGUGAAGUUAUCACCUUUGACAAUCUUAAGACACUUCUUUCUUUGAGAGAAGUGAGGACUAUUAAGGUGUUUACAACAGUAGACAACAUUAACCUCCACACGCAAGUUGUGGACAUGUCAAUGACAUAUGGACAACAGUUUGGUCCAACUUAUUUGGAUGGAGCUGAUGUUACUAAAAUAAAACCUCAUAAUUCACAUGAAGGUAAAACAUUUUAUGUUUUACCUAAUGAUGACACUCUACGUGUUGAGGCUUUUGAGUACUACCACACAACUGAUCCUAGUUUUCUGGGUAGGUACAUGUCAGCAUUAAAUCACACUAAAAAGUGGAAAUACCCACAAGUUAAUGGUUUAACUUCUAUUAAAUGGGCAGAUAACAACUGUUAUCUUGCCACUGCAUUGUUAACACUCCAACAAAUAGAGUUGAAGUUUAAUCCACCUGCUCUACAAGAUGCUUAUUACAGAGCAAGGGCUGGUGAAGCUGCUAACUUUUGUGCACUUAUCUUAGCCUACUGUAAUAAGACAGUAGGUGAGUUAGGUGAUGUUAGAGAAACAAUGAGUUACUUGUUUCAACAUGCCAAUUUAGAUUCUUGCAAAAGAGUCUUGAACGUGGUGUGUAAAACUUGUGGACAACAGCAGACAACCCUUAAGGGUGUAGAAGCUGUUAUGUACAUGGGCACACUUUCUUAUGAACAAUUUAAGAAAGGUGUUCAGAUACCUUGUACGUGUGGUAAACAAGCUACAAAAUAUCUAGUACAACAGGAGUCACCUUUUGUUAUGAUGUCAGCACCACCUGCUCAGUAUGAACUUAAGCAUGGUACAUUUACUUGUGCUAGUGAGUACACUGGUAAUUACCAGUGUGGUCACUAUAAACAUAUAACUUCUAAAGAAACUUUGUAUUGCAUAGACGGUGCUUUACUUACAAAGUCCUCAGAAUACAAAGGUCCUAUUACGGAUGUUUUCUACAAAGAAAACAGUUACACAACAACCAUAAAACCAGUUACUUAUAAAUUGGAUGGUGUUGUUUGUACAGAAAUUGACCCUAAGUUGGACAAUUAUUAUAAGAAAGACAAUUCUUAUUUCACAGAGCAACCAAUUGAUCUUGUACCAAACCAACCAUAUCCAAACGCAAGCUUCGAUAAUUUUAAGUUUGUAUGUGAUAAUAUCAAAUUUGCUGAUGAUUUAAACCAGUUAACUGGUUAUAAGAAACCUGCUUCAAGAGAGCUUAAAGUUACAUUUUUCCCUGACUUAAAUGGUGAUGUGGUGGCUAUUGAUUAUAAACACUACACACCCUCUUUUAAGAAAGGAGCUAAAUUGUUACAUAAACCUAUUGUUUGGCAUGUUAACAAUGCAACUAAUAAAGCCACGUAUAAACCAAAUACCUGGUGUAUACGUUGUCUUUGGAGCACAAAACCAGUUGAAACAUCAAAUUCGUUUGAUGUACUGAAGUCAGAGGACGCGCAGGGAAUGGAUAAUCUUGCCUGCGAAGAUCUAAAACCAGUCUCUGAAGAAGUAGUGGAAAAUCCUACCAUACAGAAAGACGUUCUUGAGUGUAAUGUGAAAACUACCGAAGUUGUAGGAGACAUUAUACUUAAACCAGCAAAUAAUAGUUUAAAAAUUACAGAAGAGGUUGGCCACACAGAUCUAAUGGCUGCUUAUGUAGACAAUUCUAGUCUUACUAUUAAGAAACCUAAUGAAUUAUCUAGAGUAUUAGGUUUGAAAACCCUUGCUACUCAUGGUUUAGCUGCUGUUAAUAGUGUCCCUUGGGAUACUAUAGCUAAUUAUGCUAAGCCUUUUCUUAACAAAGUUGUUAGUACAACUACUAACAUAGUUACACGGUGUUUAAACCGUGUUUGUACUAAUUAUAUGCCUUAUUUCUUUACUUUAUUGCUACAAUUGUGUACUUUUACUAGAAGUACAAAUUCUAGAAUUAAAGCAUCUAUGCCGACUACUAUAGCAAAGAAUACUGUUAAGAGUGUCGGUAAAUUUUGUCUAGAGGCUUCAUUUAAUUAUUUGAAGUCACCUAAUUUUUCUAAACUGAUAAAUAUUAUAAUUUGGUUUUUACUAUUAAGUGUUUGCCUAGGUUCUUUAAUCUACUCAACCGCUGCUUUAGGUGUUUUAAUGUCUAAUUUAGGCAUGCCUUCUUACUGUACUGGUUACAGAGAAGGCUAUUUGAACUCUACUAAUGUCACUAUUGCAACCUACUGUACUGGUUCUAUACCUUGUAGUGUUUGUCUUAGUGGUUUAGAUUCUUUAGACACCUAUCCUUCUUUAGAAACUAUACAAAUUACCAUUUCAUCUUUUAAAUGGGAUUUAACUGCUUUUGGCUUAGUUGCAGAGUGGUUUUUGGCAUAUAUUCUUUUCACUAGGUUUUUCUAUGUACUUGGAUUGGCUGCAAUCAUGCAAUUGUUUUUCAGCUAUUUUGCAGUACAUUUUAUUAGUAAUUCUUGGCUUAUGUGGUUAAUAAUUAAUCUUGUACAAAUGGCCCCGAUUUCAGCUAUGGUUAGAAUGUACAUCUUCUUUGCAUCAUUUUAUUAUGUAUGGAAAAGUUAUGUGCAUGUUGUAGACGGUUGUAAUUCAUCAACUUGUAUGAUGUGUUACAAACGUAAUAGAGCAACAAGAGUCGAAUGUACAACUAUUGUUAAUGGUGUUAGAAGGUCCUUUUAUGUCUAUGCUAAUGGAGGUAAAGGCUUUUGCAAACUACACAAUUGGAAUUGUGUUAAUUGUGAUACAUUCUGUGCUGGUAGUACAUUUAUUAGUGAUGAAGUUGCGAGAGACUUGUCACUACAGUUUAAAAGACCAAUAAAUCCUACUGACCAGUCUUCUUACAUCGUUGAUAGUGUUACAGUGAAGAAUGGUUCCAUCCAUCUUUACUUUGAUAAAGCUGGUCAAAAGACUUAUGAAAGACAUUCUCUCUCUCAUUUUGUUAACUUAGACAACCUGAGAGCUAAUAACACUAAAGGUUCAUUGCCUAUUAAUGUUAUAGUUUUUGAUGGUAAAUCAAAAUGUGAAGAAUCAUCUGCAAAAUCAGCGUCUGUUUACUACAGUCAGCUUAUGUGUCAACCUAUACUGUUACUAGAUCAGGCAUUAGUGUCUGAUGUUGGUGAUAGUGCGGAAGUUGCAGUUAAAAUGUUUGAUGCUUACGUUAAUACGUUUUCAUCAACUUUUAACGUACCAAUGGAAAAACUCAAAACACUAGUUGCAACUGCAGAAGCUGAACUUGCAAAGAAUGUGUCCUUAGACAAUGUCUUAUCUACUUUUAUUUCAGCAGCUCGGCAAGGGUUUGUUGAUUCAGAUGUAGAAACUAAAGAUGUUGUUGAAUGUCUUAAAUUGUCACAUCAAUCUGACAUAGAAGUUACUGGCGAUAGUUGUAAUAACUAUAUGCUCACCUAUAACAAAGUUGAAAACAUGACACCCCGUGACCUUGGUGCUUGUAUUGACUGUAGUGCGCGUCAUAUUAAUGCGCAGGUAGCAAAAAGUCACAACAUUGCUUUGAUAUGGAACGUUAAAGAUUUCAUGUCAUUGUCUGAACAACUACGAAAACAAAUACGUAGUGCUGCUAAAAAGAAUAACUUACCUUUUAAGUUGACAUGUGCAACUACUAGACAAGUUGUUAAUGUUGUAACAACAAAGAUAGCACUUAAGGGUGGUAAAAUUGUUAAUAAUUGGUUGAAGCAGUUAAUUAAAGUUACACUUGUGUUCCUUUUUGUUGCUGCUAUUUUCUAUUUAAUAACACCUGUUCAUGUCAUGUCUAAACAUACUGACUUUUCAAGUGAAAUCAUAGGAUACAAGGCUAUUGAUGGUGGUGUCACUCGUGACAUAGCAUCUACAGAUACUUGUUUUGCUAACAAACAUGCUGAUUUUGACACAUGGUUUAGCCAGCGUGGUGGUAGUUAUACUAAUGACAAAGCUUGCCCAUUGAUUGCUGCAGUCAUAACAAGAGAAGUGGGUUUUGUCGUGCCUGGUUUGCCUGGCACGAUAUUACGCACAACUAAUGGUGACUUUUUGCAUUUCUUACCUAGAGUUUUUAGUGCAGUUGGUAACAUCUGUUACACACCAUCAAAACUUAUAGAGUACACUGACUUUGCAACAUCAGCUUGUGUUUUGGCUGCUGAAUGUACAAUUUUUAAAGAUGCUUCUGGUAAGCCAGUACCAUAUUGUUAUGAUACCAAUGUACUAGAAGGUUCUGUUGCUUAUGAAAGUUUACGCCCUGACACACGUUAUGUGCUCAUGGAUGGCUCUAUUAUUCAAUUUCCUAACACCUACCUUGAAGGUUCUGUUAGAGUGGUAACAACUUUUGAUUCUGAGUACUGUAGGCACGGCACUUGUGAAAGAUCAGAAGCUGGUGUUUGUGUAUCUACUAGUGGUAGAUGGGUACUUAACAAUGAUUAUUACAGAUCUUUACCAGGAGUUUUCUGUGGUGUAGAUGCUGUAAAUUUACUUACUAAUAUGUUUACACCACUAAUUCAACCUAUUGGUGCUUUGGACAUAUCAGCAUCUAUAGUAGCUGGUGGUAUUGUAGCUAUCGUAGUAACAUGCCUUGCCUACUAUUUUAUGAGGUUUAGAAGAGCUUUUGGUGAAUACAGUCAUGUAGUUGCCUUUAAUACUUUACUAUUCCUUAUGUCAUUCACUGUACUCUGUUUAACACCAGUUUACUCAUUCUUACCUGGUGUUUAUUCUGUUAUUUACUUGUACUUGACAUUUUAUCUUACUAAUGAUGUUUCUUUUUUAGCACAUAUUCAGUGGAUGGUUAUGUUCACACCUUUAGUACCUUUCUGGAUAACAAUUGCUUAUAUCAUUUGUAUUUCCACAAAGCAUUUCUAUUGGUUCUUUAGUAAUUACCUAAAGAGACGUGUAGUCUUUAAUGGUGUUUCCUUUAGUACUUUUGAAGAAGCUGCGCUGUGCACCUUUUUGUUAAAUAAAGAAAUGUAUCUAAAGUUGCGUAGUGAUGUGCUAUUACCUCUUACGCAAUAUAAUAGAUACUUAGCUCUUUAUAAUAAGUACAAGUAUUUUAGUGGAGCAAUGGAUACAACUAGCUACAGAGAAGCUGCUUGUUGUCAUCUCGCAAAGGCUCUCAAUGACUUCAGUAACUCAGGUUCUGAUGUUCUUUACCAACCACCACAAACCUCUAUCACCUCAGCUGUUUUGCAGAGUGGUUUUAGAAAAAUGGCAUUCCCAUCUGGUAAAGUUGAGGGUUGUAUGGUACAAGUAACUUGUGGUACAACUACACUUAACGGUCUUUGGCUUGAUGACGUAGUUUACUGUCCAAGACAUGUGAUCUGCACCUCUGAAGACAUGCUUAACCCUAAUUAUGAAGAUUUACUCAUUCGUAAGUCUAAUCAUAAUUUCUUGGUACAGGCUGGUAAUGUUCAACUCAGGGUUAUUGGACAUUCUAUGCAAAAUUGUGUACUUAAGCUUAAGGUUGAUACAGCCAAUCCUAAGACACCUAAGUAUAAGUUUGUUCGCAUUCAACCAGGACAGACUUUUUCAGUGUUAGCUUGUUACAAUGGUUCACCAUCUGGUGUUUACCAAUGUGCUAUGAGGCCCAAUUUCACUAUUAAGGGUUCAUUCCUUAAUGGUUCAUGUGGUAGUGUUGGUUUUAACAUAGAUUAUGACUGUGUCUCUUUUUGUUACAUGCACCAUAUGGAAUUACCAACUGGAGUUCAUGCUGGCACAGACUUAGAAGGUAACUUUUAUGGACCUUUUGUUGACAGGCAAACAGCACAAGCAGCUGGUACGGACACAACUAUUACAGUUAAUGUUUUAGCUUGGUUGUACGCUGCUGUUAUAAAUGGAGACAGGUGGUUUCUCAAUCGAUUUACCACAACUCUUAAUGACUUUAACCUUGUGGCUAUGAAGUACAAUUAUGAACCUCUAACACAAGACCAUGUUGACAUACUAGGACCUCUUUCUGCUCAAACUGGAAUUGCCGUUUUAGAUAUGUGUGCUUCAUUAAAAGAAUUACUGCAAAAUGGUAUGAAUGGACGUACCAUAUUGGGUAGUGCUUUAUUAGAAGAUGAAUUUACACCUUUUGAUGUUGUUAGACAAUGCUCAGGUGUUACUUUCCAAAGUGCAGUGAAAAGAACAAUCAAGGGUACACACCACUGGUUGUUACUCACAAUUUUGACUUCACUUUUAGUUUUAGUCCAGAGUACUCAAUGGUCUUUGUUCUUUUUUUUGUAUGAAAAUGCCUUUUUACCUUUUGCUAUGGGUAUUAUUGCUAUGUCUGCUUUUGCAAUGAUGUUUGUCAAACAUAAGCAUGCAUUUCUCUGUUUGUUUUUGUUACCUUCUCUUGCCACUGUAGCUUAUUUUAAUAUGGUCUAUAUGCCUGCUAGUUGGGUGAUGCGUAUUAUGACAUGGUUGGAUAUGGUUGAUACUAGUUUGUCUGGUUUUAAGCUAAAAGACUGUGUUAUGUAUGCAUCAGCUGUAGUGUUACUAAUCCUUAUGACAGCAAGAACUGUGUAUGAUGAUGGUGCUAGGAGAGUGUGGACACUUAUGAAUGUCUUGACACUCGUUUAUAAAGUUUAUUAUGGUAAUGCUUUAGAUCAAGCCAUUUCCAUGUGGGCUCUUAUAAUCUCUGUUACUUCUAACUACUCAGGUGUAGUUACAACUGUCAUGUUUUUGGCCAGAGGUAUUGUUUUUAUGUGUGUUGAGUAUUGCCCUAUUUUCUUCAUAACUGGUAAUACACUUCAGUGUAUAAUGCUAGUUUAUUGUUUCUUAGGCUAUUUUUGUACUUGUUACUUUGGCCUCUUUUGUUUACUCAACCGCUACUUUAGACUGACUCUUGGUGUUUAUGAUUACUUAGUUUCUACACAGGAGUUUAGAUAUAUGAAUUCACAGGGACUACUCCCACCCAAGAAUAGCAUAGAUGCCUUCAAACUCAACAUUAAAUUGUUGGGUGUUGGUGGCAAACCUUGUAUCAAAGUAGCCACUGUACAGUCUAAAAUGUCAGAUGUAAAGUGCACAUCAGUAGUCUUACUCUCAGUUUUGCAACAACUCAGAGUAGAAUCAUCAUCUAAAUUGUGGGCUCAAUGUGUCCAGUUACACAAUGACAUUCUCUUAGCUAAAGAUACUACUGAAGCCUUUGAAAAAAUGGUUUCACUACUUUCUGUUUUGCUUUCCAUGCAGGGUGCUGUAGACAUAAACAAGCUUUGUGAAGAAAUGCUGGACAACAGGGCAACCUUACAAGCUAUAGCCUCAGAGUUUAGUUCCCUUCCAUCAUAUGCAGCUUUUGCUACUGCUCAAGAAGCUUAUGAGCAGGCUGUUGCUAAUGGUGAUUCUGAAGUUGUUCUUAAAAAGUUGAAGAAGUCUUUGAAUGUGGCUAAAUCUGAAUUUGACCGUGAUGCAGCCAUGCAACGUAAGUUGGAAAAGAUGGCUGAUCAAGCUAUGACCCAAAUGUAUAAACAGGCUAGAUCUGAGGACAAGAGGGCAAAAGUUACUAGUGCUAUGCAGACAAUGCUUUUCACUAUGCUUAGAAAGUUGGAUAAUGAUGCACUCAACAACAUUAUCAACAAUGCAAGAGAUGGUUGUGUUCCCUUGAACAUAAUACCUCUUACAACAGCAGCCAAACUAAUGGUUGUCAUACCAGACUAUAACACAUAUAAAAAUACGUGUGAUGGUACAACAUUUACUUAUGCAUCAGCAUUGUGGGAAAUCCAACAGGUUGUAGAUGCAGAUAGUAAAAUUGUUCAACUUAGUGAAAUUAGUAUGGACAAUUCACCUAAUUUAGCAUGGCCUCUUAUUGUAACAGCUUUAAGGGCCAAUUCUGCUGUCAAAUUACAGAAUAAUGAGCUUAGUCCUGUUGCACUACGACAGAUGUCUUGUGCUGCCGGUACUACACAAACUGCUUGCACUGAUGACAAUGCGUUAGCUUACUACAACACAACAAAGGGAGGUAGGUUUGUACUUGCACUGUUAUCCGAUUUACAGGAUUUGAAAUGGGCUAGAUUCCCUAAGAGUGAUGGAACUGGUACUAUCUAUACAGAACUGGAACCACCUUGUAGGUUUGUUACAGACACACCUAAAGGUCCUAAAGUGAAGUAUUUAUACUUUAUUAAAGGAUUAAACAACCUAAAUAGAGGUAUGGUACUUGGUAGUUUAGCUGCCACAGUACGUCUACAAGCUGGUAAUGCAACAGAAGUGCCUGCCAAUUCAACUGUAUUAUCUUUCUGUGCUUUUGCUGUAGAUGCUGCUAAAGCUUACAAAGAUUAUCUAGCUAGUGGGGGACAACCAAUCACUAAUUGUGUUAAGAUGUUGUGUACACACACUGGUACUGGUCAGGCAAUAACAGUUACACCGGAAGCCAAUAUGGAUCAAGAAUCCUUUGGUGGUGCAUCGUGUUGUCUGUACUGCCGUUGCCACAUAGAUCAUCCAAAUCCUAAAGGAUUUUGUGACUUAAAAGGUAAGUAUGUACAAAUACCUACAACUUGUGCUAAUGACCCUGUGGGUUUUACACUUAAAAACACAGUCUGUACCGUCUGCGGUAUGUGGAAAGGUUAUGGCUGUAGUUGUGAUCAACUCCGCGAACCCAUGCUUCAGUCAGCUGAUGCACAAUCGUUUUUAAACGGGUUUGCGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGGCACUAGUACUGAUGUCGUAUACAGGGCUUUUGACAUCUACAAUGAUAAAGUAGCUGGUUUUGCUAAAUUCCUAAAAACUAAUUGUUGUCGCUUCCAAGAAAAGGACGAAGAUGACAAUUUAAUUGAUUCUUACUUUGUAGUUAAGAGACACACUUUCUCUAACUACCAACAUGAAGAAACAAUUUAUAAUUUACUUAAGGAUUGUCCAGCUGUUGCUAAACAUGACUUCUUUAAGUUUAGAAUAGACGGUGACAUGGUACCACAUAUAUCACGUCAACGUCUUACUAAAUACACAAUGGCAGACCUCGUCUAUGCUUUAAGGCAUUUUGAUGAAGGUAAUUGUGACACAUUAAAAGAAAUACUUGUCACAUACAAUUGUUGUGAUGAUGAUUAUUUCAAUAAAAAGGACUGGUAUGAUUUUGUAGAAAACCCAGAUAUAUUACGCGUAUACGCCAACUUAGGUGAACGUGUACGCCAAGCUUUGUUAAAAACAGUACAAUUCUGUGAUGCCAUGCGAAAUGCUGGUAUUGUUGGUGUACUGACAUUAGAUAAUCAAGAUCUCAAUGGUAACUGGUAUGAUUUCGGUGAUUUCAUACAAACCACGCCAGGUAGUGGAGUUCCUGUUGUAGAUUCUUAUUAUUCAUUGUUAAUGCCUAUAUUAACCUUGACCAGGGCUUUAACUGCAGAGUCACAUGUUGACACUGACUUAACAAAGCCUUACAUUAAGUGGGAUUUGUUAAAAUAUGACUUCACGGAAGAGAGGUUAAAACUCUUUGACCGUUAUUUUAAAUAUUGGGAUCAGACAUACCACCCAAAUUGUGUUAACUGUUUGGAUGACAGAUGCAUUCUGCAUUGUGCAAACUUUAAUGUUUUAUUCUCUACAGUGUUCCCACCUACAAGUUUUGGACCACUAGUGAGAAAAAUAUUUGUUGAUGGUGUUCCAUUUGUAGUUUCAACUGGAUACCACUUCAGAGAGCUAGGUGUUGUACAUAAUCAGGAUGUAAACUUACAUAGCUCUAGACUUAGUUUUAAGGAAUUACUUGUGUAUGCUGCUGACCCUGCUAUGCACGCUGCUUCUGGUAAUCUAUUACUAGAUAAACGCACUACGUGCUUUUCAGUAGCUGCACUUACUAACAAUGUUGCUUUUCAAACUGUCAAACCCGGUAAUUUUAACAAAGACUUCUAUGACUUUGCUGUGUCUAAGGGUUUCUUUAAGGAAGGAAGUUCUGUUGAAUUAAAACACUUCUUCUUUGCUCAGGAUGGUAAUGCUGCUAUCAGCGAUUAUGACUACUAUCGUUAUAAUCUACCAACAAUGUGUGAUAUCAGACAACUACUAUUUGUAGUUGAAGUUGUUGAUAAGUACUUUGAUUGUUACGAUGGUGGCUGUAUUAAUGCUAACCAAGUCAUCGUCAACAACCUAGACAAAUCAGCUGGUUUUCCAUUUAAUAAAUGGGGUAAGGCUAGACUUUAUUAUGAUUCAAUGAGUUAUGAGGAUCAAGAUGCACUUUUCGCAUAUACAAAACGUAAUGUCAUCCCUACUAUAACUCAAAUGAAUCUUAAGUAUGCCAUUAGUGCAAAGAAUAGAGCUCGCACCGUAGCUGGUGUCUCUAUCUGUAGUACUAUGACCAAUAGACAGUUUCAUCAAAAAUUAUUGAAAUCAAUAGCCGCCACUAGAGGAGCUACUGUAGUAAUUGGAACAAGCAAAUUCUAUGGUGGUUGGCACAACAUGUUAAAAACUGUUUAUAGUGAUGUAGAAAACCCUCACCUUAUGGGUUGGGAUUAUCCUAAAUGUGAUAGAGCCAUGCCUAACAUGCUUAGAAUUAUGGCCUCACUUGUUCUUGCUCGCAAACAUACAACGUGUUGUAGCUUGUCACACCGUUUCUAUAGAUUAGCUAAUGAGUGUGCUCAAGUAUUGAGUGAAAUGGUCAUGUGUGGCGGUUCACUAUAUGUUAAACCAGGUGGAACCUCAUCAGGAGAUGCCACAACUGCUUAUGCUAAUAGUGUUUUUAACAUUUGUCAAGCUGUCACGGCCAAUGUUAAUGCACUUUUAUCUACUGAUGGUAACAAAAUUGCCGAUAAGUAUGUCCGCAAUUUACAACACAGACUUUAUGAGUGUCUCUAUAGAAAUAGAGAUGUUGACACAGACUUUGUGAAUGAGUUUUACGCAUAUUUGCGUAAACAUUUCUCAAUGAUGAUACUCUCUGACGAUGCUGUUGUGUGUUUCAAUAGCACUUAUGCAUCUCAAGGUCUAGUGGCUAGCAUAAAGAACUUUAAGUCAGUUCUUUAUUAUCAAAACAAUGUUUUUAUGUCUGAAGCAAAAUGUUGGACUGAGACUGACCUUACUAAAGGACCUCAUGAAUUUUGCUCUCAACAUACAAUGCUAGUUAAACAGGGUGAUGAUUAUGUGUACCUUCCUUACCCAGAUCCAUCAAGAAUCCUAGGGGCCGGCUGUUUUGUAGAUGAUAUCGUAAAAACAGAUGGUACACUUAUGAUUGAACGGUUCGUGUCUUUAGCUAUAGAUGCUUACCCACUUACUAAACAUCCUAAUCAGGAGUAUGCUGAUGUCUUUCAUUUGUACUUACAAUACAUAAGAAAGCUACAUGAUGAGUUAACAGGACACAUGUUAGACAUGUAUUCUGUUAUGCUUACUAAUGAUAACACUUCAAGGUAUUGGGAACCUGAGUUUUAUGAGGCUAUGUACACACCGCAUACAGUCUUACAGGCUGUUGGGGCUUGUGUUCUUUGCAAUUCACAGACUUCAUUAAGAUGUGGUGCUUGCAUACGUAGACCAUUCUUAUGUUGUAAAUGCUGUUACGACCAUGUCAUAUCAACAUCACAUAAAUUAGUCUUGUCUGUUAAUCCGUAUGUUUGCAAUGCUCCAGGUUGUGAUGUCACAGAUGUGACUCAACUUUACUUAGGAGGUAUGAGCUAUUAUUGUAAAUCACAUAAACCACCCAUUAGUUUUCCAUUGUGUGCUAAUGGACAAGUUUUUGGUUUAUAUAAAAAUACAUGUGUUGGUAGCGAUAAUGUUACUGACUUUAAUGCAAUUGCAACAUGUGACUGGACAAAUGCUGGUGAUUACAUUUUAGCUAACACCUGUACUGAAAGACUCAAGCUUUUUGCAGCAGAAACGCUCAAAGCUACUGAGGAGACAUUUAAACUGUCUUAUGGUAUUGCUACUGUACGUGAAGUGCUGUCUGACAGAGAAUUACAUCUUUCAUGGGAAGUUGGUAAACCUAGACCACCACUUAACCGAAAUUAUGUCUUUACUGGUUAUCGUGUAACUAAAAACAGUAAAGUACAAAUAGGAGAGUACACCUUUGAAAAAGGUGACUAUGGUGAUGCUGUUGUUUACCGAGGUACAACAACUUACAAAUUAAAUGUUGGUGAUUAUUUUGUGCUGACAUCACAUACAGUAAUGCCAUUAAGUGCACCUACACUAGUGCCACAAGAGCACUAUGUUAGAAUUACUGGCUUAUACCCAACACUCAAUAUCUCAGAUGAGUUUUCUAGCAAUGUUGCAAAUUAUCAAAAGGUUGGUAUGCAAAAGUAUUCUACACUCCAGGGACCACCUGGUACUGGUAAGAGUCAUUUUGCUAUUGGCCUAGCUCUCUACUACCCUUCUGCUCGCAUAGUGUAUACAGCUUGCUCUCAUGCCGCUGUUGAUGCACUAUGUGAGAAGGCAUUAAAAUAUUUGCCUAUAGAUAAAUGUAGUAGAAUUAUACCUGCACGUGCUCGUGUAGAGUGUUUUGAUAAAUUCAAAGUGAAUUCAACAUUAGAACAGUAUGUCUUUUGUACUGUAAAUGCAUUGCCUGAGACGACAGCAGAUAUAGUUGUCUUUGAUGAAAUUUCAAUGGCCACAAAUUAUGAUUUGAGUGUUGUCAAUGCCAGAUUACGUGCUAAGCACUAUGUGUACAUUGGCGACCCUGCUCAAUUACCUGCACCACGCACAUUGCUAACUAAGGGCACACUAGAACCAGAAUAUUUCAAUUCAGUGUGUAGACUUAUGAAAACUAUAGGUCCAGACAUGUUCCUCGGAACUUGUCGGCGUUGUCCUGCUGAAAUUGUUGACACUGUGAGUGCUUUGGUUUAUGAUAAUAAGCUUAAAGCACAUAAAGACAAAUCAGCUCAAUGCUUUAAAAUGUUUUAUAAGGGUGUUAUCACGCAUGAUGUUUCAUCUGCAAUUAACAGGCCACAAAUAGGCGUGGUAAGAGAAUUCCUUACACGUAACCCUGCUUGGAGAAAAGCUGUCUUUAUUUCACCUUAUAAUUCACAGAAUGCUGUAGCCUCAAAGAUUUUGGGACUACCAACUCAAACUGUUGAUUCAUCACAGGGCUCAGAAUAUGACUAUGUCAUAUUCACUCAAACCACUGAAACAGCUCACUCUUGUAAUGUAAACAGAUUUAAUGUUGCUAUUACCAGAGCAAAAGUAGGCAUACUUUGCAUAAUGUCUGAUAGAGACCUUUAUGACAAGUUGCAAUUUACAAGUCUUGAAAUUCCACGUAGGAAUGUGGCAACUUUACAAGCUGAAAAUGUAACAGGACUCUUUAAAGAUUGUAGUAAGGUAAUCACUGGGUUACAUCCUACACAGGCACCUACACACCUCAGUGUUGACACUAAAUUCAAAACUGAAGGUUUAUGUGUUGACAUACCUGGCAUACCUAAGGACAUGACCUAUAGAAGACUCAUCUCUAUGAUGGGUUUUAAAAUGAAUUAUCAAGUUAAUGGUUACCCUAACAUGUUUAUCACCCGCGAAGAAGCUAUAAGACAUGUACGUGCAUGGAUUGGCUUCGAUGUCGAGGGGUGUCAUGCUACUAGAGAAGCUGUUGGUACCAAUUUACCUUUACAGCUAGGUUUUUCUACAGGUGUUAACCUAGUUGCUGUACCUACAGGUUAUGUUGAUACACCUAAUAAUACAGAUUUUUCCAGAGUUAGUGCUAAACCACCGCCUGGAGAUCAAUUUAAACACCUCAUACCACUUAUGUACAAAGGACUUCCUUGGAAUGUAGUGCGUAUAAAGAUUGUACAAAUGUUAAGUGACACACUUAAAAAUCUCUCUGACAGAGUCGUAUUUGUCUUAUGGGCACAUGGCUUUGAGUUGACAUCUAUGAAGUAUUUUGUGAAAAUAGGACCUGAGCGCACCUGUUGUCUAUGUGAUAGACGUGCCACAUGCUUUUCCACUGCUUCAGACACUUAUGCCUGUUGGCAUCAUUCUAUUGGAUUUGAUUACGUCUAUAAUCCGUUUAUGAUUGAUGUUCAACAAUGGGGUUUUACAGGUAACCUACAAAGCAACCAUGAUCUGUAUUGUCAAGUCCAUGGUAAUGCACAUGUAGCUAGUUGUGAUGCAAUCAUGACUAGGUGUCUAGCUGUCCACGAGUGCUUUGUUAAGCGUGUUGACUGGACUAUUGAAUAUCCUAUAAUUGGUGAUGAACUGAAGAUUAAUGCGGCUUGUAGAAAGGUUCAACACAUGGUUGUUAAAGCUGCAUUAUUAGCAGACAAAUUCCCAGUUCUUCACGACAUUGGUAACCCUAAAGCUAUUAAGUGUGUACCUCAAGCUGAUGUAGAAUGGAAGUUCUAUGAUGCACAGCCUUGUAGUGACAAAGCUUAUAAAAUAGAAGAAUUAUUCUAUUCUUAUGCCACACAUUCUGACAAAUUCACAGAUGGUGUAUGCCUAUUUUGGAAUUGCAAUGUCGAUAGAUAUCCUGCUAAUUCCAUUGUUUGUAGAUUUGACACUAGAGUGCUAUCUAACCUUAACUUGCCUGGUUGUGAUGGUGGCAGUUUGUAUGUAAAUAAACAUGCAUUCCACACACCAGCUUUUGAUAAAAGUGCUUUUGUUAAUUUAAAACAAUUACCAUUUUUCUAUUACUCUGACAGUCCAUGUGAGUCUCAUGGAAAACAAGUAGUGUCAGAUAUAGAUUAUGUACCACUAAAGUCUGCUACGUGUAUAACACGUUGCAAUUUAGGUGGUGCUGUCUGUAGACAUCAUGCUAAUGAGUACAGAUUGUAUCUCGAUGCUUAUAACAUGAUGAUCUCAGCUGGCUUUAGCUUGUGGGUUUACAAACAAUUUGAUACUUAUAACCUCUGGAACACUUUUACAAGACUUCAGAGUUUAGAAAAUGUGGCUUUUAAUGUUGUAAAUAAGGGACACUUUGAUGGACAACAGGGUGAAGUACCAGUUUCUAUCAUUAAUAACACUGUUUACACAAAAGUUGAUGGUGUUGAUGUAGAAUUGUUUGAAAAUAAAACAACAUUACCUGUUAAUGUAGCAUUUGAGCUUUGGGCUAAGCGCAACAUUAAACCAGUACCAGAGGUGAAAAUACUCAAUAAUUUGGGUGUGGACAUUGCUGCUAAUACUGUGAUCUGGGACUACAAAAGAGAUGCUCCAGCACAUAUAUCUACUAUUGGUGUUUGUUCUAUGACUGACAUAGCCAAGAAACCAACUGAAACGAUUUGUGCACCACUCACUGUCUUUUUUGAUGGUAGAGUUGAUGGUCAAGUAGACUUAUUUAGAAAUGCCCGUAAUGGUGUUCUUAUUACAGAAGGUAGUGUUAAAGGUUUACAACCAUCUGUAGGUCCCAAACAAGCUAGUCUUAAUGGAGUCACAUUAAUUGGAGAAGCCGUAAAAACACAGUUCAAUUAUUAUAAGAAAGUUGAUGGUGUUGUCCAACAAUUACCUGAAACUUACUUUACUCAGAGUAGAAAUUUACAAGAAUUUAAACCCAGGAGUCAAAUGGAAAUUGAUUUCUUAGAAUUAGCUAUGGAUGAAUUCAUUGAACGGUAUAAAUUAGAAGGCUAUGCCUUCGAACAUAUCGUUUAUGGAGAUUUUAGUCAUAGUCAGUUAGGUGGUUUACAUCUACUGAUUGGACUAGCUAAACGUUUUAAGGAAUCACCUUUUGAAUUAGAAGAUUUUAUUCCUAUGGACAGUACAGUUAAAAACUAUUUCAUAACAGAUGCGCAAACAGGUUCAUCUAAGUGUGUGUGUUCUGUUAUUGAUUUAUUACUUGAUGAUUUUGUUGAAAUAAUAAAAUCCCAAGAUUUAUCUGUAGUUUCUAAGGUUGUCAAAGUGACUAUUGACUAUACAGAAAUUUCAUUUAUGCUUUGGUGUAAAGAUGGCCAUGUAGAAACAUUUUACCCAAAAUUACAAUCUAGUCAAGCGUGGCAACCGGGUGUUGCUAUGCCUAAUCUUUACAAAAUGCAAAGAAUGCUAUUAGAAAAGUGUGACCUUCAAAAUUAUGGUGAUAGUGCAACAUUACCUAAAGGCAUAAUGAUGAAUGUCGCAAAAUAUACUCAACUGUGUCAAUAUUUAAACACAUUAACAUUAGCUGUACCCUAUAAUAUGAGAGUUAUACAUUUUGGUGCUGGUUCUGAUAAAGGAGUUGCACCAGGUACAGCUGUUUUAAGACAGUGGUUGCCUACGGGUACGCUGCUUGUCGAUUCAGAUCUUAAUGACUUUGUCUCUGAUGCAGAUUCAACUUUGAUUGGUGAUUGUGCAACUGUACAUACAGCUAAUAAAUGGGAUCUCAUUAUUAGUGAUAUGUACGACCCUAAGACUAAAAAUGUUACAAAAGAAAAUGACUCUAAAGAGGGUUUUUUCACUUACAUUUGUGGGUUUAUACAACAAAAGCUAGCUCUUGGAGGUUCCGUGGCUAUAAAGAUAACAGAACAUUCUUGGAAUGCUGAUCUUUAUAAGCUCAUGGGACACUUCGCAUGGUGGACAGCCUUUGUUACUAAUGUGAAUGCGUCAUCAUCUGAAGCAUUUUUAAUUGGAUGUAAUUAUCUUGGCAAACCACGCGAACAAAUAGAUGGUUAUGUCAUGCAUGCAAAUUACAUAUUUUGGAGGAAUACAAAUCCAAUUCAGUUGUCUUCCUAUUCUUUAUUUGACAUGAGUAAAUUUCCCCUUAAAUUAAGGGGUACUGCUGUUAUGUCUUUAAAAGAAGGUCAAAUCAAUGAUAUGAUUUUAUCUCUUCUUAGUAAAGGUAGACUUAUAAUUAGAGAAAACAACAGAGUUGUUAUUUCUAGUGAUGUUCUUGUUAACAACUAAACGAACAAUGUUUGUUUUUCUUGUUUUAUUGCCACUAGUCUCUAGUCAGUGUGUUAAUCUUACAACCAGAACUCAAUUACCCCCUGCAUACACUAAUUCUUUCACACGUGGUGUUUAUUACCCUGACAAAGUUUUCAGAUCCUCAGUUUUACAUUCAACUCAGGACUUGUUCUUACCUUUCUUUUCCAAUGUUACUUGGUUCCAUGCUAUACAUGUCUCUGGGACCAAUGGUACUAAGAGGUUUGAUAACCCUGUCCUACCAUUUAAUGAUGGUGUUUAUUUUGCUUCCACUGAGAAGUCUAACAUAAUAAGAGGCUGGAUUUUUGGUACUACUUUAGAUUCGAAGACCCAGUCCCUACUUAUUGUUAAUAACGCUACUAAUGUUGUUAUUAAAGUCUGUGAAUUUCAAUUUUGUAAUGAUCCAUUUUUGGGUGUUUAUUACCACAAAAACAACAAAAGUUGGAUGGAAAGUGAGUUCAGAGUUUAUUCUAGUGCGAAUAAUUGCACUUUUGAAUAUGUCUCUCAGCCUUUUCUUAUGGACCUUGAAGGAAAACAGGGUAAUUUCAAAAAUCUUAGGGAAUUUGUGUUUAAGAAUAUUGAUGGUUAUUUUAAAAUAUAUUCUAAGCACACGCCUAUUAAUUUAGUGCGUGAUCUCCCUCAGGGUUUUUCGGCUUUAGAACCAUUGGUAGAUUUGCCAAUAGGUAUUAACAUCACUAGGUUUCAAACUUUACUUGCUUUACAUAGAAGUUAUUUGACUCCUGGUGAUUCUUCUUCAGGUUGGACAGCUGGUGCUGCAGCUUAUUAUGUGGGUUAUCUUCAACCUAGGACUUUUCUAUUAAAAUAUAAUGAAAAUGGAACCAUUACAGAUGCUGUAGACUGUGCACUUGACCCUCUCUCAGAAACAAAGUGUACGUUGAAAUCCUUCACUGUAGAAAAAGGAAUCUAUCAAACUUCUAACUUUAGAGUCCAACCAACAGAAUCUAUUGUUAGAUUUCCUAAUAUUACAAACUUGUGCCCUUUUGGUGAAGUUUUUAACGCCACCAGAUUUGCAUCUGUUUAUGCUUGGAACAGGAAGAGAAUCAGCAACUGUGUUGCUGAUUAUUCUGUCCUAUAUAAUUCCGCAUCAUUUUCCACUUUUAAGUGUUAUGGAGUGUCUCCUACUAAAUUAAAUGAUCUCUGCUUUACUAAUGUCUAUGCAGAUUCAUUUGUAAUUAGAGGUGAUGAAGUCAGACAAAUCGCUCCAGGGCAAACUGGAAAGAUUGCUGAUUAUAAUUAUAAAUUACCAGAUGAUUUUACAGGCUGCGUUAUAGCUUGGAAUUCUAACAAUCUUGAUUCUAAGGUUGGUGGUAAUUAUAAUUACCUGUAUAGAUUGUUUAGGAAGUCUAAUCUCAAACCUUUUGAGAGAGAUAUUUCAACUGAAAUCUAUCAGGCCGGUAGCACACCUUGUAAUGGUGUUGAAGGUUUUAAUUGUUACUUUCCUUUACAAUCAUAUGGUUUCCAACCCACUAAUGGUGUUGGUUACCAACCAUACAGAGUAGUAGUACUUUCUUUUGAACUUCUACAUGCACCAGCAACUGUUUGUGGACCUAAAAAGUCUACUAAUUUGGUUAAAAACAAAUGUGUCAAUUUCAACUUCAAUGGUUUAACAGGCACAGGUGUUCUUACUGAGUCUAACAAAAAGUUUCUGCCUUUCCAACAAUUUGGCAGAGACAUUGCUGACACUACUGAUGCUGUCCGUGAUCCACAGACACUUGAGAUUCUUGACAUUACACCAUGUUCUUUUGGUGGUGUCAGUGUUAUAACACCAGGAACAAAUACUUCUAACCAGGUUGCUGUUCUUUAUCAGGAUGUUAACUGCACAGAAGUCCCUGUUGCUAUUCAUGCAGAUCAACUUACUCCUACUUGGCGUGUUUAUUCUACAGGUUCUAAUGUUUUUCAAACACGUGCAGGCUGUUUAAUAGGGGCUGAACAUGUCAACAACUCAUAUGAGUGUGACAUACCCAUUGGUGCAGGUAUAUGCGCUAGUUAUCAGACUCAGACUAAUUCUCCUCGGCGGGCACGUAGUGUAGCUAGUCAAUCCAUCAUUGCCUACACUAUGUCACUUGGUGCAGAAAAUUCAGUUGCUUACUCUAAUAACUCUAUUGCCAUACCCACAAAUUUUACUAUUAGUGUUACCACAGAAAUUCUACCAGUGUCUAUGACCAAGACAUCAGUAGAUUGUACAAUGUACAUUUGUGGUGAUUCAACUGAAUGCAGCAAUCUUUUGUUGCAAUAUGGCAGUUUUUGUACACAAUUAAACCGUGCUUUAACUGGAAUAGCUGUUGAACAAGACAAAAACACCCAAGAAGUUUUUGCACAAGUCAAACAAAUUUACAAAACACCACCAAUUAAAGAUUUUGGUGGUUUUAAUUUUUCACAAAUAUUACCAGAUCCAUCAAAACCAAGCAAGAGGUCAUUUAUUGAAGAUCUACUUUUCAACAAAGUGACACUUGCAGAUGCUGGCUUCAUCAAACAAUAUGGUGAUUGCCUUGGUGAUAUUGCUGCUAGAGACCUCAUUUGUGCACAAAAGUUUAACGGCCUUACUGUUUUGCCACCUUUGCUCACAGAUGAAAUGAUUGCUCAAUACACUUCUGCACUGUUAGCGGGUACAAUCACUUCUGGUUGGACCUUUGGUGCAGGUGCUGCAUUACAAAUACCAUUUGCUAUGCAAAUGGCUUAUAGGUUUAAUGGUAUUGGAGUUACACAGAAUGUUCUCUAUGAGAACCAAAAAUUGAUUGCCAACCAAUUUAAUAGUGCUAUUGGCAAAAUUCAAGACUCACUUUCUUCCACAGCAAGUGCACUUGGAAAACUUCAAGAUGUGGUCAACCAAAAUGCACAAGCUUUAAACACGCUUGUUAAACAACUUAGCUCCAAUUUUGGUGCAAUUUCAAGUGUUUUAAAUGAUAUCCUUUCACGUCUUGACAAAGUUGAGGCUGAAGUGCAAAUUGAUAGGUUGAUCACAGGCAGACUUCAAAGUUUGCAGACAUAUGUGACUCAACAAUUAAUUAGAGCUGCAGAAAUCAGAGCUUCUGCUAAUCUUGCUGCUACUAAAAUGUCAGAGUGUGUACUUGGACAAUCAAAAAGAGUUGAUUUUUGUGGAAAGGGCUAUCAUCUUAUGUCCUUCCCUCAGUCAGCACCUCAUGGUGUAGUCUUCUUGCAUGUGACUUAUGUCCCUGCACAAGAAAAGAACUUCACAACUGCUCCUGCCAUUUGUCAUGAUGGAAAAGCACACUUUCCUCGUGAAGGUGUCUUUGUUUCAAAUGGCACACACUGGUUUGUAACACAAAGGAAUUUUUAUGAACCACAAAUCAUUACUACAGACAACACAUUUGUGUCUGGUAACUGUGAUGUUGUAAUAGGAAUUGUCAACAACACAGUUUAUGAUCCUUUGCAACCUGAAUUAGACUCAUUCAAGGAGGAGUUAGAUAAAUAUUUUAAGAAUCAUACAUCACCAGAUGUUGAUUUAGGUGACAUCUCUGGCAUUAAUGCUUCAGUUGUAAACAUUCAAAAAGAAAUUGACCGCCUCAAUGAGGUUGCCAAGAAUUUAAAUGAAUCUCUCAUCGAUCUCCAAGAACUUGGAAAGUAUGAGCAGUAUAUAAAAUGGCCAUGGUACAUUUGGCUAGGUUUUAUAGCUGGCUUGAUUGCCAUAGUAAUGGUGACAAUUAUGCUUUGCUGUAUGACCAGUUGCUGUAGUUGUCUCAAGGGCUGUUGUUCUUGUGGAUCCUGCUGCAAAUUUGAUGAAGACGACUCUGAGCCAGUGCUCAAAGGAGUCAAAUUACAUUACACAUAAACGAACUUAUGGAUUUGUUUAUGAGAAUCUUCACAAUUGGAACUGUAACUUUGAAGCAAGGUGAAAUCAAGGAUGCUACUCCUUCAGAUUUUGUUCGCGCUACUGCAACGAUACCGAUACAAGCCUCACUCCCUUUCGGAUGGCUUAUUGUUGGCGUUGCACUUCUUGCUGUUUUUCAGAGCGCUUCCAAAAUCAUAACCCUCAAAAAGAGAUGGCAACUAGCACUCUCCAAGGGUGUUCACUUUGUUUGCAACUUGCUGUUGUUGUUUGUAACAGUUUACUCACACCUUUUGCUCGUUGCUGCUGGCCUUGAAGCCCCUUUUCUCUAUCUUUAUGCUUUAGUCUACUUCUUGCAGAGUAUAAACUUUGUAAGAAUAAUAAUGAGGCUUUGGCUUUGCUGGAAAUGCCGUUCCAAAAACCCAUUACUUUAUGAUGCCAACUAUUUUCUUUGCUGGCAUACUAAUUGUUACGACUAUUGUAUACCUUACAAUAGUGUAACUUCUUCAAUUGUCAUUACUUCAGGUGAUGGCACAACAAGUCCUAUUUCUGAACAUGACUACCAGAUUGGUGGUUAUACUGAAAAAUGGGAAUCUGGAGUAAAAGACUGUGUUGUAUUACACAGUUACUUCACUUCAGACUAUUACCAGCUGUACUCAACUCAAUUGAGUACAGACACUGGUGUUGAACAUGUUACCUUCUUCAUCUACAAUAAAAUUGUUGAUGAGCCUGAAGAACAUGUCCAAAUUCACACAAUCGACGGUUCAUCCGGAGUUGUUAAUCCAGUAAUGGAACCAAUUUAUGAUGAACCGACGACGACUACUAGCGUGCCUUUGUAAGCACAAGCUGAUGAGUACGAACUUAUGUACUCAUUCGUUUCGGAAGAGACAGGUACGUUAAUAGUUAAUAGCGUACUUCUUUUUCUUGCUUUCGUGGUAUUCUUGCUAGUUACACUAGCCAUCCUUACUGCGCUUCGAUUGUGUGCGUACUGCUGCAAUAUUGUUAACGUGAGUCUUGUAAAACCUUCUUUUUACGUUUACUCUCGUGUUAAAAAUCUGAAUUCUUCUAGAGUUCCUGAUCUUCUGGUCUAAACGAACUAAAUAUUAUAUUAGUUUUUCUGUUUGGAACUUUAAUUUUAGCCAUGGCAGAUUCCAACGGUACUAUUACCGUUGAAGAGCUUAAAAAGCUCCUUGAACAAUGGAACCUAGUAAUAGGUUUCCUAUUCCUUACAUGGAUUUGUCUUCUACAAUUUGCCUAUGCCAACAGGAAUAGGUUUUUGUAUAUAAUUAAGUUAAUUUUCCUCUGGCUGUUAUGGCCAGUAACUUUAGCUUGUUUUGUGCUUGCUGCUGUUUACAGAAUAAAUUGGAUCACCGGUGGAAUUGCUAUCGCAAUGGCUUGUCUUGUAGGCUUGAUGUGGCUCAGCUACUUCAUUGCUUCUUUCAGACUGUUUGCGCGUACGCGUUCCAUGUGGUCAUUCAAUCCAGAAACUAACAUUCUUCUCAACGUGCCACUCCAUGGCACUAUUCUGACCAGACCGCUUCUAGAAAGUGAACUCGUAAUCGGAGCUGUGAUCCUUCGUGGACAUCUUCGUAUUGCUGGACACCAUCUAGGACGCUGUGACAUCAAGGACCUGCCUAAAGAAAUCACUGUUGCUACAUCACGAACGCUUUCUUAUUACAAAUUGGGAGCUUCGCAGCGUGUAGCAGGUGACUCAGGUUUUGCUGCAUACAGUCGCUACAGGAUUGGCAACUAUAAAUUAAACACAGACCAUUCCAGUAGCAGUGACAAUAUUGCUUUGCUUGUACAGUAAGUGACAACAGAUGUUUCAUCUCGUUGACUUUCAGGUUACUAUAGCAGAGAUAUUACUAAUUAUUAUGAGGACUUUUAAAGUUUCCAUUUGGAAUCUUGAUUACAUCAUAAACCUCAUAAUUAAAAAUUUAUCUAAGUCACUAACUGAGAAUAAAUAUUCUCAAUUAGAUGAAGAGCAACCAAUGGAGAUUGAUUAAACGAACAUGAAAAUUAUUCUUUUCUUGGCACUGAUAACACUCGCUACUUGUGAGCUUUAUCACUACCAAGAGUGUGUUAGAGGUACAACAGUACUUUUAAAAGAACCUUGCUCUUCUGGAACAUACGAGGGCAAUUCACCAUUUCAUCCUCUAGCUGAUAACAAAUUUGCACUGACUUGCUUUAGCACUCAAUUUGCUUUUGCUUGUCCUGACGGCGUAAAACACGUCUAUCAGUUACGUGCCAGAUCAGUUUCACCUAAACUGUUCAUCAGACAAGAGGAAGUUCAAGAACUUUACUCUCCAAUUUUUCUUAUUGUUGCGGCAAUAGUGUUUAUAACACUUUGCUUCACACUCAAAAGAAAGACAGAAUGAUUGAACUUUCAUUAAUUGACUUCUAUUUGUGCUUUUUAGCCUUUCUGCUAUUCCUUGUUUUAAUUAUGCUUAUUAUCUUUUGGUUCUCACUUGAACUGCAAGAUCAUAAUGAAACUUGUCACGCCUAAACGAACAUGAAAUUUCUUGUUUUCUUAGGAAUCAUCACAACUGUAGCUGCAUUUCACCAAGAAUGUAGUUUACAGUCAUGUACUCAACAUCAACCAUAUGUAGUUGAUGACCCGUGUCCUAUUCACUUCUAUUCUAAAUGGUAUAUUAGAGUAGGAGCUAGAAAAUCAGCACCUUUAAUUGAAUUGUGCGUGGAUGAGGCUGGUUCUAAAUCACCCAUUCAGUACAUCGAUAUCGGUAAUUAUACAGUUUCCUGUUUACCUUUUACAAUUAAUUGCCAGGAACCUAAAUUGGGUAGUCUUGUAGUGCGUUGUUCGUUCUAUGAAGACUUUUUAGAGUAUCAUGACGUUCGUGUUGUUUUAGAUUUCAUCUAAACGAACAAACUAAAAUGUCUGAUAAUGGACCCCAAAAUCAGCGAAAUGCACCCCGCAUUACGUUUGGUGGACCCUCAGAUUCAACUGGCAGUAACCAGAAUGGAGAACGCAGUGGGGCGCGAUCAAAACAACGUCGGCCCCAAGGUUUACCCAAUAAUACUGCGUCUUGGUUCACCGCUCUCACUCAACAUGGCAAGGAAGACCUUAAAUUCCCUCGAGGACAAGGCGUUCCAAUUAACACCAAUAGCAGUCCAGAUGACCAAAUUGGCUACUACCGAAGAGCUACCAGACGAAUUCGUGGUGGUGACGGUAAAAUGAAAGAUCUCAGUCCAAGAUGGUAUUUCUACUACCUAGGAACUGGGCCAGAAGCUGGACUUCCCUAUGGUGCUAACAAAGACGGCAUCAUAUGGGUUGCAACUGAGGGAGCCUUGAAUACACCAAAAGAUCACAUUGGCACCCGCAAUCCUGCUAACAAUGCUGCAAUCGUGCUACAACUUCCUCAAGGAACAACAUUGCCAAAAGGCUUCUACGCAGAAGGGAGCAGAGGCGGCAGUCAAGCCUCUUCUCGUUCCUCAUCACGUAGUCGCAACAGUUCAAGAAAUUCAACUCCAGGCAGCAGUAGGGGAACUUCUCCUGCUAGAAUGGCUGGCAAUGGCGGUGAUGCUGCUCUUGCUUUGCUGCUGCUUGACAGAUUGAACCAGCUUGAGAGCAAAAUGUCUGGUAAAGGCCAACAACAACAAGGCCAAACUGUCACUAAGAAAUCUGCUGCUGAGGCUUCUAAGAAGCCUCGGCAAAAACGUACUGCCACUAAAGCAUACAAUGUAACACAAGCUUUCGGCAGACGUGGUCCAGAACAAACCCAAGGAAAUUUUGGGGACCAGGAACUAAUCAGACAAGGAACUGAUUACAAACAUUGGCCGCAAAUUGCACAAUUUGCCCCCAGCGCUUCAGCGUUCUUCGGAAUGUCGCGCAUUGGCAUGGAAGUCACACCUUCGGGAACGUGGUUGACCUACACAGGUGCCAUCAAAUUGGAUGACAAAGAUCCAAAUUUCAAAGAUCAAGUCAUUUUGCUGAAUAAGCAUAUUGACGCAUACAAAACAUUCCCACCAACAGAGCCUAAAAAGGACAAAAAGAAGAAGGCUGAUGAAACUCAAGCCUUACCGCAGAGACAGAAGAAACAGCAAACUGUGACUCUUCUUCCUGCUGCAGAUUUGGAUGAUUUCUCCAAACAAUUGCAACAAUCCAUGAGCAGUGCUGACUCAACUCAGGCCUAAACUCAUGCAGACCACACAAGGCAGAUGGGCUAUAUAAACGUUUUCGCUUUUCCGUUUACGAUAUAUAGUCUACUCUUGUGCAGAAUGAAUUCUCGUAACUACAUAGCACAAGUAGAUGUAGUUAACUUUAAUCUCACAUAGCAAUCUUUAAUCAGUGUGUAACAUUAGGGAGGACUUGAAAGAGCCACCACAUUUUCACCGAGGCCACGCGGAGUACGAUCGAGUGUACAGUGAACAAUGCUAGGGAGAGCUGCCUAUAUGGAAGAGCCCUAAUGUGUAAAAUUAAUUUUAGUAGUGCUAUCCCCAUGUGAUUUUAAUAGCUUCUUAGGAGAAUGACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,0.3nM-7.5 nM[SARS-CoV-2];|4 µM[SARS-CoV-2 N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,"liquid, solute","Pure N-protein demixed into droplets (consistent with results from the Morgan [Carlson et al., 2020] and Fawzi [Myrto Perdikari et al., 2020] labs) and LLPS was enhanced by RNA extracted from the culture medium supernatant of infected cells containing full-length SARS-CoV-2 genome",29903
139,541,PMID: 33290746,RNAPS0000451,https://pubmed.ncbi.nlm.nih.gov/33290746,RNAs + protein,-;|-,-;|-,SARS-CoV-2 virus RNA;|SARS-CoV-2 virus RNA,996nt(13404-14400);|1000nt(1-1000),ACUGAAGUGUAUUACCAGUUAUGAAGAAAAUAGGGCAAUACUCAACACACAUAAAAACAAUACCUCUGGCCAAAAACAUGACAGUUGUAACUACACCUGAGUAGUUAGAAGUAACAGAGAUUAUAAGAGCCCACAUGGAAAUGGCUUGAUCUAAAGCAUUACCAUAAUAAACUUUAUAAACGAGUGUCAAGACAUUCAUAAGUGUCCACACUCUCCUAGCACCAUCAUCAUACACAGUUCUUGCUGUCAUAAGGAUUAGUAACACUACAGCUGAUGCAUACAUAACACAGUCUUUUAGCUUAAAACCAGACAAACUAGUAUCAACCAUAUCCAACCAUGUCAUAAUACGCAUCACCCAACUAGCAGGCAUAUAGACCAUAUUAAAAUAAGCUACAGUGGCAAGAGAAGGUAACAAAAACAAACAGAGAAAUGCAUGCUUAUGUUUGACAAACAUCAUUGCAAAAGCAGACAUAGCAAUAAUACCCAUAGCAAAAGGUAAAAAGGCAUUUUCAUACAAAAAAAAGAACAAAGACCAUUGAGUACUCUGGACUAAAACUAAAAGUGAAGUCAAAAUUGUGAGUAACAACCAGUGGUGUGUACCCUUGAUUGUUCUUUUCACUGCACUUUGGAAAGUAACACCUGAGCAUUGUCUAACAACAUCAAAAGGUGUAAAUUCAUCUUCUAAUAAAGCACUACCCAAUAUGGUACGUCCAUUCAUACCAUUUUGCAGUAAUUCUUUUAAUGAAGCACACAUAUCUAAAACGGCAAUUCCAGUUUGAGCAGAAAGAGGUCCUAGUAUGUCAACAUGGUCUUGUGUUAGAGGUUCAUAAUUGUACUUCAUAGCCACAAGGUUAAAGUCAUUAAGAGUUGUGGUAAAUCGAUUGAGAAACCACCUGUCUCCAUUUAUAACAGCAGCGUACAACCAAGCUAAAACAUUAACUGUAAUAGUUGUGUCCGUACCAGCUGCUUGUGCUGUUUGCCUGUCAACAAAAGGUC;|GGUUAAUGUUGUCUACUGUUGUAAACACCUUAAUAGUCCUCACUUCUCUCAAAGAAAGAAGUGUCUUAAGAUUGUCAAAGGUGAUAACUUCACCAUCUAGGUGGAAUGUGGUAGGAUUACUAGUGUAAUAUACACUUUUAUCACCUCUCUUAAGAAAUUCUAUACCUAGUUGUGUAGAUUGUCCAGAAUAGGACCAAUCUUUAUAGGAACCAGCAAGUGAGAUGGUUUCAAUAAAAUGUUCUUCAGGUGUUUUAGAAGAAGAAGUAAGAUAACCAUUAUACGCUGUAACAGCAUCAGGUGAAGAAACAGAAACUGUAGCUGGCACUUUGAGAGAUCUCAUAUACCGAGCAGCUUCUUCCAAAUUUAAGCCAUGUGUUACAUAGCCAAGUGGCAUUGUAACAAGAGUUUCAUUUAGAUCGUUAAGUGUGUUGAUAAGUGACGCUACAGUUGUUUUACUGGUGUAAAAGUAAAAUCUAGCACCAUAAUCAACCACACCCUCUUGUAUUUUAAUACCCUUAUAUUUACGCUGUAUAGUUGAAACUAUGGCUUUAGUUUCCACACAGACAGGCAUUAAUUUGCGUGUUUCUUCUGCAUGUGCAAGCAUUUCUCGCAAAUUCCAAGAAACAGUUCCAAGAAUUUCUUGCUUCUCAUUAGAGAUAAUAGAUGGUAGAAUGUAAAAGGCACUUUUACACUUUUUAAGCACUGUCUUUGCCUCCUCUACAGUGUAACCAUUUAAACCCUGACCCGGGUAAGUGGUUAUAUAAUUGUCUGUUGGCACUUUUCUCAAAGCUUUCGCUAGCAUUUCAGUAGUGCCACCAGCCUUUUUAGUAGGUAUAACCACAGCAGUUAAAACACCCUCUUGAACAACAUCACCCACUAUAUAUGGAGCAUCUUUCUUUAAGAAAGUGAUGUCAAUGUCACUAACAAGAGUGGCAGAAUCUGGAUGAAGAUUGCCAUUAAUGUCAAUAUAAAGUAACAAGUUUUCUGUGAGGAACUUAGU,virus RNA;|virus RNA,SARS-CoV-2 virus;|SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 nM [SARS-CoV-2 5‘end];|50 nM [SARS-CoV-2 frameshifting],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,solute,"We mixed frameshifting region RNA with either 5’ end or nucleocapsid RNA. Mixtures con taining the 5’ end and frameshifting region produced droplets of intermediate properties, including smaller size and more numerous assemblies. Similarly, frameshifting region RNA made nucleocapsid RNA condensates less flocculated and smaller",996
140,542,PMID: 33290746,RNAPS0000452,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,3000nt(5' end region),-,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5 nM[SARS-CoV-2 5'end];|2 µM[N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,liquid,"Addition of 0.3 kb or 2.4 kb of non-viral sequence to the 1 kb 5’ end or frameshifting re gion RNAs resulted in progressive increase in condensate size/ number, with the 5’ end driving enhanced condensates relative to the frameshifting region at all lengths tested",3000
141,543,PMID: 33290746,RNAPS0000452,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,SARS-CoV-2 virus RNA,3000nt(frameshift region),-,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5 nM[SARS-CoV-2 frameshifting];|2 µM[N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,liquid,"Addition of 0.3 kb or 2.4 kb of non-viral sequence to the 1 kb 5’ end or frameshifting re gion RNAs resulted in progressive increase in condensate size/ number, with the 5’ end driving enhanced condensates relative to the frameshifting region at all lengths tested",3000
142,566,PMID: 33649309,RNAPS0000473,https://pubmed.ncbi.nlm.nih.gov/33649309,RNA + protein,-,-,polyA,2100–10000nt,-,poly RNA,-,"sp|Q6ZN16|M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens OX=9606 GN=MAP3K15 PE=1 SV=2
MESGGGNAPAGALGAASESPQCPPPPGVEGAAGPAEPDGAAEGAAGGSGEGESGGGPRRA
LRAVYVRSESSQGGAAGGPEAGARQCLLRACEAEGAHLTSVPFGELDFGETAVLDAFYDA
DVAVVDMSDVSRQPSLFYHLGVRESFDMANNVILYHDTDADTALSLKDMVTQKNTASSGN
YYFIPYIVTPCADYFCCESDAQRRASEYMQPNWDNILGPLCMPLVDRFISLLKDIHVTSC
VYYKETLLNDIRKAREKYQGEELAKELARIKLRMDNTEVLTSDIIINLLLSYRDIQDYDA
MVKLVETLEMLPTCDLADQHNIKFHYAFALNRRNSTGDREKALQIMLQVLQSCDHPGPDM
FCLCGRIYKDIFLDSDCKDDTSRDSAIEWYRKGFELQSSLYSGINLAVLLIVAGQQFETS
LELRKIGVRLNSLLGRKGSLEKMNNYWDVGQFFSVSMLAHDVGKAVQAAERLFKLKPPVW
YLRSLVQNLLLIRRFKKTIIEHSPRQERLNFWLDIIFEATNEVTNGLRFPVLVIEPTKVY
QPSYVSINNEAEERTVSLWHVSPTEMKQMHEWNFTASSIKGISLSKFDERCCFLYVHDNS
DDFQIYFSTEEQCSRFFSLVKEMITNTAGSTVELEGETDGDTLEYEYDHDANGERVVLGK
GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKYLKHRNIVQYLGSVSENG
YIKIFMEQVPGGSLSALLRSKWGPMKEPTIKFYTKQILEGLKYLHENQIVHRDIKGDNVL
VNTYSGVVKISDFGTSKRLAGVNPCTETFTGTLQYMAPEIIDQGPRGYGAPADIWSLGCT
IIEMATSKPPFHELGEPQAAMFKVGMFKIHPEIPEALSAEARAFILSCFEPDPHKRATTA
ELLREGFLRQVNKGKKNRIAFKPSEGPRGVVLALPTQGEPMATSSSEHGSVSPDSDAQPD
ALFERTRAPRHHLGHLLSVPDESSALEDRGLASSPEDRDQGLFLLRKDSERRAILYKILW
EEQNQVASNLQECVAQSSEELHLSVGHIKQIIGILRDFIRSPEHRVMATTISKLKVDLDF
DSSSISQIHLVLFGFQDAVNKILRNHLIRPHWMFAMDNIIRRAVQAAVTILIPELRAHFE
PTCETEGVDKDMDEAEEGYPPATGPGQEAQPHQQHLSLQLGELRQETNRLLEHLVEKERE
YQNLLRQTLEQKTQELYHLQLKLKSNCITENPAGPYGQRTDKELIDWLRLQGADAKTIEK
IVEEGYTLSDILNEITKEDLRYLRLRGGLLCRLWSAVSQYRRAQEASETKDKA",ASK3,-,-,1313aa(1-1313),Q6ZN16,-,-,"[1-58],[939-958]","[4-16],[23-57],[73-83],[112-131],[1280-1293]",In vitro,2.5 µM[polyA],150 mM NaCl,"20 mM Tris (pH 7.5), 1 mM DTT",0˚C,15 min,crowding agent:20% PEG,Electron microscopy,solute,"Of note, we found that poly(A) RNA also inhibits the formation of solid-like ASK3 condensates in vitro, suggesting that the common physicochemical property between PAR and RNA is important for the liquidity maintenance of ASK3 condensates.",10000
143,571,PMID: 33762340,RNAPS0000144,https://pubmed.ncbi.nlm.nih.gov/33762340,RNAs + protein,NCBI ID:18870687;|-,https://www.ncbi.nlm.nih.gov/gene/18870687;|-,GLS1;|GIRGL,5926nt(1-5926);|-,CUUCUUUUAGUGUCGUAACAUCGAUUUAUACCUAACCAUCCAAUCCUUAUCAUCAUUGCCACUAACCACUGUCCUACCUUUUCUAAGAAAGCAGUAGUAAUAGCAAUAUAAAUAUAAGUCAGAUGUCGUAUAACGAUAAUAAUCACAAUUAUUAUGAUCCCAACCAACAGCCCAGUGGUGCUCCACUUCAGGGUGAUGGUUACUAUCAACAACCAUAUGAUGAUAUGAACCAACAACAACAAGAUUACUAUGAUCCAAAUGUUCAAUAUCAACAACAACCAUAUGAUAUGGAUGGAUACCAGGAUGGUGCCCAAUACGGUAGUCAACCUGCCCAAGGUUAUAAUGCUGAUCCAGAAGCCUUUUCUGAUUUCAGUUAUGGUGGUCAAACUCCAGGUGCUUCAUAUGAUCAAUAUGGUACCCAAUACACUCCUUCUCAAAUGAGUUAUGGUGGUGACCCAAGAUCUUCUGGUGCCUCAACUCCAAUUUAUGGAGGUCAAGGUCAAGGAUAUGAUCCAUCACAAUUCCAAAUGUCAUCUAACUUACCUUAUCCUGCUUGGUCUGCUGAUCCUCAAGCUCCAAUCAAGGUUGAGCAUAUUGAAGAUAUCUUUAUUGAUUUAACAAACAAGUUUGGUUUCCAAAGAGAUUCUAUGAGAAAUAUGUUUGAUUACUUUAUGACCUUGUUAGAUUCUAGAUCCUCAAGAAUGUCACCAGCUCAAGCACUUUUAAGUUUACACGCUGAUUAUAUUGGUGGUGAAAAUGCUAAUUAUAGAAAAUGGUUCUUUUCUUCCCAACAAGAUUUAGACGAUUCUCUCGGUUUUGCUAAUAUGGCCUUAGGUAAGAUUGGUAGAAAGGCUAGAAAAGCAUCCAAGAAGUCUAAGAAGGCAAGAAAGGCAGCCGAAGAACAUGGUGAAGAUGUUGAUGCUCUUGCUACUGAAUUAGAAGGUGAUUAUUCAUUGGAAGCUGCUGAAAUCAGAUGGAAAGCCAAGAUGAACACUUUAACUCCUGAAGAAAGAGUUCGUGAUAUUGCUCUUUACGUGUUAUUAUGGGGUGAAGCUAAUCAAGUUCGUUUUACUCCAGAAUGUUUAUGUUAUAUCUACAAGACUGCAUCUGAUUACUUGAACUCUCCAUUGUGUCAACAAAGACAAGAACCAGUUCCUGAAGGUGAUUAUUUGAACAGAGUUAUUACCCCAUUAUAUAGAUUCCUUAGAUCUCAAGUUUAUGAGAUUUACGAAGGUAAAUUCGUCAAACGUGAAAAGGAUCACAAUAAGGUUAUUGGUUAUGAUGAUGUUAAUCAAUUAUUUUGGUACCCAGAGGGUAUUUCCAGAAUCAUGUUUGAAGAUGGAACAAGAAUGGUGGAUAUUCCACAAGAAGAACGUUAUUUAAGACUUGGUGAAGUUGAAUGGAAUAAUGUAUUCUUCAAAACUUAUAAGGAAAUUAGAACUUGGUUACAUUUCAUUACUAAUUUCAAUAGAAUUUGGAUUAUCCAUGCAAGUAUUUACUGGAUGUAUACUGCUUACAACUCCCCAACCUUAUAUACCAAGAAUUACGUUCAAACCAGAAACCAACAACCUCUUGCUUCUUCAAGAUGGGCUGCUUGUGCUAUUGGUGGUGUCGUUGCUUCCCUUAUUCAAAUUUUUGCUACCCUUUUUGAAUGGAUGUUUGUUCCAAGAGAAUGGGCUGGUGCUCAACAUUUGACUCGUCGUUUAAUGUUUUUGAUUUUGAUUUUCUUUGUUAACUUGGCUCCUGUGGUUUAUACAUUCAAGAUUACUGGUUUAACAUUAUACUCCAAAUCUGCUUACGCGGUCUCAAUUGUUGGUUUCUUUAUUGCUGUUGCCACCAUUAUUUUCUUUGCCGUUAUGCCAUUGGGUGGGUUAUUCACUUCAUACAUGAACAAGAGAUCUAGAAGAUAUAUUUCAUCUCAAACUUUCACUGCUAAUUUCAUCAAGUUGAAGGGUUUGGAUAUGUGGAUGUCAUAUUUAUUAUGGUUCUUAGUUUUCCUUGCCAAGUUGGUCGAAUCUUAUUUCUUCUUGACCUUAUCUAUUAGAGAUCCUAUUAGAAUUUUGUCCACCACUACCAUGAGAUGUGUUGGUGAAGUUUGGUAUAAGGAAGCAGUUUGCAGAAACCAAGCUAAGAUUGUUUUGGGUUUGAUGUACCUUGUUGAUUUGUUAUUGUUCUUCUUGGAUACUUACAUGUGGUACAUUAUUUGUAACUGUAUCUUCUCCAUCGGUCGUUCCUUCUACUUGGGUAUUUCUAUCUUGACUCCAUGGAGAAACAUUUUCACCAGAUUGCCAAAGAGAAUCUACUCCAAGAUUUUAGCUACCACUGAAAUGGAAAUUAAGUAUAAGCCAAAGGUUUUGAUUUCCCAAAUCUGGAACGCUAUUGUGAUUUCUAUGUACAGAGAACAUUUGUUAGCCAUUGACCAUGUCCAAAAGUUAUUAUACCACCAAGUUCCUUCAGAAAUUGAAGGUAAGAGAACUUUGAGAGCUCCAACUUUCUUUGUUUCUCAAGAUGAUAACAACUUUGAAACUGAAUUCUUCCCAAGAAAUUCCGAAGCUGAAAGAAGAAUUUCUUUCUUUGCUCAAUCUUUAGCUACUCCAAUUCCAGAACCAUUACCAGUUGACAACAUGCCUACUUUUACUGUUUUCACUCCUCACUAUUCUGAAAAGAUUUUGUUAUCAUUGAGAGAAAUUAUUAGAGAAGAUGAUCAAUUCUCUAGAGUUACUUUAUUGGAAUACUUGAAACAAUUGCACCCAGUUGAAUGGGACUGUUUUGUCAAGGAUACUAAGAUUUUGGCUGAAGAAACUGCUGCCUACGAAAAUGGCGAUGAUUCCGAAAAGAUGUCUGAAGAUGGAUUGAAAUCUAAGAUUGAUGAUUUACCAUUCUACUGUAUUGGUUUCAAGUCUGCUGCCCCUGAAUAUACUUUAAGAACUAGAAUCUGGGCCUCUUUGAGAUCUCAAACUUUAUAUAGAACUGUUUCUGGUUUCAUGAAUUAUGCUAGAGCUAUCAAGUUGUUGUACAGAGUUGAAAACCCAGAAUUGGUUCAAUACUUUGGUGGCGAUCCAGAAGGUUUAGAAAUGGCUUUGGAAAAGAUGGCUAGAAGAAAGUUUAGAUUCUUGGUUUCUAUGCAAAGAUUGUCCAAGUUUAAGGAUGAUGAAAUGGAAAAUGCUGAAUUCUUGUUACGUGCUUACCCAGAUUUACAAAUUGCUUACUUAGAUGAAGAACCUGCUGAAGAAGGUGAAGACGCUAGAGUUUACUCCUCAUUGAUUGAUGGUCAUUGUGAAAUGUUAGAAAACGGAAGACGUCGUCCUAAGUUCAGAGUUCAAUUGUCUGGUAAUCCAAUUUUGGGUGAUGGUAAGUCUGAUAACCAAAAUCAUGCUGUUAUUUUCCACAGAGGUGAAUAUAUUCAAUUGAUUGAUGCUAACCAAGAUAACUAUUUGGAAGAAUGUUUGAAGAUUAGAUCUGUUUUGGCUGAAUUUGAAGAAUUGAAUGUUGAACAUGUUAACCCAUAUGCUCCAAACUUGAAGAGUGAAGAAUUGAAGGACAAAAAGGAACCUGUUGCUUUCUUGGGUGCUAGGGAAUAUAUUUUCUCUGAAAACUCUGGUGUUUUGGGUGAUGUUGCCGCUGGUAAAGAACAAACUUUUGGUACCUUGUUUGCUAGAACUUUGGCUCAAAUUGGUGGUAAAUUGCAUUAUGGUCACCCGGAUUUCUUAAAUGCUACAUUUAUGUUAACUAGAGGUGGUGUUUCUAAGGCUCAAAAGGGUUUACAUUUGAACGAAGAUAUUUAUGCUGGUAUGAAUGCUAUGAUGAGAGGUGGUAAGAUUAAGCAUUGUGAAUACUACCAAUGUGGUAAAGGUAGAGAUAUGGGUUUCGGCUCUAUUUUGAAUUUCACUACUAAGAUUGGUGCUGGUAUGGGUGAACAAAUGUUGUCCAGAGAAUACUACUACUUGUCUACUCAAUUACCAUUGGAUCGUUUCUUGUCUUUCUACUAUGGUCAUCCAGGUUUCCAUAUUAAUAACUUGUUCAUUCAAUUGUCUUUACAAGUUUUCAUUUUGGUUUUGGCUAACUUGAACUCUUUGGCUCAUGAAUCUAUUAUGUGUUCUUACAACAAGGAUGUUCCAAUUACUGAUGUUUUAUAUCCAUAUGGUUGUUACAACUUGGCUCCAGCUGUUGAUUGGGUUAGACGUUAUACUUUAUCCAUUUUCAUUGUCUUCUUUAUUUCCUUCAUCCCAUUGGUUGUUCAAGAAUUAAUUGAAAGAGGUGUUUGGAAGGCUUUCCAAAGAUUUGUUAGACAUUUCCUUUCCUUAUCACCAAUGUUUGAAGUUUUCGUUGCCCAAAUCUAUUCUUCAUCUGUUUUCACUGAUUUAACUGUUGGUGGUGCUAGAUAUAUUUCCACUGGUAGAGGUUUUGCCACUUCAAGAAUCCCAUUUUCAAUUUUGUACUCCCGUUUUGCUGAUUCUUCUAUUUACAUGGGUGCAAGAUUGAUGUUGAUUUUAUUAUUCGGUAGUGUUUCUAAAUGGCAAGCUCCAUUAUUGUGGUUCUGGGCUUCAUUGUCAUCAUUGAUGUUUUCACCAUUUAUUUUCAACCCUCAUCAAUUUGCUUGGGAAGAUUUCUUCAUUGAUUACAGAGAUUUCAUUAGAUGGUUAUCCAGAGGUAAUACCAAGUGGCACAGAAACUCAUGGAUUGGUUACAUUAGACUUUCUAGAUCUCGUGUUACUGGUUUCAAGAGGAAGAUGAUUGAUGAUAUUUCUGAAAAGUCUGCUGGUGAUGCAUCCAGAGCUCACAGAUCCAACAUCUUGUUUGCUGAUUUCAUUCCAUGUCUUCUUUACACUGCUGGUCUUUAUGUUGCCUUUGUUUUCAUUAAUGCCCAAACUGGGGUUACUGAAUAUCCAUAUGAAAUUUUGGGUUCUAGAAGGCCACAACCAGUCAAUGCUACUUUGAGAGUUGUUAUUUGUGCAUUAGCUCCUGUUGUUAUUGACAUGGGUAUUUUAGCUGUCUGUGUUGCCAUGGCCUGUUGUGCUGGUCCAAUGUUGGGUAUGUGUUGCAAGAAGACUGGUGCUGUUAUUGCUGGUGUUGCCCAUGGUGGUGCUGUCAUUGUUCACAUUGUUUUCUUUAUUGUCAUGUGGGUCUUGGAAGGUUUCAACUUUGCCAGAUUAUUAUUAGGAUUUGCCACUAUGAUUUACAUUCAAAGAUUAUUAUUCAAGUUUUUAACCUUGUGUUUCUUGACUAGAGAAUUCAAGAACGAUAAGGCCAACACUGCCUUCUGGACUGGUAAGUGGUAUAACACUGGUAUGGGAUGGAUGGCUUUCACUCAACCAUCUCGUGAAUUUGUUGCCAAGAUUAUUGAAAUGUCUGAAUUUGCCGGUGAUUUCGUAUUGGCUCAUAUCAUUUUAUUCUGUCAAUUACCAGUGUUGUGUAUUCCAUUGAUUGACAGAUGGCACUCUACUAUGUUAUUCUGGUUGAAACCAUCUAGAUUGAUUAGACCACCAAUUUACUCAUUGAAGCAAGCUAGAUUAAGAAAGAGAAUGGUUAGAAAAUACUGUACAUUAUACUUUGCCAUUUUGGUAUUAUUUGUUGUUAUUAUUGUUGCCCCAGCUGUUGGUUCCAGUCAAGUUGCUGUUGAUCAAUUUGCUAACAUUGGUGGUAAUGGAUCUAUCAUCAAUGGUUUGUUCCAACCAAGAAACAUCAGUAACAACGAUACUGGUCCAAACAGACCUAAAUCAUACACCUGGUCUUAUUUCAGUACUCCAGAAAAGGGUAAGACCAAGGGUUAUUCUACCAACCCAUUCUAGAGUAUUGGUUUAAAAAAAGAUGUGUAUCAUUAGAUAUUUUUGUUGCCGAUUAUCAUUUAACAUUUUGUUUAUUUUGUUUAUACAAGUUCUUUAUAUACUUUUUUUUAUAUUAAAUUCAUGGAUUAUUACUGUUAACU;|-,mRNA;|lncRNA,Spathaspora passalidarum;|Homo sapiens,"sp|Q14444|CAPR1_HUMAN Caprin-1 OS=Homo sapiens OX=9606 GN=CAPRIN1 PE=1 SV=2
MPSATSHSGSGSKSSGPPPPSGSSGSEAAAGAGAAAPASQHPATGTGAVQTEAMKQILGV
IDKKLRNLEKKKGKLDDYQERMNKGERLNQDQLDAVSKYQEVTNNLEFAKELQRSFMALS
QDIQKTIKKTARREQLMREEAEQKRLKTVLELQYVLDKLGDDEVRTDLKQGLNGVPILSE
EELSLLDEFYKLVDPERDMSLRLNEQYEHASIHLWDLLEGKEKPVCGTTYKVLKEIVERV
FQSNYFDSTHNHQNGLCEEEEAASAPAVEDQVPEAEPEPAEEYTEQSEVESTEYVNRQFM
AETQFTSGEKEQVDEWTVETVEVVNSLQQQPQAASPSVPEPHSLTPVAQADPLVRRQRVQ
DLMAQMQGPYNFIQDSMLDFENQTLDPAIVSAQPMNPTQNMDMPQLVCPPVHSESRLAQP
NQVPVQPEATQVPLVSSTSEGYTASQPLYQPSHATEQRPQKEPIDQIQATISLNTDQTTA
SSSLPAASQPQVFQAGTSKPLHSSGINVNAAPFQSMQTVFNMNAPVPPVNEPETLKQQNQ
YQASYNQSFSSQPHQVEQTELQQEQLQTVVGTYHGSPDQSHQVTGNHQQPPQQNTGFPRS
NQPYYNSRGVSRGGSRGARGLMNGYRGPANGFRGGYDGYRPSFSNTPNSGYTQSQFSAPR
DYSGYQRDGYQQNFKRGSGQSGPRGAPRGRGGPPRPNRGMPQMNTQQVN",CAPRIN1,-,-,709aa(1-709),Q14444,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0521,"[1-50],[251-251],[260-291],[417-446],[475-499],[524-709]","[2-43],[61-81],[178-188],[258-282],[311-324],[328-337],[477-491],[537-552],[555-570],[607-620],[676-704]",In vitro,0.2 µM [GLS1];|0.2 µM [GIRGL];|20 µM [CAPRIN1],30 mM NaCl,"25 mM Na2HPO4(pH 7.4), 2 mM DTT",RT,-,-,Epifluorescence microscopy,liquid,"Formation of the CAPRIN1-containing condensates was dependent on the concentration of 3'UTR-1 GLS1 mRNA (fig. S5N), and moreover, these droplets were observed to undergo fusion events (fig. S5O), characteristic of protein droplets formed by liquid-liquid phase separation. Notably, the frequency of phase droplet formation between CAPRIN1 and GLS1 mRNA was comparatively increased when full-length sense, but not antisense, GIRGL was added to these assays.",5926
144,575,PMID: 27802129,RNAPS0000518,https://pubmed.ncbi.nlm.nih.gov/27802129,RNA + protein,NCBI ID:100101736,https://www.ncbi.nlm.nih.gov/gene/100101736,ccbn1,1315nt(1-1315),UGCAGUUUGUGUAAGACAAGAGGUUGUGGAUUUCCCCUAUGAUGGCACUGAUUAUGACUCGGAGUAUGCGGCUCAAUGUGGAGAAUGUGGAACCAGGCAUGGCUGGAAGGAAAGCCGCUGUGUCCAAGCCUGUGCUGAGGCCUAGGAAUGCACUGGGUGAUAUUGGGAACCAAAUAAGCAAGGCAAAAGUUCCCCUAAAGAGAGCAACAAAAGCACUUCGCAAACCCCCUGUAGAGAAAUCGGAGAAACUGAUUGUACCAGAUGAGAAUGACCCUAAGGAAGCACAGCCCGUGCCUGAUUCUCCUAACCGAAUGGAGACUUCUGUGUGUGUAAUAGAAGAGAUACCUCCUGCUUUCUCCAGUGCCCUAAUUCCAAUGAAAGAUGUAGAUGCAGAAGAUUCAGACAACCCAAUGCUGUGCAGUGACUAUGUGAAGGACAUCUACUGUUAUCUUAGGAACAUGGAGGCUAGACAAGCAAUCAGGCCACACUAUCUAGAUGGUCAGGAGAUCAAUGGAAACAUGAGGGCCAUAUUGGUAGACUGGCUUGUGCAGGUCCAUCUGAGGUUUAAACUGCUGCAGGAGACCAUGUCUAUGACCAUAGCUAUUCUGGAUCGUUUUCUGCAGGAAAAUCCUGUUCCCAAGAAACUGUUGCAGCUGGCUGGUGUGAGCGCAAUGUUCAUUGCAUGCAAAUAUGAAGAGAUCUAUUGUCCAACAAUUGGUGACUUUGCCUUUGUCACUGACCACACUUACACAAAGUCCCAAAUCAGAAACAUGGAAAUGCAAAUCCUUAGAGUUCUCAAAUUUGACAUUGGGAGGCCACUGCCACUGCAUUUCUUGAGAAGAGCAUCUAAAAUUGGGGAGGUGGACUCUGUACAUCACACACUGGCUAAAUACCUAAUAGAGCUGGUUAUGACAGACUAUGACAUGGUGCACGUACCUCCCUCCCAGUUGGCGGCAGCAGCUUUCUGUUUGGCAAUGAAGAUUCUUAAUAGUGGAGAAUGGACUCCUGUUCUUGAGCACUACAUGGCUUAUAAAGAGAGUUCCCUUAUGCCAGUCAUGCAGCACAUCGCAAAGAAUAUUGUAAAGGUCAAUGGAGGACACACAAAGUUCCUGUCUGUAAAAAGCAAAUACAGCAGCAGUCGACAGAUGAAGGUCAGCUGCCUGCCCCAUCUGAAGUCUGAGCUUGUGGAAAGCCUGGCAAAAGCUGCAUCAUAAGACUCCUGUUUAUAACACUUUUUACCAAUGCUCUUAACUGUAUUUUAUCCUUUUAAUAAAGAUUAUUUUAAGUGUGAAAAAAAAAAAAAAAAAAAAAAAAA,mRNA,Xenopus tropicalis,"tr|F7AUA0|F7AUA0_XENTR Cytoplasmic polyadenylation element-binding protein 4 OS=Xenopus tropicalis OX=8364 GN=cpeb4 PE=3 SV=4
MGDYGFGVLVQNNTGNKSAFPVRFHPHLQPPHHHQNTTPSPAAFINNTAANGSNAGSAWL
FPAPAAHNIQDEILGSEKSKSQQQQEQQESLEKQQLSPSQSQEAGILPDPEKVKSEENQG
DSSSENGNGKDKIRIESPVLTGFDYQEASGLGSSNQTLTSSASPLTGFSNWSAAIAPSSS
TMINEDASFFHQGGVPAASANNGALLFQNFPHHVSPGFGGSFSPQIGPLSQHHPHHPHFQ
HHHNQHQQQRRSPASPHPPPFTHRNAGFNQLPHLANNLNKPPSPWSSYQSPSPTPSSSWS
PGGSGYGGWGGSQGRDHRRGLNGGMPPLNSISPLKKNFGNNHIQLQKYGRPNSAFAPKSW
MDDSLNRADNIFPFADRTRAFDMHSLESSLIDIMRAENDSLKGQSSLFPMEDGFLDDGRS
DQPLHSGLGSPHCFPHQNGERVERYSRKVFVGGLPPDIDEDEITASFRRFGPLIVDWPHK
AESKSYFPPKGYAFLLFQDESSVQALIDACIEEDGKLYLCVSSPTIKDKPVQIRPWNLSD
SDFVMDGSQPLDPRKTIFVGGVPRPLRAVELAMIMDRLYGGVCYAGIDTDPELKYPKGAG
RVAFSNQQSYIAAISARFVQLQHGEIDKRVEVKPYVLDDQLCDECQGARCSGKFAPFFCA
NVTCLQYYCEYCWAAIHSRAGREFHKPLVKEGGDRPRHISFRWN",cpeb4,-,-,704aa(1-704),F7AUA0,-,-,-,[7-15],In vitro,4 µl [xCPEB4];|20 µg tRNA,-,-,RT,> 75 min,other_molecular: 200 μM ATP,-,-,"When tested for radiolabelled RNA binding, the membrane-bound FL-xCPEB4 was able to specifically retain the B1 RNA, but not the B1-123. This RNA-binding capacity of the liquid-like droplets required the RBD, as the NTD on its own did not retain the radiolabelled probe.",1315
145,576,PMID: 31171700,RNAPS0000521,https://pubmed.ncbi.nlm.nih.gov/31171700,RNA + protein,NCBI ID:820229,https://www.ncbi.nlm.nih.gov/gene/820229,CAT7,2725nt(1-2725),CUGUUUCACCUUGUGUCUGAGCUGGUCUGAAGGCUGGUUGUUCAGACUGAGCUUCCUGCCUGCCUGUACCCCGCCAACAGCUUCAGAAGAAGGAGCAGCCCCUGGGUGCGUCCACUUUCUGGGCACGUGAGGUUGGGCCUUGGCCGCCUGAGCCCUUGAGUUGGUCACUUGAACCUUGGGAAUAUUGAGAUUAUAUUCUCCUGCCUUUUAAAAAGAUGGACUUCAGCAGAAAUCUUUAUGAUAUUGGGGAACAACUGGACAGUGAAGAUCUGGCCUCCCUCAAGUUCCUGAGCCUGGACUACAUUCCGCAAAGGAAGCAAGAACCCAUCAAGGAUGCCUUGAUGUUAUUCCAGAGACUCCAGGAAAAGAGAAUGUUGGAGGAAAGCAAUCUGUCCUUCCUGAAGGAGCUGCUCUUCCGAAUUAAUAGACUGGAUUUGCUGAUUACCUACCUAAACACUAGAAAGGAGGAGAUGGAAAGGGAACUUCAGACACCAGGCAGGGCUCAAAUUUCUGCCUACAGGGUCAUGCUCUAUCAGAUUUCAGAAGAAGUGAGCAGAUCAGAAUUGAGGUCUUUUAAGUUUCUUUUGCAAGAGGAAAUCUCCAAAUGCAAACUGGAUGAUGACAUGAACCUGCUGGAUAUUUUCAUAGAGAUGGAGAAGAGGGUCAUCCUGGGAGAAGGAAAGUUGGACAUCCUGAAAAGAGUCUGUGCCCAAAUCAACAAGAGCCUGCUGAAGAUAAUCAACGACUAUGAAGAAUUCAGCAAAGGGGAGGAGUUGUGUGGGGUAAUGACAAUCUCGGACUCUCCAAGAGAACAGGAUAGUGAAUCACAGACUUUGGACAAAGUUUACCAAAUGAAAAGCAAACCUCGGGGAUACUGUCUGAUCAUCAACAAUCACAAUUUUGCAAAAGCACGGGAGAAAGUGCCCAAACUUCACAGCAUUAGGGACAGGAAUGGAACACACUUGGAUGCAGGGGCUUUGACCACGACCUUUGAAGAGCUUCAUUUUGAGAUCAAGCCCCACGAUGACUGCACAGUAGAGCAAAUCUAUGAGAUUUUGAAAAUCUACCAACUCAUGGACCACAGUAACAUGGACUGCUUCAUCUGCUGUAUCCUCUCCCAUGGAGACAAGGGCAUCAUCUAUGGCACUGAUGGACAGGAGGCCCCCAUCUAUGAGCUGACAUCUCAGUUCACUGGUUUGAAGUGCCCUUCCCUUGCUGGAAAACCCAAAGUGUUUUUUAUUCAGGCUUGUCAGGGGGAUAACUACCAGAAAGGUAUACCUGUUGAGACUGAUUCAGAGGAGCAACCCUAUUUAGAAAUGGAUUUAUCAUCACCUCAAACGAGAUAUAUCCCGGAUGAGGCUGACUUUCUGCUGGGGAUGGCCACUGUGAAUAACUGUGUUUCCUACCGAAACCCUGCAGAGGGAACCUGGUACAUCCAGUCACUUUGCCAGAGCCUGAGAGAGCGAUGUCCUCGAGGCGAUGAUAUUCUCACCAUCCUGACUGAAGUGAACUAUGAAGUAAGCAACAAGGAUGACAAGAAAAACAUGGGGAAACAGAUGCCUCAGCCUACUUUCACACUAAGAAAAAAACUUGUCUUCCCUUCUGAUUGAUGGUGCUAUUUUGUUUGUUUUGUUUUGUUUUGUUUUUUUGAGACAGAAUCUCGCUCUGUCGCCCAGGCUGGAGUGCAGUGGCGUGAUCUCGGCUCACCGCAAGCUCCGCCUCCCGGGUUCAGGCCAUUCUCCUGCCUCAGCCUCCCGAGUAGCUGGGACUACAGGGGCCCGCCACCACACCUGGCUAAUUUUUUAAAAAUAUUUUUAGUAGAGACAGGGUUUCACUGUGUUAGCCAGGGUGGUCUUGAUCUCCUGACCUCGUGAUCCACCCACCUCGGCCUCCCAAAGUGCUGGGAUUACAGGCGUGAGCCACCGCGCCUGGCCGAUGGUACUAUUUAGAUAUAACACUAUGUUUAUUUACUAAUUUUCUAGAUUUUCUACUUUAUUAAUUGUUUUGCACUUUUUUAUAAGAGCUAAAGUUAAAUAGGAUAUUAACAACAAUAACACUGUCUCCUUUCUCUUAUGCUUAAGGCUUUGGGAAUGUUUUUAGCUGGUGGCAAUAAAUACCAGACACGUACAAAAUCCAGCUAUGAAUAUAGAGGGCUUAUGAUUCAGAUUGUUAUCUAUCAACUAUAAGCCCACUGUUAAUAUUCUAUUAACUUUAAUUCUCUUUCAAAGCUAAAUUCCACACUACCACAUUAAAAAAAUUAGAAAGUAGCCACGUAUGGUGGCUCAUGUCUAUAAUCCCAGCACUUUGGGAGGUUGAGGUGGGAGGAUUGCUUGAACCCAAGAGGUCAAGGCUGCAGUGAGCCAUGUUCACACCGCUGCACUCAAGCUUGGGUGACAGAACAAGACCCCGUCUCAAAAAAAAUUUUUUUUUUAAUAAAACAAAAUUUGUUUGAAAUCUUUUAAAAAUUCAAAUGAUUUUUACAAGUUUUAAAUAAGCUCUCCCCAAACUUGCUUUAUGCCUUCUUAUUGCUUUUAUGAUAUAUAUAUGCUUGGCUAACUAUAUUUGCUUUUUGCUAACAAUGCUCUGGGGUCUUUUUAUGCAUUUGCAUUUGCUCUUUCAUCUCUGCUUGGAUUAUUUUAAAUCAUUAGGAAUUAAGUUAUCUUUAAAAUUUAAGUAUCUUUUUUCAAAAACAUUUUUUAAUAGAAUAAAAUAUAAUUUGAUCUUA,mRNA,Homo sapiens,"sp|O43663|PRC1_HUMAN Protein regulator of cytokinesis 1 OS=Homo sapiens OX=9606 GN=PRC1 PE=1 SV=2
MRRSEVLAEESIVCLQKALNHLREIWELIGIPEDQRLQRTEVVKKHIKELLDMMIAEEES
LKERLIKSISVCQKELNTLCSELHVEPFQEEGETTILQLEKDLRTQVELMRKQKKERKQE
LKLLQEQDQELCEILCMPHYDIDSASVPSLEELNQFRQHVTTLRETKASRREEFVSIKRQ
IILCMEALDHTPDTSFERDVVCEDEDAFCLSLENIATLQKLLRQLEMQKSQNEAVCEGLR
TQIRELWDRLQIPEEEREAVATIMSGSKAKVRKALQLEVDRLEELKMQNMKKVIEAIRVE
LVQYWDQCFYSQEQRQAFAPFCAEDYTESLLQLHDAEIVRLKNYYEVHKELFEGVQKWEE
TWRLFLEFERKASDPNRFTNRGGNLLKEEKQRAKLQKMLPKLEEELKARIELWEQEHSKA
FMVNGQKFMEYVAEQWEMHRLEKERAKQERQLKNKKQTETEMLYGSAPRTPSKRRGLAPN
TPGKARKLNTTTMSNATANSSIRPIFGGTVYHSPVSRLPPSGSKPVAASTCSGKKTPRTG
RHGANKENLELNGSILSGGYPGSAPLQRNFSINSVASTYSEFAKDPSLSDSSTVGLQREL
SKASKSDATSGILNSTNIQS",PRC1,-,-,620aa(1-620),O43663,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0213,http://db.phasep.pro/browse/","[446-466],[467-620]","[107-131],[385-405],[438-458],[489-501]",In vitro,6.3 µM [mEGFP-PRC1];|0.3 µM CAT7 RNA,"100 mM KCl,1 mM MgSO4",20 mM HEPES pH 7.9,RT,-,-,Fluorescence microscopy,liquid,"We tested whether ligands of PRC1, including DNA, RNA, and nucleosomal arrays, could incorporate into PRC1 condensates in vitro. We also included Cy5-labeled 2.5-kb DNA alone as well as Cy5-labeled CAT7 RNA shown previously to associate with PRC1. All four ligands were incorporated into condensates formed by mEGFP-CBX2 + RING1b (Fig. 6A) and mEGFP-PRC1 (Fig. 6B), whereas free Cy5 dye or purified mCherry protein was not found within the condensate phase.",2725
146,597,PMID: 34159327,RNAPS0000533,https://pubmed.ncbi.nlm.nih.gov/34159327,RNA + protein,-,-,SARS-CoV-2 virus RNA,501nt(500-1000),GGGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCUGGGCCCUCGA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,15-50nM [SARS-CoV-2];|3.6 µM [SARS-CoV-2 N protein],150 mM NaCl,20 mM Tris pH 7.5,37°C,20h,-,Fluorescence microscopy,liquid,"We tested 1-1000nt, 1-267nt (the 5′UTR), 1-500nt, and 500-1000nt fragments at either 15, 25, or 50nM RNA and 3.6µM protein. All tested fragments could drive N-protein LLPS, however some fragments drove LLPS more readily (1-500 or 1-1000).",501
147,599,PMID: 34159327,RNAPS0000535,https://pubmed.ncbi.nlm.nih.gov/34159327,RNA + protein,-,-,SARS-CoV-2 virus RNA-dsRNAa,503nt(1-500+3),GGGUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGUAUUAAUUAUACUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGACAGUAAUUAGUUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGC,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,15 nM [SARS-CoV-2];|3.6 µM [SARS-CoV-2 N protein],150 mM NaCl,20 mM Tris pH 7.5,37°C,18h,-,Fluorescence microscopy,liquid,"We converted the single-stranded, principal site sequence to dsRNA (preserving the total RNA length, by recoding the sequence 5’ and 3′ to the stem-loops to pair with the principal site (+dsRNAa). Strikingly, this type of mutation resulted in enhanced LLPS in all three sequence contexts (Fig. 1D-F), with much larger droplets forming more quickly in identical protein and RNA concentrations. We next sought to induce the formation of additional double-stranded RNA in a different way. Thus, we converted the single stranded principal site region to double-stranded RNA by forcing the single stranded region to base pair by adding complementary sequence either 5′ of the first hairpin (+dsRNAb) or 3′ of the second hairpin (+dsRNAc) which flanked the single stranded principal sites. In all three sequence contexts, this type of mutation again enhanced LLPS (Fig.1 D-F).We next asked whether addition of 10 paired nucleotides (20nt per stem-loop) of dsRNA at the base of the principal site flanking stem-loops would also promote LLPS (+dsRNAd) as this mutant would preserve the ssRNA of the principal site while creating additional structure. We observed that these extended stem-loops indeed also enhanced LLPS relative to wildtype in all three sequence contexts.",503
148,600,PMID: 34159327,RNAPS0000536,https://pubmed.ncbi.nlm.nih.gov/34159327,RNA + protein,-,-,SARS-CoV-2 virus RNA-dsRNAb,525nt(1-500+25),GGGUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCAGUAAUUAGUUAUUAAUUAUACUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGC,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,15 nM [SARS-CoV-2];|3.6 µM [SARS-CoV-2 N protein],150 mM NaCl,20 mM Tris pH 7.5,37°C,18h,-,Fluorescence microscopy,liquid,"We converted the single-stranded, principal site sequence to dsRNA (preserving the total RNA length, by recoding the sequence 5’ and 3′ to the stem-loops to pair with the principal site (+dsRNAa). Strikingly, this type of mutation resulted in enhanced LLPS in all three sequence contexts (Fig. 1D-F), with much larger droplets forming more quickly in identical protein and RNA concentrations. We next sought to induce the formation of additional double-stranded RNA in a different way. Thus, we converted the single stranded principal site region to double-stranded RNA by forcing the single stranded region to base pair by adding complementary sequence either 5′ of the first hairpin (+dsRNAb) or 3′ of the second hairpin (+dsRNAc) which flanked the single stranded principal sites. In all three sequence contexts, this type of mutation again enhanced LLPS (Fig.1 D-F).We next asked whether addition of 10 paired nucleotides (20nt per stem-loop) of dsRNA at the base of the principal site flanking stem-loops would also promote LLPS (+dsRNAd) as this mutant would preserve the ssRNA of the principal site while creating additional structure. We observed that these extended stem-loops indeed also enhanced LLPS relative to wildtype in all three sequence contexts.",525
149,601,PMID: 34159327,RNAPS0000537,https://pubmed.ncbi.nlm.nih.gov/34159327,RNA + protein,-,-,SARS-CoV-2 virus RNA-dsRNAd,543nt(1-500+43),GGGUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCGAUUGCAUCCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGGAUGCAAUCGUAUAAUUAAUAACUAAUUACUGCGAUUGCAUCUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAUGCAAUCGGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGC,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,15 nM [SARS-CoV-2];|3.6 µM [SARS-CoV-2 N protein],150 mM NaCl,20 mM Tris pH 7.5,37°C,18h,-,Fluorescence microscopy,liquid,"We converted the single-stranded, principal site sequence to dsRNA (preserving the total RNA length, by recoding the sequence 5’ and 3′ to the stem-loops to pair with the principal site (+dsRNAa). Strikingly, this type of mutation resulted in enhanced LLPS in all three sequence contexts (Fig. 1D-F), with much larger droplets forming more quickly in identical protein and RNA concentrations. We next sought to induce the formation of additional double-stranded RNA in a different way. Thus, we converted the single stranded principal site region to double-stranded RNA by forcing the single stranded region to base pair by adding complementary sequence either 5′ of the first hairpin (+dsRNAb) or 3′ of the second hairpin (+dsRNAc) which flanked the single stranded principal sites. In all three sequence contexts, this type of mutation again enhanced LLPS (Fig.1 D-F).We next asked whether addition of 10 paired nucleotides (20nt per stem-loop) of dsRNA at the base of the principal site flanking stem-loops would also promote LLPS (+dsRNAd) as this mutant would preserve the ssRNA of the principal site while creating additional structure. We observed that these extended stem-loops indeed also enhanced LLPS relative to wildtype in all three sequence contexts.",543
150,602,PMID: 34159327,RNAPS0000536,https://pubmed.ncbi.nlm.nih.gov/34159327,RNA + protein,-,-,SARS-CoV-2 virus RNA-dsRNAc,525nt(1-500+25),GGGUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGACAGUAAUUAGUUAUUAAUUAUAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGC,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,15 nM [SARS-CoV-2];|3.6 µM [SARS-CoV-2 N protein],150 mM NaCl,20 mM Tris pH 7.5,37°C,18h,-,Fluorescence microscopy,liquid,"We converted the single-stranded, principal site sequence to dsRNA (preserving the total RNA length, by recoding the sequence 5’ and 3′ to the stem-loops to pair with the principal site (+dsRNAa). Strikingly, this type of mutation resulted in enhanced LLPS in all three sequence contexts (Fig. 1D-F), with much larger droplets forming more quickly in identical protein and RNA concentrations. We next sought to induce the formation of additional double-stranded RNA in a different way. Thus, we converted the single stranded principal site region to double-stranded RNA by forcing the single stranded region to base pair by adding complementary sequence either 5′ of the first hairpin (+dsRNAb) or 3′ of the second hairpin (+dsRNAc) which flanked the single stranded principal sites. In all three sequence contexts, this type of mutation again enhanced LLPS (Fig.1 D-F).We next asked whether addition of 10 paired nucleotides (20nt per stem-loop) of dsRNA at the base of the principal site flanking stem-loops would also promote LLPS (+dsRNAd) as this mutant would preserve the ssRNA of the principal site while creating additional structure. We observed that these extended stem-loops indeed also enhanced LLPS relative to wildtype in all three sequence contexts.",525
151,609,PMID: 33650968,RNAPS0000544,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:961,https://www.ncbi.nlm.nih.gov/gene/961,CD47,4194nt(3'UTR),CUGAAGUGAAGUGAUGGACUCCGAUUUGGAGAGUAGUAAGACGUGAAAGGAAUACACUUGUGUUUAAGCACCAUGGCCUUGAUGAUUCACUGUUGGGGAGAAGAAACAAGAAAAGUAACUGGUUGUCACCUAUGAGACCCUUACGUGAUUGUUAGUUAAGUUUUUAUUCAAAGCAGCUGUAAUUUAGUUAAUAAAAUAAUUAUGAUCUAUGUUGUUUGCCCAAUUGAGAUCCAGUUUUUUGUUGUUAUUUUUAAUCAAUUAGGGGCAAUAGUAGAAUGGACAAUUUCCAAGAAUGAUGCCUUUCAGGUCCUAGGGCCUCUGGCCUCUAGGUAACCAGUUUAAAUUGGUUCAGGGUGAUAACUACUUAGCACUGCCCUGGUGAUUACCCAGAGAUAUCUAUGAAAACCAGUGGCUUCCAUCAAACCUUUGCCAACUCAGGUUCACAGCAGCUUUGGGCAGUUAUGGCAGUAUGGCAUUAGCUGAGAGGUGUCUGCCACUUCUGGGUCAAUGGAAUAAUAAAUUAAGUACAGGCAGGAAUUUGGUUGGGAGCAUCUUGUAUGAUCUCCGUAUGAUGUGAUAUUGAUGGAGAUAGUGGUCCUCAUUCUUGGGGGUUGCCAUUCCCACAUUCCCCCUUCAACAAACAGUGUAACAGGUCCUUCCCAGAUUUAGGGUACUUUUAUUGAUGGAUAUGUUUUCCUUUUAUUCACAUAACCCCUUGAAACCCUGUCUUGUCCUCCUGUUACUUGCUUCUGCUGUACAAGAUGUAGCACCUUUUCUCCUCUUUGAACAUGGUCUAGUGACACGGUAGCACCAGUUGCAGGAAGGAGCCAGACUUGUUCUCAGAGCACUGUGUUCACACUUUUCAGCAAAAAUAGCUAUGGUUGUAACAUAUGUAUUCCCUUCCUCUGAUUUGAAGGCAAAAAUCUACAGUGUUUCUUCACUUCUUUUCUGAUCUGGGGCAUGAAAAAAGCAAGAUUGAAAUUUGAACUAUGAGUCUCCUGCAUGGCAACAAAAUGUGUGUCACCAUCAGGCCAACAGGCCAGCCCUUGAAUGGGGAUUUAUUACUGUUGUAUCUAUGUUGCAUGAUAAACAUUCAUCACCUUCCUCCUGUAGUCCUGCCUCGUACUCCCCUUCCCCUAUGAUUGAAAAGUAAACAAAACCCACAUUUCCUAUCCUGGUUAGAAGAAAAUUAAUGUUCUGACAGUUGUGAUCGCCUGGAGUACUUUUAGACUUUUAGCAUUCGUUUUUUACCUGUUUGUGGAUGUGUGUUUGUAUGUGCAUACGUAUGAGAUAGGCACAUGCAUCUUCUGUAUGGACAAAGGUGGGGUACCUACAGGAGAGCAAAGGUUAAUUUUGUGCUUUUAGUAAAAACAUUUAAAUACAAAGUUCUUUAUUGGGUGGAAUUAUAUUUGAUGCAAAUAUUUGAUCACUUAAAACUUUUAAAACUUCUAGGUAAUUUGCCACGCUUUUUGACUGCUCACCAAUACCCUGUAAAAAUACGUAAUUCUUCCUGUUUGUGUAAUAAGAUAUUCAUAUUUGUAGUUGCAUUAAUAAUAGUUAUUUCUUAGUCCAUCAGAUGUUCCCGUGUGCCUCUUUUAUGCCAAAUUGAUUGUCAUAUUUCAUGUUGGGACCAAGUAGUUUGCCCAUGGCAAACCUAAAUUUAUGACCUGCUGAGGCCUCUCAGAAAACUGAGCAUACUAGCAAGACAGCUCUUCUUGAAAAAAAAAAUAUGUAUACACAAAUAUAUACGUAUAUCUAUAUAUACGUAUGUAUAUACACACAUGUAUAUUCUUCCUUGAUUGUGUAGCUGUCCAAAAUAAUAACAUAUAUAGAGGGAGCUGUAUUCCUUUAUACAAAUCUGAUGGCUCCUGCAGCACUUUUUCCUUCUGAAAAUAUUUACAUUUUGCUAACCUAGUUUGUUACUUUAAAAAUCAGUUUUGAUGAAAGGAGGGAAAAGCAGAUGGACUUGAAAAAGAUCCAAGCUCCUAUUAGAAAAGGUAUGAAAAUCUUUAUAGUAAAAUUUUUUAUAAACUAAAGUUGUACCUUUUAAUAUGUAGUAAACUCUCAUUUAUUUGGGGUUCGCUCUUGGAUCUCAUCCAUCCAUUGUGUUCUCUUUAAUGCUGCCUGCCUUUUGAGGCAUUCACUGCCCUAGACAAUGCCACCAGAGAUAGUGGGGGAAAUGCCAGAUGAAACCAACUCUUGCUCUCACUAGUUGUCAGCUUCUCUGGAUAAGUGACCACAGAAGCAGGAGUCCUCCUGCUUGGGCAUCAUUGGGCCAGUUCCUUCUCUUUAAAUCAGAUUUGUAAUGGCUCCCAAAUUCCAUCACAUCACAUUUAAAUUGCAGACAGUGUUUUGCACAUCAUGUAUCUGUUUUGUCCCAUAAUAUGCUUUUUACUCCCUGAUCCCAGUUUCUGCUGUUGACUCUUCCAUUCAGUUUUAUUUAUUGUGUGUUCUCACAGUGACACCAUUUGUCCUUUUCUGCAACAACCUUUCCAGCUACUUUUGCCAAAUUCUAUUUGUCUUCUCCUUCAAAACAUUCUCCUUUGCAGUUCCUCUUCAUCUGUGUAGCUGCUCUUUUGUCUCUUAACUUACCAUUCCUAUAGUACUUUAUGCAUCUCUGCUUAGUUCUAUUAGUUUUUUGGCCUUGCUCUUCUCCUUGAUUUUAAAAUUCCUUCUAUAGCUAGAGCUUUUCUUUCUUUCAUUCUCUCUUCCUGCAGUGUUUUGCAUACAUCAGAAGCUAGGUACAUAAGUUAAAUGAUUGAGAGUUGGCUGUAUUUAGAUUUAUCACUUUUUAAUAGGGUGAGCUUGAGAGUUUUCUUUCUUUCUGUUUUUUUUUUUUGUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUGACUAAUUUCACAUGCUCUAAAAACCUUCAAAGGUGAUUAUUUUUCUCCUGGAAACUCCAGGUCCAUUCUGUUUAAAUCCCUAAGAAUGUCAGAAUUAAAAUAACAGGGCUAUCCCGUAAUUGGAAAUAUUUCUUUUUUCAGGAUGCUAUAGUCAAUUUAGUAAGUGACCACCAAAUUGUUAUUUGCACUAACAAAGCUCAAAACACGAUAAGUUUACUCCUCCAUCUCAGUAAUAAAAAUUAAGCUGUAAUCAACCUUCUAGGUUUCUCUUGUCUUAAAAUGGGUAUUCAAAAAUGGGGAUCUGUGGUGUAUGUAUGGAAACACAUACUCCUUAAUUUACCUGUUGUUGGAAACUGGAGAAAUGAUUGUCGGGCAACCGUUUAUUUUUUAUUGUAUUUUAUUUGGUUGAGGGAUUUUUUUAUAAACAGUUUUACUUGUGUCAUAUUUUAAAAUUACUAACUGCCAUCACCUGCUGGGGUCCUUUGUUAGGUCAUUUUCAGUGACUAAUAGGGAUAAUCCAGGUAACUUUGAAGAGAUGAGCAGUGAGUGACCAGGCAGUUUUUCUGCCUUUAGCUUUGACAGUUCUUAAUUAAGAUCAUUGAAGACCAGCUUUCUCAUAAAUUUCUCUUUUUGAAAAAAAGAAAGCAUUUGUACUAAGCUCCUCUGUAAGACAACAUCUUAAAUCUUAAAAGUGUUGUUAUCAUGACUGGUGAGAGAAGAAAACAUUUUGUUUUUAUUAAAUGGAGCAUUAUUUACAAAAAGCCAUUGUUGAGAAUUAGAUCCCACAUCGUAUAAAUAUCUAUUAACCAUUCUAAAUAAAGAGAACUCCAGUGUUGCUAUGUGCAAGAUCCUCUCUUGGAGCUUUUUUGCAUAGCAAUUAAAGGUGUGCUAUUUGUCAGUAGCCAUUUUUUUGCAGUGAUUUGAAGACCAAAGUUGUUUUACAGCUGUGUUACCGUUAAAGGUUUUUUUUUUUAUAUGUAUUAAAUCAAUUUAUCACUGUUUAAAGCUUUGAAUAUCUGCAAUCUUUGCCAAGGUACUUUUUUAUUUAAAAAAAAACAUAACUUUGUAAAUAUUACCCUGUAAUAUUAUAUAUACUUAAUAAAACAUUUUAAGCUAUUUUGUUGGGCUAUUUCUAUUGCUGCUACAGCAGACCACAAGCACAUUUCUGAAAAAUUUAAUUUAUUAAUGUAUUUUUAAGUUGCUUAUAUUCUAGGUAACAAUGUAAAGAAUGAUUUAAAAUAUUAAUUAUGAAUUUUUUGAGUAUAAUACCCAAUAAGCUUUUAAUUAGAGCAGAGUUUUAAUUAAAAGUUUUAAAUCAGUC,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|3-200nM[CD47 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,2 h;16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,"However, when we added 30UTRs of TIS11B target mRNAs, including CD47, CD274 (PD-L1) or ELAVL1 (HuR) (Ma and Mayr, 2018), we observed formation of mesh-like FUS-TIS condensates (Figure 2A). ",4194
152,610,PMID: 33650968,RNAPS0000545,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:1994,https://www.ncbi.nlm.nih.gov/gene/1994,ELAVL1,4909nt(3'UTR),-,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|3-200nM[ELAVL1 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,2 h;16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,"However, when we added 30UTRs of TIS11B target mRNAs, including CD47, CD274 (PD-L1) or ELAVL1 (HuR) (Ma and Mayr, 2018), we observed formation of mesh-like FUS-TIS condensates (Figure 2A). ",4909
153,611,PMID: 33650968,RNAPS0000546,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:29126,https://www.ncbi.nlm.nih.gov/gene/29126,CD274,2705nt(3'UTR),-,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|5-500nM[CD274 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,2 h;16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,"However, when we added 30UTRs of TIS11B target mRNAs, including CD47, CD274 (PD-L1) or ELAVL1 (HuR) (Ma and Mayr, 2018), we observed formation of mesh-like FUS-TIS condensates (Figure 2A). ",2705
154,612,PMID: 33650968,RNAPS0000547,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:2521,https://www.ncbi.nlm.nih.gov/gene/2521,FUS,1814nt(3'UTR),UUAGCCUGGCUCCCCAGGUUCUGGAACAGCUUUUUGUCCUGUACCCAGUGUUACCCUCGUUAUUUUGUAACCUUCCAAUUCCUGAUCACCCAAGGGUUUUUUUGUGUCGGACUAUGUAAUUGUAACUAUACCUCUGGUUCCCAUUAAAAGUGACCAUUUUAGUUAAAUUUUGUUCCUCUUCCCCCUUUUCACUUUCCUGGAAGAUCGAUGUCCCGAUCAGGAAGGUAGAGAGUUUUCCUGUUCAGAUUACCCUGCCCAGCAGGAACUGGAAUACAGUGUUCGGGGAGAAGGCCAAAUGAUAUCCUUGAGAGCAGAGAUUAAACUUUUCUGUCAUGGGGAAAGUUGGUGUAUAAAUGAGAAAUGAAGAACAUGGGAUGUCAUGAGUGUUGGCCUAAAUUUGCCCAGCUAUGGGGAAUUUUUCCUUUACCACAUUUAUUUGCAUACUGGUCUUAGUUUAUUUGCAGCAGUUUAUCCCUUUUUAAGAACUCUUUGAUCUUUUGGCCCUUUUAAUGGUGAGGCUCAAACAAACUACAUUUAAAUGGGGCAGUAUUCAGAUUUGACCAUGGUGGAGAGCGCUUAGCCACUCUGGGUCUUUCACAGGAAGGAGAGUAACUGAGUGCUGCAGGAGUUUGUGGAGUGGAGUCAGGAUCUAGGAGGUGAGUGACUCCCUUCCUAGCUGCCCUGGUGAACAGCGCUUGGGUAGAUACCUGCUAUAAGGAGACUGGUCUGGCUGGGUUACUUUCACAUCCUGCCUGUACUCAGAGGGCUUGAGGUCAUUGACAUUAUGAGAUUUUAGGCUUGAUCCCUUUUUGAUUGGAGGGUGGAAGGCCCUCCUAAGGGAAUGAUAAGUGAUAAGAGGGGGAAGGGGUUGCAGCCAAUGAGUUAAAACCUUAGAGCAGUGCUCCUCAGCCUCUUACCAUGUGGUUGUAAACUUGCACGUACCUGCCAACCAGUUAUUUAGCAUGCUUUUUAUUUUAGUUACACAGAGCGUAACAUUAACCCAAGAGCAGAAAGGUUUUAUUUACAGGGUUUUCGAACUUGGUUUGUAAGACAGCUGCCAUCACAAGCAUAGCUUACAAAUGUGCUGGGGACCCCUAAUUGGGAAGUGCUUUCCUCUCAAAUUUUUAUUUUUUAUUUUUAGAGACAGAGUCUUGCUCUGUCAUCCAGGCUGGAGUGCAGUGGCGUGAUCUCGGCUCACUGUAGCCUCUGCCUCCUGAGUUUAAGCGAUUCUCCUGCCUCAGGAGAAUCCCAGCUUCUGAGUAGCUGAGACUACAGGCGUGGGCCACCAUGCCCACCUAGUUUUUGCAUUUUUAGUGGAGGUGUGGUUUCACUGUGUUGGCCAGGCUGGUCUCUUAACUCCUGACCUCAGGUGAUCCACCUGCCUUGGCCUCCCAAAGUGCUGGAAUUACAGGCAUGAGCCGCUGCAUCUGGCCAUCCUCUCAAAUUUUCAAGUGUUCCACAAGUAUGUUCUCUACUGAAGAGUUGCUGCAUCCUUGAAUCUUGGGUGAUUUGAGGCACAGAAACUAUGACUUUAUUUUUUGAGAUGGAGUUUUGCUCUUGUUGCCCAGGCUGGAGUGCAAUGGCACGUUUUUCGGCUUACCGCAACUGCCGCCUCCUGGGUUCAAGCGAUAGCUGGGAUUACAGGCAUGCGCCACCAUGCCCAGCUAAUUUAUUUGUAUUUUUAGUAGAGACGGGGUUUCUCCAUGUUGGUCAGGCUGGUCUCGAACUCCCGACCUCAGGUGAUGUGCACACCUCAGCCUCCCAAUAAACCAUGACUUUUAAGAGGAAUAGCAGGUUUACUUCCCCUGCCAGCA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|10-500nM[FUS 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,2 h;16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,"We then added to FUS-TIS in vitro transcribed 30UTRs of mRNAs, which were recruited to FUSTIS condensates (Figure 2A). The addition of the FUS 30UTR did not change the morphology of the sphere-like condensates formed by FUS-TIS ",1814
155,613,PMID: 33650968,RNAPS0000548,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:960,https://www.ncbi.nlm.nih.gov/gene/960,CD44,3069nt(3'UTR),CACCUACACCAUUAUCUUGGAAAGAAACAACCGUUGGAAACAUAACCAUUACAGGGAGCUGGGACACUUAACAGAUGCAAUGUGCUACUGAUUGUUUCAUUGCGAAUCUUUUUUAGCAUAAAAUUUUCUACUCUUUUUGUUUUUUGUGUUUUGUUCUUUAAAGUCAGGUCCAAUUUGUAAAAACAGCAUUGCUUUCUGAAAUUAGGGCCCAAUUAAUAAUCAGCAAGAAUUUGAUCGUUCCAGUUCCCACUUGGAGGCCUUUCAUCCCUCGGGUGUGCUAUGGAUGGCUUCUAACAAAAACUACACAUAUGUAUUCCUGAUCGCCAACCUUUCCCCCACCAGCUAAGGACAUUUCCCAGGGUUAAUAGGGCCUGGUCCCUGGGAGGAAAUUUGAAUGGGUCCAUUUUGCCCUUCCAUAGCCUAAUCCCUGGGCAUUGCUUUCCACUGAGGUUGGGGGUUGGGGUGUACUAGUUACACAUCUUCAACAGACCCCCUCUAGAAAUUUUUCAGAUGCUUCUGGGAGACACCCAAAGGGUGAAGCUAUUUAUCUGUAGUAAACUAUUUAUCUGUGUUUUUGAAAUAUUAAACCCUGGAUCAGUCCUUUGAUCAGUAUAAUUUUUUAAAGUUACUUUGUCAGAGGCACAAAAGGGUUUAAACUGAUUCAUAAUAAAUAUCUGUACUUCUUCGAUCUUCACCUUUUGUGCUGUGAUUCUUCAGUUUCUAAACCAGCACUGUCUGGGUCCCUACAAUGUAUCAGGAAGAGCUGAGAAUGGUAAGGAGACUCUUCUAAGUCUUCAUCUCAGAGACCCUGAGUUCCCACUCAGACCCACUCAGCCAAAUCUCAUGGAAGACCAAGGAGGGCAGCACUGUUUUUGUUUUUUGUUUUUUGUUUUUUUUUUUUGACACUGUCCAAAGGUUUUCCAUCCUGUCCUGGAAUCAGAGUUGGAAGCUGAGGAGCUUCAGCCUCUUUUAUGGUUUAAUGGCCACCUGUUCUCUCCUGUGAAAGGCUUUGCAAAGUCACAUUAAGUUUGCAUGACCUGUUAUCCCUGGGGCCCUAUUUCAUAGAGGCUGGCCCUAUUAGUGAUUUCCAAAAACAAUAUGGAAGUGCCUUUUGAUGUCUUACAAUAAGAGAAGAAGCCAAUGGAAAUGAAAGAGAUUGGCAAAGGGGAAGGAUGAUGCCAUGUAGAUCCUGUUUGACAUUUUUAUGGCUGUAUUUGUAAACUUAAACACACCAGUGUCUGUUCUUGAUGCAGUUGCUAUUUAGGAUGAGUUAAGUGCCUGGGGAGUCCCUCAAAAGGUUAAAGGGAUUCCCAUCAUUGGAAUCUUAUCACCAGAUAGGCAAGUUUAUGACCAAACAAGAGAGUACUGGCUUUAUCCUCUAACCUCAUAUUUUCUCCCACUUGGCAAGUCCUUUGUGGCAUUUAUUCAUCAGUCAGGGUGUCCGAUUGGUCCUAGAACUUCCAAAGGCUGCUUGUCAUAGAAGCCAUUGCAUCUAUAAAGCAACGGCUCCUGUUAAAUGGUAUCUCCUUUCUGAGGCUCCUACUAAAAGUCAUUUGUUACCUAAACUUAUGUGCUUAACAGGCAAUGCUUCUCAGACCACAAAGCAGAAAGAAGAAGAAAAGCUCCUGACUAAAUCAGGGCUGGGCUUAGACAGAGUUGAUCUGUAGAAUAUCUUUAAAGGAGAGAUGUCAACUUUCUGCACUAUUCCCAGCCUCUGCUCCUCCCUGUCUACCCUCUCCCCUCCCUCUCUCCCUCCACUUCACCCCACAAUCUUGAAAAACUUCCUUUCUCUUCUGUGAACAUCAUUGGCCAGAUCCAUUUUCAGUGGUCUGGAUUUCUUUUUAUUUUCUUUUCAACUUGAAAGAAACUGGACAUUAGGCCACUAUGUGUUGUUACUGCCACUAGUGUUCAAGUGCCUCUUGUUUUCCCAGAGAUUUCCUGGGUCUGCCAGAGGCCCAGACAGGCUCACUCAAGCUCUUUAACUGAAAAGCAACAAGCCACUCCAGGACAAGGUUCAAAAUGGUUACAACAGCCUCUACCUGUCGCCCCAGGGAGAAAGGGGUAGUGAUACAAGUCUCAUAGCCAGAGAUGGUUUUCCACUCCUUCUAGAUAUUCCCAAAAAGAGGCUGAGACAGGAGGUUAUUUUCAAUUUUAUUUUGGAAUUAAAUACUUUUUUCCCUUUAUUACUGUUGUAGUCCCUCACUUGGAUAUACCUCUGUUUUCACGAUAGAAAUAAGGGAGGUCUAGAGCUUCUAUUCCUUGGCCAUUGUCAACGGAGAGCUGGCCAAGUCUUCACAAACCCUUGCAACAUUGCCUGAAGUUUAUGGAAUAAGAUGUAUUCUCACUCCCUUGAUCUCAAGGGCGUAACUCUGGAAGCACAGCUUGACUACACGUCAUUUUUACCAAUGAUUUUCAGGUGACCUGGGCUAAGUCAUUUAAACUGGGUCUUUAUAAAAGUAAAAGGCCAACAUUUAAUUAUUUUGCAAAGCAACCUAAGAGCUAAAGAUGUAAUUUUUCUUGCAAUUGUAAAUCUUUUGUGUCUCCUGAAGACUUCCCUUAAAAUUAGCUCUGAGUGAAAAAUCAAAAGAGACAAAAGACAUCUUCGAAUCCAUAUUUCAAGCCUGGUAGAAUUGGCUUUUCUAGCAGAACCUUUCCAAAAGUUUUAUAUUGAGAUUCAUAACAACACCAAGAAUUGAUUUUGUAGCCAACAUUCAUUCAAUACUGUUAUAUCAGAGGAGUAGGAGAGAGGAAACAUUUGACUUAUCUGGAAAAGCAAAAUGUACUUAAGAAUAAGAAUAACAUGGUCCAUUCACCUUUAUGUUAUAGAUAUGUCUUUGUGUAAAUCAUUUGUUUUGAGUUUUCAAAGAAUAGCCCAUUGUUCAUUCUUGUGCUGUACAAUGACCACUGUUAUUGUUACUUUGACUUUUCAGAGCACACCCUUCCUCUGGUUUUUGUAUAUUUAUUGAUGGAUCAAUAAUAAUGAGGAAAGCAUGAUAUGUAUAUUGCUGAGUUGAAAGCACUUAUUGGAAAAUAUUAAAAGGCUAACAUUAAAAGACUAAAGGAAACAGA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|30-500nM[CD44 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,"liquid, gel","We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",3069
156,614,PMID: 33650968,RNAPS0000549,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:54621,https://www.ncbi.nlm.nih.gov/gene/54621,VSIG10,3046nt(3'UTR),AGAAGAGGAUGGUCCAUGGUUGUCUUGCUCUGAAAGCUUGGAGAGCUACAUUGAAGACGAGCUCUUCAUUCAGCUUUGACUCCACCUGCACCCCUGGCGGGGGCUUGCACUAACAAUGUUUGGGUCUCAGCAAAAAACAAAACCAAGCACACACAUCUUUCCUUCCAUGUAUUGAAAAACAUUGGUUUGAUUUGCUCUAAGUUUUCCCAAUGAUGUUUAAAAGCUUUGAGAAGGAAAGCUGCUUUGGUGUCUGAGGUGCCACUUCUGCUGUGAAUCCUGGCUUUAUCCAGGUUGAUCUACUGUGAUAGAUGCUGAUUUAGAGGGAACAGAGGUCAGGGAAGCACUGGGUCUUGGUGCCUUUUGCCGCUUUUUUUUUUUUUUUUUUUUUUUUUUGAGACGGAGUCUCCCUCUAUUGCCCAGGCUGGAGUGCAAUGGCACGAUCUUGGCUCACCACAACUUCUGCCUCCCAGGUUCAAGCGAUUCUCCUGCCUCAGCCACGGCACCUUGCAAAUAUCAGCUCCUUGGAACAGGUGAAGUUCCAGGUACCAAUGCCAAUCAGAGGAAGGCAGUUUGGUUCAGGCUUUGGAGUUAGAAACACCUGAAGUUGAAUCUGGGCUCUGUUGCUUCCUUCUUUCAUGGGCUAGAGCACGACUCUUUACCUCUCUCUUGGCCUCAAUUUCCUCACCUGUAAAAUAGAUGAGGAAGCUGCUCACUUAUUAUUGUCUCGUUCUGAAAGCUUGGAAAGCUACAUCGAAGAUGAGCUCUUCAUUCAGCUUUGAUUUGACCUGUACCCCUGGUGGGGGAUUGCACUGGCAACAUUUGGGUCUCAGCAAAAAAACCAAGCACACACAUCUUUCCUUCCAUUUAUUGAAAAACAUCUUUGUAAGAUCCAUUCAUUGAAAAACAUAAUCCAUUUAUUGAAAAAUAUCUUUGUAAGAUCACCUGCUAAAUAUGAAAAUCUGACUUGAAUUUGUACUCUUUAAAGUUGCGUAUCUGCUCUAGUGGGCAGGACCUAGGGCUUAAAGGGGAACUUCCUUUCUCCAUUUCUAAGAACUGGGACUCUAAAAUGAGAAGCUGGUUGUCUGAAGUAACCCUGCAGGUGUGGUUGGGGAAGGUCUGUUUUCUUGGAUGAAGGAACUAAACUAAGCAUAUCAGAGCACUGUCUUAACCAGUUUUAUUUCCCUGGAGAUAGAAUUCUUUUAAAAAGAGUUAGGGAGCUGGUAAUAGGAAGUGCCUUUCAUUAUAACUACAUUUUGCAGAGCUUCAUAUUUAUAUACAAGCCUCCUAGGUGAUACACUGUUAGCUUGCAGACUUUCCUAUGCUUCAUUUCUCCUGUUGCUUUCAAAGAAGGCAGGAGACACGUUUAAUAACGGAGUAUCUGGUGAUAAGAAUUGCUUGGGCAAACCAGCUCAUCUGGACUCUUUCUCAGUCUUGGAAGUGGGAAGAGGAAAACUUGUUUCCUUCCUGCUUCUUAAGGAUAUUCUGAGGGUACACUGAUCAAUAACACUAAAUUUGGAAUGAAAAUACCAUGUGAUGAGUUUAGCCUGCUGAUGCUUCCAGUAGAUCCUUGUAUAGUUUCAAGAUUUAAGUUUUCCGAUUUCAUAUAAAUUUCUUAAAGUCGAGGACCUUAUAAGGGUGCAAUGGAUGUUUGCUAAAUAUGAAAAACUGACUUGAAUUUGCACUCUUUAAUGUUGCGUAUCUGCUCUAGUGGGCAGGACCUAGGGCUUAAAGGGGAACUUCCUUUCUCCAAUUCUAGGAACUGGGACUCUAAAAUGAGAAGCUGGUUGUCUGAAGUAACCCUGCAGGUGUGGUUGGGGAAGGUCUGUUUUCUUGGAUGAAGGGAUUAAACUGAGCAAAUCACUAGAAGUAUGCCCUGUCCCCUGCUCAGAACACUGGGGAGCUCAAGAGUGGGCUGCAAUGUGCACCCCUCAGGAAUAGCUGUGAAUUGCAGGUCUACUGGCUUUUUGCUUUUUGUCUUUUGCUGCAAGGUACCCCACGUACUUAACCAUUCUCAACAGUGUAAAUCAGUGUCAUUUUAGAAUGAGAUACUCAGCUUGCUUCUAAAGUCACUGAAUUACUGAGUGAGUCUCUCCUUUAGAGUCUUCGGCAACCAAAUUCCAGAAUUGAAGAGUCUACUACUCAGAGGCAACAAGAUUAAAAAAAGAAAACACAAAAACUGUUGAGGUGAAAAAAAAAAAAAACCCUAGCUAGGAACACAGAGAAUGUUUUGUAGGAUCACUGGGAUAUUUUCCACAACUUCCUCUUCUCUAGCACACACAUCUGUUGAUAGGAAAUAUUUGAGGGUUUUUCCACUACCAAAUGGGAGCUUCAUGGUCCUGGUGUCAAACACUAUAAACCUUUGACCAGCUGAGCUGUGACUGCUGUCACAUAUCUGAGUCCUGUGUGCACAGUAAUAUCCUGGGUCAGGUAAAAUCCAGGUCUUCAAGUUUUAAGGAUUUUUUGAAGAAUUCGGGCUUCUUUAAGACGAUCCAUGCCCAAAUCCACAAGCUUGUUGACAGUGGAUUACAGUUUGUGUGGCAAAGUCCAAGUUGUUACACUGUGCUUUAAAAAAAAUCUUAUCUGCAUGUAUUGUUAACUUAGAGACCAUGAGAUCUAUUUAUCAGGACCAGGAAGAUACACACUUCAGGUCCAUUGCAACUGACUUUUUUCUUGUUUUUCUCAAACCCUGGUGGAGCCUGGGAAGGGGGCCUCCACAAUUCUGUGGCUUUGAUAUUAGCCCCAAUUCUCACAAGCACAUACAAGCCCCAUAAUUGCCGCAGGAAAACACAAGAUGGAAAAUUGCAAUAACCCAUGCACUGAGACUUAGAAAAUCAUCCUUACUAGGCAAAAUGUAUUAUGAUGCAAUAAGUGCCAACUGAUAUUUCUCACGUUGGGACUGGCCAGGAACUGCUGCAAAGAAAAAUAAGCAGCUCCUUCUCCAUUAUUUACAUUUUAAGAUGUGGUGGGGGGAGGUUGGGAGAAAUUAGUUCUGAGGUUAUCAUAUGCCUUUUUUAAAAGAUAAUGGAAUAAAGCUAUUUUUAAGUAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|30-500nM[VSIG10 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,"liquid, gel","We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",3046
157,615,PMID: 33650968,RNAPS0000550,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:1812,https://www.ncbi.nlm.nih.gov/gene/1812,DRD1,1723nt(3'UTR),ACUCGCAGAUGAAUCCUGCCACACAUGCUCAUCCCAAAAGCUAGAGGAGAUUGCUCUGGGGCUUGCUAUUAAGAAACUAAGGUACGGUGAGACUCUGAGGUGUCAGGAGAGCCCUCUGCUGCUUUCCAACACACAAUUAACUCCGUUUCCAAAUACAUUCCAGUGUAUUUUCUGUGUUGUUCAUAGUCAAUCAAACAGGGACACUACAAACAUGGGGAGCCAUAAGGGACAUGUCUUUGGCUUCAGAAUUGUUUUUAGAAAUUUAUUCUUAUCUUAGGAUUUACCAAAUAGGGCAAAGAAUCAACAGUGAACAGCUUCACUUAAAAUCAAAUUUUUCUGGGAAGAAAAUGAGAUGGGUUGAGUUUGCUGUAUACAAACAGGUGCUAACACUGUUCCCAGCAAAGUUUUCAGAUUGUAAAGGUAGGUGCAUGCCUUCAUAAAUUAUUUCUAAAACAUUAAUUGAGGCUUACAGUAGGAGUGAGAAAUUUUUUUCCAGAAUUGAGAGAUGUUUUGUUGAUAUUGGUUCUAUUUAUUUAUUGUAUAUAUGGAUAUUUUUAAUUUAUGAUAUAAUAAAUAUAUAUUUAUCAUAUUUAAUAGGAUAAAUUAAUGAGUUUUAUCCAAGACCUUACAACCACAUUUCUGGCCAUUUAACUAGCACUUUAUAAGCCAAUGAAGCAAACACACAGACUCUGUGAGAUUCUAAAUGUUCAUGUGUAACUUCUAGAAACACAGCAGAAACUGAUAGAUAAGGGAAUAAAGUUGAAAUGAUUCCUUAAAAUUCAUGGACACAGAUAAAUGCAAGGUGAGAAUUGACAAAUGCUAUAAAUGCUUUCUUUUUCUGAAAAGAUUUUGAAAAAUUUAAAAAAGUAUAGCUACUACUGUGUUCAAAACGUUUUAAAUGACAAAUGACUUUCCCAGGGGAAUUUGCAGUUCUGUAAAUAUCUUAAAUAAAAGCCAACUUAAGAAGAGCCCAGCAUUAAAUUUACGAUCUUAGGUGGUAAUGAAAAGUAUAUGCUGCUUUGUAUUUAUGUAAAAUAAUUGGCCCUCUCCAUCUUUUCUCAUUUCAUGUGUCAGGUAGUUUUUCUGAACCACACAAAUGGCUUUCCUGGAGAGAGAUCUGUAGCACAGACAGUGGGUUACAGCAGCCCCACUGAGGGACCAAACUCAAACCCUGCAUUUCCAUCUUACCAGGUCAAACCAAACCAGUCAGUGGGGCUACUUUUUAUAGUGCUUUAAUCUGAAUUUAGAGCUGAUUUUUAAAGGAGUCUUUAAAUGUUAAUGGUAUACUAACUAACGAAUAGUGCCUCAUUAUCAUUCUUGAGUCAGAUACUUCUGUUGAUGGGAGAAACAGAAGAAUCCUUCCCUUUGGGUGUGUUGAGCUCCCCCAAAGCCAUCAGCAUCUCUUUUGACAAAUGCUAGUCCUUUCUCUGUGCUUUGGAAUCAGGUUCCUGCAUCAUCACCCGGACUGUAAAAAGUAUCAUAAGCCUCCCUUGCCAGAUGCCAACUCGUGGGGCAUUUCAACAGAGUUUCUUUGAAAUGUUUACAACGUAUUCUUCUUGAUAAGCAAUGAACUUAACAUUUAGAUGCAAUCCGUGAAAAGAAAAAAAAAUCUGAAAAAUAUCUCCUGCAUCAGGUCUGUGUUAUUUAUGUAUUGUGAAUGUUUUCUUAAUUUUAUUGGCUGUAUGCUUUCUUACACAUAAUAAAAAUAUUUUGUGAACUCAAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|50-500nM[DRD1 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,"liquid, gel","We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",1723
158,616,PMID: 33650968,RNAPS0000551,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:255231,https://www.ncbi.nlm.nih.gov/gene/255231,MCOLN2,1102nt(3'UTR),AGUUCUGCUAAAGAUGAUUAAAGUUCAGGCAUCCUUAUCCAGCGGCUGAGCAGAGGAACCCCAAAUGACUUGGACAAGCAGUUCCAAAAUGACUCUCUUAUUUAAUUGUGGAGUGGGAAAGAGGACUCACAGUUAGCCAGCUGACCAUGACUGAAGUUCCAGCUUUACUUUUUAUAAACUUGAAUGAUAAAGAAUAGACCAUGGGCUACUACUGGGCAUUAGUGCAAUAUAACAGCGAUAAUAAAAUUCUCUAUUAGUCUGUUAAUUUAUGACAUGAUCUCGGAAUGGAAAAAGAUCAUUUCAGAGUGUGCGAAAUAAUAGUCUUUAACCAUGUAAUUAAAUAUGUGUGUUUAUUGUCAAAUAAGGAUUUGUUUUAAAGGUGAUUCUUGGGUUUGAAGACAUUUGUUAAUUCAUGGUCUGUACAGAAAUGAAGCUGGUUGCAAUACCAAUCUAGAGAGUCCAAGCUGGUGAACUAUUAAGCUGUUUAAAGAUCACCCUUGGCCUGGCACAGUGGUUCACACCUGUAAUCCCAGCACUUUGGGAGGCCUAGGCAGGCAGACUGAGCUCAGGAGCUUGAGACCAGCCUGGGCAACAUGGCAAAAACCCACCUCUACAAAAAGUACAAAAAUUAGUCGGGCGUGAUGGCAGGCAUCUGUAGUCCCAGCUACUUGGGAAGCUGAAGUGGGAGGAUCACCUGAGCUCUGGAGGUGGAGGCUGCCAUGAGCCAUGAUCGUGCCACUACACUCCAGCCUGGGUGACAGAGUGAGAUCCUGUCUCAAAAAAAAAAAAAAAUCACCCUUAAAUCAACAAAAAGACCUCAUGCUCAUGCAGUGGACAUUUCUUGGCCUGUUUUCCUGUGGGUUUUCUUCAGCAUGAUAUGAAGCAACUGUUGGCAUAGCCAGUGGGAUAAAUAAGAAAUGGAAUCAUUUGGCUGCCUCGUCACUUGUGCUAAUGGUCAGUUGUACACACAUGACAUGUGGAAGUGACCUGUAGCAGCGGUCACUCAUUUUAACAAUUGAACUCUGCUGGGUUGGGUAUUUACCUUUGUCUAGAAAAGAAAUAUGAUAUAUUUUCUCUAAAUAAAUUUAUUUUCAUCAUUCCA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[MCOLN2 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,"liquid, gel","We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",1102
159,617,PMID: 33650968,RNAPS0000552,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:653820,https://www.ncbi.nlm.nih.gov/gene/653820,FAM72B,1095nt(3'UTR),AUGGAAUUAUGAUAUAUAUGAUAUACAAACUUUUUUCUAUUUAAAAAUAUAUUAAUGGAUCAACUUUAAAAUUGUUAGUUGCCAGUGAUCUUUUUUGGAAAACAAAAAUGGGGCAUUUGUUGAUUUAUUUAUUUUCCGUCUCUAAUUAGUUACCUCAGUUUGAUUGAAGCCAGUGGAGUUGUGCUUUUCCUCUACUUCUACUUCCUCUCCCCCACCUUUUUCUGCCCAGUGUAGGUGUAUUCUUAAAUUCAGACGGGAAGAUUCUUUCACAUAUCACUCAGUUACCUCCCAAUCUGGGGGAGUUUUUCUUACAACUUGAUACCAGAUACCAUUAAUUUUACAUUCCUGAAUAAAGGCCUAGUACCCACGCAUAUUUCAACCAUGCAUAUAUCAAGUUCAACUGAGUUUUAAUAGGGGAUUAAAAAAACAAGCUGUUAGGUUUCCAUGGGCACUGGUUCUCAUAGGUUCUAUUGGUGAUAACUGCUUUAACAUGGAGCAAGAGUUUGUGAAUCAGGAAAUAGAAUAAAUUAAAAUUUAAAAUAUAUAGAGGAAUCCUCUUGAUUGCUCAGCAUGAUGUUAGAUAAAUGAGUUUGUCAGAAAAUAUCAGUAUACGCUGUUUACCAAUGUUAUUUAUUUACAUUCUUCUAAAGCCAUUAUGGAUAUUGUAUUAUGAGAGCUAAACCUAAAUAAGUUAUCCUGUUCCCUAGGACCUUCUCUGUAAAUAGUGAAUUUUAGACGAGUAGUCUGUCCUAAAUCUUAAAUAGAAAAAAAACUAAAGCGAUUUGCUUAAGCCAUUGUACAUUAUAAAGAGCUGUUUUGUUUUGCUUUGCUUUGCUUUGUUUUGUUUUUUUAAAGCUGCAUUCAGAGCCACAAAGGAAUAGGAAAGUAGGGUAGUGUUGGAUUCUGGUUUUAUGUAACUCUAAAAUAAAUGUAUCUCUUUAAUAUCUCAGUUGUAGGGAUUUUGUCAAUACCAAAGCAGACUGAGUUGUGGUUUUGUAAAUAAAGUUUUUUCUAAAAAUGACCAUUCUUCCUUUAAUUUUUUGUUAUGCCCACAUAUUGUAUGUAAAAAUAUAAAUAAAUAGUACUUAAAGUAUA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[FAM72B 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,"liquid, gel","We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",1095
160,618,PMID: 33650968,RNAPS0000553,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:8600,https://www.ncbi.nlm.nih.gov/gene/8600,TNFSF11,1095nt(3'UTR),GCCCCAGUUUUUGGAGUGUUAUGUAUUUCCUGGAUGUUUGGAAACAUUUUUUAAAACAAGCCAAGAAAGAUGUAUAUAGGUGUGUGAGACUACUAAGAGGCAUGGCCCCAACGGUACACGACUCAGUAUCCAUGCUCUUGACCUUGUAGAGAACACGCGUAUUUACAGCCAGUGGGAGAUGUUAGACUCAUGGUGUGUUACACAAUGGUUUUUAAAUUUUGUAAUGAAUUCCUAGAAUUAAACCAGAUUGGAGCAAUUACGGGGUGACCUUAUGAGAAACUGCAUGUGGGCUAUGGGAGGGGUUGGUCCCUGGUCAUGUGCCCCUUCGCAGCUGAAGUGGAGAGGGUGUCAUCUAGCGCAAUUGAAGGAUCAUCUGAAGGGGCAAAUUCUUUUGAAUUGUUACAUCAUGCUGGAACCUGCAAAAAAUACUUUUUCUAAUGAGGAGAGAAAAUAUAUGUAUUUUUAUAUAAUAUCUAAAGUUAUAUUUCAGAUGUAAUGUUUUCUUUGCAAAGUAUUGUAAAUUAUAUUUGUGCUAUAGUAUUUGAUUCAAAAUAUUUAAAAAUGUCUUGCUGUUGACAUAUUUAAUGUUUUAAAUGUACAGACAUAUUUAACUGGUGCACUUUGUAAAUUCCCUGGGGAAAACUUGCAGCUAAGGAGGGGAAAAAAAUGUUGUUUCCUAAUAUCAAAUGCAGUAUAUUUCUUCGUUCUUUUUAAGUUAAUAGAUUUUUUCAGACUUGUCAAGCCUGUGCAAAAAAAUUAAAAUGGAUGCCUUGAAUAAUAAGCAGGAUGUUGGCCACCAGGUGCCUUUCAAAUUUAGAAACUAAUUGACUUUAGAAAGCUGACAUUGCCAAAAAGGAUACAUAAUGGGCCACUGAAAUCUGUCAAGAGUAGUUAUAUAAUUGUUGAACAGGUGUUUUUCCACAAGUGCCGCAAAUUGUACCUUUUUUGUUUUUUCAAAAUAGAAAAGUUAUUAGUGGUUUAUCAGCAAAAAAGUCCAAUUUUAAUUUAGUAAAUGUUAUCUUAUACUGUACAAUAAAAACAUUGCCUUUGAAUGUUAAUUUUUUGGUACAAAAAUAAAUUUAUAUGAAAACCUGC,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[TNFSF11 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,"liquid, gel","We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",1095
161,619,PMID: 33650968,RNAPS0000554,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:27075,https://www.ncbi.nlm.nih.gov/gene/27075,TSPAN13,1045nt(3'UTR),UGAGAAAACAAGGAAGAUUUCCUUUCGUAUUAUGAUCUUGUUCACUUUCUGUAAUUUUCUGUUAAGCUCCAUUUGCCAGUUUAAGGAAGGAAACACUAUCUGGAAAAGUACCUUAUUGAUAGUGGAAUUAUAUAUUUUUACUCUAUGUUUCUCUACAUGUUUUUUUCUUUCCGUUGCUGAAAAAUAUUUGAAACUUGUGGUCUCUGAAGCUCGGUGGCACCUGGAAUUUACUGUAUUCAUUGUCGGGCACUGUCCACUGUGGCCUUUCUUAGCAUUUUUACCUGCAGAAAAACUUUGUAUGGUACCACUGUGUUGGUUAUAUGGUGAAUCUGAACGUACAUCUCACUGGUAUAAUUAUAUGUAGCACUGUGCUGUGUAGAUAGUUCCUACUGGAAAAAGAGUGGAAAUUUAUUAAAAUCAGAAAGUAUGAGAUCCUGUUAUGUUAAGGGAAAUCCAAAUUCCCAAUUUUUUUUGGUCUUUUUAGGAAAGAUUGUUGUGGUAAAAAGUGUUAGUAUAAAAAUGAUAAUUUACUUGUAGUCUUUUAUGAUUACACCAAUGUAUUCUAGAAAUAGUUAUGUCUUAGGAAAUUGUGGUUUAAUUUUUGACUUUUACAGGUAAGUGCAAAGGAGAAGUGGUUUCAUGAAAUGUUCUAAUGUAUAAUAACAUUUACCUUCAGCCUCCAUCAGAAUGGAACGAGUUUUGAGUAAUCAGGAAGUAUAUCUAUAUGAUCUUGAUAUUGUUUUAUAAUAAUUUGAAGUCUAAAAGACUGCAUUUUUAAACAAGUUAGUAUUAAUGCGUUGGCCCACGUAGCAAAAAGAUAUUUGAUUAUCUUAAAAAUUGUUAAAUACCGUUUUCAUGAAAUUUCUCAGUAUUGUAACAGCAACUUGUCAAACCUAAGCAUAUUUGAAUAUGAUCUCCCAUAAUUUGAAAUUGAAAUCGUAUUGUGUGGCUCUGUAUAUUCUGUUAAAAAAUUAAAGGACAGAAACCUUUCUUUGUGUAUGCAUGUUUGAAUUAAAAGAAAGUAAUGGAAGAAUUGAUCGAUGAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[TSPAN13 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,"liquid, gel","We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",1045
162,620,PMID: 33650968,RNAPS0000555,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:10186,https://www.ncbi.nlm.nih.gov/gene/10186,LHFPL6,1044nt(3'UTR),GAUGGAGCUACCAAGAGCAGACAGAGGAGAAGAUGGGCCAAAGGGGCUUGGAGAGGUCAAAACAUCCACCUACCUUCAAAAGGUGGGAUAGUAGUUCUAAUCCAAUACAAUGCUAAUAAAAUGAAACCCGAUAAAAUCAGGAACAUGAUAUAGGAAGGAAGGAUUGUAGGAGAUUUGUGGGGGAAAAAAAAGGAGAGUAUAGAAUGAUGGAGAAAAAUGGACCAAAGGCUAAAAAUAUUGCAGGGCAUCGGGUGUUUCUAUUCCACAGAGUAUUGUUAAUGUACAACACACACACACACACACACACACACACACACACACACACACACACAACAAAUCUACAUAUACAAACAAGGGUUUGGGUUUUAGUUUUUUUUUUUUAAGGUGAGGACUCAGAAAAUCAAAGGGCUAGUAGAAACAGUGUUAUGUUGGGAAGCAGGGUACCCCCAAAGAUGUUCCCUGUAGGUCACGGCACUCCCAAAAGCACACAAGCACAUACAGACAUAUGCAUCCCCACACACGCCUAUGCACAAACGUGGAUUAUCGCACAGACUGGGAGGUUUAGUGGUGCAUUUCUCCUCUGUUUUCUUUUUAAUAUACAUUUAAAAUACAGUAUUAUCACUUUAUAAAACAUACAUUAAGCCUAAUAAAUGGACCAAUAAGCCAAACUAUCAGUAUUUUGUAUAUCCUGCAUAAACUCUAAUUUAGUUCCUCAACAUAUUUUCAGUGUUUAUGCAGACCUUUAGAGUUAAGCCUUUGUAUUUCCAUGUUAUUCCACAAUAUGCAAUAUUUCUCUGAGUAGCUUCUGCUAUGAUAUUCUUAUGAAGAAAAGGGGCAACUUUCUGUCCACUAUAGGAGAGAAUUCAGCCGAAGAUAUGAGAGUAAUGAGAGACAUUUUCCAGUCAUUGGAUCGUGUUUUCUUUUGUCCAUUAUUGUACUGUGCUGUACCACAUUUAUUUCUAUAUUCAUUUUGUAAAAAAUUUAAAAGUGCUAUUUUGUUUGUAUUUGAAAAUCUCUGUGAAUAAAUUCUCUCUUUGAUCAAUA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[LHFPL6 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,"liquid, gel","We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",1044
163,621,PMID: 33650968,RNAPS0000556,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:3586,https://www.ncbi.nlm.nih.gov/gene/3586,IL10,1034nt(3'UTR),GACAUCAGGGUGGCGACUCUAUAGACUCUAGGACAUAAAUUAGAGGUCUCCAAAAUCGGAUCUGGGGCUCUGGGAUAGCUGACCCAGCCCCUUGAGAAACCUUAUUGUACCUCUCUUAUAGAAUAUUUAUUACCUCUGAUACCUCAACCCCCAUUUCUAUUUAUUUACUGAGCUUCUCUGUGAACGAUUUAGAAAGAAGCCCAAUAUUAUAAUUUUUUUCAAUAUUUAUUAUUUUCACCUGUUUUUAAGCUGUUUCCAUAGGGUGACACACUAUGGUAUUUGAGUGUUUUAAGAUAAAUUAUAAGUUACAUAAGGGAGGAAAAAAAAUGUUCUUUGGGGAGCCAACAGAAGCUUCCAUUCCAAGCCUGACCACGCUUUCUAGCUGUUGAGCUGUUUUCCCUGACCUCCCUCUAAUUUAUCUUGUCUCUGGGCUUGGGGCUUCCUAACUGCUACAAAUACUCUUAGGAAGAGAAACCAGGGAGCCCCUUUGAUGAUUAAUUCACCUUCCAGUGUCUCGGAGGGAUUCCCCUAACCUCAUUCCCCAACCACUUCAUUCUUGAAAGCUGUGGCCAGCUUGUUAUUUAUAACAACCUAAAUUUGGUUCUAGGCCGGGCGCGGUGGCUCACGCCUGUAAUCCCAGCACUUUGGGAGGCUGAGGCGGGUGGAUCACUUGAGGUCAGGAGUUCCUAACCAGCCUGGUCAACAUGGUGAAACCCCGUCUCUACUAAAAAUACAAAAAUUAGCCGGGCAUGGUGGCGCGCACCUGUAAUCCCAGCUACUUGGGAGGCUGAGGCAAGAGAAUUGCUUGAACCCAGGAGAUGGAAGUUGCAGUGAGCUGAUAUCAUGCCCCUGUACUCCAGCCUGGGUGACAGAGCAAGACUCUGUCUCAAAAAAUAAAAAUAAAAAUAAAUUUGGUUCUAAUAGAACUCAGUUUUAACUAGAAUUUAUUCAAUUCCUCUGGGAAUGUUACAUUGUUUGUCUGUCUUCAUAGCAGAUUUUAAUUUUGAAUAAAUAAAUGUAUCUUAUUCACAUCA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[IL10 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,"We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",1034
164,622,PMID: 33650968,RNAPS0000557,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:51311,https://www.ncbi.nlm.nih.gov/gene/51311,TLR8,1003nt(3'UTR),CUGACGUUAAGUCAUGAUUUCGCGCCAUAAUAAAGAUGCAAAGGAAUGACAUUUCUGUAUUAGUUAUCUAUUGCUAUGUAACAAAUUAUCCCAAAACUUAGUGGUUUAAAACAACACAUUUGCUGGCCCACAGUUUUUGAGGGUCAGGAGUCCAGGCCCAGCAUAACUGGGUCCUCUGCUCAGGGUGUCUCAGAGGCUGCAAUGUAGGUGUUCACCAGAGACAUAGGCAUCACUGGGGUCACACUCAUGUGGUUGUUUUCUGGAUUCAAUUCCUCCUGGGCUAUUGGCCAAAGGCUAUACUCAUGUAAGCCAUGCGAGCCUCUCCCACAAGGCAGCUUGCUUCAUCAGAGCUAGCAAAAAAGAGAGGUUGCUAGCAAGAUGAAGUCACAAUCUUUUGUAAUCGAAUCAAAAAAGUGAUAUCUCAUCACUUUGGCCAUAUUCUAUUUGUUAGAAGUAAACCACAGGUCCCACCAGCUCCAUGGGAGUGACCACCUCAGUCCAGGGAAAACAGCUGAAGACCAAGAUGGUGAGCUCUGAUUGCUUCAGUUGGUCAUCAACUAUUUUCCCUUGACUGCUGUCCUGGGAUGGCCUGCUAUCUUGAUGAUAGAUUGUGAAUAUCAGGAGGCAGGGAUCACUGUGGACCAUCUUAGCAGUUGACCUAACACAUCUUCUUUUCAAUAUCUAAGAACUUUUGCCACUGUGACUAAUGGUCCUAAUAUUAAGCUGUUGUUUAUAUUUAUCAUAUAUCUAUGGCUACAUGGUUAUAUUAUGCUGUGGUUGCGUUCGGUUUUAUUUACAGUUGCUUUUACAAAUAUUUGCUGUAACAUUUGACUUCUAAGGUUUAGAUGCCAUUUAAGAACUGAGAUGGAUAGCUUUUAAAGCAUCUUUUACUUCUUACCAUUUUUUAAAAGUAUGCAGCUAAAUUCGAAGCUUUUGGUCUAUAUUGUUAAUUGCCAUUGCUGUAAAUCUUAAAAUGAAUGAAUAAAAAUGUUUCAUUUUACAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[TLR8 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,"We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",1003
165,623,PMID: 33650968,RNAPS0000558,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:89801,https://www.ncbi.nlm.nih.gov/gene/89801,PPP1R3F,1000nt(3'UTR),GCUCUGCUUGUGGGAUCAGCAGAGGCUUAAGAUGGGAUACAUGGCCUGUGCAGUGAGGGGACCUGGGUCCUUUGCUUCUGAGAAUGCUCAACUGAAAGAGAGGCCUUCUCAUCCCCAAGCUCUCCAGUCAACACAGGGCUCCCUGUGGUGACACCAGUGGAGAUGAGGGAACGGGUAGAUGGUGUGAGUGAGGGGAACUUUUAGAGUGGAACUGGGCAUGUCCUCCGCCUACCCCCCGAGCCUGUAUUUAUUUUUGUAUAAUUCUCUGGAUGAGGGAGAGUGGUCGUGAGCUGGUCUUGGGGCACAAUUACCCAGAGAUAUAUUUAUUAACAGCCAACCUGUGCAACCUGCUGGAGCUUUAUUUUUAAUUUAAUUUAUAUAGAGUACCUAUUAUUAUAUGCCACAAUAGAGCUCUAUGAGAAACAGUGUCUUGCGGUGUAGUGUUCUCCUGUUUGGGCAUGAGUGUGCAGGGUGGUCACUUUCUGUGGGAGGAUCACAGUGGGGAGUUGGGGGUGGGACGUGGUCGCCUGCUGCUGCUUCAACAUGUCUUUCCUUGAAGAUGUGUGUCUCCUCGUCUCGUGGUCCUAAUCCAUAUGGUUCUUUGUCUUUUCCACAUUCUGCCUGUGGGACCCUACAGGUGUGUAUUUGGAUGGUGGUGGUGGGAGCCAGGGAGGAAGAGUGGCAGCCACAUGAGGGUUUGGUGUCAGUCACAUGGUUGCAGUGGUAGCUGUGGUCUCCUGUGGAUGUGGGGACAUCAGUUGUGAAUCAGCCACAAGGUUUUGAGGUUACUGAAAAAACAGCCUUUGACACCAGCAGGGAGACCCCUUAGUCCCUGAGAUAAGGAAGGCCUCAGAAAGGAAAGAGGAGUUAAUGUACUGCAGUACUUGGUAGCACAGUUGCUGUCCACAGACAUCACAUUUCUACUAAAAACAGGAAGCCCAGAAGCUUUGAAAGAAAGAUAUAUAUUUAUUGCAUGCAAAUAAAAAACUGCUCAACAAAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[PPP1R3F 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,"liquid, gel","We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",1000
166,624,PMID: 33650968,RNAPS0000559,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:2863,https://www.ncbi.nlm.nih.gov/gene/2863,GPR39,976nt(3'UTR),AUGUCAAGCGAGGGAGCCUUGAGUGGGAACUGGCCCUCCAGCCCUAAGAAAACGUCACUCUCACUCUGCAGUCUCAAACUAUGCCCCCAUCAGGGAUGGAAUGGACACUGGAGGCUUUACAAAAGGCAGAUGCCCACCUCAGUGACUUCUAAGGACUGACUCUGCCAGCCUGGCCUUGACUCCGGUUACACAGACAUGGGGGUGAACUUUCACUCCACCUCCUUCCUUCAAGUACAUACUGAAAAUUCAGUCAGGCUGAAUUUAUUCAGAAUGCUUUACCGAGCUCUUUCAUUAUUUGCACAGGAACAAAAGAGAACACGGACUCCCGCUCCCUACCCAGAAUAAAAGGACACCCAGAAGAAACUCACUCAGGGAGGUGGGGGGUUGGGGGCGAGGGCUGGAAGAACAAUGCAGGAGGGGGUGGCAUCUCCUUCAGCUUCAGCAGUGUGCCGAGAAGAGGGCUAAUUUGAGGAACAGGAUGGUGGUGCGGAGCCCUGGCCUGAGGGCCGAGGCAGAACUUCCCCUUUUCUUGGGCCUUGGCCCGUUACAAAGAGGGGUGUUGCAGCAGCUGAUGCAAACUGAGUUCAGUUUCCCUGGGGAGCAGAAGGACUGGUACCCGGCAGAGGCGAUGAGACAGGCCGCUGAUGAUGCACAGGACUUGCGGUACAUGAUCCCUGUAACACAGACCCAAAGGAGCUGAGUUAACGUGCACCGGCAAAAGAAUAGCUGUCCCUCUCAGCCCAAAUCCAAACGGACAGCUCUUCCUUACUCCUCCCACAGCCCAGAGACUAGGUGAGGUCAGGGAAGUGCUUCGGAUUGUCUCAUUGAUAUUCAAGAUAGAUGGUGAAAGAGACAGGCACUAUUUCAUUAGUUUUAACAAAACUGUUCCAAAAGCGAUUUGAGAUGCCAAUACCUGUGAAUACCUGUUAAUAAAGAGCUGUUAAAUAGACUUAUUUACAUUUUAAGUCAGAGUUCA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[GPR39 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,"We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",976
167,625,PMID: 33650968,RNAPS0000560,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:54497,https://www.ncbi.nlm.nih.gov/gene/54497,HEATR5B,595nt(3'UTR),UUUGUAAUUUCAUUUAUUUGUAUUUAUGUUGUCAACUAGCCCCUAAUUAGUGAUGGCCACUGUAUCAUUCCAGGCUACCUAUGGGUUCUGUUUUAUUUGUAUAUUGGUAUUAUAGUGCUUCCAAGUAGGUUAAGUGAAAUAAUGCUCACACCACUUAUUGAUUUUUAAGGAGUGAUUUUUUUUAUCAUGUGGUGAAUAUGUUUUCAUUUUCCUCCUAAUAAUGUUUCUCUUUUGUUAACUUAUUUAUUUUUCAAACACUGAGCCAUAGUCUUAAAUUUAAAUGCUAAAAACAAUUGUAUCAUGUAGUCGGGCAGCCUAUUGAUACUGUCAGGGGAAAAAAAUGGGUCAGAACUCAGCAUCUGUCAUGAAAAAAAUCAAUUGAAAAACAAGCAGAUUUUAAAUUUUGAAGUAAUCAAAAUAAUGGAAAGUGUCUGUUUUGUGGUGUAUAUACUAUGAAUAAAAUCACAGCAUUUUCUAAGCAUUUCCCAAAAUGUCCUUAUCUUUCUGAUGGAUCUUUUAGCUUUCAUAUCAAAUUACUAAAUUAUGCUAUGUAUAUUUUAGUUGGUAACAAUUAAAAUUCUCAUUUAAAGGUUCA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[HEATR5B 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,"We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",595
168,626,PMID: 33650968,RNAPS0000561,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:345757,https://www.ncbi.nlm.nih.gov/gene/345757,FAM174A,557nt(3'UTR),GAAUGUGCCUUUUGAUGAAAGAACUUUAUCUUUCUACAAUGAAGAGUGGAAUUUCUAUGUUUAAGGAAUAAGAAGCCACUAUAUCAAUGUUGGGGGGGUAUUUAAGUUACAUAUAUUUUAACAACCUUUAAUUUGCUGUUGCAAUAAAUACCGUAUCCUUUUAUUAUAUCUUUAUAUGUAUAGAAGUACUCUGUUAAUGGGCUCAGAGAUGUUGGGGAUAAAGUAUACUGUAAUAAUUUAUCUGUUUGAAAAUUACUAUAAAACGGUGUUUUCUGAUCGGUUUUUGUUUCCUGCUUACCAUAUGAUUGUAAAUUGUUUUAUGUAUUAAUCAGUUAAUGCUAAUUAUUUUUGCUGAUGUCAUAUGUUAAAGAGCUAUAAAUUCCAACAACCAACUGGUGUGUAAAAAUAAUUUAAAAUUUCCUUUACUGAAAGGUAUUUCCCAUUUUUGUGGGGAAAAGAAGCCAAAUUUAUUACUUUGUGUUGGGGUUUUUAAAAUAUUAAGAAAUGUCUAAGUUAUUGUUUGCAAAACAAUAAAUAUGAUUUUAAAUUCUCUUAAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[FAM174A 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,"liquid, gel","We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",557
169,627,PMID: 33650968,RNAPS0000562,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:7130,https://www.ncbi.nlm.nih.gov/gene/7130,TNFAIP6,515nt(3'UTR),AAAAAAAAAAAAGGAUGAUCAAAACACACAGUGUUUAUGUUGGAAUCUUUUGGAACUCCUUUGAUCUCACUGUUAUUAUUAACAUUUAUUUAUUAUUUUUCUAAAUGUGAAAGCAAUACAUAAUUUAGGGAAAAUUGGAAAAUAUAGGAAACUUUAAACGAGAAAAUGAAACCUCUCAUAAUCCCACUGCAUAGAAAUAACAAGCGUUAACAUUUUCAUAUUUUUUUCUUUCAGUCAUUUUUCUAUUUGUGGUAUAUGUAUAUAUGUACCUAUAUGUAUUUGCAUUUGAAAUUUUGGAAUCCUGCUCUAUGUACAGUUUUGUAUUAUACUUUUUAAAUCUUGAACUUUAUAAACAUUUUCUGAAAUCAUUGAUUAUUCUACAAAAACAUGAUUUUAAACAGCUGUAAAAUAUUCUAUGAUAUGAAUGUUUUAUGCAUUAUUUAAGCCUGUCUCUAUUGUUGGAAUUUCAGGUCAUUUUCAUAAAUAUUGUUGCAAUAAAUAUCCUUGAACACA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[TNFAIP6 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,"We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",515
170,632,PMID: 33650968,RNAPS0000567,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:83440,https://www.ncbi.nlm.nih.gov/gene/83440,ADPGK,1047nt(3'UTR),GAAGAUUCUUAGGGGUAAUUUUUCUGAGGAAGGAGAACUAGCCAACUUAAGAAUUACAGGAAGAAAGUGGUUUGGAAGACAGCCAAAGAAAUAAAAGCAGAUUAAACUGUAUCAGGUACAUUCCAGCCUGUUGGCAACUCCAUAAAAACAUUUCAGAUUUUAAUCCGAAUUUAGCUAAUGAGACUGGAUUUUUGUUUUUUAUGUUGUGUGUCACAGAGCUAAAAACUCAGUUCCCAAAUCCCCAGUUUAUGCAGCGCCAUCAGGUAUUUUAAGCUAAACUUCUUCACCCCUGAGAGCAUGUCAGCUGGAGAAAAGCAGUUCUUCCUUGCCCACUUGAGAAGUGCACGCCCACUCACCCAACAUCCUGGUCUCUAGGAAAGCCUCAUGUGAGGUUCCUCUUUCUUUCAGCUCAGUGCCCAUGGGCAAGGAUCAUGAUUUCCAUUCCGUGUUACAAUGACAAUAUUUAAUGAGCAUAACCUUCUCAGUCUCCUGCUCUCAAAUUUAGGACAGAGCCGCUAAGGACAAAACAAUCCCUCCCGUGCUUUAUGAUGGCAGCAGGGGCUGGGGAGCCUCUGAGGGACUCUUUCAUUCUGCAGUUGUCUGGAAGCCUGGGUGGCGUCAUGAGCUGAAGGAUCAUGCUUUCCUGUCCUGGCUCCAUAGGUUAUAGGCUGGCUGGUGAAAGGUUCACGUGGCCCAGGCUGAACUUCAUUGCCUAGCUUUGGAUGUGCUUUCUGCCAUAAAGACUGAUUUUUGUUCGUUCUGAGCCUUCAAGGAAUUUGUUUUUUACAACUGGAAUAUGCUCCUGUGUGUGUUAACAGAUCAUGGAUGUUUUAUGUUUUCACUGAUCAUUUAAAGAGUUUGACCUCAGAGCUCCAGGAUCAUCAGUAAAUUUGUCAUGUUAUAUAUUUAUUUUUUUAUAAAUCAAGACUUCUGUGUGCUCUUAAAUAUAUUAAAAACAAUUUACAUUUCAGGAAUUCUGUCUGUAAUUGAUUUUUGUCUCCAUCACCACUCUGGAACCAGAUAAGAUAAAAAUCAUUCUGAUCUUCA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[ADPGK 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1047
171,633,PMID: 33650968,RNAPS0000568,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:55761,https://www.ncbi.nlm.nih.gov/gene/55761,TTC17,1027nt(3'UTR),UGCACUUCUUCCUUCUCUCUUUCUCUUUACUCAUGCUCUAAAAAAAAAGAAUAAGAAAAGAAACCAAUCAUUGUCAGUAUCUACUAUUAAUGAUGUGUGUGAAAAUAACUAAGACUUAUAACAGGACUUUUACAUAUGUGGGAAUUGGUUUGUUUUUGUUUUUACGUUUCUCCUUUCCCCCAACCAACCUCAGAAGAGGCACCUUCAGAAACACACAUUUCUUAAAAGGAAAGUGCAGCUUCAAGAUAUUGUGUAAAUACUGAGCCAAGACAUUUCUGGAGCUGUGCUCUGUCUCCAAAAACCUCAAUGCCUUUAGGGCUUUUCUCAGUGGUCCAGCUAGCCUUCUCUUUGGAGGAGGAUGAAGCCGCAUUGCACAUUCUCUGCUUCCUGUCGUAGCCUCUGUUGUCAAUGGAAAUGCGGAAGCCCAUCUGGUGCCCGUCAGUGAGAAGCAACGUUCUGCGCUCUCUCCGUUAGACCUCCAUGCUGUCCCCAGUCUUGUCCAUUCCAUGCUGCUGUGUUACAAACUCUCAGAGGUAGUUUGCAGGGGAGGAAGGGGAAUAUGAUUUUAAAAACAAAAUAUUUACAACAACAAAAAUUCUUAGGAUCACCUGACCUUUGUAAUGUUAUUUAUGUUGGGGAGGGAGGGGGGCUGAGAAGGGGAAAUCAGCAGUGUGCAACAUCUUUAUAAUUUGUACUUUAAUUACAAAUCACAAGGAAACCAAUAAGUUGAAAUCCUAUAUAACAGGUUUAUAUAUAUAGAAUAUGUAUAUUUGAAGCCCUCUACAGACUGAGUCUAUGUUUUACUAAUUCUUUGUUCACUGUGUUACCCAUCUUGGAAUAAGUUGUGAAUGUCAGCUCCCUCUCUCUGAGGCCUCCAGACUUAGCUCCUCAGGAGGGUAAUGAGCCAAGGUUGAGUGUUUCCAUACAAUGCUUUUACCUUUGAUCCCAGGAGAAUCAGAAACUCCAACAUUUUGGAAUCUUCAAGGGCACAUACUGAGAAAAAAAAUAAAAUUGUUUAUGAGCAAAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[TTC17 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1027
172,634,PMID: 33650968,RNAPS0000569,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:8320,https://www.ncbi.nlm.nih.gov/gene/8320,EOMES,1117nt(3'UTR),AGAGUUAUUUUAACCUCAAAAAUUAGCUAACUUUUUGCAGAUGGACUUGGUGGUGUUUUUUGUUGUCUUCUUUGCCUAGGUUGCCAAAAAGAUGUUUGCCUUCCACCUUGAUGCAUCCUGUUUUGUGCAAUUCUCUAAAAGAAGGUGCCAAAGCUUUUUGAUUGCUGCAGGUAACUGAAACAAACCUAGCAUUUUUAAAAAAUAAGAUUAAUGGAAGACUUUAAGGUAUUUUAAAAUUCGAAGGGUAUCCAAGGUUCUGUAUUUAUUUAUUGGGGAGACACUAACCCUUCAAAGAAGCAGGCUGUGAACAUUGGGUGCCCAGUGCUAUCAGAUGAGUUAAAACCUUUGAUUCUCAUUUCUAUUUGUAAAUUCUUAAGCAAAUAGAAGCCGAGUGUUAAGGUGUUUUGCUUCUGAAAGAGGGCUGUGCCUUCCGUUUCAGAAGGAGACAUUUUGCUGUUACAUUCUGCCAGGGGCAAAAGAUACUAGGCCCAGGAGUCAAGAAAAGCUUUUGUGAAAGUGAUAGUUUCACCUGACUUUGAUUCCUUAACCCCCGGCUUUUGGAACAAGCCAUGUUUGCCCUAGUCCAGGAUUGCCUCACUUGAGACUUGCUAGGCCUCUGCUGUGUGCUGGGGUGGCCAGUGGGACUCAGGAGAGAGCAAGCUAAGGAGUCACCAAAAAAAAAAAAAAAAAAAAGGGAGAAUUUAAAAGUGUACAGUUGUGUGUUUAGAUACACUAUAGAAUAAUGUGGUAUAUAUUGUACAAAUAGUCUACAUAGGUGUCUGGGAUAAUGUAAAACUGGUGCUUUGGCUUUGUAAAGAAUUUGCAAAUCACUUAACAGCUGCAGGGGCAAGGGGAGAGUUUCAUCAUCCCCAUGAUAUUUGGGAAUAUUCUGUUUACUUCUUAGAUAGUUAAGAAUGUAUUCAGCUACUAUGUACUAACUUGAACCGUGUUUAAGGAAAACUCCUAUUUCAUCCUCUUCUUGCGCCAUCCCCUCUCCCUAACUUGGUAAUGUGAAGAAACUAAAACCUGAUACCACAGCUCCUAUAGGCAUUUUAGAGAUCUUGGAUUUUUAUGUACAGUCUUAGUCAUUUUUAAUAAAUGUGGUUCAGUAAGGGAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[EOMES 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1117
173,635,PMID: 33650968,RNAPS0000570,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:112817,https://www.ncbi.nlm.nih.gov/gene/112817,HOGA1,1143nt(3'UTR),GGGCAGGCAGGGUCCAUGGCUGGCCUGAGCCCAUCUCAGCCUCCUGCCUUGCACUUGCAGCCUGAAGCGGAGAGCACAGGGGGAUGAGGGUGGCAGGCAGCGGGGAGCCGAUAGAGGCUCCUUUGCCUGCUGUGGUCCUCCAGGCAGCCUUUCACAGGCACGCCCAUGCAUAUCUCCUAUUCUAACGGCCCCUGACCUCUCCCUUUUGGAUCCUAAACUGUGUCUCUGGUCUGAAGACUGGGAAGGAGCAAUUUCUCAAUUUAUCUUUCUACUGUGGAUGCUUUCCUACGCCCUGAGGCACAUGAAGUCAGAAAGGAAGGGCAGAGGGGCAAGUAGGCACAGUAAGGGAAUUUUCUUUUCUUUUUUUUUUUUUUUGAGACAGAGUUUCACUCUGUCACCCAGGCUGGAGUGCAAUGGCAUGAUCUCGCCUCCUGGGUUCAAGCGAUUCUCCUGCCUCAGCCUCCCGAGUAGCUGGGAUUACAGGCGCCUGCCACCACGCCCAGCUAAUUUUUGUAUUUUUAGCAGAGAUGGGGUUUCACCGUGUUGGCCAGGCUGGUCUUGAACUCCUGACCUCAGGUGAUCCAACUGCCUCGGCCUCCCAAAGUGCUGGGAUUACAGCUGUGAGCCACUGCACCCGGCCGGGAAUUUAUCAAAGGGGGGACUACUUAGAUUUGGGGCUUCAAACCUGAGUCUAGCACAAUGCAGCUGGAGGCCAGGGCUACUCCUACAAACCCAAGUUCUGACUCCUUCCAGGGAAGUAUCAGCUUAAGAAACUUGAUCAGGAAAGUGACACUGGUCUUUCAAAGAGCCCUCUUUACCCUCCCAUCCCUGCCCUCCACACUGCAAGCUGCAUUCCAGCCACAACGCCCUUUUCUAAAUCUAUUUUCAUUCAUCUCCUAUUCUGGUCUGUAGCCUUGAUUCCAACCAUUGAAUGCACGGAGACAGCCCAGUGGCUUGUCAGAUUGGUAAAUAAUGACACCUGGUGGAUAAAUGUUACAUUCUAGAAGACUAUUCUGGUCAGCCUAGGUCUGAAACACUAAGGAGACUUGGCCUGAGAUAGGGCCAUCCACUUGCCUACAGGCACUCUGCUUUUAUUAUUAAAAAUAGUCACUUUGUUACUAUAAUAAAAUUUAACAGAAAAAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[HOGA1 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1143
174,636,PMID: 33650968,RNAPS0000571,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:127018,https://www.ncbi.nlm.nih.gov/gene/127018,LYPLAL1,1130nt(3'UTR),AUGAAUCAAGAGUGAUUUGUUAAUGUAAGUGUAAUGUCUUUGUGAAAAGUGAUUUUUACUGCCAAAUUAUAAUGAUAAUUAAAAUAUUAAGAAAUAACACUUUCCUGACUUUUUUAUUAUUAAAAUGCUUAUCACUGUAGACAGUAGCUAAUCUUAUUAAUGAAAAACAAUAGACAAACAUCUGUGCAUAAUUUUUCAGACACAAUUCUGUAAAUAUUUGGAAACCUUUUAAGUAUUUAAACUUUUAAAUUUUUGAAAUAAAGUAUUCUAAACUAAUAUAAAUAAGGACAAUGAAAAAACAUGAAAGGACUUAGCAUAAUGUUAUUUUAUCUUUUCUACAACUUUGUUUAAAUUACCUUUCCAAAGAUAUUUGUGUUUAUGUAAUUUUCCACGGAAUAACAUUAAUACUCUAGGUUUAUAAACCGGUUUCACAUUAUUUCAUUUGAUCAUCACAAGAGCUUUGUGAAGUAAGCCGAGAAGUUGUUACUGGUAUUUAAUAAUAGCAAUAGAGGAGUUAAAGACUUUCCCACAGCUUGCAGGUCAAGACAAGAAAUUCAGGUCUCCUAAUUCUCAGUGGAGCUCUAUUUCUGUUAACCCAAAUUGCUGCUCUGUUUUAGGUCUCAAUUUCAUCUGUAAAAUGAUACUAAUAGUACUUAUCCCAUUGGAUUUUUGUUGAGAUUUAAAUAAAUAGCCAAAAGCCAAUACAUAAUAAACACUCAAUAAAGAUUAACCAUAAGGAGAGUCAUGAUCUGGUUCCAGGAAUACAUUGUUAGAUGACUGAAAAAUUGUAUUACUUCAAUGAAAAUACUAUAAAUAAUAACAUUUUCAUAUAUUAGUUGGUUCUCAUGCAUACAUAAUCUAAUUUUAUUUGAUCCUCACAACUGUUUAAGUUUUAUUAAAUAUACAUUAUCCCUAUUUGUAUAAAUAGAAUCAUACAAUACCUGCCUGCUUUCAUUCAACAAAAUUAUCAUGAGAUUUUUCCAUGUUGUGUACAUCAAUAGUUCAUCUAUUUUAUUGCUCAGUAAUAUUCCAUUGUGUGGAUGUAUCACUAUUUGUUUACACAUUCACCACUGAUAUAUAAGUUGCUUCCAGUGUGAGGCUGUUUUAAAUAAAGCUGCUAUGAAUAUUCA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[LYPLAL1 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1130
175,637,PMID: 33650968,RNAPS0000572,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:55164,https://www.ncbi.nlm.nih.gov/gene/55164,SHQ1,1007nt(3'UTR),CUCUUAGGUGGUUUUAUUCAUUGUUGAGAAAUAUGGUAGAUUGGGUUUCAUUUACCGAAUGAGAAUUCUUCAUUUUCACUUUGUAAUUUUUCUUAGUAUAUAGUCAGCCCACUGUAUUUGUGUGUUCCACAUCUGUGGAUUCAACCAACUGCAGAUCAAAAAUAUUGAAGAAAAAAUCGCAUCUGUACCAAACAUGUACAGACUUUUUUCUUGUUAUUAUUCUCUAAAUAAUACAGUAUGACAACUAUUUCCACAGCAUUUACAUUGUAUUGGGUAAUAUAAGUAAUCUAGUGAUGAUUUAAACUGUGCAGGAGGAUGUGGGUAGGUUAUAUGCAAAUACUGCACCAUUUUUUAUCAGGGGCUUGAGCAUCUGAGGAUUUUAGUAUCCUCAGGAGUCCUGGAACCAACCCCCCACAGAUACGGGGACAACUUUAUGACAUUGUUUUUCAACCAAUGAAUGUUUAUACCUUUUGUUUUCCUUGCCGCGACUGUGAAGAUAAAGUUCAAAAGUAUUUUUACCAAAGUGUAGCUAAUAUUUCAAGCUGAAAAUAAUAGUUCUACUGCCCGUGUCUCCAGAAUGUAGAGCCCAUCAAUAUUUUUAUUUUAGGAGGUGUACUUGACACCCAAUAAACUGCACGUAUCAAAAGUGUACAAUGUGUUGGCGUAUGUAUACCCUGCGUAAAACUAUCACCACAACUGAAGUGAGGAACGGACCCAUCAUUCCCAAGUGCCCUUGUGCCCUGUUAUUAGUUUGCAUGUCCUAGAAUUCUAUGUAAAUUGAAUCAUACAAUAUGUAUCCCUUUUUUGGUCAGGCAUAUUUUACUCAGUAUAGUUAUUUUGAGAUUCAUCCAUGUGGUAGCAUGUGUCACGAGUUUUUGUUUUUAUGUUUUUCAUUGCUGAGUACUGCUUCAUUGAAUAGAUUUGUUCAUUGACCUAUCGAUGGACACCUGGGUUGUUUCCAGUUUGGGGCUGUUAUAAAUAAAGCUGUUAUGAACAUUUGUGUACAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[SHQ1 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1007
176,638,PMID: 33650968,RNAPS0000573,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:132203,https://www.ncbi.nlm.nih.gov/gene/132203,SNTN,1117nt(3'UTR),ACAGUUUUAAAUAUGCUGUAUAAAAUAAUGGCAAAAGACAGUGUUAUUAAAAUGUUUCCAUCUUAUUUUUGAUUAAUUGAAUAUAUCUAUCAUGCAUCUGAAAUUGCCUAGGAUGGUUCUGAUUGCUGGUAUUCAGAUCCAAUGUAACUCCAAAUAUUUACCCAUACACUUCAAGAAUGUUUGAAUGAUAAGGUCUCUGUGUGCUUUACAAUAGGAUAGAUUUGAUACCACUGAAUAAUAAAUGGCUUUUGCUGAGUCAGUAGCGACCUAGAGCACUCUACUUAUAGUCAUUGAGUCACUCAUUUAUUCACUAAACAUUUGUUGAGCAUCUACUUGAUGGAACUGCUGAGGAUACAGUAAUGAAUUGGCCAGGCAAUUCCUUCCUUCAGACAUGUUUGCAGAAGUCUAGCAGAAGAGAUAGACAUUGAACAAUUUUUAAAUAAUUGCAUACACAGUAUAAUUAGAAUUGAAAUAAGGGCUAUAGGAUGCUAAAAGAGAUUAUCACCUGAUCGGAGUUCAAAGGUCAGAAAAGCUUUACUGACAUUCUAUAAAAAGCAAAAAAAAAAAAAUUGGUCCAUGGAUGCCAGGGAUAUGGGUGGGAAAUGGGGCUGUCCACAAAUGGCACAAGGGGAGUUUUUUAUUUUAUUUUAUUUUAUUUUAUUUUAUUUUAUUUUGAGACAGAGUUUUGCUCUUGUUGCCCAGGCUGGAGUGCAAUGGCACGAUCUCAGCUUACUGCAACCUCGAUCUCCCAGGUUCAAGUGAUUCUCCUGCCUCAGCCUCCUGAGUAGCUGGGAUUACAGGCGUGUGCCACGAUGCCAGGCUAAUUUUUUUUGUAUUUUUAGUGGAGACGGGGUUUCGCCAUGUCGGCCAGGCUGGUCUCGAACUCCUGACCUCAGGUGAUCCGCCCACAGCCUCCCAAAGUGCUGGGAUUACAGGCUUGAGCCACCAAGUCUGGCCAAGGGGACUUUUAAGGGGGCUGGAAAUGGUCUCCAUUUUGAUUGUGAGGUGGUGGCUACAAGAUUGCAUGCAUUUGUCAAACUCAUAGAACUGCACACUGAAAAGAGUGAAUUGUACUGUAUGUCAAUUAUACCUAAAUAAAUCUGACUUAACAAAAAAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[SNTN 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1117
177,639,PMID: 33650968,RNAPS0000574,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:5482,https://www.ncbi.nlm.nih.gov/gene/5482,ASPN,1083nt(3'UTR),UAAUUAGUAAUUGGUAAUGUCCAUUUAAUAUAAGAUUCAAAAAUCCCUACAUUUGGAAUACUUGAACUCUAUUAAUAAUGGUAGUAUUAUAUAUACAAGCAAAUAUCUAUUCUCAAGUGGUAAGUCCACUGACUUAUUUUAUGACAAGAAAUUUCAACGGAAUUUUGCCAAACUAUUGAUACAUAAGGGUUGAGAGAAACAAGCAUCUAUUGCAGUUUCUUUUUGCGUACAAAUGAUCUUACAUAAAUCUCAUGCUUGACCAUUCCUUUCUUCAUAACAAAAAAGUAAGAUAUUCGGUAUUUAACACUUUGUUAUCAAGCAUAUUUUAAAAAGAACUGUACUGUAAAUGGAAUGCUUGACUUAGCAAAAUUUGUGCUCUUUCAUUUGCUGUUAGAAAAACAGAAUUAACAAAGACAGUAAUGUGAAGAGUGCAUUACACUAUUCUUAUUCUUUAGUAACUUGGGUAGUACUGUAAUAUUUUUAAUCAUCUUAAAGUAUGAUUUGAUAUAAUCUUAUUGAAAUUACCUUAUCAUGUCUUAGAGCCCGUCUUUAUGUUUAAAACUAAUUUCUUAAAAUAAAGCCUUCAGUAAAUGUUCAUUACCAACUUGAUAAAUGCUACUCAUAAGAGCUGGUUUGGGGCUAUAGCAUAUGCUUUUUUUUUUUUAAUUAUUACCUGAUUUAAAAAUCUCUGUAAAAACGUGUAGUGUUUCAUAAAAUCUGUAACUCGCAUUUUAAUGAUCCGCUAUUAUAAGCUUUUAAUAGCAUGAAAAUUGUUAGGCUAUAUAACAUUGCCACUUCAACUCUAAGGAAUAUUUUUGAGAUAUCCCUUUGGAAGACCUUGCUUGGAAGAGCCUGGACACUAACAAUUCUACACCAAAUUGUCUCUUCAAAUACGUAUGGACUGGAUAACUCUGAGAAACACAUCUAGUAUAACUGAAUAAGCAGAGCAUCAAAUUAAACAGACAGAAACCGAAAGCUCUAUAUAAAUGCUCAGAGUUCUUUAUGUAUUUCUUAUUGGCAUUCAACAUAUGUAAAAUCAGAAAACAGGGAAAUUUUCAUUAAAAAUAUUGGUUUGAAAUAAAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[ASPN 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1083
178,640,PMID: 33650968,RNAPS0000575,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:24150,https://www.ncbi.nlm.nih.gov/gene/24150,TP53TG3,1024nt(3'UTR),GUACUGCACGACUACUCGCUUCUGAAACUGAUAGACACUGCCUCAGCUCCGUGCAGGGCAGACGCACAAGAGCAGAAUCUCCGUGGGACAUCUCUCUGGAGCAUCAAUAUUACUGCAGUAUUUGGAAGAAACAAAUUUAAAUAAGUUCUAAGGUGAAGAAUGGAACAUUUAAGACAAGUCUGGAAAGUCAUCUGCCUUUAAUAACUGUCGUUUGUCCUUAACGUCAGACUUUCUCCAAGACCAAAACUCUAAGAACUUAUUUCCAUUCUUACAAAUAGUAAAAAUGAUAAAUCAUAUCAAGUCAAUUGAAAGUCCUGCCUGCUGCUUUCCUAAAUUGCAAUAUGGCCUUGGUAUGGUUUUAUUUGUACUUUUGUGGGGGAUUCGUGGAUCUUUAGAUUAAAAAAAAAAAAAUAGGUUUUUGAACAAUUUUUGCAAGUUUGCAGCUGUUAGUUAUUGAUUUAUUUUUCCAACCCAUCUAAUUCUUCUGUCUCUCUCCUCUCCUCAGGCUCAAUAAUUCCAUGGGUCUCUAAGGCUGUGUUUAUUUUCUUUAAAUUUUGUUGAUUUACUUUUAUACUCCAUUUGAUUUUUUCUAUCUCUCACCUUUUCUCAGACUCAGUCAUCCCACAGGUCUGUAAGGCUCUGUUCAUUUUCUUUAAACUUCUUUUUUUUUUCCUCUCCUCAGAUUGGAUAAAUUAUAUUGCUAUGUCUCUGUUUCUGAACUAUAGAAAAGCUCAAAAUUAUUAUUUUUAUUUCUCAUUUUUUAUAUGGCUAUUUUUUCUCUGCUGAUGUUUCACAUCUAUUCAUUUAUGAGAAUAUUUUCCUUUGCCCUCAUGAGCGUGUUUAUAAUAGCUGCCUUCAAAUUCUUGUCUGCCGUUUACAUCUUGGACAUCUUGGAGAUGGCUACUGCCUGCUUUUUAUCUUGUGUAUUUAUUACAUUUUCACGUGUCUUCACGCAUCCCUUGAAUUGGAAAUUGUGCCCUGGAGACUGUAUACAAGACUGGAUUAAAAAGACUGGAUUCUGUUU,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[TP53TG3 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1024
179,641,PMID: 33650968,RNAPS0000576,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:2846,https://www.ncbi.nlm.nih.gov/gene/2846,LPAR4,1130nt(3'UTR),GUAUGAGAAAUGUGUUCAGGUCCAGAUAUGGUUUCUCCUAUAAUUUUUCCUAUGCUAUAAACUAAAGAUUUGAAGCUAAUGAUACUGAGAAUAAUGCACCAAAUCCAGUCAGAUACAUUUGUUUGAAGGUAUACUGUAGAGUUUUUAUUGCUGUUUUGUUCAGUAAUUAUAGGUCAAAUCUAAUUACAACAACCAAGAUGGAUUGCCAAACUCUUCUGCUUGGUUGGAAUUUCAUUGUAUCGCAUUAUCCAGGUGGCUAGUGGCAUUUGAUAAUAUAGAGAUGACUUUGAAACUUUCAAAAAGGUAUUUCUAUUCCAAUGAUAUUUGGUAAUUAGGUUGGGCCUAUAAAUAUAGAACAAAUUCAGGGAUUUUUAAAAAAUUGUGUUACUACUGAUAUAUGCUAGUUUUAUUUUAUUUUUUUGAACUGUCAUUGAGUUUAUUUUAGCACAAGAAUAUUUUUAGCCUAACAUUAUUAAUAAGAAAUGUGUCAAAUUUUUAACAUUGGUAAAAUAUGUUAUGUGCAUUUUGAAAACAGAAAACAAAUUGCGUUGGCAUGUACGUGGGUGGGAAGAAAAAGAAAAUUAACAGGAUUUACACAAUUAUAAUCACCAGCAGUGUGAGUUUAAAAAACUUCGUUGUUUUUACACCAAAUUAAAAUUUUCAUGUCAAACUUCAAAGCCAGAAAGCUGCUAAAUACGUGUCUGGCAGGUAAAAGCUGGAAAAUUACUUAAAACAGGAAAGUGUCAAUAAAAAAACUUGAGCAACACCAACAUAUUUUUUCUUAAAAUGUCACGUUAUCUUCAUUUUGGGAAACUAGGUUCUAUAAAAUAUUUAUCCUCCCUGUUAUACUUUGGAGCACAGCACAGCCAGAAAGGGGCUGCAUUUGUGCCCAGGUCAGGAGCAAAUUGAAAAAAAAAAUAAAGUAAUACAAAAAAAUCAAACUAUAAAGCAAAAACAUUUAUUAAAACCUGAAUUAAUCCUUUUUGGAGGGAGGAGUAGAGAUAUAUAACCUGAAAAUACUUAUUCUUUCUUAUCGAAUUUUGGAGCCUAAUAUAGCCAGGAGCUGCUGAAUUUGUGCCCCUGGAUUGGAAGCAAAUAAAAAAAAAAAACAACACAUAAACUAAACCAAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[LPAR4 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1130
180,642,PMID: 33650968,RNAPS0000577,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:389396,https://www.ncbi.nlm.nih.gov/gene/389396,GLYATL3,1164nt(3'UTR),CCCAGUAAAAAACUGCAGUGGUUUUAUUACUUUCCCUGAGCAUACACACACUCUUGGCUGCCAACGAGGGGAGAGUUAAAAUGGGAAUCAGGGGACUCUUGAGUUGUUGGAAAGGGUCUGGAGAAUAUAUACAGGAUCCACUUGAGAAGCCUUAAUUUUUCGUAUCUCAGGUUUCUCCAGUAAAUAGCUGUGGGGGUGAAGAGUAGCUGUGGCUGAAGACUGAGGACGAUUGUCCUCCUGUAGGAUCCACUGUAGGAGAAUAGGUUCUAAAGCCAGCAGUUUUAGUGUACUAGGAGAAAUUACUGCAUGAGAACAAAUGAUUUAACAGAGGACCACGUGGCUACUGCUUUUUGAUUGCUGCUUGGACCUCUGCUCUGUAUUCUUAAAGCCACACCGCUUCCCUACUGCCAUCAUAUUCCCCUGUCCCCACUGCUAUGUCUCAUCAACCUCUGUUCCUAACACCUCUGCCACCAAGUUCUCUGUAGAGUAACCUCCUUUUUCCCCUUUAAUUACUUGCUCUUUACUUCUGCCUAGGACUCUAGCCUAUAGUUCACUGCCCUGGGAAUGUUCAAAUAUAGUGGUUCUUACAUUUUAGUGUUUAUCAGAAUCACCCAGAGGGCAGGUUGCAACACACAUCACUAGGCCUCUCCUUCUACGAGGUAGGGCCCAAAAUUUGCAUUUCUAACAGCUUCCCACUGCUUAUUUGCCUUGGAUGAAUGACAAUAUGGGCAUUUUGAUGCUAUAAACAAAUGCUGUCACCAUAGAACUAGACUUUACCUAUAACCUAUUUCAGCCCCCUUAUUUAUAGUCUACUUUCCCAUAUAAAACUAAGAUUUAUAUAUAGGGGUGUUUGGGGGUAUGCAAAUGAAUAUAUAACAUAUAUGCAUACACAUAUAUAUACAUUCUCUUCAUUUCUUUUAUAUGUAUAGGUAUAUACUCAUAGAAUUUUGAUAAGAUAAUAAAUUUUAACCCUUUGAUUACAUAUGAAAAAUUUGAGGACCAGAGAAAAUAAAUGACUUUUUCAAGAUUAUAUUCUUUAUAAUCAGUACUGGAGGCAAAGCCAGAAUGCUGCCAUUUUAAUUCCAAUCUGUUAUUUUCACUAAAUCAUGUAUCCUUUUUUAUAAUGAAAAUUAAAAUGCUUACAUAAUUAAAAUAUUAAUUUUA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[GLYATL3 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1164
181,643,PMID: 33650968,RNAPS0000578,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:9635,https://www.ncbi.nlm.nih.gov/gene/9635,CLCA2,1026nt(3'UTR),AUAAAUAUCCAAAGUGUCUUCCUUCUUAGAUAUAAGACCCAUGGCCUUCGACUACAAAAACAUACUAACAAAGUCAAAUUAACAUCAAAACUGUAUUAAAAUGCAUUGAGUUUUUGUACAAUACAGAUAAGAUUUUUACAUGGUAGAUCAACAAAUUCUUUUUGGGGGUAGAUUAGAAAACCCUUACACUUUGGCUAUGAACAAAUAAUAAAAAUUAUUCUUUAAAGUAAUGUCUUUAAAGGCAAAGGGAAGGGUAAAGUCGGACCAGUGUCAAGGAAAGUUUGUUUUAUUGAGGUGGAAAAAUAGCCCCAAGCAGAGAAAAGGAGGGUAGGUCUGCAUUAUAACUGUCUGUGUGAAGCAAUCAUUUAGUUACUUUGAUUAAUUUUUCUUUUCUCCUUAUCUGUGCAGAACAGGUUGCUUGUUUACAACUGAAGAUCAUGCUAUAUUUUAUAUAUGAAGCCCCUAAUGCAAAGCUCUUUACCUCUUGCUAUUUUGUUAUAUAUAUUACAGAUGAAAUCUCACUGCUAAUGCUCAGAGAUCUUUUUUCACUGUAAGAGGUAACCUUUAACAAUAUGGGUAUUACCUUUGUCUCUUCAUACCGGUUUUAUGACAAAGGUCUAUUGAAUUUAUUUGUUUGUAAGUUUCUACUCCCAUCAAAGCAGCUUUCUAAGUUAUUGCCUUGGUUAUUAUGGAUGAUAGUUAUAGCCCUUAUAAUGCCUUAACUAAGGAAGAAAAGAUGUUAUUCUGAGUUUGUUUUAAUACAUAUAUGAACAUAUAGUUUUAUUCAAUUAAACCAAAGAAGAGGUCAGCAGGGAGAUACUAACCUUUGGAAAUGAUUAGCUGGCUCUGUUUUUUGGUUAAAUAAGAGUCUUUAAUCCUUUCUCCAUCAAGAGUUACUUACCAAGGGCAGGGGAAGGGGGAUAUAGAGGUCACAAGGAAAUAAAAAUCAUCUUUCAUCUUUAAUUUUACUCCUUCCUCUUAUUUUUUUAAAAGAUUAUCGAACAAUAAAAUCAUUUGCCUUUUUAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[CLCA2 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1026
182,644,PMID: 33650968,RNAPS0000579,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:3189,https://www.ncbi.nlm.nih.gov/gene/3189,HNRNPH3,1142nt(3'UTR),AAGCAAAAACACCAACAUACAAGUCUUGACAACAGCAUCUGGUCUACUAGACUUUCUUACAGAUUUAAUUUCUUUUGUAUUUUAAGAACUUUAUAAUGACUGAAGGAAUGUGUUUUCAAAAUAUUAUUUGGUAAAGCAACAGAUUGUGAUGGGAAAAUGUUUUCUGUAGGUUUAUUUGUUGCAUACUUUGACUUAAAAAUAAAUUUUUAUAUUCAAACCACUGAUGUUGAUACUUUUUAUAUACUAGUUACUCCUAAAGAUGUGCUGCCUUCAUAAGAUUUGGGUUGAUGUAUUUUACUAUUAGUUCUACAAGAAGUAGUGUGGUGUAAUUUUAGAGGAUAAUGGUUCACCUCUGCGUAAACUGCAAGUCUUAAGCAGACAUCUGGAAUAGAGCUUGACAAAUAAUUAGUGUAACUUUUUUCUUUAGUUCCUCCUGGACAACACUGUAAAUAUAAAGCCUAAAGAUGAAGUGGCUUCAGGAGUAUAAAUUCAGCUAAUUAUUUCUAUAUUAUUAUUUUUCAAAUGUCAUUUAUCAGGCAUAGCUCUGAAACAUUGAUGAUCUAAGAGGUAUUGAUUUCUGAAUAUUCAUAAUUGUGUUACCUGGGUAUGAGAGUGUUGGAAGCUGAAUUCUAGCCCUAGAUUUUGGAGUAAAACCCCUUCAGCACUUGACCGAAAUACCAAAAAUGUCUCCAAAAAAUUGAUAGUUGCAGGUUAUCGCAAGAUGUCUUAGAGUAGGGUUAAGGUUCUCAGUGACACAAGAAUUCAGUAUUAAGUACAUAGGUAUUUACUAUGGAGUAUAAUUCUCACAAUUGUAUUUUCAGUUUUCUGCCCAAUAGAGUUUAAAUAACUGUAUAAAUGAUGACUUUAAAAAAAUGUAAGCAACAAGUCCAUGUCAUAGUCAAUAAAAACAAUCCUGCAGUUGGGUUUUGUAUCUGAUCCCUGCUUGGAGUUUUAGUUUAAAGAAUCUAUAUGUAGCAAGGAAAAGGUGCUUUUUAAUUUUAAUCCCUUUGAUCAAUAUGGCUUUUUUCCAAAUUGGCUAAUGGAUCAAAAUGAAACCUGUUGAUGUGAAUUCAGUUAUUGAACUUGUUACUUGUUUUUGCCAGAAAUGUUAUUAAUAAAUGUCAUUGUGGGAGAUAAUAGUA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[HNRNPH3 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1142
183,645,PMID: 33650968,RNAPS0000580,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:5591,https://www.ncbi.nlm.nih.gov/gene/5591,PRKDC,1062nt(3'UTR),GUCUGUGGGAGUCUGCAGAUAGAAAGCAUUACAUUGUUUAAAGAAUCUACUAUACUUUGGUUGGCAGCAUUCCAUGAGCUGAUUUUCCUGAAACACUAAAGAGAAAUGUCUUUUGUGCUACAGUUUCGUAGCAUGAGUUUAAAUCAAGAUUAUGAUGAGUAAAUGUGUAUGGGUUAAAUCAAAGAUAAGGUUAUAGUAACAUCAAAGAUUAGGUGAGGUUUAUAGAAAGAUAGAUAUCCAGGCUUACCAAAGUAUUAAGUCAAGAAUAUAAUAUGUGAUCAGCUUUCAAAGCAUUUACAAGUGCUGCAAGUUAGUGAAACAGCUGUCUCCGUAAAUGGAGGAAAUGUGGGGAAGCCUUGGAAUGCCCUUCUGGUUCUGGCACAUUGGAAAGCACACUCAGAAGGCUUCAUCACCAAGAUUUUGGGAGAGUAAAGCUAAGUAUAGUUGAUGUAACAUUGUAGAAGCAGCAUAGGAACAAUAAGAACAAUAGGUAAAGCUAUAAUUAUGGCUUAUAUUUAGAAAUGACUGCAUUUGAUAUUUUAGGAUAUUUUUCUAGGUUUUUUCCUUUCAUUUUAUUCUCUUCUAGUUUUGACAUUUUAUGAUAGAUUUGCUCUCUAGAAGGAAACGUCUUUAUUUAGGAGGGCAAAAAUUUUGGUCAUAGCAUUCACUUUUGCUAUUCCAAUCUACAACUGGAAGAUACAUAAAAGUGCUUUGCAUUGAAUUUGGGAUAACUUCAAAAAUCCCAUGGUUGUUGUUAGGGAUAGUACUAAGCAUUUCAGUUCCAGGAGAAUAAAAGAAAUUCCUAUUUGAAAUGAAUUCCUCAUUUGGAGGAAAAAAAGCAUGCAUUCUAGCACAACAAGAUGAAAUUAUGGAAUACAAAAGUGGCUCCUUCCCAUGUGCAGUCCCUGUCCCCCCCCGCCAGUCCUCCACACCCAAACUGUUUCUGAUUGGCUUUUAGCUUUUUGUUGUUUUUUUUUUUCCUUCUAACACUUGUAUUUGGAGGCUCUUCUGUGAUUUUGAGAAGUAUACUCUUGAGUGUUUAAUAAAGUUUUUUUCCAAAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[PRKDC 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1062
184,646,PMID: 33650968,RNAPS0000581,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:387,https://www.ncbi.nlm.nih.gov/gene/387,RHOA,1064nt(3'UTR),AACCUUGCUGCAAGCACAGCCCUUAUGCGGUUAAUUUUGAAGUGCUGUUUAUUAAUCUUAGUGUAUGAUUACUGGCCUUUUUCAUUUAUCUAUAAUUUACCUAAGAUUACAAAUCAGAAGUCAUCUUGCUACCAGUAUUUAGAAGCCAACUAUGAUUAUUAACGAUGUCCAACCCGUCUGGCCCACCAGGGUCCUUUUGACACUGCUCUAACAGCCCUCCUCUGCACUCCCACCUGACACACCAGGCGCUAAUUCAAGGAAUUUCUUAACUUCUUGCUUCUUUCUAGAAAGAGAAACAGUUGGUAACUUUUGUGAAUUAGGCUGUAACUACUUUAUAACUAACAUGUCCUGCCUAUUAUCUGUCAGCUGCAAGGUACUCUGGUGAGUCACCACUUCAGGGCUUUACUCCGUAACAGAUUUUGUUGGCAUAGCUCUGGGGUGGGCAGUUUUUUGAAAAUGGGCUCAACCAGAAAAGCCCAAGUUCAUGCAGCUGUGGCAGAGUUACAGUUCUGUGGUUUCAUGUUAGUUACCUUAUAGUUACUGUGUAAUUAGUGCCACUUAAUGUAUGUUACCAAAAAUAAAUAUAUCUACCCCAGACUAGAUGUAGUAUUUUUUGUAUAAUUGGAUUUCCUAAUACUGUCAUCCUCAAAGAAAGUGUAUUGGUUUUUUAAAAAAGAAAGUGUAUUUGGAAAUAAAGUCAGAUGGAAAAUUCAUUUUUUAAAUUCCCGUUUUGUCACUUUUUCUGAUAAAAGAUGGCCAUAUUACCCCUUUUCGGCCCCAUGUAUCUCAGUACCCCAUGGAGCUGGGCUAAGUAAAUAGGAAUUGGUUUCACGCCUGAGGCAAUUAGACACUUUGGAAGAUGGCAUAACCUGUCUCACCUGGACUUAAGCAUCUGGCUCUAAUUCACAGUGCUCUUUUCUCCUCACUGUAUCCAGGUUCCCUCCCAGAGGAGCCACCAGUUCUCAUGGGUGGCACUCAGUCUCUCUUCUCUCCAGCUGACUAAACUUUUUUUCUGUACCAGUUAAUUUUUCCAACUACUAAUAGAAUAAAGGCAGUUUUCUAAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[RHOA 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1064
185,647,PMID: 33650968,RNAPS0000582,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:25800,https://www.ncbi.nlm.nih.gov/gene/25800,SLC39A6,1062nt(3'UTR),UUAAGGUUUAAAUGCUAGAGUAGCUUAAAAAGUUGUCAUAGUUUCAGUAGGUCAUAGGGAGAUGAGUUUGUAUGCUGUACUAUGCAGCGUUUAAAGUUAGUGGGUUUUGUGAUUUUUGUAUUGAAUAUUGCUGUCUGUUACAAAGUCAGUUAAAGGUACGUUUUAAUAUUUAAGUUAUUCUAUCUUGGAGAUAAAAUCUGUAUGUGCAAUUCACCGGUAUUACCAGUUUAUUAUGUAAACAAGAGAUUUGGCAUGACAUGUUCUGUAUGUUUCAGGGAAAAAUGUCUUUAAUGCUUUUUCAAGAACUAACACAGUUAUUCCUAUACUGGAUUUUAGGUCUCUGAAGAACUGCUGGUGUUUAGGAAUAAGAAUGUGCAUGAAGCCUAAAAUACCAAGAAAGCUUAUACUGAAUUUAAGCAAAGAAAUAAAGGAGAAAAGAGAAGAAUCUGAGAAUUGGGGAGGCAUAGAUUCUUAUAAAAAUCACAAAAUUUGUUGUAAAUUAGAGGGGAGAAAUUUAGAAUUAAGUAUAAAAAGGCAGAAUUAGUAUAGAGUACAUUCAUUAAACAUUUUUGUCAGGAUUAUUUCCCGUAAAAACGUAGUGAGCACUUUUCAUAUACUAAUUUAGUUGUACAUUUAACUUUGUAUAAUACAGAAAUCUAAAUAUAUUUAAUGAAUUCAAGCAAUAUAUCACUUGACCAAGAAAUUGGAAUUUCAAAAUGUUCGUGCGGGUAUAUACCAGAUGAGUACAGUGAGUAGUUUUAUGUAUCACCAGACUGGGUUAUUGCCAAGUUAUAUAUCACCAAAAGCUGUAUGACUGGAUGUUCUGGUUACCUGGUUUACAAAAUUAUCAGAGUAGUAAAACUUUGAUAUAUAUGAGGAUAUUAAAACUACACUAAGUAUCAUUUGAUUCGAUUCAGAAAGUACUUUGAUAUCUCUCAGUGCUUCAGUGCUAUCAUUGUGAGCAAUUGUCUUUUAUAUACGGUACUGUAGCCAUACUAGGCCUGUCUGUGGCAUUCUCUAGAUGUUUCUUUUUUACACAAUAAAUUCCUUAUAUCAGCUUGA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[SLC39A6 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1062
186,648,PMID: 33650968,RNAPS0000583,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:200010,https://www.ncbi.nlm.nih.gov/gene/200010,SLC5A9,1095nt(3'UTR),UUCCACAGACCUGGCUUCAGUGUAGACAGAUUAAACAAAGCCCAAGCCUGUCAGCCACAGAAACAGGCUCUCCUCUUACUUUGCUGUCUAAACUGGAGAUCACAGAAGUCAAGACUGCAAGCUCCCCUGAAGAGAAUCCAACUCAACCUGCACACUUGACAAGUGGAGAAACAGAAGCCCAGAGAGAGCACUGGGUUUGUUCAGGACCACCCAGAAGGUGUCACACGGGGUUUCCCCACUCUUUCUGAUAUAUUGCCUUACAGACCUACCUCAAACACACUGUUUCCACCCUCUUCUUGAAUGUAUUCAGUAGCCUUUACUGAAUGUGUGUCUUGAGAGUAGAAAAAUGGAGGAUACAAGAAAAGGAGCAGGAAGAAAUUUGCAAAAAUCCAAGAGCACCUUUGCUCCCCCUUAUCCUCCUUCCUCUUCCCCUUUCUAGUUCCCCUACCUCUCUAUCUUUCUAUUCUCACCAAUAAUCUCUUUGUUGCAUGAAUUUACCCAGGAGAGUCCUAUAUUUCCAUUGGUGGCUCCACAGUGGUGGCUGUCAGACCCGAAGGGGUGGGGAGCCAAGGGUGGACUUUAAGCAUGGUGACAGAUGGUAUUUUGGGCAGAAAGCUCUUAGACAAUGGACUAUCCAAAGCACUAUUUAAAUUCUGCCUCUUCCUACUCUCUAACCCAAAUAUGCACAAACUCUCUAUGGCCUUGAGAAGCAGUUGGAGAGACAUGACUUGUUAAAACCUCAAGGAAUCAAGACAUGUUACUCUGUAUUUAAGGGUAAGCCCCACAGCGGGCAGCACAAACAGCCUGGGAGCCACUGUGCCUGUGCUUCUCUGUCCUUCUCCCUUUGCUUGCCAUGAAUCCGCAUACCUUGGAAUACACUGUGACCCCAGUUAAGUGUCCCUUCGCCAGGAAGCUGCCGCAACGUCCAGACCUGGGUCAAGUUCCCACUCCUGCUCCCAUAGCCUUGACCUGCUUCUGUCACAGCACUGAUCACACUGAGAUGGAAGACUCCAGGGGGCAAGGACCAAGGGCCAUAUCCCAAGUGACUUUGUACCCAGAAAAUAACAGCUGUUCAAUAAAUGUGUAUUGAGUUAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[SLC39A6 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1095
187,649,PMID: 33650968,RNAPS0000584,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:85027,https://www.ncbi.nlm.nih.gov/gene/85027,SMIM3,1113nt(3'UTR),GAGCCUCCCAAGAGGGCCGGGUGAGGGAUGAGGACAGGCAUCCUAUCCCCAGCCUCUUCCUGUCUUCAGAAAAGCAGCAGGAGGGACUUUGGGGCAUGGACCUGAGUUCUGGUUUUGAUUCUGCCACGAGCCAGCUGUGUGAAUUUGGUCAAGGGACCUAACUCUCUGAGUUCCAGGUUCCUUAUCUUUCAAAUGGGGAUGGUGAUCCCUGCCCUUUCUACCUCAUAGGGAUGUGAGAACCACCUGACUUAGUGGAUGUGAAAGCUGUUUGUGAUCAGUAAAGCUACCACAGAUAUAAGGGUGUUAUGCUGAAUCCUGAGAAGCUUUCAAGAACCAGAGAACCUGAUUGCUGAUGAUGGCCUUAAAGGUGGUGAGGGAGAUACUGGGGGCAGAGCAGACUUUGCCAGUGCCCCUCAGGUCAAACCAAGCCAAGAGCACCCUGUCCCCAUUCCAAGGGGCCAGCAGCACUUUGGCCCAAAGUAUUUUCUUUAAGGUGCCAUUCCUUCAUGUUUUCUCAGUUUGGAGGGUGAUGGGUAGAGCUUUCCAGAACCUUCUCCAUUCCAGAAUCUCUGCCCCUGUGUAAUCUGAAGGAAGGCUGUGCCAUCUUUGGGCACUGCCAAGGGAGUUGGGGUGAUGGGCUUCUUUCUGCACUGGAGUCUCACAUCUGUUAGCUUUGACACUCAAGCAAUGUUGGAAAAUGCAGGGUGACUGAGUUCCCUGCCCAGCUUUCGGGAUCUCUGGCCCCCAUCCCCUUGUGUGUGUCCCUCUGCCCAGCUCCUGCUGUAAUUAGCUCCACGUGUACCCCCUUCACUCCCUCCCACCAGCUCUGCAGCCAGCCUAUGGCAAUUAUAUUUUAAGAGGUGUUCCCAGGACUUUUGGGACCUACUAAAACAAUGAUGGUUAUUUUAGAUGUGAUGAUUUAUAUUUAUGUAGAGAUAUUUCUGGACCACUCAAGCUCUUCGAUACCAAAAUCAGGAGCAUCUUGGGAUUUAUUAAAUUAUGUAAGAAGAUAGCACAGAUAUCGGGAUAUUAUUGUGUGAAAAUGCUGCUUUUACUUUGAUGUGAUCUCAUUGAUGUACACAACCAAGUUCCAAUAAAGUGCUAGAAUGUGCA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[SMIM3 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1113
188,650,PMID: 33650968,RNAPS0000585,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:25928,https://www.ncbi.nlm.nih.gov/gene/25928,SOSTDC1,1067nt(3'UTR),AACUCAGACUCCCAUAACUAGACUUACUAGUAACCAUCUGCUUUACAGAUUUGAUUGCUUGGAAGACUCAAGCCUGCCACUGCUGUUUUCUCACUUGAAAGUAUAUGCUUUCUGCUUUGAUCAAACCCAGCAAGCUGUCUUAAGUAUCAGGACCUUCUUUGGGAAUAGUUUUUCCUUUUCAAGUUUUUCAAGAUGUAGGUAUAUCCAUGAAUGCAAUUUGCAUUUAAAUUCCACGUAUCCUGUAGUUUUAAUUCCUCAUUGUUCUUAAAAGACUGUUGAUACUAUAAACAUCAGUGAAUCAUUAUAUUUUAAAACAGAAAAGGGCUUCUCAGAUACCCUCCAUCUACUGGCCCAUCCCCUCUCCUAAACAAAACUCCUUCAAAACAGGUUAAAAAAAAUAUGUUGUCAUGAAUCUUCACAGUAACAUUUCAGAAAGGUGCUUUUUUGGUACUCUUCAUGGGAACAGUUUAGCAGCCAUGAGUGAUCUUCCUUUGAAAGAGAAUGAAAGACCCUGUGACAUUUCACUUCAAAAAUAAGCCCUGUAGCUCUUUACGGUCGCAUAGUAUGAAAUUAUACCCUGCAUGCUGACCCUCGCUUGGAAUGGAAUGCCAGAAAUGCAUGGCAGCAGCUAAUAAGUAAAGCUGAUUAACUAUUUAUUUGUCAAUGUUAUUAUUUAAUGAGCUUUCACAUGUGAUUUGUUUCAAAACUUUAAUUUUUUAAUGUUUUGAAACUUUUUCAUGGACCUAAAUAUUUUCCUAUAUGAUUUGUGGUUGAUUAGAAAUAUGAAAUACAUGUUGUAGAUAUGUAAAAUGAAUAUUUUAGUCUCCUUAUUACAUAUAUGUUCAUGGUGAACUUUAUCAAUAGUAUGGAUCUUUUUAAAUCAAUAAGAUGCUUUGUAAAGUUGAAAUAAGUAAUACUUUCUUGUUUAAUCUGUGCAAUCAGAAGGUGUCUUGACCUUCAAUUCAAUUGGUUUCUUUUAACAAAAAUAAACACUGCUAAAAGUUAUUGUUGUUGCCUCUAACAUGUAUAAAGGGUGCAAAAAUUGUAGAAUAAAUGUAUAAGGGUAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[SOSTDC1 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1067
189,651,PMID: 33650968,RNAPS0000586,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:8987,https://www.ncbi.nlm.nih.gov/gene/8987,STBD1,1130nt(3'UTR),UUCAGUUUGCAAAGUAAUGGAGAAGCUGUAGAACAAUGUGGAAGAGGCUGAGGUUGUGGAACACACUGAAUAAAAUAAAGGCAGUGUGACUCCAAAUUCAGCCAUCUGAAUUGUUUAAAUUUGCUAGUGGAUUUUGUCUAAUGUGCAGAAAUAUAUAUGUCUAAUGUGCAGAAAUAUAUAUGUGUGUAUGUGUGUAUAUAUAUGCACACACACACAGAUAAUGCUUCCAGUGAAUGUGAACUUCUUUUCCCUGUGGCACUGAUUGACAGACUUGUGCUGAUCCAUUAUUACUUUAGGGCUUGAUUCUCUUGGGGAGUGACUUGGCUAAGCUUCAGGUGUAAACUGUGGUCACGGAGCAAAAACAUUAACCAGCUGCCCAGGGUUCAAGCUUGAGCCUUUAGGUGAUCUUUAAACUAUGGUAGUAAAAUAAGCCUCACUCAAACAUAGCUGACUUCCUAUUGGUACAGCUUGAAAAGCACUUUUUACUACAUACACAUUUUAUGCUUAAAAAGUUAACAUGAUACGAAACUGUGAUUAGAAAAUAUCUGGUCUGGAUGUGAUUAGUAAGGAUACAAGAUAAUGUUCUAAGACUGCCUAAUGCUUUUUGUUUGAUUUUCAUCUGCCAGGCGUUGUUAUGUGCUAUGAGGGUAGCAAGUACGUCUUUGUCUUAAUGAUCUAAGGCUGGUGUAGAAACAAAGGGCCUAAUGAGAACCAAUCAUCAUGGAAGUCAGUUGCGGGGGCAGCCCAUAAGGAAAGGGAAAGUGAGUGGGGUUGGGCAUAGGCUGAGUGAGGUGGCCUGAAUGACACCUCUUAGAGGACUGUGAAGUACAGGCACAGCCCGACUGCAGGGAGGGAUGCACCCAUCAUUUACCCAUGGGAGCAUCUGUAGGACCAUCUCUCUCCCACUUCUUCUCCCCUCCCCCACCGCAUCUGGCCAGAUGGACUGUCCUACAGCAAUCGUUUCCAUCUGUCACCCUCUUCCCUCUCCUUUCAUACCAGUCACUAUCUUGGGUAACAAAUUUAUACAGGACAGUGGUACAGAAAUACAUCUUUGCUCUGAGAAUACAGCAAAUAUUAACUUAAAUUAUUAUAACUGAACAAAUAAUAAAACCUGAAUUUUAAUAUCUUCA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[STBD1 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1130
190,652,PMID: 33650968,RNAPS0000587,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:841,https://www.ncbi.nlm.nih.gov/gene/841,CASP8,1117nt(3'UTR),UGGUGCUAUUUUGUUUGUUUUGUUUUGUUUUGUUUUUUUGAGACAGAAUCUCGCUCUGUCGCCCAGGCUGGAGUGCAGUGGCGUGAUCUCGGCUCACCGCAAGCUCCGCCUCCCGGGUUCAGGCCAUUCUCCUGCCUCAGCCUCCCGAGUAGCUGGGACUACAGGGGCCCGCCACCACACCUGGCUAAUUUUUUAAAAAUAUUUUUAGUAGAGACAGGGUUUCACUGUGUUAGCCAGGGUGGUCUUGAUCUCCUGACCUCGUGAUCCACCCACCUCGGCCUCCCAAAGUGCUGGGAUUACAGGCGUGAGCCACCGCGCCUGGCCGAUGGUACUAUUUAGAUAUAACACUAUGUUUAUUUACUAAUUUUCUAGAUUUUCUACUUUAUUAAUUGUUUUGCACUUUUUUAUAAGAGCUAAAGUUAAAUAGGAUAUUAACAACAAUAACACUGUCUCCUUUCUCUUAUGCUUAAGGCUUUGGGAAUGUUUUUAGCUGGUGGCAAUAAAUACCAGACACGUACAAAAUCCAGCUAUGAAUAUAGAGGGCUUAUGAUUCAGAUUGUUAUCUAUCAACUAUAAGCCCACUGUUAAUAUUCUAUUAACUUUAAUUCUCUUUCAAAGCUAAAUUCCACACUACCACAUUAAAAAAAUUAGAAAGUAGCCACGUAUGGUGGCUCAUGUCUAUAAUCCCAGCACUUUGGGAGGUUGAGGUGGGAGGAUUGCUUGAACCCAAGAGGUCAAGGCUGCAGUGAGCCAUGUUCACACCGCUGCACUCAAGCUUGGGUGACAGAACAAGACCCCGUCUCAAAAAAAAUUUUUUUUUUAAUAAAACAAAAUUUGUUUGAAAUCUUUUAAAAAUUCAAAUGAUUUUUACAAGUUUUAAAUAAGCUCUCCCCAAACUUGCUUUAUGCCUUCUUAUUGCUUUUAUGAUAUAUAUAUGCUUGGCUAACUAUAUUUGCUUUUUGCUAACAAUGCUCUGGGGUCUUUUUAUGCAUUUGCAUUUGCUCUUUCAUCUCUGCUUGGAUUAUUUUAAAUCAUUAGGAAUUAAGUUAUCUUUAAAAUUUAAGUAUCUUUUUUCAAAAACAUUUUUUAAUAGAAUAAAAUAUAAUUUGAUCUUAUU,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[CASP8 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1117
191,653,PMID: 33650968,RNAPS0000588,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:114799,https://www.ncbi.nlm.nih.gov/gene/114799,ESCO1,1059nt(3'UTR),AACAAAUUCUUGCCUACACCACUAGAAGACAUCUAUUGAAGAGAAUGGAUUGGUUGCUGACUUUAACCAGGAACUAGGGCCAUUUUUAUUACAAUGAACUCAGGACUGGCAACAACCAUAUGGUUGUUCCAUUUUCAUAAAAUUGGAAACAAUGCAGUAAUAGCUUAUUGUUUUGUUUUUUAAAGAAGAUAUUUUAUUAUCUUUUACAGAAAUUUAUGAUUGAUGUAUUUUAUCUAUAGUUAUUUAGACAUGUUUACAUGCAGCAGAUAAUUGUUCAUAGUGGACUGAAAACUAAUGCAAGGACUAUGGUCUCAGUGAUAAGUAUAUUUUGAAGUUCUUAAUAUGGAAAUAUACCAGUGUAGCUUGGUACUGUAUUUUUUUAUAUUGAUCUGCUGAUACCAGUGAUAGGCUUAAAGAUUGUAUUUUCACAGAGUGGAAACCAAUUUUUUUAGUUAUUGUUCAAGGAGGGUGCAAUAUUAAGUGUUUUGGAAUUUGAAGCUAAUUUUUAAAAGGCCUGAACUAUACUUUGAAGAAACCCCUAUAGAAAAGGAAAGCUCCAGCUAAAUAGGAAGAAUUAGAAUAUUGAGCUUUUUUUUCCUGAUUUUUCUCUUUCCUAUCUUUGAUGGAAGGAGGAAGUAGAAAGUGGUAAAGAAUUGAGGCUUUCCUUCUUGGAGAGCUGUAAAUGACAAGCAUUAGGAAAGGUACCCUCCUAGAUUCAUUAUUCUUUCAUUCUGGUUUCACUUUUAAAAUAAAUGGCAACUUGGCACACCUAGGCUGUUAACAAAUCUCAAAGAGGUUUAUAAAAACGUAUAGAAUACUUGGAAGCAAAGUAUGGAUGACUCGGUAUCUGCUUUGUUAUUCCUCAGAAAUACUGCACUGAGUAUAUGCCCUCAUUACUGGACUUCAUUUUGAUACUUGUCUAUCCUUCAUAGUGCCCUCUACUUUUAAAGGGUUUAUAUGUUGAAAAACUGCUGUGGCCUUUUAUGACCUGUAUAUAAUGUAGAAUAAAAAUAAUAAAAUACUUGAUAGCUUUUUCUAAGUGACCAAUGUACUAACUGA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[ESCO1 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1059
192,654,PMID: 33650968,RNAPS0000589,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:987,https://www.ncbi.nlm.nih.gov/gene/987,LRBA,1063nt(3'UTR),UGGUGACAGCUGUACAUCAACUCUGCCCCUAGGAUGAGCAGAAGUACCUGGAGCAUCAUUCUCUUCUACCACAUCUGAAUGUAACUUAAAUUUGCUCAAAGAAGCAAAAUAUUUUUUAAAGUUAUUAAUAAUUGCUAUUUUUGUAGUCUUUGCUUGACUUUUUUGGGGGGGAUUAGCAAAGCAGAAAACUGGCUGCUGGGUUCUGUAGUUUUAAAAAAUCUAUAUUUUUAGUCAUAAUGAGAAGUCUAUUUUCACCAAUUAUGGAAACAUACAGUGGAGCAAGUAAACCACUUAUUCCAGCUAUAAUAUUAUGAAGAACAUUUCCCAUGCAUCUACAAGCUUGAGAAAUAGGAUUUUCACAGUGGGGAAGUGGGUUACAAUAUUGGAAUAGGAAAAUUUGAUGCUGUAAUUUGGGUCCUGUAUUUUUCCAAACAACUGUGCUUCUUCAGCACUAAUAUUUCUGGGAUUUAAAUAGUAAUGUUUAAAUUAUGGUAAAUGUAAUUUAAAACAUCUCAAUUAAGUCUGUCUAUCAAUAUUGUUCUUCAAGCAUGUUUUAGACCUAGAAAAGUAUGGUUUGGGGGAGGCUAUUUUAUUGUGUGGUUAGCACAAGGAAUCUAAUUUAUAGCAAGUGUGAAAUAGUUACCAUUUUUUCCUGAUCUGUCAUCUUCAUAGCACAACAAAACGAAAUGAUGGAAAUGCUCUUGAGCUCACAACAUUUGUUUUUCUUUUAAAGUAAAUGCAAGUACCAAAGCUCACUACUGCGGUUUGCCUGUGCCUGGACAAUGAGGCGGAGCCACUGUUGUUUUGUUGGGGCACCCCCUUCCCUCCCCGGGUUUGCAAAUAGAGGCUACCGGGUGCUGUAUUCAGCAACACCUGUUUUACUAUUUGUUAUUAAACUAUCAUCUCCACCUUCCUUUUGAUUAGCAAUUUGUACUAAGAAACGAAACAAUGUUAUUUGGUGGUGUAUAAUUCUACUUUUCUAGUAGAUUACUGUGUGGAAUUCUGUGAAAAAUAUUUGAGAAAAGGCCUGUAUUGCAUAAAUAAAUUCUUUGUAUGUUGUGAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[LRBA 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1063
193,655,PMID: 33650968,RNAPS0000590,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:4957,https://www.ncbi.nlm.nih.gov/gene/4957,ODF2,1037nt(3'UTR),GGCCACUUAUCAGGGCCUGGAGCCCUGAUGGAAGCCAUAGGAACUCCAGAGUUGCCAAGCCAUAGCUGAGAAGCCUGGUGGUUUUCCUCUCCCAGUGAAAAAAUGGGUUCAGGGUCUUGUCCUUAGCUACUAGCUCUAGAAAAGUCCCAAAAGCAGCAGAAGGUGAAGCAGGAAGCACUUGGUUUUCUCCUUCCUGAUAUAGUCACCUGUUGGAAGUGUUAAAAUUUCCUCGACAGGCCUUAAAUUUACUACUACAUUAGGGUACCACAUUUUAACUUACCAUGACUUUGCUCCUUCCUUUCCUGAGAAAAUAUUUCCACUGGAUUUUUUCCACCAGUCCCCUUACAGCCCUCAUUGUUUUAGGAAUCUCUCUCAGGUUUUUUCUGACCUAAACCAGCAGGAAGUCGUCCUGGGCUGUAAGCACCAUCACUUGCUUUUUUUUUUUUUCUGAUUUCACAAGUGUGGUGUUUUCCCAAGGCUCCCUUCCCAAGCUCAGUGCAAACCUCUCACUCCCAAGUUUCUUUGAGGCCACUUGCCCCCAAGCACUUCACAAUAGACCCUCGAGGGCUUGUGUCCAUUUGGCCUUUUACAAGUGUAAUGCCAAUUUCAUUGAUUUUUGUUUCUUUUGGCCUGAUUUGUAUCUCUGGAAUGCAUUUAUUCUUGAAAUAUUUGUGUGAUUUUACAAAAAGCUUUUGUAAUCAGUUAUUUAAGGCUCCAUUUGAUGAUUUCCUUUACCCAACCAGUCCUCAUCCCUCCUCUAAAAAAUGAUUAAGUAAAAUGCUGCAGGACAGCCAGUAGACAUUUUUAAAGUACUUGGUGCCUGAAACAUCAGGCUUCUCAUUUCAUUUUAGCUCAGGUUGGUGCUUUCACAUUGUAAUCAAUGAACUGUCAGGAGGGAACAAACUGUAAGAAGGAUUGCUUGGUGUUUUAGGGUAGAUCACUUUAGCUAUUAGGAAGAGGAUGGGGUAGUGUACAGUAUAUAUUUUUAAAAUGUGAAUUGGUUUCUGAAUAAGAAUCUGGGCCAUUUUUGUUCACCA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[ODF2 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,The normalized ensemble diversity (NED) value of RNAs is highly predictive for their ability to form sphere- or mesh-like condensates.,1037
194,656,PMID: 33650968,RNAPS0000591,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:8600,https://www.ncbi.nlm.nih.gov/gene/8600,TNFSF11,1125nt(3'UTR+2*15nt),GCCCCAGUUUUUGGAGUGUUAUGUAUUUCCUGGAUGUUUGGAAACAUUUUUUAAAACAAGCCAAGAAAGAUGUAUAUAGGUGUGUGAGACUACUAAGAGGCAUGGCCCCAACGGUACACGACUCAGUAUCCAUGCUCUUGACCUUGUAGAGAACACGCGUAUUUACAGCCAGUGGGAGAUGUUAGACUCAUGGUGUGUUACACAAUGGUUUUUAAAUUUUGUAAUGAAUUCCUAGAAUUAAACCAGAUUGGAGCAAUUACGGGGUGACCUUAUGAGAAACUGCAUGUGGGCUAUGGGAGGGGUUGGUCCCUGGUCAUGUGCCCCUUCGCAGCUGAAGUGGAGAGGGUGUCAUCUAGCGCAAUUGAAGGAUCAUCUGAAGGGGCAAAUUCUUUUGAAUUGUUACAUCAUGCUGGAACCUGCAAAAAAUACUUUUUCUAAUGAGGAGAGAAAAUAUAUGUAUUUUUAUAUAAUAUCUAAAGUUAUAUUUCAGAUGUAAUGUUUUCUUUGCAAAGUAUUGUAAAUUAUAUUUGUGCUAUAGUAUUUGAUUCAAAAUAUUUAAAAAUGUCUUGCUGUUGACAUAUUUAAUGUUUUAAAUGUACAGACAUAUUUAACUGGUGCACUUUGUCAGUUUCUCAUAAGGAAAUUCCCUGGGGAAAACUUGCAGCUAAGGAGGGGAAAAAAAUGUUGUUUCCUAAUAUCAAAUGCAGUAUAUUUCUUCGUUCUUUUUAAGUUAAUAGAUUUUUUCAGACUUGUCAAGCCUGUGCAAAAAAAUUAAAAUGGAUGCCUUGAAUAAUAAGCAGGAUGUUGGCCACCAGGUGCCUUUCAAAUUUAGAAACUAAUUGACUUUAGAAAGCUGACAUUGCCAAAAAGGAUACAUAAUGGGCCACUGAAAUCUGUCAAGAGUAGUUAUAUAAUUGUUGAACAGGUGUUUUUCCACAAGUGCCGCAAAUUGUACCUUUUUUGUUUUUUCAAAAUAGAAAAGUUAUUAGUGGUUUAUCAGCAAAAAAGUCCAAUUUUAAUUUAGUAAAUGUUAUCUUAUACUGUACAAUAAAAACAUUGCCUUUGAAUGUUAAUUUUUUGGUACAAAAAUAAAUUUAUAUGAAAACCUGCGCAGGUUUUCAUAUA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|150nM[TNFSF11 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,"The TNFSF11 3'UTR mutant has stronger local structures indicated by increased base-pairing and a lower NED value, and it has largely lost the ability for network formation",1125
195,657,PMID: 33650968,RNAPS0000592,https://pubmed.ncbi.nlm.nih.gov/33650968,RNAs + protein,NCBI ID:961;|NCBI ID:1994,https://www.ncbi.nlm.nih.gov/gene/961;|https://www.ncbi.nlm.nih.gov/gene/1994,CD47;|ELAVL1,4194nt(3'UTR);|4909nt(3'UTR),CUGAAGUGAAGUGAUGGACUCCGAUUUGGAGAGUAGUAAGACGUGAAAGGAAUACACUUGUGUUUAAGCACCAUGGCCUUGAUGAUUCACUGUUGGGGAGAAGAAACAAGAAAAGUAACUGGUUGUCACCUAUGAGACCCUUACGUGAUUGUUAGUUAAGUUUUUAUUCAAAGCAGCUGUAAUUUAGUUAAUAAAAUAAUUAUGAUCUAUGUUGUUUGCCCAAUUGAGAUCCAGUUUUUUGUUGUUAUUUUUAAUCAAUUAGGGGCAAUAGUAGAAUGGACAAUUUCCAAGAAUGAUGCCUUUCAGGUCCUAGGGCCUCUGGCCUCUAGGUAACCAGUUUAAAUUGGUUCAGGGUGAUAACUACUUAGCACUGCCCUGGUGAUUACCCAGAGAUAUCUAUGAAAACCAGUGGCUUCCAUCAAACCUUUGCCAACUCAGGUUCACAGCAGCUUUGGGCAGUUAUGGCAGUAUGGCAUUAGCUGAGAGGUGUCUGCCACUUCUGGGUCAAUGGAAUAAUAAAUUAAGUACAGGCAGGAAUUUGGUUGGGAGCAUCUUGUAUGAUCUCCGUAUGAUGUGAUAUUGAUGGAGAUAGUGGUCCUCAUUCUUGGGGGUUGCCAUUCCCACAUUCCCCCUUCAACAAACAGUGUAACAGGUCCUUCCCAGAUUUAGGGUACUUUUAUUGAUGGAUAUGUUUUCCUUUUAUUCACAUAACCCCUUGAAACCCUGUCUUGUCCUCCUGUUACUUGCUUCUGCUGUACAAGAUGUAGCACCUUUUCUCCUCUUUGAACAUGGUCUAGUGACACGGUAGCACCAGUUGCAGGAAGGAGCCAGACUUGUUCUCAGAGCACUGUGUUCACACUUUUCAGCAAAAAUAGCUAUGGUUGUAACAUAUGUAUUCCCUUCCUCUGAUUUGAAGGCAAAAAUCUACAGUGUUUCUUCACUUCUUUUCUGAUCUGGGGCAUGAAAAAAGCAAGAUUGAAAUUUGAACUAUGAGUCUCCUGCAUGGCAACAAAAUGUGUGUCACCAUCAGGCCAACAGGCCAGCCCUUGAAUGGGGAUUUAUUACUGUUGUAUCUAUGUUGCAUGAUAAACAUUCAUCACCUUCCUCCUGUAGUCCUGCCUCGUACUCCCCUUCCCCUAUGAUUGAAAAGUAAACAAAACCCACAUUUCCUAUCCUGGUUAGAAGAAAAUUAAUGUUCUGACAGUUGUGAUCGCCUGGAGUACUUUUAGACUUUUAGCAUUCGUUUUUUACCUGUUUGUGGAUGUGUGUUUGUAUGUGCAUACGUAUGAGAUAGGCACAUGCAUCUUCUGUAUGGACAAAGGUGGGGUACCUACAGGAGAGCAAAGGUUAAUUUUGUGCUUUUAGUAAAAACAUUUAAAUACAAAGUUCUUUAUUGGGUGGAAUUAUAUUUGAUGCAAAUAUUUGAUCACUUAAAACUUUUAAAACUUCUAGGUAAUUUGCCACGCUUUUUGACUGCUCACCAAUACCCUGUAAAAAUACGUAAUUCUUCCUGUUUGUGUAAUAAGAUAUUCAUAUUUGUAGUUGCAUUAAUAAUAGUUAUUUCUUAGUCCAUCAGAUGUUCCCGUGUGCCUCUUUUAUGCCAAAUUGAUUGUCAUAUUUCAUGUUGGGACCAAGUAGUUUGCCCAUGGCAAACCUAAAUUUAUGACCUGCUGAGGCCUCUCAGAAAACUGAGCAUACUAGCAAGACAGCUCUUCUUGAAAAAAAAAAUAUGUAUACACAAAUAUAUACGUAUAUCUAUAUAUACGUAUGUAUAUACACACAUGUAUAUUCUUCCUUGAUUGUGUAGCUGUCCAAAAUAAUAACAUAUAUAGAGGGAGCUGUAUUCCUUUAUACAAAUCUGAUGGCUCCUGCAGCACUUUUUCCUUCUGAAAAUAUUUACAUUUUGCUAACCUAGUUUGUUACUUUAAAAAUCAGUUUUGAUGAAAGGAGGGAAAAGCAGAUGGACUUGAAAAAGAUCCAAGCUCCUAUUAGAAAAGGUAUGAAAAUCUUUAUAGUAAAAUUUUUUAUAAACUAAAGUUGUACCUUUUAAUAUGUAGUAAACUCUCAUUUAUUUGGGGUUCGCUCUUGGAUCUCAUCCAUCCAUUGUGUUCUCUUUAAUGCUGCCUGCCUUUUGAGGCAUUCACUGCCCUAGACAAUGCCACCAGAGAUAGUGGGGGAAAUGCCAGAUGAAACCAACUCUUGCUCUCACUAGUUGUCAGCUUCUCUGGAUAAGUGACCACAGAAGCAGGAGUCCUCCUGCUUGGGCAUCAUUGGGCCAGUUCCUUCUCUUUAAAUCAGAUUUGUAAUGGCUCCCAAAUUCCAUCACAUCACAUUUAAAUUGCAGACAGUGUUUUGCACAUCAUGUAUCUGUUUUGUCCCAUAAUAUGCUUUUUACUCCCUGAUCCCAGUUUCUGCUGUUGACUCUUCCAUUCAGUUUUAUUUAUUGUGUGUUCUCACAGUGACACCAUUUGUCCUUUUCUGCAACAACCUUUCCAGCUACUUUUGCCAAAUUCUAUUUGUCUUCUCCUUCAAAACAUUCUCCUUUGCAGUUCCUCUUCAUCUGUGUAGCUGCUCUUUUGUCUCUUAACUUACCAUUCCUAUAGUACUUUAUGCAUCUCUGCUUAGUUCUAUUAGUUUUUUGGCCUUGCUCUUCUCCUUGAUUUUAAAAUUCCUUCUAUAGCUAGAGCUUUUCUUUCUUUCAUUCUCUCUUCCUGCAGUGUUUUGCAUACAUCAGAAGCUAGGUACAUAAGUUAAAUGAUUGAGAGUUGGCUGUAUUUAGAUUUAUCACUUUUUAAUAGGGUGAGCUUGAGAGUUUUCUUUCUUUCUGUUUUUUUUUUUUGUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUGACUAAUUUCACAUGCUCUAAAAACCUUCAAAGGUGAUUAUUUUUCUCCUGGAAACUCCAGGUCCAUUCUGUUUAAAUCCCUAAGAAUGUCAGAAUUAAAAUAACAGGGCUAUCCCGUAAUUGGAAAUAUUUCUUUUUUCAGGAUGCUAUAGUCAAUUUAGUAAGUGACCACCAAAUUGUUAUUUGCACUAACAAAGCUCAAAACACGAUAAGUUUACUCCUCCAUCUCAGUAAUAAAAAUUAAGCUGUAAUCAACCUUCUAGGUUUCUCUUGUCUUAAAAUGGGUAUUCAAAAAUGGGGAUCUGUGGUGUAUGUAUGGAAACACAUACUCCUUAAUUUACCUGUUGUUGGAAACUGGAGAAAUGAUUGUCGGGCAACCGUUUAUUUUUUAUUGUAUUUUAUUUGGUUGAGGGAUUUUUUUAUAAACAGUUUUACUUGUGUCAUAUUUUAAAAUUACUAACUGCCAUCACCUGCUGGGGUCCUUUGUUAGGUCAUUUUCAGUGACUAAUAGGGAUAAUCCAGGUAACUUUGAAGAGAUGAGCAGUGAGUGACCAGGCAGUUUUUCUGCCUUUAGCUUUGACAGUUCUUAAUUAAGAUCAUUGAAGACCAGCUUUCUCAUAAAUUUCUCUUUUUGAAAAAAAGAAAGCAUUUGUACUAAGCUCCUCUGUAAGACAACAUCUUAAAUCUUAAAAGUGUUGUUAUCAUGACUGGUGAGAGAAGAAAACAUUUUGUUUUUAUUAAAUGGAGCAUUAUUUACAAAAAGCCAUUGUUGAGAAUUAGAUCCCACAUCGUAUAAAUAUCUAUUAACCAUUCUAAAUAAAGAGAACUCCAGUGUUGCUAUGUGCAAGAUCCUCUCUUGGAGCUUUUUUGCAUAGCAAUUAAAGGUGUGCUAUUUGUCAGUAGCCAUUUUUUUGCAGUGAUUUGAAGACCAAAGUUGUUUUACAGCUGUGUUACCGUUAAAGGUUUUUUUUUUUAUAUGUAUUAAAUCAAUUUAUCACUGUUUAAAGCUUUGAAUAUCUGCAAUCUUUGCCAAGGUACUUUUUUAUUUAAAAAAAAACAUAACUUUGUAAAUAUUACCCUGUAAUAUUAUAUAUACUUAAUAAAACAUUUUAAGCUAUUUUGUUGGGCUAUUUCUAUUGCUGCUACAGCAGACCACAAGCACAUUUCUGAAAAAUUUAAUUUAUUAAUGUAUUUUUAAGUUGCUUAUAUUCUAGGUAACAAUGUAAAGAAUGAUUUAAAAUAUUAAUUAUGAAUUUUUUGAGUAUAAUACCCAAUAAGCUUUUAAUUAGAGCAGAGUUUUAAUUAAAAGUUUUAAAUCAGUC;|-,mRNA;|mRNA,Homo sapiens;|Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|CD47 3'UTR;|ELAVL1 3'UTR,"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,"Therefore, we tested whether two RNAs co-localize in the network. Labeling of several pairs of RNAs with two different fluorescent dyes showed that they colocalize",4194
196,658,PMID: 33650968,RNAPS0000593,https://pubmed.ncbi.nlm.nih.gov/33650968,RNAs + protein,NCBI ID:961;|NCBI ID:8600,https://www.ncbi.nlm.nih.gov/gene/961;|https://www.ncbi.nlm.nih.gov/gene/8600,CD47;|TNFSF11,4194nt(3'UTR);|1095nt(3'UTR),CUGAAGUGAAGUGAUGGACUCCGAUUUGGAGAGUAGUAAGACGUGAAAGGAAUACACUUGUGUUUAAGCACCAUGGCCUUGAUGAUUCACUGUUGGGGAGAAGAAACAAGAAAAGUAACUGGUUGUCACCUAUGAGACCCUUACGUGAUUGUUAGUUAAGUUUUUAUUCAAAGCAGCUGUAAUUUAGUUAAUAAAAUAAUUAUGAUCUAUGUUGUUUGCCCAAUUGAGAUCCAGUUUUUUGUUGUUAUUUUUAAUCAAUUAGGGGCAAUAGUAGAAUGGACAAUUUCCAAGAAUGAUGCCUUUCAGGUCCUAGGGCCUCUGGCCUCUAGGUAACCAGUUUAAAUUGGUUCAGGGUGAUAACUACUUAGCACUGCCCUGGUGAUUACCCAGAGAUAUCUAUGAAAACCAGUGGCUUCCAUCAAACCUUUGCCAACUCAGGUUCACAGCAGCUUUGGGCAGUUAUGGCAGUAUGGCAUUAGCUGAGAGGUGUCUGCCACUUCUGGGUCAAUGGAAUAAUAAAUUAAGUACAGGCAGGAAUUUGGUUGGGAGCAUCUUGUAUGAUCUCCGUAUGAUGUGAUAUUGAUGGAGAUAGUGGUCCUCAUUCUUGGGGGUUGCCAUUCCCACAUUCCCCCUUCAACAAACAGUGUAACAGGUCCUUCCCAGAUUUAGGGUACUUUUAUUGAUGGAUAUGUUUUCCUUUUAUUCACAUAACCCCUUGAAACCCUGUCUUGUCCUCCUGUUACUUGCUUCUGCUGUACAAGAUGUAGCACCUUUUCUCCUCUUUGAACAUGGUCUAGUGACACGGUAGCACCAGUUGCAGGAAGGAGCCAGACUUGUUCUCAGAGCACUGUGUUCACACUUUUCAGCAAAAAUAGCUAUGGUUGUAACAUAUGUAUUCCCUUCCUCUGAUUUGAAGGCAAAAAUCUACAGUGUUUCUUCACUUCUUUUCUGAUCUGGGGCAUGAAAAAAGCAAGAUUGAAAUUUGAACUAUGAGUCUCCUGCAUGGCAACAAAAUGUGUGUCACCAUCAGGCCAACAGGCCAGCCCUUGAAUGGGGAUUUAUUACUGUUGUAUCUAUGUUGCAUGAUAAACAUUCAUCACCUUCCUCCUGUAGUCCUGCCUCGUACUCCCCUUCCCCUAUGAUUGAAAAGUAAACAAAACCCACAUUUCCUAUCCUGGUUAGAAGAAAAUUAAUGUUCUGACAGUUGUGAUCGCCUGGAGUACUUUUAGACUUUUAGCAUUCGUUUUUUACCUGUUUGUGGAUGUGUGUUUGUAUGUGCAUACGUAUGAGAUAGGCACAUGCAUCUUCUGUAUGGACAAAGGUGGGGUACCUACAGGAGAGCAAAGGUUAAUUUUGUGCUUUUAGUAAAAACAUUUAAAUACAAAGUUCUUUAUUGGGUGGAAUUAUAUUUGAUGCAAAUAUUUGAUCACUUAAAACUUUUAAAACUUCUAGGUAAUUUGCCACGCUUUUUGACUGCUCACCAAUACCCUGUAAAAAUACGUAAUUCUUCCUGUUUGUGUAAUAAGAUAUUCAUAUUUGUAGUUGCAUUAAUAAUAGUUAUUUCUUAGUCCAUCAGAUGUUCCCGUGUGCCUCUUUUAUGCCAAAUUGAUUGUCAUAUUUCAUGUUGGGACCAAGUAGUUUGCCCAUGGCAAACCUAAAUUUAUGACCUGCUGAGGCCUCUCAGAAAACUGAGCAUACUAGCAAGACAGCUCUUCUUGAAAAAAAAAAUAUGUAUACACAAAUAUAUACGUAUAUCUAUAUAUACGUAUGUAUAUACACACAUGUAUAUUCUUCCUUGAUUGUGUAGCUGUCCAAAAUAAUAACAUAUAUAGAGGGAGCUGUAUUCCUUUAUACAAAUCUGAUGGCUCCUGCAGCACUUUUUCCUUCUGAAAAUAUUUACAUUUUGCUAACCUAGUUUGUUACUUUAAAAAUCAGUUUUGAUGAAAGGAGGGAAAAGCAGAUGGACUUGAAAAAGAUCCAAGCUCCUAUUAGAAAAGGUAUGAAAAUCUUUAUAGUAAAAUUUUUUAUAAACUAAAGUUGUACCUUUUAAUAUGUAGUAAACUCUCAUUUAUUUGGGGUUCGCUCUUGGAUCUCAUCCAUCCAUUGUGUUCUCUUUAAUGCUGCCUGCCUUUUGAGGCAUUCACUGCCCUAGACAAUGCCACCAGAGAUAGUGGGGGAAAUGCCAGAUGAAACCAACUCUUGCUCUCACUAGUUGUCAGCUUCUCUGGAUAAGUGACCACAGAAGCAGGAGUCCUCCUGCUUGGGCAUCAUUGGGCCAGUUCCUUCUCUUUAAAUCAGAUUUGUAAUGGCUCCCAAAUUCCAUCACAUCACAUUUAAAUUGCAGACAGUGUUUUGCACAUCAUGUAUCUGUUUUGUCCCAUAAUAUGCUUUUUACUCCCUGAUCCCAGUUUCUGCUGUUGACUCUUCCAUUCAGUUUUAUUUAUUGUGUGUUCUCACAGUGACACCAUUUGUCCUUUUCUGCAACAACCUUUCCAGCUACUUUUGCCAAAUUCUAUUUGUCUUCUCCUUCAAAACAUUCUCCUUUGCAGUUCCUCUUCAUCUGUGUAGCUGCUCUUUUGUCUCUUAACUUACCAUUCCUAUAGUACUUUAUGCAUCUCUGCUUAGUUCUAUUAGUUUUUUGGCCUUGCUCUUCUCCUUGAUUUUAAAAUUCCUUCUAUAGCUAGAGCUUUUCUUUCUUUCAUUCUCUCUUCCUGCAGUGUUUUGCAUACAUCAGAAGCUAGGUACAUAAGUUAAAUGAUUGAGAGUUGGCUGUAUUUAGAUUUAUCACUUUUUAAUAGGGUGAGCUUGAGAGUUUUCUUUCUUUCUGUUUUUUUUUUUUGUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUGACUAAUUUCACAUGCUCUAAAAACCUUCAAAGGUGAUUAUUUUUCUCCUGGAAACUCCAGGUCCAUUCUGUUUAAAUCCCUAAGAAUGUCAGAAUUAAAAUAACAGGGCUAUCCCGUAAUUGGAAAUAUUUCUUUUUUCAGGAUGCUAUAGUCAAUUUAGUAAGUGACCACCAAAUUGUUAUUUGCACUAACAAAGCUCAAAACACGAUAAGUUUACUCCUCCAUCUCAGUAAUAAAAAUUAAGCUGUAAUCAACCUUCUAGGUUUCUCUUGUCUUAAAAUGGGUAUUCAAAAAUGGGGAUCUGUGGUGUAUGUAUGGAAACACAUACUCCUUAAUUUACCUGUUGUUGGAAACUGGAGAAAUGAUUGUCGGGCAACCGUUUAUUUUUUAUUGUAUUUUAUUUGGUUGAGGGAUUUUUUUAUAAACAGUUUUACUUGUGUCAUAUUUUAAAAUUACUAACUGCCAUCACCUGCUGGGGUCCUUUGUUAGGUCAUUUUCAGUGACUAAUAGGGAUAAUCCAGGUAACUUUGAAGAGAUGAGCAGUGAGUGACCAGGCAGUUUUUCUGCCUUUAGCUUUGACAGUUCUUAAUUAAGAUCAUUGAAGACCAGCUUUCUCAUAAAUUUCUCUUUUUGAAAAAAAGAAAGCAUUUGUACUAAGCUCCUCUGUAAGACAACAUCUUAAAUCUUAAAAGUGUUGUUAUCAUGACUGGUGAGAGAAGAAAACAUUUUGUUUUUAUUAAAUGGAGCAUUAUUUACAAAAAGCCAUUGUUGAGAAUUAGAUCCCACAUCGUAUAAAUAUCUAUUAACCAUUCUAAAUAAAGAGAACUCCAGUGUUGCUAUGUGCAAGAUCCUCUCUUGGAGCUUUUUUGCAUAGCAAUUAAAGGUGUGCUAUUUGUCAGUAGCCAUUUUUUUGCAGUGAUUUGAAGACCAAAGUUGUUUUACAGCUGUGUUACCGUUAAAGGUUUUUUUUUUUAUAUGUAUUAAAUCAAUUUAUCACUGUUUAAAGCUUUGAAUAUCUGCAAUCUUUGCCAAGGUACUUUUUUAUUUAAAAAAAAACAUAACUUUGUAAAUAUUACCCUGUAAUAUUAUAUAUACUUAAUAAAACAUUUUAAGCUAUUUUGUUGGGCUAUUUCUAUUGCUGCUACAGCAGACCACAAGCACAUUUCUGAAAAAUUUAAUUUAUUAAUGUAUUUUUAAGUUGCUUAUAUUCUAGGUAACAAUGUAAAGAAUGAUUUAAAAUAUUAAUUAUGAAUUUUUUGAGUAUAAUACCCAAUAAGCUUUUAAUUAGAGCAGAGUUUUAAUUAAAAGUUUUAAAUCAGUC;|GCCCCAGUUUUUGGAGUGUUAUGUAUUUCCUGGAUGUUUGGAAACAUUUUUUAAAACAAGCCAAGAAAGAUGUAUAUAGGUGUGUGAGACUACUAAGAGGCAUGGCCCCAACGGUACACGACUCAGUAUCCAUGCUCUUGACCUUGUAGAGAACACGCGUAUUUACAGCCAGUGGGAGAUGUUAGACUCAUGGUGUGUUACACAAUGGUUUUUAAAUUUUGUAAUGAAUUCCUAGAAUUAAACCAGAUUGGAGCAAUUACGGGGUGACCUUAUGAGAAACUGCAUGUGGGCUAUGGGAGGGGUUGGUCCCUGGUCAUGUGCCCCUUCGCAGCUGAAGUGGAGAGGGUGUCAUCUAGCGCAAUUGAAGGAUCAUCUGAAGGGGCAAAUUCUUUUGAAUUGUUACAUCAUGCUGGAACCUGCAAAAAAUACUUUUUCUAAUGAGGAGAGAAAAUAUAUGUAUUUUUAUAUAAUAUCUAAAGUUAUAUUUCAGAUGUAAUGUUUUCUUUGCAAAGUAUUGUAAAUUAUAUUUGUGCUAUAGUAUUUGAUUCAAAAUAUUUAAAAAUGUCUUGCUGUUGACAUAUUUAAUGUUUUAAAUGUACAGACAUAUUUAACUGGUGCACUUUGUAAAUUCCCUGGGGAAAACUUGCAGCUAAGGAGGGGAAAAAAAUGUUGUUUCCUAAUAUCAAAUGCAGUAUAUUUCUUCGUUCUUUUUAAGUUAAUAGAUUUUUUCAGACUUGUCAAGCCUGUGCAAAAAAAUUAAAAUGGAUGCCUUGAAUAAUAAGCAGGAUGUUGGCCACCAGGUGCCUUUCAAAUUUAGAAACUAAUUGACUUUAGAAAGCUGACAUUGCCAAAAAGGAUACAUAAUGGGCCACUGAAAUCUGUCAAGAGUAGUUAUAUAAUUGUUGAACAGGUGUUUUUCCACAAGUGCCGCAAAUUGUACCUUUUUUGUUUUUUCAAAAUAGAAAAGUUAUUAGUGGUUUAUCAGCAAAAAAGUCCAAUUUUAAUUUAGUAAAUGUUAUCUUAUACUGUACAAUAAAAACAUUGCCUUUGAAUGUUAAUUUUUUGGUACAAAAAUAAAUUUAUAUGAAAACCUGC,mRNA;|mRNA,Homo sapiens;|Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|CD47 3'UTR;|TNFSF11 3'UTR,"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,"Therefore, we tested whether two RNAs co-localize in the network. Labeling of several pairs of RNAs with two different fluorescent dyes showed that they colocalize",4194
197,659,PMID: 33650968,RNAPS0000594,https://pubmed.ncbi.nlm.nih.gov/33650968,RNAs + protein,NCBI ID:961;|NCBI ID:51311,https://www.ncbi.nlm.nih.gov/gene/961;|https://www.ncbi.nlm.nih.gov/gene/51311,CD47;|TLR8,4194nt(3'UTR);|1003nt(3'UTR),CUGAAGUGAAGUGAUGGACUCCGAUUUGGAGAGUAGUAAGACGUGAAAGGAAUACACUUGUGUUUAAGCACCAUGGCCUUGAUGAUUCACUGUUGGGGAGAAGAAACAAGAAAAGUAACUGGUUGUCACCUAUGAGACCCUUACGUGAUUGUUAGUUAAGUUUUUAUUCAAAGCAGCUGUAAUUUAGUUAAUAAAAUAAUUAUGAUCUAUGUUGUUUGCCCAAUUGAGAUCCAGUUUUUUGUUGUUAUUUUUAAUCAAUUAGGGGCAAUAGUAGAAUGGACAAUUUCCAAGAAUGAUGCCUUUCAGGUCCUAGGGCCUCUGGCCUCUAGGUAACCAGUUUAAAUUGGUUCAGGGUGAUAACUACUUAGCACUGCCCUGGUGAUUACCCAGAGAUAUCUAUGAAAACCAGUGGCUUCCAUCAAACCUUUGCCAACUCAGGUUCACAGCAGCUUUGGGCAGUUAUGGCAGUAUGGCAUUAGCUGAGAGGUGUCUGCCACUUCUGGGUCAAUGGAAUAAUAAAUUAAGUACAGGCAGGAAUUUGGUUGGGAGCAUCUUGUAUGAUCUCCGUAUGAUGUGAUAUUGAUGGAGAUAGUGGUCCUCAUUCUUGGGGGUUGCCAUUCCCACAUUCCCCCUUCAACAAACAGUGUAACAGGUCCUUCCCAGAUUUAGGGUACUUUUAUUGAUGGAUAUGUUUUCCUUUUAUUCACAUAACCCCUUGAAACCCUGUCUUGUCCUCCUGUUACUUGCUUCUGCUGUACAAGAUGUAGCACCUUUUCUCCUCUUUGAACAUGGUCUAGUGACACGGUAGCACCAGUUGCAGGAAGGAGCCAGACUUGUUCUCAGAGCACUGUGUUCACACUUUUCAGCAAAAAUAGCUAUGGUUGUAACAUAUGUAUUCCCUUCCUCUGAUUUGAAGGCAAAAAUCUACAGUGUUUCUUCACUUCUUUUCUGAUCUGGGGCAUGAAAAAAGCAAGAUUGAAAUUUGAACUAUGAGUCUCCUGCAUGGCAACAAAAUGUGUGUCACCAUCAGGCCAACAGGCCAGCCCUUGAAUGGGGAUUUAUUACUGUUGUAUCUAUGUUGCAUGAUAAACAUUCAUCACCUUCCUCCUGUAGUCCUGCCUCGUACUCCCCUUCCCCUAUGAUUGAAAAGUAAACAAAACCCACAUUUCCUAUCCUGGUUAGAAGAAAAUUAAUGUUCUGACAGUUGUGAUCGCCUGGAGUACUUUUAGACUUUUAGCAUUCGUUUUUUACCUGUUUGUGGAUGUGUGUUUGUAUGUGCAUACGUAUGAGAUAGGCACAUGCAUCUUCUGUAUGGACAAAGGUGGGGUACCUACAGGAGAGCAAAGGUUAAUUUUGUGCUUUUAGUAAAAACAUUUAAAUACAAAGUUCUUUAUUGGGUGGAAUUAUAUUUGAUGCAAAUAUUUGAUCACUUAAAACUUUUAAAACUUCUAGGUAAUUUGCCACGCUUUUUGACUGCUCACCAAUACCCUGUAAAAAUACGUAAUUCUUCCUGUUUGUGUAAUAAGAUAUUCAUAUUUGUAGUUGCAUUAAUAAUAGUUAUUUCUUAGUCCAUCAGAUGUUCCCGUGUGCCUCUUUUAUGCCAAAUUGAUUGUCAUAUUUCAUGUUGGGACCAAGUAGUUUGCCCAUGGCAAACCUAAAUUUAUGACCUGCUGAGGCCUCUCAGAAAACUGAGCAUACUAGCAAGACAGCUCUUCUUGAAAAAAAAAAUAUGUAUACACAAAUAUAUACGUAUAUCUAUAUAUACGUAUGUAUAUACACACAUGUAUAUUCUUCCUUGAUUGUGUAGCUGUCCAAAAUAAUAACAUAUAUAGAGGGAGCUGUAUUCCUUUAUACAAAUCUGAUGGCUCCUGCAGCACUUUUUCCUUCUGAAAAUAUUUACAUUUUGCUAACCUAGUUUGUUACUUUAAAAAUCAGUUUUGAUGAAAGGAGGGAAAAGCAGAUGGACUUGAAAAAGAUCCAAGCUCCUAUUAGAAAAGGUAUGAAAAUCUUUAUAGUAAAAUUUUUUAUAAACUAAAGUUGUACCUUUUAAUAUGUAGUAAACUCUCAUUUAUUUGGGGUUCGCUCUUGGAUCUCAUCCAUCCAUUGUGUUCUCUUUAAUGCUGCCUGCCUUUUGAGGCAUUCACUGCCCUAGACAAUGCCACCAGAGAUAGUGGGGGAAAUGCCAGAUGAAACCAACUCUUGCUCUCACUAGUUGUCAGCUUCUCUGGAUAAGUGACCACAGAAGCAGGAGUCCUCCUGCUUGGGCAUCAUUGGGCCAGUUCCUUCUCUUUAAAUCAGAUUUGUAAUGGCUCCCAAAUUCCAUCACAUCACAUUUAAAUUGCAGACAGUGUUUUGCACAUCAUGUAUCUGUUUUGUCCCAUAAUAUGCUUUUUACUCCCUGAUCCCAGUUUCUGCUGUUGACUCUUCCAUUCAGUUUUAUUUAUUGUGUGUUCUCACAGUGACACCAUUUGUCCUUUUCUGCAACAACCUUUCCAGCUACUUUUGCCAAAUUCUAUUUGUCUUCUCCUUCAAAACAUUCUCCUUUGCAGUUCCUCUUCAUCUGUGUAGCUGCUCUUUUGUCUCUUAACUUACCAUUCCUAUAGUACUUUAUGCAUCUCUGCUUAGUUCUAUUAGUUUUUUGGCCUUGCUCUUCUCCUUGAUUUUAAAAUUCCUUCUAUAGCUAGAGCUUUUCUUUCUUUCAUUCUCUCUUCCUGCAGUGUUUUGCAUACAUCAGAAGCUAGGUACAUAAGUUAAAUGAUUGAGAGUUGGCUGUAUUUAGAUUUAUCACUUUUUAAUAGGGUGAGCUUGAGAGUUUUCUUUCUUUCUGUUUUUUUUUUUUGUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUGACUAAUUUCACAUGCUCUAAAAACCUUCAAAGGUGAUUAUUUUUCUCCUGGAAACUCCAGGUCCAUUCUGUUUAAAUCCCUAAGAAUGUCAGAAUUAAAAUAACAGGGCUAUCCCGUAAUUGGAAAUAUUUCUUUUUUCAGGAUGCUAUAGUCAAUUUAGUAAGUGACCACCAAAUUGUUAUUUGCACUAACAAAGCUCAAAACACGAUAAGUUUACUCCUCCAUCUCAGUAAUAAAAAUUAAGCUGUAAUCAACCUUCUAGGUUUCUCUUGUCUUAAAAUGGGUAUUCAAAAAUGGGGAUCUGUGGUGUAUGUAUGGAAACACAUACUCCUUAAUUUACCUGUUGUUGGAAACUGGAGAAAUGAUUGUCGGGCAACCGUUUAUUUUUUAUUGUAUUUUAUUUGGUUGAGGGAUUUUUUUAUAAACAGUUUUACUUGUGUCAUAUUUUAAAAUUACUAACUGCCAUCACCUGCUGGGGUCCUUUGUUAGGUCAUUUUCAGUGACUAAUAGGGAUAAUCCAGGUAACUUUGAAGAGAUGAGCAGUGAGUGACCAGGCAGUUUUUCUGCCUUUAGCUUUGACAGUUCUUAAUUAAGAUCAUUGAAGACCAGCUUUCUCAUAAAUUUCUCUUUUUGAAAAAAAGAAAGCAUUUGUACUAAGCUCCUCUGUAAGACAACAUCUUAAAUCUUAAAAGUGUUGUUAUCAUGACUGGUGAGAGAAGAAAACAUUUUGUUUUUAUUAAAUGGAGCAUUAUUUACAAAAAGCCAUUGUUGAGAAUUAGAUCCCACAUCGUAUAAAUAUCUAUUAACCAUUCUAAAUAAAGAGAACUCCAGUGUUGCUAUGUGCAAGAUCCUCUCUUGGAGCUUUUUUGCAUAGCAAUUAAAGGUGUGCUAUUUGUCAGUAGCCAUUUUUUUGCAGUGAUUUGAAGACCAAAGUUGUUUUACAGCUGUGUUACCGUUAAAGGUUUUUUUUUUUAUAUGUAUUAAAUCAAUUUAUCACUGUUUAAAGCUUUGAAUAUCUGCAAUCUUUGCCAAGGUACUUUUUUAUUUAAAAAAAAACAUAACUUUGUAAAUAUUACCCUGUAAUAUUAUAUAUACUUAAUAAAACAUUUUAAGCUAUUUUGUUGGGCUAUUUCUAUUGCUGCUACAGCAGACCACAAGCACAUUUCUGAAAAAUUUAAUUUAUUAAUGUAUUUUUAAGUUGCUUAUAUUCUAGGUAACAAUGUAAAGAAUGAUUUAAAAUAUUAAUUAUGAAUUUUUUGAGUAUAAUACCCAAUAAGCUUUUAAUUAGAGCAGAGUUUUAAUUAAAAGUUUUAAAUCAGUC;|CUGACGUUAAGUCAUGAUUUCGCGCCAUAAUAAAGAUGCAAAGGAAUGACAUUUCUGUAUUAGUUAUCUAUUGCUAUGUAACAAAUUAUCCCAAAACUUAGUGGUUUAAAACAACACAUUUGCUGGCCCACAGUUUUUGAGGGUCAGGAGUCCAGGCCCAGCAUAACUGGGUCCUCUGCUCAGGGUGUCUCAGAGGCUGCAAUGUAGGUGUUCACCAGAGACAUAGGCAUCACUGGGGUCACACUCAUGUGGUUGUUUUCUGGAUUCAAUUCCUCCUGGGCUAUUGGCCAAAGGCUAUACUCAUGUAAGCCAUGCGAGCCUCUCCCACAAGGCAGCUUGCUUCAUCAGAGCUAGCAAAAAAGAGAGGUUGCUAGCAAGAUGAAGUCACAAUCUUUUGUAAUCGAAUCAAAAAAGUGAUAUCUCAUCACUUUGGCCAUAUUCUAUUUGUUAGAAGUAAACCACAGGUCCCACCAGCUCCAUGGGAGUGACCACCUCAGUCCAGGGAAAACAGCUGAAGACCAAGAUGGUGAGCUCUGAUUGCUUCAGUUGGUCAUCAACUAUUUUCCCUUGACUGCUGUCCUGGGAUGGCCUGCUAUCUUGAUGAUAGAUUGUGAAUAUCAGGAGGCAGGGAUCACUGUGGACCAUCUUAGCAGUUGACCUAACACAUCUUCUUUUCAAUAUCUAAGAACUUUUGCCACUGUGACUAAUGGUCCUAAUAUUAAGCUGUUGUUUAUAUUUAUCAUAUAUCUAUGGCUACAUGGUUAUAUUAUGCUGUGGUUGCGUUCGGUUUUAUUUACAGUUGCUUUUACAAAUAUUUGCUGUAACAUUUGACUUCUAAGGUUUAGAUGCCAUUUAAGAACUGAGAUGGAUAGCUUUUAAAGCAUCUUUUACUUCUUACCAUUUUUUAAAAGUAUGCAGCUAAAUUCGAAGCUUUUGGUCUAUAUUGUUAAUUGCCAUUGCUGUAAAUCUUAAAAUGAAUGAAUAAAAAUGUUUCAUUUUACAA,mRNA;|mRNA,Homo sapiens;|Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|CD47 3'UTR;|TLR8 3'UTR,"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,"Therefore, we tested whether two RNAs co-localize in the network. Labeling of several pairs of RNAs with two different fluorescent dyes showed that they colocalize",4194
198,660,PMID: 33650968,RNAPS0000595,https://pubmed.ncbi.nlm.nih.gov/33650968,RNAs + protein,NCBI ID:961;|NCBI ID:919;|NCBI ID:8600;|NCBI ID:10186,https://www.ncbi.nlm.nih.gov/gene/961;|https://www.ncbi.nlm.nih.gov/gene/919;|https://www.ncbi.nlm.nih.gov/gene/8600;|https://www.ncbi.nlm.nih.gov/gene/10186,CD47;|CD274;|TNFSF11;|LHFPL6,4194nt(3'UTR);|2705nt(3'UTR);|1095nt(3'UTR);|1044nt(3'UTR),CUGAAGUGAAGUGAUGGACUCCGAUUUGGAGAGUAGUAAGACGUGAAAGGAAUACACUUGUGUUUAAGCACCAUGGCCUUGAUGAUUCACUGUUGGGGAGAAGAAACAAGAAAAGUAACUGGUUGUCACCUAUGAGACCCUUACGUGAUUGUUAGUUAAGUUUUUAUUCAAAGCAGCUGUAAUUUAGUUAAUAAAAUAAUUAUGAUCUAUGUUGUUUGCCCAAUUGAGAUCCAGUUUUUUGUUGUUAUUUUUAAUCAAUUAGGGGCAAUAGUAGAAUGGACAAUUUCCAAGAAUGAUGCCUUUCAGGUCCUAGGGCCUCUGGCCUCUAGGUAACCAGUUUAAAUUGGUUCAGGGUGAUAACUACUUAGCACUGCCCUGGUGAUUACCCAGAGAUAUCUAUGAAAACCAGUGGCUUCCAUCAAACCUUUGCCAACUCAGGUUCACAGCAGCUUUGGGCAGUUAUGGCAGUAUGGCAUUAGCUGAGAGGUGUCUGCCACUUCUGGGUCAAUGGAAUAAUAAAUUAAGUACAGGCAGGAAUUUGGUUGGGAGCAUCUUGUAUGAUCUCCGUAUGAUGUGAUAUUGAUGGAGAUAGUGGUCCUCAUUCUUGGGGGUUGCCAUUCCCACAUUCCCCCUUCAACAAACAGUGUAACAGGUCCUUCCCAGAUUUAGGGUACUUUUAUUGAUGGAUAUGUUUUCCUUUUAUUCACAUAACCCCUUGAAACCCUGUCUUGUCCUCCUGUUACUUGCUUCUGCUGUACAAGAUGUAGCACCUUUUCUCCUCUUUGAACAUGGUCUAGUGACACGGUAGCACCAGUUGCAGGAAGGAGCCAGACUUGUUCUCAGAGCACUGUGUUCACACUUUUCAGCAAAAAUAGCUAUGGUUGUAACAUAUGUAUUCCCUUCCUCUGAUUUGAAGGCAAAAAUCUACAGUGUUUCUUCACUUCUUUUCUGAUCUGGGGCAUGAAAAAAGCAAGAUUGAAAUUUGAACUAUGAGUCUCCUGCAUGGCAACAAAAUGUGUGUCACCAUCAGGCCAACAGGCCAGCCCUUGAAUGGGGAUUUAUUACUGUUGUAUCUAUGUUGCAUGAUAAACAUUCAUCACCUUCCUCCUGUAGUCCUGCCUCGUACUCCCCUUCCCCUAUGAUUGAAAAGUAAACAAAACCCACAUUUCCUAUCCUGGUUAGAAGAAAAUUAAUGUUCUGACAGUUGUGAUCGCCUGGAGUACUUUUAGACUUUUAGCAUUCGUUUUUUACCUGUUUGUGGAUGUGUGUUUGUAUGUGCAUACGUAUGAGAUAGGCACAUGCAUCUUCUGUAUGGACAAAGGUGGGGUACCUACAGGAGAGCAAAGGUUAAUUUUGUGCUUUUAGUAAAAACAUUUAAAUACAAAGUUCUUUAUUGGGUGGAAUUAUAUUUGAUGCAAAUAUUUGAUCACUUAAAACUUUUAAAACUUCUAGGUAAUUUGCCACGCUUUUUGACUGCUCACCAAUACCCUGUAAAAAUACGUAAUUCUUCCUGUUUGUGUAAUAAGAUAUUCAUAUUUGUAGUUGCAUUAAUAAUAGUUAUUUCUUAGUCCAUCAGAUGUUCCCGUGUGCCUCUUUUAUGCCAAAUUGAUUGUCAUAUUUCAUGUUGGGACCAAGUAGUUUGCCCAUGGCAAACCUAAAUUUAUGACCUGCUGAGGCCUCUCAGAAAACUGAGCAUACUAGCAAGACAGCUCUUCUUGAAAAAAAAAAUAUGUAUACACAAAUAUAUACGUAUAUCUAUAUAUACGUAUGUAUAUACACACAUGUAUAUUCUUCCUUGAUUGUGUAGCUGUCCAAAAUAAUAACAUAUAUAGAGGGAGCUGUAUUCCUUUAUACAAAUCUGAUGGCUCCUGCAGCACUUUUUCCUUCUGAAAAUAUUUACAUUUUGCUAACCUAGUUUGUUACUUUAAAAAUCAGUUUUGAUGAAAGGAGGGAAAAGCAGAUGGACUUGAAAAAGAUCCAAGCUCCUAUUAGAAAAGGUAUGAAAAUCUUUAUAGUAAAAUUUUUUAUAAACUAAAGUUGUACCUUUUAAUAUGUAGUAAACUCUCAUUUAUUUGGGGUUCGCUCUUGGAUCUCAUCCAUCCAUUGUGUUCUCUUUAAUGCUGCCUGCCUUUUGAGGCAUUCACUGCCCUAGACAAUGCCACCAGAGAUAGUGGGGGAAAUGCCAGAUGAAACCAACUCUUGCUCUCACUAGUUGUCAGCUUCUCUGGAUAAGUGACCACAGAAGCAGGAGUCCUCCUGCUUGGGCAUCAUUGGGCCAGUUCCUUCUCUUUAAAUCAGAUUUGUAAUGGCUCCCAAAUUCCAUCACAUCACAUUUAAAUUGCAGACAGUGUUUUGCACAUCAUGUAUCUGUUUUGUCCCAUAAUAUGCUUUUUACUCCCUGAUCCCAGUUUCUGCUGUUGACUCUUCCAUUCAGUUUUAUUUAUUGUGUGUUCUCACAGUGACACCAUUUGUCCUUUUCUGCAACAACCUUUCCAGCUACUUUUGCCAAAUUCUAUUUGUCUUCUCCUUCAAAACAUUCUCCUUUGCAGUUCCUCUUCAUCUGUGUAGCUGCUCUUUUGUCUCUUAACUUACCAUUCCUAUAGUACUUUAUGCAUCUCUGCUUAGUUCUAUUAGUUUUUUGGCCUUGCUCUUCUCCUUGAUUUUAAAAUUCCUUCUAUAGCUAGAGCUUUUCUUUCUUUCAUUCUCUCUUCCUGCAGUGUUUUGCAUACAUCAGAAGCUAGGUACAUAAGUUAAAUGAUUGAGAGUUGGCUGUAUUUAGAUUUAUCACUUUUUAAUAGGGUGAGCUUGAGAGUUUUCUUUCUUUCUGUUUUUUUUUUUUGUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUGACUAAUUUCACAUGCUCUAAAAACCUUCAAAGGUGAUUAUUUUUCUCCUGGAAACUCCAGGUCCAUUCUGUUUAAAUCCCUAAGAAUGUCAGAAUUAAAAUAACAGGGCUAUCCCGUAAUUGGAAAUAUUUCUUUUUUCAGGAUGCUAUAGUCAAUUUAGUAAGUGACCACCAAAUUGUUAUUUGCACUAACAAAGCUCAAAACACGAUAAGUUUACUCCUCCAUCUCAGUAAUAAAAAUUAAGCUGUAAUCAACCUUCUAGGUUUCUCUUGUCUUAAAAUGGGUAUUCAAAAAUGGGGAUCUGUGGUGUAUGUAUGGAAACACAUACUCCUUAAUUUACCUGUUGUUGGAAACUGGAGAAAUGAUUGUCGGGCAACCGUUUAUUUUUUAUUGUAUUUUAUUUGGUUGAGGGAUUUUUUUAUAAACAGUUUUACUUGUGUCAUAUUUUAAAAUUACUAACUGCCAUCACCUGCUGGGGUCCUUUGUUAGGUCAUUUUCAGUGACUAAUAGGGAUAAUCCAGGUAACUUUGAAGAGAUGAGCAGUGAGUGACCAGGCAGUUUUUCUGCCUUUAGCUUUGACAGUUCUUAAUUAAGAUCAUUGAAGACCAGCUUUCUCAUAAAUUUCUCUUUUUGAAAAAAAGAAAGCAUUUGUACUAAGCUCCUCUGUAAGACAACAUCUUAAAUCUUAAAAGUGUUGUUAUCAUGACUGGUGAGAGAAGAAAACAUUUUGUUUUUAUUAAAUGGAGCAUUAUUUACAAAAAGCCAUUGUUGAGAAUUAGAUCCCACAUCGUAUAAAUAUCUAUUAACCAUUCUAAAUAAAGAGAACUCCAGUGUUGCUAUGUGCAAGAUCCUCUCUUGGAGCUUUUUUGCAUAGCAAUUAAAGGUGUGCUAUUUGUCAGUAGCCAUUUUUUUGCAGUGAUUUGAAGACCAAAGUUGUUUUACAGCUGUGUUACCGUUAAAGGUUUUUUUUUUUAUAUGUAUUAAAUCAAUUUAUCACUGUUUAAAGCUUUGAAUAUCUGCAAUCUUUGCCAAGGUACUUUUUUAUUUAAAAAAAAACAUAACUUUGUAAAUAUUACCCUGUAAUAUUAUAUAUACUUAAUAAAACAUUUUAAGCUAUUUUGUUGGGCUAUUUCUAUUGCUGCUACAGCAGACCACAAGCACAUUUCUGAAAAAUUUAAUUUAUUAAUGUAUUUUUAAGUUGCUUAUAUUCUAGGUAACAAUGUAAAGAAUGAUUUAAAAUAUUAAUUAUGAAUUUUUUGAGUAUAAUACCCAAUAAGCUUUUAAUUAGAGCAGAGUUUUAAUUAAAAGUUUUAAAUCAGUC;|-;|GCCCCAGUUUUUGGAGUGUUAUGUAUUUCCUGGAUGUUUGGAAACAUUUUUUAAAACAAGCCAAGAAAGAUGUAUAUAGGUGUGUGAGACUACUAAGAGGCAUGGCCCCAACGGUACACGACUCAGUAUCCAUGCUCUUGACCUUGUAGAGAACACGCGUAUUUACAGCCAGUGGGAGAUGUUAGACUCAUGGUGUGUUACACAAUGGUUUUUAAAUUUUGUAAUGAAUUCCUAGAAUUAAACCAGAUUGGAGCAAUUACGGGGUGACCUUAUGAGAAACUGCAUGUGGGCUAUGGGAGGGGUUGGUCCCUGGUCAUGUGCCCCUUCGCAGCUGAAGUGGAGAGGGUGUCAUCUAGCGCAAUUGAAGGAUCAUCUGAAGGGGCAAAUUCUUUUGAAUUGUUACAUCAUGCUGGAACCUGCAAAAAAUACUUUUUCUAAUGAGGAGAGAAAAUAUAUGUAUUUUUAUAUAAUAUCUAAAGUUAUAUUUCAGAUGUAAUGUUUUCUUUGCAAAGUAUUGUAAAUUAUAUUUGUGCUAUAGUAUUUGAUUCAAAAUAUUUAAAAAUGUCUUGCUGUUGACAUAUUUAAUGUUUUAAAUGUACAGACAUAUUUAACUGGUGCACUUUGUAAAUUCCCUGGGGAAAACUUGCAGCUAAGGAGGGGAAAAAAAUGUUGUUUCCUAAUAUCAAAUGCAGUAUAUUUCUUCGUUCUUUUUAAGUUAAUAGAUUUUUUCAGACUUGUCAAGCCUGUGCAAAAAAAUUAAAAUGGAUGCCUUGAAUAAUAAGCAGGAUGUUGGCCACCAGGUGCCUUUCAAAUUUAGAAACUAAUUGACUUUAGAAAGCUGACAUUGCCAAAAAGGAUACAUAAUGGGCCACUGAAAUCUGUCAAGAGUAGUUAUAUAAUUGUUGAACAGGUGUUUUUCCACAAGUGCCGCAAAUUGUACCUUUUUUGUUUUUUCAAAAUAGAAAAGUUAUUAGUGGUUUAUCAGCAAAAAAGUCCAAUUUUAAUUUAGUAAAUGUUAUCUUAUACUGUACAAUAAAAACAUUGCCUUUGAAUGUUAAUUUUUUGGUACAAAAAUAAAUUUAUAUGAAAACCUGC;|GAUGGAGCUACCAAGAGCAGACAGAGGAGAAGAUGGGCCAAAGGGGCUUGGAGAGGUCAAAACAUCCACCUACCUUCAAAAGGUGGGAUAGUAGUUCUAAUCCAAUACAAUGCUAAUAAAAUGAAACCCGAUAAAAUCAGGAACAUGAUAUAGGAAGGAAGGAUUGUAGGAGAUUUGUGGGGGAAAAAAAAGGAGAGUAUAGAAUGAUGGAGAAAAAUGGACCAAAGGCUAAAAAUAUUGCAGGGCAUCGGGUGUUUCUAUUCCACAGAGUAUUGUUAAUGUACAACACACACACACACACACACACACACACACACACACACACACACACAACAAAUCUACAUAUACAAACAAGGGUUUGGGUUUUAGUUUUUUUUUUUUAAGGUGAGGACUCAGAAAAUCAAAGGGCUAGUAGAAACAGUGUUAUGUUGGGAAGCAGGGUACCCCCAAAGAUGUUCCCUGUAGGUCACGGCACUCCCAAAAGCACACAAGCACAUACAGACAUAUGCAUCCCCACACACGCCUAUGCACAAACGUGGAUUAUCGCACAGACUGGGAGGUUUAGUGGUGCAUUUCUCCUCUGUUUUCUUUUUAAUAUACAUUUAAAAUACAGUAUUAUCACUUUAUAAAACAUACAUUAAGCCUAAUAAAUGGACCAAUAAGCCAAACUAUCAGUAUUUUGUAUAUCCUGCAUAAACUCUAAUUUAGUUCCUCAACAUAUUUUCAGUGUUUAUGCAGACCUUUAGAGUUAAGCCUUUGUAUUUCCAUGUUAUUCCACAAUAUGCAAUAUUUCUCUGAGUAGCUUCUGCUAUGAUAUUCUUAUGAAGAAAAGGGGCAACUUUCUGUCCACUAUAGGAGAGAAUUCAGCCGAAGAUAUGAGAGUAAUGAGAGACAUUUUCCAGUCAUUGGAUCGUGUUUUCUUUUGUCCAUUAUUGUACUGUGCUGUACCACAUUUAUUUCUAUAUUCAUUUUGUAAAAAAUUUAAAAGUGCUAUUUUGUUUGUAUUUGAAAAUCUCUGUGAAUAAAUUCUCUCUUUGAUCAAUA,mRNA;|mRNA;|mRNA;|mRNA,Homo sapiens;|Homo sapiens;|Homo sapiens;|Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|3nM[CD47 3'UTR];|3nM[CD274 3'UTR];|50nM[TNFSF11 3'UTR];|50nM[LHFPL6 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,"Furthermore, the mixing of suboptimal amounts of four network-forming RNAs, together with FUS-TIS, resulted in network formation, indicating that the different RNAs have an additive effect",4194
199,661,PMID: 33650968,RNAPS0000596,https://pubmed.ncbi.nlm.nih.gov/33650968,RNAs + protein,NCBI ID:961;|NCBI ID:1994;|NCBI ID:29126;|NCBI ID:960;|NCBI ID:54621;|NCBI ID:1812;|NCBI ID:10186;|NCBI ID:8600;|NCBI ID:27075;|NCBI ID:127018,https://www.ncbi.nlm.nih.gov/gene/961;|https://www.ncbi.nlm.nih.gov/gene/1994;;|https://www.ncbi.nlm.nih.gov/gene/29126;|https://www.ncbi.nlm.nih.gov/gene/960;|https://www.ncbi.nlm.nih.gov/gene/54621;|https://www.ncbi.nlm.nih.gov/gene/1812;|https://www.ncbi.nlm.nih.gov/gene/10186;|https://www.ncbi.nlm.nih.gov/gene/8600;|https://www.ncbi.nlm.nih.gov/gene/27075;|https://www.ncbi.nlm.nih.gov/gene/127018,CD47;|ELAVL1;|CD274;|CD44;|VSIG10;|DRD1;|LHFPL6;|TNFSF11;|TSPAN13;|LYPLAL1,4194nt(3'UTR);|4909nt(3'UTR);|2705nt(3'UTR);|3069nt(3'UTR);|3046nt(3'UTR);|1723nt(3'UTR);|1044nt(3'UTR);|515nt(3'UTR);|1045nt(3'UTR);|1130nt(3'UTR),CUGAAGUGAAGUGAUGGACUCCGAUUUGGAGAGUAGUAAGACGUGAAAGGAAUACACUUGUGUUUAAGCACCAUGGCCUUGAUGAUUCACUGUUGGGGAGAAGAAACAAGAAAAGUAACUGGUUGUCACCUAUGAGACCCUUACGUGAUUGUUAGUUAAGUUUUUAUUCAAAGCAGCUGUAAUUUAGUUAAUAAAAUAAUUAUGAUCUAUGUUGUUUGCCCAAUUGAGAUCCAGUUUUUUGUUGUUAUUUUUAAUCAAUUAGGGGCAAUAGUAGAAUGGACAAUUUCCAAGAAUGAUGCCUUUCAGGUCCUAGGGCCUCUGGCCUCUAGGUAACCAGUUUAAAUUGGUUCAGGGUGAUAACUACUUAGCACUGCCCUGGUGAUUACCCAGAGAUAUCUAUGAAAACCAGUGGCUUCCAUCAAACCUUUGCCAACUCAGGUUCACAGCAGCUUUGGGCAGUUAUGGCAGUAUGGCAUUAGCUGAGAGGUGUCUGCCACUUCUGGGUCAAUGGAAUAAUAAAUUAAGUACAGGCAGGAAUUUGGUUGGGAGCAUCUUGUAUGAUCUCCGUAUGAUGUGAUAUUGAUGGAGAUAGUGGUCCUCAUUCUUGGGGGUUGCCAUUCCCACAUUCCCCCUUCAACAAACAGUGUAACAGGUCCUUCCCAGAUUUAGGGUACUUUUAUUGAUGGAUAUGUUUUCCUUUUAUUCACAUAACCCCUUGAAACCCUGUCUUGUCCUCCUGUUACUUGCUUCUGCUGUACAAGAUGUAGCACCUUUUCUCCUCUUUGAACAUGGUCUAGUGACACGGUAGCACCAGUUGCAGGAAGGAGCCAGACUUGUUCUCAGAGCACUGUGUUCACACUUUUCAGCAAAAAUAGCUAUGGUUGUAACAUAUGUAUUCCCUUCCUCUGAUUUGAAGGCAAAAAUCUACAGUGUUUCUUCACUUCUUUUCUGAUCUGGGGCAUGAAAAAAGCAAGAUUGAAAUUUGAACUAUGAGUCUCCUGCAUGGCAACAAAAUGUGUGUCACCAUCAGGCCAACAGGCCAGCCCUUGAAUGGGGAUUUAUUACUGUUGUAUCUAUGUUGCAUGAUAAACAUUCAUCACCUUCCUCCUGUAGUCCUGCCUCGUACUCCCCUUCCCCUAUGAUUGAAAAGUAAACAAAACCCACAUUUCCUAUCCUGGUUAGAAGAAAAUUAAUGUUCUGACAGUUGUGAUCGCCUGGAGUACUUUUAGACUUUUAGCAUUCGUUUUUUACCUGUUUGUGGAUGUGUGUUUGUAUGUGCAUACGUAUGAGAUAGGCACAUGCAUCUUCUGUAUGGACAAAGGUGGGGUACCUACAGGAGAGCAAAGGUUAAUUUUGUGCUUUUAGUAAAAACAUUUAAAUACAAAGUUCUUUAUUGGGUGGAAUUAUAUUUGAUGCAAAUAUUUGAUCACUUAAAACUUUUAAAACUUCUAGGUAAUUUGCCACGCUUUUUGACUGCUCACCAAUACCCUGUAAAAAUACGUAAUUCUUCCUGUUUGUGUAAUAAGAUAUUCAUAUUUGUAGUUGCAUUAAUAAUAGUUAUUUCUUAGUCCAUCAGAUGUUCCCGUGUGCCUCUUUUAUGCCAAAUUGAUUGUCAUAUUUCAUGUUGGGACCAAGUAGUUUGCCCAUGGCAAACCUAAAUUUAUGACCUGCUGAGGCCUCUCAGAAAACUGAGCAUACUAGCAAGACAGCUCUUCUUGAAAAAAAAAAUAUGUAUACACAAAUAUAUACGUAUAUCUAUAUAUACGUAUGUAUAUACACACAUGUAUAUUCUUCCUUGAUUGUGUAGCUGUCCAAAAUAAUAACAUAUAUAGAGGGAGCUGUAUUCCUUUAUACAAAUCUGAUGGCUCCUGCAGCACUUUUUCCUUCUGAAAAUAUUUACAUUUUGCUAACCUAGUUUGUUACUUUAAAAAUCAGUUUUGAUGAAAGGAGGGAAAAGCAGAUGGACUUGAAAAAGAUCCAAGCUCCUAUUAGAAAAGGUAUGAAAAUCUUUAUAGUAAAAUUUUUUAUAAACUAAAGUUGUACCUUUUAAUAUGUAGUAAACUCUCAUUUAUUUGGGGUUCGCUCUUGGAUCUCAUCCAUCCAUUGUGUUCUCUUUAAUGCUGCCUGCCUUUUGAGGCAUUCACUGCCCUAGACAAUGCCACCAGAGAUAGUGGGGGAAAUGCCAGAUGAAACCAACUCUUGCUCUCACUAGUUGUCAGCUUCUCUGGAUAAGUGACCACAGAAGCAGGAGUCCUCCUGCUUGGGCAUCAUUGGGCCAGUUCCUUCUCUUUAAAUCAGAUUUGUAAUGGCUCCCAAAUUCCAUCACAUCACAUUUAAAUUGCAGACAGUGUUUUGCACAUCAUGUAUCUGUUUUGUCCCAUAAUAUGCUUUUUACUCCCUGAUCCCAGUUUCUGCUGUUGACUCUUCCAUUCAGUUUUAUUUAUUGUGUGUUCUCACAGUGACACCAUUUGUCCUUUUCUGCAACAACCUUUCCAGCUACUUUUGCCAAAUUCUAUUUGUCUUCUCCUUCAAAACAUUCUCCUUUGCAGUUCCUCUUCAUCUGUGUAGCUGCUCUUUUGUCUCUUAACUUACCAUUCCUAUAGUACUUUAUGCAUCUCUGCUUAGUUCUAUUAGUUUUUUGGCCUUGCUCUUCUCCUUGAUUUUAAAAUUCCUUCUAUAGCUAGAGCUUUUCUUUCUUUCAUUCUCUCUUCCUGCAGUGUUUUGCAUACAUCAGAAGCUAGGUACAUAAGUUAAAUGAUUGAGAGUUGGCUGUAUUUAGAUUUAUCACUUUUUAAUAGGGUGAGCUUGAGAGUUUUCUUUCUUUCUGUUUUUUUUUUUUGUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUGACUAAUUUCACAUGCUCUAAAAACCUUCAAAGGUGAUUAUUUUUCUCCUGGAAACUCCAGGUCCAUUCUGUUUAAAUCCCUAAGAAUGUCAGAAUUAAAAUAACAGGGCUAUCCCGUAAUUGGAAAUAUUUCUUUUUUCAGGAUGCUAUAGUCAAUUUAGUAAGUGACCACCAAAUUGUUAUUUGCACUAACAAAGCUCAAAACACGAUAAGUUUACUCCUCCAUCUCAGUAAUAAAAAUUAAGCUGUAAUCAACCUUCUAGGUUUCUCUUGUCUUAAAAUGGGUAUUCAAAAAUGGGGAUCUGUGGUGUAUGUAUGGAAACACAUACUCCUUAAUUUACCUGUUGUUGGAAACUGGAGAAAUGAUUGUCGGGCAACCGUUUAUUUUUUAUUGUAUUUUAUUUGGUUGAGGGAUUUUUUUAUAAACAGUUUUACUUGUGUCAUAUUUUAAAAUUACUAACUGCCAUCACCUGCUGGGGUCCUUUGUUAGGUCAUUUUCAGUGACUAAUAGGGAUAAUCCAGGUAACUUUGAAGAGAUGAGCAGUGAGUGACCAGGCAGUUUUUCUGCCUUUAGCUUUGACAGUUCUUAAUUAAGAUCAUUGAAGACCAGCUUUCUCAUAAAUUUCUCUUUUUGAAAAAAAGAAAGCAUUUGUACUAAGCUCCUCUGUAAGACAACAUCUUAAAUCUUAAAAGUGUUGUUAUCAUGACUGGUGAGAGAAGAAAACAUUUUGUUUUUAUUAAAUGGAGCAUUAUUUACAAAAAGCCAUUGUUGAGAAUUAGAUCCCACAUCGUAUAAAUAUCUAUUAACCAUUCUAAAUAAAGAGAACUCCAGUGUUGCUAUGUGCAAGAUCCUCUCUUGGAGCUUUUUUGCAUAGCAAUUAAAGGUGUGCUAUUUGUCAGUAGCCAUUUUUUUGCAGUGAUUUGAAGACCAAAGUUGUUUUACAGCUGUGUUACCGUUAAAGGUUUUUUUUUUUAUAUGUAUUAAAUCAAUUUAUCACUGUUUAAAGCUUUGAAUAUCUGCAAUCUUUGCCAAGGUACUUUUUUAUUUAAAAAAAAACAUAACUUUGUAAAUAUUACCCUGUAAUAUUAUAUAUACUUAAUAAAACAUUUUAAGCUAUUUUGUUGGGCUAUUUCUAUUGCUGCUACAGCAGACCACAAGCACAUUUCUGAAAAAUUUAAUUUAUUAAUGUAUUUUUAAGUUGCUUAUAUUCUAGGUAACAAUGUAAAGAAUGAUUUAAAAUAUUAAUUAUGAAUUUUUUGAGUAUAAUACCCAAUAAGCUUUUAAUUAGAGCAGAGUUUUAAUUAAAAGUUUUAAAUCAGUC;|-;|-;|CACCUACACCAUUAUCUUGGAAAGAAACAACCGUUGGAAACAUAACCAUUACAGGGAGCUGGGACACUUAACAGAUGCAAUGUGCUACUGAUUGUUUCAUUGCGAAUCUUUUUUAGCAUAAAAUUUUCUACUCUUUUUGUUUUUUGUGUUUUGUUCUUUAAAGUCAGGUCCAAUUUGUAAAAACAGCAUUGCUUUCUGAAAUUAGGGCCCAAUUAAUAAUCAGCAAGAAUUUGAUCGUUCCAGUUCCCACUUGGAGGCCUUUCAUCCCUCGGGUGUGCUAUGGAUGGCUUCUAACAAAAACUACACAUAUGUAUUCCUGAUCGCCAACCUUUCCCCCACCAGCUAAGGACAUUUCCCAGGGUUAAUAGGGCCUGGUCCCUGGGAGGAAAUUUGAAUGGGUCCAUUUUGCCCUUCCAUAGCCUAAUCCCUGGGCAUUGCUUUCCACUGAGGUUGGGGGUUGGGGUGUACUAGUUACACAUCUUCAACAGACCCCCUCUAGAAAUUUUUCAGAUGCUUCUGGGAGACACCCAAAGGGUGAAGCUAUUUAUCUGUAGUAAACUAUUUAUCUGUGUUUUUGAAAUAUUAAACCCUGGAUCAGUCCUUUGAUCAGUAUAAUUUUUUAAAGUUACUUUGUCAGAGGCACAAAAGGGUUUAAACUGAUUCAUAAUAAAUAUCUGUACUUCUUCGAUCUUCACCUUUUGUGCUGUGAUUCUUCAGUUUCUAAACCAGCACUGUCUGGGUCCCUACAAUGUAUCAGGAAGAGCUGAGAAUGGUAAGGAGACUCUUCUAAGUCUUCAUCUCAGAGACCCUGAGUUCCCACUCAGACCCACUCAGCCAAAUCUCAUGGAAGACCAAGGAGGGCAGCACUGUUUUUGUUUUUUGUUUUUUGUUUUUUUUUUUUGACACUGUCCAAAGGUUUUCCAUCCUGUCCUGGAAUCAGAGUUGGAAGCUGAGGAGCUUCAGCCUCUUUUAUGGUUUAAUGGCCACCUGUUCUCUCCUGUGAAAGGCUUUGCAAAGUCACAUUAAGUUUGCAUGACCUGUUAUCCCUGGGGCCCUAUUUCAUAGAGGCUGGCCCUAUUAGUGAUUUCCAAAAACAAUAUGGAAGUGCCUUUUGAUGUCUUACAAUAAGAGAAGAAGCCAAUGGAAAUGAAAGAGAUUGGCAAAGGGGAAGGAUGAUGCCAUGUAGAUCCUGUUUGACAUUUUUAUGGCUGUAUUUGUAAACUUAAACACACCAGUGUCUGUUCUUGAUGCAGUUGCUAUUUAGGAUGAGUUAAGUGCCUGGGGAGUCCCUCAAAAGGUUAAAGGGAUUCCCAUCAUUGGAAUCUUAUCACCAGAUAGGCAAGUUUAUGACCAAACAAGAGAGUACUGGCUUUAUCCUCUAACCUCAUAUUUUCUCCCACUUGGCAAGUCCUUUGUGGCAUUUAUUCAUCAGUCAGGGUGUCCGAUUGGUCCUAGAACUUCCAAAGGCUGCUUGUCAUAGAAGCCAUUGCAUCUAUAAAGCAACGGCUCCUGUUAAAUGGUAUCUCCUUUCUGAGGCUCCUACUAAAAGUCAUUUGUUACCUAAACUUAUGUGCUUAACAGGCAAUGCUUCUCAGACCACAAAGCAGAAAGAAGAAGAAAAGCUCCUGACUAAAUCAGGGCUGGGCUUAGACAGAGUUGAUCUGUAGAAUAUCUUUAAAGGAGAGAUGUCAACUUUCUGCACUAUUCCCAGCCUCUGCUCCUCCCUGUCUACCCUCUCCCCUCCCUCUCUCCCUCCACUUCACCCCACAAUCUUGAAAAACUUCCUUUCUCUUCUGUGAACAUCAUUGGCCAGAUCCAUUUUCAGUGGUCUGGAUUUCUUUUUAUUUUCUUUUCAACUUGAAAGAAACUGGACAUUAGGCCACUAUGUGUUGUUACUGCCACUAGUGUUCAAGUGCCUCUUGUUUUCCCAGAGAUUUCCUGGGUCUGCCAGAGGCCCAGACAGGCUCACUCAAGCUCUUUAACUGAAAAGCAACAAGCCACUCCAGGACAAGGUUCAAAAUGGUUACAACAGCCUCUACCUGUCGCCCCAGGGAGAAAGGGGUAGUGAUACAAGUCUCAUAGCCAGAGAUGGUUUUCCACUCCUUCUAGAUAUUCCCAAAAAGAGGCUGAGACAGGAGGUUAUUUUCAAUUUUAUUUUGGAAUUAAAUACUUUUUUCCCUUUAUUACUGUUGUAGUCCCUCACUUGGAUAUACCUCUGUUUUCACGAUAGAAAUAAGGGAGGUCUAGAGCUUCUAUUCCUUGGCCAUUGUCAACGGAGAGCUGGCCAAGUCUUCACAAACCCUUGCAACAUUGCCUGAAGUUUAUGGAAUAAGAUGUAUUCUCACUCCCUUGAUCUCAAGGGCGUAACUCUGGAAGCACAGCUUGACUACACGUCAUUUUUACCAAUGAUUUUCAGGUGACCUGGGCUAAGUCAUUUAAACUGGGUCUUUAUAAAAGUAAAAGGCCAACAUUUAAUUAUUUUGCAAAGCAACCUAAGAGCUAAAGAUGUAAUUUUUCUUGCAAUUGUAAAUCUUUUGUGUCUCCUGAAGACUUCCCUUAAAAUUAGCUCUGAGUGAAAAAUCAAAAGAGACAAAAGACAUCUUCGAAUCCAUAUUUCAAGCCUGGUAGAAUUGGCUUUUCUAGCAGAACCUUUCCAAAAGUUUUAUAUUGAGAUUCAUAACAACACCAAGAAUUGAUUUUGUAGCCAACAUUCAUUCAAUACUGUUAUAUCAGAGGAGUAGGAGAGAGGAAACAUUUGACUUAUCUGGAAAAGCAAAAUGUACUUAAGAAUAAGAAUAACAUGGUCCAUUCACCUUUAUGUUAUAGAUAUGUCUUUGUGUAAAUCAUUUGUUUUGAGUUUUCAAAGAAUAGCCCAUUGUUCAUUCUUGUGCUGUACAAUGACCACUGUUAUUGUUACUUUGACUUUUCAGAGCACACCCUUCCUCUGGUUUUUGUAUAUUUAUUGAUGGAUCAAUAAUAAUGAGGAAAGCAUGAUAUGUAUAUUGCUGAGUUGAAAGCACUUAUUGGAAAAUAUUAAAAGGCUAACAUUAAAAGACUAAAGGAAACAGA;|AGAAGAGGAUGGUCCAUGGUUGUCUUGCUCUGAAAGCUUGGAGAGCUACAUUGAAGACGAGCUCUUCAUUCAGCUUUGACUCCACCUGCACCCCUGGCGGGGGCUUGCACUAACAAUGUUUGGGUCUCAGCAAAAAACAAAACCAAGCACACACAUCUUUCCUUCCAUGUAUUGAAAAACAUUGGUUUGAUUUGCUCUAAGUUUUCCCAAUGAUGUUUAAAAGCUUUGAGAAGGAAAGCUGCUUUGGUGUCUGAGGUGCCACUUCUGCUGUGAAUCCUGGCUUUAUCCAGGUUGAUCUACUGUGAUAGAUGCUGAUUUAGAGGGAACAGAGGUCAGGGAAGCACUGGGUCUUGGUGCCUUUUGCCGCUUUUUUUUUUUUUUUUUUUUUUUUUUGAGACGGAGUCUCCCUCUAUUGCCCAGGCUGGAGUGCAAUGGCACGAUCUUGGCUCACCACAACUUCUGCCUCCCAGGUUCAAGCGAUUCUCCUGCCUCAGCCACGGCACCUUGCAAAUAUCAGCUCCUUGGAACAGGUGAAGUUCCAGGUACCAAUGCCAAUCAGAGGAAGGCAGUUUGGUUCAGGCUUUGGAGUUAGAAACACCUGAAGUUGAAUCUGGGCUCUGUUGCUUCCUUCUUUCAUGGGCUAGAGCACGACUCUUUACCUCUCUCUUGGCCUCAAUUUCCUCACCUGUAAAAUAGAUGAGGAAGCUGCUCACUUAUUAUUGUCUCGUUCUGAAAGCUUGGAAAGCUACAUCGAAGAUGAGCUCUUCAUUCAGCUUUGAUUUGACCUGUACCCCUGGUGGGGGAUUGCACUGGCAACAUUUGGGUCUCAGCAAAAAAACCAAGCACACACAUCUUUCCUUCCAUUUAUUGAAAAACAUCUUUGUAAGAUCCAUUCAUUGAAAAACAUAAUCCAUUUAUUGAAAAAUAUCUUUGUAAGAUCACCUGCUAAAUAUGAAAAUCUGACUUGAAUUUGUACUCUUUAAAGUUGCGUAUCUGCUCUAGUGGGCAGGACCUAGGGCUUAAAGGGGAACUUCCUUUCUCCAUUUCUAAGAACUGGGACUCUAAAAUGAGAAGCUGGUUGUCUGAAGUAACCCUGCAGGUGUGGUUGGGGAAGGUCUGUUUUCUUGGAUGAAGGAACUAAACUAAGCAUAUCAGAGCACUGUCUUAACCAGUUUUAUUUCCCUGGAGAUAGAAUUCUUUUAAAAAGAGUUAGGGAGCUGGUAAUAGGAAGUGCCUUUCAUUAUAACUACAUUUUGCAGAGCUUCAUAUUUAUAUACAAGCCUCCUAGGUGAUACACUGUUAGCUUGCAGACUUUCCUAUGCUUCAUUUCUCCUGUUGCUUUCAAAGAAGGCAGGAGACACGUUUAAUAACGGAGUAUCUGGUGAUAAGAAUUGCUUGGGCAAACCAGCUCAUCUGGACUCUUUCUCAGUCUUGGAAGUGGGAAGAGGAAAACUUGUUUCCUUCCUGCUUCUUAAGGAUAUUCUGAGGGUACACUGAUCAAUAACACUAAAUUUGGAAUGAAAAUACCAUGUGAUGAGUUUAGCCUGCUGAUGCUUCCAGUAGAUCCUUGUAUAGUUUCAAGAUUUAAGUUUUCCGAUUUCAUAUAAAUUUCUUAAAGUCGAGGACCUUAUAAGGGUGCAAUGGAUGUUUGCUAAAUAUGAAAAACUGACUUGAAUUUGCACUCUUUAAUGUUGCGUAUCUGCUCUAGUGGGCAGGACCUAGGGCUUAAAGGGGAACUUCCUUUCUCCAAUUCUAGGAACUGGGACUCUAAAAUGAGAAGCUGGUUGUCUGAAGUAACCCUGCAGGUGUGGUUGGGGAAGGUCUGUUUUCUUGGAUGAAGGGAUUAAACUGAGCAAAUCACUAGAAGUAUGCCCUGUCCCCUGCUCAGAACACUGGGGAGCUCAAGAGUGGGCUGCAAUGUGCACCCCUCAGGAAUAGCUGUGAAUUGCAGGUCUACUGGCUUUUUGCUUUUUGUCUUUUGCUGCAAGGUACCCCACGUACUUAACCAUUCUCAACAGUGUAAAUCAGUGUCAUUUUAGAAUGAGAUACUCAGCUUGCUUCUAAAGUCACUGAAUUACUGAGUGAGUCUCUCCUUUAGAGUCUUCGGCAACCAAAUUCCAGAAUUGAAGAGUCUACUACUCAGAGGCAACAAGAUUAAAAAAAGAAAACACAAAAACUGUUGAGGUGAAAAAAAAAAAAAACCCUAGCUAGGAACACAGAGAAUGUUUUGUAGGAUCACUGGGAUAUUUUCCACAACUUCCUCUUCUCUAGCACACACAUCUGUUGAUAGGAAAUAUUUGAGGGUUUUUCCACUACCAAAUGGGAGCUUCAUGGUCCUGGUGUCAAACACUAUAAACCUUUGACCAGCUGAGCUGUGACUGCUGUCACAUAUCUGAGUCCUGUGUGCACAGUAAUAUCCUGGGUCAGGUAAAAUCCAGGUCUUCAAGUUUUAAGGAUUUUUUGAAGAAUUCGGGCUUCUUUAAGACGAUCCAUGCCCAAAUCCACAAGCUUGUUGACAGUGGAUUACAGUUUGUGUGGCAAAGUCCAAGUUGUUACACUGUGCUUUAAAAAAAAUCUUAUCUGCAUGUAUUGUUAACUUAGAGACCAUGAGAUCUAUUUAUCAGGACCAGGAAGAUACACACUUCAGGUCCAUUGCAACUGACUUUUUUCUUGUUUUUCUCAAACCCUGGUGGAGCCUGGGAAGGGGGCCUCCACAAUUCUGUGGCUUUGAUAUUAGCCCCAAUUCUCACAAGCACAUACAAGCCCCAUAAUUGCCGCAGGAAAACACAAGAUGGAAAAUUGCAAUAACCCAUGCACUGAGACUUAGAAAAUCAUCCUUACUAGGCAAAAUGUAUUAUGAUGCAAUAAGUGCCAACUGAUAUUUCUCACGUUGGGACUGGCCAGGAACUGCUGCAAAGAAAAAUAAGCAGCUCCUUCUCCAUUAUUUACAUUUUAAGAUGUGGUGGGGGGAGGUUGGGAGAAAUUAGUUCUGAGGUUAUCAUAUGCCUUUUUUAAAAGAUAAUGGAAUAAAGCUAUUUUUAAGUAA;|ACUCGCAGAUGAAUCCUGCCACACAUGCUCAUCCCAAAAGCUAGAGGAGAUUGCUCUGGGGCUUGCUAUUAAGAAACUAAGGUACGGUGAGACUCUGAGGUGUCAGGAGAGCCCUCUGCUGCUUUCCAACACACAAUUAACUCCGUUUCCAAAUACAUUCCAGUGUAUUUUCUGUGUUGUUCAUAGUCAAUCAAACAGGGACACUACAAACAUGGGGAGCCAUAAGGGACAUGUCUUUGGCUUCAGAAUUGUUUUUAGAAAUUUAUUCUUAUCUUAGGAUUUACCAAAUAGGGCAAAGAAUCAACAGUGAACAGCUUCACUUAAAAUCAAAUUUUUCUGGGAAGAAAAUGAGAUGGGUUGAGUUUGCUGUAUACAAACAGGUGCUAACACUGUUCCCAGCAAAGUUUUCAGAUUGUAAAGGUAGGUGCAUGCCUUCAUAAAUUAUUUCUAAAACAUUAAUUGAGGCUUACAGUAGGAGUGAGAAAUUUUUUUCCAGAAUUGAGAGAUGUUUUGUUGAUAUUGGUUCUAUUUAUUUAUUGUAUAUAUGGAUAUUUUUAAUUUAUGAUAUAAUAAAUAUAUAUUUAUCAUAUUUAAUAGGAUAAAUUAAUGAGUUUUAUCCAAGACCUUACAACCACAUUUCUGGCCAUUUAACUAGCACUUUAUAAGCCAAUGAAGCAAACACACAGACUCUGUGAGAUUCUAAAUGUUCAUGUGUAACUUCUAGAAACACAGCAGAAACUGAUAGAUAAGGGAAUAAAGUUGAAAUGAUUCCUUAAAAUUCAUGGACACAGAUAAAUGCAAGGUGAGAAUUGACAAAUGCUAUAAAUGCUUUCUUUUUCUGAAAAGAUUUUGAAAAAUUUAAAAAAGUAUAGCUACUACUGUGUUCAAAACGUUUUAAAUGACAAAUGACUUUCCCAGGGGAAUUUGCAGUUCUGUAAAUAUCUUAAAUAAAAGCCAACUUAAGAAGAGCCCAGCAUUAAAUUUACGAUCUUAGGUGGUAAUGAAAAGUAUAUGCUGCUUUGUAUUUAUGUAAAAUAAUUGGCCCUCUCCAUCUUUUCUCAUUUCAUGUGUCAGGUAGUUUUUCUGAACCACACAAAUGGCUUUCCUGGAGAGAGAUCUGUAGCACAGACAGUGGGUUACAGCAGCCCCACUGAGGGACCAAACUCAAACCCUGCAUUUCCAUCUUACCAGGUCAAACCAAACCAGUCAGUGGGGCUACUUUUUAUAGUGCUUUAAUCUGAAUUUAGAGCUGAUUUUUAAAGGAGUCUUUAAAUGUUAAUGGUAUACUAACUAACGAAUAGUGCCUCAUUAUCAUUCUUGAGUCAGAUACUUCUGUUGAUGGGAGAAACAGAAGAAUCCUUCCCUUUGGGUGUGUUGAGCUCCCCCAAAGCCAUCAGCAUCUCUUUUGACAAAUGCUAGUCCUUUCUCUGUGCUUUGGAAUCAGGUUCCUGCAUCAUCACCCGGACUGUAAAAAGUAUCAUAAGCCUCCCUUGCCAGAUGCCAACUCGUGGGGCAUUUCAACAGAGUUUCUUUGAAAUGUUUACAACGUAUUCUUCUUGAUAAGCAAUGAACUUAACAUUUAGAUGCAAUCCGUGAAAAGAAAAAAAAAUCUGAAAAAUAUCUCCUGCAUCAGGUCUGUGUUAUUUAUGUAUUGUGAAUGUUUUCUUAAUUUUAUUGGCUGUAUGCUUUCUUACACAUAAUAAAAAUAUUUUGUGAACUCAAA;|GAUGGAGCUACCAAGAGCAGACAGAGGAGAAGAUGGGCCAAAGGGGCUUGGAGAGGUCAAAACAUCCACCUACCUUCAAAAGGUGGGAUAGUAGUUCUAAUCCAAUACAAUGCUAAUAAAAUGAAACCCGAUAAAAUCAGGAACAUGAUAUAGGAAGGAAGGAUUGUAGGAGAUUUGUGGGGGAAAAAAAAGGAGAGUAUAGAAUGAUGGAGAAAAAUGGACCAAAGGCUAAAAAUAUUGCAGGGCAUCGGGUGUUUCUAUUCCACAGAGUAUUGUUAAUGUACAACACACACACACACACACACACACACACACACACACACACACACACAACAAAUCUACAUAUACAAACAAGGGUUUGGGUUUUAGUUUUUUUUUUUUAAGGUGAGGACUCAGAAAAUCAAAGGGCUAGUAGAAACAGUGUUAUGUUGGGAAGCAGGGUACCCCCAAAGAUGUUCCCUGUAGGUCACGGCACUCCCAAAAGCACACAAGCACAUACAGACAUAUGCAUCCCCACACACGCCUAUGCACAAACGUGGAUUAUCGCACAGACUGGGAGGUUUAGUGGUGCAUUUCUCCUCUGUUUUCUUUUUAAUAUACAUUUAAAAUACAGUAUUAUCACUUUAUAAAACAUACAUUAAGCCUAAUAAAUGGACCAAUAAGCCAAACUAUCAGUAUUUUGUAUAUCCUGCAUAAACUCUAAUUUAGUUCCUCAACAUAUUUUCAGUGUUUAUGCAGACCUUUAGAGUUAAGCCUUUGUAUUUCCAUGUUAUUCCACAAUAUGCAAUAUUUCUCUGAGUAGCUUCUGCUAUGAUAUUCUUAUGAAGAAAAGGGGCAACUUUCUGUCCACUAUAGGAGAGAAUUCAGCCGAAGAUAUGAGAGUAAUGAGAGACAUUUUCCAGUCAUUGGAUCGUGUUUUCUUUUGUCCAUUAUUGUACUGUGCUGUACCACAUUUAUUUCUAUAUUCAUUUUGUAAAAAAUUUAAAAGUGCUAUUUUGUUUGUAUUUGAAAAUCUCUGUGAAUAAAUUCUCUCUUUGAUCAAUA;|GCCCCAGUUUUUGGAGUGUUAUGUAUUUCCUGGAUGUUUGGAAACAUUUUUUAAAACAAGCCAAGAAAGAUGUAUAUAGGUGUGUGAGACUACUAAGAGGCAUGGCCCCAACGGUACACGACUCAGUAUCCAUGCUCUUGACCUUGUAGAGAACACGCGUAUUUACAGCCAGUGGGAGAUGUUAGACUCAUGGUGUGUUACACAAUGGUUUUUAAAUUUUGUAAUGAAUUCCUAGAAUUAAACCAGAUUGGAGCAAUUACGGGGUGACCUUAUGAGAAACUGCAUGUGGGCUAUGGGAGGGGUUGGUCCCUGGUCAUGUGCCCCUUCGCAGCUGAAGUGGAGAGGGUGUCAUCUAGCGCAAUUGAAGGAUCAUCUGAAGGGGCAAAUUCUUUUGAAUUGUUACAUCAUGCUGGAACCUGCAAAAAAUACUUUUUCUAAUGAGGAGAGAAAAUAUAUGUAUUUUUAUAUAAUAUCUAAAGUUAUAUUUCAGAUGUAAUGUUUUCUUUGCAAAGUAUUGUAAAUUAUAUUUGUGCUAUAGUAUUUGAUUCAAAAUAUUUAAAAAUGUCUUGCUGUUGACAUAUUUAAUGUUUUAAAUGUACAGACAUAUUUAACUGGUGCACUUUGUAAAUUCCCUGGGGAAAACUUGCAGCUAAGGAGGGGAAAAAAAUGUUGUUUCCUAAUAUCAAAUGCAGUAUAUUUCUUCGUUCUUUUUAAGUUAAUAGAUUUUUUCAGACUUGUCAAGCCUGUGCAAAAAAAUUAAAAUGGAUGCCUUGAAUAAUAAGCAGGAUGUUGGCCACCAGGUGCCUUUCAAAUUUAGAAACUAAUUGACUUUAGAAAGCUGACAUUGCCAAAAAGGAUACAUAAUGGGCCACUGAAAUCUGUCAAGAGUAGUUAUAUAAUUGUUGAACAGGUGUUUUUCCACAAGUGCCGCAAAUUGUACCUUUUUUGUUUUUUCAAAAUAGAAAAGUUAUUAGUGGUUUAUCAGCAAAAAAGUCCAAUUUUAAUUUAGUAAAUGUUAUCUUAUACUGUACAAUAAAAACAUUGCCUUUGAAUGUUAAUUUUUUGGUACAAAAAUAAAUUUAUAUGAAAACCUGC;|UGAGAAAACAAGGAAGAUUUCCUUUCGUAUUAUGAUCUUGUUCACUUUCUGUAAUUUUCUGUUAAGCUCCAUUUGCCAGUUUAAGGAAGGAAACACUAUCUGGAAAAGUACCUUAUUGAUAGUGGAAUUAUAUAUUUUUACUCUAUGUUUCUCUACAUGUUUUUUUCUUUCCGUUGCUGAAAAAUAUUUGAAACUUGUGGUCUCUGAAGCUCGGUGGCACCUGGAAUUUACUGUAUUCAUUGUCGGGCACUGUCCACUGUGGCCUUUCUUAGCAUUUUUACCUGCAGAAAAACUUUGUAUGGUACCACUGUGUUGGUUAUAUGGUGAAUCUGAACGUACAUCUCACUGGUAUAAUUAUAUGUAGCACUGUGCUGUGUAGAUAGUUCCUACUGGAAAAAGAGUGGAAAUUUAUUAAAAUCAGAAAGUAUGAGAUCCUGUUAUGUUAAGGGAAAUCCAAAUUCCCAAUUUUUUUUGGUCUUUUUAGGAAAGAUUGUUGUGGUAAAAAGUGUUAGUAUAAAAAUGAUAAUUUACUUGUAGUCUUUUAUGAUUACACCAAUGUAUUCUAGAAAUAGUUAUGUCUUAGGAAAUUGUGGUUUAAUUUUUGACUUUUACAGGUAAGUGCAAAGGAGAAGUGGUUUCAUGAAAUGUUCUAAUGUAUAAUAACAUUUACCUUCAGCCUCCAUCAGAAUGGAACGAGUUUUGAGUAAUCAGGAAGUAUAUCUAUAUGAUCUUGAUAUUGUUUUAUAAUAAUUUGAAGUCUAAAAGACUGCAUUUUUAAACAAGUUAGUAUUAAUGCGUUGGCCCACGUAGCAAAAAGAUAUUUGAUUAUCUUAAAAAUUGUUAAAUACCGUUUUCAUGAAAUUUCUCAGUAUUGUAACAGCAACUUGUCAAACCUAAGCAUAUUUGAAUAUGAUCUCCCAUAAUUUGAAAUUGAAAUCGUAUUGUGUGGCUCUGUAUAUUCUGUUAAAAAAUUAAAGGACAGAAACCUUUCUUUGUGUAUGCAUGUUUGAAUUAAAAGAAAGUAAUGGAAGAAUUGAUCGAUGAA;|AUGAAUCAAGAGUGAUUUGUUAAUGUAAGUGUAAUGUCUUUGUGAAAAGUGAUUUUUACUGCCAAAUUAUAAUGAUAAUUAAAAUAUUAAGAAAUAACACUUUCCUGACUUUUUUAUUAUUAAAAUGCUUAUCACUGUAGACAGUAGCUAAUCUUAUUAAUGAAAAACAAUAGACAAACAUCUGUGCAUAAUUUUUCAGACACAAUUCUGUAAAUAUUUGGAAACCUUUUAAGUAUUUAAACUUUUAAAUUUUUGAAAUAAAGUAUUCUAAACUAAUAUAAAUAAGGACAAUGAAAAAACAUGAAAGGACUUAGCAUAAUGUUAUUUUAUCUUUUCUACAACUUUGUUUAAAUUACCUUUCCAAAGAUAUUUGUGUUUAUGUAAUUUUCCACGGAAUAACAUUAAUACUCUAGGUUUAUAAACCGGUUUCACAUUAUUUCAUUUGAUCAUCACAAGAGCUUUGUGAAGUAAGCCGAGAAGUUGUUACUGGUAUUUAAUAAUAGCAAUAGAGGAGUUAAAGACUUUCCCACAGCUUGCAGGUCAAGACAAGAAAUUCAGGUCUCCUAAUUCUCAGUGGAGCUCUAUUUCUGUUAACCCAAAUUGCUGCUCUGUUUUAGGUCUCAAUUUCAUCUGUAAAAUGAUACUAAUAGUACUUAUCCCAUUGGAUUUUUGUUGAGAUUUAAAUAAAUAGCCAAAAGCCAAUACAUAAUAAACACUCAAUAAAGAUUAACCAUAAGGAGAGUCAUGAUCUGGUUCCAGGAAUACAUUGUUAGAUGACUGAAAAAUUGUAUUACUUCAAUGAAAAUACUAUAAAUAAUAACAUUUUCAUAUAUUAGUUGGUUCUCAUGCAUACAUAAUCUAAUUUUAUUUGAUCCUCACAACUGUUUAAGUUUUAUUAAAUAUACAUUAUCCCUAUUUGUAUAAAUAGAAUCAUACAAUACCUGCCUGCUUUCAUUCAACAAAAUUAUCAUGAGAUUUUUCCAUGUUGUGUACAUCAAUAGUUCAUCUAUUUUAUUGCUCAGUAAUAUUCCAUUGUGUGGAUGUAUCACUAUUUGUUUACACAUUCACCACUGAUAUAUAAGUUGCUUCCAGUGUGAGGCUGUUUUAAAUAAAGCUGCUAUGAAUAUUCA,mRNA;|mRNA;|mRNA;|mRNA;|mRNA;|mRNA;|mRNA;|mRNA;|mRNA;|mRNA,Homo sapiens;|Homo sapiens;|Homo sapiens;|Homo sapiens;|Homo sapiens;|Homo sapiens;|Homo sapiens;|Homo sapiens;|Homo sapiens;|Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|2nM[CD47 3'UTR];|2nM[ELAVL1 3'UTR];|2nM[CD274 3'UTR];|2nM[CD44 3'UTR];|2nM[VSIG10 3'UTR];|2nM[DRD1 3'UTR];|2nM[LHFPL6 3'UTR];|2nM[TNFSF11 3'UTR];|2nM[TSPAN13 3'UTR];|2nM[LYPLAL1 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,gel,"Importantly, mixing 10 mRNAs together with FUS-TIS only required 2 nM (0.7–3.2 ng/ml) of each mRNA which is substantially lower than the average mRNA expression in cells (Figure 4B). ",4194
200,662,PMID: 33650968,RNAPS0000597,https://pubmed.ncbi.nlm.nih.gov/33650968,RNAs + protein,NCBI ID:51311;|NCBI ID:4609,https://www.ncbi.nlm.nih.gov/gene/51311;|https://www.ncbi.nlm.nih.gov/gene/4609,TLR8;|MYC,1003nt(3'UTR);|476nt(3'UTR),CUGACGUUAAGUCAUGAUUUCGCGCCAUAAUAAAGAUGCAAAGGAAUGACAUUUCUGUAUUAGUUAUCUAUUGCUAUGUAACAAAUUAUCCCAAAACUUAGUGGUUUAAAACAACACAUUUGCUGGCCCACAGUUUUUGAGGGUCAGGAGUCCAGGCCCAGCAUAACUGGGUCCUCUGCUCAGGGUGUCUCAGAGGCUGCAAUGUAGGUGUUCACCAGAGACAUAGGCAUCACUGGGGUCACACUCAUGUGGUUGUUUUCUGGAUUCAAUUCCUCCUGGGCUAUUGGCCAAAGGCUAUACUCAUGUAAGCCAUGCGAGCCUCUCCCACAAGGCAGCUUGCUUCAUCAGAGCUAGCAAAAAAGAGAGGUUGCUAGCAAGAUGAAGUCACAAUCUUUUGUAAUCGAAUCAAAAAAGUGAUAUCUCAUCACUUUGGCCAUAUUCUAUUUGUUAGAAGUAAACCACAGGUCCCACCAGCUCCAUGGGAGUGACCACCUCAGUCCAGGGAAAACAGCUGAAGACCAAGAUGGUGAGCUCUGAUUGCUUCAGUUGGUCAUCAACUAUUUUCCCUUGACUGCUGUCCUGGGAUGGCCUGCUAUCUUGAUGAUAGAUUGUGAAUAUCAGGAGGCAGGGAUCACUGUGGACCAUCUUAGCAGUUGACCUAACACAUCUUCUUUUCAAUAUCUAAGAACUUUUGCCACUGUGACUAAUGGUCCUAAUAUUAAGCUGUUGUUUAUAUUUAUCAUAUAUCUAUGGCUACAUGGUUAUAUUAUGCUGUGGUUGCGUUCGGUUUUAUUUACAGUUGCUUUUACAAAUAUUUGCUGUAACAUUUGACUUCUAAGGUUUAGAUGCCAUUUAAGAACUGAGAUGGAUAGCUUUUAAAGCAUCUUUUACUUCUUACCAUUUUUUAAAAGUAUGCAGCUAAAUUCGAAGCUUUUGGUCUAUAUUGUUAAUUGCCAUUGCUGUAAAUCUUAAAAUGAAUGAAUAAAAAUGUUUCAUUUUACAA;|GGAAAAGUAAGGAAAACGAUUCCUUCUAACAGAAAUGUCCUGAGCAAUCACCUAUGAACUUGUUUCAAAUGCAUGAUCAAAUGCAACCUCACAACCUUGGCUGAGUCUUGAGACUGAAAGAUUUAGCCAUAAUGUAAACUGCCUCAAAUUGGACUUUGGGCAUAAAAGAACUUUUUUAUGCUUACCAUCUUUUUUUUUUCUUUAACAGAUUUGUAUUUAAGAAUUGUUUUUAAAAAAUUUUAAGAUUUACACAAUGUUUCUCUGUAAAUAUUGCCAUUAAAUGUAAAUAACUUUAAUAAAACGUUUAUAGCAGUUACACAGAAUUUCAAUCCUAGUAUAUAGUACCUAGUAUUAUAGGUACUAUAAACCCUAAUUUUUUUUAUUUAAGUACAUUUUGCUUUUUAAAGUUGAUUUUUUUCUAUUGUUUUUAGAAAAAAUAAAAUAACUGGCAAAUAUAUCAUUGAGCCAAAUCUUAA,mRNA;|mRNA,Homo sapiens;|Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100nM[TLR8 3'UTR];|100nM[MYC 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,"A phase separation experiment with FUS-TIS confirmed that the addition of the two predominantly structured 3'UTRs (TLR8 and MYC) generates sphere-like condensates, whereas the addition of RNAs capable of forming a crosslinked RNA network (D1-TLR8-D2 and D1-MYC-D2), which we call an RNA matrix, induces formation of mesh-like FUS-TIS condensates ",1003
201,666,PMID: 33762340,RNAPS0000150,https://pubmed.ncbi.nlm.nih.gov/33762340,RNAs + protein,NCBI ID:18870687;|-,https://www.ncbi.nlm.nih.gov/gene/18870687,GLS1;|GIRGL,-(3'UTR);|740nt(1-740),-;|-,mRNA;|lncRNA,Spathaspora passalidarum;|Homo sapiens,"sp|Q14444|CAPR1_HUMAN Caprin-1 OS=Homo sapiens OX=9606 GN=CAPRIN1 PE=1 SV=2
MPSATSHSGSGSKSSGPPPPSGSSGSEAAAGAGAAAPASQHPATGTGAVQTEAMKQILGV
IDKKLRNLEKKKGKLDDYQERMNKGERLNQDQLDAVSKYQEVTNNLEFAKELQRSFMALS
QDIQKTIKKTARREQLMREEAEQKRLKTVLELQYVLDKLGDDEVRTDLKQGLNGVPILSE
EELSLLDEFYKLVDPERDMSLRLNEQYEHASIHLWDLLEGKEKPVCGTTYKVLKEIVERV
FQSNYFDSTHNHQNGLCEEEEAASAPAVEDQVPEAEPEPAEEYTEQSEVESTEYVNRQFM
AETQFTSGEKEQVDEWTVETVEVVNSLQQQPQAASPSVPEPHSLTPVAQADPLVRRQRVQ
DLMAQMQGPYNFIQDSMLDFENQTLDPAIVSAQPMNPTQNMDMPQLVCPPVHSESRLAQP
NQVPVQPEATQVPLVSSTSEGYTASQPLYQPSHATEQRPQKEPIDQIQATISLNTDQTTA
SSSLPAASQPQVFQAGTSKPLHSSGINVNAAPFQSMQTVFNMNAPVPPVNEPETLKQQNQ
YQASYNQSFSSQPHQVEQTELQQEQLQTVVGTYHGSPDQSHQVTGNHQQPPQQNTGFPRS
NQPYYNSRGVSRGGSRGARGLMNGYRGPANGFRGGYDGYRPSFSNTPNSGYTQSQFSAPR
DYSGYQRDGYQQNFKRGSGQSGPRGAPRGRGGPPRPNRGMPQMNTQQVN",CAPRIN1,-,-,709aa(1-709),Q14444,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0521,"[1-50],[251-251],[260-291],[417-446],[475-499],[524-709]","[2-43],[61-81],[178-188],[258-282],[311-324],[328-337],[477-491],[537-552],[555-570],[607-620],[676-704]",In vitro,20µM[CAPRIN1];|0.2µM[GLS1 mRNA 3'UTR];|0.2µM[sense GIRGL],30 mM NaCl,"25 mM Na2HPO4(pH 7.4),2 mM DTT",RT,immediately ,-,FRAP,liquid,"Notably, the frequency of phase droplet formation between CAPRIN1 and GLS1 mRNA was comparatively increased when full-length sense, but not antisense, GIRGL was added to these assays.",740
202,667,PMID: 33762340,RNAPS0000154,https://pubmed.ncbi.nlm.nih.gov/33762340,RNAs + protein,NCBI ID:18870687;|-,https://www.ncbi.nlm.nih.gov/gene/18870687,GLS1;|GIRGL_antisense,-(3'UTR);|740nt(1-740),-;|-,mRNA;|lncRNA,Spathaspora passalidarum;|Homo sapiens,"sp|Q14444|CAPR1_HUMAN Caprin-1 OS=Homo sapiens OX=9606 GN=CAPRIN1 PE=1 SV=2
MPSATSHSGSGSKSSGPPPPSGSSGSEAAAGAGAAAPASQHPATGTGAVQTEAMKQILGV
IDKKLRNLEKKKGKLDDYQERMNKGERLNQDQLDAVSKYQEVTNNLEFAKELQRSFMALS
QDIQKTIKKTARREQLMREEAEQKRLKTVLELQYVLDKLGDDEVRTDLKQGLNGVPILSE
EELSLLDEFYKLVDPERDMSLRLNEQYEHASIHLWDLLEGKEKPVCGTTYKVLKEIVERV
FQSNYFDSTHNHQNGLCEEEEAASAPAVEDQVPEAEPEPAEEYTEQSEVESTEYVNRQFM
AETQFTSGEKEQVDEWTVETVEVVNSLQQQPQAASPSVPEPHSLTPVAQADPLVRRQRVQ
DLMAQMQGPYNFIQDSMLDFENQTLDPAIVSAQPMNPTQNMDMPQLVCPPVHSESRLAQP
NQVPVQPEATQVPLVSSTSEGYTASQPLYQPSHATEQRPQKEPIDQIQATISLNTDQTTA
SSSLPAASQPQVFQAGTSKPLHSSGINVNAAPFQSMQTVFNMNAPVPPVNEPETLKQQNQ
YQASYNQSFSSQPHQVEQTELQQEQLQTVVGTYHGSPDQSHQVTGNHQQPPQQNTGFPRS
NQPYYNSRGVSRGGSRGARGLMNGYRGPANGFRGGYDGYRPSFSNTPNSGYTQSQFSAPR
DYSGYQRDGYQQNFKRGSGQSGPRGAPRGRGGPPRPNRGMPQMNTQQVN",CAPRIN1,-,-,709aa(1-709),Q14444,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0521,"[1-50],[251-251],[260-291],[417-446],[475-499],[524-709]","[2-43],[61-81],[178-188],[258-282],[311-324],[328-337],[477-491],[537-552],[555-570],[607-620],[676-704]",In vitro,20µM[CAPRIN1];|0.2µM[GLS1 mRNA 3'UTR];|0.2µM[antisense GIRGL],30 mM NaCl,"25 mM Na2HPO4(pH 7.4),2 mM DTT",RT,immediately ,-,FRAP,liquid,"Notably, the frequency of phase droplet formation between CAPRIN1 and GLS1 mRNA was comparatively increased when full-length sense, but not antisense, GIRGL was added to these assays.",740
203,687,PMID: 34108682,RNAPS0000618,https://pubmed.ncbi.nlm.nih.gov/34108682,RNA + protein,NCBI ID: 647979,https://www.ncbi.nlm.nih.gov/gene/647979,NORAD,5378nt(1-5378),AGUUCCGGUCCGGCAGAGAUCGCGGAGAGACGCAGAACGCAGCCCGCUCCUCCAGGGCCCUCCAGGCCCUCCGGCCCCGGGCCGGCGGGUGAACUGGGGGGCCCCGGGACAGGCCGAGCCCUCUGCCCUGCAGAUAACGGAGGCCUCUGCUGUGGCUGCCCACUGGCUGUGCCCGCCCACUGGCUGUGCCCAGACCUUGAAGCCGCAGCGAACCUCUCUUUCCCACCCCACCUCGGUGACUAAUGGCGGCCGUGGCGUCUCCCAGCCCGGACCCCGCCGGCACCCGGGUCUCCCGACCCAAGCCUCGACGAAACCCCCGCAGAGCCGCCGGGACGCAGCGCCUUUGGGCGGCGCUGGGCGUGGUGGGCCGGGAAGUAUGGCGGCAGCUCGAACGCCGCGCGGCGGAGGCCAUUAAGGCGUGGACGGCCCGGGAAGGCGGCCUAGGGACGCAAGCAGGCUCGGCCGCCUCUUUAGGCCACGGAGCCGCGCAGAUCCGGUUCCCGGGUGACCACUCUGUCGCCAUUGGGCGAGACCUACCUAGUCCUGACGACAACGGACAAAGGCCUUAAGGGGCCUGGAAGGUGAGCGAAGUCCCGAACGACGACGGGUGGAACGGUUAGCGGCCAUCGGGCGGUUGGUCUUCAUUCUACCAGACUUUGCUGUCGGAAGAGAGAAAUGGUAGAAUGACAGGCCACGUUUGGCCCGUUGGAAAUGCCCACCACCCUCUGGGAAGAUUUACUGGCCGUUUAUGGAAGGCCUGUGUAUAUAAUAUGAAAAAGCUGCUCUCAACUCCACCCCAACCUUUUAAUAGAAAACAUUUGUCACAUCUAGCCCUUCUAGAUGGAAAGAGGUUGCCGACGUAUGAUAAAAUAGAGUUAGAAAGUUACACAUCUUGUAAAUUCUCAUUUGUUUAAAAGAAAUCAUAGAAAAUACAUGUCUUCUGGAGAUGACUUUUGGAAAUGGAGUUGUUAAGACGGCCUCUGGAAGCGAUACGUCCACGUUUGUUAAGUGGGUUAGAUGACAUGGAGCUGGAAGACCUGAGAAGGAAGAGAAGAAGGUUCUAUGCUAGACUGGUCAUAUUUAGAAGACAUUUUCAUAUUCUAUCCAUUGUUUUGUGUGCAUUUUAUUCCUCACUACUGUGUAUAUAGUUGACAAUGCUAAGCUUUUUUGAAAUGUCUCUUCUUUUUAGAUGUUCUGAAGUGCCUGAUAUGUUAAAAUUAGAGGUAGCAAAAUCACAUUUUGUAAAUACCUUUUUGUUACAAUUCAUAGGAAAUAUUUUUGGGGGGGAAUGGCCAAAUCACCUGUUGAGUAAUACUCAUUGUGUUUGUGCAGUGGUUCAGGGGAGGAGAGAGGAGGGGGAGGUGCAGAGAGCUCUAUGCCAUCCUGUUUACAGCGAGGCAAGAUGAAUCAUUAUGUCUGUGCAUUUUGUUUUACUUAUCUGUGUAUAUAGUGUACAUAAAGGACAGACGAGUCCUAAUUGACAACAUCUAGUCUUUCUGGAUGUUAAAGAGGUUGCCAGUGUAUGACAAAAGUAGAGUUAGUAAACUAAUAUAUUUUGUACAUUUUGUUUUACAAGUCCUAGGAAAGAUUGUCUUCUGAAAAUUUGAUGUCUUCUGGGUUGAUGGAGAUGGGAAGGGUUCUAGGCCAGAAUGUUCACAUUUGGAAGACUCUUUCAAAUUAUAACUGUUGUUACAUGUUUGCAGUUUAUUCAAGACUGCUGUAUACAUAGUAGACAAAUUAACUCCUUACUUGAAACAUCUAGUCUAUCUAGAUGUUUAGAAGUGCCCGAUGUAUGUUAAAUGUAUAGGUAGUAAAAUACCACUUUGUAAAUAUCUUUUUGCUAAAAUUCAUAGGAAAUGCUUUUGGAAAUUGAAUUGUGAAGCCACCUUUGUGAACAGUAUAGUAAUGUCUAUACUUGUUCAAUAGUUUAGAGGAGGUAGGAGGGAAGAAAUUGCAAAAGGUAAUAUUACUAGUGUGUUCAUACUUGGACAUUUUCAGACACCAUUUUUCUAUAUGUUUUGUGCAUUUUGUUUUGCUCUGUAUAUAGUAUAUAUAAUGGACAAAUAGUCCUAAUUUUUCAACAUCUAGUCUCUAGAUGUUAAAGAGGUUGCCAGUGUAUGACAAAGGAGUAAAAUUAGCAUAUUUUGUACACUUUGUGUUGAAAUUCGUAGGAAAACUUGUCUUCUGUAAAGACUUUUGCAUAGGAAUUUGUUUGACCAUCUCUAAGCAUUACACGUGCCUGUACUUGUCCACUGGAUUGAAGGCAGAGAAGGAAGGGAGGAGGGAAUGAUUCAAGGCCAAAAUGGCCACAUUUAGAAGAUACCUCAGAUGAUAACCAUUGUUAUGUGUGUGCAAUUUUAUUUAACAGUGCUGUGUAUGUGGUGGACAAGUUAUAUGAAAUAUCUAGUCUUUCUAGAUAUUUGGAAGUGCUUGAUGUAUUUAAAAGUGGUAGUAGAAUAACACUUUGUAAAUAGCUUUUAAAAACUGAUGGGAAAUGCUGUUUGGAAGUGGAAUUGUUGAACCACCUGGGAGGUGGGAGGGAAGAAAUUGCAAAUGGUGUUUUGCCAUUGUUUAUUAGAAAAUUUCAGCUUAAUCCAUUGUGUAUAUGUUACAUGCAUUUCAUUUAACUUUGCUAUACUGUAUAUAUUGUAUAUAUAACGGACAAAUUAGUCCCGAUUUUAUAAUAUCUAGUCUCUAGAUAUUAAAGAGGUUGCCAAUGUAUGACAGAAGUAGAGUUAGUAAACUAACACAUUUUGUACACUUUGUUAAAAUUUGUAGAAAGGCUGUCUUCUGAAAAGGACUUUUGGAAGUGAGAUAACAUCAGCUCUAAGUGACACGUGCCUAUAUCCAUCAGGUUGGUGGUGGAGAGGAGUUGGAAGGAAUGAAGGGUUCUAGACCAGAAUGUUCGUAUUUAGAAGACACUAUCAGAUAUAACCAUUGUUACAUGUGUGUAGUUUAUUCAACCCUACUGUGUAUAUAGCGGACAAACUUAAGUCCUUAUUUGAAACAUCUAGUCUUUCUAGAUGUUUAGAAGUGCACAAAGUAUGUUAAAAGUAGAGGUAGUAAAUAACACAUUUUGUAGCUAUCCUUUUGAUAUGAAAUAUUGUCUUGGAAAUUGAUCAAUUCUCUGAGCAGUACCCAUUUUGAUAUUUGUGCUGGUUCAGGGGGAAGGAGGAGCACAAAGUGCAAAGGGCUUUCUACCAGUGUCCAGUGUGUUUAUGAGGAGGCACAUUGACCAUUGUCCCUUAUGUCUGCAUUUUCAUUUACUGUGCUGUGUAUAUAGUGUAUAUAAGCGGACAUAGGAGUCCUAAUUUACGUCUAGUCGAUGUUAAAAAGGUUGCCAGUAUAUGACAAAAGUAGAAUUAGUAAACUACUACAUUGAGUACACUUUGUGUUAAAAUUCAUAGGGAAGACUUCUUAAAAACAAGUGAAAUUGUUAAAACCCCCCCUAAGCAUUACAGAUGGCUUAUAGCUGUCCACGGGGUUGGUAGAGGUGGGAAAGGGAAGGGUUCUAGGCCAGAAUGUUCCUAUUUAGAAGACACUCAAAUUACAGUCUGUGUUAUGUAUGUAUACCAUUUAUUCAAUGCUACUGUGUAUAUAAUGGAAAACUUAAGUCCAGUUUGAAACAUCUAGUCUUUCUAGGUGUUUAAAAGUGUACAACGGCCUGUCGCAGUGGCGCAUGCCUGUAAUCCCAGCACUUUGGGAGGCCGAGGCAGGCGGAUCACGAGGUCAAGAGAUCAGGACCAUCUUGGCCAACAUGGUGAAACCCCAUCUUUACUAAAAAUACAAAAAUUAGCUGGUCGUGGUGGUGCCCACCUGUAGCCCCAGUUACUCGAGAGGCUGAGGCAGGAGAAUCGCUUGAACUUGGGAGGCGGAAGUUGCAGUGAGCCAAGAUCGCACCACUGCACUCCAGCCUGGCGACAGAGCGAGGCUCCGUUUCAAAAAAAAAAGUGCACAAUGUAGGUUAACAGUAGAGGGCUUAAGUAACACCCCUCUAAGCAUUUGUUUUCAGUACUUCCUAGGAGUGGUUGCAUUUGGGAAUGGAAUUGUUAAAACUUGAUGCUUAGGAGCGAAUGCAGACUAUUCAUUGGGUGUUUGGGGUGGGGGAAGGGGGGGUGGGCAGAGGAGGUAUGCAGGGAGAGGGGUUCUGUGCUCCUGAGAUUAGUUCAGAUGGUCUAACCAUUGUUCUAUAUGUGCAUUUUAGUUAAUAUUGUGUAUUAAAGGAUAAGUCUUAAUGCUCAAAGUAUGUUAAAAAUAGAUGUAGUAAAUCAGUCCCUUUGUGAAUGUCCUUUUGUUAGUUUUUAGGAAGGCCUGUCCUCUGGGAGUGACCUUUAUUAGUCCACCCCUUGGAGCUAGACAUCCUGUACUUAGUCACGGGGAUGGUGGAAGAGGGAGAAGAGGAAGGGUGAAGGGAAGGGCUCUUUGCUAGUAUCUCCAUAUCUAGACGAUGGUUUUAGAUGAUAACCACAGGUCUACAAGAGCGUUUUUAGUAAAGUGCCUGUGUUCAUUGUGGACAAAGUUAUUAUUUUGCAACAUCUAAGCUUUACGAAUGGGGUGACAACUUAUGAUAAAAACUAGAGCUAGUGAAUUAGCCUAUUUGUAAAUACCUUUGUUAUAAUUGAUAGGAUACAUCUUGGACAUGGAAUUGUUAAGCCACCUCUGAGCAGUGUAUGUCAGGACUUGUUCAUUAGGUUGGCAGCAGAGGGGCAGAAGGAAUUAUACAGGUAGAGAUGUAUGCAGAUGUGUCCAUAUAUGUCCAUAUUUACAUUUUGAUAGCCAUUGAUGUAUGCAUCUCUUGGCUGUACUAUAAGAACACAUUAAUUCAAUGGAAAUACACUUUGCUAAUAUUUUAAUGGUAUAGAUCUGCUAAUGAAUUCUCUUAAAAACAUACUGUAUUCUGUUGCUGUGUGUUUCAUUUUAAAUUGAGCAUUAAGGGAAUGCAGCAUUUAAAUCAGAACUCUGCCAAUGCUUUUAUCUAGAGGCGUGUUGCCAUUUUUGUCUUAUAUGAAAUUUCUGUCCCAAGAAAGGCAGGAUUACAUCUUUUUUUUUUUUUUUAGCAGUUUGAGUUGGUGUAGUGUAUUCUUGGUUAUCAGAAUACUCAUAUAGCUUUGGGAUUUUGAAUUGGUAAAUAUUCAUGAUGUGUGAAAAAUCAUGAUACAUACUGUACAGUCUCAGUCCCAUAAAAUUGGAUGUUGUGCCUACACACAGGAUCUAGAAGAAUAUGUCAAACUAUAAACUGCUUGUGAUUGUGAAUGACUUUGUUCUUUGCUUGUGUUUUUCAAUUUCCUAUAAUGCACAUACUAACUUUUAAAAAAUAAAGGUUAUUUUAAAAGCCUGUAUUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,lncRNA,Homo sapiens,"sp|Q14671|PUM1_HUMAN Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1 PE=1 SV=3
MSVACVLKRKAVLWQDSFSPHLKHHPQEPANPNMPVVLTSGTGSQAQPQPAANQALAAGT
HSSPVPGSIGVAGRSQDDAMVDYFFQRQHGEQLGGGGSGGGGYNNSKHRWPTGDNIHAEH
QVRSMDELNHDFQALALEGRAMGEQLLPGKKFWETDESSKDGPKGIFLGDQWRDSAWGTS
DHSVSQPIMVQRRPGQSFHVNSEVNSVLSPRSESGGLGVSMVEYVLSSSPGDSCLRKGGF
GPRDADSDENDKGEKKNKGTFDGDKLGDLKEEGDVMDKTNGLPVQNGIDADVKDFSRTPG
NCQNSANEVDLLGPNQNGSEGLAQLTSTNGAKPVEDFSNMESQSVPLDPMEHVGMEPLQF
DYSGTQVPVDSAAATVGLFDYNSQQQLFQRPNALAVQQLTAAQQQQYALAAAHQPHIGLA
PAAFVPNPYIISAAPPGTDPYTAGLAAAATLGPAVVPHQYYGVTPWGVYPASLFQQQAAA
AAAATNSANQQTTPQAQQGQQQVLRGGASQRPLTPNQNQQGQQTDPLVAAAAVNSALAFG
QGLAAGMPGYPVLAPAAYYDQTGALVVNAGARNGLGAPVRLVAPAPVIISSSAAQAAVAA
AAASANGAAGGLAGTTNGPFRPLGTQQPQPQPQQQPNNNLASSSFYGNNSLNSNSQSSSL
FSQGSAQPANTSLGFGSSSSLGATLGSALGGFGTAVANSNTGSGSRRDSLTGSSDLYKRT
SSSLTPIGHSFYNGLSFSSSPGPVGMPLPSQGPGHSQTPPPSLSSHGSSSSLNLGGLTNG
SGRYISAAPGAEAKYRSASSASSLFSPSSTLFSSSRLRYGMSDVMPSGRSRLLEDFRNNR
YPNLQLREIAGHIMEFSQDQHGSRFIQLKLERATPAERQLVFNEILQAAYQLMVDVFGNY
VIQKFFEFGSLEQKLALAERIRGHVLSLALQMYGCRVIQKALEFIPSDQQNEMVRELDGH
VLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFALSTHPYGCRVIQRILEHCLPD
QTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVAEIRGNVLVLSQHKFASN
VVEKCVTHASRTERAVLIDEVCTMNDGPHSALYTMMKDQYANYVVQKMIDVAEPGQRKIV
MHKIRPHIATLRKYTYGKHILAKLEKYYMKNGVDLGPICGPPNGII",PUM1,-,-,1186aa(1-1186),Q14671,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1307,http://db.phasep.pro/browse/","[22-73],[233-272],[485-524],[613-648],[742-773]","[45-58],[94-102],[393-414],[442-457],[475-502],[527-538],[583-614],[625-639],[647-665],[671-695],[762-782],[797-815]",In vitro,2.7 nM[NORAD];|5 µM [PUM1],"150 mM NaCl, 1 mM MgCl2","20 mM Tris HCl pH 7.5, 1 mM DTT, 10% glycerol",RT,30 min,crowding agent:5% PEG3350;other_molecular: 1 U TEV protease,"Differential interference contrast microscopy,FRAP",liquid,"Moreover, in vitro-transcribed NORAD RNA was incorporated into preformed PUM droplets and further increased PUM1 phase separation",5378
204,688,PMID: 34108682,RNAPS0000619,https://pubmed.ncbi.nlm.nih.gov/34108682,RNA + protein,NCBI ID: 647979,https://www.ncbi.nlm.nih.gov/gene/647979,NORAD,5378nt(1-5378),AGUUCCGGUCCGGCAGAGAUCGCGGAGAGACGCAGAACGCAGCCCGCUCCUCCAGGGCCCUCCAGGCCCUCCGGCCCCGGGCCGGCGGGUGAACUGGGGGGCCCCGGGACAGGCCGAGCCCUCUGCCCUGCAGAUAACGGAGGCCUCUGCUGUGGCUGCCCACUGGCUGUGCCCGCCCACUGGCUGUGCCCAGACCUUGAAGCCGCAGCGAACCUCUCUUUCCCACCCCACCUCGGUGACUAAUGGCGGCCGUGGCGUCUCCCAGCCCGGACCCCGCCGGCACCCGGGUCUCCCGACCCAAGCCUCGACGAAACCCCCGCAGAGCCGCCGGGACGCAGCGCCUUUGGGCGGCGCUGGGCGUGGUGGGCCGGGAAGUAUGGCGGCAGCUCGAACGCCGCGCGGCGGAGGCCAUUAAGGCGUGGACGGCCCGGGAAGGCGGCCUAGGGACGCAAGCAGGCUCGGCCGCCUCUUUAGGCCACGGAGCCGCGCAGAUCCGGUUCCCGGGUGACCACUCUGUCGCCAUUGGGCGAGACCUACCUAGUCCUGACGACAACGGACAAAGGCCUUAAGGGGCCUGGAAGGUGAGCGAAGUCCCGAACGACGACGGGUGGAACGGUUAGCGGCCAUCGGGCGGUUGGUCUUCAUUCUACCAGACUUUGCUGUCGGAAGAGAGAAAUGGUAGAAUGACAGGCCACGUUUGGCCCGUUGGAAAUGCCCACCACCCUCUGGGAAGAUUUACUGGCCGUUUAUGGAAGGCCUGUGUAUAUAAUAUGAAAAAGCUGCUCUCAACUCCACCCCAACCUUUUAAUAGAAAACAUUUGUCACAUCUAGCCCUUCUAGAUGGAAAGAGGUUGCCGACGUAUGAUAAAAUAGAGUUAGAAAGUUACACAUCUUGUAAAUUCUCAUUUGUUUAAAAGAAAUCAUAGAAAAUACAUGUCUUCUGGAGAUGACUUUUGGAAAUGGAGUUGUUAAGACGGCCUCUGGAAGCGAUACGUCCACGUUUGUUAAGUGGGUUAGAUGACAUGGAGCUGGAAGACCUGAGAAGGAAGAGAAGAAGGUUCUAUGCUAGACUGGUCAUAUUUAGAAGACAUUUUCAUAUUCUAUCCAUUGUUUUGUGUGCAUUUUAUUCCUCACUACUGUGUAUAUAGUUGACAAUGCUAAGCUUUUUUGAAAUGUCUCUUCUUUUUAGAUGUUCUGAAGUGCCUGAUAUGUUAAAAUUAGAGGUAGCAAAAUCACAUUUUGUAAAUACCUUUUUGUUACAAUUCAUAGGAAAUAUUUUUGGGGGGGAAUGGCCAAAUCACCUGUUGAGUAAUACUCAUUGUGUUUGUGCAGUGGUUCAGGGGAGGAGAGAGGAGGGGGAGGUGCAGAGAGCUCUAUGCCAUCCUGUUUACAGCGAGGCAAGAUGAAUCAUUAUGUCUGUGCAUUUUGUUUUACUUAUCUGUGUAUAUAGUGUACAUAAAGGACAGACGAGUCCUAAUUGACAACAUCUAGUCUUUCUGGAUGUUAAAGAGGUUGCCAGUGUAUGACAAAAGUAGAGUUAGUAAACUAAUAUAUUUUGUACAUUUUGUUUUACAAGUCCUAGGAAAGAUUGUCUUCUGAAAAUUUGAUGUCUUCUGGGUUGAUGGAGAUGGGAAGGGUUCUAGGCCAGAAUGUUCACAUUUGGAAGACUCUUUCAAAUUAUAACUGUUGUUACAUGUUUGCAGUUUAUUCAAGACUGCUGUAUACAUAGUAGACAAAUUAACUCCUUACUUGAAACAUCUAGUCUAUCUAGAUGUUUAGAAGUGCCCGAUGUAUGUUAAAUGUAUAGGUAGUAAAAUACCACUUUGUAAAUAUCUUUUUGCUAAAAUUCAUAGGAAAUGCUUUUGGAAAUUGAAUUGUGAAGCCACCUUUGUGAACAGUAUAGUAAUGUCUAUACUUGUUCAAUAGUUUAGAGGAGGUAGGAGGGAAGAAAUUGCAAAAGGUAAUAUUACUAGUGUGUUCAUACUUGGACAUUUUCAGACACCAUUUUUCUAUAUGUUUUGUGCAUUUUGUUUUGCUCUGUAUAUAGUAUAUAUAAUGGACAAAUAGUCCUAAUUUUUCAACAUCUAGUCUCUAGAUGUUAAAGAGGUUGCCAGUGUAUGACAAAGGAGUAAAAUUAGCAUAUUUUGUACACUUUGUGUUGAAAUUCGUAGGAAAACUUGUCUUCUGUAAAGACUUUUGCAUAGGAAUUUGUUUGACCAUCUCUAAGCAUUACACGUGCCUGUACUUGUCCACUGGAUUGAAGGCAGAGAAGGAAGGGAGGAGGGAAUGAUUCAAGGCCAAAAUGGCCACAUUUAGAAGAUACCUCAGAUGAUAACCAUUGUUAUGUGUGUGCAAUUUUAUUUAACAGUGCUGUGUAUGUGGUGGACAAGUUAUAUGAAAUAUCUAGUCUUUCUAGAUAUUUGGAAGUGCUUGAUGUAUUUAAAAGUGGUAGUAGAAUAACACUUUGUAAAUAGCUUUUAAAAACUGAUGGGAAAUGCUGUUUGGAAGUGGAAUUGUUGAACCACCUGGGAGGUGGGAGGGAAGAAAUUGCAAAUGGUGUUUUGCCAUUGUUUAUUAGAAAAUUUCAGCUUAAUCCAUUGUGUAUAUGUUACAUGCAUUUCAUUUAACUUUGCUAUACUGUAUAUAUUGUAUAUAUAACGGACAAAUUAGUCCCGAUUUUAUAAUAUCUAGUCUCUAGAUAUUAAAGAGGUUGCCAAUGUAUGACAGAAGUAGAGUUAGUAAACUAACACAUUUUGUACACUUUGUUAAAAUUUGUAGAAAGGCUGUCUUCUGAAAAGGACUUUUGGAAGUGAGAUAACAUCAGCUCUAAGUGACACGUGCCUAUAUCCAUCAGGUUGGUGGUGGAGAGGAGUUGGAAGGAAUGAAGGGUUCUAGACCAGAAUGUUCGUAUUUAGAAGACACUAUCAGAUAUAACCAUUGUUACAUGUGUGUAGUUUAUUCAACCCUACUGUGUAUAUAGCGGACAAACUUAAGUCCUUAUUUGAAACAUCUAGUCUUUCUAGAUGUUUAGAAGUGCACAAAGUAUGUUAAAAGUAGAGGUAGUAAAUAACACAUUUUGUAGCUAUCCUUUUGAUAUGAAAUAUUGUCUUGGAAAUUGAUCAAUUCUCUGAGCAGUACCCAUUUUGAUAUUUGUGCUGGUUCAGGGGGAAGGAGGAGCACAAAGUGCAAAGGGCUUUCUACCAGUGUCCAGUGUGUUUAUGAGGAGGCACAUUGACCAUUGUCCCUUAUGUCUGCAUUUUCAUUUACUGUGCUGUGUAUAUAGUGUAUAUAAGCGGACAUAGGAGUCCUAAUUUACGUCUAGUCGAUGUUAAAAAGGUUGCCAGUAUAUGACAAAAGUAGAAUUAGUAAACUACUACAUUGAGUACACUUUGUGUUAAAAUUCAUAGGGAAGACUUCUUAAAAACAAGUGAAAUUGUUAAAACCCCCCCUAAGCAUUACAGAUGGCUUAUAGCUGUCCACGGGGUUGGUAGAGGUGGGAAAGGGAAGGGUUCUAGGCCAGAAUGUUCCUAUUUAGAAGACACUCAAAUUACAGUCUGUGUUAUGUAUGUAUACCAUUUAUUCAAUGCUACUGUGUAUAUAAUGGAAAACUUAAGUCCAGUUUGAAACAUCUAGUCUUUCUAGGUGUUUAAAAGUGUACAACGGCCUGUCGCAGUGGCGCAUGCCUGUAAUCCCAGCACUUUGGGAGGCCGAGGCAGGCGGAUCACGAGGUCAAGAGAUCAGGACCAUCUUGGCCAACAUGGUGAAACCCCAUCUUUACUAAAAAUACAAAAAUUAGCUGGUCGUGGUGGUGCCCACCUGUAGCCCCAGUUACUCGAGAGGCUGAGGCAGGAGAAUCGCUUGAACUUGGGAGGCGGAAGUUGCAGUGAGCCAAGAUCGCACCACUGCACUCCAGCCUGGCGACAGAGCGAGGCUCCGUUUCAAAAAAAAAAGUGCACAAUGUAGGUUAACAGUAGAGGGCUUAAGUAACACCCCUCUAAGCAUUUGUUUUCAGUACUUCCUAGGAGUGGUUGCAUUUGGGAAUGGAAUUGUUAAAACUUGAUGCUUAGGAGCGAAUGCAGACUAUUCAUUGGGUGUUUGGGGUGGGGGAAGGGGGGGUGGGCAGAGGAGGUAUGCAGGGAGAGGGGUUCUGUGCUCCUGAGAUUAGUUCAGAUGGUCUAACCAUUGUUCUAUAUGUGCAUUUUAGUUAAUAUUGUGUAUUAAAGGAUAAGUCUUAAUGCUCAAAGUAUGUUAAAAAUAGAUGUAGUAAAUCAGUCCCUUUGUGAAUGUCCUUUUGUUAGUUUUUAGGAAGGCCUGUCCUCUGGGAGUGACCUUUAUUAGUCCACCCCUUGGAGCUAGACAUCCUGUACUUAGUCACGGGGAUGGUGGAAGAGGGAGAAGAGGAAGGGUGAAGGGAAGGGCUCUUUGCUAGUAUCUCCAUAUCUAGACGAUGGUUUUAGAUGAUAACCACAGGUCUACAAGAGCGUUUUUAGUAAAGUGCCUGUGUUCAUUGUGGACAAAGUUAUUAUUUUGCAACAUCUAAGCUUUACGAAUGGGGUGACAACUUAUGAUAAAAACUAGAGCUAGUGAAUUAGCCUAUUUGUAAAUACCUUUGUUAUAAUUGAUAGGAUACAUCUUGGACAUGGAAUUGUUAAGCCACCUCUGAGCAGUGUAUGUCAGGACUUGUUCAUUAGGUUGGCAGCAGAGGGGCAGAAGGAAUUAUACAGGUAGAGAUGUAUGCAGAUGUGUCCAUAUAUGUCCAUAUUUACAUUUUGAUAGCCAUUGAUGUAUGCAUCUCUUGGCUGUACUAUAAGAACACAUUAAUUCAAUGGAAAUACACUUUGCUAAUAUUUUAAUGGUAUAGAUCUGCUAAUGAAUUCUCUUAAAAACAUACUGUAUUCUGUUGCUGUGUGUUUCAUUUUAAAUUGAGCAUUAAGGGAAUGCAGCAUUUAAAUCAGAACUCUGCCAAUGCUUUUAUCUAGAGGCGUGUUGCCAUUUUUGUCUUAUAUGAAAUUUCUGUCCCAAGAAAGGCAGGAUUACAUCUUUUUUUUUUUUUUUAGCAGUUUGAGUUGGUGUAGUGUAUUCUUGGUUAUCAGAAUACUCAUAUAGCUUUGGGAUUUUGAAUUGGUAAAUAUUCAUGAUGUGUGAAAAAUCAUGAUACAUACUGUACAGUCUCAGUCCCAUAAAAUUGGAUGUUGUGCCUACACACAGGAUCUAGAAGAAUAUGUCAAACUAUAAACUGCUUGUGAUUGUGAAUGACUUUGUUCUUUGCUUGUGUUUUUCAAUUUCCUAUAAUGCACAUACUAACUUUUAAAAAAUAAAGGUUAUUUUAAAAGCCUGUAUUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,lncRNA,Homo sapiens,"sp|Q8TB72|PUM2_HUMAN Pumilio homolog 2 OS=Homo sapiens OX=9606 GN=PUM2 PE=1 SV=2
MNHDFQALALESRGMGELLPTKKFWEPDDSTKDGQKGIFLGDDEWRETAWGASHHSMSQP
IMVQRRSGQGFHGNSEVNAILSPRSESGGLGVSMVEYVLSSSPADKLDSRFRKGNFGTRD
AETDGPEKGDQKGKASPFEEDQNRDLKQGDDDDSKINGRGLPNGMDADCKDFNRTPGSRQ
ASPTEVVERLGPNTNPSEGLGPLPNPTANKPLVEEFSNPETQNLDAMEQVGLESLQFDYP
GNQVPMDSSGATVGLFDYNSQQQLFQRTNALTVQQLTAAQQQQYALAAAQQPHIAGVFSA
GLAPAAFVPNPYIISAAPPGTDPYTAAGLAAAATLAGPAVVPPQYYGVPWGVYPANLFQQ
QAAAAANNTASQQAASQAQPGQQQVLRAGAGQRPLTPNQGQQGQQAESLAAAAAANPTLA
FGQGLATGMPGYQVLAPTAYYDQTGALVVGPGARTGLGAPVRLMAPTPVLISSAAAQAAA
AAAAGGTASSLTGSTNGLFRPIGTQPPQQQQQQPSTNLQSNSFYGSSSLTNSSQSSSLFS
HGPGQPGSTSLGFGSGNSLGAAIGSALSGFGSSVGSSASSSATRRESLSTSSDLYKRSSS
SLAPIGQPFYNSLGFSSSPSPIGMPLPSQTPGHSLTPPPSLSSHGSSSSLHLGGLTNGSG
RYISAAPGAEAKYRSASSTSSLFSSSSQLFPPSRLRYNRSDIMPSGRSRLLEDFRNNRFP
NLQLRDLIGHIVEFSQDQHGSRFIQQKLERATPAERQMVFNEILQAAYQLMTDVFGNYVI
QKFFEFGSLDQKLALATRIRGHVLPLALQMYGCRVIQKALESISSDQQVISEMVKELDGH
VLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFVLSTHPYGCRVIQRILEHCTAE
QTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVSEIRGKVLALSQHKFASN
VVEKCVTHASRAERALLIDEVCCQNDGPHSALYTMMKDQYANYVVQKMIDMAEPAQRKII
MHKIRPHITTLRKYTYGKHILAKLEKYYLKNSPDLGPIGGPPNGML",PUM2,-,-,1066(1-1066),Q8TB72,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0193,http://db.phasep.pro/browse/","[1-11],[20-20],[77-102],[108-159],[179-243],[277-288],[309-343],[363-412],[420-425],[431-492],[494-528],[534-543],[549-558],[565-599],[617-679],[697-704],[752-761],[823-832],[899-911],[934-945],[1018-1027],[1055-1062],[1064-1066]",-,In vitro,2.7 nM[NORAD];|5 µM [PUM2],"150 mM NaCl, 1 mM MgCl2","20 mM Tris HCl pH 7.5, 1 mM DTT, 10% glycerol",RT,30 min,crowding agent:5% PEG3350;other_molecular: 1 U TEV protease,"Differential interference contrast microscopy,FRAP",liquid,"Moreover, in vitro-transcribed NORAD RNA was incorporated into preformed PUM droplets and further increased PUM1 phase separation",5378
205,689,PMID: 34108682,RNAPS0000618,https://pubmed.ncbi.nlm.nih.gov/34108682,RNA + protein,NCBI ID: 647979,https://www.ncbi.nlm.nih.gov/gene/647979,NORAD,5378nt(1-5378),AGUUCCGGUCCGGCAGAGAUCGCGGAGAGACGCAGAACGCAGCCCGCUCCUCCAGGGCCCUCCAGGCCCUCCGGCCCCGGGCCGGCGGGUGAACUGGGGGGCCCCGGGACAGGCCGAGCCCUCUGCCCUGCAGAUAACGGAGGCCUCUGCUGUGGCUGCCCACUGGCUGUGCCCGCCCACUGGCUGUGCCCAGACCUUGAAGCCGCAGCGAACCUCUCUUUCCCACCCCACCUCGGUGACUAAUGGCGGCCGUGGCGUCUCCCAGCCCGGACCCCGCCGGCACCCGGGUCUCCCGACCCAAGCCUCGACGAAACCCCCGCAGAGCCGCCGGGACGCAGCGCCUUUGGGCGGCGCUGGGCGUGGUGGGCCGGGAAGUAUGGCGGCAGCUCGAACGCCGCGCGGCGGAGGCCAUUAAGGCGUGGACGGCCCGGGAAGGCGGCCUAGGGACGCAAGCAGGCUCGGCCGCCUCUUUAGGCCACGGAGCCGCGCAGAUCCGGUUCCCGGGUGACCACUCUGUCGCCAUUGGGCGAGACCUACCUAGUCCUGACGACAACGGACAAAGGCCUUAAGGGGCCUGGAAGGUGAGCGAAGUCCCGAACGACGACGGGUGGAACGGUUAGCGGCCAUCGGGCGGUUGGUCUUCAUUCUACCAGACUUUGCUGUCGGAAGAGAGAAAUGGUAGAAUGACAGGCCACGUUUGGCCCGUUGGAAAUGCCCACCACCCUCUGGGAAGAUUUACUGGCCGUUUAUGGAAGGCCUGUGUAUAUAAUAUGAAAAAGCUGCUCUCAACUCCACCCCAACCUUUUAAUAGAAAACAUUUGUCACAUCUAGCCCUUCUAGAUGGAAAGAGGUUGCCGACGUAUGAUAAAAUAGAGUUAGAAAGUUACACAUCUUGUAAAUUCUCAUUUGUUUAAAAGAAAUCAUAGAAAAUACAUGUCUUCUGGAGAUGACUUUUGGAAAUGGAGUUGUUAAGACGGCCUCUGGAAGCGAUACGUCCACGUUUGUUAAGUGGGUUAGAUGACAUGGAGCUGGAAGACCUGAGAAGGAAGAGAAGAAGGUUCUAUGCUAGACUGGUCAUAUUUAGAAGACAUUUUCAUAUUCUAUCCAUUGUUUUGUGUGCAUUUUAUUCCUCACUACUGUGUAUAUAGUUGACAAUGCUAAGCUUUUUUGAAAUGUCUCUUCUUUUUAGAUGUUCUGAAGUGCCUGAUAUGUUAAAAUUAGAGGUAGCAAAAUCACAUUUUGUAAAUACCUUUUUGUUACAAUUCAUAGGAAAUAUUUUUGGGGGGGAAUGGCCAAAUCACCUGUUGAGUAAUACUCAUUGUGUUUGUGCAGUGGUUCAGGGGAGGAGAGAGGAGGGGGAGGUGCAGAGAGCUCUAUGCCAUCCUGUUUACAGCGAGGCAAGAUGAAUCAUUAUGUCUGUGCAUUUUGUUUUACUUAUCUGUGUAUAUAGUGUACAUAAAGGACAGACGAGUCCUAAUUGACAACAUCUAGUCUUUCUGGAUGUUAAAGAGGUUGCCAGUGUAUGACAAAAGUAGAGUUAGUAAACUAAUAUAUUUUGUACAUUUUGUUUUACAAGUCCUAGGAAAGAUUGUCUUCUGAAAAUUUGAUGUCUUCUGGGUUGAUGGAGAUGGGAAGGGUUCUAGGCCAGAAUGUUCACAUUUGGAAGACUCUUUCAAAUUAUAACUGUUGUUACAUGUUUGCAGUUUAUUCAAGACUGCUGUAUACAUAGUAGACAAAUUAACUCCUUACUUGAAACAUCUAGUCUAUCUAGAUGUUUAGAAGUGCCCGAUGUAUGUUAAAUGUAUAGGUAGUAAAAUACCACUUUGUAAAUAUCUUUUUGCUAAAAUUCAUAGGAAAUGCUUUUGGAAAUUGAAUUGUGAAGCCACCUUUGUGAACAGUAUAGUAAUGUCUAUACUUGUUCAAUAGUUUAGAGGAGGUAGGAGGGAAGAAAUUGCAAAAGGUAAUAUUACUAGUGUGUUCAUACUUGGACAUUUUCAGACACCAUUUUUCUAUAUGUUUUGUGCAUUUUGUUUUGCUCUGUAUAUAGUAUAUAUAAUGGACAAAUAGUCCUAAUUUUUCAACAUCUAGUCUCUAGAUGUUAAAGAGGUUGCCAGUGUAUGACAAAGGAGUAAAAUUAGCAUAUUUUGUACACUUUGUGUUGAAAUUCGUAGGAAAACUUGUCUUCUGUAAAGACUUUUGCAUAGGAAUUUGUUUGACCAUCUCUAAGCAUUACACGUGCCUGUACUUGUCCACUGGAUUGAAGGCAGAGAAGGAAGGGAGGAGGGAAUGAUUCAAGGCCAAAAUGGCCACAUUUAGAAGAUACCUCAGAUGAUAACCAUUGUUAUGUGUGUGCAAUUUUAUUUAACAGUGCUGUGUAUGUGGUGGACAAGUUAUAUGAAAUAUCUAGUCUUUCUAGAUAUUUGGAAGUGCUUGAUGUAUUUAAAAGUGGUAGUAGAAUAACACUUUGUAAAUAGCUUUUAAAAACUGAUGGGAAAUGCUGUUUGGAAGUGGAAUUGUUGAACCACCUGGGAGGUGGGAGGGAAGAAAUUGCAAAUGGUGUUUUGCCAUUGUUUAUUAGAAAAUUUCAGCUUAAUCCAUUGUGUAUAUGUUACAUGCAUUUCAUUUAACUUUGCUAUACUGUAUAUAUUGUAUAUAUAACGGACAAAUUAGUCCCGAUUUUAUAAUAUCUAGUCUCUAGAUAUUAAAGAGGUUGCCAAUGUAUGACAGAAGUAGAGUUAGUAAACUAACACAUUUUGUACACUUUGUUAAAAUUUGUAGAAAGGCUGUCUUCUGAAAAGGACUUUUGGAAGUGAGAUAACAUCAGCUCUAAGUGACACGUGCCUAUAUCCAUCAGGUUGGUGGUGGAGAGGAGUUGGAAGGAAUGAAGGGUUCUAGACCAGAAUGUUCGUAUUUAGAAGACACUAUCAGAUAUAACCAUUGUUACAUGUGUGUAGUUUAUUCAACCCUACUGUGUAUAUAGCGGACAAACUUAAGUCCUUAUUUGAAACAUCUAGUCUUUCUAGAUGUUUAGAAGUGCACAAAGUAUGUUAAAAGUAGAGGUAGUAAAUAACACAUUUUGUAGCUAUCCUUUUGAUAUGAAAUAUUGUCUUGGAAAUUGAUCAAUUCUCUGAGCAGUACCCAUUUUGAUAUUUGUGCUGGUUCAGGGGGAAGGAGGAGCACAAAGUGCAAAGGGCUUUCUACCAGUGUCCAGUGUGUUUAUGAGGAGGCACAUUGACCAUUGUCCCUUAUGUCUGCAUUUUCAUUUACUGUGCUGUGUAUAUAGUGUAUAUAAGCGGACAUAGGAGUCCUAAUUUACGUCUAGUCGAUGUUAAAAAGGUUGCCAGUAUAUGACAAAAGUAGAAUUAGUAAACUACUACAUUGAGUACACUUUGUGUUAAAAUUCAUAGGGAAGACUUCUUAAAAACAAGUGAAAUUGUUAAAACCCCCCCUAAGCAUUACAGAUGGCUUAUAGCUGUCCACGGGGUUGGUAGAGGUGGGAAAGGGAAGGGUUCUAGGCCAGAAUGUUCCUAUUUAGAAGACACUCAAAUUACAGUCUGUGUUAUGUAUGUAUACCAUUUAUUCAAUGCUACUGUGUAUAUAAUGGAAAACUUAAGUCCAGUUUGAAACAUCUAGUCUUUCUAGGUGUUUAAAAGUGUACAACGGCCUGUCGCAGUGGCGCAUGCCUGUAAUCCCAGCACUUUGGGAGGCCGAGGCAGGCGGAUCACGAGGUCAAGAGAUCAGGACCAUCUUGGCCAACAUGGUGAAACCCCAUCUUUACUAAAAAUACAAAAAUUAGCUGGUCGUGGUGGUGCCCACCUGUAGCCCCAGUUACUCGAGAGGCUGAGGCAGGAGAAUCGCUUGAACUUGGGAGGCGGAAGUUGCAGUGAGCCAAGAUCGCACCACUGCACUCCAGCCUGGCGACAGAGCGAGGCUCCGUUUCAAAAAAAAAAGUGCACAAUGUAGGUUAACAGUAGAGGGCUUAAGUAACACCCCUCUAAGCAUUUGUUUUCAGUACUUCCUAGGAGUGGUUGCAUUUGGGAAUGGAAUUGUUAAAACUUGAUGCUUAGGAGCGAAUGCAGACUAUUCAUUGGGUGUUUGGGGUGGGGGAAGGGGGGGUGGGCAGAGGAGGUAUGCAGGGAGAGGGGUUCUGUGCUCCUGAGAUUAGUUCAGAUGGUCUAACCAUUGUUCUAUAUGUGCAUUUUAGUUAAUAUUGUGUAUUAAAGGAUAAGUCUUAAUGCUCAAAGUAUGUUAAAAAUAGAUGUAGUAAAUCAGUCCCUUUGUGAAUGUCCUUUUGUUAGUUUUUAGGAAGGCCUGUCCUCUGGGAGUGACCUUUAUUAGUCCACCCCUUGGAGCUAGACAUCCUGUACUUAGUCACGGGGAUGGUGGAAGAGGGAGAAGAGGAAGGGUGAAGGGAAGGGCUCUUUGCUAGUAUCUCCAUAUCUAGACGAUGGUUUUAGAUGAUAACCACAGGUCUACAAGAGCGUUUUUAGUAAAGUGCCUGUGUUCAUUGUGGACAAAGUUAUUAUUUUGCAACAUCUAAGCUUUACGAAUGGGGUGACAACUUAUGAUAAAAACUAGAGCUAGUGAAUUAGCCUAUUUGUAAAUACCUUUGUUAUAAUUGAUAGGAUACAUCUUGGACAUGGAAUUGUUAAGCCACCUCUGAGCAGUGUAUGUCAGGACUUGUUCAUUAGGUUGGCAGCAGAGGGGCAGAAGGAAUUAUACAGGUAGAGAUGUAUGCAGAUGUGUCCAUAUAUGUCCAUAUUUACAUUUUGAUAGCCAUUGAUGUAUGCAUCUCUUGGCUGUACUAUAAGAACACAUUAAUUCAAUGGAAAUACACUUUGCUAAUAUUUUAAUGGUAUAGAUCUGCUAAUGAAUUCUCUUAAAAACAUACUGUAUUCUGUUGCUGUGUGUUUCAUUUUAAAUUGAGCAUUAAGGGAAUGCAGCAUUUAAAUCAGAACUCUGCCAAUGCUUUUAUCUAGAGGCGUGUUGCCAUUUUUGUCUUAUAUGAAAUUUCUGUCCCAAGAAAGGCAGGAUUACAUCUUUUUUUUUUUUUUUAGCAGUUUGAGUUGGUGUAGUGUAUUCUUGGUUAUCAGAAUACUCAUAUAGCUUUGGGAUUUUGAAUUGGUAAAUAUUCAUGAUGUGUGAAAAAUCAUGAUACAUACUGUACAGUCUCAGUCCCAUAAAAUUGGAUGUUGUGCCUACACACAGGAUCUAGAAGAAUAUGUCAAACUAUAAACUGCUUGUGAUUGUGAAUGACUUUGUUCUUUGCUUGUGUUUUUCAAUUUCCUAUAAUGCACAUACUAACUUUUAAAAAAUAAAGGUUAUUUUAAAAGCCUGUAUUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,lncRNA,Homo sapiens,"sp|Q14671|PUM1_HUMAN Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1 PE=1 SV=3
MSVACVLKRKAVLWQDSFSPHLKHHPQEPANPNMPVVLTSGTGSQAQPQPAANQALAAGT
HSSPVPGSIGVAGRSQDDAMVDYFFQRQHGEQLGGGGSGGGGYNNSKHRWPTGDNIHAEH
QVRSMDELNHDFQALALEGRAMGEQLLPGKKFWETDESSKDGPKGIFLGDQWRDSAWGTS
DHSVSQPIMVQRRPGQSFHVNSEVNSVLSPRSESGGLGVSMVEYVLSSSPGDSCLRKGGF
GPRDADSDENDKGEKKNKGTFDGDKLGDLKEEGDVMDKTNGLPVQNGIDADVKDFSRTPG
NCQNSANEVDLLGPNQNGSEGLAQLTSTNGAKPVEDFSNMESQSVPLDPMEHVGMEPLQF
DYSGTQVPVDSAAATVGLFDYNSQQQLFQRPNALAVQQLTAAQQQQYALAAAHQPHIGLA
PAAFVPNPYIISAAPPGTDPYTAGLAAAATLGPAVVPHQYYGVTPWGVYPASLFQQQAAA
AAAATNSANQQTTPQAQQGQQQVLRGGASQRPLTPNQNQQGQQTDPLVAAAAVNSALAFG
QGLAAGMPGYPVLAPAAYYDQTGALVVNAGARNGLGAPVRLVAPAPVIISSSAAQAAVAA
AAASANGAAGGLAGTTNGPFRPLGTQQPQPQPQQQPNNNLASSSFYGNNSLNSNSQSSSL
FSQGSAQPANTSLGFGSSSSLGATLGSALGGFGTAVANSNTGSGSRRDSLTGSSDLYKRT
SSSLTPIGHSFYNGLSFSSSPGPVGMPLPSQGPGHSQTPPPSLSSHGSSSSLNLGGLTNG
SGRYISAAPGAEAKYRSASSASSLFSPSSTLFSSSRLRYGMSDVMPSGRSRLLEDFRNNR
YPNLQLREIAGHIMEFSQDQHGSRFIQLKLERATPAERQLVFNEILQAAYQLMVDVFGNY
VIQKFFEFGSLEQKLALAERIRGHVLSLALQMYGCRVIQKALEFIPSDQQNEMVRELDGH
VLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFALSTHPYGCRVIQRILEHCLPD
QTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVAEIRGNVLVLSQHKFASN
VVEKCVTHASRTERAVLIDEVCTMNDGPHSALYTMMKDQYANYVVQKMIDVAEPGQRKIV
MHKIRPHIATLRKYTYGKHILAKLEKYYMKNGVDLGPICGPPNGII",PUM1,-,-,1186aa(1-1186),Q14671,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1307,http://db.phasep.pro/browse/","[22-73],[233-272],[485-524],[613-648],[742-773]","[45-58],[94-102],[393-414],[442-457],[475-502],[527-538],[583-614],[625-639],[647-665],[671-695],[762-782],[797-815]",In vitro,2 nM[NORAD];|5 µM [PUM1],"150 mM NaCl, 1 mM MgCl2","20 mM Tris HCl pH 7.5, 1 mM DTT, 10% glycerol",RT,30 min,crowding agent:5% PEG3350;other_molecular: 1 U TEV protease,FRAP,liquid,"Both RNA and protein components remained dynamic within these droplets, although NORAD exhibited slower FRAP recovery than PUM1, as observed in other RNA–protein condensates19 ",5378
206,690,PMID: 34108682,RNAPS0000618,https://pubmed.ncbi.nlm.nih.gov/34108682,RNA + protein,NCBI ID: 647979,https://www.ncbi.nlm.nih.gov/gene/647979,NORAD,5378nt(1-5378),AGUUCCGGUCCGGCAGAGAUCGCGGAGAGACGCAGAACGCAGCCCGCUCCUCCAGGGCCCUCCAGGCCCUCCGGCCCCGGGCCGGCGGGUGAACUGGGGGGCCCCGGGACAGGCCGAGCCCUCUGCCCUGCAGAUAACGGAGGCCUCUGCUGUGGCUGCCCACUGGCUGUGCCCGCCCACUGGCUGUGCCCAGACCUUGAAGCCGCAGCGAACCUCUCUUUCCCACCCCACCUCGGUGACUAAUGGCGGCCGUGGCGUCUCCCAGCCCGGACCCCGCCGGCACCCGGGUCUCCCGACCCAAGCCUCGACGAAACCCCCGCAGAGCCGCCGGGACGCAGCGCCUUUGGGCGGCGCUGGGCGUGGUGGGCCGGGAAGUAUGGCGGCAGCUCGAACGCCGCGCGGCGGAGGCCAUUAAGGCGUGGACGGCCCGGGAAGGCGGCCUAGGGACGCAAGCAGGCUCGGCCGCCUCUUUAGGCCACGGAGCCGCGCAGAUCCGGUUCCCGGGUGACCACUCUGUCGCCAUUGGGCGAGACCUACCUAGUCCUGACGACAACGGACAAAGGCCUUAAGGGGCCUGGAAGGUGAGCGAAGUCCCGAACGACGACGGGUGGAACGGUUAGCGGCCAUCGGGCGGUUGGUCUUCAUUCUACCAGACUUUGCUGUCGGAAGAGAGAAAUGGUAGAAUGACAGGCCACGUUUGGCCCGUUGGAAAUGCCCACCACCCUCUGGGAAGAUUUACUGGCCGUUUAUGGAAGGCCUGUGUAUAUAAUAUGAAAAAGCUGCUCUCAACUCCACCCCAACCUUUUAAUAGAAAACAUUUGUCACAUCUAGCCCUUCUAGAUGGAAAGAGGUUGCCGACGUAUGAUAAAAUAGAGUUAGAAAGUUACACAUCUUGUAAAUUCUCAUUUGUUUAAAAGAAAUCAUAGAAAAUACAUGUCUUCUGGAGAUGACUUUUGGAAAUGGAGUUGUUAAGACGGCCUCUGGAAGCGAUACGUCCACGUUUGUUAAGUGGGUUAGAUGACAUGGAGCUGGAAGACCUGAGAAGGAAGAGAAGAAGGUUCUAUGCUAGACUGGUCAUAUUUAGAAGACAUUUUCAUAUUCUAUCCAUUGUUUUGUGUGCAUUUUAUUCCUCACUACUGUGUAUAUAGUUGACAAUGCUAAGCUUUUUUGAAAUGUCUCUUCUUUUUAGAUGUUCUGAAGUGCCUGAUAUGUUAAAAUUAGAGGUAGCAAAAUCACAUUUUGUAAAUACCUUUUUGUUACAAUUCAUAGGAAAUAUUUUUGGGGGGGAAUGGCCAAAUCACCUGUUGAGUAAUACUCAUUGUGUUUGUGCAGUGGUUCAGGGGAGGAGAGAGGAGGGGGAGGUGCAGAGAGCUCUAUGCCAUCCUGUUUACAGCGAGGCAAGAUGAAUCAUUAUGUCUGUGCAUUUUGUUUUACUUAUCUGUGUAUAUAGUGUACAUAAAGGACAGACGAGUCCUAAUUGACAACAUCUAGUCUUUCUGGAUGUUAAAGAGGUUGCCAGUGUAUGACAAAAGUAGAGUUAGUAAACUAAUAUAUUUUGUACAUUUUGUUUUACAAGUCCUAGGAAAGAUUGUCUUCUGAAAAUUUGAUGUCUUCUGGGUUGAUGGAGAUGGGAAGGGUUCUAGGCCAGAAUGUUCACAUUUGGAAGACUCUUUCAAAUUAUAACUGUUGUUACAUGUUUGCAGUUUAUUCAAGACUGCUGUAUACAUAGUAGACAAAUUAACUCCUUACUUGAAACAUCUAGUCUAUCUAGAUGUUUAGAAGUGCCCGAUGUAUGUUAAAUGUAUAGGUAGUAAAAUACCACUUUGUAAAUAUCUUUUUGCUAAAAUUCAUAGGAAAUGCUUUUGGAAAUUGAAUUGUGAAGCCACCUUUGUGAACAGUAUAGUAAUGUCUAUACUUGUUCAAUAGUUUAGAGGAGGUAGGAGGGAAGAAAUUGCAAAAGGUAAUAUUACUAGUGUGUUCAUACUUGGACAUUUUCAGACACCAUUUUUCUAUAUGUUUUGUGCAUUUUGUUUUGCUCUGUAUAUAGUAUAUAUAAUGGACAAAUAGUCCUAAUUUUUCAACAUCUAGUCUCUAGAUGUUAAAGAGGUUGCCAGUGUAUGACAAAGGAGUAAAAUUAGCAUAUUUUGUACACUUUGUGUUGAAAUUCGUAGGAAAACUUGUCUUCUGUAAAGACUUUUGCAUAGGAAUUUGUUUGACCAUCUCUAAGCAUUACACGUGCCUGUACUUGUCCACUGGAUUGAAGGCAGAGAAGGAAGGGAGGAGGGAAUGAUUCAAGGCCAAAAUGGCCACAUUUAGAAGAUACCUCAGAUGAUAACCAUUGUUAUGUGUGUGCAAUUUUAUUUAACAGUGCUGUGUAUGUGGUGGACAAGUUAUAUGAAAUAUCUAGUCUUUCUAGAUAUUUGGAAGUGCUUGAUGUAUUUAAAAGUGGUAGUAGAAUAACACUUUGUAAAUAGCUUUUAAAAACUGAUGGGAAAUGCUGUUUGGAAGUGGAAUUGUUGAACCACCUGGGAGGUGGGAGGGAAGAAAUUGCAAAUGGUGUUUUGCCAUUGUUUAUUAGAAAAUUUCAGCUUAAUCCAUUGUGUAUAUGUUACAUGCAUUUCAUUUAACUUUGCUAUACUGUAUAUAUUGUAUAUAUAACGGACAAAUUAGUCCCGAUUUUAUAAUAUCUAGUCUCUAGAUAUUAAAGAGGUUGCCAAUGUAUGACAGAAGUAGAGUUAGUAAACUAACACAUUUUGUACACUUUGUUAAAAUUUGUAGAAAGGCUGUCUUCUGAAAAGGACUUUUGGAAGUGAGAUAACAUCAGCUCUAAGUGACACGUGCCUAUAUCCAUCAGGUUGGUGGUGGAGAGGAGUUGGAAGGAAUGAAGGGUUCUAGACCAGAAUGUUCGUAUUUAGAAGACACUAUCAGAUAUAACCAUUGUUACAUGUGUGUAGUUUAUUCAACCCUACUGUGUAUAUAGCGGACAAACUUAAGUCCUUAUUUGAAACAUCUAGUCUUUCUAGAUGUUUAGAAGUGCACAAAGUAUGUUAAAAGUAGAGGUAGUAAAUAACACAUUUUGUAGCUAUCCUUUUGAUAUGAAAUAUUGUCUUGGAAAUUGAUCAAUUCUCUGAGCAGUACCCAUUUUGAUAUUUGUGCUGGUUCAGGGGGAAGGAGGAGCACAAAGUGCAAAGGGCUUUCUACCAGUGUCCAGUGUGUUUAUGAGGAGGCACAUUGACCAUUGUCCCUUAUGUCUGCAUUUUCAUUUACUGUGCUGUGUAUAUAGUGUAUAUAAGCGGACAUAGGAGUCCUAAUUUACGUCUAGUCGAUGUUAAAAAGGUUGCCAGUAUAUGACAAAAGUAGAAUUAGUAAACUACUACAUUGAGUACACUUUGUGUUAAAAUUCAUAGGGAAGACUUCUUAAAAACAAGUGAAAUUGUUAAAACCCCCCCUAAGCAUUACAGAUGGCUUAUAGCUGUCCACGGGGUUGGUAGAGGUGGGAAAGGGAAGGGUUCUAGGCCAGAAUGUUCCUAUUUAGAAGACACUCAAAUUACAGUCUGUGUUAUGUAUGUAUACCAUUUAUUCAAUGCUACUGUGUAUAUAAUGGAAAACUUAAGUCCAGUUUGAAACAUCUAGUCUUUCUAGGUGUUUAAAAGUGUACAACGGCCUGUCGCAGUGGCGCAUGCCUGUAAUCCCAGCACUUUGGGAGGCCGAGGCAGGCGGAUCACGAGGUCAAGAGAUCAGGACCAUCUUGGCCAACAUGGUGAAACCCCAUCUUUACUAAAAAUACAAAAAUUAGCUGGUCGUGGUGGUGCCCACCUGUAGCCCCAGUUACUCGAGAGGCUGAGGCAGGAGAAUCGCUUGAACUUGGGAGGCGGAAGUUGCAGUGAGCCAAGAUCGCACCACUGCACUCCAGCCUGGCGACAGAGCGAGGCUCCGUUUCAAAAAAAAAAGUGCACAAUGUAGGUUAACAGUAGAGGGCUUAAGUAACACCCCUCUAAGCAUUUGUUUUCAGUACUUCCUAGGAGUGGUUGCAUUUGGGAAUGGAAUUGUUAAAACUUGAUGCUUAGGAGCGAAUGCAGACUAUUCAUUGGGUGUUUGGGGUGGGGGAAGGGGGGGUGGGCAGAGGAGGUAUGCAGGGAGAGGGGUUCUGUGCUCCUGAGAUUAGUUCAGAUGGUCUAACCAUUGUUCUAUAUGUGCAUUUUAGUUAAUAUUGUGUAUUAAAGGAUAAGUCUUAAUGCUCAAAGUAUGUUAAAAAUAGAUGUAGUAAAUCAGUCCCUUUGUGAAUGUCCUUUUGUUAGUUUUUAGGAAGGCCUGUCCUCUGGGAGUGACCUUUAUUAGUCCACCCCUUGGAGCUAGACAUCCUGUACUUAGUCACGGGGAUGGUGGAAGAGGGAGAAGAGGAAGGGUGAAGGGAAGGGCUCUUUGCUAGUAUCUCCAUAUCUAGACGAUGGUUUUAGAUGAUAACCACAGGUCUACAAGAGCGUUUUUAGUAAAGUGCCUGUGUUCAUUGUGGACAAAGUUAUUAUUUUGCAACAUCUAAGCUUUACGAAUGGGGUGACAACUUAUGAUAAAAACUAGAGCUAGUGAAUUAGCCUAUUUGUAAAUACCUUUGUUAUAAUUGAUAGGAUACAUCUUGGACAUGGAAUUGUUAAGCCACCUCUGAGCAGUGUAUGUCAGGACUUGUUCAUUAGGUUGGCAGCAGAGGGGCAGAAGGAAUUAUACAGGUAGAGAUGUAUGCAGAUGUGUCCAUAUAUGUCCAUAUUUACAUUUUGAUAGCCAUUGAUGUAUGCAUCUCUUGGCUGUACUAUAAGAACACAUUAAUUCAAUGGAAAUACACUUUGCUAAUAUUUUAAUGGUAUAGAUCUGCUAAUGAAUUCUCUUAAAAACAUACUGUAUUCUGUUGCUGUGUGUUUCAUUUUAAAUUGAGCAUUAAGGGAAUGCAGCAUUUAAAUCAGAACUCUGCCAAUGCUUUUAUCUAGAGGCGUGUUGCCAUUUUUGUCUUAUAUGAAAUUUCUGUCCCAAGAAAGGCAGGAUUACAUCUUUUUUUUUUUUUUUAGCAGUUUGAGUUGGUGUAGUGUAUUCUUGGUUAUCAGAAUACUCAUAUAGCUUUGGGAUUUUGAAUUGGUAAAUAUUCAUGAUGUGUGAAAAAUCAUGAUACAUACUGUACAGUCUCAGUCCCAUAAAAUUGGAUGUUGUGCCUACACACAGGAUCUAGAAGAAUAUGUCAAACUAUAAACUGCUUGUGAUUGUGAAUGACUUUGUUCUUUGCUUGUGUUUUUCAAUUUCCUAUAAUGCACAUACUAACUUUUAAAAAAUAAAGGUUAUUUUAAAAGCCUGUAUUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,lncRNA,Homo sapiens,"sp|Q14671|PUM1_HUMAN Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1 PE=1 SV=3
MSVACVLKRKAVLWQDSFSPHLKHHPQEPANPNMPVVLTSGTGSQAQPQPAANQALAAGT
HSSPVPGSIGVAGRSQDDAMVDYFFQRQHGEQLGGGGSGGGGYNNSKHRWPTGDNIHAEH
QVRSMDELNHDFQALALEGRAMGEQLLPGKKFWETDESSKDGPKGIFLGDQWRDSAWGTS
DHSVSQPIMVQRRPGQSFHVNSEVNSVLSPRSESGGLGVSMVEYVLSSSPGDSCLRKGGF
GPRDADSDENDKGEKKNKGTFDGDKLGDLKEEGDVMDKTNGLPVQNGIDADVKDFSRTPG
NCQNSANEVDLLGPNQNGSEGLAQLTSTNGAKPVEDFSNMESQSVPLDPMEHVGMEPLQF
DYSGTQVPVDSAAATVGLFDYNSQQQLFQRPNALAVQQLTAAQQQQYALAAAHQPHIGLA
PAAFVPNPYIISAAPPGTDPYTAGLAAAATLGPAVVPHQYYGVTPWGVYPASLFQQQAAA
AAAATNSANQQTTPQAQQGQQQVLRGGASQRPLTPNQNQQGQQTDPLVAAAAVNSALAFG
QGLAAGMPGYPVLAPAAYYDQTGALVVNAGARNGLGAPVRLVAPAPVIISSSAAQAAVAA
AAASANGAAGGLAGTTNGPFRPLGTQQPQPQPQQQPNNNLASSSFYGNNSLNSNSQSSSL
FSQGSAQPANTSLGFGSSSSLGATLGSALGGFGTAVANSNTGSGSRRDSLTGSSDLYKRT
SSSLTPIGHSFYNGLSFSSSPGPVGMPLPSQGPGHSQTPPPSLSSHGSSSSLNLGGLTNG
SGRYISAAPGAEAKYRSASSASSLFSPSSTLFSSSRLRYGMSDVMPSGRSRLLEDFRNNR
YPNLQLREIAGHIMEFSQDQHGSRFIQLKLERATPAERQLVFNEILQAAYQLMVDVFGNY
VIQKFFEFGSLEQKLALAERIRGHVLSLALQMYGCRVIQKALEFIPSDQQNEMVRELDGH
VLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFALSTHPYGCRVIQRILEHCLPD
QTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVAEIRGNVLVLSQHKFASN
VVEKCVTHASRTERAVLIDEVCTMNDGPHSALYTMMKDQYANYVVQKMIDVAEPGQRKIV
MHKIRPHIATLRKYTYGKHILAKLEKYYMKNGVDLGPICGPPNGII",PUM1,-,-,1186aa(1-1186),Q14671,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1307,http://db.phasep.pro/browse/","[22-73],[233-272],[485-524],[613-648],[742-773]","[45-58],[94-102],[393-414],[442-457],[475-502],[527-538],[583-614],[625-639],[647-665],[671-695],[762-782],[797-815]",In vitro,150 nM [PUM1];|0.5-50nM[NORAD],"150 mM NaCl, 1 mM MgCl2","20 mM Tris HCl pH 7.5, 1 mM DTT, 10% glycerol",RT,30 min,crowding agent:5% PEG3350;other_molecular: 1 U TEV protease,Confocal microscopy,liquid,"The addition of NORAD at or below its endogenous concentration, however, robustly induced formation of PUM1 droplets",5378
207,691,PMID: 34108682,RNAPS0000620,https://pubmed.ncbi.nlm.nih.gov/34108682,RNA + protein,NCBI ID:72,https://www.ncbi.nlm.nih.gov/gene/72,ACTG2,1372nt(1-1372),ACACCAGCCCUCAGUCACUGGGAGAAGAACCUCUCAUACCCUCGGUGCUCCAGUCCCCAGCUCACUCAGCCACACACACCAUGUGUGAAGAGGAGACCACCGCGCUCGUGUGUGACAAUGGCUCUGGCCUGUGCAAGGCAGGCUUCGCAGGAGAUGAUGCCCCCCGGGCUGUCUUCCCCUCCAUUGUGGGCCGCCCUCGCCACCAGAUCUGGCACCACUCCUUCUACAAUGAGCUGCGUGUAGCACCUGAAGAGCACCCCACCCUGCUCACAGAGGCUCCCCUAAAUCCCAAGGCCAACAGGGAAAAGAUGACCCAGAUCAUGUUUGAAACCUUCAAUGUCCCUGCCAUGUACGUCGCCAUUCAAGCUGUGCUCUCCCUCUAUGCCUCUGGCCGCACGACAGGCAUCGUCCUGGAUUCAGGUGAUGGCGUCACCCACAAUGUCCCCAUCUAUGAAGGCUAUGCCCUGCCCCAUGCCAUCAUGCGCCUGGACUUGGCUGGCCGUGACCUCACGGACUACCUCAUGAAGAUCCUCACAGAGAGAGGCUAUUCCUUUGUGACCACAGCUGAGAGAGAAAUUGUGCGAGACAUCAAGGAGAAGCUGUGCUAUGUGGCCCUGGAUUUUGAGAAUGAGAUGGCCACAGCAGCUUCCUCUUCCUCCCUGGAGAAGAGCUAUGAGCUGCCAGAUGGGCAGGUUAUCACCAUUGGCAAUGAGCGCUUCCGCUGCCCUGAGACCCUCUUCCAGCCUUCCUUUAUUGGCAUGGAGUCCGCUGGAAUUCAUGAGACAACCUACAAUUCCAUCAUGAAGUGUGACAUUGACAUCCGUAAGGACUUAUAUGCCAACAAUGUCCUCUCUGGGGGCACCACCAUGUACCCUGGCAUUGCUGACAGGAUGCAGAAGGAGAUCACAGCCCUGGCCCCCAGCACCAUGAAGAUCAAGAUUAUUGCUCCCCCAGAGCGGAAGUACUCAGUCUGGAUCGGGGGCUCUAUCCUGGCCUCUCUCUCCACCUUCCAGCAGAUGUGGAUCAGCAAGCCUGAGUAUGAUGAGGCAGGGCCCUCCAUUGUCCACAGGAAGUGCUUCUAAAGUCAGAACAGGUUCUCCAAGGAUCCCCUCGAGACUACUCUGUUACCAGUCAUGAAACAUUAAAACCUACAAGCCUUACUUCUCUGUGUGGGGCUCUUUUUUCCUGGGCUAUGUCUCAUACACAGUGCUAAGGACUUUUCACACAUUACUUUUAAUCCAUGCAAUAGUGCUGUAAGGUAGGUGCUAUCAUUAUACCCAUAUUACAGAUGAGGAAAUUGAGGCUCAGAGAAGUCAAGGACUUGCGAAGAUCACACAGAUUCCAGAUUAAAAUUCAAGUAUCUGACUGCAAA,mRNA,Homo sapiens,"sp|Q14671|PUM1_HUMAN Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1 PE=1 SV=3
MSVACVLKRKAVLWQDSFSPHLKHHPQEPANPNMPVVLTSGTGSQAQPQPAANQALAAGT
HSSPVPGSIGVAGRSQDDAMVDYFFQRQHGEQLGGGGSGGGGYNNSKHRWPTGDNIHAEH
QVRSMDELNHDFQALALEGRAMGEQLLPGKKFWETDESSKDGPKGIFLGDQWRDSAWGTS
DHSVSQPIMVQRRPGQSFHVNSEVNSVLSPRSESGGLGVSMVEYVLSSSPGDSCLRKGGF
GPRDADSDENDKGEKKNKGTFDGDKLGDLKEEGDVMDKTNGLPVQNGIDADVKDFSRTPG
NCQNSANEVDLLGPNQNGSEGLAQLTSTNGAKPVEDFSNMESQSVPLDPMEHVGMEPLQF
DYSGTQVPVDSAAATVGLFDYNSQQQLFQRPNALAVQQLTAAQQQQYALAAAHQPHIGLA
PAAFVPNPYIISAAPPGTDPYTAGLAAAATLGPAVVPHQYYGVTPWGVYPASLFQQQAAA
AAAATNSANQQTTPQAQQGQQQVLRGGASQRPLTPNQNQQGQQTDPLVAAAAVNSALAFG
QGLAAGMPGYPVLAPAAYYDQTGALVVNAGARNGLGAPVRLVAPAPVIISSSAAQAAVAA
AAASANGAAGGLAGTTNGPFRPLGTQQPQPQPQQQPNNNLASSSFYGNNSLNSNSQSSSL
FSQGSAQPANTSLGFGSSSSLGATLGSALGGFGTAVANSNTGSGSRRDSLTGSSDLYKRT
SSSLTPIGHSFYNGLSFSSSPGPVGMPLPSQGPGHSQTPPPSLSSHGSSSSLNLGGLTNG
SGRYISAAPGAEAKYRSASSASSLFSPSSTLFSSSRLRYGMSDVMPSGRSRLLEDFRNNR
YPNLQLREIAGHIMEFSQDQHGSRFIQLKLERATPAERQLVFNEILQAAYQLMVDVFGNY
VIQKFFEFGSLEQKLALAERIRGHVLSLALQMYGCRVIQKALEFIPSDQQNEMVRELDGH
VLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFALSTHPYGCRVIQRILEHCLPD
QTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVAEIRGNVLVLSQHKFASN
VVEKCVTHASRTERAVLIDEVCTMNDGPHSALYTMMKDQYANYVVQKMIDVAEPGQRKIV
MHKIRPHIATLRKYTYGKHILAKLEKYYMKNGVDLGPICGPPNGII",PUM1,-,-,1186aa(1-1186),Q14671,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1307,http://db.phasep.pro/browse/","[22-73],[233-272],[485-524],[613-648],[742-773]","[45-58],[94-102],[393-414],[442-457],[475-502],[527-538],[583-614],[625-639],[647-665],[671-695],[762-782],[797-815]",In vitro,150 nM [PUM1];|0.1-20nM[ACTG2 3'UTR],"150 mM NaCl, 1 mM MgCl2","20 mM Tris HCl pH 7.5, 1 mM DTT, 10% glycerol",RT,30 min,crowding agent:5% PEG3350;other_molecular: 1 U TEV protease,Confocal microscopy,solute,"Unlike NORAD, none of these transcripts promoted PUM1 phase separation at or below their physiological concentrations in vitro, although the PUM1 and PUM2 3′ UTRs were able to induce the formation of small droplets at concentrations 4–10 times their physiological levels",1372
208,692,PMID: 34108682,RNAPS0000621,https://pubmed.ncbi.nlm.nih.gov/34108682,RNA + protein,NCBI ID:54407,https://www.ncbi.nlm.nih.gov/gene/54407,SLC38A2,4679nt,ACAGCCGCGCGACGCCGCCGCCUUAGAACGCCUUUCCAGUACUGCUAGCAGCAGCCCGACCACGCGUUACCGCACGCUCGCGCCUUUCCCUUGACACGGCGGACGCCGGAGGAUUGGGGCGGCAAUUUGUCUUUUCCUUUUUUAUUAAAAUUAUUUUUCCUGCCUGUUGUUGGAUUUGGGGAAAUUUUUUGUUUGUUUUUUAUGAUUUGUAUUUGACUGAGAGAAACCCACUGAAGACGUCUGCGUGAGAAUAGAGACCACCGAGGCCGACUCGCGGGCCGCUGCACCCACCGCCAAGGACAAAAGGAGCCCAGCGCUACUAGCUGCACCCGAUUCCUCCCAGUGCUUAGCAUGAAGAAGGCCGAAAUGGGACGAUUCAGUAUUUCCCCGGAUGAAGACAGCAGCAGCUACAGUUCCAACAGCGACUUCAACUACUCCUACCCCACCAAGCAAGCUGCUCUGAAAAGCCAUUAUGCAGAUGUAGAUCCUGAAAACCAGAACUUUUUACUUGAAUCGAAUUUGGGGAAGAAGAAGUAUGAAACAGAAUUUAAUUCUCUUGACAUUUGUGUCAAUAUUUUCCCUGUAUUCUGUUCAUCUCCUUUUGAAGACUGCCAAUGAAGGAGGGUCUUUAUUAUAUGAACAAUUGGGAUAUAAGGCAUUUGGAUUAGUUGGAAAGCUUGCAGCAUCUGGAUCAAUUACAAUGCAGAACAUUGGAGCUAUGUCAAGCUACCUCUUCAUAGUGAAAUAUGAGUUGCCUUUGGUGAUCCAGGCAUUAACGAACAUUGAAGAUAAAACUGGAUUGUGGUAUCUGAACGGGAACUAUUUGGUUCUGUUGGUGUCAUUGGUGGUCAUUCUUCCUUUGUCGCUGUUUAGAAAUUUAGGAUAUUUGGGAUAUACCAGUGGCCUUUCCUUGUUGUGUAUGGUGUUCUUUCUGAUUGUGGUCAUUUGCAAGAAAUUUCAGGUUCCGUGUCCUGUGGAAGCUGCUUUGAUAAUUAACGAAACAAUAAACACCACCUUAACACAGCCAACAGCUCUUGUACCUGCUUUGUCACAUAACGUGACUGAAAAUGACUCUUGCAGACCUCACUAUUUUAUUUUCAACUCACAGACUGUCUAUGCUGUGCCAAUUCUGAUCUUUUCAUUUGUCUGUCAUCCUGCUGUUCUUCCCAUCUAUGAAGAACUGAAAGACCGCAGCCGUAGAAGAAUGAUGAAUGUGUCCAAGAUUUCAUUUUUUGCUAUGUUUCUCAUGUAUCUGCUUGCCGCCCUCUUUGGAUACCUAACAUUUUACGAACAUGUUGAGUCAGAAUUGCUUCAUACCUACUCUUCUAUCUUGGGAACUGAUAUUCUUCUUCUCAUUGUCCGUCUGGCUGUGUUAAUGGCUGUGACCCUGACAGUACCAGUAGUUAUUUUCCCAAUCCGGAGUUCUGUAACUCACUUGUUGUGUGCAUCAAAAGAUUUCAGUUGGUGGCGUCAUAGUCUCAUUACAGUGUCUAUCUUGGCAUUUACCAAUUUACUUGUCAUCUUUGUCCCAACUAUUAGGGAUAUCUUUGGUUUUAUUGGUGCAUCUGCAGCUUCUAUGUUGAUUUUUAUUCUUCCUUCUGCCUUCUAUAUCAAGUUGGUGAAGAAAGAACCUAUGAAAUCUGUACAAAAGAUUGGGGCUUUGUUCUUCCUGUUAAGUGGUGUACUGGUGAUGACCGGAAGCAUGGCCUUGAUUGUUUUGGAUUGGGUACACAAUGCACCUGGAGGUGGCCAUUAAUUGGCACCACUCAAACUCAAACUCAGUCCAUCUGAUGCCAGUGUUGAGUAAACUCAACUACUAUGAAAUUUCACCUAAUGUUUUCAGUUUCACUUCCUUUUGAAGUGCAGAUUCCUCGCUGGUUCUUCUGAGUGCAGAAUAAGUGAACUUUUUUGUUUUGUUUUGUUUUUUUAAGAAACUUAUCUGUAUGUUAGAAAUGGAUAUGAACAACAAAACCACGAGUCUCGGGUUAAGGGAAGUGACAAUUUUAUUCCAUUCCAGAGAAUGGACAAACUCUUAACUUUUAUCAAGCCACAUGCUUGGCUGUGUCAUUGUUUAACUUGGAUAUUUUAUGAUUUUACUUGAAUGUGCCUAAUGGAACCAUUUGAUGUGAGAAACAAUUCUUUUUAAUUUACAGCAAAAUAUUGAAUAACCAUUGACAAAAACACUAUUAUUUUUUGUACCAAAAAUACUUAAAGACCUCAGAAGCACUCUUUUACUUUUAAGAAAUUGCUUUUUUGAACUUUAUUCAGAAGCAGUUAUCAAUAAAUUCCAUAAAAUAAUGUCAUUGGUAUUUAAAAAUGAAUAUUAAUAUAAUGAAAUGGUUUGCCUUUUUGUAGGCAUAAUAAGCCAAAUACUUUUUUACCCAAAAUAAUUUUUAGAGAAAAUGAUGUAAUGAAAAAUUGUACCAUGAAUUAGGAGCAUAGUUUUUUCCAUUUAAACGUCACCAUUACUUAAAAGAUGAUUGAUUAUUGCUAUACCAAAUCAGAUGAACUCUGUUCAUCACUUUUCUUCUCUGUCCCCAAACAAUUUGGUUCAUUCAGACUGAAAUGUUUGUGUCUUCAACUUAUUAGAAUGGAAGAUAAUGCAGAUAUUUCUGUGGGAAAUAAAAUAACUAAUUUUGAGGUACCAAAUAGUGCAAUUGGGUAAAACAGGGUUUAUUCAGUUGCAUCUGUCUCCAGUGUUGUAUUGACAGCUCUGGGUCUUUUUUUGGGCCAGCCCUUUUUUGACAUUGCUUCCAGCAGUGGAAAAUGGGCAUUUGAUGGCAAUAGGCCAAAAUUAUUGUGUCCAGAGAGUACACUUUUUCAAAAUGCUCACCUACUGGAAGUGUGAAUUACUUGACAAUGUAUGGCUUAGUUGUGUUCAUGUUUUGUCUACAGUAGAGGUCUAAUCCACAGGUUACACCUAUGUUUGAUAUGAUAUAAGUUCUCUUUGCGUAGGCCACUGGGUUUCUCAUGCAGUAAGCUUUAUAAAAACUCAUUUGCACUGGACUGUCAUCUCAUUCUUGUACAACGUAGAAUUACUUGUUUACAUCCAACAAAUGGUUAGCUAGGGAAAACAGUGCAAACUGAGUGUUAGUAGUCAUUUUGGUCCAACUGCAUGUCAACCCUUCCAUUUCAAUCCCAGUUAGAAAUGAAAAUAAUUACUUUGAAACUUGGCUUUAAGAGCACAUUUAUCGUACGUCACAGUGUAUGGUGAAUAUAUUAUUAAAUAAUGUGGUACUUCGCUCAUCAGGCAUAAUGUCUAAAAUCUAAUAUACAUAAUUCCAUUAAGUGGUUGAAGGAAGCAAAUAAUGGAAUUGUCAAUUGGUCAUCUGGCUGUAAGGUUUGCCCUUGAACUAAAAAUGUUGUUUGGGGCAAGGGCCAGAAAUGUGGAGACAUGGUUUUUGUUACGCAUUCUUGUAUUAUAUGUGACUAAAUUUACAAACAAGAUACAUGUGUAAUUAAAGACCCUUAUGGAACUGGAAGACGUCUUGUAGUGCUACAUUGGGUGAAACCGUUGGUCCAUUUUUGUCUGUUUCUAUGAAGAUAAAAUAAUUGGGGGCCAUCUAGAAAUAGAAAGGCAGUGGGAAGACAGAUUCUACGGCACUGCUUUCAUUUAAUUGGGCUUUAGGCACUCCAUUCGAAUGCAGAACCUCACCUCUAGUUGAGACCAAGAAUUGGCAAAUUUGCAUGAGCUCCUGGAAAGAGUUGCUGACUUUGUAUCUAAGACCUGCCAGGGAAUACCAAGAGUUGUUUCUACAGACUUUUUUUUUUUUUUUUGUAUGGGAGAAGAUACUGUGGCAACCAGGAAGGAAUGGAAAAAAAAUUCUUUUCUCUACAGCAAAUUAAUGUGAGGAAGCUCCUCCAAUCCUCUGGCUAUUUAAGGUUCAAAAUCAAGUGCCUAGGGAAAAUUCCAAUGGAUGAUUUUCUGGGAGCUAUCUUGUCUACCUUGAGGUUCCUGAACAAUGAAUUCCCAUUAAUGAGCAGUCUUCAGUAUUAAAACCACUGUCUUGUCACCUCAUUUUGCAUUACUGUCUUCCGUGGAUGUUUCAGUUACAACUGUAAUGUUAUUUAUAGAACAACAUUAAUCCAUUAAAGCUAACCUAUUUUUCAAUAUUUAUGAUAAUCUAUGUACAUAUAUUGUCUGUCCAUAUGUAUUUGUAAAUAGGUUGUAUAUAAUGUCAGGUUUGGGUCUUGGGUUCAAGUGUAUAUAUUCCUGUAAGUUUCUUAACUGCAUUUUGAUGAAUUCACAUUAUGUAACUAUAAGAAUUGUCCCAAAAGUACCUGUACAGAAAAUUGAAUAUUGAAAAAUUGACAAAUUGUGUACAAACACUAAAAAAAACUUGUUUAAAUUGUAUUUGCAAUAAACAACAUCAAAUUUUUUCAUGAAAUCUUGGUACAAAUUCAGAUCUCUUAUUUAAAAUUUAAAUAAGGAAUACAUUUUCAAAAUGCAGUAAUCAAAAUGUGAUCUAGUGUAAUGAAAUAAAAUGUGAUCUAGUGUAAUGGAAGACCUUUGAGAACCUGGGUGUAUUAACUUUGUGUAUAUAGUGUAAAUAUCCCCACUGUACUGUUAGAGGCCAACAAUUCUAGUAUGGCUUGUUGGCAAAGAGUGCUACACCGUUUCAAUGAAACAAUGUAUGUUUGUUUUAACUGAACUAAAAUAAAUACAUGCUUAAUCCUGA,mRNA,Homo sapiens,"sp|Q14671|PUM1_HUMAN Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1 PE=1 SV=3
MSVACVLKRKAVLWQDSFSPHLKHHPQEPANPNMPVVLTSGTGSQAQPQPAANQALAAGT
HSSPVPGSIGVAGRSQDDAMVDYFFQRQHGEQLGGGGSGGGGYNNSKHRWPTGDNIHAEH
QVRSMDELNHDFQALALEGRAMGEQLLPGKKFWETDESSKDGPKGIFLGDQWRDSAWGTS
DHSVSQPIMVQRRPGQSFHVNSEVNSVLSPRSESGGLGVSMVEYVLSSSPGDSCLRKGGF
GPRDADSDENDKGEKKNKGTFDGDKLGDLKEEGDVMDKTNGLPVQNGIDADVKDFSRTPG
NCQNSANEVDLLGPNQNGSEGLAQLTSTNGAKPVEDFSNMESQSVPLDPMEHVGMEPLQF
DYSGTQVPVDSAAATVGLFDYNSQQQLFQRPNALAVQQLTAAQQQQYALAAAHQPHIGLA
PAAFVPNPYIISAAPPGTDPYTAGLAAAATLGPAVVPHQYYGVTPWGVYPASLFQQQAAA
AAAATNSANQQTTPQAQQGQQQVLRGGASQRPLTPNQNQQGQQTDPLVAAAAVNSALAFG
QGLAAGMPGYPVLAPAAYYDQTGALVVNAGARNGLGAPVRLVAPAPVIISSSAAQAAVAA
AAASANGAAGGLAGTTNGPFRPLGTQQPQPQPQQQPNNNLASSSFYGNNSLNSNSQSSSL
FSQGSAQPANTSLGFGSSSSLGATLGSALGGFGTAVANSNTGSGSRRDSLTGSSDLYKRT
SSSLTPIGHSFYNGLSFSSSPGPVGMPLPSQGPGHSQTPPPSLSSHGSSSSLNLGGLTNG
SGRYISAAPGAEAKYRSASSASSLFSPSSTLFSSSRLRYGMSDVMPSGRSRLLEDFRNNR
YPNLQLREIAGHIMEFSQDQHGSRFIQLKLERATPAERQLVFNEILQAAYQLMVDVFGNY
VIQKFFEFGSLEQKLALAERIRGHVLSLALQMYGCRVIQKALEFIPSDQQNEMVRELDGH
VLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFALSTHPYGCRVIQRILEHCLPD
QTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVAEIRGNVLVLSQHKFASN
VVEKCVTHASRTERAVLIDEVCTMNDGPHSALYTMMKDQYANYVVQKMIDVAEPGQRKIV
MHKIRPHIATLRKYTYGKHILAKLEKYYMKNGVDLGPICGPPNGII",PUM1,-,-,1186aa(1-1186),Q14671,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1307,http://db.phasep.pro/browse/","[22-73],[233-272],[485-524],[613-648],[742-773]","[45-58],[94-102],[393-414],[442-457],[475-502],[527-538],[583-614],[625-639],[647-665],[671-695],[762-782],[797-815]",In vitro,150 nM [PUM1];|0.1-20nM[SLC38A2 3'UTR],"150 mM NaCl, 1 mM MgCl2","20 mM Tris HCl pH 7.5, 1 mM DTT, 10% glycerol",RT,30 min,crowding agent:5% PEG3350;other_molecular: 1 U TEV protease,Confocal microscopy,solute,"Unlike NORAD, none of these transcripts promoted PUM1 phase separation at or below their physiological concentrations in vitro, although the PUM1 and PUM2 3′ UTRs were able to induce the formation of small droplets at concentrations 4–10 times their physiological levels",4679
209,693,PMID: 34108682,RNAPS0000622,https://pubmed.ncbi.nlm.nih.gov/34108682,RNA + protein,NCBI ID:9698,https://www.ncbi.nlm.nih.gov/gene/9698,PUM1,5385nt(1-5385),AGUGGGCCGCCAUGUUGUCGGAGUGAAAGGUAAGGGGGAGCGAGAGCGCCAGAGAGAGAAGAUCGGGGGGCUGAAAUCCAUCUUCAUCCUACCGCUCCGCCCGUGUUGGUGGAAUGAGCGUUGCAUGUGUCUUGAAGAGAAAAGCAGUGCUUUGGCAGGACUCUUUCAGCCCCCACCUGAAACAUCACCCUCAAGAACCAGCUAAUCCCAACAUGCCUGUUGUUUUGACAUCUGGAACAGGGUCGCAAGCGCAGCCACAACCAGCUGCAAAUCAGGCUCUUGCAGCUGGGACUCACUCCAGCCCUGUCCCAGGAUCUAUAGGAGUUGCAGGCCGUUCCCAGGACGACGCUAUGGUGGACUACUUCUUUCAGAGGCAGCAUGGUGAGCAGCUUGGGGGAGGAGGAAGUGGAGGAGGCGGCUAUAAUAAUAGCAAACAUCGAUGGCCUACUGGGGAUAACAUUCAUGCAGAACAUCAGGUGCGUUCCAUGGAUGAACUGAAUCAUGAUUUUCAAGCACUUGCUCUGGAGGGAAGAGCGAUGGGAGAGCAGCUCUUGCCAGGUAAAAAGUUUUGGGAAACAGAUGAAUCCAGCAAAGAUGGACCAAAAGGAAUAUUCCUGGGUGAUCAAUGGCGAGACAGUGCCUGGGGAACAUCAGAUCAUUCAGUUUCCCAGCCAAUCAUGGUGCAGAGAAGACCUGGUCAGAGUUUCCAUGUGAACAGUGAGGUCAAUUCUGUACUGUCCCCACGAUCGGAGAGUGGGGGACUAGGCGUUAGCAUGGUGGAGUAUGUGUUGAGCUCAUCCCCGGGCGAUUCCUGUCUAAGAAAAGGAGGAUUUGGCCCAAGGGAUGCAGACAGUGAUGAAAACGACAAAGGUGAAAAGAAGAACAAGGGUACGUUUGAUGGAGAUAAGCUAGGAGAUUUGAAGGAGGAGGGUGAUGUGAUGGACAAGACCAAUGGUUUACCAGUGCAGAAUGGGAUUGAUGCAGACGUCAAAGAUUUUAGCCGUACCCCUGGUAAUUGCCAGAACUCUGCUAAUGAAGUGGAUCUUCUGGGUCCAAACCAGAAUGGUUCUGAGGGCUUAGCCCAGCUGACCAGCACCAAUGGUGCCAAGCCUGUGGAGGAUUUCUCCAACAUGGAGUCCCAGAGUGUCCCCUUGGACCCCAUGGAACAUGUGGGCAUGGAGCCUCUUCAGUUUGAUUAUUCAGGCACGCAGGUACCUGUGGACUCAGCAGCAGCAACUGUGGGACUUUUUGACUACAAUUCUCAACAACAGCUGUUCCAAAGACCUAAUGCGCUUGCUGUCCAGCAGUUGACAGCUGCUCAGCAGCAGCAGUAUGCACUGGCAGCUGCUCAUCAGCCGCACAUCGGUUUAGCUCCCGCUGCGUUUGUCCCCAAUCCAUACAUCAUCAGCGCUGCUCCCCCAGGGACGGACCCCUACACAGCUGGAUUGGCUGCAGCAGCGACACUAGGCCCAGCUGUGGUCCCUCACCAGUAUUAUGGAGUUACUCCCUGGGGAGUCUACCCUGCCAGUCUUUUCCAGCAGCAAGCUGCCGCUGCCGCUGCAGCAACUAAUUCAGCUAAUCAACAGACCACCCCACAGGCUCAGCAAGGACAGCAGCAGGUUCUCCGUGGAGGAGCCAGCCAACGUCCUUUGACCCCAAACCAGAACCAGCAGGGACAGCAAACGGAUCCCCUUGUGGCAGCUGCAGCAGUGAAUUCUGCCCUUGCAUUUGGACAAGGUCUGGCAGCAGGCAUGCCAGGUUAUCCGGUGUUGGCUCCUGCUGCUUACUAUGACCAAACUGGUGCCCUUGUAGUGAAUGCAGGCGCGAGAAAUGGUCUUGGAGCUCCUGUUCGACUUGUAGCUCCUGCCCCAGUCAUCAUUAGUUCCUCAGCUGCACAAGCAGCUGUUGCAGCAGCCGCAGCUUCAGCAAAUGGAGCAGCUGGUGGUCUUGCUGGAACAACAAAUGGACCAUUUCGCCCUUUAGGAACACAGCAGCCUCAGCCCCAGCCCCAGCAGCAGCCCAAUAACAACCUGGCAUCCAGUUCUUUCUACGGCAACAACUCUCUGAACAGCAAUUCACAGAGCAGCUCCCUCUUCUCCCAGGGCUCUGCCCAGCCUGCCAACACAUCCUUGGGAUUCGGAAGUAGCAGUUCUCUCGGCGCCACCCUGGGAUCCGCCCUUGGAGGGUUUGGAACAGCAGUUGCAAACUCCAACACUGGCAGUGGCUCCCGCCGUGACUCCCUGACUGGCAGCAGUGACCUUUAUAAGAGGACAUCGAGCAGCUUGACCCCCAUUGGACACAGUUUUUAUAACGGCCUUAGCUUUUCCUCCUCUCCUGGACCCGUGGGCAUGCCUCUCCCUAGUCAGGGACCAGGACAUUCACAGACACCACCUCCUUCCCUCUCUUCACAUGGAUCCUCUUCAAGCUUAAACCUGGGAGGACUCACGAAUGGCAGUGGAAGAUACAUCUCUGCUGCUCCAGGCGCUGAAGCCAAGUACCGCAGUGCAAGCAGCGCCUCCAGCCUCUUCAGCCCGAGCAGCACUCUUUUCUCUUCCUCUCGUUUGCGAUAUGGAAUGUCUGAUGUCAUGCCUUCUGGCAGGAGCAGGCUUUUGGAAGAUUUUCGAAACAACCGGUACCCCAAUUUACAACUGCGGGAGAUUGCUGGACAUAUAAUGGAAUUUUCCCAAGACCAGCAUGGGUCCAGAUUCAUUCAGCUGAAACUGGAGCGUGCCACACCAGCUGAGCGCCAGCUUGUCUUCAAUGAAAUCCUCCAGGCUGCCUACCAACUCAUGGUGGAUGUGUUUGGUAAUUACGUCAUUCAGAAGUUCUUUGAAUUUGGCAGUCUUGAACAGAAGCUGGCUUUGGCAGAACGGAUUCGAGGCCACGUCCUGUCAUUGGCACUACAGAUGUAUGGCUGCCGUGUUAUCCAGAAAGCUCUUGAGUUUAUUCCUUCAGACCAGCAGGUAAUUAAUGAGAUGGUUCGGGAACUAGAUGGCCAUGUCUUGAAGUGUGUGAAAGAUCAGAAUGGCAAUCACGUGGUUCAGAAAUGCAUUGAAUGUGUACAGCCCCAGUCUUUGCAAUUUAUCAUCGAUGCGUUUAAGGGACAGGUAUUUGCCUUAUCCACACAUCCUUAUGGCUGCCGAGUGAUUCAGAGAAUCCUGGAGCACUGUCUCCCUGACCAGACACUCCCUAUUUUAGAGGAGCUUCACCAGCACACAGAGCAGCUUGUACAGGAUCAAUAUGGAAAUUAUGUAAUCCAACAUGUACUGGAGCACGGUCGUCCUGAGGAUAAAAGCAAAAUUGUAGCAGAAAUCCGAGGCAAUGUACUUGUAUUGAGUCAGCACAAAUUUGCAAGCAAUGUUGUGGAGAAGUGUGUUACUCACGCCUCACGUACGGAGCGCGCUGUGCUCAUCGAUGAGGUGUGCACCAUGAACGACGGUCCCCACAGUGCCUUAUACACCAUGAUGAAGGACCAGUAUGCCAACUACGUGGUCCAGAAGAUGAUUGACGUGGCGGAGCCAGGCCAGCGGAAGAUCGUCAUGCAUAAGAUCCGGCCCCACAUCGCAACUCUUCGUAAGUACACCUAUGGCAAGCACAUUCUGGCCAAGCUGGAGAAGUACUACAUGAAGAACGGUGUUGACUUAGGGCCCAUCUGUGGCCCCCCUAAUGGUAUCAUCUGAGGCAGUGUCACCCGCUGUUCCCUCAUUCCCGCUGACCUCACUGGCCCACUGGCAAAUCCAACCAGCAACCAGAAAUGUUCUAGUGUAGAGUCUGAGACGGGCAAGUGGUUGCUCCAGGAUUACUCCCUCCUCCAAAAAAGGAAUCAAAUCCACGAGUGGAAAAGCCUUUGUAAAUUUAAUUUUAUUACACAUAACAUGUACUAUUUUUUUUAAUUGACUAAUUGCCCUGCUGUUUUACUGGUGUAUAGGAUACUUGUACAUAGGUAACCAAUGUACAUGGGAGGCCACAUAUUUUGUUCACUGUUGUAUCUAUAUUUCACAUGUGGAAACUUUCAGGGUGGUUGGUUUAACAAAAAAAAAAAGCUUUAAAAAAAAAAGAAAAAAAGGAAAAGGUUUUUAGCUCAUUUGCCUGGCCGGCAAGUUUUGCAAAUAGCUCUUCCCCACCUCCUCAUUUUAGUAAAAAACAAACAAAAACAAAAAAACCUGAGAAGUUUGAAUUGUAGUUAAAUGACCCCAAACUGGCAUUUAACACUGUUUAUAAAAAAUAUAUAUAUAUAUAUAUAUAUAUAUAAUGAAAAAGGUUUCAGAGUUGCUAAAGCUUCAGUUUGUGACAUUAAGUUUAUGAAAUUCUAAAAAAUGCCUUUUUUGGAGACUAUAUUAUGCUGAAGAAGGCUGUUCGUGAGGAGGAGAUGCGAGCACCCAGAACGUCUUUUGAGGCUGGGCGGGUGUGAUUGUUUACUGCCUACUGGAUUUUUUUCUAUUAACAUUGAAAGGUAAAAUCUGAUUAUUUAGCAUGAGAAAAAAAAAUCCAACUCUGCUUUUGGUCUUGCUUCUAUAAAUAUAUAGUGUAUACUUGGUGUAGACUUUGCAUAUAUACAAAUUUGUAGUAUUUUCUUGUUUUGAUGUCUAAUCUGUAUCUAUAAUGUACCCUAGUAGUCGAACAUACUUUUGAUUGUACAAUUGUACAUUUGUAUACCUGUAAUGUAAAUGUGGAGAAGUUUGAAUCAACAUAAACACGUUUUUUGGUAAGAAAAGAGAAUUAGCCAGCCCUGUGCAUUCAGUGUAUAUUCUCACCUUUUAUGGUCGUAGCAUAUAGUGUUGUAUAUUGUAAAUUGUAAUUUCAACCAGAAGUAAAUUUUUUUCUUUUGAAGGAAUAAAUGUUCUUUAUACAGCCUAGUUAAUGUUUAAAAAGAAAAAAAUAGCUUGGUUUUAUUUGUCAUCUAGUCUCAAGUAUAGCGAGAUUCUUUCUAAAUGUUAUUCAAGAUUGAGUUCUCACUAGUGUUUUUUUAAUCCUAAAAAAGUAAUGUUUUGAUUUUGUGACAGUCAAAAGGACGUGCAAAAGUCUAGCCUUGCCCGAGCUUUCCUUACAAUCAGAGCCCCUCUCACCUUGUAAAGUGUGAAUCGCCCUUCCCUUUUGUACAGAAGAUGAACUGUAUUUUGCAUUUUGUCUACUUGUAAGUGAAUGUAACAUACUGUCAAUUUUCCUUGUUUGAAUAUAGAAUUGUAACACUACACGGUGUACAUUUCCAGAGCCUUGUGUAUAUUUCCAAUGAACUUUUUUGCAAGCACACUUGUAACCAUAUGUGUAUAAUUAACAAACCUGUGUAUGCUUAUGCCUGGGCAACUAUUUUUUGUAACUCUUGUGUAGAUUGUCUCUAAACAAUGUGUGAUCUUUAUUUUGAAAAAUACAGAACUUUGGAAUCUG,mRNA,Homo sapiens,"sp|Q14671|PUM1_HUMAN Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1 PE=1 SV=3
MSVACVLKRKAVLWQDSFSPHLKHHPQEPANPNMPVVLTSGTGSQAQPQPAANQALAAGT
HSSPVPGSIGVAGRSQDDAMVDYFFQRQHGEQLGGGGSGGGGYNNSKHRWPTGDNIHAEH
QVRSMDELNHDFQALALEGRAMGEQLLPGKKFWETDESSKDGPKGIFLGDQWRDSAWGTS
DHSVSQPIMVQRRPGQSFHVNSEVNSVLSPRSESGGLGVSMVEYVLSSSPGDSCLRKGGF
GPRDADSDENDKGEKKNKGTFDGDKLGDLKEEGDVMDKTNGLPVQNGIDADVKDFSRTPG
NCQNSANEVDLLGPNQNGSEGLAQLTSTNGAKPVEDFSNMESQSVPLDPMEHVGMEPLQF
DYSGTQVPVDSAAATVGLFDYNSQQQLFQRPNALAVQQLTAAQQQQYALAAAHQPHIGLA
PAAFVPNPYIISAAPPGTDPYTAGLAAAATLGPAVVPHQYYGVTPWGVYPASLFQQQAAA
AAAATNSANQQTTPQAQQGQQQVLRGGASQRPLTPNQNQQGQQTDPLVAAAAVNSALAFG
QGLAAGMPGYPVLAPAAYYDQTGALVVNAGARNGLGAPVRLVAPAPVIISSSAAQAAVAA
AAASANGAAGGLAGTTNGPFRPLGTQQPQPQPQQQPNNNLASSSFYGNNSLNSNSQSSSL
FSQGSAQPANTSLGFGSSSSLGATLGSALGGFGTAVANSNTGSGSRRDSLTGSSDLYKRT
SSSLTPIGHSFYNGLSFSSSPGPVGMPLPSQGPGHSQTPPPSLSSHGSSSSLNLGGLTNG
SGRYISAAPGAEAKYRSASSASSLFSPSSTLFSSSRLRYGMSDVMPSGRSRLLEDFRNNR
YPNLQLREIAGHIMEFSQDQHGSRFIQLKLERATPAERQLVFNEILQAAYQLMVDVFGNY
VIQKFFEFGSLEQKLALAERIRGHVLSLALQMYGCRVIQKALEFIPSDQQNEMVRELDGH
VLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFALSTHPYGCRVIQRILEHCLPD
QTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVAEIRGNVLVLSQHKFASN
VVEKCVTHASRTERAVLIDEVCTMNDGPHSALYTMMKDQYANYVVQKMIDVAEPGQRKIV
MHKIRPHIATLRKYTYGKHILAKLEKYYMKNGVDLGPICGPPNGII",PUM1,-,-,1186aa(1-1186),Q14671,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1307,http://db.phasep.pro/browse/","[22-73],[233-272],[485-524],[613-648],[742-773]","[45-58],[94-102],[393-414],[442-457],[475-502],[527-538],[583-614],[625-639],[647-665],[671-695],[762-782],[797-815]",In vitro,150 nM [PUM1];|0.1-20nM[PUM1 3'UTR],"150 mM NaCl, 1 mM MgCl2","20 mM Tris HCl pH 7.5, 1 mM DTT, 10% glycerol",RT,30 min,crowding agent:5% PEG3350;other_molecular: 1 U TEV protease,Confocal microscopy,"solute, liquid","Unlike NORAD, none of these transcripts promoted PUM1 phase separation at or below their physiological concentrations in vitro, although the PUM1 and PUM2 3′ UTRs were able to induce the formation of small droplets at concentrations 4–10 times their physiological levels",5385
210,694,PMID: 34108682,RNAPS0000623,https://pubmed.ncbi.nlm.nih.gov/34108682,RNA + protein,NCBI ID:23369,https://www.ncbi.nlm.nih.gov/gene/23369,PUM2,6200nt(1-6200),AGGGGAGGGCAGGCGGCGGUGGCAGCCAUGUUGUUGUGAGUCUCUGUGUCUCACCCUCGGUACUUCGGUGGUUCGGAGGAGGAGGGGGAGGAGAAGGAGGAGGUGGGGUGGGGGGGGAGGGUGGUAGGUGGAGAAAGAAGACAUUGCCGCCACCGAAGGCGGAGGAGGGGGAGGACCGCCAAGAGCGACGCCGCCGUGUGCCCAACGGUCGGUGUCCCCGGCUGAGGCAGCGCGGCCGCAGCAGCCCUGUUUGAUCUGUGGAUGAAAUGAAUCAUGAUUUUCAAGCUCUUGCAUUAGAAUCUCGGGGAAUGGGAGAGACCAUUCAAUGUCCCAGCCUAUUAUGGUACAGAGAAGAUCUGGACAGGGUUUUCAUGGAAACAGUGAAGUAAAUGCAAUACUGUCUCCGCGAUCAGAAAGUGGAGGCCUUGGUGUGAGCAUGGUAGAAUAUGUAUUAAGUUCUUCUCCUGCUGAUAAAUUGGAUUCUCGAUUUAGGAAGGGAAAUUUUGGCACUAGAGAUGCUGAAACAGAUGGACCUGAGAAAGGAGAUCAAAAAGGCAAGGCUUCUCCAUUUGAGGAGGACCAAAACAGAGAUCUUAAACAAGGAGAUGAUGAUGAUUCUAAAAUAAAUGGCAGAGGUUUGCCAAAUGGAAUGGAUGCCGAUUGCAAAGAUUUUAAUCGUACUCCUGGAAGUCGUCAAGCCUCUCCAACUGAAGUAGUUGAGCGCUUGGGCCCCAAUACUAAUCCCUCAGAAGGACUGGGGCCUCUUCCUAAUCCUACAGCUAAUAAACCACUUGUUGAAGAAUUUUCAAAUCCUGAAACUCAGAAUCUGGAUGCCAUGGAACAAGUUGGUCUGGAAUCCUUACAGUUUGACUAUCCUGGUAAUCAGGUACCAAUGGACUCUUCAGGAGCUACUGUAGGCCUUUUUGACUACAAUUCCCAGCAGCAGCUCUUUCAGAGGACUAAUGCACUAACAGUUCAACAGUUAACUGCAGCUCAACAGCAGCAAUAUGCAUUAGCAGCAGCUCAGCAGCCACAUAUAGCUGGUGUAUUCUCAGCAGGCCUUGCUCCAGCUGCAUUUGUGCCAAAUCCAUACAUUAUUAGUGCUGCUCCUCCAGGGACCGAUCCGUAUACUGCAGCAGGAUUGGCUGCAGCAGCUACAUUAGCAGGUCCAGCAGUGGUUCCACCUCAGUAUUACGGCGUUCCAUGGGGGGUGUAUCCAGCCAACUUAUUUCAGCAGCAAGCUGCAGCUGCGGCAAAUAACACAGCCAGUCAGCAAGCAGCAUCACAAGCUCAGCCUGGACAGCAACAGGUUCUCCGUGCUGGAGCAGGUCAGCGUCCUCUUACUCCCAAUCAGGGUCAGCAAGGGCAGCAAGCAGAAUCACUUGCGGCAGCUGCAGCAGCAAAUCCAACAUUGGCUUUUGGUCAGGGUCUUGCUACUGGCAUGCCAGGCUAUCAAGUACUAGCUCCAACUGCCUAUUAUGAUCAGACUGGUGCCUUAGUGGUUGGCCCUGGAGCAAGGACUGGCCUUGGAGCUCCAGUUCGGUUAAUGGCUCCAACACCUGUUUUAAUUAGUUCAGCAGCAGCACAAGCUGCAGCAGCAGCAGCAGCUGGAGGAACUGCAAGUAGCCUUACAGGCAGCACAAAUGGUCUGUUUCGGCCAAUUGGCACUCAGCCACCACAGCAGCAGCAACAGCAGCCAAGCACUAAUCUGCAAUCUAAUUCAUUUUAUGGAAGCAGUUCUUUGACUAAUAGCUCCCAGAGUAGUUCUUUAUUUUCUCAUGGACCUGGUCAACCUGGAAGUACAUCUCUUGGCUUUGGAAGUGGUAACUCUUUGGGUGCUGCUAUAGGCUCAGCCCUCAGUGGAUUUGGUUCAUCAGUUGGCAGUUCUGCAAGUAGUAGUGCCACAAGGAGAGAGUCUCUAUCUACUAGCUCUGACUUGUACAAAAGAUCUAGUAGCAGCCUAGCACCCAUAGGGCAACCAUUUUACAAUAGUCUGGGAUUUUCCUCCUCUCCAAGUCCAAUAGGCAUGCCUCUGCCAAGCCAAACUCCAGGACAUUCACUUACGCCACCGCCAUCACUUUCAUCACAUGGAUCCUCAUCCAGUUUGCAUUUAGGAGGACUGACAAAUGGUAGUGGUCGAUAUAUCUCUGCAGCACCUGGAGCAGAAGCAAAAUAUCGAAGUGCUUCAAGCACUUCCAGUCUAUUUAGCUCCAGCAGCCAGCUCUUUCCUCCUUCCCGGCUUCGGUAUAAUAGGUCUGAUAUUAUGCCUUCUGGCCGCAGUAGAUUAUUGGAAGAUUUCAGAAACAACCGCUUCCCAAACCUUCAGCUUAGAGACUUGAUUGGACAUAUAGUUGAGUUUUCUCAAGACCAGCAUGGUUCUAGAUUCAUACAGCAAAAACUAGAGAGAGCUACUCCAGCUGAGCGACAGAUGGUAUUUAAUGAAAUUCUGCAAGCAGCCUAUCAAUUAAUGACUGAUGUUUUUGGCAACUAUGUUAUACAGAAGUUUUUUGAGUUUGGGAGUCUGGAUCAAAAAUUAGCCCUGGCUACUCGUAUUCGUGGUCAUGUUCUACCCUUAGCCUUGCAGAUGUAUGGCUGCCGCGUUAUUCAGAAAGCAUUAGAAUCUAUUUCUUCUGACCAGCAGAGUGAAAUGGUAAAGGAGCUGGAUGGUCAUGUGCUCAAAUGUGUGAAAGAUCAGAAUGGAAACCAUGUUGUACAAAAAUGUAUCGAAUGUGUUCAGCCACAGUCACUACAGUUCAUCAUUGAUGCUUUCAAGGGACAAGUAUUUGUGCUUUCAACUCAUCCUUAUGGCUGCAGAGUAAUUCAGCGCAUCCUAGAGCAUUGCACUGCAGAACAGACCUUACCUAUCUUAGAAGAACUCCACCAACAUACAGAGCAGUUGGUACAGGAUCAGUAUGGCAAUUAUGUUAUUCAGCAUGUACUGGAACACGGUCGACCUGAAGACAAGAGCAAAAUUGUUUCCGAAAUCAGGGGAAAGGUUUUAGCCCUGAGUCAACACAAAUUUGCCAGCAAUGUAGUAGAAAAGUGUGUUACUCAUGCCUCCCGUGCUGAGAGAGCUUUACUGAUUGACGAGGUUUGCUGCCAGAAUGAUGGUCCUCACAGUGCCUUAUACACCAUGAUGAAGGACCAGUAUGCCAAUUACGUGGUUCAAAAGAUGAUUGAUAUGGCUGAACCUGCUCAGAGAAAGAUAAUCAUGCACAAGAUUCGACCUCACAUUACUACUUUGCGCAAAUACACAUACGGGAAGCAUAUACUGGCCAAGUUGGAAAAGUAUUAUUUGAAGAAUAGCCCGGACCUAGGACCUAUUGGAGGACCACCAAAUGGAAUGCUGUAAAUUACAGGAGCAAGAGAAAGAAGAUAAUUUAACCAUGUGAAAAGAAUUUUUUUGUGUGUGAAUUAUCAAAACACAACUCAACUAUGAAUCUUCAAUUUUUUUUUAAAGCAAAACUAUUUAUUGACUUUAUUCAUCCAUUUGUAAAUUUUUUAAGGUUCUUGUGUAUAUUUGGGGGGUGGGGGAUGAAUUAUAAAUUAUAUUCAGCCCUGAGUGGAGACCUAUCAGAUUGGAUUGCUGGCAAAGCACAGAAUGCCUGUAUAUGAUGUAACUGUAUCAAAAAUAAAAAGCUGUCACAUAUUUUGUAAAUUUUUACCUUGUAAAGUCACAAAAAUAGUUUUUAAAGGAAAAAGUACAGUAUUCUUUUAAUAAACUGGCUCACAGUCUGGUAGGUCUACAACCCCAUAGCACAACAGGUUUAUAGAGAUGUAUAUAGAAUUAUAGUCCUUAUUUUUUUCCUUUGCGUGAAACCUUUUAUAACAGAUUAACAAUCAACUGCAUAAAUAUUAUUAAUAUUUUAAAAAGAGUUAAGUUGUAUUUUGAUAAUUCACAAACUAUCAUGCAAAUAACGAGUAAGUAGACAAGAAUAAAGUGGUUUGAGAUGAAAAGAACCUAACAUUAUUUACAGUAGAUGUGGUUUUAAUACAAUUACUGCCCUAAAAUGUCUCUGGCAAUGUACAGAAAUAUUGUAUAUACUUACAUAUGUAAUUGUUGUAAGAGUUAAAUACAAAAUCAUGGUGACACUUCCAAUUAAGUGCACUAAAUGAAAAGUUAAGUCACUUAUUAACUUUUCAGUUUGGUUUGCAAUGAGAAAGAGUGGAAAUUUGUAUUUUGUUUUGCUUAUAGAAUUACAGACAUGUUGAGGAAGUGUUGAGCUUUAUUUUGCUUUUUCAUAGAGGCAGAAAGUAGGAACCAGAUAGAGAUGAAAAGGGGCCACUGAAAAGUGAAUUUGAUAGCUCAGCAUUUAAGCAUGAUUACAUAUUCAGAUAGCUCUUUUUGCUUUCUAUAAAUAUAUGCAUUGUGUGUGUAGUAAUAGAUGUAAGUUUACACUUUGAAAGGAAAUCUUGUUUCAAUGUUUAUUAUAAAAGCCUUGCUAAUUUAGUAGUGAUGCUUUCCUUGGUUGUACAGGUGUACAUUUGUAAACCUUCAUGCUGUAAAUGGAAUUUGUUUUAUCUCUUUGGGAUACAUUUGCAUUUUAGUGUACAUUUACGUCCCUGCCCUCUUUGACCUGGCAAUAUAGUGUUGUAUAAUGUAAAUUUAUUUCUCCAAAUCGAGAGUGAUUUUUUAAAAAUUUUUUAUCUUUAUAUGGUUUCAGAAGUAUGAACCAGCUUUCUUUUUAUUAUUGUGAGAUCAUUUUGUUUUAUAACAUAGUUGUUGACUGUUAAUAUGGACCUGCUAGAAUUUGGAUCACUUUCAAUUGAAGUCAGGGUAUUGUGCAUAAUAGAAAGUAUUGGACUGAGAUAUUUGGUUACCAUGGAGGCCAAUGCUUUUUUCAUCUUAUUAAAUGUGAUGUGACUUUUUUCUUUGUACAGAAGAGUACUGUAUUUUUGAAUAGCCUACUCCCAAGUAAGAGCAAAUCUGUAUGAUAACAUUUUUUCCUCUGGACAUAAGACAUAACAGUAACACGAUGUACAUUUACAAGCGGCCUUAUGUACAUUUCCCAACAAUCUUUUUAAGGCAAAAUUGUGACCAUAUGUGUAUAAUUAAAAUCGUUUUUAAUCCUUUGCCUAUGAAAAUAUUUUGGAAAAAAACUUGCUGUGUAUAUUCAGUUUCUGAAAGAUAAAGAAAGUGCUUUGUAUUUUGUUGAAGUCAGUAUUUUGUAUAAACAUUUAUGUUGACCCACUUAUGUUCAGUGCUGAAAACUAAAAUGAACAUGCUAUUCUGUCAGCUGAAUAUGGAAGAGAUCUUUUUUUACUAGAGAUCUGCAGAAGAAACGCAAUCUUCUGAGCACAAUAUGGAAUCUAAAGGUUUUAUCACUUAGUUGUUCAUAUUAUGAACCUAAAAAUAAUGGCAUAAAGUUUGGGGAUGCCAGGCAUACUUUUUCAUGUUUGGUGUUGAGUUAUUUUACUUUUCUAACCCAACAUUCCUUGGUGAGACCAUUAAAUCCAAACACUUGUCACCGUUCCUUCUCAUAGUCACUCUGGGUCAUCAGCAUGUCCCAGUCACUGCAGCAACGCCUUGUGUUUGUUUCAUUUUUUUAAAACCCACACAAAGCCGCUGUCUCACUUUUUCCUACUUUACCAACCUCAGAGUAUUUCGGCCCGUAUCGAACUUUUGUUCUCAGUAUCAGCCCAUGGUUUCAGGAUCAAAGCUGUCAUGUUGGAGAUUGGUAAUGGCUUUCCUGUCUUUGUACAGUUGAAUUCCUAGUCUUCCUUCAUCCUUGCCCUCUGUUGGCACAGGCAUUAUCUCUGCAAUUUUAGAAAAUGACAAGUAGAGAAUACUACAUUGAGAAACUAAACCCUCUUCUUGGGGUCCUGAUACUCAUUCCCAUUUGUCCCAGUGCUGACAACCCAAUCUUCCCAAUACUUUCAGGCCUGCUCUACAAAAGUACCUGUUCUUGUAGAAAUUUUACAGUCUGCCAUUUUGGGUGCCCACCCCAAUUUUUACCUUUUAGUAAGUUGGCAUGAAAUUUUGGUAAAAUCUGAAAAUCACAUUUCAGAAUAAAACAAUUGGGCAAAACUACCUAGGCUUUACUCUUGAGUGUCUCCUUUUGAUAGGGAUUGUUUCUGGACCAGUUUGUCUAAGUCCUGGCUCUUAUUGGUUCAUAUGAAAUAAUGUUAACUUCACUUCUUUGUAUAUUAUGUAUAAAUUAGAAAAUGAAAAAUGUGUGAAUAACAUUGUAUGAAAUAAA,mRNA,Homo sapiens,"sp|Q14671|PUM1_HUMAN Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1 PE=1 SV=3
MSVACVLKRKAVLWQDSFSPHLKHHPQEPANPNMPVVLTSGTGSQAQPQPAANQALAAGT
HSSPVPGSIGVAGRSQDDAMVDYFFQRQHGEQLGGGGSGGGGYNNSKHRWPTGDNIHAEH
QVRSMDELNHDFQALALEGRAMGEQLLPGKKFWETDESSKDGPKGIFLGDQWRDSAWGTS
DHSVSQPIMVQRRPGQSFHVNSEVNSVLSPRSESGGLGVSMVEYVLSSSPGDSCLRKGGF
GPRDADSDENDKGEKKNKGTFDGDKLGDLKEEGDVMDKTNGLPVQNGIDADVKDFSRTPG
NCQNSANEVDLLGPNQNGSEGLAQLTSTNGAKPVEDFSNMESQSVPLDPMEHVGMEPLQF
DYSGTQVPVDSAAATVGLFDYNSQQQLFQRPNALAVQQLTAAQQQQYALAAAHQPHIGLA
PAAFVPNPYIISAAPPGTDPYTAGLAAAATLGPAVVPHQYYGVTPWGVYPASLFQQQAAA
AAAATNSANQQTTPQAQQGQQQVLRGGASQRPLTPNQNQQGQQTDPLVAAAAVNSALAFG
QGLAAGMPGYPVLAPAAYYDQTGALVVNAGARNGLGAPVRLVAPAPVIISSSAAQAAVAA
AAASANGAAGGLAGTTNGPFRPLGTQQPQPQPQQQPNNNLASSSFYGNNSLNSNSQSSSL
FSQGSAQPANTSLGFGSSSSLGATLGSALGGFGTAVANSNTGSGSRRDSLTGSSDLYKRT
SSSLTPIGHSFYNGLSFSSSPGPVGMPLPSQGPGHSQTPPPSLSSHGSSSSLNLGGLTNG
SGRYISAAPGAEAKYRSASSASSLFSPSSTLFSSSRLRYGMSDVMPSGRSRLLEDFRNNR
YPNLQLREIAGHIMEFSQDQHGSRFIQLKLERATPAERQLVFNEILQAAYQLMVDVFGNY
VIQKFFEFGSLEQKLALAERIRGHVLSLALQMYGCRVIQKALEFIPSDQQNEMVRELDGH
VLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFALSTHPYGCRVIQRILEHCLPD
QTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVAEIRGNVLVLSQHKFASN
VVEKCVTHASRTERAVLIDEVCTMNDGPHSALYTMMKDQYANYVVQKMIDVAEPGQRKIV
MHKIRPHIATLRKYTYGKHILAKLEKYYMKNGVDLGPICGPPNGII",PUM1,-,-,1186aa(1-1186),Q14671,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1307,http://db.phasep.pro/browse/","[22-73],[233-272],[485-524],[613-648],[742-773]","[45-58],[94-102],[393-414],[442-457],[475-502],[527-538],[583-614],[625-639],[647-665],[671-695],[762-782],[797-815]",In vitro,150 nM [PUM1];|0.1-20nM[PUM2 3'UTR],"150 mM NaCl, 1 mM MgCl2","20 mM Tris HCl pH 7.5, 1 mM DTT, 10% glycerol",RT,30 min,crowding agent:5% PEG3350;other_molecular: 1 U TEV protease,Confocal microscopy,"solute, liquid","Unlike NORAD, none of these transcripts promoted PUM1 phase separation at or below their physiological concentrations in vitro, although the PUM1 and PUM2 3′ UTRs were able to induce the formation of small droplets at concentrations 4–10 times their physiological levels",6200
211,699,PMID: 34239064,RNAPS0000450,https://pubmed.ncbi.nlm.nih.gov/34239064,RNA + protein,-,-,SARS-CoV-2 virus RNA,29903nt(1-29903),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCUGAAAAGAGCUAUGAAUUGCAGACACCUUUUGAAAUUAAAUUGGCAAAGAAAUUUGACACCUUCAAUGGGGAAUGUCCAAAUUUUGUAUUUCCCUUAAAUUCCAUAAUCAAGACUAUUCAACCAAGGGUUGAAAAGAAAAAGCUUGAUGGCUUUAUGGGUAGAAUUCGAUCUGUCUAUCCAGUUGCGUCACCAAAUGAAUGCAACCAAAUGUGCCUUUCAACUCUCAUGAAGUGUGAUCAUUGUGGUGAAACUUCAUGGCAGACGGGCGAUUUUGUUAAAGCCACUUGCGAAUUUUGUGGCACUGAGAAUUUGACUAAAGAAGGUGCCACUACUUGUGGUUACUUACCCCAAAAUGCUGUUGUUAAAAUUUAUUGUCCAGCAUGUCACAAUUCAGAAGUAGGACCUGAGCAUAGUCUUGCCGAAUACCAUAAUGAAUCUGGCUUGAAAACCAUUCUUCGUAAGGGUGGUCGCACUAUUGCCUUUGGAGGCUGUGUGUUCUCUUAUGUUGGUUGCCAUAACAAGUGUGCCUAUUGGGUUCCACGUGCUAGCGCUAACAUAGGUUGUAACCAUACAGGUGUUGUUGGAGAAGGUUCCGAAGGUCUUAAUGACAACCUUCUUGAAAUACUCCAAAAAGAGAAAGUCAACAUCAAUAUUGUUGGUGACUUUAAACUUAAUGAAGAGAUCGCCAUUAUUUUGGCAUCUUUUUCUGCUUCCACAAGUGCUUUUGUGGAAACUGUGAAAGGUUUGGAUUAUAAAGCAUUCAAACAAAUUGUUGAAUCCUGUGGUAAUUUUAAAGUUACAAAAGGAAAAGCUAAAAAAGGUGCCUGGAAUAUUGGUGAACAGAAAUCAAUACUGAGUCCUCUUUAUGCAUUUGCAUCAGAGGCUGCUCGUGUUGUACGAUCAAUUUUCUCCCGCACUCUUGAAACUGCUCAAAAUUCUGUGCGUGUUUUACAGAAGGCCGCUAUAACAAUACUAGAUGGAAUUUCACAGUAUUCACUGAGACUCAUUGAUGCUAUGAUGUUCACAUCUGAUUUGGCUACUAACAAUCUAGUUGUAAUGGCCUACAUUACAGGUGGUGUUGUUCAGUUGACUUCGCAGUGGCUAACUAACAUCUUUGGCACUGUUUAUGAAAAACUCAAACCCGUCCUUGAUUGGCUUGAAGAGAAGUUUAAGGAAGGUGUAGAGUUUCUUAGAGACGGUUGGGAAAUUGUUAAAUUUAUCUCAACCUGUGCUUGUGAAAUUGUCGGUGGACAAAUUGUCACCUGUGCAAAGGAAAUUAAGGAGAGUGUUCAGACAUUCUUUAAGCUUGUAAAUAAAUUUUUGGCUUUGUGUGCUGACUCUAUCAUUAUUGGUGGAGCUAAACUUAAAGCCUUGAAUUUAGGUGAAACAUUUGUCACGCACUCAAAGGGAUUGUACAGAAAGUGUGUUAAAUCCAGAGAAGAAACUGGCCUACUCAUGCCUCUAAAAGCCCCAAAAGAAAUUAUCUUCUUAGAGGGAGAAACACUUCCCACAGAAGUGUUAACAGAGGAAGUUGUCUUGAAAACUGGUGAUUUACAACCAUUAGAACAACCUACUAGUGAAGCUGUUGAAGCUCCAUUGGUUGGUACACCAGUUUGUAUUAACGGGCUUAUGUUGCUCGAAAUCAAAGACACAGAAAAGUACUGUGCCCUUGCACCUAAUAUGAUGGUAACAAACAAUACCUUCACACUCAAAGGCGGUGCACCAACAAAGGUUACUUUUGGUGAUGACACUGUGAUAGAAGUGCAAGGUUACAAGAGUGUGAAUAUCACUUUUGAACUUGAUGAAAGGAUUGAUAAAGUACUUAAUGAGAAGUGCUCUGCCUAUACAGUUGAACUCGGUACAGAAGUAAAUGAGUUCGCCUGUGUUGUGGCAGAUGCUGUCAUAAAAACUUUGCAACCAGUAUCUGAAUUACUUACACCACUGGGCAUUGAUUUAGAUGAGUGGAGUAUGGCUACAUACUACUUAUUUGAUGAGUCUGGUGAGUUUAAAUUGGCUUCACAUAUGUAUUGUUCUUUCUACCCUCCAGAUGAGGAUGAAGAAGAAGGUGAUUGUGAAGAAGAAGAGUUUGAGCCAUCAACUCAAUAUGAGUAUGGUACUGAAGAUGAUUACCAAGGUAAACCUUUGGAAUUUGGUGCCACUUCUGCUGCUCUUCAACCUGAAGAAGAGCAAGAAGAAGAUUGGUUAGAUGAUGAUAGUCAACAAACUGUUGGUCAACAAGACGGCAGUGAGGACAAUCAGACAACUACUAUUCAAACAAUUGUUGAGGUUCAACCUCAAUUAGAGAUGGAACUUACACCAGUUGUUCAGACUAUUGAAGUGAAUAGUUUUAGUGGUUAUUUAAAACUUACUGACAAUGUAUACAUUAAAAAUGCAGACAUUGUGGAAGAAGCUAAAAAGGUAAAACCAACAGUGGUUGUUAAUGCAGCCAAUGUUUACCUUAAACAUGGAGGAGGUGUUGCAGGAGCCUUAAAUAAGGCUACUAACAAUGCCAUGCAAGUUGAAUCUGAUGAUUACAUAGCUACUAAUGGACCACUUAAAGUGGGUGGUAGUUGUGUUUUAAGCGGACACAAUCUUGCUAAACACUGUCUUCAUGUUGUCGGCCCAAAUGUUAACAAAGGUGAAGACAUUCAACUUCUUAAGAGUGCUUAUGAAAAUUUUAAUCAGCACGAAGUUCUACUUGCACCAUUAUUAUCAGCUGGUAUUUUUGGUGCUGACCCUAUACAUUCUUUAAGAGUUUGUGUAGAUACUGUUCGCACAAAUGUCUACUUAGCUGUCUUUGAUAAAAAUCUCUAUGACAAACUUGUUUCAAGCUUUUUGGAAAUGAAGAGUGAAAAGCAAGUUGAACAAAAGAUCGCUGAGAUUCCUAAAGAGGAAGUUAAGCCAUUUAUAACUGAAAGUAAACCUUCAGUUGAACAGAGAAAACAAGAUGAUAAGAAAAUCAAAGCUUGUGUUGAAGAAGUUACAACAACUCUGGAAGAAACUAAGUUCCUCACAGAAAACUUGUUACUUUAUAUUGACAUUAAUGGCAAUCUUCAUCCAGAUUCUGCCACUCUUGUUAGUGACAUUGACAUCACUUUCUUAAAGAAAGAUGCUCCAUAUAUAGUGGGUGAUGUUGUUCAAGAGGGUGUUUUAACUGCUGUGGUUAUACCUACUAAAAAGGCUGGUGGCACUACUGAAAUGCUAGCGAAAGCUUUGAGAAAAGUGCCAACAGACAAUUAUAUAACCACUUACCCGGGUCAGGGUUUAAAUGGUUACACUGUAGAGGAGGCAAAGACAGUGCUUAAAAAGUGUAAAAGUGCCUUUUACAUUCUACCAUCUAUUAUCUCUAAUGAGAAGCAAGAAAUUCUUGGAACUGUUUCUUGGAAUUUGCGAGAAAUGCUUGCACAUGCAGAAGAAACACGCAAAUUAAUGCCUGUCUGUGUGGAAACUAAAGCCAUAGUUUCAACUAUACAGCGUAAAUAUAAGGGUAUUAAAAUACAAGAGGGUGUGGUUGAUUAUGGUGCUAGAUUUUACUUUUACACCAGUAAAACAACUGUAGCGUCACUUAUCAACACACUUAACGAUCUAAAUGAAACUCUUGUUACAAUGCCACUUGGCUAUGUAACACAUGGCUUAAAUUUGGAAGAAGCUGCUCGGUAUAUGAGAUCUCUCAAAGUGCCAGCUACAGUUUCUGUUUCUUCACCUGAUGCUGUUACAGCGUAUAAUGGUUAUCUUACUUCUUCUUCUAAAACACCUGAAGAACAUUUUAUUGAAACCAUCUCACUUGCUGGUUCCUAUAAAGAUUGGUCCUAUUCUGGACAAUCUACACAACUAGGUAUAGAAUUUCUUAAGAGAGGUGAUAAAAGUGUAUAUUACACUAGUAAUCCUACCACAUUCCACCUAGAUGGUGAAGUUAUCACCUUUGACAAUCUUAAGACACUUCUUUCUUUGAGAGAAGUGAGGACUAUUAAGGUGUUUACAACAGUAGACAACAUUAACCUCCACACGCAAGUUGUGGACAUGUCAAUGACAUAUGGACAACAGUUUGGUCCAACUUAUUUGGAUGGAGCUGAUGUUACUAAAAUAAAACCUCAUAAUUCACAUGAAGGUAAAACAUUUUAUGUUUUACCUAAUGAUGACACUCUACGUGUUGAGGCUUUUGAGUACUACCACACAACUGAUCCUAGUUUUCUGGGUAGGUACAUGUCAGCAUUAAAUCACACUAAAAAGUGGAAAUACCCACAAGUUAAUGGUUUAACUUCUAUUAAAUGGGCAGAUAACAACUGUUAUCUUGCCACUGCAUUGUUAACACUCCAACAAAUAGAGUUGAAGUUUAAUCCACCUGCUCUACAAGAUGCUUAUUACAGAGCAAGGGCUGGUGAAGCUGCUAACUUUUGUGCACUUAUCUUAGCCUACUGUAAUAAGACAGUAGGUGAGUUAGGUGAUGUUAGAGAAACAAUGAGUUACUUGUUUCAACAUGCCAAUUUAGAUUCUUGCAAAAGAGUCUUGAACGUGGUGUGUAAAACUUGUGGACAACAGCAGACAACCCUUAAGGGUGUAGAAGCUGUUAUGUACAUGGGCACACUUUCUUAUGAACAAUUUAAGAAAGGUGUUCAGAUACCUUGUACGUGUGGUAAACAAGCUACAAAAUAUCUAGUACAACAGGAGUCACCUUUUGUUAUGAUGUCAGCACCACCUGCUCAGUAUGAACUUAAGCAUGGUACAUUUACUUGUGCUAGUGAGUACACUGGUAAUUACCAGUGUGGUCACUAUAAACAUAUAACUUCUAAAGAAACUUUGUAUUGCAUAGACGGUGCUUUACUUACAAAGUCCUCAGAAUACAAAGGUCCUAUUACGGAUGUUUUCUACAAAGAAAACAGUUACACAACAACCAUAAAACCAGUUACUUAUAAAUUGGAUGGUGUUGUUUGUACAGAAAUUGACCCUAAGUUGGACAAUUAUUAUAAGAAAGACAAUUCUUAUUUCACAGAGCAACCAAUUGAUCUUGUACCAAACCAACCAUAUCCAAACGCAAGCUUCGAUAAUUUUAAGUUUGUAUGUGAUAAUAUCAAAUUUGCUGAUGAUUUAAACCAGUUAACUGGUUAUAAGAAACCUGCUUCAAGAGAGCUUAAAGUUACAUUUUUCCCUGACUUAAAUGGUGAUGUGGUGGCUAUUGAUUAUAAACACUACACACCCUCUUUUAAGAAAGGAGCUAAAUUGUUACAUAAACCUAUUGUUUGGCAUGUUAACAAUGCAACUAAUAAAGCCACGUAUAAACCAAAUACCUGGUGUAUACGUUGUCUUUGGAGCACAAAACCAGUUGAAACAUCAAAUUCGUUUGAUGUACUGAAGUCAGAGGACGCGCAGGGAAUGGAUAAUCUUGCCUGCGAAGAUCUAAAACCAGUCUCUGAAGAAGUAGUGGAAAAUCCUACCAUACAGAAAGACGUUCUUGAGUGUAAUGUGAAAACUACCGAAGUUGUAGGAGACAUUAUACUUAAACCAGCAAAUAAUAGUUUAAAAAUUACAGAAGAGGUUGGCCACACAGAUCUAAUGGCUGCUUAUGUAGACAAUUCUAGUCUUACUAUUAAGAAACCUAAUGAAUUAUCUAGAGUAUUAGGUUUGAAAACCCUUGCUACUCAUGGUUUAGCUGCUGUUAAUAGUGUCCCUUGGGAUACUAUAGCUAAUUAUGCUAAGCCUUUUCUUAACAAAGUUGUUAGUACAACUACUAACAUAGUUACACGGUGUUUAAACCGUGUUUGUACUAAUUAUAUGCCUUAUUUCUUUACUUUAUUGCUACAAUUGUGUACUUUUACUAGAAGUACAAAUUCUAGAAUUAAAGCAUCUAUGCCGACUACUAUAGCAAAGAAUACUGUUAAGAGUGUCGGUAAAUUUUGUCUAGAGGCUUCAUUUAAUUAUUUGAAGUCACCUAAUUUUUCUAAACUGAUAAAUAUUAUAAUUUGGUUUUUACUAUUAAGUGUUUGCCUAGGUUCUUUAAUCUACUCAACCGCUGCUUUAGGUGUUUUAAUGUCUAAUUUAGGCAUGCCUUCUUACUGUACUGGUUACAGAGAAGGCUAUUUGAACUCUACUAAUGUCACUAUUGCAACCUACUGUACUGGUUCUAUACCUUGUAGUGUUUGUCUUAGUGGUUUAGAUUCUUUAGACACCUAUCCUUCUUUAGAAACUAUACAAAUUACCAUUUCAUCUUUUAAAUGGGAUUUAACUGCUUUUGGCUUAGUUGCAGAGUGGUUUUUGGCAUAUAUUCUUUUCACUAGGUUUUUCUAUGUACUUGGAUUGGCUGCAAUCAUGCAAUUGUUUUUCAGCUAUUUUGCAGUACAUUUUAUUAGUAAUUCUUGGCUUAUGUGGUUAAUAAUUAAUCUUGUACAAAUGGCCCCGAUUUCAGCUAUGGUUAGAAUGUACAUCUUCUUUGCAUCAUUUUAUUAUGUAUGGAAAAGUUAUGUGCAUGUUGUAGACGGUUGUAAUUCAUCAACUUGUAUGAUGUGUUACAAACGUAAUAGAGCAACAAGAGUCGAAUGUACAACUAUUGUUAAUGGUGUUAGAAGGUCCUUUUAUGUCUAUGCUAAUGGAGGUAAAGGCUUUUGCAAACUACACAAUUGGAAUUGUGUUAAUUGUGAUACAUUCUGUGCUGGUAGUACAUUUAUUAGUGAUGAAGUUGCGAGAGACUUGUCACUACAGUUUAAAAGACCAAUAAAUCCUACUGACCAGUCUUCUUACAUCGUUGAUAGUGUUACAGUGAAGAAUGGUUCCAUCCAUCUUUACUUUGAUAAAGCUGGUCAAAAGACUUAUGAAAGACAUUCUCUCUCUCAUUUUGUUAACUUAGACAACCUGAGAGCUAAUAACACUAAAGGUUCAUUGCCUAUUAAUGUUAUAGUUUUUGAUGGUAAAUCAAAAUGUGAAGAAUCAUCUGCAAAAUCAGCGUCUGUUUACUACAGUCAGCUUAUGUGUCAACCUAUACUGUUACUAGAUCAGGCAUUAGUGUCUGAUGUUGGUGAUAGUGCGGAAGUUGCAGUUAAAAUGUUUGAUGCUUACGUUAAUACGUUUUCAUCAACUUUUAACGUACCAAUGGAAAAACUCAAAACACUAGUUGCAACUGCAGAAGCUGAACUUGCAAAGAAUGUGUCCUUAGACAAUGUCUUAUCUACUUUUAUUUCAGCAGCUCGGCAAGGGUUUGUUGAUUCAGAUGUAGAAACUAAAGAUGUUGUUGAAUGUCUUAAAUUGUCACAUCAAUCUGACAUAGAAGUUACUGGCGAUAGUUGUAAUAACUAUAUGCUCACCUAUAACAAAGUUGAAAACAUGACACCCCGUGACCUUGGUGCUUGUAUUGACUGUAGUGCGCGUCAUAUUAAUGCGCAGGUAGCAAAAAGUCACAACAUUGCUUUGAUAUGGAACGUUAAAGAUUUCAUGUCAUUGUCUGAACAACUACGAAAACAAAUACGUAGUGCUGCUAAAAAGAAUAACUUACCUUUUAAGUUGACAUGUGCAACUACUAGACAAGUUGUUAAUGUUGUAACAACAAAGAUAGCACUUAAGGGUGGUAAAAUUGUUAAUAAUUGGUUGAAGCAGUUAAUUAAAGUUACACUUGUGUUCCUUUUUGUUGCUGCUAUUUUCUAUUUAAUAACACCUGUUCAUGUCAUGUCUAAACAUACUGACUUUUCAAGUGAAAUCAUAGGAUACAAGGCUAUUGAUGGUGGUGUCACUCGUGACAUAGCAUCUACAGAUACUUGUUUUGCUAACAAACAUGCUGAUUUUGACACAUGGUUUAGCCAGCGUGGUGGUAGUUAUACUAAUGACAAAGCUUGCCCAUUGAUUGCUGCAGUCAUAACAAGAGAAGUGGGUUUUGUCGUGCCUGGUUUGCCUGGCACGAUAUUACGCACAACUAAUGGUGACUUUUUGCAUUUCUUACCUAGAGUUUUUAGUGCAGUUGGUAACAUCUGUUACACACCAUCAAAACUUAUAGAGUACACUGACUUUGCAACAUCAGCUUGUGUUUUGGCUGCUGAAUGUACAAUUUUUAAAGAUGCUUCUGGUAAGCCAGUACCAUAUUGUUAUGAUACCAAUGUACUAGAAGGUUCUGUUGCUUAUGAAAGUUUACGCCCUGACACACGUUAUGUGCUCAUGGAUGGCUCUAUUAUUCAAUUUCCUAACACCUACCUUGAAGGUUCUGUUAGAGUGGUAACAACUUUUGAUUCUGAGUACUGUAGGCACGGCACUUGUGAAAGAUCAGAAGCUGGUGUUUGUGUAUCUACUAGUGGUAGAUGGGUACUUAACAAUGAUUAUUACAGAUCUUUACCAGGAGUUUUCUGUGGUGUAGAUGCUGUAAAUUUACUUACUAAUAUGUUUACACCACUAAUUCAACCUAUUGGUGCUUUGGACAUAUCAGCAUCUAUAGUAGCUGGUGGUAUUGUAGCUAUCGUAGUAACAUGCCUUGCCUACUAUUUUAUGAGGUUUAGAAGAGCUUUUGGUGAAUACAGUCAUGUAGUUGCCUUUAAUACUUUACUAUUCCUUAUGUCAUUCACUGUACUCUGUUUAACACCAGUUUACUCAUUCUUACCUGGUGUUUAUUCUGUUAUUUACUUGUACUUGACAUUUUAUCUUACUAAUGAUGUUUCUUUUUUAGCACAUAUUCAGUGGAUGGUUAUGUUCACACCUUUAGUACCUUUCUGGAUAACAAUUGCUUAUAUCAUUUGUAUUUCCACAAAGCAUUUCUAUUGGUUCUUUAGUAAUUACCUAAAGAGACGUGUAGUCUUUAAUGGUGUUUCCUUUAGUACUUUUGAAGAAGCUGCGCUGUGCACCUUUUUGUUAAAUAAAGAAAUGUAUCUAAAGUUGCGUAGUGAUGUGCUAUUACCUCUUACGCAAUAUAAUAGAUACUUAGCUCUUUAUAAUAAGUACAAGUAUUUUAGUGGAGCAAUGGAUACAACUAGCUACAGAGAAGCUGCUUGUUGUCAUCUCGCAAAGGCUCUCAAUGACUUCAGUAACUCAGGUUCUGAUGUUCUUUACCAACCACCACAAACCUCUAUCACCUCAGCUGUUUUGCAGAGUGGUUUUAGAAAAAUGGCAUUCCCAUCUGGUAAAGUUGAGGGUUGUAUGGUACAAGUAACUUGUGGUACAACUACACUUAACGGUCUUUGGCUUGAUGACGUAGUUUACUGUCCAAGACAUGUGAUCUGCACCUCUGAAGACAUGCUUAACCCUAAUUAUGAAGAUUUACUCAUUCGUAAGUCUAAUCAUAAUUUCUUGGUACAGGCUGGUAAUGUUCAACUCAGGGUUAUUGGACAUUCUAUGCAAAAUUGUGUACUUAAGCUUAAGGUUGAUACAGCCAAUCCUAAGACACCUAAGUAUAAGUUUGUUCGCAUUCAACCAGGACAGACUUUUUCAGUGUUAGCUUGUUACAAUGGUUCACCAUCUGGUGUUUACCAAUGUGCUAUGAGGCCCAAUUUCACUAUUAAGGGUUCAUUCCUUAAUGGUUCAUGUGGUAGUGUUGGUUUUAACAUAGAUUAUGACUGUGUCUCUUUUUGUUACAUGCACCAUAUGGAAUUACCAACUGGAGUUCAUGCUGGCACAGACUUAGAAGGUAACUUUUAUGGACCUUUUGUUGACAGGCAAACAGCACAAGCAGCUGGUACGGACACAACUAUUACAGUUAAUGUUUUAGCUUGGUUGUACGCUGCUGUUAUAAAUGGAGACAGGUGGUUUCUCAAUCGAUUUACCACAACUCUUAAUGACUUUAACCUUGUGGCUAUGAAGUACAAUUAUGAACCUCUAACACAAGACCAUGUUGACAUACUAGGACCUCUUUCUGCUCAAACUGGAAUUGCCGUUUUAGAUAUGUGUGCUUCAUUAAAAGAAUUACUGCAAAAUGGUAUGAAUGGACGUACCAUAUUGGGUAGUGCUUUAUUAGAAGAUGAAUUUACACCUUUUGAUGUUGUUAGACAAUGCUCAGGUGUUACUUUCCAAAGUGCAGUGAAAAGAACAAUCAAGGGUACACACCACUGGUUGUUACUCACAAUUUUGACUUCACUUUUAGUUUUAGUCCAGAGUACUCAAUGGUCUUUGUUCUUUUUUUUGUAUGAAAAUGCCUUUUUACCUUUUGCUAUGGGUAUUAUUGCUAUGUCUGCUUUUGCAAUGAUGUUUGUCAAACAUAAGCAUGCAUUUCUCUGUUUGUUUUUGUUACCUUCUCUUGCCACUGUAGCUUAUUUUAAUAUGGUCUAUAUGCCUGCUAGUUGGGUGAUGCGUAUUAUGACAUGGUUGGAUAUGGUUGAUACUAGUUUGUCUGGUUUUAAGCUAAAAGACUGUGUUAUGUAUGCAUCAGCUGUAGUGUUACUAAUCCUUAUGACAGCAAGAACUGUGUAUGAUGAUGGUGCUAGGAGAGUGUGGACACUUAUGAAUGUCUUGACACUCGUUUAUAAAGUUUAUUAUGGUAAUGCUUUAGAUCAAGCCAUUUCCAUGUGGGCUCUUAUAAUCUCUGUUACUUCUAACUACUCAGGUGUAGUUACAACUGUCAUGUUUUUGGCCAGAGGUAUUGUUUUUAUGUGUGUUGAGUAUUGCCCUAUUUUCUUCAUAACUGGUAAUACACUUCAGUGUAUAAUGCUAGUUUAUUGUUUCUUAGGCUAUUUUUGUACUUGUUACUUUGGCCUCUUUUGUUUACUCAACCGCUACUUUAGACUGACUCUUGGUGUUUAUGAUUACUUAGUUUCUACACAGGAGUUUAGAUAUAUGAAUUCACAGGGACUACUCCCACCCAAGAAUAGCAUAGAUGCCUUCAAACUCAACAUUAAAUUGUUGGGUGUUGGUGGCAAACCUUGUAUCAAAGUAGCCACUGUACAGUCUAAAAUGUCAGAUGUAAAGUGCACAUCAGUAGUCUUACUCUCAGUUUUGCAACAACUCAGAGUAGAAUCAUCAUCUAAAUUGUGGGCUCAAUGUGUCCAGUUACACAAUGACAUUCUCUUAGCUAAAGAUACUACUGAAGCCUUUGAAAAAAUGGUUUCACUACUUUCUGUUUUGCUUUCCAUGCAGGGUGCUGUAGACAUAAACAAGCUUUGUGAAGAAAUGCUGGACAACAGGGCAACCUUACAAGCUAUAGCCUCAGAGUUUAGUUCCCUUCCAUCAUAUGCAGCUUUUGCUACUGCUCAAGAAGCUUAUGAGCAGGCUGUUGCUAAUGGUGAUUCUGAAGUUGUUCUUAAAAAGUUGAAGAAGUCUUUGAAUGUGGCUAAAUCUGAAUUUGACCGUGAUGCAGCCAUGCAACGUAAGUUGGAAAAGAUGGCUGAUCAAGCUAUGACCCAAAUGUAUAAACAGGCUAGAUCUGAGGACAAGAGGGCAAAAGUUACUAGUGCUAUGCAGACAAUGCUUUUCACUAUGCUUAGAAAGUUGGAUAAUGAUGCACUCAACAACAUUAUCAACAAUGCAAGAGAUGGUUGUGUUCCCUUGAACAUAAUACCUCUUACAACAGCAGCCAAACUAAUGGUUGUCAUACCAGACUAUAACACAUAUAAAAAUACGUGUGAUGGUACAACAUUUACUUAUGCAUCAGCAUUGUGGGAAAUCCAACAGGUUGUAGAUGCAGAUAGUAAAAUUGUUCAACUUAGUGAAAUUAGUAUGGACAAUUCACCUAAUUUAGCAUGGCCUCUUAUUGUAACAGCUUUAAGGGCCAAUUCUGCUGUCAAAUUACAGAAUAAUGAGCUUAGUCCUGUUGCACUACGACAGAUGUCUUGUGCUGCCGGUACUACACAAACUGCUUGCACUGAUGACAAUGCGUUAGCUUACUACAACACAACAAAGGGAGGUAGGUUUGUACUUGCACUGUUAUCCGAUUUACAGGAUUUGAAAUGGGCUAGAUUCCCUAAGAGUGAUGGAACUGGUACUAUCUAUACAGAACUGGAACCACCUUGUAGGUUUGUUACAGACACACCUAAAGGUCCUAAAGUGAAGUAUUUAUACUUUAUUAAAGGAUUAAACAACCUAAAUAGAGGUAUGGUACUUGGUAGUUUAGCUGCCACAGUACGUCUACAAGCUGGUAAUGCAACAGAAGUGCCUGCCAAUUCAACUGUAUUAUCUUUCUGUGCUUUUGCUGUAGAUGCUGCUAAAGCUUACAAAGAUUAUCUAGCUAGUGGGGGACAACCAAUCACUAAUUGUGUUAAGAUGUUGUGUACACACACUGGUACUGGUCAGGCAAUAACAGUUACACCGGAAGCCAAUAUGGAUCAAGAAUCCUUUGGUGGUGCAUCGUGUUGUCUGUACUGCCGUUGCCACAUAGAUCAUCCAAAUCCUAAAGGAUUUUGUGACUUAAAAGGUAAGUAUGUACAAAUACCUACAACUUGUGCUAAUGACCCUGUGGGUUUUACACUUAAAAACACAGUCUGUACCGUCUGCGGUAUGUGGAAAGGUUAUGGCUGUAGUUGUGAUCAACUCCGCGAACCCAUGCUUCAGUCAGCUGAUGCACAAUCGUUUUUAAACGGGUUUGCGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGGCACUAGUACUGAUGUCGUAUACAGGGCUUUUGACAUCUACAAUGAUAAAGUAGCUGGUUUUGCUAAAUUCCUAAAAACUAAUUGUUGUCGCUUCCAAGAAAAGGACGAAGAUGACAAUUUAAUUGAUUCUUACUUUGUAGUUAAGAGACACACUUUCUCUAACUACCAACAUGAAGAAACAAUUUAUAAUUUACUUAAGGAUUGUCCAGCUGUUGCUAAACAUGACUUCUUUAAGUUUAGAAUAGACGGUGACAUGGUACCACAUAUAUCACGUCAACGUCUUACUAAAUACACAAUGGCAGACCUCGUCUAUGCUUUAAGGCAUUUUGAUGAAGGUAAUUGUGACACAUUAAAAGAAAUACUUGUCACAUACAAUUGUUGUGAUGAUGAUUAUUUCAAUAAAAAGGACUGGUAUGAUUUUGUAGAAAACCCAGAUAUAUUACGCGUAUACGCCAACUUAGGUGAACGUGUACGCCAAGCUUUGUUAAAAACAGUACAAUUCUGUGAUGCCAUGCGAAAUGCUGGUAUUGUUGGUGUACUGACAUUAGAUAAUCAAGAUCUCAAUGGUAACUGGUAUGAUUUCGGUGAUUUCAUACAAACCACGCCAGGUAGUGGAGUUCCUGUUGUAGAUUCUUAUUAUUCAUUGUUAAUGCCUAUAUUAACCUUGACCAGGGCUUUAACUGCAGAGUCACAUGUUGACACUGACUUAACAAAGCCUUACAUUAAGUGGGAUUUGUUAAAAUAUGACUUCACGGAAGAGAGGUUAAAACUCUUUGACCGUUAUUUUAAAUAUUGGGAUCAGACAUACCACCCAAAUUGUGUUAACUGUUUGGAUGACAGAUGCAUUCUGCAUUGUGCAAACUUUAAUGUUUUAUUCUCUACAGUGUUCCCACCUACAAGUUUUGGACCACUAGUGAGAAAAAUAUUUGUUGAUGGUGUUCCAUUUGUAGUUUCAACUGGAUACCACUUCAGAGAGCUAGGUGUUGUACAUAAUCAGGAUGUAAACUUACAUAGCUCUAGACUUAGUUUUAAGGAAUUACUUGUGUAUGCUGCUGACCCUGCUAUGCACGCUGCUUCUGGUAAUCUAUUACUAGAUAAACGCACUACGUGCUUUUCAGUAGCUGCACUUACUAACAAUGUUGCUUUUCAAACUGUCAAACCCGGUAAUUUUAACAAAGACUUCUAUGACUUUGCUGUGUCUAAGGGUUUCUUUAAGGAAGGAAGUUCUGUUGAAUUAAAACACUUCUUCUUUGCUCAGGAUGGUAAUGCUGCUAUCAGCGAUUAUGACUACUAUCGUUAUAAUCUACCAACAAUGUGUGAUAUCAGACAACUACUAUUUGUAGUUGAAGUUGUUGAUAAGUACUUUGAUUGUUACGAUGGUGGCUGUAUUAAUGCUAACCAAGUCAUCGUCAACAACCUAGACAAAUCAGCUGGUUUUCCAUUUAAUAAAUGGGGUAAGGCUAGACUUUAUUAUGAUUCAAUGAGUUAUGAGGAUCAAGAUGCACUUUUCGCAUAUACAAAACGUAAUGUCAUCCCUACUAUAACUCAAAUGAAUCUUAAGUAUGCCAUUAGUGCAAAGAAUAGAGCUCGCACCGUAGCUGGUGUCUCUAUCUGUAGUACUAUGACCAAUAGACAGUUUCAUCAAAAAUUAUUGAAAUCAAUAGCCGCCACUAGAGGAGCUACUGUAGUAAUUGGAACAAGCAAAUUCUAUGGUGGUUGGCACAACAUGUUAAAAACUGUUUAUAGUGAUGUAGAAAACCCUCACCUUAUGGGUUGGGAUUAUCCUAAAUGUGAUAGAGCCAUGCCUAACAUGCUUAGAAUUAUGGCCUCACUUGUUCUUGCUCGCAAACAUACAACGUGUUGUAGCUUGUCACACCGUUUCUAUAGAUUAGCUAAUGAGUGUGCUCAAGUAUUGAGUGAAAUGGUCAUGUGUGGCGGUUCACUAUAUGUUAAACCAGGUGGAACCUCAUCAGGAGAUGCCACAACUGCUUAUGCUAAUAGUGUUUUUAACAUUUGUCAAGCUGUCACGGCCAAUGUUAAUGCACUUUUAUCUACUGAUGGUAACAAAAUUGCCGAUAAGUAUGUCCGCAAUUUACAACACAGACUUUAUGAGUGUCUCUAUAGAAAUAGAGAUGUUGACACAGACUUUGUGAAUGAGUUUUACGCAUAUUUGCGUAAACAUUUCUCAAUGAUGAUACUCUCUGACGAUGCUGUUGUGUGUUUCAAUAGCACUUAUGCAUCUCAAGGUCUAGUGGCUAGCAUAAAGAACUUUAAGUCAGUUCUUUAUUAUCAAAACAAUGUUUUUAUGUCUGAAGCAAAAUGUUGGACUGAGACUGACCUUACUAAAGGACCUCAUGAAUUUUGCUCUCAACAUACAAUGCUAGUUAAACAGGGUGAUGAUUAUGUGUACCUUCCUUACCCAGAUCCAUCAAGAAUCCUAGGGGCCGGCUGUUUUGUAGAUGAUAUCGUAAAAACAGAUGGUACACUUAUGAUUGAACGGUUCGUGUCUUUAGCUAUAGAUGCUUACCCACUUACUAAACAUCCUAAUCAGGAGUAUGCUGAUGUCUUUCAUUUGUACUUACAAUACAUAAGAAAGCUACAUGAUGAGUUAACAGGACACAUGUUAGACAUGUAUUCUGUUAUGCUUACUAAUGAUAACACUUCAAGGUAUUGGGAACCUGAGUUUUAUGAGGCUAUGUACACACCGCAUACAGUCUUACAGGCUGUUGGGGCUUGUGUUCUUUGCAAUUCACAGACUUCAUUAAGAUGUGGUGCUUGCAUACGUAGACCAUUCUUAUGUUGUAAAUGCUGUUACGACCAUGUCAUAUCAACAUCACAUAAAUUAGUCUUGUCUGUUAAUCCGUAUGUUUGCAAUGCUCCAGGUUGUGAUGUCACAGAUGUGACUCAACUUUACUUAGGAGGUAUGAGCUAUUAUUGUAAAUCACAUAAACCACCCAUUAGUUUUCCAUUGUGUGCUAAUGGACAAGUUUUUGGUUUAUAUAAAAAUACAUGUGUUGGUAGCGAUAAUGUUACUGACUUUAAUGCAAUUGCAACAUGUGACUGGACAAAUGCUGGUGAUUACAUUUUAGCUAACACCUGUACUGAAAGACUCAAGCUUUUUGCAGCAGAAACGCUCAAAGCUACUGAGGAGACAUUUAAACUGUCUUAUGGUAUUGCUACUGUACGUGAAGUGCUGUCUGACAGAGAAUUACAUCUUUCAUGGGAAGUUGGUAAACCUAGACCACCACUUAACCGAAAUUAUGUCUUUACUGGUUAUCGUGUAACUAAAAACAGUAAAGUACAAAUAGGAGAGUACACCUUUGAAAAAGGUGACUAUGGUGAUGCUGUUGUUUACCGAGGUACAACAACUUACAAAUUAAAUGUUGGUGAUUAUUUUGUGCUGACAUCACAUACAGUAAUGCCAUUAAGUGCACCUACACUAGUGCCACAAGAGCACUAUGUUAGAAUUACUGGCUUAUACCCAACACUCAAUAUCUCAGAUGAGUUUUCUAGCAAUGUUGCAAAUUAUCAAAAGGUUGGUAUGCAAAAGUAUUCUACACUCCAGGGACCACCUGGUACUGGUAAGAGUCAUUUUGCUAUUGGCCUAGCUCUCUACUACCCUUCUGCUCGCAUAGUGUAUACAGCUUGCUCUCAUGCCGCUGUUGAUGCACUAUGUGAGAAGGCAUUAAAAUAUUUGCCUAUAGAUAAAUGUAGUAGAAUUAUACCUGCACGUGCUCGUGUAGAGUGUUUUGAUAAAUUCAAAGUGAAUUCAACAUUAGAACAGUAUGUCUUUUGUACUGUAAAUGCAUUGCCUGAGACGACAGCAGAUAUAGUUGUCUUUGAUGAAAUUUCAAUGGCCACAAAUUAUGAUUUGAGUGUUGUCAAUGCCAGAUUACGUGCUAAGCACUAUGUGUACAUUGGCGACCCUGCUCAAUUACCUGCACCACGCACAUUGCUAACUAAGGGCACACUAGAACCAGAAUAUUUCAAUUCAGUGUGUAGACUUAUGAAAACUAUAGGUCCAGACAUGUUCCUCGGAACUUGUCGGCGUUGUCCUGCUGAAAUUGUUGACACUGUGAGUGCUUUGGUUUAUGAUAAUAAGCUUAAAGCACAUAAAGACAAAUCAGCUCAAUGCUUUAAAAUGUUUUAUAAGGGUGUUAUCACGCAUGAUGUUUCAUCUGCAAUUAACAGGCCACAAAUAGGCGUGGUAAGAGAAUUCCUUACACGUAACCCUGCUUGGAGAAAAGCUGUCUUUAUUUCACCUUAUAAUUCACAGAAUGCUGUAGCCUCAAAGAUUUUGGGACUACCAACUCAAACUGUUGAUUCAUCACAGGGCUCAGAAUAUGACUAUGUCAUAUUCACUCAAACCACUGAAACAGCUCACUCUUGUAAUGUAAACAGAUUUAAUGUUGCUAUUACCAGAGCAAAAGUAGGCAUACUUUGCAUAAUGUCUGAUAGAGACCUUUAUGACAAGUUGCAAUUUACAAGUCUUGAAAUUCCACGUAGGAAUGUGGCAACUUUACAAGCUGAAAAUGUAACAGGACUCUUUAAAGAUUGUAGUAAGGUAAUCACUGGGUUACAUCCUACACAGGCACCUACACACCUCAGUGUUGACACUAAAUUCAAAACUGAAGGUUUAUGUGUUGACAUACCUGGCAUACCUAAGGACAUGACCUAUAGAAGACUCAUCUCUAUGAUGGGUUUUAAAAUGAAUUAUCAAGUUAAUGGUUACCCUAACAUGUUUAUCACCCGCGAAGAAGCUAUAAGACAUGUACGUGCAUGGAUUGGCUUCGAUGUCGAGGGGUGUCAUGCUACUAGAGAAGCUGUUGGUACCAAUUUACCUUUACAGCUAGGUUUUUCUACAGGUGUUAACCUAGUUGCUGUACCUACAGGUUAUGUUGAUACACCUAAUAAUACAGAUUUUUCCAGAGUUAGUGCUAAACCACCGCCUGGAGAUCAAUUUAAACACCUCAUACCACUUAUGUACAAAGGACUUCCUUGGAAUGUAGUGCGUAUAAAGAUUGUACAAAUGUUAAGUGACACACUUAAAAAUCUCUCUGACAGAGUCGUAUUUGUCUUAUGGGCACAUGGCUUUGAGUUGACAUCUAUGAAGUAUUUUGUGAAAAUAGGACCUGAGCGCACCUGUUGUCUAUGUGAUAGACGUGCCACAUGCUUUUCCACUGCUUCAGACACUUAUGCCUGUUGGCAUCAUUCUAUUGGAUUUGAUUACGUCUAUAAUCCGUUUAUGAUUGAUGUUCAACAAUGGGGUUUUACAGGUAACCUACAAAGCAACCAUGAUCUGUAUUGUCAAGUCCAUGGUAAUGCACAUGUAGCUAGUUGUGAUGCAAUCAUGACUAGGUGUCUAGCUGUCCACGAGUGCUUUGUUAAGCGUGUUGACUGGACUAUUGAAUAUCCUAUAAUUGGUGAUGAACUGAAGAUUAAUGCGGCUUGUAGAAAGGUUCAACACAUGGUUGUUAAAGCUGCAUUAUUAGCAGACAAAUUCCCAGUUCUUCACGACAUUGGUAACCCUAAAGCUAUUAAGUGUGUACCUCAAGCUGAUGUAGAAUGGAAGUUCUAUGAUGCACAGCCUUGUAGUGACAAAGCUUAUAAAAUAGAAGAAUUAUUCUAUUCUUAUGCCACACAUUCUGACAAAUUCACAGAUGGUGUAUGCCUAUUUUGGAAUUGCAAUGUCGAUAGAUAUCCUGCUAAUUCCAUUGUUUGUAGAUUUGACACUAGAGUGCUAUCUAACCUUAACUUGCCUGGUUGUGAUGGUGGCAGUUUGUAUGUAAAUAAACAUGCAUUCCACACACCAGCUUUUGAUAAAAGUGCUUUUGUUAAUUUAAAACAAUUACCAUUUUUCUAUUACUCUGACAGUCCAUGUGAGUCUCAUGGAAAACAAGUAGUGUCAGAUAUAGAUUAUGUACCACUAAAGUCUGCUACGUGUAUAACACGUUGCAAUUUAGGUGGUGCUGUCUGUAGACAUCAUGCUAAUGAGUACAGAUUGUAUCUCGAUGCUUAUAACAUGAUGAUCUCAGCUGGCUUUAGCUUGUGGGUUUACAAACAAUUUGAUACUUAUAACCUCUGGAACACUUUUACAAGACUUCAGAGUUUAGAAAAUGUGGCUUUUAAUGUUGUAAAUAAGGGACACUUUGAUGGACAACAGGGUGAAGUACCAGUUUCUAUCAUUAAUAACACUGUUUACACAAAAGUUGAUGGUGUUGAUGUAGAAUUGUUUGAAAAUAAAACAACAUUACCUGUUAAUGUAGCAUUUGAGCUUUGGGCUAAGCGCAACAUUAAACCAGUACCAGAGGUGAAAAUACUCAAUAAUUUGGGUGUGGACAUUGCUGCUAAUACUGUGAUCUGGGACUACAAAAGAGAUGCUCCAGCACAUAUAUCUACUAUUGGUGUUUGUUCUAUGACUGACAUAGCCAAGAAACCAACUGAAACGAUUUGUGCACCACUCACUGUCUUUUUUGAUGGUAGAGUUGAUGGUCAAGUAGACUUAUUUAGAAAUGCCCGUAAUGGUGUUCUUAUUACAGAAGGUAGUGUUAAAGGUUUACAACCAUCUGUAGGUCCCAAACAAGCUAGUCUUAAUGGAGUCACAUUAAUUGGAGAAGCCGUAAAAACACAGUUCAAUUAUUAUAAGAAAGUUGAUGGUGUUGUCCAACAAUUACCUGAAACUUACUUUACUCAGAGUAGAAAUUUACAAGAAUUUAAACCCAGGAGUCAAAUGGAAAUUGAUUUCUUAGAAUUAGCUAUGGAUGAAUUCAUUGAACGGUAUAAAUUAGAAGGCUAUGCCUUCGAACAUAUCGUUUAUGGAGAUUUUAGUCAUAGUCAGUUAGGUGGUUUACAUCUACUGAUUGGACUAGCUAAACGUUUUAAGGAAUCACCUUUUGAAUUAGAAGAUUUUAUUCCUAUGGACAGUACAGUUAAAAACUAUUUCAUAACAGAUGCGCAAACAGGUUCAUCUAAGUGUGUGUGUUCUGUUAUUGAUUUAUUACUUGAUGAUUUUGUUGAAAUAAUAAAAUCCCAAGAUUUAUCUGUAGUUUCUAAGGUUGUCAAAGUGACUAUUGACUAUACAGAAAUUUCAUUUAUGCUUUGGUGUAAAGAUGGCCAUGUAGAAACAUUUUACCCAAAAUUACAAUCUAGUCAAGCGUGGCAACCGGGUGUUGCUAUGCCUAAUCUUUACAAAAUGCAAAGAAUGCUAUUAGAAAAGUGUGACCUUCAAAAUUAUGGUGAUAGUGCAACAUUACCUAAAGGCAUAAUGAUGAAUGUCGCAAAAUAUACUCAACUGUGUCAAUAUUUAAACACAUUAACAUUAGCUGUACCCUAUAAUAUGAGAGUUAUACAUUUUGGUGCUGGUUCUGAUAAAGGAGUUGCACCAGGUACAGCUGUUUUAAGACAGUGGUUGCCUACGGGUACGCUGCUUGUCGAUUCAGAUCUUAAUGACUUUGUCUCUGAUGCAGAUUCAACUUUGAUUGGUGAUUGUGCAACUGUACAUACAGCUAAUAAAUGGGAUCUCAUUAUUAGUGAUAUGUACGACCCUAAGACUAAAAAUGUUACAAAAGAAAAUGACUCUAAAGAGGGUUUUUUCACUUACAUUUGUGGGUUUAUACAACAAAAGCUAGCUCUUGGAGGUUCCGUGGCUAUAAAGAUAACAGAACAUUCUUGGAAUGCUGAUCUUUAUAAGCUCAUGGGACACUUCGCAUGGUGGACAGCCUUUGUUACUAAUGUGAAUGCGUCAUCAUCUGAAGCAUUUUUAAUUGGAUGUAAUUAUCUUGGCAAACCACGCGAACAAAUAGAUGGUUAUGUCAUGCAUGCAAAUUACAUAUUUUGGAGGAAUACAAAUCCAAUUCAGUUGUCUUCCUAUUCUUUAUUUGACAUGAGUAAAUUUCCCCUUAAAUUAAGGGGUACUGCUGUUAUGUCUUUAAAAGAAGGUCAAAUCAAUGAUAUGAUUUUAUCUCUUCUUAGUAAAGGUAGACUUAUAAUUAGAGAAAACAACAGAGUUGUUAUUUCUAGUGAUGUUCUUGUUAACAACUAAACGAACAAUGUUUGUUUUUCUUGUUUUAUUGCCACUAGUCUCUAGUCAGUGUGUUAAUCUUACAACCAGAACUCAAUUACCCCCUGCAUACACUAAUUCUUUCACACGUGGUGUUUAUUACCCUGACAAAGUUUUCAGAUCCUCAGUUUUACAUUCAACUCAGGACUUGUUCUUACCUUUCUUUUCCAAUGUUACUUGGUUCCAUGCUAUACAUGUCUCUGGGACCAAUGGUACUAAGAGGUUUGAUAACCCUGUCCUACCAUUUAAUGAUGGUGUUUAUUUUGCUUCCACUGAGAAGUCUAACAUAAUAAGAGGCUGGAUUUUUGGUACUACUUUAGAUUCGAAGACCCAGUCCCUACUUAUUGUUAAUAACGCUACUAAUGUUGUUAUUAAAGUCUGUGAAUUUCAAUUUUGUAAUGAUCCAUUUUUGGGUGUUUAUUACCACAAAAACAACAAAAGUUGGAUGGAAAGUGAGUUCAGAGUUUAUUCUAGUGCGAAUAAUUGCACUUUUGAAUAUGUCUCUCAGCCUUUUCUUAUGGACCUUGAAGGAAAACAGGGUAAUUUCAAAAAUCUUAGGGAAUUUGUGUUUAAGAAUAUUGAUGGUUAUUUUAAAAUAUAUUCUAAGCACACGCCUAUUAAUUUAGUGCGUGAUCUCCCUCAGGGUUUUUCGGCUUUAGAACCAUUGGUAGAUUUGCCAAUAGGUAUUAACAUCACUAGGUUUCAAACUUUACUUGCUUUACAUAGAAGUUAUUUGACUCCUGGUGAUUCUUCUUCAGGUUGGACAGCUGGUGCUGCAGCUUAUUAUGUGGGUUAUCUUCAACCUAGGACUUUUCUAUUAAAAUAUAAUGAAAAUGGAACCAUUACAGAUGCUGUAGACUGUGCACUUGACCCUCUCUCAGAAACAAAGUGUACGUUGAAAUCCUUCACUGUAGAAAAAGGAAUCUAUCAAACUUCUAACUUUAGAGUCCAACCAACAGAAUCUAUUGUUAGAUUUCCUAAUAUUACAAACUUGUGCCCUUUUGGUGAAGUUUUUAACGCCACCAGAUUUGCAUCUGUUUAUGCUUGGAACAGGAAGAGAAUCAGCAACUGUGUUGCUGAUUAUUCUGUCCUAUAUAAUUCCGCAUCAUUUUCCACUUUUAAGUGUUAUGGAGUGUCUCCUACUAAAUUAAAUGAUCUCUGCUUUACUAAUGUCUAUGCAGAUUCAUUUGUAAUUAGAGGUGAUGAAGUCAGACAAAUCGCUCCAGGGCAAACUGGAAAGAUUGCUGAUUAUAAUUAUAAAUUACCAGAUGAUUUUACAGGCUGCGUUAUAGCUUGGAAUUCUAACAAUCUUGAUUCUAAGGUUGGUGGUAAUUAUAAUUACCUGUAUAGAUUGUUUAGGAAGUCUAAUCUCAAACCUUUUGAGAGAGAUAUUUCAACUGAAAUCUAUCAGGCCGGUAGCACACCUUGUAAUGGUGUUGAAGGUUUUAAUUGUUACUUUCCUUUACAAUCAUAUGGUUUCCAACCCACUAAUGGUGUUGGUUACCAACCAUACAGAGUAGUAGUACUUUCUUUUGAACUUCUACAUGCACCAGCAACUGUUUGUGGACCUAAAAAGUCUACUAAUUUGGUUAAAAACAAAUGUGUCAAUUUCAACUUCAAUGGUUUAACAGGCACAGGUGUUCUUACUGAGUCUAACAAAAAGUUUCUGCCUUUCCAACAAUUUGGCAGAGACAUUGCUGACACUACUGAUGCUGUCCGUGAUCCACAGACACUUGAGAUUCUUGACAUUACACCAUGUUCUUUUGGUGGUGUCAGUGUUAUAACACCAGGAACAAAUACUUCUAACCAGGUUGCUGUUCUUUAUCAGGAUGUUAACUGCACAGAAGUCCCUGUUGCUAUUCAUGCAGAUCAACUUACUCCUACUUGGCGUGUUUAUUCUACAGGUUCUAAUGUUUUUCAAACACGUGCAGGCUGUUUAAUAGGGGCUGAACAUGUCAACAACUCAUAUGAGUGUGACAUACCCAUUGGUGCAGGUAUAUGCGCUAGUUAUCAGACUCAGACUAAUUCUCCUCGGCGGGCACGUAGUGUAGCUAGUCAAUCCAUCAUUGCCUACACUAUGUCACUUGGUGCAGAAAAUUCAGUUGCUUACUCUAAUAACUCUAUUGCCAUACCCACAAAUUUUACUAUUAGUGUUACCACAGAAAUUCUACCAGUGUCUAUGACCAAGACAUCAGUAGAUUGUACAAUGUACAUUUGUGGUGAUUCAACUGAAUGCAGCAAUCUUUUGUUGCAAUAUGGCAGUUUUUGUACACAAUUAAACCGUGCUUUAACUGGAAUAGCUGUUGAACAAGACAAAAACACCCAAGAAGUUUUUGCACAAGUCAAACAAAUUUACAAAACACCACCAAUUAAAGAUUUUGGUGGUUUUAAUUUUUCACAAAUAUUACCAGAUCCAUCAAAACCAAGCAAGAGGUCAUUUAUUGAAGAUCUACUUUUCAACAAAGUGACACUUGCAGAUGCUGGCUUCAUCAAACAAUAUGGUGAUUGCCUUGGUGAUAUUGCUGCUAGAGACCUCAUUUGUGCACAAAAGUUUAACGGCCUUACUGUUUUGCCACCUUUGCUCACAGAUGAAAUGAUUGCUCAAUACACUUCUGCACUGUUAGCGGGUACAAUCACUUCUGGUUGGACCUUUGGUGCAGGUGCUGCAUUACAAAUACCAUUUGCUAUGCAAAUGGCUUAUAGGUUUAAUGGUAUUGGAGUUACACAGAAUGUUCUCUAUGAGAACCAAAAAUUGAUUGCCAACCAAUUUAAUAGUGCUAUUGGCAAAAUUCAAGACUCACUUUCUUCCACAGCAAGUGCACUUGGAAAACUUCAAGAUGUGGUCAACCAAAAUGCACAAGCUUUAAACACGCUUGUUAAACAACUUAGCUCCAAUUUUGGUGCAAUUUCAAGUGUUUUAAAUGAUAUCCUUUCACGUCUUGACAAAGUUGAGGCUGAAGUGCAAAUUGAUAGGUUGAUCACAGGCAGACUUCAAAGUUUGCAGACAUAUGUGACUCAACAAUUAAUUAGAGCUGCAGAAAUCAGAGCUUCUGCUAAUCUUGCUGCUACUAAAAUGUCAGAGUGUGUACUUGGACAAUCAAAAAGAGUUGAUUUUUGUGGAAAGGGCUAUCAUCUUAUGUCCUUCCCUCAGUCAGCACCUCAUGGUGUAGUCUUCUUGCAUGUGACUUAUGUCCCUGCACAAGAAAAGAACUUCACAACUGCUCCUGCCAUUUGUCAUGAUGGAAAAGCACACUUUCCUCGUGAAGGUGUCUUUGUUUCAAAUGGCACACACUGGUUUGUAACACAAAGGAAUUUUUAUGAACCACAAAUCAUUACUACAGACAACACAUUUGUGUCUGGUAACUGUGAUGUUGUAAUAGGAAUUGUCAACAACACAGUUUAUGAUCCUUUGCAACCUGAAUUAGACUCAUUCAAGGAGGAGUUAGAUAAAUAUUUUAAGAAUCAUACAUCACCAGAUGUUGAUUUAGGUGACAUCUCUGGCAUUAAUGCUUCAGUUGUAAACAUUCAAAAAGAAAUUGACCGCCUCAAUGAGGUUGCCAAGAAUUUAAAUGAAUCUCUCAUCGAUCUCCAAGAACUUGGAAAGUAUGAGCAGUAUAUAAAAUGGCCAUGGUACAUUUGGCUAGGUUUUAUAGCUGGCUUGAUUGCCAUAGUAAUGGUGACAAUUAUGCUUUGCUGUAUGACCAGUUGCUGUAGUUGUCUCAAGGGCUGUUGUUCUUGUGGAUCCUGCUGCAAAUUUGAUGAAGACGACUCUGAGCCAGUGCUCAAAGGAGUCAAAUUACAUUACACAUAAACGAACUUAUGGAUUUGUUUAUGAGAAUCUUCACAAUUGGAACUGUAACUUUGAAGCAAGGUGAAAUCAAGGAUGCUACUCCUUCAGAUUUUGUUCGCGCUACUGCAACGAUACCGAUACAAGCCUCACUCCCUUUCGGAUGGCUUAUUGUUGGCGUUGCACUUCUUGCUGUUUUUCAGAGCGCUUCCAAAAUCAUAACCCUCAAAAAGAGAUGGCAACUAGCACUCUCCAAGGGUGUUCACUUUGUUUGCAACUUGCUGUUGUUGUUUGUAACAGUUUACUCACACCUUUUGCUCGUUGCUGCUGGCCUUGAAGCCCCUUUUCUCUAUCUUUAUGCUUUAGUCUACUUCUUGCAGAGUAUAAACUUUGUAAGAAUAAUAAUGAGGCUUUGGCUUUGCUGGAAAUGCCGUUCCAAAAACCCAUUACUUUAUGAUGCCAACUAUUUUCUUUGCUGGCAUACUAAUUGUUACGACUAUUGUAUACCUUACAAUAGUGUAACUUCUUCAAUUGUCAUUACUUCAGGUGAUGGCACAACAAGUCCUAUUUCUGAACAUGACUACCAGAUUGGUGGUUAUACUGAAAAAUGGGAAUCUGGAGUAAAAGACUGUGUUGUAUUACACAGUUACUUCACUUCAGACUAUUACCAGCUGUACUCAACUCAAUUGAGUACAGACACUGGUGUUGAACAUGUUACCUUCUUCAUCUACAAUAAAAUUGUUGAUGAGCCUGAAGAACAUGUCCAAAUUCACACAAUCGACGGUUCAUCCGGAGUUGUUAAUCCAGUAAUGGAACCAAUUUAUGAUGAACCGACGACGACUACUAGCGUGCCUUUGUAAGCACAAGCUGAUGAGUACGAACUUAUGUACUCAUUCGUUUCGGAAGAGACAGGUACGUUAAUAGUUAAUAGCGUACUUCUUUUUCUUGCUUUCGUGGUAUUCUUGCUAGUUACACUAGCCAUCCUUACUGCGCUUCGAUUGUGUGCGUACUGCUGCAAUAUUGUUAACGUGAGUCUUGUAAAACCUUCUUUUUACGUUUACUCUCGUGUUAAAAAUCUGAAUUCUUCUAGAGUUCCUGAUCUUCUGGUCUAAACGAACUAAAUAUUAUAUUAGUUUUUCUGUUUGGAACUUUAAUUUUAGCCAUGGCAGAUUCCAACGGUACUAUUACCGUUGAAGAGCUUAAAAAGCUCCUUGAACAAUGGAACCUAGUAAUAGGUUUCCUAUUCCUUACAUGGAUUUGUCUUCUACAAUUUGCCUAUGCCAACAGGAAUAGGUUUUUGUAUAUAAUUAAGUUAAUUUUCCUCUGGCUGUUAUGGCCAGUAACUUUAGCUUGUUUUGUGCUUGCUGCUGUUUACAGAAUAAAUUGGAUCACCGGUGGAAUUGCUAUCGCAAUGGCUUGUCUUGUAGGCUUGAUGUGGCUCAGCUACUUCAUUGCUUCUUUCAGACUGUUUGCGCGUACGCGUUCCAUGUGGUCAUUCAAUCCAGAAACUAACAUUCUUCUCAACGUGCCACUCCAUGGCACUAUUCUGACCAGACCGCUUCUAGAAAGUGAACUCGUAAUCGGAGCUGUGAUCCUUCGUGGACAUCUUCGUAUUGCUGGACACCAUCUAGGACGCUGUGACAUCAAGGACCUGCCUAAAGAAAUCACUGUUGCUACAUCACGAACGCUUUCUUAUUACAAAUUGGGAGCUUCGCAGCGUGUAGCAGGUGACUCAGGUUUUGCUGCAUACAGUCGCUACAGGAUUGGCAACUAUAAAUUAAACACAGACCAUUCCAGUAGCAGUGACAAUAUUGCUUUGCUUGUACAGUAAGUGACAACAGAUGUUUCAUCUCGUUGACUUUCAGGUUACUAUAGCAGAGAUAUUACUAAUUAUUAUGAGGACUUUUAAAGUUUCCAUUUGGAAUCUUGAUUACAUCAUAAACCUCAUAAUUAAAAAUUUAUCUAAGUCACUAACUGAGAAUAAAUAUUCUCAAUUAGAUGAAGAGCAACCAAUGGAGAUUGAUUAAACGAACAUGAAAAUUAUUCUUUUCUUGGCACUGAUAACACUCGCUACUUGUGAGCUUUAUCACUACCAAGAGUGUGUUAGAGGUACAACAGUACUUUUAAAAGAACCUUGCUCUUCUGGAACAUACGAGGGCAAUUCACCAUUUCAUCCUCUAGCUGAUAACAAAUUUGCACUGACUUGCUUUAGCACUCAAUUUGCUUUUGCUUGUCCUGACGGCGUAAAACACGUCUAUCAGUUACGUGCCAGAUCAGUUUCACCUAAACUGUUCAUCAGACAAGAGGAAGUUCAAGAACUUUACUCUCCAAUUUUUCUUAUUGUUGCGGCAAUAGUGUUUAUAACACUUUGCUUCACACUCAAAAGAAAGACAGAAUGAUUGAACUUUCAUUAAUUGACUUCUAUUUGUGCUUUUUAGCCUUUCUGCUAUUCCUUGUUUUAAUUAUGCUUAUUAUCUUUUGGUUCUCACUUGAACUGCAAGAUCAUAAUGAAACUUGUCACGCCUAAACGAACAUGAAAUUUCUUGUUUUCUUAGGAAUCAUCACAACUGUAGCUGCAUUUCACCAAGAAUGUAGUUUACAGUCAUGUACUCAACAUCAACCAUAUGUAGUUGAUGACCCGUGUCCUAUUCACUUCUAUUCUAAAUGGUAUAUUAGAGUAGGAGCUAGAAAAUCAGCACCUUUAAUUGAAUUGUGCGUGGAUGAGGCUGGUUCUAAAUCACCCAUUCAGUACAUCGAUAUCGGUAAUUAUACAGUUUCCUGUUUACCUUUUACAAUUAAUUGCCAGGAACCUAAAUUGGGUAGUCUUGUAGUGCGUUGUUCGUUCUAUGAAGACUUUUUAGAGUAUCAUGACGUUCGUGUUGUUUUAGAUUUCAUCUAAACGAACAAACUAAAAUGUCUGAUAAUGGACCCCAAAAUCAGCGAAAUGCACCCCGCAUUACGUUUGGUGGACCCUCAGAUUCAACUGGCAGUAACCAGAAUGGAGAACGCAGUGGGGCGCGAUCAAAACAACGUCGGCCCCAAGGUUUACCCAAUAAUACUGCGUCUUGGUUCACCGCUCUCACUCAACAUGGCAAGGAAGACCUUAAAUUCCCUCGAGGACAAGGCGUUCCAAUUAACACCAAUAGCAGUCCAGAUGACCAAAUUGGCUACUACCGAAGAGCUACCAGACGAAUUCGUGGUGGUGACGGUAAAAUGAAAGAUCUCAGUCCAAGAUGGUAUUUCUACUACCUAGGAACUGGGCCAGAAGCUGGACUUCCCUAUGGUGCUAACAAAGACGGCAUCAUAUGGGUUGCAACUGAGGGAGCCUUGAAUACACCAAAAGAUCACAUUGGCACCCGCAAUCCUGCUAACAAUGCUGCAAUCGUGCUACAACUUCCUCAAGGAACAACAUUGCCAAAAGGCUUCUACGCAGAAGGGAGCAGAGGCGGCAGUCAAGCCUCUUCUCGUUCCUCAUCACGUAGUCGCAACAGUUCAAGAAAUUCAACUCCAGGCAGCAGUAGGGGAACUUCUCCUGCUAGAAUGGCUGGCAAUGGCGGUGAUGCUGCUCUUGCUUUGCUGCUGCUUGACAGAUUGAACCAGCUUGAGAGCAAAAUGUCUGGUAAAGGCCAACAACAACAAGGCCAAACUGUCACUAAGAAAUCUGCUGCUGAGGCUUCUAAGAAGCCUCGGCAAAAACGUACUGCCACUAAAGCAUACAAUGUAACACAAGCUUUCGGCAGACGUGGUCCAGAACAAACCCAAGGAAAUUUUGGGGACCAGGAACUAAUCAGACAAGGAACUGAUUACAAACAUUGGCCGCAAAUUGCACAAUUUGCCCCCAGCGCUUCAGCGUUCUUCGGAAUGUCGCGCAUUGGCAUGGAAGUCACACCUUCGGGAACGUGGUUGACCUACACAGGUGCCAUCAAAUUGGAUGACAAAGAUCCAAAUUUCAAAGAUCAAGUCAUUUUGCUGAAUAAGCAUAUUGACGCAUACAAAACAUUCCCACCAACAGAGCCUAAAAAGGACAAAAAGAAGAAGGCUGAUGAAACUCAAGCCUUACCGCAGAGACAGAAGAAACAGCAAACUGUGACUCUUCUUCCUGCUGCAGAUUUGGAUGAUUUCUCCAAACAAUUGCAACAAUCCAUGAGCAGUGCUGACUCAACUCAGGCCUAAACUCAUGCAGACCACACAAGGCAGAUGGGCUAUAUAAACGUUUUCGCUUUUCCGUUUACGAUAUAUAGUCUACUCUUGUGCAGAAUGAAUUCUCGUAACUACAUAGCACAAGUAGAUGUAGUUAACUUUAAUCUCACAUAGCAAUCUUUAAUCAGUGUGUAACAUUAGGGAGGACUUGAAAGAGCCACCACAUUUUCACCGAGGCCACGCGGAGUACGAUCGAGUGUACAGUGAACAAUGCUAGGGAGAGCUGCCUAUAUGGAAGAGCCCUAAUGUGUAAAAUUAAUUUUAGUAGUGCUAUCCCCAUGUGAUUUUAAUAGCUUCUUAGGAGAAUGACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,1–5 nM[SARS-CoV-2],"15 mM NaCl, 135 mM KCl, 5 mM phosphate, 1.5 mM MgCl2","20 mM Tris–HCl, pH 7.0",37˚C,-,other_molecular:1 mg ml−1 BSA,Surface plasmon resonance,liquid,"As expected, the SARS2-NP exhibited a high binding capacity for viral RNA, which was substantially reduced in the DD-depleted mutant (Fig. 1n), indicating that the DD is required for SARS2-NP to bind viral RNA",29903
212,700,PMID: 34239064,RNAPS0000450,https://pubmed.ncbi.nlm.nih.gov/34239064,RNA + protein,-,-,SARS-CoV-2 virus RNA,29903nt(1-29903),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCUGAAAAGAGCUAUGAAUUGCAGACACCUUUUGAAAUUAAAUUGGCAAAGAAAUUUGACACCUUCAAUGGGGAAUGUCCAAAUUUUGUAUUUCCCUUAAAUUCCAUAAUCAAGACUAUUCAACCAAGGGUUGAAAAGAAAAAGCUUGAUGGCUUUAUGGGUAGAAUUCGAUCUGUCUAUCCAGUUGCGUCACCAAAUGAAUGCAACCAAAUGUGCCUUUCAACUCUCAUGAAGUGUGAUCAUUGUGGUGAAACUUCAUGGCAGACGGGCGAUUUUGUUAAAGCCACUUGCGAAUUUUGUGGCACUGAGAAUUUGACUAAAGAAGGUGCCACUACUUGUGGUUACUUACCCCAAAAUGCUGUUGUUAAAAUUUAUUGUCCAGCAUGUCACAAUUCAGAAGUAGGACCUGAGCAUAGUCUUGCCGAAUACCAUAAUGAAUCUGGCUUGAAAACCAUUCUUCGUAAGGGUGGUCGCACUAUUGCCUUUGGAGGCUGUGUGUUCUCUUAUGUUGGUUGCCAUAACAAGUGUGCCUAUUGGGUUCCACGUGCUAGCGCUAACAUAGGUUGUAACCAUACAGGUGUUGUUGGAGAAGGUUCCGAAGGUCUUAAUGACAACCUUCUUGAAAUACUCCAAAAAGAGAAAGUCAACAUCAAUAUUGUUGGUGACUUUAAACUUAAUGAAGAGAUCGCCAUUAUUUUGGCAUCUUUUUCUGCUUCCACAAGUGCUUUUGUGGAAACUGUGAAAGGUUUGGAUUAUAAAGCAUUCAAACAAAUUGUUGAAUCCUGUGGUAAUUUUAAAGUUACAAAAGGAAAAGCUAAAAAAGGUGCCUGGAAUAUUGGUGAACAGAAAUCAAUACUGAGUCCUCUUUAUGCAUUUGCAUCAGAGGCUGCUCGUGUUGUACGAUCAAUUUUCUCCCGCACUCUUGAAACUGCUCAAAAUUCUGUGCGUGUUUUACAGAAGGCCGCUAUAACAAUACUAGAUGGAAUUUCACAGUAUUCACUGAGACUCAUUGAUGCUAUGAUGUUCACAUCUGAUUUGGCUACUAACAAUCUAGUUGUAAUGGCCUACAUUACAGGUGGUGUUGUUCAGUUGACUUCGCAGUGGCUAACUAACAUCUUUGGCACUGUUUAUGAAAAACUCAAACCCGUCCUUGAUUGGCUUGAAGAGAAGUUUAAGGAAGGUGUAGAGUUUCUUAGAGACGGUUGGGAAAUUGUUAAAUUUAUCUCAACCUGUGCUUGUGAAAUUGUCGGUGGACAAAUUGUCACCUGUGCAAAGGAAAUUAAGGAGAGUGUUCAGACAUUCUUUAAGCUUGUAAAUAAAUUUUUGGCUUUGUGUGCUGACUCUAUCAUUAUUGGUGGAGCUAAACUUAAAGCCUUGAAUUUAGGUGAAACAUUUGUCACGCACUCAAAGGGAUUGUACAGAAAGUGUGUUAAAUCCAGAGAAGAAACUGGCCUACUCAUGCCUCUAAAAGCCCCAAAAGAAAUUAUCUUCUUAGAGGGAGAAACACUUCCCACAGAAGUGUUAACAGAGGAAGUUGUCUUGAAAACUGGUGAUUUACAACCAUUAGAACAACCUACUAGUGAAGCUGUUGAAGCUCCAUUGGUUGGUACACCAGUUUGUAUUAACGGGCUUAUGUUGCUCGAAAUCAAAGACACAGAAAAGUACUGUGCCCUUGCACCUAAUAUGAUGGUAACAAACAAUACCUUCACACUCAAAGGCGGUGCACCAACAAAGGUUACUUUUGGUGAUGACACUGUGAUAGAAGUGCAAGGUUACAAGAGUGUGAAUAUCACUUUUGAACUUGAUGAAAGGAUUGAUAAAGUACUUAAUGAGAAGUGCUCUGCCUAUACAGUUGAACUCGGUACAGAAGUAAAUGAGUUCGCCUGUGUUGUGGCAGAUGCUGUCAUAAAAACUUUGCAACCAGUAUCUGAAUUACUUACACCACUGGGCAUUGAUUUAGAUGAGUGGAGUAUGGCUACAUACUACUUAUUUGAUGAGUCUGGUGAGUUUAAAUUGGCUUCACAUAUGUAUUGUUCUUUCUACCCUCCAGAUGAGGAUGAAGAAGAAGGUGAUUGUGAAGAAGAAGAGUUUGAGCCAUCAACUCAAUAUGAGUAUGGUACUGAAGAUGAUUACCAAGGUAAACCUUUGGAAUUUGGUGCCACUUCUGCUGCUCUUCAACCUGAAGAAGAGCAAGAAGAAGAUUGGUUAGAUGAUGAUAGUCAACAAACUGUUGGUCAACAAGACGGCAGUGAGGACAAUCAGACAACUACUAUUCAAACAAUUGUUGAGGUUCAACCUCAAUUAGAGAUGGAACUUACACCAGUUGUUCAGACUAUUGAAGUGAAUAGUUUUAGUGGUUAUUUAAAACUUACUGACAAUGUAUACAUUAAAAAUGCAGACAUUGUGGAAGAAGCUAAAAAGGUAAAACCAACAGUGGUUGUUAAUGCAGCCAAUGUUUACCUUAAACAUGGAGGAGGUGUUGCAGGAGCCUUAAAUAAGGCUACUAACAAUGCCAUGCAAGUUGAAUCUGAUGAUUACAUAGCUACUAAUGGACCACUUAAAGUGGGUGGUAGUUGUGUUUUAAGCGGACACAAUCUUGCUAAACACUGUCUUCAUGUUGUCGGCCCAAAUGUUAACAAAGGUGAAGACAUUCAACUUCUUAAGAGUGCUUAUGAAAAUUUUAAUCAGCACGAAGUUCUACUUGCACCAUUAUUAUCAGCUGGUAUUUUUGGUGCUGACCCUAUACAUUCUUUAAGAGUUUGUGUAGAUACUGUUCGCACAAAUGUCUACUUAGCUGUCUUUGAUAAAAAUCUCUAUGACAAACUUGUUUCAAGCUUUUUGGAAAUGAAGAGUGAAAAGCAAGUUGAACAAAAGAUCGCUGAGAUUCCUAAAGAGGAAGUUAAGCCAUUUAUAACUGAAAGUAAACCUUCAGUUGAACAGAGAAAACAAGAUGAUAAGAAAAUCAAAGCUUGUGUUGAAGAAGUUACAACAACUCUGGAAGAAACUAAGUUCCUCACAGAAAACUUGUUACUUUAUAUUGACAUUAAUGGCAAUCUUCAUCCAGAUUCUGCCACUCUUGUUAGUGACAUUGACAUCACUUUCUUAAAGAAAGAUGCUCCAUAUAUAGUGGGUGAUGUUGUUCAAGAGGGUGUUUUAACUGCUGUGGUUAUACCUACUAAAAAGGCUGGUGGCACUACUGAAAUGCUAGCGAAAGCUUUGAGAAAAGUGCCAACAGACAAUUAUAUAACCACUUACCCGGGUCAGGGUUUAAAUGGUUACACUGUAGAGGAGGCAAAGACAGUGCUUAAAAAGUGUAAAAGUGCCUUUUACAUUCUACCAUCUAUUAUCUCUAAUGAGAAGCAAGAAAUUCUUGGAACUGUUUCUUGGAAUUUGCGAGAAAUGCUUGCACAUGCAGAAGAAACACGCAAAUUAAUGCCUGUCUGUGUGGAAACUAAAGCCAUAGUUUCAACUAUACAGCGUAAAUAUAAGGGUAUUAAAAUACAAGAGGGUGUGGUUGAUUAUGGUGCUAGAUUUUACUUUUACACCAGUAAAACAACUGUAGCGUCACUUAUCAACACACUUAACGAUCUAAAUGAAACUCUUGUUACAAUGCCACUUGGCUAUGUAACACAUGGCUUAAAUUUGGAAGAAGCUGCUCGGUAUAUGAGAUCUCUCAAAGUGCCAGCUACAGUUUCUGUUUCUUCACCUGAUGCUGUUACAGCGUAUAAUGGUUAUCUUACUUCUUCUUCUAAAACACCUGAAGAACAUUUUAUUGAAACCAUCUCACUUGCUGGUUCCUAUAAAGAUUGGUCCUAUUCUGGACAAUCUACACAACUAGGUAUAGAAUUUCUUAAGAGAGGUGAUAAAAGUGUAUAUUACACUAGUAAUCCUACCACAUUCCACCUAGAUGGUGAAGUUAUCACCUUUGACAAUCUUAAGACACUUCUUUCUUUGAGAGAAGUGAGGACUAUUAAGGUGUUUACAACAGUAGACAACAUUAACCUCCACACGCAAGUUGUGGACAUGUCAAUGACAUAUGGACAACAGUUUGGUCCAACUUAUUUGGAUGGAGCUGAUGUUACUAAAAUAAAACCUCAUAAUUCACAUGAAGGUAAAACAUUUUAUGUUUUACCUAAUGAUGACACUCUACGUGUUGAGGCUUUUGAGUACUACCACACAACUGAUCCUAGUUUUCUGGGUAGGUACAUGUCAGCAUUAAAUCACACUAAAAAGUGGAAAUACCCACAAGUUAAUGGUUUAACUUCUAUUAAAUGGGCAGAUAACAACUGUUAUCUUGCCACUGCAUUGUUAACACUCCAACAAAUAGAGUUGAAGUUUAAUCCACCUGCUCUACAAGAUGCUUAUUACAGAGCAAGGGCUGGUGAAGCUGCUAACUUUUGUGCACUUAUCUUAGCCUACUGUAAUAAGACAGUAGGUGAGUUAGGUGAUGUUAGAGAAACAAUGAGUUACUUGUUUCAACAUGCCAAUUUAGAUUCUUGCAAAAGAGUCUUGAACGUGGUGUGUAAAACUUGUGGACAACAGCAGACAACCCUUAAGGGUGUAGAAGCUGUUAUGUACAUGGGCACACUUUCUUAUGAACAAUUUAAGAAAGGUGUUCAGAUACCUUGUACGUGUGGUAAACAAGCUACAAAAUAUCUAGUACAACAGGAGUCACCUUUUGUUAUGAUGUCAGCACCACCUGCUCAGUAUGAACUUAAGCAUGGUACAUUUACUUGUGCUAGUGAGUACACUGGUAAUUACCAGUGUGGUCACUAUAAACAUAUAACUUCUAAAGAAACUUUGUAUUGCAUAGACGGUGCUUUACUUACAAAGUCCUCAGAAUACAAAGGUCCUAUUACGGAUGUUUUCUACAAAGAAAACAGUUACACAACAACCAUAAAACCAGUUACUUAUAAAUUGGAUGGUGUUGUUUGUACAGAAAUUGACCCUAAGUUGGACAAUUAUUAUAAGAAAGACAAUUCUUAUUUCACAGAGCAACCAAUUGAUCUUGUACCAAACCAACCAUAUCCAAACGCAAGCUUCGAUAAUUUUAAGUUUGUAUGUGAUAAUAUCAAAUUUGCUGAUGAUUUAAACCAGUUAACUGGUUAUAAGAAACCUGCUUCAAGAGAGCUUAAAGUUACAUUUUUCCCUGACUUAAAUGGUGAUGUGGUGGCUAUUGAUUAUAAACACUACACACCCUCUUUUAAGAAAGGAGCUAAAUUGUUACAUAAACCUAUUGUUUGGCAUGUUAACAAUGCAACUAAUAAAGCCACGUAUAAACCAAAUACCUGGUGUAUACGUUGUCUUUGGAGCACAAAACCAGUUGAAACAUCAAAUUCGUUUGAUGUACUGAAGUCAGAGGACGCGCAGGGAAUGGAUAAUCUUGCCUGCGAAGAUCUAAAACCAGUCUCUGAAGAAGUAGUGGAAAAUCCUACCAUACAGAAAGACGUUCUUGAGUGUAAUGUGAAAACUACCGAAGUUGUAGGAGACAUUAUACUUAAACCAGCAAAUAAUAGUUUAAAAAUUACAGAAGAGGUUGGCCACACAGAUCUAAUGGCUGCUUAUGUAGACAAUUCUAGUCUUACUAUUAAGAAACCUAAUGAAUUAUCUAGAGUAUUAGGUUUGAAAACCCUUGCUACUCAUGGUUUAGCUGCUGUUAAUAGUGUCCCUUGGGAUACUAUAGCUAAUUAUGCUAAGCCUUUUCUUAACAAAGUUGUUAGUACAACUACUAACAUAGUUACACGGUGUUUAAACCGUGUUUGUACUAAUUAUAUGCCUUAUUUCUUUACUUUAUUGCUACAAUUGUGUACUUUUACUAGAAGUACAAAUUCUAGAAUUAAAGCAUCUAUGCCGACUACUAUAGCAAAGAAUACUGUUAAGAGUGUCGGUAAAUUUUGUCUAGAGGCUUCAUUUAAUUAUUUGAAGUCACCUAAUUUUUCUAAACUGAUAAAUAUUAUAAUUUGGUUUUUACUAUUAAGUGUUUGCCUAGGUUCUUUAAUCUACUCAACCGCUGCUUUAGGUGUUUUAAUGUCUAAUUUAGGCAUGCCUUCUUACUGUACUGGUUACAGAGAAGGCUAUUUGAACUCUACUAAUGUCACUAUUGCAACCUACUGUACUGGUUCUAUACCUUGUAGUGUUUGUCUUAGUGGUUUAGAUUCUUUAGACACCUAUCCUUCUUUAGAAACUAUACAAAUUACCAUUUCAUCUUUUAAAUGGGAUUUAACUGCUUUUGGCUUAGUUGCAGAGUGGUUUUUGGCAUAUAUUCUUUUCACUAGGUUUUUCUAUGUACUUGGAUUGGCUGCAAUCAUGCAAUUGUUUUUCAGCUAUUUUGCAGUACAUUUUAUUAGUAAUUCUUGGCUUAUGUGGUUAAUAAUUAAUCUUGUACAAAUGGCCCCGAUUUCAGCUAUGGUUAGAAUGUACAUCUUCUUUGCAUCAUUUUAUUAUGUAUGGAAAAGUUAUGUGCAUGUUGUAGACGGUUGUAAUUCAUCAACUUGUAUGAUGUGUUACAAACGUAAUAGAGCAACAAGAGUCGAAUGUACAACUAUUGUUAAUGGUGUUAGAAGGUCCUUUUAUGUCUAUGCUAAUGGAGGUAAAGGCUUUUGCAAACUACACAAUUGGAAUUGUGUUAAUUGUGAUACAUUCUGUGCUGGUAGUACAUUUAUUAGUGAUGAAGUUGCGAGAGACUUGUCACUACAGUUUAAAAGACCAAUAAAUCCUACUGACCAGUCUUCUUACAUCGUUGAUAGUGUUACAGUGAAGAAUGGUUCCAUCCAUCUUUACUUUGAUAAAGCUGGUCAAAAGACUUAUGAAAGACAUUCUCUCUCUCAUUUUGUUAACUUAGACAACCUGAGAGCUAAUAACACUAAAGGUUCAUUGCCUAUUAAUGUUAUAGUUUUUGAUGGUAAAUCAAAAUGUGAAGAAUCAUCUGCAAAAUCAGCGUCUGUUUACUACAGUCAGCUUAUGUGUCAACCUAUACUGUUACUAGAUCAGGCAUUAGUGUCUGAUGUUGGUGAUAGUGCGGAAGUUGCAGUUAAAAUGUUUGAUGCUUACGUUAAUACGUUUUCAUCAACUUUUAACGUACCAAUGGAAAAACUCAAAACACUAGUUGCAACUGCAGAAGCUGAACUUGCAAAGAAUGUGUCCUUAGACAAUGUCUUAUCUACUUUUAUUUCAGCAGCUCGGCAAGGGUUUGUUGAUUCAGAUGUAGAAACUAAAGAUGUUGUUGAAUGUCUUAAAUUGUCACAUCAAUCUGACAUAGAAGUUACUGGCGAUAGUUGUAAUAACUAUAUGCUCACCUAUAACAAAGUUGAAAACAUGACACCCCGUGACCUUGGUGCUUGUAUUGACUGUAGUGCGCGUCAUAUUAAUGCGCAGGUAGCAAAAAGUCACAACAUUGCUUUGAUAUGGAACGUUAAAGAUUUCAUGUCAUUGUCUGAACAACUACGAAAACAAAUACGUAGUGCUGCUAAAAAGAAUAACUUACCUUUUAAGUUGACAUGUGCAACUACUAGACAAGUUGUUAAUGUUGUAACAACAAAGAUAGCACUUAAGGGUGGUAAAAUUGUUAAUAAUUGGUUGAAGCAGUUAAUUAAAGUUACACUUGUGUUCCUUUUUGUUGCUGCUAUUUUCUAUUUAAUAACACCUGUUCAUGUCAUGUCUAAACAUACUGACUUUUCAAGUGAAAUCAUAGGAUACAAGGCUAUUGAUGGUGGUGUCACUCGUGACAUAGCAUCUACAGAUACUUGUUUUGCUAACAAACAUGCUGAUUUUGACACAUGGUUUAGCCAGCGUGGUGGUAGUUAUACUAAUGACAAAGCUUGCCCAUUGAUUGCUGCAGUCAUAACAAGAGAAGUGGGUUUUGUCGUGCCUGGUUUGCCUGGCACGAUAUUACGCACAACUAAUGGUGACUUUUUGCAUUUCUUACCUAGAGUUUUUAGUGCAGUUGGUAACAUCUGUUACACACCAUCAAAACUUAUAGAGUACACUGACUUUGCAACAUCAGCUUGUGUUUUGGCUGCUGAAUGUACAAUUUUUAAAGAUGCUUCUGGUAAGCCAGUACCAUAUUGUUAUGAUACCAAUGUACUAGAAGGUUCUGUUGCUUAUGAAAGUUUACGCCCUGACACACGUUAUGUGCUCAUGGAUGGCUCUAUUAUUCAAUUUCCUAACACCUACCUUGAAGGUUCUGUUAGAGUGGUAACAACUUUUGAUUCUGAGUACUGUAGGCACGGCACUUGUGAAAGAUCAGAAGCUGGUGUUUGUGUAUCUACUAGUGGUAGAUGGGUACUUAACAAUGAUUAUUACAGAUCUUUACCAGGAGUUUUCUGUGGUGUAGAUGCUGUAAAUUUACUUACUAAUAUGUUUACACCACUAAUUCAACCUAUUGGUGCUUUGGACAUAUCAGCAUCUAUAGUAGCUGGUGGUAUUGUAGCUAUCGUAGUAACAUGCCUUGCCUACUAUUUUAUGAGGUUUAGAAGAGCUUUUGGUGAAUACAGUCAUGUAGUUGCCUUUAAUACUUUACUAUUCCUUAUGUCAUUCACUGUACUCUGUUUAACACCAGUUUACUCAUUCUUACCUGGUGUUUAUUCUGUUAUUUACUUGUACUUGACAUUUUAUCUUACUAAUGAUGUUUCUUUUUUAGCACAUAUUCAGUGGAUGGUUAUGUUCACACCUUUAGUACCUUUCUGGAUAACAAUUGCUUAUAUCAUUUGUAUUUCCACAAAGCAUUUCUAUUGGUUCUUUAGUAAUUACCUAAAGAGACGUGUAGUCUUUAAUGGUGUUUCCUUUAGUACUUUUGAAGAAGCUGCGCUGUGCACCUUUUUGUUAAAUAAAGAAAUGUAUCUAAAGUUGCGUAGUGAUGUGCUAUUACCUCUUACGCAAUAUAAUAGAUACUUAGCUCUUUAUAAUAAGUACAAGUAUUUUAGUGGAGCAAUGGAUACAACUAGCUACAGAGAAGCUGCUUGUUGUCAUCUCGCAAAGGCUCUCAAUGACUUCAGUAACUCAGGUUCUGAUGUUCUUUACCAACCACCACAAACCUCUAUCACCUCAGCUGUUUUGCAGAGUGGUUUUAGAAAAAUGGCAUUCCCAUCUGGUAAAGUUGAGGGUUGUAUGGUACAAGUAACUUGUGGUACAACUACACUUAACGGUCUUUGGCUUGAUGACGUAGUUUACUGUCCAAGACAUGUGAUCUGCACCUCUGAAGACAUGCUUAACCCUAAUUAUGAAGAUUUACUCAUUCGUAAGUCUAAUCAUAAUUUCUUGGUACAGGCUGGUAAUGUUCAACUCAGGGUUAUUGGACAUUCUAUGCAAAAUUGUGUACUUAAGCUUAAGGUUGAUACAGCCAAUCCUAAGACACCUAAGUAUAAGUUUGUUCGCAUUCAACCAGGACAGACUUUUUCAGUGUUAGCUUGUUACAAUGGUUCACCAUCUGGUGUUUACCAAUGUGCUAUGAGGCCCAAUUUCACUAUUAAGGGUUCAUUCCUUAAUGGUUCAUGUGGUAGUGUUGGUUUUAACAUAGAUUAUGACUGUGUCUCUUUUUGUUACAUGCACCAUAUGGAAUUACCAACUGGAGUUCAUGCUGGCACAGACUUAGAAGGUAACUUUUAUGGACCUUUUGUUGACAGGCAAACAGCACAAGCAGCUGGUACGGACACAACUAUUACAGUUAAUGUUUUAGCUUGGUUGUACGCUGCUGUUAUAAAUGGAGACAGGUGGUUUCUCAAUCGAUUUACCACAACUCUUAAUGACUUUAACCUUGUGGCUAUGAAGUACAAUUAUGAACCUCUAACACAAGACCAUGUUGACAUACUAGGACCUCUUUCUGCUCAAACUGGAAUUGCCGUUUUAGAUAUGUGUGCUUCAUUAAAAGAAUUACUGCAAAAUGGUAUGAAUGGACGUACCAUAUUGGGUAGUGCUUUAUUAGAAGAUGAAUUUACACCUUUUGAUGUUGUUAGACAAUGCUCAGGUGUUACUUUCCAAAGUGCAGUGAAAAGAACAAUCAAGGGUACACACCACUGGUUGUUACUCACAAUUUUGACUUCACUUUUAGUUUUAGUCCAGAGUACUCAAUGGUCUUUGUUCUUUUUUUUGUAUGAAAAUGCCUUUUUACCUUUUGCUAUGGGUAUUAUUGCUAUGUCUGCUUUUGCAAUGAUGUUUGUCAAACAUAAGCAUGCAUUUCUCUGUUUGUUUUUGUUACCUUCUCUUGCCACUGUAGCUUAUUUUAAUAUGGUCUAUAUGCCUGCUAGUUGGGUGAUGCGUAUUAUGACAUGGUUGGAUAUGGUUGAUACUAGUUUGUCUGGUUUUAAGCUAAAAGACUGUGUUAUGUAUGCAUCAGCUGUAGUGUUACUAAUCCUUAUGACAGCAAGAACUGUGUAUGAUGAUGGUGCUAGGAGAGUGUGGACACUUAUGAAUGUCUUGACACUCGUUUAUAAAGUUUAUUAUGGUAAUGCUUUAGAUCAAGCCAUUUCCAUGUGGGCUCUUAUAAUCUCUGUUACUUCUAACUACUCAGGUGUAGUUACAACUGUCAUGUUUUUGGCCAGAGGUAUUGUUUUUAUGUGUGUUGAGUAUUGCCCUAUUUUCUUCAUAACUGGUAAUACACUUCAGUGUAUAAUGCUAGUUUAUUGUUUCUUAGGCUAUUUUUGUACUUGUUACUUUGGCCUCUUUUGUUUACUCAACCGCUACUUUAGACUGACUCUUGGUGUUUAUGAUUACUUAGUUUCUACACAGGAGUUUAGAUAUAUGAAUUCACAGGGACUACUCCCACCCAAGAAUAGCAUAGAUGCCUUCAAACUCAACAUUAAAUUGUUGGGUGUUGGUGGCAAACCUUGUAUCAAAGUAGCCACUGUACAGUCUAAAAUGUCAGAUGUAAAGUGCACAUCAGUAGUCUUACUCUCAGUUUUGCAACAACUCAGAGUAGAAUCAUCAUCUAAAUUGUGGGCUCAAUGUGUCCAGUUACACAAUGACAUUCUCUUAGCUAAAGAUACUACUGAAGCCUUUGAAAAAAUGGUUUCACUACUUUCUGUUUUGCUUUCCAUGCAGGGUGCUGUAGACAUAAACAAGCUUUGUGAAGAAAUGCUGGACAACAGGGCAACCUUACAAGCUAUAGCCUCAGAGUUUAGUUCCCUUCCAUCAUAUGCAGCUUUUGCUACUGCUCAAGAAGCUUAUGAGCAGGCUGUUGCUAAUGGUGAUUCUGAAGUUGUUCUUAAAAAGUUGAAGAAGUCUUUGAAUGUGGCUAAAUCUGAAUUUGACCGUGAUGCAGCCAUGCAACGUAAGUUGGAAAAGAUGGCUGAUCAAGCUAUGACCCAAAUGUAUAAACAGGCUAGAUCUGAGGACAAGAGGGCAAAAGUUACUAGUGCUAUGCAGACAAUGCUUUUCACUAUGCUUAGAAAGUUGGAUAAUGAUGCACUCAACAACAUUAUCAACAAUGCAAGAGAUGGUUGUGUUCCCUUGAACAUAAUACCUCUUACAACAGCAGCCAAACUAAUGGUUGUCAUACCAGACUAUAACACAUAUAAAAAUACGUGUGAUGGUACAACAUUUACUUAUGCAUCAGCAUUGUGGGAAAUCCAACAGGUUGUAGAUGCAGAUAGUAAAAUUGUUCAACUUAGUGAAAUUAGUAUGGACAAUUCACCUAAUUUAGCAUGGCCUCUUAUUGUAACAGCUUUAAGGGCCAAUUCUGCUGUCAAAUUACAGAAUAAUGAGCUUAGUCCUGUUGCACUACGACAGAUGUCUUGUGCUGCCGGUACUACACAAACUGCUUGCACUGAUGACAAUGCGUUAGCUUACUACAACACAACAAAGGGAGGUAGGUUUGUACUUGCACUGUUAUCCGAUUUACAGGAUUUGAAAUGGGCUAGAUUCCCUAAGAGUGAUGGAACUGGUACUAUCUAUACAGAACUGGAACCACCUUGUAGGUUUGUUACAGACACACCUAAAGGUCCUAAAGUGAAGUAUUUAUACUUUAUUAAAGGAUUAAACAACCUAAAUAGAGGUAUGGUACUUGGUAGUUUAGCUGCCACAGUACGUCUACAAGCUGGUAAUGCAACAGAAGUGCCUGCCAAUUCAACUGUAUUAUCUUUCUGUGCUUUUGCUGUAGAUGCUGCUAAAGCUUACAAAGAUUAUCUAGCUAGUGGGGGACAACCAAUCACUAAUUGUGUUAAGAUGUUGUGUACACACACUGGUACUGGUCAGGCAAUAACAGUUACACCGGAAGCCAAUAUGGAUCAAGAAUCCUUUGGUGGUGCAUCGUGUUGUCUGUACUGCCGUUGCCACAUAGAUCAUCCAAAUCCUAAAGGAUUUUGUGACUUAAAAGGUAAGUAUGUACAAAUACCUACAACUUGUGCUAAUGACCCUGUGGGUUUUACACUUAAAAACACAGUCUGUACCGUCUGCGGUAUGUGGAAAGGUUAUGGCUGUAGUUGUGAUCAACUCCGCGAACCCAUGCUUCAGUCAGCUGAUGCACAAUCGUUUUUAAACGGGUUUGCGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGGCACUAGUACUGAUGUCGUAUACAGGGCUUUUGACAUCUACAAUGAUAAAGUAGCUGGUUUUGCUAAAUUCCUAAAAACUAAUUGUUGUCGCUUCCAAGAAAAGGACGAAGAUGACAAUUUAAUUGAUUCUUACUUUGUAGUUAAGAGACACACUUUCUCUAACUACCAACAUGAAGAAACAAUUUAUAAUUUACUUAAGGAUUGUCCAGCUGUUGCUAAACAUGACUUCUUUAAGUUUAGAAUAGACGGUGACAUGGUACCACAUAUAUCACGUCAACGUCUUACUAAAUACACAAUGGCAGACCUCGUCUAUGCUUUAAGGCAUUUUGAUGAAGGUAAUUGUGACACAUUAAAAGAAAUACUUGUCACAUACAAUUGUUGUGAUGAUGAUUAUUUCAAUAAAAAGGACUGGUAUGAUUUUGUAGAAAACCCAGAUAUAUUACGCGUAUACGCCAACUUAGGUGAACGUGUACGCCAAGCUUUGUUAAAAACAGUACAAUUCUGUGAUGCCAUGCGAAAUGCUGGUAUUGUUGGUGUACUGACAUUAGAUAAUCAAGAUCUCAAUGGUAACUGGUAUGAUUUCGGUGAUUUCAUACAAACCACGCCAGGUAGUGGAGUUCCUGUUGUAGAUUCUUAUUAUUCAUUGUUAAUGCCUAUAUUAACCUUGACCAGGGCUUUAACUGCAGAGUCACAUGUUGACACUGACUUAACAAAGCCUUACAUUAAGUGGGAUUUGUUAAAAUAUGACUUCACGGAAGAGAGGUUAAAACUCUUUGACCGUUAUUUUAAAUAUUGGGAUCAGACAUACCACCCAAAUUGUGUUAACUGUUUGGAUGACAGAUGCAUUCUGCAUUGUGCAAACUUUAAUGUUUUAUUCUCUACAGUGUUCCCACCUACAAGUUUUGGACCACUAGUGAGAAAAAUAUUUGUUGAUGGUGUUCCAUUUGUAGUUUCAACUGGAUACCACUUCAGAGAGCUAGGUGUUGUACAUAAUCAGGAUGUAAACUUACAUAGCUCUAGACUUAGUUUUAAGGAAUUACUUGUGUAUGCUGCUGACCCUGCUAUGCACGCUGCUUCUGGUAAUCUAUUACUAGAUAAACGCACUACGUGCUUUUCAGUAGCUGCACUUACUAACAAUGUUGCUUUUCAAACUGUCAAACCCGGUAAUUUUAACAAAGACUUCUAUGACUUUGCUGUGUCUAAGGGUUUCUUUAAGGAAGGAAGUUCUGUUGAAUUAAAACACUUCUUCUUUGCUCAGGAUGGUAAUGCUGCUAUCAGCGAUUAUGACUACUAUCGUUAUAAUCUACCAACAAUGUGUGAUAUCAGACAACUACUAUUUGUAGUUGAAGUUGUUGAUAAGUACUUUGAUUGUUACGAUGGUGGCUGUAUUAAUGCUAACCAAGUCAUCGUCAACAACCUAGACAAAUCAGCUGGUUUUCCAUUUAAUAAAUGGGGUAAGGCUAGACUUUAUUAUGAUUCAAUGAGUUAUGAGGAUCAAGAUGCACUUUUCGCAUAUACAAAACGUAAUGUCAUCCCUACUAUAACUCAAAUGAAUCUUAAGUAUGCCAUUAGUGCAAAGAAUAGAGCUCGCACCGUAGCUGGUGUCUCUAUCUGUAGUACUAUGACCAAUAGACAGUUUCAUCAAAAAUUAUUGAAAUCAAUAGCCGCCACUAGAGGAGCUACUGUAGUAAUUGGAACAAGCAAAUUCUAUGGUGGUUGGCACAACAUGUUAAAAACUGUUUAUAGUGAUGUAGAAAACCCUCACCUUAUGGGUUGGGAUUAUCCUAAAUGUGAUAGAGCCAUGCCUAACAUGCUUAGAAUUAUGGCCUCACUUGUUCUUGCUCGCAAACAUACAACGUGUUGUAGCUUGUCACACCGUUUCUAUAGAUUAGCUAAUGAGUGUGCUCAAGUAUUGAGUGAAAUGGUCAUGUGUGGCGGUUCACUAUAUGUUAAACCAGGUGGAACCUCAUCAGGAGAUGCCACAACUGCUUAUGCUAAUAGUGUUUUUAACAUUUGUCAAGCUGUCACGGCCAAUGUUAAUGCACUUUUAUCUACUGAUGGUAACAAAAUUGCCGAUAAGUAUGUCCGCAAUUUACAACACAGACUUUAUGAGUGUCUCUAUAGAAAUAGAGAUGUUGACACAGACUUUGUGAAUGAGUUUUACGCAUAUUUGCGUAAACAUUUCUCAAUGAUGAUACUCUCUGACGAUGCUGUUGUGUGUUUCAAUAGCACUUAUGCAUCUCAAGGUCUAGUGGCUAGCAUAAAGAACUUUAAGUCAGUUCUUUAUUAUCAAAACAAUGUUUUUAUGUCUGAAGCAAAAUGUUGGACUGAGACUGACCUUACUAAAGGACCUCAUGAAUUUUGCUCUCAACAUACAAUGCUAGUUAAACAGGGUGAUGAUUAUGUGUACCUUCCUUACCCAGAUCCAUCAAGAAUCCUAGGGGCCGGCUGUUUUGUAGAUGAUAUCGUAAAAACAGAUGGUACACUUAUGAUUGAACGGUUCGUGUCUUUAGCUAUAGAUGCUUACCCACUUACUAAACAUCCUAAUCAGGAGUAUGCUGAUGUCUUUCAUUUGUACUUACAAUACAUAAGAAAGCUACAUGAUGAGUUAACAGGACACAUGUUAGACAUGUAUUCUGUUAUGCUUACUAAUGAUAACACUUCAAGGUAUUGGGAACCUGAGUUUUAUGAGGCUAUGUACACACCGCAUACAGUCUUACAGGCUGUUGGGGCUUGUGUUCUUUGCAAUUCACAGACUUCAUUAAGAUGUGGUGCUUGCAUACGUAGACCAUUCUUAUGUUGUAAAUGCUGUUACGACCAUGUCAUAUCAACAUCACAUAAAUUAGUCUUGUCUGUUAAUCCGUAUGUUUGCAAUGCUCCAGGUUGUGAUGUCACAGAUGUGACUCAACUUUACUUAGGAGGUAUGAGCUAUUAUUGUAAAUCACAUAAACCACCCAUUAGUUUUCCAUUGUGUGCUAAUGGACAAGUUUUUGGUUUAUAUAAAAAUACAUGUGUUGGUAGCGAUAAUGUUACUGACUUUAAUGCAAUUGCAACAUGUGACUGGACAAAUGCUGGUGAUUACAUUUUAGCUAACACCUGUACUGAAAGACUCAAGCUUUUUGCAGCAGAAACGCUCAAAGCUACUGAGGAGACAUUUAAACUGUCUUAUGGUAUUGCUACUGUACGUGAAGUGCUGUCUGACAGAGAAUUACAUCUUUCAUGGGAAGUUGGUAAACCUAGACCACCACUUAACCGAAAUUAUGUCUUUACUGGUUAUCGUGUAACUAAAAACAGUAAAGUACAAAUAGGAGAGUACACCUUUGAAAAAGGUGACUAUGGUGAUGCUGUUGUUUACCGAGGUACAACAACUUACAAAUUAAAUGUUGGUGAUUAUUUUGUGCUGACAUCACAUACAGUAAUGCCAUUAAGUGCACCUACACUAGUGCCACAAGAGCACUAUGUUAGAAUUACUGGCUUAUACCCAACACUCAAUAUCUCAGAUGAGUUUUCUAGCAAUGUUGCAAAUUAUCAAAAGGUUGGUAUGCAAAAGUAUUCUACACUCCAGGGACCACCUGGUACUGGUAAGAGUCAUUUUGCUAUUGGCCUAGCUCUCUACUACCCUUCUGCUCGCAUAGUGUAUACAGCUUGCUCUCAUGCCGCUGUUGAUGCACUAUGUGAGAAGGCAUUAAAAUAUUUGCCUAUAGAUAAAUGUAGUAGAAUUAUACCUGCACGUGCUCGUGUAGAGUGUUUUGAUAAAUUCAAAGUGAAUUCAACAUUAGAACAGUAUGUCUUUUGUACUGUAAAUGCAUUGCCUGAGACGACAGCAGAUAUAGUUGUCUUUGAUGAAAUUUCAAUGGCCACAAAUUAUGAUUUGAGUGUUGUCAAUGCCAGAUUACGUGCUAAGCACUAUGUGUACAUUGGCGACCCUGCUCAAUUACCUGCACCACGCACAUUGCUAACUAAGGGCACACUAGAACCAGAAUAUUUCAAUUCAGUGUGUAGACUUAUGAAAACUAUAGGUCCAGACAUGUUCCUCGGAACUUGUCGGCGUUGUCCUGCUGAAAUUGUUGACACUGUGAGUGCUUUGGUUUAUGAUAAUAAGCUUAAAGCACAUAAAGACAAAUCAGCUCAAUGCUUUAAAAUGUUUUAUAAGGGUGUUAUCACGCAUGAUGUUUCAUCUGCAAUUAACAGGCCACAAAUAGGCGUGGUAAGAGAAUUCCUUACACGUAACCCUGCUUGGAGAAAAGCUGUCUUUAUUUCACCUUAUAAUUCACAGAAUGCUGUAGCCUCAAAGAUUUUGGGACUACCAACUCAAACUGUUGAUUCAUCACAGGGCUCAGAAUAUGACUAUGUCAUAUUCACUCAAACCACUGAAACAGCUCACUCUUGUAAUGUAAACAGAUUUAAUGUUGCUAUUACCAGAGCAAAAGUAGGCAUACUUUGCAUAAUGUCUGAUAGAGACCUUUAUGACAAGUUGCAAUUUACAAGUCUUGAAAUUCCACGUAGGAAUGUGGCAACUUUACAAGCUGAAAAUGUAACAGGACUCUUUAAAGAUUGUAGUAAGGUAAUCACUGGGUUACAUCCUACACAGGCACCUACACACCUCAGUGUUGACACUAAAUUCAAAACUGAAGGUUUAUGUGUUGACAUACCUGGCAUACCUAAGGACAUGACCUAUAGAAGACUCAUCUCUAUGAUGGGUUUUAAAAUGAAUUAUCAAGUUAAUGGUUACCCUAACAUGUUUAUCACCCGCGAAGAAGCUAUAAGACAUGUACGUGCAUGGAUUGGCUUCGAUGUCGAGGGGUGUCAUGCUACUAGAGAAGCUGUUGGUACCAAUUUACCUUUACAGCUAGGUUUUUCUACAGGUGUUAACCUAGUUGCUGUACCUACAGGUUAUGUUGAUACACCUAAUAAUACAGAUUUUUCCAGAGUUAGUGCUAAACCACCGCCUGGAGAUCAAUUUAAACACCUCAUACCACUUAUGUACAAAGGACUUCCUUGGAAUGUAGUGCGUAUAAAGAUUGUACAAAUGUUAAGUGACACACUUAAAAAUCUCUCUGACAGAGUCGUAUUUGUCUUAUGGGCACAUGGCUUUGAGUUGACAUCUAUGAAGUAUUUUGUGAAAAUAGGACCUGAGCGCACCUGUUGUCUAUGUGAUAGACGUGCCACAUGCUUUUCCACUGCUUCAGACACUUAUGCCUGUUGGCAUCAUUCUAUUGGAUUUGAUUACGUCUAUAAUCCGUUUAUGAUUGAUGUUCAACAAUGGGGUUUUACAGGUAACCUACAAAGCAACCAUGAUCUGUAUUGUCAAGUCCAUGGUAAUGCACAUGUAGCUAGUUGUGAUGCAAUCAUGACUAGGUGUCUAGCUGUCCACGAGUGCUUUGUUAAGCGUGUUGACUGGACUAUUGAAUAUCCUAUAAUUGGUGAUGAACUGAAGAUUAAUGCGGCUUGUAGAAAGGUUCAACACAUGGUUGUUAAAGCUGCAUUAUUAGCAGACAAAUUCCCAGUUCUUCACGACAUUGGUAACCCUAAAGCUAUUAAGUGUGUACCUCAAGCUGAUGUAGAAUGGAAGUUCUAUGAUGCACAGCCUUGUAGUGACAAAGCUUAUAAAAUAGAAGAAUUAUUCUAUUCUUAUGCCACACAUUCUGACAAAUUCACAGAUGGUGUAUGCCUAUUUUGGAAUUGCAAUGUCGAUAGAUAUCCUGCUAAUUCCAUUGUUUGUAGAUUUGACACUAGAGUGCUAUCUAACCUUAACUUGCCUGGUUGUGAUGGUGGCAGUUUGUAUGUAAAUAAACAUGCAUUCCACACACCAGCUUUUGAUAAAAGUGCUUUUGUUAAUUUAAAACAAUUACCAUUUUUCUAUUACUCUGACAGUCCAUGUGAGUCUCAUGGAAAACAAGUAGUGUCAGAUAUAGAUUAUGUACCACUAAAGUCUGCUACGUGUAUAACACGUUGCAAUUUAGGUGGUGCUGUCUGUAGACAUCAUGCUAAUGAGUACAGAUUGUAUCUCGAUGCUUAUAACAUGAUGAUCUCAGCUGGCUUUAGCUUGUGGGUUUACAAACAAUUUGAUACUUAUAACCUCUGGAACACUUUUACAAGACUUCAGAGUUUAGAAAAUGUGGCUUUUAAUGUUGUAAAUAAGGGACACUUUGAUGGACAACAGGGUGAAGUACCAGUUUCUAUCAUUAAUAACACUGUUUACACAAAAGUUGAUGGUGUUGAUGUAGAAUUGUUUGAAAAUAAAACAACAUUACCUGUUAAUGUAGCAUUUGAGCUUUGGGCUAAGCGCAACAUUAAACCAGUACCAGAGGUGAAAAUACUCAAUAAUUUGGGUGUGGACAUUGCUGCUAAUACUGUGAUCUGGGACUACAAAAGAGAUGCUCCAGCACAUAUAUCUACUAUUGGUGUUUGUUCUAUGACUGACAUAGCCAAGAAACCAACUGAAACGAUUUGUGCACCACUCACUGUCUUUUUUGAUGGUAGAGUUGAUGGUCAAGUAGACUUAUUUAGAAAUGCCCGUAAUGGUGUUCUUAUUACAGAAGGUAGUGUUAAAGGUUUACAACCAUCUGUAGGUCCCAAACAAGCUAGUCUUAAUGGAGUCACAUUAAUUGGAGAAGCCGUAAAAACACAGUUCAAUUAUUAUAAGAAAGUUGAUGGUGUUGUCCAACAAUUACCUGAAACUUACUUUACUCAGAGUAGAAAUUUACAAGAAUUUAAACCCAGGAGUCAAAUGGAAAUUGAUUUCUUAGAAUUAGCUAUGGAUGAAUUCAUUGAACGGUAUAAAUUAGAAGGCUAUGCCUUCGAACAUAUCGUUUAUGGAGAUUUUAGUCAUAGUCAGUUAGGUGGUUUACAUCUACUGAUUGGACUAGCUAAACGUUUUAAGGAAUCACCUUUUGAAUUAGAAGAUUUUAUUCCUAUGGACAGUACAGUUAAAAACUAUUUCAUAACAGAUGCGCAAACAGGUUCAUCUAAGUGUGUGUGUUCUGUUAUUGAUUUAUUACUUGAUGAUUUUGUUGAAAUAAUAAAAUCCCAAGAUUUAUCUGUAGUUUCUAAGGUUGUCAAAGUGACUAUUGACUAUACAGAAAUUUCAUUUAUGCUUUGGUGUAAAGAUGGCCAUGUAGAAACAUUUUACCCAAAAUUACAAUCUAGUCAAGCGUGGCAACCGGGUGUUGCUAUGCCUAAUCUUUACAAAAUGCAAAGAAUGCUAUUAGAAAAGUGUGACCUUCAAAAUUAUGGUGAUAGUGCAACAUUACCUAAAGGCAUAAUGAUGAAUGUCGCAAAAUAUACUCAACUGUGUCAAUAUUUAAACACAUUAACAUUAGCUGUACCCUAUAAUAUGAGAGUUAUACAUUUUGGUGCUGGUUCUGAUAAAGGAGUUGCACCAGGUACAGCUGUUUUAAGACAGUGGUUGCCUACGGGUACGCUGCUUGUCGAUUCAGAUCUUAAUGACUUUGUCUCUGAUGCAGAUUCAACUUUGAUUGGUGAUUGUGCAACUGUACAUACAGCUAAUAAAUGGGAUCUCAUUAUUAGUGAUAUGUACGACCCUAAGACUAAAAAUGUUACAAAAGAAAAUGACUCUAAAGAGGGUUUUUUCACUUACAUUUGUGGGUUUAUACAACAAAAGCUAGCUCUUGGAGGUUCCGUGGCUAUAAAGAUAACAGAACAUUCUUGGAAUGCUGAUCUUUAUAAGCUCAUGGGACACUUCGCAUGGUGGACAGCCUUUGUUACUAAUGUGAAUGCGUCAUCAUCUGAAGCAUUUUUAAUUGGAUGUAAUUAUCUUGGCAAACCACGCGAACAAAUAGAUGGUUAUGUCAUGCAUGCAAAUUACAUAUUUUGGAGGAAUACAAAUCCAAUUCAGUUGUCUUCCUAUUCUUUAUUUGACAUGAGUAAAUUUCCCCUUAAAUUAAGGGGUACUGCUGUUAUGUCUUUAAAAGAAGGUCAAAUCAAUGAUAUGAUUUUAUCUCUUCUUAGUAAAGGUAGACUUAUAAUUAGAGAAAACAACAGAGUUGUUAUUUCUAGUGAUGUUCUUGUUAACAACUAAACGAACAAUGUUUGUUUUUCUUGUUUUAUUGCCACUAGUCUCUAGUCAGUGUGUUAAUCUUACAACCAGAACUCAAUUACCCCCUGCAUACACUAAUUCUUUCACACGUGGUGUUUAUUACCCUGACAAAGUUUUCAGAUCCUCAGUUUUACAUUCAACUCAGGACUUGUUCUUACCUUUCUUUUCCAAUGUUACUUGGUUCCAUGCUAUACAUGUCUCUGGGACCAAUGGUACUAAGAGGUUUGAUAACCCUGUCCUACCAUUUAAUGAUGGUGUUUAUUUUGCUUCCACUGAGAAGUCUAACAUAAUAAGAGGCUGGAUUUUUGGUACUACUUUAGAUUCGAAGACCCAGUCCCUACUUAUUGUUAAUAACGCUACUAAUGUUGUUAUUAAAGUCUGUGAAUUUCAAUUUUGUAAUGAUCCAUUUUUGGGUGUUUAUUACCACAAAAACAACAAAAGUUGGAUGGAAAGUGAGUUCAGAGUUUAUUCUAGUGCGAAUAAUUGCACUUUUGAAUAUGUCUCUCAGCCUUUUCUUAUGGACCUUGAAGGAAAACAGGGUAAUUUCAAAAAUCUUAGGGAAUUUGUGUUUAAGAAUAUUGAUGGUUAUUUUAAAAUAUAUUCUAAGCACACGCCUAUUAAUUUAGUGCGUGAUCUCCCUCAGGGUUUUUCGGCUUUAGAACCAUUGGUAGAUUUGCCAAUAGGUAUUAACAUCACUAGGUUUCAAACUUUACUUGCUUUACAUAGAAGUUAUUUGACUCCUGGUGAUUCUUCUUCAGGUUGGACAGCUGGUGCUGCAGCUUAUUAUGUGGGUUAUCUUCAACCUAGGACUUUUCUAUUAAAAUAUAAUGAAAAUGGAACCAUUACAGAUGCUGUAGACUGUGCACUUGACCCUCUCUCAGAAACAAAGUGUACGUUGAAAUCCUUCACUGUAGAAAAAGGAAUCUAUCAAACUUCUAACUUUAGAGUCCAACCAACAGAAUCUAUUGUUAGAUUUCCUAAUAUUACAAACUUGUGCCCUUUUGGUGAAGUUUUUAACGCCACCAGAUUUGCAUCUGUUUAUGCUUGGAACAGGAAGAGAAUCAGCAACUGUGUUGCUGAUUAUUCUGUCCUAUAUAAUUCCGCAUCAUUUUCCACUUUUAAGUGUUAUGGAGUGUCUCCUACUAAAUUAAAUGAUCUCUGCUUUACUAAUGUCUAUGCAGAUUCAUUUGUAAUUAGAGGUGAUGAAGUCAGACAAAUCGCUCCAGGGCAAACUGGAAAGAUUGCUGAUUAUAAUUAUAAAUUACCAGAUGAUUUUACAGGCUGCGUUAUAGCUUGGAAUUCUAACAAUCUUGAUUCUAAGGUUGGUGGUAAUUAUAAUUACCUGUAUAGAUUGUUUAGGAAGUCUAAUCUCAAACCUUUUGAGAGAGAUAUUUCAACUGAAAUCUAUCAGGCCGGUAGCACACCUUGUAAUGGUGUUGAAGGUUUUAAUUGUUACUUUCCUUUACAAUCAUAUGGUUUCCAACCCACUAAUGGUGUUGGUUACCAACCAUACAGAGUAGUAGUACUUUCUUUUGAACUUCUACAUGCACCAGCAACUGUUUGUGGACCUAAAAAGUCUACUAAUUUGGUUAAAAACAAAUGUGUCAAUUUCAACUUCAAUGGUUUAACAGGCACAGGUGUUCUUACUGAGUCUAACAAAAAGUUUCUGCCUUUCCAACAAUUUGGCAGAGACAUUGCUGACACUACUGAUGCUGUCCGUGAUCCACAGACACUUGAGAUUCUUGACAUUACACCAUGUUCUUUUGGUGGUGUCAGUGUUAUAACACCAGGAACAAAUACUUCUAACCAGGUUGCUGUUCUUUAUCAGGAUGUUAACUGCACAGAAGUCCCUGUUGCUAUUCAUGCAGAUCAACUUACUCCUACUUGGCGUGUUUAUUCUACAGGUUCUAAUGUUUUUCAAACACGUGCAGGCUGUUUAAUAGGGGCUGAACAUGUCAACAACUCAUAUGAGUGUGACAUACCCAUUGGUGCAGGUAUAUGCGCUAGUUAUCAGACUCAGACUAAUUCUCCUCGGCGGGCACGUAGUGUAGCUAGUCAAUCCAUCAUUGCCUACACUAUGUCACUUGGUGCAGAAAAUUCAGUUGCUUACUCUAAUAACUCUAUUGCCAUACCCACAAAUUUUACUAUUAGUGUUACCACAGAAAUUCUACCAGUGUCUAUGACCAAGACAUCAGUAGAUUGUACAAUGUACAUUUGUGGUGAUUCAACUGAAUGCAGCAAUCUUUUGUUGCAAUAUGGCAGUUUUUGUACACAAUUAAACCGUGCUUUAACUGGAAUAGCUGUUGAACAAGACAAAAACACCCAAGAAGUUUUUGCACAAGUCAAACAAAUUUACAAAACACCACCAAUUAAAGAUUUUGGUGGUUUUAAUUUUUCACAAAUAUUACCAGAUCCAUCAAAACCAAGCAAGAGGUCAUUUAUUGAAGAUCUACUUUUCAACAAAGUGACACUUGCAGAUGCUGGCUUCAUCAAACAAUAUGGUGAUUGCCUUGGUGAUAUUGCUGCUAGAGACCUCAUUUGUGCACAAAAGUUUAACGGCCUUACUGUUUUGCCACCUUUGCUCACAGAUGAAAUGAUUGCUCAAUACACUUCUGCACUGUUAGCGGGUACAAUCACUUCUGGUUGGACCUUUGGUGCAGGUGCUGCAUUACAAAUACCAUUUGCUAUGCAAAUGGCUUAUAGGUUUAAUGGUAUUGGAGUUACACAGAAUGUUCUCUAUGAGAACCAAAAAUUGAUUGCCAACCAAUUUAAUAGUGCUAUUGGCAAAAUUCAAGACUCACUUUCUUCCACAGCAAGUGCACUUGGAAAACUUCAAGAUGUGGUCAACCAAAAUGCACAAGCUUUAAACACGCUUGUUAAACAACUUAGCUCCAAUUUUGGUGCAAUUUCAAGUGUUUUAAAUGAUAUCCUUUCACGUCUUGACAAAGUUGAGGCUGAAGUGCAAAUUGAUAGGUUGAUCACAGGCAGACUUCAAAGUUUGCAGACAUAUGUGACUCAACAAUUAAUUAGAGCUGCAGAAAUCAGAGCUUCUGCUAAUCUUGCUGCUACUAAAAUGUCAGAGUGUGUACUUGGACAAUCAAAAAGAGUUGAUUUUUGUGGAAAGGGCUAUCAUCUUAUGUCCUUCCCUCAGUCAGCACCUCAUGGUGUAGUCUUCUUGCAUGUGACUUAUGUCCCUGCACAAGAAAAGAACUUCACAACUGCUCCUGCCAUUUGUCAUGAUGGAAAAGCACACUUUCCUCGUGAAGGUGUCUUUGUUUCAAAUGGCACACACUGGUUUGUAACACAAAGGAAUUUUUAUGAACCACAAAUCAUUACUACAGACAACACAUUUGUGUCUGGUAACUGUGAUGUUGUAAUAGGAAUUGUCAACAACACAGUUUAUGAUCCUUUGCAACCUGAAUUAGACUCAUUCAAGGAGGAGUUAGAUAAAUAUUUUAAGAAUCAUACAUCACCAGAUGUUGAUUUAGGUGACAUCUCUGGCAUUAAUGCUUCAGUUGUAAACAUUCAAAAAGAAAUUGACCGCCUCAAUGAGGUUGCCAAGAAUUUAAAUGAAUCUCUCAUCGAUCUCCAAGAACUUGGAAAGUAUGAGCAGUAUAUAAAAUGGCCAUGGUACAUUUGGCUAGGUUUUAUAGCUGGCUUGAUUGCCAUAGUAAUGGUGACAAUUAUGCUUUGCUGUAUGACCAGUUGCUGUAGUUGUCUCAAGGGCUGUUGUUCUUGUGGAUCCUGCUGCAAAUUUGAUGAAGACGACUCUGAGCCAGUGCUCAAAGGAGUCAAAUUACAUUACACAUAAACGAACUUAUGGAUUUGUUUAUGAGAAUCUUCACAAUUGGAACUGUAACUUUGAAGCAAGGUGAAAUCAAGGAUGCUACUCCUUCAGAUUUUGUUCGCGCUACUGCAACGAUACCGAUACAAGCCUCACUCCCUUUCGGAUGGCUUAUUGUUGGCGUUGCACUUCUUGCUGUUUUUCAGAGCGCUUCCAAAAUCAUAACCCUCAAAAAGAGAUGGCAACUAGCACUCUCCAAGGGUGUUCACUUUGUUUGCAACUUGCUGUUGUUGUUUGUAACAGUUUACUCACACCUUUUGCUCGUUGCUGCUGGCCUUGAAGCCCCUUUUCUCUAUCUUUAUGCUUUAGUCUACUUCUUGCAGAGUAUAAACUUUGUAAGAAUAAUAAUGAGGCUUUGGCUUUGCUGGAAAUGCCGUUCCAAAAACCCAUUACUUUAUGAUGCCAACUAUUUUCUUUGCUGGCAUACUAAUUGUUACGACUAUUGUAUACCUUACAAUAGUGUAACUUCUUCAAUUGUCAUUACUUCAGGUGAUGGCACAACAAGUCCUAUUUCUGAACAUGACUACCAGAUUGGUGGUUAUACUGAAAAAUGGGAAUCUGGAGUAAAAGACUGUGUUGUAUUACACAGUUACUUCACUUCAGACUAUUACCAGCUGUACUCAACUCAAUUGAGUACAGACACUGGUGUUGAACAUGUUACCUUCUUCAUCUACAAUAAAAUUGUUGAUGAGCCUGAAGAACAUGUCCAAAUUCACACAAUCGACGGUUCAUCCGGAGUUGUUAAUCCAGUAAUGGAACCAAUUUAUGAUGAACCGACGACGACUACUAGCGUGCCUUUGUAAGCACAAGCUGAUGAGUACGAACUUAUGUACUCAUUCGUUUCGGAAGAGACAGGUACGUUAAUAGUUAAUAGCGUACUUCUUUUUCUUGCUUUCGUGGUAUUCUUGCUAGUUACACUAGCCAUCCUUACUGCGCUUCGAUUGUGUGCGUACUGCUGCAAUAUUGUUAACGUGAGUCUUGUAAAACCUUCUUUUUACGUUUACUCUCGUGUUAAAAAUCUGAAUUCUUCUAGAGUUCCUGAUCUUCUGGUCUAAACGAACUAAAUAUUAUAUUAGUUUUUCUGUUUGGAACUUUAAUUUUAGCCAUGGCAGAUUCCAACGGUACUAUUACCGUUGAAGAGCUUAAAAAGCUCCUUGAACAAUGGAACCUAGUAAUAGGUUUCCUAUUCCUUACAUGGAUUUGUCUUCUACAAUUUGCCUAUGCCAACAGGAAUAGGUUUUUGUAUAUAAUUAAGUUAAUUUUCCUCUGGCUGUUAUGGCCAGUAACUUUAGCUUGUUUUGUGCUUGCUGCUGUUUACAGAAUAAAUUGGAUCACCGGUGGAAUUGCUAUCGCAAUGGCUUGUCUUGUAGGCUUGAUGUGGCUCAGCUACUUCAUUGCUUCUUUCAGACUGUUUGCGCGUACGCGUUCCAUGUGGUCAUUCAAUCCAGAAACUAACAUUCUUCUCAACGUGCCACUCCAUGGCACUAUUCUGACCAGACCGCUUCUAGAAAGUGAACUCGUAAUCGGAGCUGUGAUCCUUCGUGGACAUCUUCGUAUUGCUGGACACCAUCUAGGACGCUGUGACAUCAAGGACCUGCCUAAAGAAAUCACUGUUGCUACAUCACGAACGCUUUCUUAUUACAAAUUGGGAGCUUCGCAGCGUGUAGCAGGUGACUCAGGUUUUGCUGCAUACAGUCGCUACAGGAUUGGCAACUAUAAAUUAAACACAGACCAUUCCAGUAGCAGUGACAAUAUUGCUUUGCUUGUACAGUAAGUGACAACAGAUGUUUCAUCUCGUUGACUUUCAGGUUACUAUAGCAGAGAUAUUACUAAUUAUUAUGAGGACUUUUAAAGUUUCCAUUUGGAAUCUUGAUUACAUCAUAAACCUCAUAAUUAAAAAUUUAUCUAAGUCACUAACUGAGAAUAAAUAUUCUCAAUUAGAUGAAGAGCAACCAAUGGAGAUUGAUUAAACGAACAUGAAAAUUAUUCUUUUCUUGGCACUGAUAACACUCGCUACUUGUGAGCUUUAUCACUACCAAGAGUGUGUUAGAGGUACAACAGUACUUUUAAAAGAACCUUGCUCUUCUGGAACAUACGAGGGCAAUUCACCAUUUCAUCCUCUAGCUGAUAACAAAUUUGCACUGACUUGCUUUAGCACUCAAUUUGCUUUUGCUUGUCCUGACGGCGUAAAACACGUCUAUCAGUUACGUGCCAGAUCAGUUUCACCUAAACUGUUCAUCAGACAAGAGGAAGUUCAAGAACUUUACUCUCCAAUUUUUCUUAUUGUUGCGGCAAUAGUGUUUAUAACACUUUGCUUCACACUCAAAAGAAAGACAGAAUGAUUGAACUUUCAUUAAUUGACUUCUAUUUGUGCUUUUUAGCCUUUCUGCUAUUCCUUGUUUUAAUUAUGCUUAUUAUCUUUUGGUUCUCACUUGAACUGCAAGAUCAUAAUGAAACUUGUCACGCCUAAACGAACAUGAAAUUUCUUGUUUUCUUAGGAAUCAUCACAACUGUAGCUGCAUUUCACCAAGAAUGUAGUUUACAGUCAUGUACUCAACAUCAACCAUAUGUAGUUGAUGACCCGUGUCCUAUUCACUUCUAUUCUAAAUGGUAUAUUAGAGUAGGAGCUAGAAAAUCAGCACCUUUAAUUGAAUUGUGCGUGGAUGAGGCUGGUUCUAAAUCACCCAUUCAGUACAUCGAUAUCGGUAAUUAUACAGUUUCCUGUUUACCUUUUACAAUUAAUUGCCAGGAACCUAAAUUGGGUAGUCUUGUAGUGCGUUGUUCGUUCUAUGAAGACUUUUUAGAGUAUCAUGACGUUCGUGUUGUUUUAGAUUUCAUCUAAACGAACAAACUAAAAUGUCUGAUAAUGGACCCCAAAAUCAGCGAAAUGCACCCCGCAUUACGUUUGGUGGACCCUCAGAUUCAACUGGCAGUAACCAGAAUGGAGAACGCAGUGGGGCGCGAUCAAAACAACGUCGGCCCCAAGGUUUACCCAAUAAUACUGCGUCUUGGUUCACCGCUCUCACUCAACAUGGCAAGGAAGACCUUAAAUUCCCUCGAGGACAAGGCGUUCCAAUUAACACCAAUAGCAGUCCAGAUGACCAAAUUGGCUACUACCGAAGAGCUACCAGACGAAUUCGUGGUGGUGACGGUAAAAUGAAAGAUCUCAGUCCAAGAUGGUAUUUCUACUACCUAGGAACUGGGCCAGAAGCUGGACUUCCCUAUGGUGCUAACAAAGACGGCAUCAUAUGGGUUGCAACUGAGGGAGCCUUGAAUACACCAAAAGAUCACAUUGGCACCCGCAAUCCUGCUAACAAUGCUGCAAUCGUGCUACAACUUCCUCAAGGAACAACAUUGCCAAAAGGCUUCUACGCAGAAGGGAGCAGAGGCGGCAGUCAAGCCUCUUCUCGUUCCUCAUCACGUAGUCGCAACAGUUCAAGAAAUUCAACUCCAGGCAGCAGUAGGGGAACUUCUCCUGCUAGAAUGGCUGGCAAUGGCGGUGAUGCUGCUCUUGCUUUGCUGCUGCUUGACAGAUUGAACCAGCUUGAGAGCAAAAUGUCUGGUAAAGGCCAACAACAACAAGGCCAAACUGUCACUAAGAAAUCUGCUGCUGAGGCUUCUAAGAAGCCUCGGCAAAAACGUACUGCCACUAAAGCAUACAAUGUAACACAAGCUUUCGGCAGACGUGGUCCAGAACAAACCCAAGGAAAUUUUGGGGACCAGGAACUAAUCAGACAAGGAACUGAUUACAAACAUUGGCCGCAAAUUGCACAAUUUGCCCCCAGCGCUUCAGCGUUCUUCGGAAUGUCGCGCAUUGGCAUGGAAGUCACACCUUCGGGAACGUGGUUGACCUACACAGGUGCCAUCAAAUUGGAUGACAAAGAUCCAAAUUUCAAAGAUCAAGUCAUUUUGCUGAAUAAGCAUAUUGACGCAUACAAAACAUUCCCACCAACAGAGCCUAAAAAGGACAAAAAGAAGAAGGCUGAUGAAACUCAAGCCUUACCGCAGAGACAGAAGAAACAGCAAACUGUGACUCUUCUUCCUGCUGCAGAUUUGGAUGAUUUCUCCAAACAAUUGCAACAAUCCAUGAGCAGUGCUGACUCAACUCAGGCCUAAACUCAUGCAGACCACACAAGGCAGAUGGGCUAUAUAAACGUUUUCGCUUUUCCGUUUACGAUAUAUAGUCUACUCUUGUGCAGAAUGAAUUCUCGUAACUACAUAGCACAAGUAGAUGUAGUUAACUUUAAUCUCACAUAGCAAUCUUUAAUCAGUGUGUAACAUUAGGGAGGACUUGAAAGAGCCACCACAUUUUCACCGAGGCCACGCGGAGUACGAUCGAGUGUACAGUGAACAAUGCUAGGGAGAGCUGCCUAUAUGGAAGAGCCCUAAUGUGUAAAAUUAAUUUUAGUAGUGCUAUCCCCAUGUGAUUUUAAUAGCUUCUUAGGAGAAUGACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|△DD
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,△DD,-,413aa(1-413),P0DTC9,-,-,"[1-43],[74-100],[143-147],[150-158],[170-213],[233-269],[361-383],[405-413]",-,In vitro,1–5 nM[SARS-CoV-2],"15 mM NaCl, 135 mM KCl, 5 mM phosphate, 1.5 mM MgCl2","20 mM Tris–HCl, pH 7.0",37˚C,-,other_molecular:1 mg ml−1 BSA,Surface plasmon resonance,liquid,"As expected, the SARS2-NP exhibited a high binding capacity for viral RNA, which was substantially reduced in the DD-depleted mutant (Fig. 1n), indicating that the DD is required for SARS2-NP to bind viral RNA",29903
213,701,PMID: 34239064,RNAPS0000450,https://pubmed.ncbi.nlm.nih.gov/34239064,RNA + protein,-,-,SARS-CoV-2 virus RNA,29903nt(1-29903),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCUGAAAAGAGCUAUGAAUUGCAGACACCUUUUGAAAUUAAAUUGGCAAAGAAAUUUGACACCUUCAAUGGGGAAUGUCCAAAUUUUGUAUUUCCCUUAAAUUCCAUAAUCAAGACUAUUCAACCAAGGGUUGAAAAGAAAAAGCUUGAUGGCUUUAUGGGUAGAAUUCGAUCUGUCUAUCCAGUUGCGUCACCAAAUGAAUGCAACCAAAUGUGCCUUUCAACUCUCAUGAAGUGUGAUCAUUGUGGUGAAACUUCAUGGCAGACGGGCGAUUUUGUUAAAGCCACUUGCGAAUUUUGUGGCACUGAGAAUUUGACUAAAGAAGGUGCCACUACUUGUGGUUACUUACCCCAAAAUGCUGUUGUUAAAAUUUAUUGUCCAGCAUGUCACAAUUCAGAAGUAGGACCUGAGCAUAGUCUUGCCGAAUACCAUAAUGAAUCUGGCUUGAAAACCAUUCUUCGUAAGGGUGGUCGCACUAUUGCCUUUGGAGGCUGUGUGUUCUCUUAUGUUGGUUGCCAUAACAAGUGUGCCUAUUGGGUUCCACGUGCUAGCGCUAACAUAGGUUGUAACCAUACAGGUGUUGUUGGAGAAGGUUCCGAAGGUCUUAAUGACAACCUUCUUGAAAUACUCCAAAAAGAGAAAGUCAACAUCAAUAUUGUUGGUGACUUUAAACUUAAUGAAGAGAUCGCCAUUAUUUUGGCAUCUUUUUCUGCUUCCACAAGUGCUUUUGUGGAAACUGUGAAAGGUUUGGAUUAUAAAGCAUUCAAACAAAUUGUUGAAUCCUGUGGUAAUUUUAAAGUUACAAAAGGAAAAGCUAAAAAAGGUGCCUGGAAUAUUGGUGAACAGAAAUCAAUACUGAGUCCUCUUUAUGCAUUUGCAUCAGAGGCUGCUCGUGUUGUACGAUCAAUUUUCUCCCGCACUCUUGAAACUGCUCAAAAUUCUGUGCGUGUUUUACAGAAGGCCGCUAUAACAAUACUAGAUGGAAUUUCACAGUAUUCACUGAGACUCAUUGAUGCUAUGAUGUUCACAUCUGAUUUGGCUACUAACAAUCUAGUUGUAAUGGCCUACAUUACAGGUGGUGUUGUUCAGUUGACUUCGCAGUGGCUAACUAACAUCUUUGGCACUGUUUAUGAAAAACUCAAACCCGUCCUUGAUUGGCUUGAAGAGAAGUUUAAGGAAGGUGUAGAGUUUCUUAGAGACGGUUGGGAAAUUGUUAAAUUUAUCUCAACCUGUGCUUGUGAAAUUGUCGGUGGACAAAUUGUCACCUGUGCAAAGGAAAUUAAGGAGAGUGUUCAGACAUUCUUUAAGCUUGUAAAUAAAUUUUUGGCUUUGUGUGCUGACUCUAUCAUUAUUGGUGGAGCUAAACUUAAAGCCUUGAAUUUAGGUGAAACAUUUGUCACGCACUCAAAGGGAUUGUACAGAAAGUGUGUUAAAUCCAGAGAAGAAACUGGCCUACUCAUGCCUCUAAAAGCCCCAAAAGAAAUUAUCUUCUUAGAGGGAGAAACACUUCCCACAGAAGUGUUAACAGAGGAAGUUGUCUUGAAAACUGGUGAUUUACAACCAUUAGAACAACCUACUAGUGAAGCUGUUGAAGCUCCAUUGGUUGGUACACCAGUUUGUAUUAACGGGCUUAUGUUGCUCGAAAUCAAAGACACAGAAAAGUACUGUGCCCUUGCACCUAAUAUGAUGGUAACAAACAAUACCUUCACACUCAAAGGCGGUGCACCAACAAAGGUUACUUUUGGUGAUGACACUGUGAUAGAAGUGCAAGGUUACAAGAGUGUGAAUAUCACUUUUGAACUUGAUGAAAGGAUUGAUAAAGUACUUAAUGAGAAGUGCUCUGCCUAUACAGUUGAACUCGGUACAGAAGUAAAUGAGUUCGCCUGUGUUGUGGCAGAUGCUGUCAUAAAAACUUUGCAACCAGUAUCUGAAUUACUUACACCACUGGGCAUUGAUUUAGAUGAGUGGAGUAUGGCUACAUACUACUUAUUUGAUGAGUCUGGUGAGUUUAAAUUGGCUUCACAUAUGUAUUGUUCUUUCUACCCUCCAGAUGAGGAUGAAGAAGAAGGUGAUUGUGAAGAAGAAGAGUUUGAGCCAUCAACUCAAUAUGAGUAUGGUACUGAAGAUGAUUACCAAGGUAAACCUUUGGAAUUUGGUGCCACUUCUGCUGCUCUUCAACCUGAAGAAGAGCAAGAAGAAGAUUGGUUAGAUGAUGAUAGUCAACAAACUGUUGGUCAACAAGACGGCAGUGAGGACAAUCAGACAACUACUAUUCAAACAAUUGUUGAGGUUCAACCUCAAUUAGAGAUGGAACUUACACCAGUUGUUCAGACUAUUGAAGUGAAUAGUUUUAGUGGUUAUUUAAAACUUACUGACAAUGUAUACAUUAAAAAUGCAGACAUUGUGGAAGAAGCUAAAAAGGUAAAACCAACAGUGGUUGUUAAUGCAGCCAAUGUUUACCUUAAACAUGGAGGAGGUGUUGCAGGAGCCUUAAAUAAGGCUACUAACAAUGCCAUGCAAGUUGAAUCUGAUGAUUACAUAGCUACUAAUGGACCACUUAAAGUGGGUGGUAGUUGUGUUUUAAGCGGACACAAUCUUGCUAAACACUGUCUUCAUGUUGUCGGCCCAAAUGUUAACAAAGGUGAAGACAUUCAACUUCUUAAGAGUGCUUAUGAAAAUUUUAAUCAGCACGAAGUUCUACUUGCACCAUUAUUAUCAGCUGGUAUUUUUGGUGCUGACCCUAUACAUUCUUUAAGAGUUUGUGUAGAUACUGUUCGCACAAAUGUCUACUUAGCUGUCUUUGAUAAAAAUCUCUAUGACAAACUUGUUUCAAGCUUUUUGGAAAUGAAGAGUGAAAAGCAAGUUGAACAAAAGAUCGCUGAGAUUCCUAAAGAGGAAGUUAAGCCAUUUAUAACUGAAAGUAAACCUUCAGUUGAACAGAGAAAACAAGAUGAUAAGAAAAUCAAAGCUUGUGUUGAAGAAGUUACAACAACUCUGGAAGAAACUAAGUUCCUCACAGAAAACUUGUUACUUUAUAUUGACAUUAAUGGCAAUCUUCAUCCAGAUUCUGCCACUCUUGUUAGUGACAUUGACAUCACUUUCUUAAAGAAAGAUGCUCCAUAUAUAGUGGGUGAUGUUGUUCAAGAGGGUGUUUUAACUGCUGUGGUUAUACCUACUAAAAAGGCUGGUGGCACUACUGAAAUGCUAGCGAAAGCUUUGAGAAAAGUGCCAACAGACAAUUAUAUAACCACUUACCCGGGUCAGGGUUUAAAUGGUUACACUGUAGAGGAGGCAAAGACAGUGCUUAAAAAGUGUAAAAGUGCCUUUUACAUUCUACCAUCUAUUAUCUCUAAUGAGAAGCAAGAAAUUCUUGGAACUGUUUCUUGGAAUUUGCGAGAAAUGCUUGCACAUGCAGAAGAAACACGCAAAUUAAUGCCUGUCUGUGUGGAAACUAAAGCCAUAGUUUCAACUAUACAGCGUAAAUAUAAGGGUAUUAAAAUACAAGAGGGUGUGGUUGAUUAUGGUGCUAGAUUUUACUUUUACACCAGUAAAACAACUGUAGCGUCACUUAUCAACACACUUAACGAUCUAAAUGAAACUCUUGUUACAAUGCCACUUGGCUAUGUAACACAUGGCUUAAAUUUGGAAGAAGCUGCUCGGUAUAUGAGAUCUCUCAAAGUGCCAGCUACAGUUUCUGUUUCUUCACCUGAUGCUGUUACAGCGUAUAAUGGUUAUCUUACUUCUUCUUCUAAAACACCUGAAGAACAUUUUAUUGAAACCAUCUCACUUGCUGGUUCCUAUAAAGAUUGGUCCUAUUCUGGACAAUCUACACAACUAGGUAUAGAAUUUCUUAAGAGAGGUGAUAAAAGUGUAUAUUACACUAGUAAUCCUACCACAUUCCACCUAGAUGGUGAAGUUAUCACCUUUGACAAUCUUAAGACACUUCUUUCUUUGAGAGAAGUGAGGACUAUUAAGGUGUUUACAACAGUAGACAACAUUAACCUCCACACGCAAGUUGUGGACAUGUCAAUGACAUAUGGACAACAGUUUGGUCCAACUUAUUUGGAUGGAGCUGAUGUUACUAAAAUAAAACCUCAUAAUUCACAUGAAGGUAAAACAUUUUAUGUUUUACCUAAUGAUGACACUCUACGUGUUGAGGCUUUUGAGUACUACCACACAACUGAUCCUAGUUUUCUGGGUAGGUACAUGUCAGCAUUAAAUCACACUAAAAAGUGGAAAUACCCACAAGUUAAUGGUUUAACUUCUAUUAAAUGGGCAGAUAACAACUGUUAUCUUGCCACUGCAUUGUUAACACUCCAACAAAUAGAGUUGAAGUUUAAUCCACCUGCUCUACAAGAUGCUUAUUACAGAGCAAGGGCUGGUGAAGCUGCUAACUUUUGUGCACUUAUCUUAGCCUACUGUAAUAAGACAGUAGGUGAGUUAGGUGAUGUUAGAGAAACAAUGAGUUACUUGUUUCAACAUGCCAAUUUAGAUUCUUGCAAAAGAGUCUUGAACGUGGUGUGUAAAACUUGUGGACAACAGCAGACAACCCUUAAGGGUGUAGAAGCUGUUAUGUACAUGGGCACACUUUCUUAUGAACAAUUUAAGAAAGGUGUUCAGAUACCUUGUACGUGUGGUAAACAAGCUACAAAAUAUCUAGUACAACAGGAGUCACCUUUUGUUAUGAUGUCAGCACCACCUGCUCAGUAUGAACUUAAGCAUGGUACAUUUACUUGUGCUAGUGAGUACACUGGUAAUUACCAGUGUGGUCACUAUAAACAUAUAACUUCUAAAGAAACUUUGUAUUGCAUAGACGGUGCUUUACUUACAAAGUCCUCAGAAUACAAAGGUCCUAUUACGGAUGUUUUCUACAAAGAAAACAGUUACACAACAACCAUAAAACCAGUUACUUAUAAAUUGGAUGGUGUUGUUUGUACAGAAAUUGACCCUAAGUUGGACAAUUAUUAUAAGAAAGACAAUUCUUAUUUCACAGAGCAACCAAUUGAUCUUGUACCAAACCAACCAUAUCCAAACGCAAGCUUCGAUAAUUUUAAGUUUGUAUGUGAUAAUAUCAAAUUUGCUGAUGAUUUAAACCAGUUAACUGGUUAUAAGAAACCUGCUUCAAGAGAGCUUAAAGUUACAUUUUUCCCUGACUUAAAUGGUGAUGUGGUGGCUAUUGAUUAUAAACACUACACACCCUCUUUUAAGAAAGGAGCUAAAUUGUUACAUAAACCUAUUGUUUGGCAUGUUAACAAUGCAACUAAUAAAGCCACGUAUAAACCAAAUACCUGGUGUAUACGUUGUCUUUGGAGCACAAAACCAGUUGAAACAUCAAAUUCGUUUGAUGUACUGAAGUCAGAGGACGCGCAGGGAAUGGAUAAUCUUGCCUGCGAAGAUCUAAAACCAGUCUCUGAAGAAGUAGUGGAAAAUCCUACCAUACAGAAAGACGUUCUUGAGUGUAAUGUGAAAACUACCGAAGUUGUAGGAGACAUUAUACUUAAACCAGCAAAUAAUAGUUUAAAAAUUACAGAAGAGGUUGGCCACACAGAUCUAAUGGCUGCUUAUGUAGACAAUUCUAGUCUUACUAUUAAGAAACCUAAUGAAUUAUCUAGAGUAUUAGGUUUGAAAACCCUUGCUACUCAUGGUUUAGCUGCUGUUAAUAGUGUCCCUUGGGAUACUAUAGCUAAUUAUGCUAAGCCUUUUCUUAACAAAGUUGUUAGUACAACUACUAACAUAGUUACACGGUGUUUAAACCGUGUUUGUACUAAUUAUAUGCCUUAUUUCUUUACUUUAUUGCUACAAUUGUGUACUUUUACUAGAAGUACAAAUUCUAGAAUUAAAGCAUCUAUGCCGACUACUAUAGCAAAGAAUACUGUUAAGAGUGUCGGUAAAUUUUGUCUAGAGGCUUCAUUUAAUUAUUUGAAGUCACCUAAUUUUUCUAAACUGAUAAAUAUUAUAAUUUGGUUUUUACUAUUAAGUGUUUGCCUAGGUUCUUUAAUCUACUCAACCGCUGCUUUAGGUGUUUUAAUGUCUAAUUUAGGCAUGCCUUCUUACUGUACUGGUUACAGAGAAGGCUAUUUGAACUCUACUAAUGUCACUAUUGCAACCUACUGUACUGGUUCUAUACCUUGUAGUGUUUGUCUUAGUGGUUUAGAUUCUUUAGACACCUAUCCUUCUUUAGAAACUAUACAAAUUACCAUUUCAUCUUUUAAAUGGGAUUUAACUGCUUUUGGCUUAGUUGCAGAGUGGUUUUUGGCAUAUAUUCUUUUCACUAGGUUUUUCUAUGUACUUGGAUUGGCUGCAAUCAUGCAAUUGUUUUUCAGCUAUUUUGCAGUACAUUUUAUUAGUAAUUCUUGGCUUAUGUGGUUAAUAAUUAAUCUUGUACAAAUGGCCCCGAUUUCAGCUAUGGUUAGAAUGUACAUCUUCUUUGCAUCAUUUUAUUAUGUAUGGAAAAGUUAUGUGCAUGUUGUAGACGGUUGUAAUUCAUCAACUUGUAUGAUGUGUUACAAACGUAAUAGAGCAACAAGAGUCGAAUGUACAACUAUUGUUAAUGGUGUUAGAAGGUCCUUUUAUGUCUAUGCUAAUGGAGGUAAAGGCUUUUGCAAACUACACAAUUGGAAUUGUGUUAAUUGUGAUACAUUCUGUGCUGGUAGUACAUUUAUUAGUGAUGAAGUUGCGAGAGACUUGUCACUACAGUUUAAAAGACCAAUAAAUCCUACUGACCAGUCUUCUUACAUCGUUGAUAGUGUUACAGUGAAGAAUGGUUCCAUCCAUCUUUACUUUGAUAAAGCUGGUCAAAAGACUUAUGAAAGACAUUCUCUCUCUCAUUUUGUUAACUUAGACAACCUGAGAGCUAAUAACACUAAAGGUUCAUUGCCUAUUAAUGUUAUAGUUUUUGAUGGUAAAUCAAAAUGUGAAGAAUCAUCUGCAAAAUCAGCGUCUGUUUACUACAGUCAGCUUAUGUGUCAACCUAUACUGUUACUAGAUCAGGCAUUAGUGUCUGAUGUUGGUGAUAGUGCGGAAGUUGCAGUUAAAAUGUUUGAUGCUUACGUUAAUACGUUUUCAUCAACUUUUAACGUACCAAUGGAAAAACUCAAAACACUAGUUGCAACUGCAGAAGCUGAACUUGCAAAGAAUGUGUCCUUAGACAAUGUCUUAUCUACUUUUAUUUCAGCAGCUCGGCAAGGGUUUGUUGAUUCAGAUGUAGAAACUAAAGAUGUUGUUGAAUGUCUUAAAUUGUCACAUCAAUCUGACAUAGAAGUUACUGGCGAUAGUUGUAAUAACUAUAUGCUCACCUAUAACAAAGUUGAAAACAUGACACCCCGUGACCUUGGUGCUUGUAUUGACUGUAGUGCGCGUCAUAUUAAUGCGCAGGUAGCAAAAAGUCACAACAUUGCUUUGAUAUGGAACGUUAAAGAUUUCAUGUCAUUGUCUGAACAACUACGAAAACAAAUACGUAGUGCUGCUAAAAAGAAUAACUUACCUUUUAAGUUGACAUGUGCAACUACUAGACAAGUUGUUAAUGUUGUAACAACAAAGAUAGCACUUAAGGGUGGUAAAAUUGUUAAUAAUUGGUUGAAGCAGUUAAUUAAAGUUACACUUGUGUUCCUUUUUGUUGCUGCUAUUUUCUAUUUAAUAACACCUGUUCAUGUCAUGUCUAAACAUACUGACUUUUCAAGUGAAAUCAUAGGAUACAAGGCUAUUGAUGGUGGUGUCACUCGUGACAUAGCAUCUACAGAUACUUGUUUUGCUAACAAACAUGCUGAUUUUGACACAUGGUUUAGCCAGCGUGGUGGUAGUUAUACUAAUGACAAAGCUUGCCCAUUGAUUGCUGCAGUCAUAACAAGAGAAGUGGGUUUUGUCGUGCCUGGUUUGCCUGGCACGAUAUUACGCACAACUAAUGGUGACUUUUUGCAUUUCUUACCUAGAGUUUUUAGUGCAGUUGGUAACAUCUGUUACACACCAUCAAAACUUAUAGAGUACACUGACUUUGCAACAUCAGCUUGUGUUUUGGCUGCUGAAUGUACAAUUUUUAAAGAUGCUUCUGGUAAGCCAGUACCAUAUUGUUAUGAUACCAAUGUACUAGAAGGUUCUGUUGCUUAUGAAAGUUUACGCCCUGACACACGUUAUGUGCUCAUGGAUGGCUCUAUUAUUCAAUUUCCUAACACCUACCUUGAAGGUUCUGUUAGAGUGGUAACAACUUUUGAUUCUGAGUACUGUAGGCACGGCACUUGUGAAAGAUCAGAAGCUGGUGUUUGUGUAUCUACUAGUGGUAGAUGGGUACUUAACAAUGAUUAUUACAGAUCUUUACCAGGAGUUUUCUGUGGUGUAGAUGCUGUAAAUUUACUUACUAAUAUGUUUACACCACUAAUUCAACCUAUUGGUGCUUUGGACAUAUCAGCAUCUAUAGUAGCUGGUGGUAUUGUAGCUAUCGUAGUAACAUGCCUUGCCUACUAUUUUAUGAGGUUUAGAAGAGCUUUUGGUGAAUACAGUCAUGUAGUUGCCUUUAAUACUUUACUAUUCCUUAUGUCAUUCACUGUACUCUGUUUAACACCAGUUUACUCAUUCUUACCUGGUGUUUAUUCUGUUAUUUACUUGUACUUGACAUUUUAUCUUACUAAUGAUGUUUCUUUUUUAGCACAUAUUCAGUGGAUGGUUAUGUUCACACCUUUAGUACCUUUCUGGAUAACAAUUGCUUAUAUCAUUUGUAUUUCCACAAAGCAUUUCUAUUGGUUCUUUAGUAAUUACCUAAAGAGACGUGUAGUCUUUAAUGGUGUUUCCUUUAGUACUUUUGAAGAAGCUGCGCUGUGCACCUUUUUGUUAAAUAAAGAAAUGUAUCUAAAGUUGCGUAGUGAUGUGCUAUUACCUCUUACGCAAUAUAAUAGAUACUUAGCUCUUUAUAAUAAGUACAAGUAUUUUAGUGGAGCAAUGGAUACAACUAGCUACAGAGAAGCUGCUUGUUGUCAUCUCGCAAAGGCUCUCAAUGACUUCAGUAACUCAGGUUCUGAUGUUCUUUACCAACCACCACAAACCUCUAUCACCUCAGCUGUUUUGCAGAGUGGUUUUAGAAAAAUGGCAUUCCCAUCUGGUAAAGUUGAGGGUUGUAUGGUACAAGUAACUUGUGGUACAACUACACUUAACGGUCUUUGGCUUGAUGACGUAGUUUACUGUCCAAGACAUGUGAUCUGCACCUCUGAAGACAUGCUUAACCCUAAUUAUGAAGAUUUACUCAUUCGUAAGUCUAAUCAUAAUUUCUUGGUACAGGCUGGUAAUGUUCAACUCAGGGUUAUUGGACAUUCUAUGCAAAAUUGUGUACUUAAGCUUAAGGUUGAUACAGCCAAUCCUAAGACACCUAAGUAUAAGUUUGUUCGCAUUCAACCAGGACAGACUUUUUCAGUGUUAGCUUGUUACAAUGGUUCACCAUCUGGUGUUUACCAAUGUGCUAUGAGGCCCAAUUUCACUAUUAAGGGUUCAUUCCUUAAUGGUUCAUGUGGUAGUGUUGGUUUUAACAUAGAUUAUGACUGUGUCUCUUUUUGUUACAUGCACCAUAUGGAAUUACCAACUGGAGUUCAUGCUGGCACAGACUUAGAAGGUAACUUUUAUGGACCUUUUGUUGACAGGCAAACAGCACAAGCAGCUGGUACGGACACAACUAUUACAGUUAAUGUUUUAGCUUGGUUGUACGCUGCUGUUAUAAAUGGAGACAGGUGGUUUCUCAAUCGAUUUACCACAACUCUUAAUGACUUUAACCUUGUGGCUAUGAAGUACAAUUAUGAACCUCUAACACAAGACCAUGUUGACAUACUAGGACCUCUUUCUGCUCAAACUGGAAUUGCCGUUUUAGAUAUGUGUGCUUCAUUAAAAGAAUUACUGCAAAAUGGUAUGAAUGGACGUACCAUAUUGGGUAGUGCUUUAUUAGAAGAUGAAUUUACACCUUUUGAUGUUGUUAGACAAUGCUCAGGUGUUACUUUCCAAAGUGCAGUGAAAAGAACAAUCAAGGGUACACACCACUGGUUGUUACUCACAAUUUUGACUUCACUUUUAGUUUUAGUCCAGAGUACUCAAUGGUCUUUGUUCUUUUUUUUGUAUGAAAAUGCCUUUUUACCUUUUGCUAUGGGUAUUAUUGCUAUGUCUGCUUUUGCAAUGAUGUUUGUCAAACAUAAGCAUGCAUUUCUCUGUUUGUUUUUGUUACCUUCUCUUGCCACUGUAGCUUAUUUUAAUAUGGUCUAUAUGCCUGCUAGUUGGGUGAUGCGUAUUAUGACAUGGUUGGAUAUGGUUGAUACUAGUUUGUCUGGUUUUAAGCUAAAAGACUGUGUUAUGUAUGCAUCAGCUGUAGUGUUACUAAUCCUUAUGACAGCAAGAACUGUGUAUGAUGAUGGUGCUAGGAGAGUGUGGACACUUAUGAAUGUCUUGACACUCGUUUAUAAAGUUUAUUAUGGUAAUGCUUUAGAUCAAGCCAUUUCCAUGUGGGCUCUUAUAAUCUCUGUUACUUCUAACUACUCAGGUGUAGUUACAACUGUCAUGUUUUUGGCCAGAGGUAUUGUUUUUAUGUGUGUUGAGUAUUGCCCUAUUUUCUUCAUAACUGGUAAUACACUUCAGUGUAUAAUGCUAGUUUAUUGUUUCUUAGGCUAUUUUUGUACUUGUUACUUUGGCCUCUUUUGUUUACUCAACCGCUACUUUAGACUGACUCUUGGUGUUUAUGAUUACUUAGUUUCUACACAGGAGUUUAGAUAUAUGAAUUCACAGGGACUACUCCCACCCAAGAAUAGCAUAGAUGCCUUCAAACUCAACAUUAAAUUGUUGGGUGUUGGUGGCAAACCUUGUAUCAAAGUAGCCACUGUACAGUCUAAAAUGUCAGAUGUAAAGUGCACAUCAGUAGUCUUACUCUCAGUUUUGCAACAACUCAGAGUAGAAUCAUCAUCUAAAUUGUGGGCUCAAUGUGUCCAGUUACACAAUGACAUUCUCUUAGCUAAAGAUACUACUGAAGCCUUUGAAAAAAUGGUUUCACUACUUUCUGUUUUGCUUUCCAUGCAGGGUGCUGUAGACAUAAACAAGCUUUGUGAAGAAAUGCUGGACAACAGGGCAACCUUACAAGCUAUAGCCUCAGAGUUUAGUUCCCUUCCAUCAUAUGCAGCUUUUGCUACUGCUCAAGAAGCUUAUGAGCAGGCUGUUGCUAAUGGUGAUUCUGAAGUUGUUCUUAAAAAGUUGAAGAAGUCUUUGAAUGUGGCUAAAUCUGAAUUUGACCGUGAUGCAGCCAUGCAACGUAAGUUGGAAAAGAUGGCUGAUCAAGCUAUGACCCAAAUGUAUAAACAGGCUAGAUCUGAGGACAAGAGGGCAAAAGUUACUAGUGCUAUGCAGACAAUGCUUUUCACUAUGCUUAGAAAGUUGGAUAAUGAUGCACUCAACAACAUUAUCAACAAUGCAAGAGAUGGUUGUGUUCCCUUGAACAUAAUACCUCUUACAACAGCAGCCAAACUAAUGGUUGUCAUACCAGACUAUAACACAUAUAAAAAUACGUGUGAUGGUACAACAUUUACUUAUGCAUCAGCAUUGUGGGAAAUCCAACAGGUUGUAGAUGCAGAUAGUAAAAUUGUUCAACUUAGUGAAAUUAGUAUGGACAAUUCACCUAAUUUAGCAUGGCCUCUUAUUGUAACAGCUUUAAGGGCCAAUUCUGCUGUCAAAUUACAGAAUAAUGAGCUUAGUCCUGUUGCACUACGACAGAUGUCUUGUGCUGCCGGUACUACACAAACUGCUUGCACUGAUGACAAUGCGUUAGCUUACUACAACACAACAAAGGGAGGUAGGUUUGUACUUGCACUGUUAUCCGAUUUACAGGAUUUGAAAUGGGCUAGAUUCCCUAAGAGUGAUGGAACUGGUACUAUCUAUACAGAACUGGAACCACCUUGUAGGUUUGUUACAGACACACCUAAAGGUCCUAAAGUGAAGUAUUUAUACUUUAUUAAAGGAUUAAACAACCUAAAUAGAGGUAUGGUACUUGGUAGUUUAGCUGCCACAGUACGUCUACAAGCUGGUAAUGCAACAGAAGUGCCUGCCAAUUCAACUGUAUUAUCUUUCUGUGCUUUUGCUGUAGAUGCUGCUAAAGCUUACAAAGAUUAUCUAGCUAGUGGGGGACAACCAAUCACUAAUUGUGUUAAGAUGUUGUGUACACACACUGGUACUGGUCAGGCAAUAACAGUUACACCGGAAGCCAAUAUGGAUCAAGAAUCCUUUGGUGGUGCAUCGUGUUGUCUGUACUGCCGUUGCCACAUAGAUCAUCCAAAUCCUAAAGGAUUUUGUGACUUAAAAGGUAAGUAUGUACAAAUACCUACAACUUGUGCUAAUGACCCUGUGGGUUUUACACUUAAAAACACAGUCUGUACCGUCUGCGGUAUGUGGAAAGGUUAUGGCUGUAGUUGUGAUCAACUCCGCGAACCCAUGCUUCAGUCAGCUGAUGCACAAUCGUUUUUAAACGGGUUUGCGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGGCACUAGUACUGAUGUCGUAUACAGGGCUUUUGACAUCUACAAUGAUAAAGUAGCUGGUUUUGCUAAAUUCCUAAAAACUAAUUGUUGUCGCUUCCAAGAAAAGGACGAAGAUGACAAUUUAAUUGAUUCUUACUUUGUAGUUAAGAGACACACUUUCUCUAACUACCAACAUGAAGAAACAAUUUAUAAUUUACUUAAGGAUUGUCCAGCUGUUGCUAAACAUGACUUCUUUAAGUUUAGAAUAGACGGUGACAUGGUACCACAUAUAUCACGUCAACGUCUUACUAAAUACACAAUGGCAGACCUCGUCUAUGCUUUAAGGCAUUUUGAUGAAGGUAAUUGUGACACAUUAAAAGAAAUACUUGUCACAUACAAUUGUUGUGAUGAUGAUUAUUUCAAUAAAAAGGACUGGUAUGAUUUUGUAGAAAACCCAGAUAUAUUACGCGUAUACGCCAACUUAGGUGAACGUGUACGCCAAGCUUUGUUAAAAACAGUACAAUUCUGUGAUGCCAUGCGAAAUGCUGGUAUUGUUGGUGUACUGACAUUAGAUAAUCAAGAUCUCAAUGGUAACUGGUAUGAUUUCGGUGAUUUCAUACAAACCACGCCAGGUAGUGGAGUUCCUGUUGUAGAUUCUUAUUAUUCAUUGUUAAUGCCUAUAUUAACCUUGACCAGGGCUUUAACUGCAGAGUCACAUGUUGACACUGACUUAACAAAGCCUUACAUUAAGUGGGAUUUGUUAAAAUAUGACUUCACGGAAGAGAGGUUAAAACUCUUUGACCGUUAUUUUAAAUAUUGGGAUCAGACAUACCACCCAAAUUGUGUUAACUGUUUGGAUGACAGAUGCAUUCUGCAUUGUGCAAACUUUAAUGUUUUAUUCUCUACAGUGUUCCCACCUACAAGUUUUGGACCACUAGUGAGAAAAAUAUUUGUUGAUGGUGUUCCAUUUGUAGUUUCAACUGGAUACCACUUCAGAGAGCUAGGUGUUGUACAUAAUCAGGAUGUAAACUUACAUAGCUCUAGACUUAGUUUUAAGGAAUUACUUGUGUAUGCUGCUGACCCUGCUAUGCACGCUGCUUCUGGUAAUCUAUUACUAGAUAAACGCACUACGUGCUUUUCAGUAGCUGCACUUACUAACAAUGUUGCUUUUCAAACUGUCAAACCCGGUAAUUUUAACAAAGACUUCUAUGACUUUGCUGUGUCUAAGGGUUUCUUUAAGGAAGGAAGUUCUGUUGAAUUAAAACACUUCUUCUUUGCUCAGGAUGGUAAUGCUGCUAUCAGCGAUUAUGACUACUAUCGUUAUAAUCUACCAACAAUGUGUGAUAUCAGACAACUACUAUUUGUAGUUGAAGUUGUUGAUAAGUACUUUGAUUGUUACGAUGGUGGCUGUAUUAAUGCUAACCAAGUCAUCGUCAACAACCUAGACAAAUCAGCUGGUUUUCCAUUUAAUAAAUGGGGUAAGGCUAGACUUUAUUAUGAUUCAAUGAGUUAUGAGGAUCAAGAUGCACUUUUCGCAUAUACAAAACGUAAUGUCAUCCCUACUAUAACUCAAAUGAAUCUUAAGUAUGCCAUUAGUGCAAAGAAUAGAGCUCGCACCGUAGCUGGUGUCUCUAUCUGUAGUACUAUGACCAAUAGACAGUUUCAUCAAAAAUUAUUGAAAUCAAUAGCCGCCACUAGAGGAGCUACUGUAGUAAUUGGAACAAGCAAAUUCUAUGGUGGUUGGCACAACAUGUUAAAAACUGUUUAUAGUGAUGUAGAAAACCCUCACCUUAUGGGUUGGGAUUAUCCUAAAUGUGAUAGAGCCAUGCCUAACAUGCUUAGAAUUAUGGCCUCACUUGUUCUUGCUCGCAAACAUACAACGUGUUGUAGCUUGUCACACCGUUUCUAUAGAUUAGCUAAUGAGUGUGCUCAAGUAUUGAGUGAAAUGGUCAUGUGUGGCGGUUCACUAUAUGUUAAACCAGGUGGAACCUCAUCAGGAGAUGCCACAACUGCUUAUGCUAAUAGUGUUUUUAACAUUUGUCAAGCUGUCACGGCCAAUGUUAAUGCACUUUUAUCUACUGAUGGUAACAAAAUUGCCGAUAAGUAUGUCCGCAAUUUACAACACAGACUUUAUGAGUGUCUCUAUAGAAAUAGAGAUGUUGACACAGACUUUGUGAAUGAGUUUUACGCAUAUUUGCGUAAACAUUUCUCAAUGAUGAUACUCUCUGACGAUGCUGUUGUGUGUUUCAAUAGCACUUAUGCAUCUCAAGGUCUAGUGGCUAGCAUAAAGAACUUUAAGUCAGUUCUUUAUUAUCAAAACAAUGUUUUUAUGUCUGAAGCAAAAUGUUGGACUGAGACUGACCUUACUAAAGGACCUCAUGAAUUUUGCUCUCAACAUACAAUGCUAGUUAAACAGGGUGAUGAUUAUGUGUACCUUCCUUACCCAGAUCCAUCAAGAAUCCUAGGGGCCGGCUGUUUUGUAGAUGAUAUCGUAAAAACAGAUGGUACACUUAUGAUUGAACGGUUCGUGUCUUUAGCUAUAGAUGCUUACCCACUUACUAAACAUCCUAAUCAGGAGUAUGCUGAUGUCUUUCAUUUGUACUUACAAUACAUAAGAAAGCUACAUGAUGAGUUAACAGGACACAUGUUAGACAUGUAUUCUGUUAUGCUUACUAAUGAUAACACUUCAAGGUAUUGGGAACCUGAGUUUUAUGAGGCUAUGUACACACCGCAUACAGUCUUACAGGCUGUUGGGGCUUGUGUUCUUUGCAAUUCACAGACUUCAUUAAGAUGUGGUGCUUGCAUACGUAGACCAUUCUUAUGUUGUAAAUGCUGUUACGACCAUGUCAUAUCAACAUCACAUAAAUUAGUCUUGUCUGUUAAUCCGUAUGUUUGCAAUGCUCCAGGUUGUGAUGUCACAGAUGUGACUCAACUUUACUUAGGAGGUAUGAGCUAUUAUUGUAAAUCACAUAAACCACCCAUUAGUUUUCCAUUGUGUGCUAAUGGACAAGUUUUUGGUUUAUAUAAAAAUACAUGUGUUGGUAGCGAUAAUGUUACUGACUUUAAUGCAAUUGCAACAUGUGACUGGACAAAUGCUGGUGAUUACAUUUUAGCUAACACCUGUACUGAAAGACUCAAGCUUUUUGCAGCAGAAACGCUCAAAGCUACUGAGGAGACAUUUAAACUGUCUUAUGGUAUUGCUACUGUACGUGAAGUGCUGUCUGACAGAGAAUUACAUCUUUCAUGGGAAGUUGGUAAACCUAGACCACCACUUAACCGAAAUUAUGUCUUUACUGGUUAUCGUGUAACUAAAAACAGUAAAGUACAAAUAGGAGAGUACACCUUUGAAAAAGGUGACUAUGGUGAUGCUGUUGUUUACCGAGGUACAACAACUUACAAAUUAAAUGUUGGUGAUUAUUUUGUGCUGACAUCACAUACAGUAAUGCCAUUAAGUGCACCUACACUAGUGCCACAAGAGCACUAUGUUAGAAUUACUGGCUUAUACCCAACACUCAAUAUCUCAGAUGAGUUUUCUAGCAAUGUUGCAAAUUAUCAAAAGGUUGGUAUGCAAAAGUAUUCUACACUCCAGGGACCACCUGGUACUGGUAAGAGUCAUUUUGCUAUUGGCCUAGCUCUCUACUACCCUUCUGCUCGCAUAGUGUAUACAGCUUGCUCUCAUGCCGCUGUUGAUGCACUAUGUGAGAAGGCAUUAAAAUAUUUGCCUAUAGAUAAAUGUAGUAGAAUUAUACCUGCACGUGCUCGUGUAGAGUGUUUUGAUAAAUUCAAAGUGAAUUCAACAUUAGAACAGUAUGUCUUUUGUACUGUAAAUGCAUUGCCUGAGACGACAGCAGAUAUAGUUGUCUUUGAUGAAAUUUCAAUGGCCACAAAUUAUGAUUUGAGUGUUGUCAAUGCCAGAUUACGUGCUAAGCACUAUGUGUACAUUGGCGACCCUGCUCAAUUACCUGCACCACGCACAUUGCUAACUAAGGGCACACUAGAACCAGAAUAUUUCAAUUCAGUGUGUAGACUUAUGAAAACUAUAGGUCCAGACAUGUUCCUCGGAACUUGUCGGCGUUGUCCUGCUGAAAUUGUUGACACUGUGAGUGCUUUGGUUUAUGAUAAUAAGCUUAAAGCACAUAAAGACAAAUCAGCUCAAUGCUUUAAAAUGUUUUAUAAGGGUGUUAUCACGCAUGAUGUUUCAUCUGCAAUUAACAGGCCACAAAUAGGCGUGGUAAGAGAAUUCCUUACACGUAACCCUGCUUGGAGAAAAGCUGUCUUUAUUUCACCUUAUAAUUCACAGAAUGCUGUAGCCUCAAAGAUUUUGGGACUACCAACUCAAACUGUUGAUUCAUCACAGGGCUCAGAAUAUGACUAUGUCAUAUUCACUCAAACCACUGAAACAGCUCACUCUUGUAAUGUAAACAGAUUUAAUGUUGCUAUUACCAGAGCAAAAGUAGGCAUACUUUGCAUAAUGUCUGAUAGAGACCUUUAUGACAAGUUGCAAUUUACAAGUCUUGAAAUUCCACGUAGGAAUGUGGCAACUUUACAAGCUGAAAAUGUAACAGGACUCUUUAAAGAUUGUAGUAAGGUAAUCACUGGGUUACAUCCUACACAGGCACCUACACACCUCAGUGUUGACACUAAAUUCAAAACUGAAGGUUUAUGUGUUGACAUACCUGGCAUACCUAAGGACAUGACCUAUAGAAGACUCAUCUCUAUGAUGGGUUUUAAAAUGAAUUAUCAAGUUAAUGGUUACCCUAACAUGUUUAUCACCCGCGAAGAAGCUAUAAGACAUGUACGUGCAUGGAUUGGCUUCGAUGUCGAGGGGUGUCAUGCUACUAGAGAAGCUGUUGGUACCAAUUUACCUUUACAGCUAGGUUUUUCUACAGGUGUUAACCUAGUUGCUGUACCUACAGGUUAUGUUGAUACACCUAAUAAUACAGAUUUUUCCAGAGUUAGUGCUAAACCACCGCCUGGAGAUCAAUUUAAACACCUCAUACCACUUAUGUACAAAGGACUUCCUUGGAAUGUAGUGCGUAUAAAGAUUGUACAAAUGUUAAGUGACACACUUAAAAAUCUCUCUGACAGAGUCGUAUUUGUCUUAUGGGCACAUGGCUUUGAGUUGACAUCUAUGAAGUAUUUUGUGAAAAUAGGACCUGAGCGCACCUGUUGUCUAUGUGAUAGACGUGCCACAUGCUUUUCCACUGCUUCAGACACUUAUGCCUGUUGGCAUCAUUCUAUUGGAUUUGAUUACGUCUAUAAUCCGUUUAUGAUUGAUGUUCAACAAUGGGGUUUUACAGGUAACCUACAAAGCAACCAUGAUCUGUAUUGUCAAGUCCAUGGUAAUGCACAUGUAGCUAGUUGUGAUGCAAUCAUGACUAGGUGUCUAGCUGUCCACGAGUGCUUUGUUAAGCGUGUUGACUGGACUAUUGAAUAUCCUAUAAUUGGUGAUGAACUGAAGAUUAAUGCGGCUUGUAGAAAGGUUCAACACAUGGUUGUUAAAGCUGCAUUAUUAGCAGACAAAUUCCCAGUUCUUCACGACAUUGGUAACCCUAAAGCUAUUAAGUGUGUACCUCAAGCUGAUGUAGAAUGGAAGUUCUAUGAUGCACAGCCUUGUAGUGACAAAGCUUAUAAAAUAGAAGAAUUAUUCUAUUCUUAUGCCACACAUUCUGACAAAUUCACAGAUGGUGUAUGCCUAUUUUGGAAUUGCAAUGUCGAUAGAUAUCCUGCUAAUUCCAUUGUUUGUAGAUUUGACACUAGAGUGCUAUCUAACCUUAACUUGCCUGGUUGUGAUGGUGGCAGUUUGUAUGUAAAUAAACAUGCAUUCCACACACCAGCUUUUGAUAAAAGUGCUUUUGUUAAUUUAAAACAAUUACCAUUUUUCUAUUACUCUGACAGUCCAUGUGAGUCUCAUGGAAAACAAGUAGUGUCAGAUAUAGAUUAUGUACCACUAAAGUCUGCUACGUGUAUAACACGUUGCAAUUUAGGUGGUGCUGUCUGUAGACAUCAUGCUAAUGAGUACAGAUUGUAUCUCGAUGCUUAUAACAUGAUGAUCUCAGCUGGCUUUAGCUUGUGGGUUUACAAACAAUUUGAUACUUAUAACCUCUGGAACACUUUUACAAGACUUCAGAGUUUAGAAAAUGUGGCUUUUAAUGUUGUAAAUAAGGGACACUUUGAUGGACAACAGGGUGAAGUACCAGUUUCUAUCAUUAAUAACACUGUUUACACAAAAGUUGAUGGUGUUGAUGUAGAAUUGUUUGAAAAUAAAACAACAUUACCUGUUAAUGUAGCAUUUGAGCUUUGGGCUAAGCGCAACAUUAAACCAGUACCAGAGGUGAAAAUACUCAAUAAUUUGGGUGUGGACAUUGCUGCUAAUACUGUGAUCUGGGACUACAAAAGAGAUGCUCCAGCACAUAUAUCUACUAUUGGUGUUUGUUCUAUGACUGACAUAGCCAAGAAACCAACUGAAACGAUUUGUGCACCACUCACUGUCUUUUUUGAUGGUAGAGUUGAUGGUCAAGUAGACUUAUUUAGAAAUGCCCGUAAUGGUGUUCUUAUUACAGAAGGUAGUGUUAAAGGUUUACAACCAUCUGUAGGUCCCAAACAAGCUAGUCUUAAUGGAGUCACAUUAAUUGGAGAAGCCGUAAAAACACAGUUCAAUUAUUAUAAGAAAGUUGAUGGUGUUGUCCAACAAUUACCUGAAACUUACUUUACUCAGAGUAGAAAUUUACAAGAAUUUAAACCCAGGAGUCAAAUGGAAAUUGAUUUCUUAGAAUUAGCUAUGGAUGAAUUCAUUGAACGGUAUAAAUUAGAAGGCUAUGCCUUCGAACAUAUCGUUUAUGGAGAUUUUAGUCAUAGUCAGUUAGGUGGUUUACAUCUACUGAUUGGACUAGCUAAACGUUUUAAGGAAUCACCUUUUGAAUUAGAAGAUUUUAUUCCUAUGGACAGUACAGUUAAAAACUAUUUCAUAACAGAUGCGCAAACAGGUUCAUCUAAGUGUGUGUGUUCUGUUAUUGAUUUAUUACUUGAUGAUUUUGUUGAAAUAAUAAAAUCCCAAGAUUUAUCUGUAGUUUCUAAGGUUGUCAAAGUGACUAUUGACUAUACAGAAAUUUCAUUUAUGCUUUGGUGUAAAGAUGGCCAUGUAGAAACAUUUUACCCAAAAUUACAAUCUAGUCAAGCGUGGCAACCGGGUGUUGCUAUGCCUAAUCUUUACAAAAUGCAAAGAAUGCUAUUAGAAAAGUGUGACCUUCAAAAUUAUGGUGAUAGUGCAACAUUACCUAAAGGCAUAAUGAUGAAUGUCGCAAAAUAUACUCAACUGUGUCAAUAUUUAAACACAUUAACAUUAGCUGUACCCUAUAAUAUGAGAGUUAUACAUUUUGGUGCUGGUUCUGAUAAAGGAGUUGCACCAGGUACAGCUGUUUUAAGACAGUGGUUGCCUACGGGUACGCUGCUUGUCGAUUCAGAUCUUAAUGACUUUGUCUCUGAUGCAGAUUCAACUUUGAUUGGUGAUUGUGCAACUGUACAUACAGCUAAUAAAUGGGAUCUCAUUAUUAGUGAUAUGUACGACCCUAAGACUAAAAAUGUUACAAAAGAAAAUGACUCUAAAGAGGGUUUUUUCACUUACAUUUGUGGGUUUAUACAACAAAAGCUAGCUCUUGGAGGUUCCGUGGCUAUAAAGAUAACAGAACAUUCUUGGAAUGCUGAUCUUUAUAAGCUCAUGGGACACUUCGCAUGGUGGACAGCCUUUGUUACUAAUGUGAAUGCGUCAUCAUCUGAAGCAUUUUUAAUUGGAUGUAAUUAUCUUGGCAAACCACGCGAACAAAUAGAUGGUUAUGUCAUGCAUGCAAAUUACAUAUUUUGGAGGAAUACAAAUCCAAUUCAGUUGUCUUCCUAUUCUUUAUUUGACAUGAGUAAAUUUCCCCUUAAAUUAAGGGGUACUGCUGUUAUGUCUUUAAAAGAAGGUCAAAUCAAUGAUAUGAUUUUAUCUCUUCUUAGUAAAGGUAGACUUAUAAUUAGAGAAAACAACAGAGUUGUUAUUUCUAGUGAUGUUCUUGUUAACAACUAAACGAACAAUGUUUGUUUUUCUUGUUUUAUUGCCACUAGUCUCUAGUCAGUGUGUUAAUCUUACAACCAGAACUCAAUUACCCCCUGCAUACACUAAUUCUUUCACACGUGGUGUUUAUUACCCUGACAAAGUUUUCAGAUCCUCAGUUUUACAUUCAACUCAGGACUUGUUCUUACCUUUCUUUUCCAAUGUUACUUGGUUCCAUGCUAUACAUGUCUCUGGGACCAAUGGUACUAAGAGGUUUGAUAACCCUGUCCUACCAUUUAAUGAUGGUGUUUAUUUUGCUUCCACUGAGAAGUCUAACAUAAUAAGAGGCUGGAUUUUUGGUACUACUUUAGAUUCGAAGACCCAGUCCCUACUUAUUGUUAAUAACGCUACUAAUGUUGUUAUUAAAGUCUGUGAAUUUCAAUUUUGUAAUGAUCCAUUUUUGGGUGUUUAUUACCACAAAAACAACAAAAGUUGGAUGGAAAGUGAGUUCAGAGUUUAUUCUAGUGCGAAUAAUUGCACUUUUGAAUAUGUCUCUCAGCCUUUUCUUAUGGACCUUGAAGGAAAACAGGGUAAUUUCAAAAAUCUUAGGGAAUUUGUGUUUAAGAAUAUUGAUGGUUAUUUUAAAAUAUAUUCUAAGCACACGCCUAUUAAUUUAGUGCGUGAUCUCCCUCAGGGUUUUUCGGCUUUAGAACCAUUGGUAGAUUUGCCAAUAGGUAUUAACAUCACUAGGUUUCAAACUUUACUUGCUUUACAUAGAAGUUAUUUGACUCCUGGUGAUUCUUCUUCAGGUUGGACAGCUGGUGCUGCAGCUUAUUAUGUGGGUUAUCUUCAACCUAGGACUUUUCUAUUAAAAUAUAAUGAAAAUGGAACCAUUACAGAUGCUGUAGACUGUGCACUUGACCCUCUCUCAGAAACAAAGUGUACGUUGAAAUCCUUCACUGUAGAAAAAGGAAUCUAUCAAACUUCUAACUUUAGAGUCCAACCAACAGAAUCUAUUGUUAGAUUUCCUAAUAUUACAAACUUGUGCCCUUUUGGUGAAGUUUUUAACGCCACCAGAUUUGCAUCUGUUUAUGCUUGGAACAGGAAGAGAAUCAGCAACUGUGUUGCUGAUUAUUCUGUCCUAUAUAAUUCCGCAUCAUUUUCCACUUUUAAGUGUUAUGGAGUGUCUCCUACUAAAUUAAAUGAUCUCUGCUUUACUAAUGUCUAUGCAGAUUCAUUUGUAAUUAGAGGUGAUGAAGUCAGACAAAUCGCUCCAGGGCAAACUGGAAAGAUUGCUGAUUAUAAUUAUAAAUUACCAGAUGAUUUUACAGGCUGCGUUAUAGCUUGGAAUUCUAACAAUCUUGAUUCUAAGGUUGGUGGUAAUUAUAAUUACCUGUAUAGAUUGUUUAGGAAGUCUAAUCUCAAACCUUUUGAGAGAGAUAUUUCAACUGAAAUCUAUCAGGCCGGUAGCACACCUUGUAAUGGUGUUGAAGGUUUUAAUUGUUACUUUCCUUUACAAUCAUAUGGUUUCCAACCCACUAAUGGUGUUGGUUACCAACCAUACAGAGUAGUAGUACUUUCUUUUGAACUUCUACAUGCACCAGCAACUGUUUGUGGACCUAAAAAGUCUACUAAUUUGGUUAAAAACAAAUGUGUCAAUUUCAACUUCAAUGGUUUAACAGGCACAGGUGUUCUUACUGAGUCUAACAAAAAGUUUCUGCCUUUCCAACAAUUUGGCAGAGACAUUGCUGACACUACUGAUGCUGUCCGUGAUCCACAGACACUUGAGAUUCUUGACAUUACACCAUGUUCUUUUGGUGGUGUCAGUGUUAUAACACCAGGAACAAAUACUUCUAACCAGGUUGCUGUUCUUUAUCAGGAUGUUAACUGCACAGAAGUCCCUGUUGCUAUUCAUGCAGAUCAACUUACUCCUACUUGGCGUGUUUAUUCUACAGGUUCUAAUGUUUUUCAAACACGUGCAGGCUGUUUAAUAGGGGCUGAACAUGUCAACAACUCAUAUGAGUGUGACAUACCCAUUGGUGCAGGUAUAUGCGCUAGUUAUCAGACUCAGACUAAUUCUCCUCGGCGGGCACGUAGUGUAGCUAGUCAAUCCAUCAUUGCCUACACUAUGUCACUUGGUGCAGAAAAUUCAGUUGCUUACUCUAAUAACUCUAUUGCCAUACCCACAAAUUUUACUAUUAGUGUUACCACAGAAAUUCUACCAGUGUCUAUGACCAAGACAUCAGUAGAUUGUACAAUGUACAUUUGUGGUGAUUCAACUGAAUGCAGCAAUCUUUUGUUGCAAUAUGGCAGUUUUUGUACACAAUUAAACCGUGCUUUAACUGGAAUAGCUGUUGAACAAGACAAAAACACCCAAGAAGUUUUUGCACAAGUCAAACAAAUUUACAAAACACCACCAAUUAAAGAUUUUGGUGGUUUUAAUUUUUCACAAAUAUUACCAGAUCCAUCAAAACCAAGCAAGAGGUCAUUUAUUGAAGAUCUACUUUUCAACAAAGUGACACUUGCAGAUGCUGGCUUCAUCAAACAAUAUGGUGAUUGCCUUGGUGAUAUUGCUGCUAGAGACCUCAUUUGUGCACAAAAGUUUAACGGCCUUACUGUUUUGCCACCUUUGCUCACAGAUGAAAUGAUUGCUCAAUACACUUCUGCACUGUUAGCGGGUACAAUCACUUCUGGUUGGACCUUUGGUGCAGGUGCUGCAUUACAAAUACCAUUUGCUAUGCAAAUGGCUUAUAGGUUUAAUGGUAUUGGAGUUACACAGAAUGUUCUCUAUGAGAACCAAAAAUUGAUUGCCAACCAAUUUAAUAGUGCUAUUGGCAAAAUUCAAGACUCACUUUCUUCCACAGCAAGUGCACUUGGAAAACUUCAAGAUGUGGUCAACCAAAAUGCACAAGCUUUAAACACGCUUGUUAAACAACUUAGCUCCAAUUUUGGUGCAAUUUCAAGUGUUUUAAAUGAUAUCCUUUCACGUCUUGACAAAGUUGAGGCUGAAGUGCAAAUUGAUAGGUUGAUCACAGGCAGACUUCAAAGUUUGCAGACAUAUGUGACUCAACAAUUAAUUAGAGCUGCAGAAAUCAGAGCUUCUGCUAAUCUUGCUGCUACUAAAAUGUCAGAGUGUGUACUUGGACAAUCAAAAAGAGUUGAUUUUUGUGGAAAGGGCUAUCAUCUUAUGUCCUUCCCUCAGUCAGCACCUCAUGGUGUAGUCUUCUUGCAUGUGACUUAUGUCCCUGCACAAGAAAAGAACUUCACAACUGCUCCUGCCAUUUGUCAUGAUGGAAAAGCACACUUUCCUCGUGAAGGUGUCUUUGUUUCAAAUGGCACACACUGGUUUGUAACACAAAGGAAUUUUUAUGAACCACAAAUCAUUACUACAGACAACACAUUUGUGUCUGGUAACUGUGAUGUUGUAAUAGGAAUUGUCAACAACACAGUUUAUGAUCCUUUGCAACCUGAAUUAGACUCAUUCAAGGAGGAGUUAGAUAAAUAUUUUAAGAAUCAUACAUCACCAGAUGUUGAUUUAGGUGACAUCUCUGGCAUUAAUGCUUCAGUUGUAAACAUUCAAAAAGAAAUUGACCGCCUCAAUGAGGUUGCCAAGAAUUUAAAUGAAUCUCUCAUCGAUCUCCAAGAACUUGGAAAGUAUGAGCAGUAUAUAAAAUGGCCAUGGUACAUUUGGCUAGGUUUUAUAGCUGGCUUGAUUGCCAUAGUAAUGGUGACAAUUAUGCUUUGCUGUAUGACCAGUUGCUGUAGUUGUCUCAAGGGCUGUUGUUCUUGUGGAUCCUGCUGCAAAUUUGAUGAAGACGACUCUGAGCCAGUGCUCAAAGGAGUCAAAUUACAUUACACAUAAACGAACUUAUGGAUUUGUUUAUGAGAAUCUUCACAAUUGGAACUGUAACUUUGAAGCAAGGUGAAAUCAAGGAUGCUACUCCUUCAGAUUUUGUUCGCGCUACUGCAACGAUACCGAUACAAGCCUCACUCCCUUUCGGAUGGCUUAUUGUUGGCGUUGCACUUCUUGCUGUUUUUCAGAGCGCUUCCAAAAUCAUAACCCUCAAAAAGAGAUGGCAACUAGCACUCUCCAAGGGUGUUCACUUUGUUUGCAACUUGCUGUUGUUGUUUGUAACAGUUUACUCACACCUUUUGCUCGUUGCUGCUGGCCUUGAAGCCCCUUUUCUCUAUCUUUAUGCUUUAGUCUACUUCUUGCAGAGUAUAAACUUUGUAAGAAUAAUAAUGAGGCUUUGGCUUUGCUGGAAAUGCCGUUCCAAAAACCCAUUACUUUAUGAUGCCAACUAUUUUCUUUGCUGGCAUACUAAUUGUUACGACUAUUGUAUACCUUACAAUAGUGUAACUUCUUCAAUUGUCAUUACUUCAGGUGAUGGCACAACAAGUCCUAUUUCUGAACAUGACUACCAGAUUGGUGGUUAUACUGAAAAAUGGGAAUCUGGAGUAAAAGACUGUGUUGUAUUACACAGUUACUUCACUUCAGACUAUUACCAGCUGUACUCAACUCAAUUGAGUACAGACACUGGUGUUGAACAUGUUACCUUCUUCAUCUACAAUAAAAUUGUUGAUGAGCCUGAAGAACAUGUCCAAAUUCACACAAUCGACGGUUCAUCCGGAGUUGUUAAUCCAGUAAUGGAACCAAUUUAUGAUGAACCGACGACGACUACUAGCGUGCCUUUGUAAGCACAAGCUGAUGAGUACGAACUUAUGUACUCAUUCGUUUCGGAAGAGACAGGUACGUUAAUAGUUAAUAGCGUACUUCUUUUUCUUGCUUUCGUGGUAUUCUUGCUAGUUACACUAGCCAUCCUUACUGCGCUUCGAUUGUGUGCGUACUGCUGCAAUAUUGUUAACGUGAGUCUUGUAAAACCUUCUUUUUACGUUUACUCUCGUGUUAAAAAUCUGAAUUCUUCUAGAGUUCCUGAUCUUCUGGUCUAAACGAACUAAAUAUUAUAUUAGUUUUUCUGUUUGGAACUUUAAUUUUAGCCAUGGCAGAUUCCAACGGUACUAUUACCGUUGAAGAGCUUAAAAAGCUCCUUGAACAAUGGAACCUAGUAAUAGGUUUCCUAUUCCUUACAUGGAUUUGUCUUCUACAAUUUGCCUAUGCCAACAGGAAUAGGUUUUUGUAUAUAAUUAAGUUAAUUUUCCUCUGGCUGUUAUGGCCAGUAACUUUAGCUUGUUUUGUGCUUGCUGCUGUUUACAGAAUAAAUUGGAUCACCGGUGGAAUUGCUAUCGCAAUGGCUUGUCUUGUAGGCUUGAUGUGGCUCAGCUACUUCAUUGCUUCUUUCAGACUGUUUGCGCGUACGCGUUCCAUGUGGUCAUUCAAUCCAGAAACUAACAUUCUUCUCAACGUGCCACUCCAUGGCACUAUUCUGACCAGACCGCUUCUAGAAAGUGAACUCGUAAUCGGAGCUGUGAUCCUUCGUGGACAUCUUCGUAUUGCUGGACACCAUCUAGGACGCUGUGACAUCAAGGACCUGCCUAAAGAAAUCACUGUUGCUACAUCACGAACGCUUUCUUAUUACAAAUUGGGAGCUUCGCAGCGUGUAGCAGGUGACUCAGGUUUUGCUGCAUACAGUCGCUACAGGAUUGGCAACUAUAAAUUAAACACAGACCAUUCCAGUAGCAGUGACAAUAUUGCUUUGCUUGUACAGUAAGUGACAACAGAUGUUUCAUCUCGUUGACUUUCAGGUUACUAUAGCAGAGAUAUUACUAAUUAUUAUGAGGACUUUUAAAGUUUCCAUUUGGAAUCUUGAUUACAUCAUAAACCUCAUAAUUAAAAAUUUAUCUAAGUCACUAACUGAGAAUAAAUAUUCUCAAUUAGAUGAAGAGCAACCAAUGGAGAUUGAUUAAACGAACAUGAAAAUUAUUCUUUUCUUGGCACUGAUAACACUCGCUACUUGUGAGCUUUAUCACUACCAAGAGUGUGUUAGAGGUACAACAGUACUUUUAAAAGAACCUUGCUCUUCUGGAACAUACGAGGGCAAUUCACCAUUUCAUCCUCUAGCUGAUAACAAAUUUGCACUGACUUGCUUUAGCACUCAAUUUGCUUUUGCUUGUCCUGACGGCGUAAAACACGUCUAUCAGUUACGUGCCAGAUCAGUUUCACCUAAACUGUUCAUCAGACAAGAGGAAGUUCAAGAACUUUACUCUCCAAUUUUUCUUAUUGUUGCGGCAAUAGUGUUUAUAACACUUUGCUUCACACUCAAAAGAAAGACAGAAUGAUUGAACUUUCAUUAAUUGACUUCUAUUUGUGCUUUUUAGCCUUUCUGCUAUUCCUUGUUUUAAUUAUGCUUAUUAUCUUUUGGUUCUCACUUGAACUGCAAGAUCAUAAUGAAACUUGUCACGCCUAAACGAACAUGAAAUUUCUUGUUUUCUUAGGAAUCAUCACAACUGUAGCUGCAUUUCACCAAGAAUGUAGUUUACAGUCAUGUACUCAACAUCAACCAUAUGUAGUUGAUGACCCGUGUCCUAUUCACUUCUAUUCUAAAUGGUAUAUUAGAGUAGGAGCUAGAAAAUCAGCACCUUUAAUUGAAUUGUGCGUGGAUGAGGCUGGUUCUAAAUCACCCAUUCAGUACAUCGAUAUCGGUAAUUAUACAGUUUCCUGUUUACCUUUUACAAUUAAUUGCCAGGAACCUAAAUUGGGUAGUCUUGUAGUGCGUUGUUCGUUCUAUGAAGACUUUUUAGAGUAUCAUGACGUUCGUGUUGUUUUAGAUUUCAUCUAAACGAACAAACUAAAAUGUCUGAUAAUGGACCCCAAAAUCAGCGAAAUGCACCCCGCAUUACGUUUGGUGGACCCUCAGAUUCAACUGGCAGUAACCAGAAUGGAGAACGCAGUGGGGCGCGAUCAAAACAACGUCGGCCCCAAGGUUUACCCAAUAAUACUGCGUCUUGGUUCACCGCUCUCACUCAACAUGGCAAGGAAGACCUUAAAUUCCCUCGAGGACAAGGCGUUCCAAUUAACACCAAUAGCAGUCCAGAUGACCAAAUUGGCUACUACCGAAGAGCUACCAGACGAAUUCGUGGUGGUGACGGUAAAAUGAAAGAUCUCAGUCCAAGAUGGUAUUUCUACUACCUAGGAACUGGGCCAGAAGCUGGACUUCCCUAUGGUGCUAACAAAGACGGCAUCAUAUGGGUUGCAACUGAGGGAGCCUUGAAUACACCAAAAGAUCACAUUGGCACCCGCAAUCCUGCUAACAAUGCUGCAAUCGUGCUACAACUUCCUCAAGGAACAACAUUGCCAAAAGGCUUCUACGCAGAAGGGAGCAGAGGCGGCAGUCAAGCCUCUUCUCGUUCCUCAUCACGUAGUCGCAACAGUUCAAGAAAUUCAACUCCAGGCAGCAGUAGGGGAACUUCUCCUGCUAGAAUGGCUGGCAAUGGCGGUGAUGCUGCUCUUGCUUUGCUGCUGCUUGACAGAUUGAACCAGCUUGAGAGCAAAAUGUCUGGUAAAGGCCAACAACAACAAGGCCAAACUGUCACUAAGAAAUCUGCUGCUGAGGCUUCUAAGAAGCCUCGGCAAAAACGUACUGCCACUAAAGCAUACAAUGUAACACAAGCUUUCGGCAGACGUGGUCCAGAACAAACCCAAGGAAAUUUUGGGGACCAGGAACUAAUCAGACAAGGAACUGAUUACAAACAUUGGCCGCAAAUUGCACAAUUUGCCCCCAGCGCUUCAGCGUUCUUCGGAAUGUCGCGCAUUGGCAUGGAAGUCACACCUUCGGGAACGUGGUUGACCUACACAGGUGCCAUCAAAUUGGAUGACAAAGAUCCAAAUUUCAAAGAUCAAGUCAUUUUGCUGAAUAAGCAUAUUGACGCAUACAAAACAUUCCCACCAACAGAGCCUAAAAAGGACAAAAAGAAGAAGGCUGAUGAAACUCAAGCCUUACCGCAGAGACAGAAGAAACAGCAAACUGUGACUCUUCUUCCUGCUGCAGAUUUGGAUGAUUUCUCCAAACAAUUGCAACAAUCCAUGAGCAGUGCUGACUCAACUCAGGCCUAAACUCAUGCAGACCACACAAGGCAGAUGGGCUAUAUAAACGUUUUCGCUUUUCCGUUUACGAUAUAUAGUCUACUCUUGUGCAGAAUGAAUUCUCGUAACUACAUAGCACAAGUAGAUGUAGUUAACUUUAAUCUCACAUAGCAAUCUUUAAUCAGUGUGUAACAUUAGGGAGGACUUGAAAGAGCCACCACAUUUUCACCGAGGCCACGCGGAGUACGAUCGAGUGUACAGUGAACAAUGCUAGGGAGAGCUGCCUAUAUGGAAGAGCCCUAAUGUGUAAAAUUAAUUUUAGUAGUGCUAUCCCCAUGUGAUUUUAAUAGCUUCUUAGGAGAAUGACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,protein_ptm:deacetylated,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5µM[SARS2-NPNon-Ac];|5µM[SARS-CoV-2],"15 mM NaCl, 135 mM KCl, 5 mM phosphate, 1.5 mM MgCl2","20 mM Tris–HCl, pH 7.0",37˚C,-,other_molecular:1 mg ml−1 BSA,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"SARS2-NP Non-Ac and RNA rapidly formed micrometre-sized liquid droplets and the small liquid droplets quickly fused into larger ones, accompanied by increased fluorescence intensity and a larger equivalent diameter",29903
214,702,PMID: 34239064,RNAPS0000450,https://pubmed.ncbi.nlm.nih.gov/34239064,RNA + protein,-,-,SARS-CoV-2 virus RNA,29903nt(1-29903),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCUGAAAAGAGCUAUGAAUUGCAGACACCUUUUGAAAUUAAAUUGGCAAAGAAAUUUGACACCUUCAAUGGGGAAUGUCCAAAUUUUGUAUUUCCCUUAAAUUCCAUAAUCAAGACUAUUCAACCAAGGGUUGAAAAGAAAAAGCUUGAUGGCUUUAUGGGUAGAAUUCGAUCUGUCUAUCCAGUUGCGUCACCAAAUGAAUGCAACCAAAUGUGCCUUUCAACUCUCAUGAAGUGUGAUCAUUGUGGUGAAACUUCAUGGCAGACGGGCGAUUUUGUUAAAGCCACUUGCGAAUUUUGUGGCACUGAGAAUUUGACUAAAGAAGGUGCCACUACUUGUGGUUACUUACCCCAAAAUGCUGUUGUUAAAAUUUAUUGUCCAGCAUGUCACAAUUCAGAAGUAGGACCUGAGCAUAGUCUUGCCGAAUACCAUAAUGAAUCUGGCUUGAAAACCAUUCUUCGUAAGGGUGGUCGCACUAUUGCCUUUGGAGGCUGUGUGUUCUCUUAUGUUGGUUGCCAUAACAAGUGUGCCUAUUGGGUUCCACGUGCUAGCGCUAACAUAGGUUGUAACCAUACAGGUGUUGUUGGAGAAGGUUCCGAAGGUCUUAAUGACAACCUUCUUGAAAUACUCCAAAAAGAGAAAGUCAACAUCAAUAUUGUUGGUGACUUUAAACUUAAUGAAGAGAUCGCCAUUAUUUUGGCAUCUUUUUCUGCUUCCACAAGUGCUUUUGUGGAAACUGUGAAAGGUUUGGAUUAUAAAGCAUUCAAACAAAUUGUUGAAUCCUGUGGUAAUUUUAAAGUUACAAAAGGAAAAGCUAAAAAAGGUGCCUGGAAUAUUGGUGAACAGAAAUCAAUACUGAGUCCUCUUUAUGCAUUUGCAUCAGAGGCUGCUCGUGUUGUACGAUCAAUUUUCUCCCGCACUCUUGAAACUGCUCAAAAUUCUGUGCGUGUUUUACAGAAGGCCGCUAUAACAAUACUAGAUGGAAUUUCACAGUAUUCACUGAGACUCAUUGAUGCUAUGAUGUUCACAUCUGAUUUGGCUACUAACAAUCUAGUUGUAAUGGCCUACAUUACAGGUGGUGUUGUUCAGUUGACUUCGCAGUGGCUAACUAACAUCUUUGGCACUGUUUAUGAAAAACUCAAACCCGUCCUUGAUUGGCUUGAAGAGAAGUUUAAGGAAGGUGUAGAGUUUCUUAGAGACGGUUGGGAAAUUGUUAAAUUUAUCUCAACCUGUGCUUGUGAAAUUGUCGGUGGACAAAUUGUCACCUGUGCAAAGGAAAUUAAGGAGAGUGUUCAGACAUUCUUUAAGCUUGUAAAUAAAUUUUUGGCUUUGUGUGCUGACUCUAUCAUUAUUGGUGGAGCUAAACUUAAAGCCUUGAAUUUAGGUGAAACAUUUGUCACGCACUCAAAGGGAUUGUACAGAAAGUGUGUUAAAUCCAGAGAAGAAACUGGCCUACUCAUGCCUCUAAAAGCCCCAAAAGAAAUUAUCUUCUUAGAGGGAGAAACACUUCCCACAGAAGUGUUAACAGAGGAAGUUGUCUUGAAAACUGGUGAUUUACAACCAUUAGAACAACCUACUAGUGAAGCUGUUGAAGCUCCAUUGGUUGGUACACCAGUUUGUAUUAACGGGCUUAUGUUGCUCGAAAUCAAAGACACAGAAAAGUACUGUGCCCUUGCACCUAAUAUGAUGGUAACAAACAAUACCUUCACACUCAAAGGCGGUGCACCAACAAAGGUUACUUUUGGUGAUGACACUGUGAUAGAAGUGCAAGGUUACAAGAGUGUGAAUAUCACUUUUGAACUUGAUGAAAGGAUUGAUAAAGUACUUAAUGAGAAGUGCUCUGCCUAUACAGUUGAACUCGGUACAGAAGUAAAUGAGUUCGCCUGUGUUGUGGCAGAUGCUGUCAUAAAAACUUUGCAACCAGUAUCUGAAUUACUUACACCACUGGGCAUUGAUUUAGAUGAGUGGAGUAUGGCUACAUACUACUUAUUUGAUGAGUCUGGUGAGUUUAAAUUGGCUUCACAUAUGUAUUGUUCUUUCUACCCUCCAGAUGAGGAUGAAGAAGAAGGUGAUUGUGAAGAAGAAGAGUUUGAGCCAUCAACUCAAUAUGAGUAUGGUACUGAAGAUGAUUACCAAGGUAAACCUUUGGAAUUUGGUGCCACUUCUGCUGCUCUUCAACCUGAAGAAGAGCAAGAAGAAGAUUGGUUAGAUGAUGAUAGUCAACAAACUGUUGGUCAACAAGACGGCAGUGAGGACAAUCAGACAACUACUAUUCAAACAAUUGUUGAGGUUCAACCUCAAUUAGAGAUGGAACUUACACCAGUUGUUCAGACUAUUGAAGUGAAUAGUUUUAGUGGUUAUUUAAAACUUACUGACAAUGUAUACAUUAAAAAUGCAGACAUUGUGGAAGAAGCUAAAAAGGUAAAACCAACAGUGGUUGUUAAUGCAGCCAAUGUUUACCUUAAACAUGGAGGAGGUGUUGCAGGAGCCUUAAAUAAGGCUACUAACAAUGCCAUGCAAGUUGAAUCUGAUGAUUACAUAGCUACUAAUGGACCACUUAAAGUGGGUGGUAGUUGUGUUUUAAGCGGACACAAUCUUGCUAAACACUGUCUUCAUGUUGUCGGCCCAAAUGUUAACAAAGGUGAAGACAUUCAACUUCUUAAGAGUGCUUAUGAAAAUUUUAAUCAGCACGAAGUUCUACUUGCACCAUUAUUAUCAGCUGGUAUUUUUGGUGCUGACCCUAUACAUUCUUUAAGAGUUUGUGUAGAUACUGUUCGCACAAAUGUCUACUUAGCUGUCUUUGAUAAAAAUCUCUAUGACAAACUUGUUUCAAGCUUUUUGGAAAUGAAGAGUGAAAAGCAAGUUGAACAAAAGAUCGCUGAGAUUCCUAAAGAGGAAGUUAAGCCAUUUAUAACUGAAAGUAAACCUUCAGUUGAACAGAGAAAACAAGAUGAUAAGAAAAUCAAAGCUUGUGUUGAAGAAGUUACAACAACUCUGGAAGAAACUAAGUUCCUCACAGAAAACUUGUUACUUUAUAUUGACAUUAAUGGCAAUCUUCAUCCAGAUUCUGCCACUCUUGUUAGUGACAUUGACAUCACUUUCUUAAAGAAAGAUGCUCCAUAUAUAGUGGGUGAUGUUGUUCAAGAGGGUGUUUUAACUGCUGUGGUUAUACCUACUAAAAAGGCUGGUGGCACUACUGAAAUGCUAGCGAAAGCUUUGAGAAAAGUGCCAACAGACAAUUAUAUAACCACUUACCCGGGUCAGGGUUUAAAUGGUUACACUGUAGAGGAGGCAAAGACAGUGCUUAAAAAGUGUAAAAGUGCCUUUUACAUUCUACCAUCUAUUAUCUCUAAUGAGAAGCAAGAAAUUCUUGGAACUGUUUCUUGGAAUUUGCGAGAAAUGCUUGCACAUGCAGAAGAAACACGCAAAUUAAUGCCUGUCUGUGUGGAAACUAAAGCCAUAGUUUCAACUAUACAGCGUAAAUAUAAGGGUAUUAAAAUACAAGAGGGUGUGGUUGAUUAUGGUGCUAGAUUUUACUUUUACACCAGUAAAACAACUGUAGCGUCACUUAUCAACACACUUAACGAUCUAAAUGAAACUCUUGUUACAAUGCCACUUGGCUAUGUAACACAUGGCUUAAAUUUGGAAGAAGCUGCUCGGUAUAUGAGAUCUCUCAAAGUGCCAGCUACAGUUUCUGUUUCUUCACCUGAUGCUGUUACAGCGUAUAAUGGUUAUCUUACUUCUUCUUCUAAAACACCUGAAGAACAUUUUAUUGAAACCAUCUCACUUGCUGGUUCCUAUAAAGAUUGGUCCUAUUCUGGACAAUCUACACAACUAGGUAUAGAAUUUCUUAAGAGAGGUGAUAAAAGUGUAUAUUACACUAGUAAUCCUACCACAUUCCACCUAGAUGGUGAAGUUAUCACCUUUGACAAUCUUAAGACACUUCUUUCUUUGAGAGAAGUGAGGACUAUUAAGGUGUUUACAACAGUAGACAACAUUAACCUCCACACGCAAGUUGUGGACAUGUCAAUGACAUAUGGACAACAGUUUGGUCCAACUUAUUUGGAUGGAGCUGAUGUUACUAAAAUAAAACCUCAUAAUUCACAUGAAGGUAAAACAUUUUAUGUUUUACCUAAUGAUGACACUCUACGUGUUGAGGCUUUUGAGUACUACCACACAACUGAUCCUAGUUUUCUGGGUAGGUACAUGUCAGCAUUAAAUCACACUAAAAAGUGGAAAUACCCACAAGUUAAUGGUUUAACUUCUAUUAAAUGGGCAGAUAACAACUGUUAUCUUGCCACUGCAUUGUUAACACUCCAACAAAUAGAGUUGAAGUUUAAUCCACCUGCUCUACAAGAUGCUUAUUACAGAGCAAGGGCUGGUGAAGCUGCUAACUUUUGUGCACUUAUCUUAGCCUACUGUAAUAAGACAGUAGGUGAGUUAGGUGAUGUUAGAGAAACAAUGAGUUACUUGUUUCAACAUGCCAAUUUAGAUUCUUGCAAAAGAGUCUUGAACGUGGUGUGUAAAACUUGUGGACAACAGCAGACAACCCUUAAGGGUGUAGAAGCUGUUAUGUACAUGGGCACACUUUCUUAUGAACAAUUUAAGAAAGGUGUUCAGAUACCUUGUACGUGUGGUAAACAAGCUACAAAAUAUCUAGUACAACAGGAGUCACCUUUUGUUAUGAUGUCAGCACCACCUGCUCAGUAUGAACUUAAGCAUGGUACAUUUACUUGUGCUAGUGAGUACACUGGUAAUUACCAGUGUGGUCACUAUAAACAUAUAACUUCUAAAGAAACUUUGUAUUGCAUAGACGGUGCUUUACUUACAAAGUCCUCAGAAUACAAAGGUCCUAUUACGGAUGUUUUCUACAAAGAAAACAGUUACACAACAACCAUAAAACCAGUUACUUAUAAAUUGGAUGGUGUUGUUUGUACAGAAAUUGACCCUAAGUUGGACAAUUAUUAUAAGAAAGACAAUUCUUAUUUCACAGAGCAACCAAUUGAUCUUGUACCAAACCAACCAUAUCCAAACGCAAGCUUCGAUAAUUUUAAGUUUGUAUGUGAUAAUAUCAAAUUUGCUGAUGAUUUAAACCAGUUAACUGGUUAUAAGAAACCUGCUUCAAGAGAGCUUAAAGUUACAUUUUUCCCUGACUUAAAUGGUGAUGUGGUGGCUAUUGAUUAUAAACACUACACACCCUCUUUUAAGAAAGGAGCUAAAUUGUUACAUAAACCUAUUGUUUGGCAUGUUAACAAUGCAACUAAUAAAGCCACGUAUAAACCAAAUACCUGGUGUAUACGUUGUCUUUGGAGCACAAAACCAGUUGAAACAUCAAAUUCGUUUGAUGUACUGAAGUCAGAGGACGCGCAGGGAAUGGAUAAUCUUGCCUGCGAAGAUCUAAAACCAGUCUCUGAAGAAGUAGUGGAAAAUCCUACCAUACAGAAAGACGUUCUUGAGUGUAAUGUGAAAACUACCGAAGUUGUAGGAGACAUUAUACUUAAACCAGCAAAUAAUAGUUUAAAAAUUACAGAAGAGGUUGGCCACACAGAUCUAAUGGCUGCUUAUGUAGACAAUUCUAGUCUUACUAUUAAGAAACCUAAUGAAUUAUCUAGAGUAUUAGGUUUGAAAACCCUUGCUACUCAUGGUUUAGCUGCUGUUAAUAGUGUCCCUUGGGAUACUAUAGCUAAUUAUGCUAAGCCUUUUCUUAACAAAGUUGUUAGUACAACUACUAACAUAGUUACACGGUGUUUAAACCGUGUUUGUACUAAUUAUAUGCCUUAUUUCUUUACUUUAUUGCUACAAUUGUGUACUUUUACUAGAAGUACAAAUUCUAGAAUUAAAGCAUCUAUGCCGACUACUAUAGCAAAGAAUACUGUUAAGAGUGUCGGUAAAUUUUGUCUAGAGGCUUCAUUUAAUUAUUUGAAGUCACCUAAUUUUUCUAAACUGAUAAAUAUUAUAAUUUGGUUUUUACUAUUAAGUGUUUGCCUAGGUUCUUUAAUCUACUCAACCGCUGCUUUAGGUGUUUUAAUGUCUAAUUUAGGCAUGCCUUCUUACUGUACUGGUUACAGAGAAGGCUAUUUGAACUCUACUAAUGUCACUAUUGCAACCUACUGUACUGGUUCUAUACCUUGUAGUGUUUGUCUUAGUGGUUUAGAUUCUUUAGACACCUAUCCUUCUUUAGAAACUAUACAAAUUACCAUUUCAUCUUUUAAAUGGGAUUUAACUGCUUUUGGCUUAGUUGCAGAGUGGUUUUUGGCAUAUAUUCUUUUCACUAGGUUUUUCUAUGUACUUGGAUUGGCUGCAAUCAUGCAAUUGUUUUUCAGCUAUUUUGCAGUACAUUUUAUUAGUAAUUCUUGGCUUAUGUGGUUAAUAAUUAAUCUUGUACAAAUGGCCCCGAUUUCAGCUAUGGUUAGAAUGUACAUCUUCUUUGCAUCAUUUUAUUAUGUAUGGAAAAGUUAUGUGCAUGUUGUAGACGGUUGUAAUUCAUCAACUUGUAUGAUGUGUUACAAACGUAAUAGAGCAACAAGAGUCGAAUGUACAACUAUUGUUAAUGGUGUUAGAAGGUCCUUUUAUGUCUAUGCUAAUGGAGGUAAAGGCUUUUGCAAACUACACAAUUGGAAUUGUGUUAAUUGUGAUACAUUCUGUGCUGGUAGUACAUUUAUUAGUGAUGAAGUUGCGAGAGACUUGUCACUACAGUUUAAAAGACCAAUAAAUCCUACUGACCAGUCUUCUUACAUCGUUGAUAGUGUUACAGUGAAGAAUGGUUCCAUCCAUCUUUACUUUGAUAAAGCUGGUCAAAAGACUUAUGAAAGACAUUCUCUCUCUCAUUUUGUUAACUUAGACAACCUGAGAGCUAAUAACACUAAAGGUUCAUUGCCUAUUAAUGUUAUAGUUUUUGAUGGUAAAUCAAAAUGUGAAGAAUCAUCUGCAAAAUCAGCGUCUGUUUACUACAGUCAGCUUAUGUGUCAACCUAUACUGUUACUAGAUCAGGCAUUAGUGUCUGAUGUUGGUGAUAGUGCGGAAGUUGCAGUUAAAAUGUUUGAUGCUUACGUUAAUACGUUUUCAUCAACUUUUAACGUACCAAUGGAAAAACUCAAAACACUAGUUGCAACUGCAGAAGCUGAACUUGCAAAGAAUGUGUCCUUAGACAAUGUCUUAUCUACUUUUAUUUCAGCAGCUCGGCAAGGGUUUGUUGAUUCAGAUGUAGAAACUAAAGAUGUUGUUGAAUGUCUUAAAUUGUCACAUCAAUCUGACAUAGAAGUUACUGGCGAUAGUUGUAAUAACUAUAUGCUCACCUAUAACAAAGUUGAAAACAUGACACCCCGUGACCUUGGUGCUUGUAUUGACUGUAGUGCGCGUCAUAUUAAUGCGCAGGUAGCAAAAAGUCACAACAUUGCUUUGAUAUGGAACGUUAAAGAUUUCAUGUCAUUGUCUGAACAACUACGAAAACAAAUACGUAGUGCUGCUAAAAAGAAUAACUUACCUUUUAAGUUGACAUGUGCAACUACUAGACAAGUUGUUAAUGUUGUAACAACAAAGAUAGCACUUAAGGGUGGUAAAAUUGUUAAUAAUUGGUUGAAGCAGUUAAUUAAAGUUACACUUGUGUUCCUUUUUGUUGCUGCUAUUUUCUAUUUAAUAACACCUGUUCAUGUCAUGUCUAAACAUACUGACUUUUCAAGUGAAAUCAUAGGAUACAAGGCUAUUGAUGGUGGUGUCACUCGUGACAUAGCAUCUACAGAUACUUGUUUUGCUAACAAACAUGCUGAUUUUGACACAUGGUUUAGCCAGCGUGGUGGUAGUUAUACUAAUGACAAAGCUUGCCCAUUGAUUGCUGCAGUCAUAACAAGAGAAGUGGGUUUUGUCGUGCCUGGUUUGCCUGGCACGAUAUUACGCACAACUAAUGGUGACUUUUUGCAUUUCUUACCUAGAGUUUUUAGUGCAGUUGGUAACAUCUGUUACACACCAUCAAAACUUAUAGAGUACACUGACUUUGCAACAUCAGCUUGUGUUUUGGCUGCUGAAUGUACAAUUUUUAAAGAUGCUUCUGGUAAGCCAGUACCAUAUUGUUAUGAUACCAAUGUACUAGAAGGUUCUGUUGCUUAUGAAAGUUUACGCCCUGACACACGUUAUGUGCUCAUGGAUGGCUCUAUUAUUCAAUUUCCUAACACCUACCUUGAAGGUUCUGUUAGAGUGGUAACAACUUUUGAUUCUGAGUACUGUAGGCACGGCACUUGUGAAAGAUCAGAAGCUGGUGUUUGUGUAUCUACUAGUGGUAGAUGGGUACUUAACAAUGAUUAUUACAGAUCUUUACCAGGAGUUUUCUGUGGUGUAGAUGCUGUAAAUUUACUUACUAAUAUGUUUACACCACUAAUUCAACCUAUUGGUGCUUUGGACAUAUCAGCAUCUAUAGUAGCUGGUGGUAUUGUAGCUAUCGUAGUAACAUGCCUUGCCUACUAUUUUAUGAGGUUUAGAAGAGCUUUUGGUGAAUACAGUCAUGUAGUUGCCUUUAAUACUUUACUAUUCCUUAUGUCAUUCACUGUACUCUGUUUAACACCAGUUUACUCAUUCUUACCUGGUGUUUAUUCUGUUAUUUACUUGUACUUGACAUUUUAUCUUACUAAUGAUGUUUCUUUUUUAGCACAUAUUCAGUGGAUGGUUAUGUUCACACCUUUAGUACCUUUCUGGAUAACAAUUGCUUAUAUCAUUUGUAUUUCCACAAAGCAUUUCUAUUGGUUCUUUAGUAAUUACCUAAAGAGACGUGUAGUCUUUAAUGGUGUUUCCUUUAGUACUUUUGAAGAAGCUGCGCUGUGCACCUUUUUGUUAAAUAAAGAAAUGUAUCUAAAGUUGCGUAGUGAUGUGCUAUUACCUCUUACGCAAUAUAAUAGAUACUUAGCUCUUUAUAAUAAGUACAAGUAUUUUAGUGGAGCAAUGGAUACAACUAGCUACAGAGAAGCUGCUUGUUGUCAUCUCGCAAAGGCUCUCAAUGACUUCAGUAACUCAGGUUCUGAUGUUCUUUACCAACCACCACAAACCUCUAUCACCUCAGCUGUUUUGCAGAGUGGUUUUAGAAAAAUGGCAUUCCCAUCUGGUAAAGUUGAGGGUUGUAUGGUACAAGUAACUUGUGGUACAACUACACUUAACGGUCUUUGGCUUGAUGACGUAGUUUACUGUCCAAGACAUGUGAUCUGCACCUCUGAAGACAUGCUUAACCCUAAUUAUGAAGAUUUACUCAUUCGUAAGUCUAAUCAUAAUUUCUUGGUACAGGCUGGUAAUGUUCAACUCAGGGUUAUUGGACAUUCUAUGCAAAAUUGUGUACUUAAGCUUAAGGUUGAUACAGCCAAUCCUAAGACACCUAAGUAUAAGUUUGUUCGCAUUCAACCAGGACAGACUUUUUCAGUGUUAGCUUGUUACAAUGGUUCACCAUCUGGUGUUUACCAAUGUGCUAUGAGGCCCAAUUUCACUAUUAAGGGUUCAUUCCUUAAUGGUUCAUGUGGUAGUGUUGGUUUUAACAUAGAUUAUGACUGUGUCUCUUUUUGUUACAUGCACCAUAUGGAAUUACCAACUGGAGUUCAUGCUGGCACAGACUUAGAAGGUAACUUUUAUGGACCUUUUGUUGACAGGCAAACAGCACAAGCAGCUGGUACGGACACAACUAUUACAGUUAAUGUUUUAGCUUGGUUGUACGCUGCUGUUAUAAAUGGAGACAGGUGGUUUCUCAAUCGAUUUACCACAACUCUUAAUGACUUUAACCUUGUGGCUAUGAAGUACAAUUAUGAACCUCUAACACAAGACCAUGUUGACAUACUAGGACCUCUUUCUGCUCAAACUGGAAUUGCCGUUUUAGAUAUGUGUGCUUCAUUAAAAGAAUUACUGCAAAAUGGUAUGAAUGGACGUACCAUAUUGGGUAGUGCUUUAUUAGAAGAUGAAUUUACACCUUUUGAUGUUGUUAGACAAUGCUCAGGUGUUACUUUCCAAAGUGCAGUGAAAAGAACAAUCAAGGGUACACACCACUGGUUGUUACUCACAAUUUUGACUUCACUUUUAGUUUUAGUCCAGAGUACUCAAUGGUCUUUGUUCUUUUUUUUGUAUGAAAAUGCCUUUUUACCUUUUGCUAUGGGUAUUAUUGCUAUGUCUGCUUUUGCAAUGAUGUUUGUCAAACAUAAGCAUGCAUUUCUCUGUUUGUUUUUGUUACCUUCUCUUGCCACUGUAGCUUAUUUUAAUAUGGUCUAUAUGCCUGCUAGUUGGGUGAUGCGUAUUAUGACAUGGUUGGAUAUGGUUGAUACUAGUUUGUCUGGUUUUAAGCUAAAAGACUGUGUUAUGUAUGCAUCAGCUGUAGUGUUACUAAUCCUUAUGACAGCAAGAACUGUGUAUGAUGAUGGUGCUAGGAGAGUGUGGACACUUAUGAAUGUCUUGACACUCGUUUAUAAAGUUUAUUAUGGUAAUGCUUUAGAUCAAGCCAUUUCCAUGUGGGCUCUUAUAAUCUCUGUUACUUCUAACUACUCAGGUGUAGUUACAACUGUCAUGUUUUUGGCCAGAGGUAUUGUUUUUAUGUGUGUUGAGUAUUGCCCUAUUUUCUUCAUAACUGGUAAUACACUUCAGUGUAUAAUGCUAGUUUAUUGUUUCUUAGGCUAUUUUUGUACUUGUUACUUUGGCCUCUUUUGUUUACUCAACCGCUACUUUAGACUGACUCUUGGUGUUUAUGAUUACUUAGUUUCUACACAGGAGUUUAGAUAUAUGAAUUCACAGGGACUACUCCCACCCAAGAAUAGCAUAGAUGCCUUCAAACUCAACAUUAAAUUGUUGGGUGUUGGUGGCAAACCUUGUAUCAAAGUAGCCACUGUACAGUCUAAAAUGUCAGAUGUAAAGUGCACAUCAGUAGUCUUACUCUCAGUUUUGCAACAACUCAGAGUAGAAUCAUCAUCUAAAUUGUGGGCUCAAUGUGUCCAGUUACACAAUGACAUUCUCUUAGCUAAAGAUACUACUGAAGCCUUUGAAAAAAUGGUUUCACUACUUUCUGUUUUGCUUUCCAUGCAGGGUGCUGUAGACAUAAACAAGCUUUGUGAAGAAAUGCUGGACAACAGGGCAACCUUACAAGCUAUAGCCUCAGAGUUUAGUUCCCUUCCAUCAUAUGCAGCUUUUGCUACUGCUCAAGAAGCUUAUGAGCAGGCUGUUGCUAAUGGUGAUUCUGAAGUUGUUCUUAAAAAGUUGAAGAAGUCUUUGAAUGUGGCUAAAUCUGAAUUUGACCGUGAUGCAGCCAUGCAACGUAAGUUGGAAAAGAUGGCUGAUCAAGCUAUGACCCAAAUGUAUAAACAGGCUAGAUCUGAGGACAAGAGGGCAAAAGUUACUAGUGCUAUGCAGACAAUGCUUUUCACUAUGCUUAGAAAGUUGGAUAAUGAUGCACUCAACAACAUUAUCAACAAUGCAAGAGAUGGUUGUGUUCCCUUGAACAUAAUACCUCUUACAACAGCAGCCAAACUAAUGGUUGUCAUACCAGACUAUAACACAUAUAAAAAUACGUGUGAUGGUACAACAUUUACUUAUGCAUCAGCAUUGUGGGAAAUCCAACAGGUUGUAGAUGCAGAUAGUAAAAUUGUUCAACUUAGUGAAAUUAGUAUGGACAAUUCACCUAAUUUAGCAUGGCCUCUUAUUGUAACAGCUUUAAGGGCCAAUUCUGCUGUCAAAUUACAGAAUAAUGAGCUUAGUCCUGUUGCACUACGACAGAUGUCUUGUGCUGCCGGUACUACACAAACUGCUUGCACUGAUGACAAUGCGUUAGCUUACUACAACACAACAAAGGGAGGUAGGUUUGUACUUGCACUGUUAUCCGAUUUACAGGAUUUGAAAUGGGCUAGAUUCCCUAAGAGUGAUGGAACUGGUACUAUCUAUACAGAACUGGAACCACCUUGUAGGUUUGUUACAGACACACCUAAAGGUCCUAAAGUGAAGUAUUUAUACUUUAUUAAAGGAUUAAACAACCUAAAUAGAGGUAUGGUACUUGGUAGUUUAGCUGCCACAGUACGUCUACAAGCUGGUAAUGCAACAGAAGUGCCUGCCAAUUCAACUGUAUUAUCUUUCUGUGCUUUUGCUGUAGAUGCUGCUAAAGCUUACAAAGAUUAUCUAGCUAGUGGGGGACAACCAAUCACUAAUUGUGUUAAGAUGUUGUGUACACACACUGGUACUGGUCAGGCAAUAACAGUUACACCGGAAGCCAAUAUGGAUCAAGAAUCCUUUGGUGGUGCAUCGUGUUGUCUGUACUGCCGUUGCCACAUAGAUCAUCCAAAUCCUAAAGGAUUUUGUGACUUAAAAGGUAAGUAUGUACAAAUACCUACAACUUGUGCUAAUGACCCUGUGGGUUUUACACUUAAAAACACAGUCUGUACCGUCUGCGGUAUGUGGAAAGGUUAUGGCUGUAGUUGUGAUCAACUCCGCGAACCCAUGCUUCAGUCAGCUGAUGCACAAUCGUUUUUAAACGGGUUUGCGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGGCACUAGUACUGAUGUCGUAUACAGGGCUUUUGACAUCUACAAUGAUAAAGUAGCUGGUUUUGCUAAAUUCCUAAAAACUAAUUGUUGUCGCUUCCAAGAAAAGGACGAAGAUGACAAUUUAAUUGAUUCUUACUUUGUAGUUAAGAGACACACUUUCUCUAACUACCAACAUGAAGAAACAAUUUAUAAUUUACUUAAGGAUUGUCCAGCUGUUGCUAAACAUGACUUCUUUAAGUUUAGAAUAGACGGUGACAUGGUACCACAUAUAUCACGUCAACGUCUUACUAAAUACACAAUGGCAGACCUCGUCUAUGCUUUAAGGCAUUUUGAUGAAGGUAAUUGUGACACAUUAAAAGAAAUACUUGUCACAUACAAUUGUUGUGAUGAUGAUUAUUUCAAUAAAAAGGACUGGUAUGAUUUUGUAGAAAACCCAGAUAUAUUACGCGUAUACGCCAACUUAGGUGAACGUGUACGCCAAGCUUUGUUAAAAACAGUACAAUUCUGUGAUGCCAUGCGAAAUGCUGGUAUUGUUGGUGUACUGACAUUAGAUAAUCAAGAUCUCAAUGGUAACUGGUAUGAUUUCGGUGAUUUCAUACAAACCACGCCAGGUAGUGGAGUUCCUGUUGUAGAUUCUUAUUAUUCAUUGUUAAUGCCUAUAUUAACCUUGACCAGGGCUUUAACUGCAGAGUCACAUGUUGACACUGACUUAACAAAGCCUUACAUUAAGUGGGAUUUGUUAAAAUAUGACUUCACGGAAGAGAGGUUAAAACUCUUUGACCGUUAUUUUAAAUAUUGGGAUCAGACAUACCACCCAAAUUGUGUUAACUGUUUGGAUGACAGAUGCAUUCUGCAUUGUGCAAACUUUAAUGUUUUAUUCUCUACAGUGUUCCCACCUACAAGUUUUGGACCACUAGUGAGAAAAAUAUUUGUUGAUGGUGUUCCAUUUGUAGUUUCAACUGGAUACCACUUCAGAGAGCUAGGUGUUGUACAUAAUCAGGAUGUAAACUUACAUAGCUCUAGACUUAGUUUUAAGGAAUUACUUGUGUAUGCUGCUGACCCUGCUAUGCACGCUGCUUCUGGUAAUCUAUUACUAGAUAAACGCACUACGUGCUUUUCAGUAGCUGCACUUACUAACAAUGUUGCUUUUCAAACUGUCAAACCCGGUAAUUUUAACAAAGACUUCUAUGACUUUGCUGUGUCUAAGGGUUUCUUUAAGGAAGGAAGUUCUGUUGAAUUAAAACACUUCUUCUUUGCUCAGGAUGGUAAUGCUGCUAUCAGCGAUUAUGACUACUAUCGUUAUAAUCUACCAACAAUGUGUGAUAUCAGACAACUACUAUUUGUAGUUGAAGUUGUUGAUAAGUACUUUGAUUGUUACGAUGGUGGCUGUAUUAAUGCUAACCAAGUCAUCGUCAACAACCUAGACAAAUCAGCUGGUUUUCCAUUUAAUAAAUGGGGUAAGGCUAGACUUUAUUAUGAUUCAAUGAGUUAUGAGGAUCAAGAUGCACUUUUCGCAUAUACAAAACGUAAUGUCAUCCCUACUAUAACUCAAAUGAAUCUUAAGUAUGCCAUUAGUGCAAAGAAUAGAGCUCGCACCGUAGCUGGUGUCUCUAUCUGUAGUACUAUGACCAAUAGACAGUUUCAUCAAAAAUUAUUGAAAUCAAUAGCCGCCACUAGAGGAGCUACUGUAGUAAUUGGAACAAGCAAAUUCUAUGGUGGUUGGCACAACAUGUUAAAAACUGUUUAUAGUGAUGUAGAAAACCCUCACCUUAUGGGUUGGGAUUAUCCUAAAUGUGAUAGAGCCAUGCCUAACAUGCUUAGAAUUAUGGCCUCACUUGUUCUUGCUCGCAAACAUACAACGUGUUGUAGCUUGUCACACCGUUUCUAUAGAUUAGCUAAUGAGUGUGCUCAAGUAUUGAGUGAAAUGGUCAUGUGUGGCGGUUCACUAUAUGUUAAACCAGGUGGAACCUCAUCAGGAGAUGCCACAACUGCUUAUGCUAAUAGUGUUUUUAACAUUUGUCAAGCUGUCACGGCCAAUGUUAAUGCACUUUUAUCUACUGAUGGUAACAAAAUUGCCGAUAAGUAUGUCCGCAAUUUACAACACAGACUUUAUGAGUGUCUCUAUAGAAAUAGAGAUGUUGACACAGACUUUGUGAAUGAGUUUUACGCAUAUUUGCGUAAACAUUUCUCAAUGAUGAUACUCUCUGACGAUGCUGUUGUGUGUUUCAAUAGCACUUAUGCAUCUCAAGGUCUAGUGGCUAGCAUAAAGAACUUUAAGUCAGUUCUUUAUUAUCAAAACAAUGUUUUUAUGUCUGAAGCAAAAUGUUGGACUGAGACUGACCUUACUAAAGGACCUCAUGAAUUUUGCUCUCAACAUACAAUGCUAGUUAAACAGGGUGAUGAUUAUGUGUACCUUCCUUACCCAGAUCCAUCAAGAAUCCUAGGGGCCGGCUGUUUUGUAGAUGAUAUCGUAAAAACAGAUGGUACACUUAUGAUUGAACGGUUCGUGUCUUUAGCUAUAGAUGCUUACCCACUUACUAAACAUCCUAAUCAGGAGUAUGCUGAUGUCUUUCAUUUGUACUUACAAUACAUAAGAAAGCUACAUGAUGAGUUAACAGGACACAUGUUAGACAUGUAUUCUGUUAUGCUUACUAAUGAUAACACUUCAAGGUAUUGGGAACCUGAGUUUUAUGAGGCUAUGUACACACCGCAUACAGUCUUACAGGCUGUUGGGGCUUGUGUUCUUUGCAAUUCACAGACUUCAUUAAGAUGUGGUGCUUGCAUACGUAGACCAUUCUUAUGUUGUAAAUGCUGUUACGACCAUGUCAUAUCAACAUCACAUAAAUUAGUCUUGUCUGUUAAUCCGUAUGUUUGCAAUGCUCCAGGUUGUGAUGUCACAGAUGUGACUCAACUUUACUUAGGAGGUAUGAGCUAUUAUUGUAAAUCACAUAAACCACCCAUUAGUUUUCCAUUGUGUGCUAAUGGACAAGUUUUUGGUUUAUAUAAAAAUACAUGUGUUGGUAGCGAUAAUGUUACUGACUUUAAUGCAAUUGCAACAUGUGACUGGACAAAUGCUGGUGAUUACAUUUUAGCUAACACCUGUACUGAAAGACUCAAGCUUUUUGCAGCAGAAACGCUCAAAGCUACUGAGGAGACAUUUAAACUGUCUUAUGGUAUUGCUACUGUACGUGAAGUGCUGUCUGACAGAGAAUUACAUCUUUCAUGGGAAGUUGGUAAACCUAGACCACCACUUAACCGAAAUUAUGUCUUUACUGGUUAUCGUGUAACUAAAAACAGUAAAGUACAAAUAGGAGAGUACACCUUUGAAAAAGGUGACUAUGGUGAUGCUGUUGUUUACCGAGGUACAACAACUUACAAAUUAAAUGUUGGUGAUUAUUUUGUGCUGACAUCACAUACAGUAAUGCCAUUAAGUGCACCUACACUAGUGCCACAAGAGCACUAUGUUAGAAUUACUGGCUUAUACCCAACACUCAAUAUCUCAGAUGAGUUUUCUAGCAAUGUUGCAAAUUAUCAAAAGGUUGGUAUGCAAAAGUAUUCUACACUCCAGGGACCACCUGGUACUGGUAAGAGUCAUUUUGCUAUUGGCCUAGCUCUCUACUACCCUUCUGCUCGCAUAGUGUAUACAGCUUGCUCUCAUGCCGCUGUUGAUGCACUAUGUGAGAAGGCAUUAAAAUAUUUGCCUAUAGAUAAAUGUAGUAGAAUUAUACCUGCACGUGCUCGUGUAGAGUGUUUUGAUAAAUUCAAAGUGAAUUCAACAUUAGAACAGUAUGUCUUUUGUACUGUAAAUGCAUUGCCUGAGACGACAGCAGAUAUAGUUGUCUUUGAUGAAAUUUCAAUGGCCACAAAUUAUGAUUUGAGUGUUGUCAAUGCCAGAUUACGUGCUAAGCACUAUGUGUACAUUGGCGACCCUGCUCAAUUACCUGCACCACGCACAUUGCUAACUAAGGGCACACUAGAACCAGAAUAUUUCAAUUCAGUGUGUAGACUUAUGAAAACUAUAGGUCCAGACAUGUUCCUCGGAACUUGUCGGCGUUGUCCUGCUGAAAUUGUUGACACUGUGAGUGCUUUGGUUUAUGAUAAUAAGCUUAAAGCACAUAAAGACAAAUCAGCUCAAUGCUUUAAAAUGUUUUAUAAGGGUGUUAUCACGCAUGAUGUUUCAUCUGCAAUUAACAGGCCACAAAUAGGCGUGGUAAGAGAAUUCCUUACACGUAACCCUGCUUGGAGAAAAGCUGUCUUUAUUUCACCUUAUAAUUCACAGAAUGCUGUAGCCUCAAAGAUUUUGGGACUACCAACUCAAACUGUUGAUUCAUCACAGGGCUCAGAAUAUGACUAUGUCAUAUUCACUCAAACCACUGAAACAGCUCACUCUUGUAAUGUAAACAGAUUUAAUGUUGCUAUUACCAGAGCAAAAGUAGGCAUACUUUGCAUAAUGUCUGAUAGAGACCUUUAUGACAAGUUGCAAUUUACAAGUCUUGAAAUUCCACGUAGGAAUGUGGCAACUUUACAAGCUGAAAAUGUAACAGGACUCUUUAAAGAUUGUAGUAAGGUAAUCACUGGGUUACAUCCUACACAGGCACCUACACACCUCAGUGUUGACACUAAAUUCAAAACUGAAGGUUUAUGUGUUGACAUACCUGGCAUACCUAAGGACAUGACCUAUAGAAGACUCAUCUCUAUGAUGGGUUUUAAAAUGAAUUAUCAAGUUAAUGGUUACCCUAACAUGUUUAUCACCCGCGAAGAAGCUAUAAGACAUGUACGUGCAUGGAUUGGCUUCGAUGUCGAGGGGUGUCAUGCUACUAGAGAAGCUGUUGGUACCAAUUUACCUUUACAGCUAGGUUUUUCUACAGGUGUUAACCUAGUUGCUGUACCUACAGGUUAUGUUGAUACACCUAAUAAUACAGAUUUUUCCAGAGUUAGUGCUAAACCACCGCCUGGAGAUCAAUUUAAACACCUCAUACCACUUAUGUACAAAGGACUUCCUUGGAAUGUAGUGCGUAUAAAGAUUGUACAAAUGUUAAGUGACACACUUAAAAAUCUCUCUGACAGAGUCGUAUUUGUCUUAUGGGCACAUGGCUUUGAGUUGACAUCUAUGAAGUAUUUUGUGAAAAUAGGACCUGAGCGCACCUGUUGUCUAUGUGAUAGACGUGCCACAUGCUUUUCCACUGCUUCAGACACUUAUGCCUGUUGGCAUCAUUCUAUUGGAUUUGAUUACGUCUAUAAUCCGUUUAUGAUUGAUGUUCAACAAUGGGGUUUUACAGGUAACCUACAAAGCAACCAUGAUCUGUAUUGUCAAGUCCAUGGUAAUGCACAUGUAGCUAGUUGUGAUGCAAUCAUGACUAGGUGUCUAGCUGUCCACGAGUGCUUUGUUAAGCGUGUUGACUGGACUAUUGAAUAUCCUAUAAUUGGUGAUGAACUGAAGAUUAAUGCGGCUUGUAGAAAGGUUCAACACAUGGUUGUUAAAGCUGCAUUAUUAGCAGACAAAUUCCCAGUUCUUCACGACAUUGGUAACCCUAAAGCUAUUAAGUGUGUACCUCAAGCUGAUGUAGAAUGGAAGUUCUAUGAUGCACAGCCUUGUAGUGACAAAGCUUAUAAAAUAGAAGAAUUAUUCUAUUCUUAUGCCACACAUUCUGACAAAUUCACAGAUGGUGUAUGCCUAUUUUGGAAUUGCAAUGUCGAUAGAUAUCCUGCUAAUUCCAUUGUUUGUAGAUUUGACACUAGAGUGCUAUCUAACCUUAACUUGCCUGGUUGUGAUGGUGGCAGUUUGUAUGUAAAUAAACAUGCAUUCCACACACCAGCUUUUGAUAAAAGUGCUUUUGUUAAUUUAAAACAAUUACCAUUUUUCUAUUACUCUGACAGUCCAUGUGAGUCUCAUGGAAAACAAGUAGUGUCAGAUAUAGAUUAUGUACCACUAAAGUCUGCUACGUGUAUAACACGUUGCAAUUUAGGUGGUGCUGUCUGUAGACAUCAUGCUAAUGAGUACAGAUUGUAUCUCGAUGCUUAUAACAUGAUGAUCUCAGCUGGCUUUAGCUUGUGGGUUUACAAACAAUUUGAUACUUAUAACCUCUGGAACACUUUUACAAGACUUCAGAGUUUAGAAAAUGUGGCUUUUAAUGUUGUAAAUAAGGGACACUUUGAUGGACAACAGGGUGAAGUACCAGUUUCUAUCAUUAAUAACACUGUUUACACAAAAGUUGAUGGUGUUGAUGUAGAAUUGUUUGAAAAUAAAACAACAUUACCUGUUAAUGUAGCAUUUGAGCUUUGGGCUAAGCGCAACAUUAAACCAGUACCAGAGGUGAAAAUACUCAAUAAUUUGGGUGUGGACAUUGCUGCUAAUACUGUGAUCUGGGACUACAAAAGAGAUGCUCCAGCACAUAUAUCUACUAUUGGUGUUUGUUCUAUGACUGACAUAGCCAAGAAACCAACUGAAACGAUUUGUGCACCACUCACUGUCUUUUUUGAUGGUAGAGUUGAUGGUCAAGUAGACUUAUUUAGAAAUGCCCGUAAUGGUGUUCUUAUUACAGAAGGUAGUGUUAAAGGUUUACAACCAUCUGUAGGUCCCAAACAAGCUAGUCUUAAUGGAGUCACAUUAAUUGGAGAAGCCGUAAAAACACAGUUCAAUUAUUAUAAGAAAGUUGAUGGUGUUGUCCAACAAUUACCUGAAACUUACUUUACUCAGAGUAGAAAUUUACAAGAAUUUAAACCCAGGAGUCAAAUGGAAAUUGAUUUCUUAGAAUUAGCUAUGGAUGAAUUCAUUGAACGGUAUAAAUUAGAAGGCUAUGCCUUCGAACAUAUCGUUUAUGGAGAUUUUAGUCAUAGUCAGUUAGGUGGUUUACAUCUACUGAUUGGACUAGCUAAACGUUUUAAGGAAUCACCUUUUGAAUUAGAAGAUUUUAUUCCUAUGGACAGUACAGUUAAAAACUAUUUCAUAACAGAUGCGCAAACAGGUUCAUCUAAGUGUGUGUGUUCUGUUAUUGAUUUAUUACUUGAUGAUUUUGUUGAAAUAAUAAAAUCCCAAGAUUUAUCUGUAGUUUCUAAGGUUGUCAAAGUGACUAUUGACUAUACAGAAAUUUCAUUUAUGCUUUGGUGUAAAGAUGGCCAUGUAGAAACAUUUUACCCAAAAUUACAAUCUAGUCAAGCGUGGCAACCGGGUGUUGCUAUGCCUAAUCUUUACAAAAUGCAAAGAAUGCUAUUAGAAAAGUGUGACCUUCAAAAUUAUGGUGAUAGUGCAACAUUACCUAAAGGCAUAAUGAUGAAUGUCGCAAAAUAUACUCAACUGUGUCAAUAUUUAAACACAUUAACAUUAGCUGUACCCUAUAAUAUGAGAGUUAUACAUUUUGGUGCUGGUUCUGAUAAAGGAGUUGCACCAGGUACAGCUGUUUUAAGACAGUGGUUGCCUACGGGUACGCUGCUUGUCGAUUCAGAUCUUAAUGACUUUGUCUCUGAUGCAGAUUCAACUUUGAUUGGUGAUUGUGCAACUGUACAUACAGCUAAUAAAUGGGAUCUCAUUAUUAGUGAUAUGUACGACCCUAAGACUAAAAAUGUUACAAAAGAAAAUGACUCUAAAGAGGGUUUUUUCACUUACAUUUGUGGGUUUAUACAACAAAAGCUAGCUCUUGGAGGUUCCGUGGCUAUAAAGAUAACAGAACAUUCUUGGAAUGCUGAUCUUUAUAAGCUCAUGGGACACUUCGCAUGGUGGACAGCCUUUGUUACUAAUGUGAAUGCGUCAUCAUCUGAAGCAUUUUUAAUUGGAUGUAAUUAUCUUGGCAAACCACGCGAACAAAUAGAUGGUUAUGUCAUGCAUGCAAAUUACAUAUUUUGGAGGAAUACAAAUCCAAUUCAGUUGUCUUCCUAUUCUUUAUUUGACAUGAGUAAAUUUCCCCUUAAAUUAAGGGGUACUGCUGUUAUGUCUUUAAAAGAAGGUCAAAUCAAUGAUAUGAUUUUAUCUCUUCUUAGUAAAGGUAGACUUAUAAUUAGAGAAAACAACAGAGUUGUUAUUUCUAGUGAUGUUCUUGUUAACAACUAAACGAACAAUGUUUGUUUUUCUUGUUUUAUUGCCACUAGUCUCUAGUCAGUGUGUUAAUCUUACAACCAGAACUCAAUUACCCCCUGCAUACACUAAUUCUUUCACACGUGGUGUUUAUUACCCUGACAAAGUUUUCAGAUCCUCAGUUUUACAUUCAACUCAGGACUUGUUCUUACCUUUCUUUUCCAAUGUUACUUGGUUCCAUGCUAUACAUGUCUCUGGGACCAAUGGUACUAAGAGGUUUGAUAACCCUGUCCUACCAUUUAAUGAUGGUGUUUAUUUUGCUUCCACUGAGAAGUCUAACAUAAUAAGAGGCUGGAUUUUUGGUACUACUUUAGAUUCGAAGACCCAGUCCCUACUUAUUGUUAAUAACGCUACUAAUGUUGUUAUUAAAGUCUGUGAAUUUCAAUUUUGUAAUGAUCCAUUUUUGGGUGUUUAUUACCACAAAAACAACAAAAGUUGGAUGGAAAGUGAGUUCAGAGUUUAUUCUAGUGCGAAUAAUUGCACUUUUGAAUAUGUCUCUCAGCCUUUUCUUAUGGACCUUGAAGGAAAACAGGGUAAUUUCAAAAAUCUUAGGGAAUUUGUGUUUAAGAAUAUUGAUGGUUAUUUUAAAAUAUAUUCUAAGCACACGCCUAUUAAUUUAGUGCGUGAUCUCCCUCAGGGUUUUUCGGCUUUAGAACCAUUGGUAGAUUUGCCAAUAGGUAUUAACAUCACUAGGUUUCAAACUUUACUUGCUUUACAUAGAAGUUAUUUGACUCCUGGUGAUUCUUCUUCAGGUUGGACAGCUGGUGCUGCAGCUUAUUAUGUGGGUUAUCUUCAACCUAGGACUUUUCUAUUAAAAUAUAAUGAAAAUGGAACCAUUACAGAUGCUGUAGACUGUGCACUUGACCCUCUCUCAGAAACAAAGUGUACGUUGAAAUCCUUCACUGUAGAAAAAGGAAUCUAUCAAACUUCUAACUUUAGAGUCCAACCAACAGAAUCUAUUGUUAGAUUUCCUAAUAUUACAAACUUGUGCCCUUUUGGUGAAGUUUUUAACGCCACCAGAUUUGCAUCUGUUUAUGCUUGGAACAGGAAGAGAAUCAGCAACUGUGUUGCUGAUUAUUCUGUCCUAUAUAAUUCCGCAUCAUUUUCCACUUUUAAGUGUUAUGGAGUGUCUCCUACUAAAUUAAAUGAUCUCUGCUUUACUAAUGUCUAUGCAGAUUCAUUUGUAAUUAGAGGUGAUGAAGUCAGACAAAUCGCUCCAGGGCAAACUGGAAAGAUUGCUGAUUAUAAUUAUAAAUUACCAGAUGAUUUUACAGGCUGCGUUAUAGCUUGGAAUUCUAACAAUCUUGAUUCUAAGGUUGGUGGUAAUUAUAAUUACCUGUAUAGAUUGUUUAGGAAGUCUAAUCUCAAACCUUUUGAGAGAGAUAUUUCAACUGAAAUCUAUCAGGCCGGUAGCACACCUUGUAAUGGUGUUGAAGGUUUUAAUUGUUACUUUCCUUUACAAUCAUAUGGUUUCCAACCCACUAAUGGUGUUGGUUACCAACCAUACAGAGUAGUAGUACUUUCUUUUGAACUUCUACAUGCACCAGCAACUGUUUGUGGACCUAAAAAGUCUACUAAUUUGGUUAAAAACAAAUGUGUCAAUUUCAACUUCAAUGGUUUAACAGGCACAGGUGUUCUUACUGAGUCUAACAAAAAGUUUCUGCCUUUCCAACAAUUUGGCAGAGACAUUGCUGACACUACUGAUGCUGUCCGUGAUCCACAGACACUUGAGAUUCUUGACAUUACACCAUGUUCUUUUGGUGGUGUCAGUGUUAUAACACCAGGAACAAAUACUUCUAACCAGGUUGCUGUUCUUUAUCAGGAUGUUAACUGCACAGAAGUCCCUGUUGCUAUUCAUGCAGAUCAACUUACUCCUACUUGGCGUGUUUAUUCUACAGGUUCUAAUGUUUUUCAAACACGUGCAGGCUGUUUAAUAGGGGCUGAACAUGUCAACAACUCAUAUGAGUGUGACAUACCCAUUGGUGCAGGUAUAUGCGCUAGUUAUCAGACUCAGACUAAUUCUCCUCGGCGGGCACGUAGUGUAGCUAGUCAAUCCAUCAUUGCCUACACUAUGUCACUUGGUGCAGAAAAUUCAGUUGCUUACUCUAAUAACUCUAUUGCCAUACCCACAAAUUUUACUAUUAGUGUUACCACAGAAAUUCUACCAGUGUCUAUGACCAAGACAUCAGUAGAUUGUACAAUGUACAUUUGUGGUGAUUCAACUGAAUGCAGCAAUCUUUUGUUGCAAUAUGGCAGUUUUUGUACACAAUUAAACCGUGCUUUAACUGGAAUAGCUGUUGAACAAGACAAAAACACCCAAGAAGUUUUUGCACAAGUCAAACAAAUUUACAAAACACCACCAAUUAAAGAUUUUGGUGGUUUUAAUUUUUCACAAAUAUUACCAGAUCCAUCAAAACCAAGCAAGAGGUCAUUUAUUGAAGAUCUACUUUUCAACAAAGUGACACUUGCAGAUGCUGGCUUCAUCAAACAAUAUGGUGAUUGCCUUGGUGAUAUUGCUGCUAGAGACCUCAUUUGUGCACAAAAGUUUAACGGCCUUACUGUUUUGCCACCUUUGCUCACAGAUGAAAUGAUUGCUCAAUACACUUCUGCACUGUUAGCGGGUACAAUCACUUCUGGUUGGACCUUUGGUGCAGGUGCUGCAUUACAAAUACCAUUUGCUAUGCAAAUGGCUUAUAGGUUUAAUGGUAUUGGAGUUACACAGAAUGUUCUCUAUGAGAACCAAAAAUUGAUUGCCAACCAAUUUAAUAGUGCUAUUGGCAAAAUUCAAGACUCACUUUCUUCCACAGCAAGUGCACUUGGAAAACUUCAAGAUGUGGUCAACCAAAAUGCACAAGCUUUAAACACGCUUGUUAAACAACUUAGCUCCAAUUUUGGUGCAAUUUCAAGUGUUUUAAAUGAUAUCCUUUCACGUCUUGACAAAGUUGAGGCUGAAGUGCAAAUUGAUAGGUUGAUCACAGGCAGACUUCAAAGUUUGCAGACAUAUGUGACUCAACAAUUAAUUAGAGCUGCAGAAAUCAGAGCUUCUGCUAAUCUUGCUGCUACUAAAAUGUCAGAGUGUGUACUUGGACAAUCAAAAAGAGUUGAUUUUUGUGGAAAGGGCUAUCAUCUUAUGUCCUUCCCUCAGUCAGCACCUCAUGGUGUAGUCUUCUUGCAUGUGACUUAUGUCCCUGCACAAGAAAAGAACUUCACAACUGCUCCUGCCAUUUGUCAUGAUGGAAAAGCACACUUUCCUCGUGAAGGUGUCUUUGUUUCAAAUGGCACACACUGGUUUGUAACACAAAGGAAUUUUUAUGAACCACAAAUCAUUACUACAGACAACACAUUUGUGUCUGGUAACUGUGAUGUUGUAAUAGGAAUUGUCAACAACACAGUUUAUGAUCCUUUGCAACCUGAAUUAGACUCAUUCAAGGAGGAGUUAGAUAAAUAUUUUAAGAAUCAUACAUCACCAGAUGUUGAUUUAGGUGACAUCUCUGGCAUUAAUGCUUCAGUUGUAAACAUUCAAAAAGAAAUUGACCGCCUCAAUGAGGUUGCCAAGAAUUUAAAUGAAUCUCUCAUCGAUCUCCAAGAACUUGGAAAGUAUGAGCAGUAUAUAAAAUGGCCAUGGUACAUUUGGCUAGGUUUUAUAGCUGGCUUGAUUGCCAUAGUAAUGGUGACAAUUAUGCUUUGCUGUAUGACCAGUUGCUGUAGUUGUCUCAAGGGCUGUUGUUCUUGUGGAUCCUGCUGCAAAUUUGAUGAAGACGACUCUGAGCCAGUGCUCAAAGGAGUCAAAUUACAUUACACAUAAACGAACUUAUGGAUUUGUUUAUGAGAAUCUUCACAAUUGGAACUGUAACUUUGAAGCAAGGUGAAAUCAAGGAUGCUACUCCUUCAGAUUUUGUUCGCGCUACUGCAACGAUACCGAUACAAGCCUCACUCCCUUUCGGAUGGCUUAUUGUUGGCGUUGCACUUCUUGCUGUUUUUCAGAGCGCUUCCAAAAUCAUAACCCUCAAAAAGAGAUGGCAACUAGCACUCUCCAAGGGUGUUCACUUUGUUUGCAACUUGCUGUUGUUGUUUGUAACAGUUUACUCACACCUUUUGCUCGUUGCUGCUGGCCUUGAAGCCCCUUUUCUCUAUCUUUAUGCUUUAGUCUACUUCUUGCAGAGUAUAAACUUUGUAAGAAUAAUAAUGAGGCUUUGGCUUUGCUGGAAAUGCCGUUCCAAAAACCCAUUACUUUAUGAUGCCAACUAUUUUCUUUGCUGGCAUACUAAUUGUUACGACUAUUGUAUACCUUACAAUAGUGUAACUUCUUCAAUUGUCAUUACUUCAGGUGAUGGCACAACAAGUCCUAUUUCUGAACAUGACUACCAGAUUGGUGGUUAUACUGAAAAAUGGGAAUCUGGAGUAAAAGACUGUGUUGUAUUACACAGUUACUUCACUUCAGACUAUUACCAGCUGUACUCAACUCAAUUGAGUACAGACACUGGUGUUGAACAUGUUACCUUCUUCAUCUACAAUAAAAUUGUUGAUGAGCCUGAAGAACAUGUCCAAAUUCACACAAUCGACGGUUCAUCCGGAGUUGUUAAUCCAGUAAUGGAACCAAUUUAUGAUGAACCGACGACGACUACUAGCGUGCCUUUGUAAGCACAAGCUGAUGAGUACGAACUUAUGUACUCAUUCGUUUCGGAAGAGACAGGUACGUUAAUAGUUAAUAGCGUACUUCUUUUUCUUGCUUUCGUGGUAUUCUUGCUAGUUACACUAGCCAUCCUUACUGCGCUUCGAUUGUGUGCGUACUGCUGCAAUAUUGUUAACGUGAGUCUUGUAAAACCUUCUUUUUACGUUUACUCUCGUGUUAAAAAUCUGAAUUCUUCUAGAGUUCCUGAUCUUCUGGUCUAAACGAACUAAAUAUUAUAUUAGUUUUUCUGUUUGGAACUUUAAUUUUAGCCAUGGCAGAUUCCAACGGUACUAUUACCGUUGAAGAGCUUAAAAAGCUCCUUGAACAAUGGAACCUAGUAAUAGGUUUCCUAUUCCUUACAUGGAUUUGUCUUCUACAAUUUGCCUAUGCCAACAGGAAUAGGUUUUUGUAUAUAAUUAAGUUAAUUUUCCUCUGGCUGUUAUGGCCAGUAACUUUAGCUUGUUUUGUGCUUGCUGCUGUUUACAGAAUAAAUUGGAUCACCGGUGGAAUUGCUAUCGCAAUGGCUUGUCUUGUAGGCUUGAUGUGGCUCAGCUACUUCAUUGCUUCUUUCAGACUGUUUGCGCGUACGCGUUCCAUGUGGUCAUUCAAUCCAGAAACUAACAUUCUUCUCAACGUGCCACUCCAUGGCACUAUUCUGACCAGACCGCUUCUAGAAAGUGAACUCGUAAUCGGAGCUGUGAUCCUUCGUGGACAUCUUCGUAUUGCUGGACACCAUCUAGGACGCUGUGACAUCAAGGACCUGCCUAAAGAAAUCACUGUUGCUACAUCACGAACGCUUUCUUAUUACAAAUUGGGAGCUUCGCAGCGUGUAGCAGGUGACUCAGGUUUUGCUGCAUACAGUCGCUACAGGAUUGGCAACUAUAAAUUAAACACAGACCAUUCCAGUAGCAGUGACAAUAUUGCUUUGCUUGUACAGUAAGUGACAACAGAUGUUUCAUCUCGUUGACUUUCAGGUUACUAUAGCAGAGAUAUUACUAAUUAUUAUGAGGACUUUUAAAGUUUCCAUUUGGAAUCUUGAUUACAUCAUAAACCUCAUAAUUAAAAAUUUAUCUAAGUCACUAACUGAGAAUAAAUAUUCUCAAUUAGAUGAAGAGCAACCAAUGGAGAUUGAUUAAACGAACAUGAAAAUUAUUCUUUUCUUGGCACUGAUAACACUCGCUACUUGUGAGCUUUAUCACUACCAAGAGUGUGUUAGAGGUACAACAGUACUUUUAAAAGAACCUUGCUCUUCUGGAACAUACGAGGGCAAUUCACCAUUUCAUCCUCUAGCUGAUAACAAAUUUGCACUGACUUGCUUUAGCACUCAAUUUGCUUUUGCUUGUCCUGACGGCGUAAAACACGUCUAUCAGUUACGUGCCAGAUCAGUUUCACCUAAACUGUUCAUCAGACAAGAGGAAGUUCAAGAACUUUACUCUCCAAUUUUUCUUAUUGUUGCGGCAAUAGUGUUUAUAACACUUUGCUUCACACUCAAAAGAAAGACAGAAUGAUUGAACUUUCAUUAAUUGACUUCUAUUUGUGCUUUUUAGCCUUUCUGCUAUUCCUUGUUUUAAUUAUGCUUAUUAUCUUUUGGUUCUCACUUGAACUGCAAGAUCAUAAUGAAACUUGUCACGCCUAAACGAACAUGAAAUUUCUUGUUUUCUUAGGAAUCAUCACAACUGUAGCUGCAUUUCACCAAGAAUGUAGUUUACAGUCAUGUACUCAACAUCAACCAUAUGUAGUUGAUGACCCGUGUCCUAUUCACUUCUAUUCUAAAUGGUAUAUUAGAGUAGGAGCUAGAAAAUCAGCACCUUUAAUUGAAUUGUGCGUGGAUGAGGCUGGUUCUAAAUCACCCAUUCAGUACAUCGAUAUCGGUAAUUAUACAGUUUCCUGUUUACCUUUUACAAUUAAUUGCCAGGAACCUAAAUUGGGUAGUCUUGUAGUGCGUUGUUCGUUCUAUGAAGACUUUUUAGAGUAUCAUGACGUUCGUGUUGUUUUAGAUUUCAUCUAAACGAACAAACUAAAAUGUCUGAUAAUGGACCCCAAAAUCAGCGAAAUGCACCCCGCAUUACGUUUGGUGGACCCUCAGAUUCAACUGGCAGUAACCAGAAUGGAGAACGCAGUGGGGCGCGAUCAAAACAACGUCGGCCCCAAGGUUUACCCAAUAAUACUGCGUCUUGGUUCACCGCUCUCACUCAACAUGGCAAGGAAGACCUUAAAUUCCCUCGAGGACAAGGCGUUCCAAUUAACACCAAUAGCAGUCCAGAUGACCAAAUUGGCUACUACCGAAGAGCUACCAGACGAAUUCGUGGUGGUGACGGUAAAAUGAAAGAUCUCAGUCCAAGAUGGUAUUUCUACUACCUAGGAACUGGGCCAGAAGCUGGACUUCCCUAUGGUGCUAACAAAGACGGCAUCAUAUGGGUUGCAACUGAGGGAGCCUUGAAUACACCAAAAGAUCACAUUGGCACCCGCAAUCCUGCUAACAAUGCUGCAAUCGUGCUACAACUUCCUCAAGGAACAACAUUGCCAAAAGGCUUCUACGCAGAAGGGAGCAGAGGCGGCAGUCAAGCCUCUUCUCGUUCCUCAUCACGUAGUCGCAACAGUUCAAGAAAUUCAACUCCAGGCAGCAGUAGGGGAACUUCUCCUGCUAGAAUGGCUGGCAAUGGCGGUGAUGCUGCUCUUGCUUUGCUGCUGCUUGACAGAUUGAACCAGCUUGAGAGCAAAAUGUCUGGUAAAGGCCAACAACAACAAGGCCAAACUGUCACUAAGAAAUCUGCUGCUGAGGCUUCUAAGAAGCCUCGGCAAAAACGUACUGCCACUAAAGCAUACAAUGUAACACAAGCUUUCGGCAGACGUGGUCCAGAACAAACCCAAGGAAAUUUUGGGGACCAGGAACUAAUCAGACAAGGAACUGAUUACAAACAUUGGCCGCAAAUUGCACAAUUUGCCCCCAGCGCUUCAGCGUUCUUCGGAAUGUCGCGCAUUGGCAUGGAAGUCACACCUUCGGGAACGUGGUUGACCUACACAGGUGCCAUCAAAUUGGAUGACAAAGAUCCAAAUUUCAAAGAUCAAGUCAUUUUGCUGAAUAAGCAUAUUGACGCAUACAAAACAUUCCCACCAACAGAGCCUAAAAAGGACAAAAAGAAGAAGGCUGAUGAAACUCAAGCCUUACCGCAGAGACAGAAGAAACAGCAAACUGUGACUCUUCUUCCUGCUGCAGAUUUGGAUGAUUUCUCCAAACAAUUGCAACAAUCCAUGAGCAGUGCUGACUCAACUCAGGCCUAAACUCAUGCAGACCACACAAGGCAGAUGGGCUAUAUAAACGUUUUCGCUUUUCCGUUUACGAUAUAUAGUCUACUCUUGUGCAGAAUGAAUUCUCGUAACUACAUAGCACAAGUAGAUGUAGUUAACUUUAAUCUCACAUAGCAAUCUUUAAUCAGUGUGUAACAUUAGGGAGGACUUGAAAGAGCCACCACAUUUUCACCGAGGCCACGCGGAGUACGAUCGAGUGUACAGUGAACAAUGCUAGGGAGAGCUGCCUAUAUGGAAGAGCCCUAAUGUGUAAAAUUAAUUUUAGUAGUGCUAUCCCCAUGUGAUUUUAAUAGCUUCUUAGGAGAAUGACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,protein_ptm:acetylated(Lys375),419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5µM[SARS2-NPLys375-Ac];|5µM[SARS-CoV-2],"15 mM NaCl, 135 mM KCl, 5 mM phosphate, 1.5 mM MgCl2","20 mM Tris–HCl, pH 7.0",37˚C,-,other_molecular:1 mg ml−1 BSA,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"In contrast, SARS2-NPLys375-Ac and RNA slowly formed smaller droplets with much less liquid ",29903
215,703,PMID: 34239064,RNAPS0000450,https://pubmed.ncbi.nlm.nih.gov/34239064,RNA + protein,-,-,SARS-CoV-2 virus RNA,29903nt(1-29903),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCUGAAAAGAGCUAUGAAUUGCAGACACCUUUUGAAAUUAAAUUGGCAAAGAAAUUUGACACCUUCAAUGGGGAAUGUCCAAAUUUUGUAUUUCCCUUAAAUUCCAUAAUCAAGACUAUUCAACCAAGGGUUGAAAAGAAAAAGCUUGAUGGCUUUAUGGGUAGAAUUCGAUCUGUCUAUCCAGUUGCGUCACCAAAUGAAUGCAACCAAAUGUGCCUUUCAACUCUCAUGAAGUGUGAUCAUUGUGGUGAAACUUCAUGGCAGACGGGCGAUUUUGUUAAAGCCACUUGCGAAUUUUGUGGCACUGAGAAUUUGACUAAAGAAGGUGCCACUACUUGUGGUUACUUACCCCAAAAUGCUGUUGUUAAAAUUUAUUGUCCAGCAUGUCACAAUUCAGAAGUAGGACCUGAGCAUAGUCUUGCCGAAUACCAUAAUGAAUCUGGCUUGAAAACCAUUCUUCGUAAGGGUGGUCGCACUAUUGCCUUUGGAGGCUGUGUGUUCUCUUAUGUUGGUUGCCAUAACAAGUGUGCCUAUUGGGUUCCACGUGCUAGCGCUAACAUAGGUUGUAACCAUACAGGUGUUGUUGGAGAAGGUUCCGAAGGUCUUAAUGACAACCUUCUUGAAAUACUCCAAAAAGAGAAAGUCAACAUCAAUAUUGUUGGUGACUUUAAACUUAAUGAAGAGAUCGCCAUUAUUUUGGCAUCUUUUUCUGCUUCCACAAGUGCUUUUGUGGAAACUGUGAAAGGUUUGGAUUAUAAAGCAUUCAAACAAAUUGUUGAAUCCUGUGGUAAUUUUAAAGUUACAAAAGGAAAAGCUAAAAAAGGUGCCUGGAAUAUUGGUGAACAGAAAUCAAUACUGAGUCCUCUUUAUGCAUUUGCAUCAGAGGCUGCUCGUGUUGUACGAUCAAUUUUCUCCCGCACUCUUGAAACUGCUCAAAAUUCUGUGCGUGUUUUACAGAAGGCCGCUAUAACAAUACUAGAUGGAAUUUCACAGUAUUCACUGAGACUCAUUGAUGCUAUGAUGUUCACAUCUGAUUUGGCUACUAACAAUCUAGUUGUAAUGGCCUACAUUACAGGUGGUGUUGUUCAGUUGACUUCGCAGUGGCUAACUAACAUCUUUGGCACUGUUUAUGAAAAACUCAAACCCGUCCUUGAUUGGCUUGAAGAGAAGUUUAAGGAAGGUGUAGAGUUUCUUAGAGACGGUUGGGAAAUUGUUAAAUUUAUCUCAACCUGUGCUUGUGAAAUUGUCGGUGGACAAAUUGUCACCUGUGCAAAGGAAAUUAAGGAGAGUGUUCAGACAUUCUUUAAGCUUGUAAAUAAAUUUUUGGCUUUGUGUGCUGACUCUAUCAUUAUUGGUGGAGCUAAACUUAAAGCCUUGAAUUUAGGUGAAACAUUUGUCACGCACUCAAAGGGAUUGUACAGAAAGUGUGUUAAAUCCAGAGAAGAAACUGGCCUACUCAUGCCUCUAAAAGCCCCAAAAGAAAUUAUCUUCUUAGAGGGAGAAACACUUCCCACAGAAGUGUUAACAGAGGAAGUUGUCUUGAAAACUGGUGAUUUACAACCAUUAGAACAACCUACUAGUGAAGCUGUUGAAGCUCCAUUGGUUGGUACACCAGUUUGUAUUAACGGGCUUAUGUUGCUCGAAAUCAAAGACACAGAAAAGUACUGUGCCCUUGCACCUAAUAUGAUGGUAACAAACAAUACCUUCACACUCAAAGGCGGUGCACCAACAAAGGUUACUUUUGGUGAUGACACUGUGAUAGAAGUGCAAGGUUACAAGAGUGUGAAUAUCACUUUUGAACUUGAUGAAAGGAUUGAUAAAGUACUUAAUGAGAAGUGCUCUGCCUAUACAGUUGAACUCGGUACAGAAGUAAAUGAGUUCGCCUGUGUUGUGGCAGAUGCUGUCAUAAAAACUUUGCAACCAGUAUCUGAAUUACUUACACCACUGGGCAUUGAUUUAGAUGAGUGGAGUAUGGCUACAUACUACUUAUUUGAUGAGUCUGGUGAGUUUAAAUUGGCUUCACAUAUGUAUUGUUCUUUCUACCCUCCAGAUGAGGAUGAAGAAGAAGGUGAUUGUGAAGAAGAAGAGUUUGAGCCAUCAACUCAAUAUGAGUAUGGUACUGAAGAUGAUUACCAAGGUAAACCUUUGGAAUUUGGUGCCACUUCUGCUGCUCUUCAACCUGAAGAAGAGCAAGAAGAAGAUUGGUUAGAUGAUGAUAGUCAACAAACUGUUGGUCAACAAGACGGCAGUGAGGACAAUCAGACAACUACUAUUCAAACAAUUGUUGAGGUUCAACCUCAAUUAGAGAUGGAACUUACACCAGUUGUUCAGACUAUUGAAGUGAAUAGUUUUAGUGGUUAUUUAAAACUUACUGACAAUGUAUACAUUAAAAAUGCAGACAUUGUGGAAGAAGCUAAAAAGGUAAAACCAACAGUGGUUGUUAAUGCAGCCAAUGUUUACCUUAAACAUGGAGGAGGUGUUGCAGGAGCCUUAAAUAAGGCUACUAACAAUGCCAUGCAAGUUGAAUCUGAUGAUUACAUAGCUACUAAUGGACCACUUAAAGUGGGUGGUAGUUGUGUUUUAAGCGGACACAAUCUUGCUAAACACUGUCUUCAUGUUGUCGGCCCAAAUGUUAACAAAGGUGAAGACAUUCAACUUCUUAAGAGUGCUUAUGAAAAUUUUAAUCAGCACGAAGUUCUACUUGCACCAUUAUUAUCAGCUGGUAUUUUUGGUGCUGACCCUAUACAUUCUUUAAGAGUUUGUGUAGAUACUGUUCGCACAAAUGUCUACUUAGCUGUCUUUGAUAAAAAUCUCUAUGACAAACUUGUUUCAAGCUUUUUGGAAAUGAAGAGUGAAAAGCAAGUUGAACAAAAGAUCGCUGAGAUUCCUAAAGAGGAAGUUAAGCCAUUUAUAACUGAAAGUAAACCUUCAGUUGAACAGAGAAAACAAGAUGAUAAGAAAAUCAAAGCUUGUGUUGAAGAAGUUACAACAACUCUGGAAGAAACUAAGUUCCUCACAGAAAACUUGUUACUUUAUAUUGACAUUAAUGGCAAUCUUCAUCCAGAUUCUGCCACUCUUGUUAGUGACAUUGACAUCACUUUCUUAAAGAAAGAUGCUCCAUAUAUAGUGGGUGAUGUUGUUCAAGAGGGUGUUUUAACUGCUGUGGUUAUACCUACUAAAAAGGCUGGUGGCACUACUGAAAUGCUAGCGAAAGCUUUGAGAAAAGUGCCAACAGACAAUUAUAUAACCACUUACCCGGGUCAGGGUUUAAAUGGUUACACUGUAGAGGAGGCAAAGACAGUGCUUAAAAAGUGUAAAAGUGCCUUUUACAUUCUACCAUCUAUUAUCUCUAAUGAGAAGCAAGAAAUUCUUGGAACUGUUUCUUGGAAUUUGCGAGAAAUGCUUGCACAUGCAGAAGAAACACGCAAAUUAAUGCCUGUCUGUGUGGAAACUAAAGCCAUAGUUUCAACUAUACAGCGUAAAUAUAAGGGUAUUAAAAUACAAGAGGGUGUGGUUGAUUAUGGUGCUAGAUUUUACUUUUACACCAGUAAAACAACUGUAGCGUCACUUAUCAACACACUUAACGAUCUAAAUGAAACUCUUGUUACAAUGCCACUUGGCUAUGUAACACAUGGCUUAAAUUUGGAAGAAGCUGCUCGGUAUAUGAGAUCUCUCAAAGUGCCAGCUACAGUUUCUGUUUCUUCACCUGAUGCUGUUACAGCGUAUAAUGGUUAUCUUACUUCUUCUUCUAAAACACCUGAAGAACAUUUUAUUGAAACCAUCUCACUUGCUGGUUCCUAUAAAGAUUGGUCCUAUUCUGGACAAUCUACACAACUAGGUAUAGAAUUUCUUAAGAGAGGUGAUAAAAGUGUAUAUUACACUAGUAAUCCUACCACAUUCCACCUAGAUGGUGAAGUUAUCACCUUUGACAAUCUUAAGACACUUCUUUCUUUGAGAGAAGUGAGGACUAUUAAGGUGUUUACAACAGUAGACAACAUUAACCUCCACACGCAAGUUGUGGACAUGUCAAUGACAUAUGGACAACAGUUUGGUCCAACUUAUUUGGAUGGAGCUGAUGUUACUAAAAUAAAACCUCAUAAUUCACAUGAAGGUAAAACAUUUUAUGUUUUACCUAAUGAUGACACUCUACGUGUUGAGGCUUUUGAGUACUACCACACAACUGAUCCUAGUUUUCUGGGUAGGUACAUGUCAGCAUUAAAUCACACUAAAAAGUGGAAAUACCCACAAGUUAAUGGUUUAACUUCUAUUAAAUGGGCAGAUAACAACUGUUAUCUUGCCACUGCAUUGUUAACACUCCAACAAAUAGAGUUGAAGUUUAAUCCACCUGCUCUACAAGAUGCUUAUUACAGAGCAAGGGCUGGUGAAGCUGCUAACUUUUGUGCACUUAUCUUAGCCUACUGUAAUAAGACAGUAGGUGAGUUAGGUGAUGUUAGAGAAACAAUGAGUUACUUGUUUCAACAUGCCAAUUUAGAUUCUUGCAAAAGAGUCUUGAACGUGGUGUGUAAAACUUGUGGACAACAGCAGACAACCCUUAAGGGUGUAGAAGCUGUUAUGUACAUGGGCACACUUUCUUAUGAACAAUUUAAGAAAGGUGUUCAGAUACCUUGUACGUGUGGUAAACAAGCUACAAAAUAUCUAGUACAACAGGAGUCACCUUUUGUUAUGAUGUCAGCACCACCUGCUCAGUAUGAACUUAAGCAUGGUACAUUUACUUGUGCUAGUGAGUACACUGGUAAUUACCAGUGUGGUCACUAUAAACAUAUAACUUCUAAAGAAACUUUGUAUUGCAUAGACGGUGCUUUACUUACAAAGUCCUCAGAAUACAAAGGUCCUAUUACGGAUGUUUUCUACAAAGAAAACAGUUACACAACAACCAUAAAACCAGUUACUUAUAAAUUGGAUGGUGUUGUUUGUACAGAAAUUGACCCUAAGUUGGACAAUUAUUAUAAGAAAGACAAUUCUUAUUUCACAGAGCAACCAAUUGAUCUUGUACCAAACCAACCAUAUCCAAACGCAAGCUUCGAUAAUUUUAAGUUUGUAUGUGAUAAUAUCAAAUUUGCUGAUGAUUUAAACCAGUUAACUGGUUAUAAGAAACCUGCUUCAAGAGAGCUUAAAGUUACAUUUUUCCCUGACUUAAAUGGUGAUGUGGUGGCUAUUGAUUAUAAACACUACACACCCUCUUUUAAGAAAGGAGCUAAAUUGUUACAUAAACCUAUUGUUUGGCAUGUUAACAAUGCAACUAAUAAAGCCACGUAUAAACCAAAUACCUGGUGUAUACGUUGUCUUUGGAGCACAAAACCAGUUGAAACAUCAAAUUCGUUUGAUGUACUGAAGUCAGAGGACGCGCAGGGAAUGGAUAAUCUUGCCUGCGAAGAUCUAAAACCAGUCUCUGAAGAAGUAGUGGAAAAUCCUACCAUACAGAAAGACGUUCUUGAGUGUAAUGUGAAAACUACCGAAGUUGUAGGAGACAUUAUACUUAAACCAGCAAAUAAUAGUUUAAAAAUUACAGAAGAGGUUGGCCACACAGAUCUAAUGGCUGCUUAUGUAGACAAUUCUAGUCUUACUAUUAAGAAACCUAAUGAAUUAUCUAGAGUAUUAGGUUUGAAAACCCUUGCUACUCAUGGUUUAGCUGCUGUUAAUAGUGUCCCUUGGGAUACUAUAGCUAAUUAUGCUAAGCCUUUUCUUAACAAAGUUGUUAGUACAACUACUAACAUAGUUACACGGUGUUUAAACCGUGUUUGUACUAAUUAUAUGCCUUAUUUCUUUACUUUAUUGCUACAAUUGUGUACUUUUACUAGAAGUACAAAUUCUAGAAUUAAAGCAUCUAUGCCGACUACUAUAGCAAAGAAUACUGUUAAGAGUGUCGGUAAAUUUUGUCUAGAGGCUUCAUUUAAUUAUUUGAAGUCACCUAAUUUUUCUAAACUGAUAAAUAUUAUAAUUUGGUUUUUACUAUUAAGUGUUUGCCUAGGUUCUUUAAUCUACUCAACCGCUGCUUUAGGUGUUUUAAUGUCUAAUUUAGGCAUGCCUUCUUACUGUACUGGUUACAGAGAAGGCUAUUUGAACUCUACUAAUGUCACUAUUGCAACCUACUGUACUGGUUCUAUACCUUGUAGUGUUUGUCUUAGUGGUUUAGAUUCUUUAGACACCUAUCCUUCUUUAGAAACUAUACAAAUUACCAUUUCAUCUUUUAAAUGGGAUUUAACUGCUUUUGGCUUAGUUGCAGAGUGGUUUUUGGCAUAUAUUCUUUUCACUAGGUUUUUCUAUGUACUUGGAUUGGCUGCAAUCAUGCAAUUGUUUUUCAGCUAUUUUGCAGUACAUUUUAUUAGUAAUUCUUGGCUUAUGUGGUUAAUAAUUAAUCUUGUACAAAUGGCCCCGAUUUCAGCUAUGGUUAGAAUGUACAUCUUCUUUGCAUCAUUUUAUUAUGUAUGGAAAAGUUAUGUGCAUGUUGUAGACGGUUGUAAUUCAUCAACUUGUAUGAUGUGUUACAAACGUAAUAGAGCAACAAGAGUCGAAUGUACAACUAUUGUUAAUGGUGUUAGAAGGUCCUUUUAUGUCUAUGCUAAUGGAGGUAAAGGCUUUUGCAAACUACACAAUUGGAAUUGUGUUAAUUGUGAUACAUUCUGUGCUGGUAGUACAUUUAUUAGUGAUGAAGUUGCGAGAGACUUGUCACUACAGUUUAAAAGACCAAUAAAUCCUACUGACCAGUCUUCUUACAUCGUUGAUAGUGUUACAGUGAAGAAUGGUUCCAUCCAUCUUUACUUUGAUAAAGCUGGUCAAAAGACUUAUGAAAGACAUUCUCUCUCUCAUUUUGUUAACUUAGACAACCUGAGAGCUAAUAACACUAAAGGUUCAUUGCCUAUUAAUGUUAUAGUUUUUGAUGGUAAAUCAAAAUGUGAAGAAUCAUCUGCAAAAUCAGCGUCUGUUUACUACAGUCAGCUUAUGUGUCAACCUAUACUGUUACUAGAUCAGGCAUUAGUGUCUGAUGUUGGUGAUAGUGCGGAAGUUGCAGUUAAAAUGUUUGAUGCUUACGUUAAUACGUUUUCAUCAACUUUUAACGUACCAAUGGAAAAACUCAAAACACUAGUUGCAACUGCAGAAGCUGAACUUGCAAAGAAUGUGUCCUUAGACAAUGUCUUAUCUACUUUUAUUUCAGCAGCUCGGCAAGGGUUUGUUGAUUCAGAUGUAGAAACUAAAGAUGUUGUUGAAUGUCUUAAAUUGUCACAUCAAUCUGACAUAGAAGUUACUGGCGAUAGUUGUAAUAACUAUAUGCUCACCUAUAACAAAGUUGAAAACAUGACACCCCGUGACCUUGGUGCUUGUAUUGACUGUAGUGCGCGUCAUAUUAAUGCGCAGGUAGCAAAAAGUCACAACAUUGCUUUGAUAUGGAACGUUAAAGAUUUCAUGUCAUUGUCUGAACAACUACGAAAACAAAUACGUAGUGCUGCUAAAAAGAAUAACUUACCUUUUAAGUUGACAUGUGCAACUACUAGACAAGUUGUUAAUGUUGUAACAACAAAGAUAGCACUUAAGGGUGGUAAAAUUGUUAAUAAUUGGUUGAAGCAGUUAAUUAAAGUUACACUUGUGUUCCUUUUUGUUGCUGCUAUUUUCUAUUUAAUAACACCUGUUCAUGUCAUGUCUAAACAUACUGACUUUUCAAGUGAAAUCAUAGGAUACAAGGCUAUUGAUGGUGGUGUCACUCGUGACAUAGCAUCUACAGAUACUUGUUUUGCUAACAAACAUGCUGAUUUUGACACAUGGUUUAGCCAGCGUGGUGGUAGUUAUACUAAUGACAAAGCUUGCCCAUUGAUUGCUGCAGUCAUAACAAGAGAAGUGGGUUUUGUCGUGCCUGGUUUGCCUGGCACGAUAUUACGCACAACUAAUGGUGACUUUUUGCAUUUCUUACCUAGAGUUUUUAGUGCAGUUGGUAACAUCUGUUACACACCAUCAAAACUUAUAGAGUACACUGACUUUGCAACAUCAGCUUGUGUUUUGGCUGCUGAAUGUACAAUUUUUAAAGAUGCUUCUGGUAAGCCAGUACCAUAUUGUUAUGAUACCAAUGUACUAGAAGGUUCUGUUGCUUAUGAAAGUUUACGCCCUGACACACGUUAUGUGCUCAUGGAUGGCUCUAUUAUUCAAUUUCCUAACACCUACCUUGAAGGUUCUGUUAGAGUGGUAACAACUUUUGAUUCUGAGUACUGUAGGCACGGCACUUGUGAAAGAUCAGAAGCUGGUGUUUGUGUAUCUACUAGUGGUAGAUGGGUACUUAACAAUGAUUAUUACAGAUCUUUACCAGGAGUUUUCUGUGGUGUAGAUGCUGUAAAUUUACUUACUAAUAUGUUUACACCACUAAUUCAACCUAUUGGUGCUUUGGACAUAUCAGCAUCUAUAGUAGCUGGUGGUAUUGUAGCUAUCGUAGUAACAUGCCUUGCCUACUAUUUUAUGAGGUUUAGAAGAGCUUUUGGUGAAUACAGUCAUGUAGUUGCCUUUAAUACUUUACUAUUCCUUAUGUCAUUCACUGUACUCUGUUUAACACCAGUUUACUCAUUCUUACCUGGUGUUUAUUCUGUUAUUUACUUGUACUUGACAUUUUAUCUUACUAAUGAUGUUUCUUUUUUAGCACAUAUUCAGUGGAUGGUUAUGUUCACACCUUUAGUACCUUUCUGGAUAACAAUUGCUUAUAUCAUUUGUAUUUCCACAAAGCAUUUCUAUUGGUUCUUUAGUAAUUACCUAAAGAGACGUGUAGUCUUUAAUGGUGUUUCCUUUAGUACUUUUGAAGAAGCUGCGCUGUGCACCUUUUUGUUAAAUAAAGAAAUGUAUCUAAAGUUGCGUAGUGAUGUGCUAUUACCUCUUACGCAAUAUAAUAGAUACUUAGCUCUUUAUAAUAAGUACAAGUAUUUUAGUGGAGCAAUGGAUACAACUAGCUACAGAGAAGCUGCUUGUUGUCAUCUCGCAAAGGCUCUCAAUGACUUCAGUAACUCAGGUUCUGAUGUUCUUUACCAACCACCACAAACCUCUAUCACCUCAGCUGUUUUGCAGAGUGGUUUUAGAAAAAUGGCAUUCCCAUCUGGUAAAGUUGAGGGUUGUAUGGUACAAGUAACUUGUGGUACAACUACACUUAACGGUCUUUGGCUUGAUGACGUAGUUUACUGUCCAAGACAUGUGAUCUGCACCUCUGAAGACAUGCUUAACCCUAAUUAUGAAGAUUUACUCAUUCGUAAGUCUAAUCAUAAUUUCUUGGUACAGGCUGGUAAUGUUCAACUCAGGGUUAUUGGACAUUCUAUGCAAAAUUGUGUACUUAAGCUUAAGGUUGAUACAGCCAAUCCUAAGACACCUAAGUAUAAGUUUGUUCGCAUUCAACCAGGACAGACUUUUUCAGUGUUAGCUUGUUACAAUGGUUCACCAUCUGGUGUUUACCAAUGUGCUAUGAGGCCCAAUUUCACUAUUAAGGGUUCAUUCCUUAAUGGUUCAUGUGGUAGUGUUGGUUUUAACAUAGAUUAUGACUGUGUCUCUUUUUGUUACAUGCACCAUAUGGAAUUACCAACUGGAGUUCAUGCUGGCACAGACUUAGAAGGUAACUUUUAUGGACCUUUUGUUGACAGGCAAACAGCACAAGCAGCUGGUACGGACACAACUAUUACAGUUAAUGUUUUAGCUUGGUUGUACGCUGCUGUUAUAAAUGGAGACAGGUGGUUUCUCAAUCGAUUUACCACAACUCUUAAUGACUUUAACCUUGUGGCUAUGAAGUACAAUUAUGAACCUCUAACACAAGACCAUGUUGACAUACUAGGACCUCUUUCUGCUCAAACUGGAAUUGCCGUUUUAGAUAUGUGUGCUUCAUUAAAAGAAUUACUGCAAAAUGGUAUGAAUGGACGUACCAUAUUGGGUAGUGCUUUAUUAGAAGAUGAAUUUACACCUUUUGAUGUUGUUAGACAAUGCUCAGGUGUUACUUUCCAAAGUGCAGUGAAAAGAACAAUCAAGGGUACACACCACUGGUUGUUACUCACAAUUUUGACUUCACUUUUAGUUUUAGUCCAGAGUACUCAAUGGUCUUUGUUCUUUUUUUUGUAUGAAAAUGCCUUUUUACCUUUUGCUAUGGGUAUUAUUGCUAUGUCUGCUUUUGCAAUGAUGUUUGUCAAACAUAAGCAUGCAUUUCUCUGUUUGUUUUUGUUACCUUCUCUUGCCACUGUAGCUUAUUUUAAUAUGGUCUAUAUGCCUGCUAGUUGGGUGAUGCGUAUUAUGACAUGGUUGGAUAUGGUUGAUACUAGUUUGUCUGGUUUUAAGCUAAAAGACUGUGUUAUGUAUGCAUCAGCUGUAGUGUUACUAAUCCUUAUGACAGCAAGAACUGUGUAUGAUGAUGGUGCUAGGAGAGUGUGGACACUUAUGAAUGUCUUGACACUCGUUUAUAAAGUUUAUUAUGGUAAUGCUUUAGAUCAAGCCAUUUCCAUGUGGGCUCUUAUAAUCUCUGUUACUUCUAACUACUCAGGUGUAGUUACAACUGUCAUGUUUUUGGCCAGAGGUAUUGUUUUUAUGUGUGUUGAGUAUUGCCCUAUUUUCUUCAUAACUGGUAAUACACUUCAGUGUAUAAUGCUAGUUUAUUGUUUCUUAGGCUAUUUUUGUACUUGUUACUUUGGCCUCUUUUGUUUACUCAACCGCUACUUUAGACUGACUCUUGGUGUUUAUGAUUACUUAGUUUCUACACAGGAGUUUAGAUAUAUGAAUUCACAGGGACUACUCCCACCCAAGAAUAGCAUAGAUGCCUUCAAACUCAACAUUAAAUUGUUGGGUGUUGGUGGCAAACCUUGUAUCAAAGUAGCCACUGUACAGUCUAAAAUGUCAGAUGUAAAGUGCACAUCAGUAGUCUUACUCUCAGUUUUGCAACAACUCAGAGUAGAAUCAUCAUCUAAAUUGUGGGCUCAAUGUGUCCAGUUACACAAUGACAUUCUCUUAGCUAAAGAUACUACUGAAGCCUUUGAAAAAAUGGUUUCACUACUUUCUGUUUUGCUUUCCAUGCAGGGUGCUGUAGACAUAAACAAGCUUUGUGAAGAAAUGCUGGACAACAGGGCAACCUUACAAGCUAUAGCCUCAGAGUUUAGUUCCCUUCCAUCAUAUGCAGCUUUUGCUACUGCUCAAGAAGCUUAUGAGCAGGCUGUUGCUAAUGGUGAUUCUGAAGUUGUUCUUAAAAAGUUGAAGAAGUCUUUGAAUGUGGCUAAAUCUGAAUUUGACCGUGAUGCAGCCAUGCAACGUAAGUUGGAAAAGAUGGCUGAUCAAGCUAUGACCCAAAUGUAUAAACAGGCUAGAUCUGAGGACAAGAGGGCAAAAGUUACUAGUGCUAUGCAGACAAUGCUUUUCACUAUGCUUAGAAAGUUGGAUAAUGAUGCACUCAACAACAUUAUCAACAAUGCAAGAGAUGGUUGUGUUCCCUUGAACAUAAUACCUCUUACAACAGCAGCCAAACUAAUGGUUGUCAUACCAGACUAUAACACAUAUAAAAAUACGUGUGAUGGUACAACAUUUACUUAUGCAUCAGCAUUGUGGGAAAUCCAACAGGUUGUAGAUGCAGAUAGUAAAAUUGUUCAACUUAGUGAAAUUAGUAUGGACAAUUCACCUAAUUUAGCAUGGCCUCUUAUUGUAACAGCUUUAAGGGCCAAUUCUGCUGUCAAAUUACAGAAUAAUGAGCUUAGUCCUGUUGCACUACGACAGAUGUCUUGUGCUGCCGGUACUACACAAACUGCUUGCACUGAUGACAAUGCGUUAGCUUACUACAACACAACAAAGGGAGGUAGGUUUGUACUUGCACUGUUAUCCGAUUUACAGGAUUUGAAAUGGGCUAGAUUCCCUAAGAGUGAUGGAACUGGUACUAUCUAUACAGAACUGGAACCACCUUGUAGGUUUGUUACAGACACACCUAAAGGUCCUAAAGUGAAGUAUUUAUACUUUAUUAAAGGAUUAAACAACCUAAAUAGAGGUAUGGUACUUGGUAGUUUAGCUGCCACAGUACGUCUACAAGCUGGUAAUGCAACAGAAGUGCCUGCCAAUUCAACUGUAUUAUCUUUCUGUGCUUUUGCUGUAGAUGCUGCUAAAGCUUACAAAGAUUAUCUAGCUAGUGGGGGACAACCAAUCACUAAUUGUGUUAAGAUGUUGUGUACACACACUGGUACUGGUCAGGCAAUAACAGUUACACCGGAAGCCAAUAUGGAUCAAGAAUCCUUUGGUGGUGCAUCGUGUUGUCUGUACUGCCGUUGCCACAUAGAUCAUCCAAAUCCUAAAGGAUUUUGUGACUUAAAAGGUAAGUAUGUACAAAUACCUACAACUUGUGCUAAUGACCCUGUGGGUUUUACACUUAAAAACACAGUCUGUACCGUCUGCGGUAUGUGGAAAGGUUAUGGCUGUAGUUGUGAUCAACUCCGCGAACCCAUGCUUCAGUCAGCUGAUGCACAAUCGUUUUUAAACGGGUUUGCGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGGCACUAGUACUGAUGUCGUAUACAGGGCUUUUGACAUCUACAAUGAUAAAGUAGCUGGUUUUGCUAAAUUCCUAAAAACUAAUUGUUGUCGCUUCCAAGAAAAGGACGAAGAUGACAAUUUAAUUGAUUCUUACUUUGUAGUUAAGAGACACACUUUCUCUAACUACCAACAUGAAGAAACAAUUUAUAAUUUACUUAAGGAUUGUCCAGCUGUUGCUAAACAUGACUUCUUUAAGUUUAGAAUAGACGGUGACAUGGUACCACAUAUAUCACGUCAACGUCUUACUAAAUACACAAUGGCAGACCUCGUCUAUGCUUUAAGGCAUUUUGAUGAAGGUAAUUGUGACACAUUAAAAGAAAUACUUGUCACAUACAAUUGUUGUGAUGAUGAUUAUUUCAAUAAAAAGGACUGGUAUGAUUUUGUAGAAAACCCAGAUAUAUUACGCGUAUACGCCAACUUAGGUGAACGUGUACGCCAAGCUUUGUUAAAAACAGUACAAUUCUGUGAUGCCAUGCGAAAUGCUGGUAUUGUUGGUGUACUGACAUUAGAUAAUCAAGAUCUCAAUGGUAACUGGUAUGAUUUCGGUGAUUUCAUACAAACCACGCCAGGUAGUGGAGUUCCUGUUGUAGAUUCUUAUUAUUCAUUGUUAAUGCCUAUAUUAACCUUGACCAGGGCUUUAACUGCAGAGUCACAUGUUGACACUGACUUAACAAAGCCUUACAUUAAGUGGGAUUUGUUAAAAUAUGACUUCACGGAAGAGAGGUUAAAACUCUUUGACCGUUAUUUUAAAUAUUGGGAUCAGACAUACCACCCAAAUUGUGUUAACUGUUUGGAUGACAGAUGCAUUCUGCAUUGUGCAAACUUUAAUGUUUUAUUCUCUACAGUGUUCCCACCUACAAGUUUUGGACCACUAGUGAGAAAAAUAUUUGUUGAUGGUGUUCCAUUUGUAGUUUCAACUGGAUACCACUUCAGAGAGCUAGGUGUUGUACAUAAUCAGGAUGUAAACUUACAUAGCUCUAGACUUAGUUUUAAGGAAUUACUUGUGUAUGCUGCUGACCCUGCUAUGCACGCUGCUUCUGGUAAUCUAUUACUAGAUAAACGCACUACGUGCUUUUCAGUAGCUGCACUUACUAACAAUGUUGCUUUUCAAACUGUCAAACCCGGUAAUUUUAACAAAGACUUCUAUGACUUUGCUGUGUCUAAGGGUUUCUUUAAGGAAGGAAGUUCUGUUGAAUUAAAACACUUCUUCUUUGCUCAGGAUGGUAAUGCUGCUAUCAGCGAUUAUGACUACUAUCGUUAUAAUCUACCAACAAUGUGUGAUAUCAGACAACUACUAUUUGUAGUUGAAGUUGUUGAUAAGUACUUUGAUUGUUACGAUGGUGGCUGUAUUAAUGCUAACCAAGUCAUCGUCAACAACCUAGACAAAUCAGCUGGUUUUCCAUUUAAUAAAUGGGGUAAGGCUAGACUUUAUUAUGAUUCAAUGAGUUAUGAGGAUCAAGAUGCACUUUUCGCAUAUACAAAACGUAAUGUCAUCCCUACUAUAACUCAAAUGAAUCUUAAGUAUGCCAUUAGUGCAAAGAAUAGAGCUCGCACCGUAGCUGGUGUCUCUAUCUGUAGUACUAUGACCAAUAGACAGUUUCAUCAAAAAUUAUUGAAAUCAAUAGCCGCCACUAGAGGAGCUACUGUAGUAAUUGGAACAAGCAAAUUCUAUGGUGGUUGGCACAACAUGUUAAAAACUGUUUAUAGUGAUGUAGAAAACCCUCACCUUAUGGGUUGGGAUUAUCCUAAAUGUGAUAGAGCCAUGCCUAACAUGCUUAGAAUUAUGGCCUCACUUGUUCUUGCUCGCAAACAUACAACGUGUUGUAGCUUGUCACACCGUUUCUAUAGAUUAGCUAAUGAGUGUGCUCAAGUAUUGAGUGAAAUGGUCAUGUGUGGCGGUUCACUAUAUGUUAAACCAGGUGGAACCUCAUCAGGAGAUGCCACAACUGCUUAUGCUAAUAGUGUUUUUAACAUUUGUCAAGCUGUCACGGCCAAUGUUAAUGCACUUUUAUCUACUGAUGGUAACAAAAUUGCCGAUAAGUAUGUCCGCAAUUUACAACACAGACUUUAUGAGUGUCUCUAUAGAAAUAGAGAUGUUGACACAGACUUUGUGAAUGAGUUUUACGCAUAUUUGCGUAAACAUUUCUCAAUGAUGAUACUCUCUGACGAUGCUGUUGUGUGUUUCAAUAGCACUUAUGCAUCUCAAGGUCUAGUGGCUAGCAUAAAGAACUUUAAGUCAGUUCUUUAUUAUCAAAACAAUGUUUUUAUGUCUGAAGCAAAAUGUUGGACUGAGACUGACCUUACUAAAGGACCUCAUGAAUUUUGCUCUCAACAUACAAUGCUAGUUAAACAGGGUGAUGAUUAUGUGUACCUUCCUUACCCAGAUCCAUCAAGAAUCCUAGGGGCCGGCUGUUUUGUAGAUGAUAUCGUAAAAACAGAUGGUACACUUAUGAUUGAACGGUUCGUGUCUUUAGCUAUAGAUGCUUACCCACUUACUAAACAUCCUAAUCAGGAGUAUGCUGAUGUCUUUCAUUUGUACUUACAAUACAUAAGAAAGCUACAUGAUGAGUUAACAGGACACAUGUUAGACAUGUAUUCUGUUAUGCUUACUAAUGAUAACACUUCAAGGUAUUGGGAACCUGAGUUUUAUGAGGCUAUGUACACACCGCAUACAGUCUUACAGGCUGUUGGGGCUUGUGUUCUUUGCAAUUCACAGACUUCAUUAAGAUGUGGUGCUUGCAUACGUAGACCAUUCUUAUGUUGUAAAUGCUGUUACGACCAUGUCAUAUCAACAUCACAUAAAUUAGUCUUGUCUGUUAAUCCGUAUGUUUGCAAUGCUCCAGGUUGUGAUGUCACAGAUGUGACUCAACUUUACUUAGGAGGUAUGAGCUAUUAUUGUAAAUCACAUAAACCACCCAUUAGUUUUCCAUUGUGUGCUAAUGGACAAGUUUUUGGUUUAUAUAAAAAUACAUGUGUUGGUAGCGAUAAUGUUACUGACUUUAAUGCAAUUGCAACAUGUGACUGGACAAAUGCUGGUGAUUACAUUUUAGCUAACACCUGUACUGAAAGACUCAAGCUUUUUGCAGCAGAAACGCUCAAAGCUACUGAGGAGACAUUUAAACUGUCUUAUGGUAUUGCUACUGUACGUGAAGUGCUGUCUGACAGAGAAUUACAUCUUUCAUGGGAAGUUGGUAAACCUAGACCACCACUUAACCGAAAUUAUGUCUUUACUGGUUAUCGUGUAACUAAAAACAGUAAAGUACAAAUAGGAGAGUACACCUUUGAAAAAGGUGACUAUGGUGAUGCUGUUGUUUACCGAGGUACAACAACUUACAAAUUAAAUGUUGGUGAUUAUUUUGUGCUGACAUCACAUACAGUAAUGCCAUUAAGUGCACCUACACUAGUGCCACAAGAGCACUAUGUUAGAAUUACUGGCUUAUACCCAACACUCAAUAUCUCAGAUGAGUUUUCUAGCAAUGUUGCAAAUUAUCAAAAGGUUGGUAUGCAAAAGUAUUCUACACUCCAGGGACCACCUGGUACUGGUAAGAGUCAUUUUGCUAUUGGCCUAGCUCUCUACUACCCUUCUGCUCGCAUAGUGUAUACAGCUUGCUCUCAUGCCGCUGUUGAUGCACUAUGUGAGAAGGCAUUAAAAUAUUUGCCUAUAGAUAAAUGUAGUAGAAUUAUACCUGCACGUGCUCGUGUAGAGUGUUUUGAUAAAUUCAAAGUGAAUUCAACAUUAGAACAGUAUGUCUUUUGUACUGUAAAUGCAUUGCCUGAGACGACAGCAGAUAUAGUUGUCUUUGAUGAAAUUUCAAUGGCCACAAAUUAUGAUUUGAGUGUUGUCAAUGCCAGAUUACGUGCUAAGCACUAUGUGUACAUUGGCGACCCUGCUCAAUUACCUGCACCACGCACAUUGCUAACUAAGGGCACACUAGAACCAGAAUAUUUCAAUUCAGUGUGUAGACUUAUGAAAACUAUAGGUCCAGACAUGUUCCUCGGAACUUGUCGGCGUUGUCCUGCUGAAAUUGUUGACACUGUGAGUGCUUUGGUUUAUGAUAAUAAGCUUAAAGCACAUAAAGACAAAUCAGCUCAAUGCUUUAAAAUGUUUUAUAAGGGUGUUAUCACGCAUGAUGUUUCAUCUGCAAUUAACAGGCCACAAAUAGGCGUGGUAAGAGAAUUCCUUACACGUAACCCUGCUUGGAGAAAAGCUGUCUUUAUUUCACCUUAUAAUUCACAGAAUGCUGUAGCCUCAAAGAUUUUGGGACUACCAACUCAAACUGUUGAUUCAUCACAGGGCUCAGAAUAUGACUAUGUCAUAUUCACUCAAACCACUGAAACAGCUCACUCUUGUAAUGUAAACAGAUUUAAUGUUGCUAUUACCAGAGCAAAAGUAGGCAUACUUUGCAUAAUGUCUGAUAGAGACCUUUAUGACAAGUUGCAAUUUACAAGUCUUGAAAUUCCACGUAGGAAUGUGGCAACUUUACAAGCUGAAAAUGUAACAGGACUCUUUAAAGAUUGUAGUAAGGUAAUCACUGGGUUACAUCCUACACAGGCACCUACACACCUCAGUGUUGACACUAAAUUCAAAACUGAAGGUUUAUGUGUUGACAUACCUGGCAUACCUAAGGACAUGACCUAUAGAAGACUCAUCUCUAUGAUGGGUUUUAAAAUGAAUUAUCAAGUUAAUGGUUACCCUAACAUGUUUAUCACCCGCGAAGAAGCUAUAAGACAUGUACGUGCAUGGAUUGGCUUCGAUGUCGAGGGGUGUCAUGCUACUAGAGAAGCUGUUGGUACCAAUUUACCUUUACAGCUAGGUUUUUCUACAGGUGUUAACCUAGUUGCUGUACCUACAGGUUAUGUUGAUACACCUAAUAAUACAGAUUUUUCCAGAGUUAGUGCUAAACCACCGCCUGGAGAUCAAUUUAAACACCUCAUACCACUUAUGUACAAAGGACUUCCUUGGAAUGUAGUGCGUAUAAAGAUUGUACAAAUGUUAAGUGACACACUUAAAAAUCUCUCUGACAGAGUCGUAUUUGUCUUAUGGGCACAUGGCUUUGAGUUGACAUCUAUGAAGUAUUUUGUGAAAAUAGGACCUGAGCGCACCUGUUGUCUAUGUGAUAGACGUGCCACAUGCUUUUCCACUGCUUCAGACACUUAUGCCUGUUGGCAUCAUUCUAUUGGAUUUGAUUACGUCUAUAAUCCGUUUAUGAUUGAUGUUCAACAAUGGGGUUUUACAGGUAACCUACAAAGCAACCAUGAUCUGUAUUGUCAAGUCCAUGGUAAUGCACAUGUAGCUAGUUGUGAUGCAAUCAUGACUAGGUGUCUAGCUGUCCACGAGUGCUUUGUUAAGCGUGUUGACUGGACUAUUGAAUAUCCUAUAAUUGGUGAUGAACUGAAGAUUAAUGCGGCUUGUAGAAAGGUUCAACACAUGGUUGUUAAAGCUGCAUUAUUAGCAGACAAAUUCCCAGUUCUUCACGACAUUGGUAACCCUAAAGCUAUUAAGUGUGUACCUCAAGCUGAUGUAGAAUGGAAGUUCUAUGAUGCACAGCCUUGUAGUGACAAAGCUUAUAAAAUAGAAGAAUUAUUCUAUUCUUAUGCCACACAUUCUGACAAAUUCACAGAUGGUGUAUGCCUAUUUUGGAAUUGCAAUGUCGAUAGAUAUCCUGCUAAUUCCAUUGUUUGUAGAUUUGACACUAGAGUGCUAUCUAACCUUAACUUGCCUGGUUGUGAUGGUGGCAGUUUGUAUGUAAAUAAACAUGCAUUCCACACACCAGCUUUUGAUAAAAGUGCUUUUGUUAAUUUAAAACAAUUACCAUUUUUCUAUUACUCUGACAGUCCAUGUGAGUCUCAUGGAAAACAAGUAGUGUCAGAUAUAGAUUAUGUACCACUAAAGUCUGCUACGUGUAUAACACGUUGCAAUUUAGGUGGUGCUGUCUGUAGACAUCAUGCUAAUGAGUACAGAUUGUAUCUCGAUGCUUAUAACAUGAUGAUCUCAGCUGGCUUUAGCUUGUGGGUUUACAAACAAUUUGAUACUUAUAACCUCUGGAACACUUUUACAAGACUUCAGAGUUUAGAAAAUGUGGCUUUUAAUGUUGUAAAUAAGGGACACUUUGAUGGACAACAGGGUGAAGUACCAGUUUCUAUCAUUAAUAACACUGUUUACACAAAAGUUGAUGGUGUUGAUGUAGAAUUGUUUGAAAAUAAAACAACAUUACCUGUUAAUGUAGCAUUUGAGCUUUGGGCUAAGCGCAACAUUAAACCAGUACCAGAGGUGAAAAUACUCAAUAAUUUGGGUGUGGACAUUGCUGCUAAUACUGUGAUCUGGGACUACAAAAGAGAUGCUCCAGCACAUAUAUCUACUAUUGGUGUUUGUUCUAUGACUGACAUAGCCAAGAAACCAACUGAAACGAUUUGUGCACCACUCACUGUCUUUUUUGAUGGUAGAGUUGAUGGUCAAGUAGACUUAUUUAGAAAUGCCCGUAAUGGUGUUCUUAUUACAGAAGGUAGUGUUAAAGGUUUACAACCAUCUGUAGGUCCCAAACAAGCUAGUCUUAAUGGAGUCACAUUAAUUGGAGAAGCCGUAAAAACACAGUUCAAUUAUUAUAAGAAAGUUGAUGGUGUUGUCCAACAAUUACCUGAAACUUACUUUACUCAGAGUAGAAAUUUACAAGAAUUUAAACCCAGGAGUCAAAUGGAAAUUGAUUUCUUAGAAUUAGCUAUGGAUGAAUUCAUUGAACGGUAUAAAUUAGAAGGCUAUGCCUUCGAACAUAUCGUUUAUGGAGAUUUUAGUCAUAGUCAGUUAGGUGGUUUACAUCUACUGAUUGGACUAGCUAAACGUUUUAAGGAAUCACCUUUUGAAUUAGAAGAUUUUAUUCCUAUGGACAGUACAGUUAAAAACUAUUUCAUAACAGAUGCGCAAACAGGUUCAUCUAAGUGUGUGUGUUCUGUUAUUGAUUUAUUACUUGAUGAUUUUGUUGAAAUAAUAAAAUCCCAAGAUUUAUCUGUAGUUUCUAAGGUUGUCAAAGUGACUAUUGACUAUACAGAAAUUUCAUUUAUGCUUUGGUGUAAAGAUGGCCAUGUAGAAACAUUUUACCCAAAAUUACAAUCUAGUCAAGCGUGGCAACCGGGUGUUGCUAUGCCUAAUCUUUACAAAAUGCAAAGAAUGCUAUUAGAAAAGUGUGACCUUCAAAAUUAUGGUGAUAGUGCAACAUUACCUAAAGGCAUAAUGAUGAAUGUCGCAAAAUAUACUCAACUGUGUCAAUAUUUAAACACAUUAACAUUAGCUGUACCCUAUAAUAUGAGAGUUAUACAUUUUGGUGCUGGUUCUGAUAAAGGAGUUGCACCAGGUACAGCUGUUUUAAGACAGUGGUUGCCUACGGGUACGCUGCUUGUCGAUUCAGAUCUUAAUGACUUUGUCUCUGAUGCAGAUUCAACUUUGAUUGGUGAUUGUGCAACUGUACAUACAGCUAAUAAAUGGGAUCUCAUUAUUAGUGAUAUGUACGACCCUAAGACUAAAAAUGUUACAAAAGAAAAUGACUCUAAAGAGGGUUUUUUCACUUACAUUUGUGGGUUUAUACAACAAAAGCUAGCUCUUGGAGGUUCCGUGGCUAUAAAGAUAACAGAACAUUCUUGGAAUGCUGAUCUUUAUAAGCUCAUGGGACACUUCGCAUGGUGGACAGCCUUUGUUACUAAUGUGAAUGCGUCAUCAUCUGAAGCAUUUUUAAUUGGAUGUAAUUAUCUUGGCAAACCACGCGAACAAAUAGAUGGUUAUGUCAUGCAUGCAAAUUACAUAUUUUGGAGGAAUACAAAUCCAAUUCAGUUGUCUUCCUAUUCUUUAUUUGACAUGAGUAAAUUUCCCCUUAAAUUAAGGGGUACUGCUGUUAUGUCUUUAAAAGAAGGUCAAAUCAAUGAUAUGAUUUUAUCUCUUCUUAGUAAAGGUAGACUUAUAAUUAGAGAAAACAACAGAGUUGUUAUUUCUAGUGAUGUUCUUGUUAACAACUAAACGAACAAUGUUUGUUUUUCUUGUUUUAUUGCCACUAGUCUCUAGUCAGUGUGUUAAUCUUACAACCAGAACUCAAUUACCCCCUGCAUACACUAAUUCUUUCACACGUGGUGUUUAUUACCCUGACAAAGUUUUCAGAUCCUCAGUUUUACAUUCAACUCAGGACUUGUUCUUACCUUUCUUUUCCAAUGUUACUUGGUUCCAUGCUAUACAUGUCUCUGGGACCAAUGGUACUAAGAGGUUUGAUAACCCUGUCCUACCAUUUAAUGAUGGUGUUUAUUUUGCUUCCACUGAGAAGUCUAACAUAAUAAGAGGCUGGAUUUUUGGUACUACUUUAGAUUCGAAGACCCAGUCCCUACUUAUUGUUAAUAACGCUACUAAUGUUGUUAUUAAAGUCUGUGAAUUUCAAUUUUGUAAUGAUCCAUUUUUGGGUGUUUAUUACCACAAAAACAACAAAAGUUGGAUGGAAAGUGAGUUCAGAGUUUAUUCUAGUGCGAAUAAUUGCACUUUUGAAUAUGUCUCUCAGCCUUUUCUUAUGGACCUUGAAGGAAAACAGGGUAAUUUCAAAAAUCUUAGGGAAUUUGUGUUUAAGAAUAUUGAUGGUUAUUUUAAAAUAUAUUCUAAGCACACGCCUAUUAAUUUAGUGCGUGAUCUCCCUCAGGGUUUUUCGGCUUUAGAACCAUUGGUAGAUUUGCCAAUAGGUAUUAACAUCACUAGGUUUCAAACUUUACUUGCUUUACAUAGAAGUUAUUUGACUCCUGGUGAUUCUUCUUCAGGUUGGACAGCUGGUGCUGCAGCUUAUUAUGUGGGUUAUCUUCAACCUAGGACUUUUCUAUUAAAAUAUAAUGAAAAUGGAACCAUUACAGAUGCUGUAGACUGUGCACUUGACCCUCUCUCAGAAACAAAGUGUACGUUGAAAUCCUUCACUGUAGAAAAAGGAAUCUAUCAAACUUCUAACUUUAGAGUCCAACCAACAGAAUCUAUUGUUAGAUUUCCUAAUAUUACAAACUUGUGCCCUUUUGGUGAAGUUUUUAACGCCACCAGAUUUGCAUCUGUUUAUGCUUGGAACAGGAAGAGAAUCAGCAACUGUGUUGCUGAUUAUUCUGUCCUAUAUAAUUCCGCAUCAUUUUCCACUUUUAAGUGUUAUGGAGUGUCUCCUACUAAAUUAAAUGAUCUCUGCUUUACUAAUGUCUAUGCAGAUUCAUUUGUAAUUAGAGGUGAUGAAGUCAGACAAAUCGCUCCAGGGCAAACUGGAAAGAUUGCUGAUUAUAAUUAUAAAUUACCAGAUGAUUUUACAGGCUGCGUUAUAGCUUGGAAUUCUAACAAUCUUGAUUCUAAGGUUGGUGGUAAUUAUAAUUACCUGUAUAGAUUGUUUAGGAAGUCUAAUCUCAAACCUUUUGAGAGAGAUAUUUCAACUGAAAUCUAUCAGGCCGGUAGCACACCUUGUAAUGGUGUUGAAGGUUUUAAUUGUUACUUUCCUUUACAAUCAUAUGGUUUCCAACCCACUAAUGGUGUUGGUUACCAACCAUACAGAGUAGUAGUACUUUCUUUUGAACUUCUACAUGCACCAGCAACUGUUUGUGGACCUAAAAAGUCUACUAAUUUGGUUAAAAACAAAUGUGUCAAUUUCAACUUCAAUGGUUUAACAGGCACAGGUGUUCUUACUGAGUCUAACAAAAAGUUUCUGCCUUUCCAACAAUUUGGCAGAGACAUUGCUGACACUACUGAUGCUGUCCGUGAUCCACAGACACUUGAGAUUCUUGACAUUACACCAUGUUCUUUUGGUGGUGUCAGUGUUAUAACACCAGGAACAAAUACUUCUAACCAGGUUGCUGUUCUUUAUCAGGAUGUUAACUGCACAGAAGUCCCUGUUGCUAUUCAUGCAGAUCAACUUACUCCUACUUGGCGUGUUUAUUCUACAGGUUCUAAUGUUUUUCAAACACGUGCAGGCUGUUUAAUAGGGGCUGAACAUGUCAACAACUCAUAUGAGUGUGACAUACCCAUUGGUGCAGGUAUAUGCGCUAGUUAUCAGACUCAGACUAAUUCUCCUCGGCGGGCACGUAGUGUAGCUAGUCAAUCCAUCAUUGCCUACACUAUGUCACUUGGUGCAGAAAAUUCAGUUGCUUACUCUAAUAACUCUAUUGCCAUACCCACAAAUUUUACUAUUAGUGUUACCACAGAAAUUCUACCAGUGUCUAUGACCAAGACAUCAGUAGAUUGUACAAUGUACAUUUGUGGUGAUUCAACUGAAUGCAGCAAUCUUUUGUUGCAAUAUGGCAGUUUUUGUACACAAUUAAACCGUGCUUUAACUGGAAUAGCUGUUGAACAAGACAAAAACACCCAAGAAGUUUUUGCACAAGUCAAACAAAUUUACAAAACACCACCAAUUAAAGAUUUUGGUGGUUUUAAUUUUUCACAAAUAUUACCAGAUCCAUCAAAACCAAGCAAGAGGUCAUUUAUUGAAGAUCUACUUUUCAACAAAGUGACACUUGCAGAUGCUGGCUUCAUCAAACAAUAUGGUGAUUGCCUUGGUGAUAUUGCUGCUAGAGACCUCAUUUGUGCACAAAAGUUUAACGGCCUUACUGUUUUGCCACCUUUGCUCACAGAUGAAAUGAUUGCUCAAUACACUUCUGCACUGUUAGCGGGUACAAUCACUUCUGGUUGGACCUUUGGUGCAGGUGCUGCAUUACAAAUACCAUUUGCUAUGCAAAUGGCUUAUAGGUUUAAUGGUAUUGGAGUUACACAGAAUGUUCUCUAUGAGAACCAAAAAUUGAUUGCCAACCAAUUUAAUAGUGCUAUUGGCAAAAUUCAAGACUCACUUUCUUCCACAGCAAGUGCACUUGGAAAACUUCAAGAUGUGGUCAACCAAAAUGCACAAGCUUUAAACACGCUUGUUAAACAACUUAGCUCCAAUUUUGGUGCAAUUUCAAGUGUUUUAAAUGAUAUCCUUUCACGUCUUGACAAAGUUGAGGCUGAAGUGCAAAUUGAUAGGUUGAUCACAGGCAGACUUCAAAGUUUGCAGACAUAUGUGACUCAACAAUUAAUUAGAGCUGCAGAAAUCAGAGCUUCUGCUAAUCUUGCUGCUACUAAAAUGUCAGAGUGUGUACUUGGACAAUCAAAAAGAGUUGAUUUUUGUGGAAAGGGCUAUCAUCUUAUGUCCUUCCCUCAGUCAGCACCUCAUGGUGUAGUCUUCUUGCAUGUGACUUAUGUCCCUGCACAAGAAAAGAACUUCACAACUGCUCCUGCCAUUUGUCAUGAUGGAAAAGCACACUUUCCUCGUGAAGGUGUCUUUGUUUCAAAUGGCACACACUGGUUUGUAACACAAAGGAAUUUUUAUGAACCACAAAUCAUUACUACAGACAACACAUUUGUGUCUGGUAACUGUGAUGUUGUAAUAGGAAUUGUCAACAACACAGUUUAUGAUCCUUUGCAACCUGAAUUAGACUCAUUCAAGGAGGAGUUAGAUAAAUAUUUUAAGAAUCAUACAUCACCAGAUGUUGAUUUAGGUGACAUCUCUGGCAUUAAUGCUUCAGUUGUAAACAUUCAAAAAGAAAUUGACCGCCUCAAUGAGGUUGCCAAGAAUUUAAAUGAAUCUCUCAUCGAUCUCCAAGAACUUGGAAAGUAUGAGCAGUAUAUAAAAUGGCCAUGGUACAUUUGGCUAGGUUUUAUAGCUGGCUUGAUUGCCAUAGUAAUGGUGACAAUUAUGCUUUGCUGUAUGACCAGUUGCUGUAGUUGUCUCAAGGGCUGUUGUUCUUGUGGAUCCUGCUGCAAAUUUGAUGAAGACGACUCUGAGCCAGUGCUCAAAGGAGUCAAAUUACAUUACACAUAAACGAACUUAUGGAUUUGUUUAUGAGAAUCUUCACAAUUGGAACUGUAACUUUGAAGCAAGGUGAAAUCAAGGAUGCUACUCCUUCAGAUUUUGUUCGCGCUACUGCAACGAUACCGAUACAAGCCUCACUCCCUUUCGGAUGGCUUAUUGUUGGCGUUGCACUUCUUGCUGUUUUUCAGAGCGCUUCCAAAAUCAUAACCCUCAAAAAGAGAUGGCAACUAGCACUCUCCAAGGGUGUUCACUUUGUUUGCAACUUGCUGUUGUUGUUUGUAACAGUUUACUCACACCUUUUGCUCGUUGCUGCUGGCCUUGAAGCCCCUUUUCUCUAUCUUUAUGCUUUAGUCUACUUCUUGCAGAGUAUAAACUUUGUAAGAAUAAUAAUGAGGCUUUGGCUUUGCUGGAAAUGCCGUUCCAAAAACCCAUUACUUUAUGAUGCCAACUAUUUUCUUUGCUGGCAUACUAAUUGUUACGACUAUUGUAUACCUUACAAUAGUGUAACUUCUUCAAUUGUCAUUACUUCAGGUGAUGGCACAACAAGUCCUAUUUCUGAACAUGACUACCAGAUUGGUGGUUAUACUGAAAAAUGGGAAUCUGGAGUAAAAGACUGUGUUGUAUUACACAGUUACUUCACUUCAGACUAUUACCAGCUGUACUCAACUCAAUUGAGUACAGACACUGGUGUUGAACAUGUUACCUUCUUCAUCUACAAUAAAAUUGUUGAUGAGCCUGAAGAACAUGUCCAAAUUCACACAAUCGACGGUUCAUCCGGAGUUGUUAAUCCAGUAAUGGAACCAAUUUAUGAUGAACCGACGACGACUACUAGCGUGCCUUUGUAAGCACAAGCUGAUGAGUACGAACUUAUGUACUCAUUCGUUUCGGAAGAGACAGGUACGUUAAUAGUUAAUAGCGUACUUCUUUUUCUUGCUUUCGUGGUAUUCUUGCUAGUUACACUAGCCAUCCUUACUGCGCUUCGAUUGUGUGCGUACUGCUGCAAUAUUGUUAACGUGAGUCUUGUAAAACCUUCUUUUUACGUUUACUCUCGUGUUAAAAAUCUGAAUUCUUCUAGAGUUCCUGAUCUUCUGGUCUAAACGAACUAAAUAUUAUAUUAGUUUUUCUGUUUGGAACUUUAAUUUUAGCCAUGGCAGAUUCCAACGGUACUAUUACCGUUGAAGAGCUUAAAAAGCUCCUUGAACAAUGGAACCUAGUAAUAGGUUUCCUAUUCCUUACAUGGAUUUGUCUUCUACAAUUUGCCUAUGCCAACAGGAAUAGGUUUUUGUAUAUAAUUAAGUUAAUUUUCCUCUGGCUGUUAUGGCCAGUAACUUUAGCUUGUUUUGUGCUUGCUGCUGUUUACAGAAUAAAUUGGAUCACCGGUGGAAUUGCUAUCGCAAUGGCUUGUCUUGUAGGCUUGAUGUGGCUCAGCUACUUCAUUGCUUCUUUCAGACUGUUUGCGCGUACGCGUUCCAUGUGGUCAUUCAAUCCAGAAACUAACAUUCUUCUCAACGUGCCACUCCAUGGCACUAUUCUGACCAGACCGCUUCUAGAAAGUGAACUCGUAAUCGGAGCUGUGAUCCUUCGUGGACAUCUUCGUAUUGCUGGACACCAUCUAGGACGCUGUGACAUCAAGGACCUGCCUAAAGAAAUCACUGUUGCUACAUCACGAACGCUUUCUUAUUACAAAUUGGGAGCUUCGCAGCGUGUAGCAGGUGACUCAGGUUUUGCUGCAUACAGUCGCUACAGGAUUGGCAACUAUAAAUUAAACACAGACCAUUCCAGUAGCAGUGACAAUAUUGCUUUGCUUGUACAGUAAGUGACAACAGAUGUUUCAUCUCGUUGACUUUCAGGUUACUAUAGCAGAGAUAUUACUAAUUAUUAUGAGGACUUUUAAAGUUUCCAUUUGGAAUCUUGAUUACAUCAUAAACCUCAUAAUUAAAAAUUUAUCUAAGUCACUAACUGAGAAUAAAUAUUCUCAAUUAGAUGAAGAGCAACCAAUGGAGAUUGAUUAAACGAACAUGAAAAUUAUUCUUUUCUUGGCACUGAUAACACUCGCUACUUGUGAGCUUUAUCACUACCAAGAGUGUGUUAGAGGUACAACAGUACUUUUAAAAGAACCUUGCUCUUCUGGAACAUACGAGGGCAAUUCACCAUUUCAUCCUCUAGCUGAUAACAAAUUUGCACUGACUUGCUUUAGCACUCAAUUUGCUUUUGCUUGUCCUGACGGCGUAAAACACGUCUAUCAGUUACGUGCCAGAUCAGUUUCACCUAAACUGUUCAUCAGACAAGAGGAAGUUCAAGAACUUUACUCUCCAAUUUUUCUUAUUGUUGCGGCAAUAGUGUUUAUAACACUUUGCUUCACACUCAAAAGAAAGACAGAAUGAUUGAACUUUCAUUAAUUGACUUCUAUUUGUGCUUUUUAGCCUUUCUGCUAUUCCUUGUUUUAAUUAUGCUUAUUAUCUUUUGGUUCUCACUUGAACUGCAAGAUCAUAAUGAAACUUGUCACGCCUAAACGAACAUGAAAUUUCUUGUUUUCUUAGGAAUCAUCACAACUGUAGCUGCAUUUCACCAAGAAUGUAGUUUACAGUCAUGUACUCAACAUCAACCAUAUGUAGUUGAUGACCCGUGUCCUAUUCACUUCUAUUCUAAAUGGUAUAUUAGAGUAGGAGCUAGAAAAUCAGCACCUUUAAUUGAAUUGUGCGUGGAUGAGGCUGGUUCUAAAUCACCCAUUCAGUACAUCGAUAUCGGUAAUUAUACAGUUUCCUGUUUACCUUUUACAAUUAAUUGCCAGGAACCUAAAUUGGGUAGUCUUGUAGUGCGUUGUUCGUUCUAUGAAGACUUUUUAGAGUAUCAUGACGUUCGUGUUGUUUUAGAUUUCAUCUAAACGAACAAACUAAAAUGUCUGAUAAUGGACCCCAAAAUCAGCGAAAUGCACCCCGCAUUACGUUUGGUGGACCCUCAGAUUCAACUGGCAGUAACCAGAAUGGAGAACGCAGUGGGGCGCGAUCAAAACAACGUCGGCCCCAAGGUUUACCCAAUAAUACUGCGUCUUGGUUCACCGCUCUCACUCAACAUGGCAAGGAAGACCUUAAAUUCCCUCGAGGACAAGGCGUUCCAAUUAACACCAAUAGCAGUCCAGAUGACCAAAUUGGCUACUACCGAAGAGCUACCAGACGAAUUCGUGGUGGUGACGGUAAAAUGAAAGAUCUCAGUCCAAGAUGGUAUUUCUACUACCUAGGAACUGGGCCAGAAGCUGGACUUCCCUAUGGUGCUAACAAAGACGGCAUCAUAUGGGUUGCAACUGAGGGAGCCUUGAAUACACCAAAAGAUCACAUUGGCACCCGCAAUCCUGCUAACAAUGCUGCAAUCGUGCUACAACUUCCUCAAGGAACAACAUUGCCAAAAGGCUUCUACGCAGAAGGGAGCAGAGGCGGCAGUCAAGCCUCUUCUCGUUCCUCAUCACGUAGUCGCAACAGUUCAAGAAAUUCAACUCCAGGCAGCAGUAGGGGAACUUCUCCUGCUAGAAUGGCUGGCAAUGGCGGUGAUGCUGCUCUUGCUUUGCUGCUGCUUGACAGAUUGAACCAGCUUGAGAGCAAAAUGUCUGGUAAAGGCCAACAACAACAAGGCCAAACUGUCACUAAGAAAUCUGCUGCUGAGGCUUCUAAGAAGCCUCGGCAAAAACGUACUGCCACUAAAGCAUACAAUGUAACACAAGCUUUCGGCAGACGUGGUCCAGAACAAACCCAAGGAAAUUUUGGGGACCAGGAACUAAUCAGACAAGGAACUGAUUACAAACAUUGGCCGCAAAUUGCACAAUUUGCCCCCAGCGCUUCAGCGUUCUUCGGAAUGUCGCGCAUUGGCAUGGAAGUCACACCUUCGGGAACGUGGUUGACCUACACAGGUGCCAUCAAAUUGGAUGACAAAGAUCCAAAUUUCAAAGAUCAAGUCAUUUUGCUGAAUAAGCAUAUUGACGCAUACAAAACAUUCCCACCAACAGAGCCUAAAAAGGACAAAAAGAAGAAGGCUGAUGAAACUCAAGCCUUACCGCAGAGACAGAAGAAACAGCAAACUGUGACUCUUCUUCCUGCUGCAGAUUUGGAUGAUUUCUCCAAACAAUUGCAACAAUCCAUGAGCAGUGCUGACUCAACUCAGGCCUAAACUCAUGCAGACCACACAAGGCAGAUGGGCUAUAUAAACGUUUUCGCUUUUCCGUUUACGAUAUAUAGUCUACUCUUGUGCAGAAUGAAUUCUCGUAACUACAUAGCACAAGUAGAUGUAGUUAACUUUAAUCUCACAUAGCAAUCUUUAAUCAGUGUGUAACAUUAGGGAGGACUUGAAAGAGCCACCACAUUUUCACCGAGGCCACGCGGAGUACGAUCGAGUGUACAGUGAACAAUGCUAGGGAGAGCUGCCUAUAUGGAAGAGCCCUAAUGUGUAAAAUUAAUUUUAGUAGUGCUAUCCCCAUGUGAUUUUAAUAGCUUCUUAGGAGAAUGACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|protein_mutation:K375N
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKNADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,protein_mutation:K375N,419aa(1-419),P0DTC9,-,-,"[1-43],[73-102],[145-149],[152-160],[172-215],[235-271],[366-386],[409-419]",-,In vitro,5-20µM[SARS2-NP–VSV K375N];|200nM[SARS-CoV-2],"15 mM NaCl, 135 mM KCl, 5 mM phosphate, 1.5 mM MgCl2","20 mM Tris–HCl, pH 7.0",37˚C,-,other_molecular:1 mg ml−1 BSA,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"To test whether these viral mutations induce changes in the phase separation of SARS2-NP , we incubated fluorescently labelled K375N and K375E with viral RNA and compared the micrometre-sized liquid droplet formation with that of SARS2-NP WT. Both the K375N and K375E mutants seemed to have compromised LLPS ",29903
216,704,PMID: 34239064,RNAPS0000450,https://pubmed.ncbi.nlm.nih.gov/34239064,RNA + protein,-,-,SARS-CoV-2 virus RNA,29903nt(1-29903),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCUGAAAAGAGCUAUGAAUUGCAGACACCUUUUGAAAUUAAAUUGGCAAAGAAAUUUGACACCUUCAAUGGGGAAUGUCCAAAUUUUGUAUUUCCCUUAAAUUCCAUAAUCAAGACUAUUCAACCAAGGGUUGAAAAGAAAAAGCUUGAUGGCUUUAUGGGUAGAAUUCGAUCUGUCUAUCCAGUUGCGUCACCAAAUGAAUGCAACCAAAUGUGCCUUUCAACUCUCAUGAAGUGUGAUCAUUGUGGUGAAACUUCAUGGCAGACGGGCGAUUUUGUUAAAGCCACUUGCGAAUUUUGUGGCACUGAGAAUUUGACUAAAGAAGGUGCCACUACUUGUGGUUACUUACCCCAAAAUGCUGUUGUUAAAAUUUAUUGUCCAGCAUGUCACAAUUCAGAAGUAGGACCUGAGCAUAGUCUUGCCGAAUACCAUAAUGAAUCUGGCUUGAAAACCAUUCUUCGUAAGGGUGGUCGCACUAUUGCCUUUGGAGGCUGUGUGUUCUCUUAUGUUGGUUGCCAUAACAAGUGUGCCUAUUGGGUUCCACGUGCUAGCGCUAACAUAGGUUGUAACCAUACAGGUGUUGUUGGAGAAGGUUCCGAAGGUCUUAAUGACAACCUUCUUGAAAUACUCCAAAAAGAGAAAGUCAACAUCAAUAUUGUUGGUGACUUUAAACUUAAUGAAGAGAUCGCCAUUAUUUUGGCAUCUUUUUCUGCUUCCACAAGUGCUUUUGUGGAAACUGUGAAAGGUUUGGAUUAUAAAGCAUUCAAACAAAUUGUUGAAUCCUGUGGUAAUUUUAAAGUUACAAAAGGAAAAGCUAAAAAAGGUGCCUGGAAUAUUGGUGAACAGAAAUCAAUACUGAGUCCUCUUUAUGCAUUUGCAUCAGAGGCUGCUCGUGUUGUACGAUCAAUUUUCUCCCGCACUCUUGAAACUGCUCAAAAUUCUGUGCGUGUUUUACAGAAGGCCGCUAUAACAAUACUAGAUGGAAUUUCACAGUAUUCACUGAGACUCAUUGAUGCUAUGAUGUUCACAUCUGAUUUGGCUACUAACAAUCUAGUUGUAAUGGCCUACAUUACAGGUGGUGUUGUUCAGUUGACUUCGCAGUGGCUAACUAACAUCUUUGGCACUGUUUAUGAAAAACUCAAACCCGUCCUUGAUUGGCUUGAAGAGAAGUUUAAGGAAGGUGUAGAGUUUCUUAGAGACGGUUGGGAAAUUGUUAAAUUUAUCUCAACCUGUGCUUGUGAAAUUGUCGGUGGACAAAUUGUCACCUGUGCAAAGGAAAUUAAGGAGAGUGUUCAGACAUUCUUUAAGCUUGUAAAUAAAUUUUUGGCUUUGUGUGCUGACUCUAUCAUUAUUGGUGGAGCUAAACUUAAAGCCUUGAAUUUAGGUGAAACAUUUGUCACGCACUCAAAGGGAUUGUACAGAAAGUGUGUUAAAUCCAGAGAAGAAACUGGCCUACUCAUGCCUCUAAAAGCCCCAAAAGAAAUUAUCUUCUUAGAGGGAGAAACACUUCCCACAGAAGUGUUAACAGAGGAAGUUGUCUUGAAAACUGGUGAUUUACAACCAUUAGAACAACCUACUAGUGAAGCUGUUGAAGCUCCAUUGGUUGGUACACCAGUUUGUAUUAACGGGCUUAUGUUGCUCGAAAUCAAAGACACAGAAAAGUACUGUGCCCUUGCACCUAAUAUGAUGGUAACAAACAAUACCUUCACACUCAAAGGCGGUGCACCAACAAAGGUUACUUUUGGUGAUGACACUGUGAUAGAAGUGCAAGGUUACAAGAGUGUGAAUAUCACUUUUGAACUUGAUGAAAGGAUUGAUAAAGUACUUAAUGAGAAGUGCUCUGCCUAUACAGUUGAACUCGGUACAGAAGUAAAUGAGUUCGCCUGUGUUGUGGCAGAUGCUGUCAUAAAAACUUUGCAACCAGUAUCUGAAUUACUUACACCACUGGGCAUUGAUUUAGAUGAGUGGAGUAUGGCUACAUACUACUUAUUUGAUGAGUCUGGUGAGUUUAAAUUGGCUUCACAUAUGUAUUGUUCUUUCUACCCUCCAGAUGAGGAUGAAGAAGAAGGUGAUUGUGAAGAAGAAGAGUUUGAGCCAUCAACUCAAUAUGAGUAUGGUACUGAAGAUGAUUACCAAGGUAAACCUUUGGAAUUUGGUGCCACUUCUGCUGCUCUUCAACCUGAAGAAGAGCAAGAAGAAGAUUGGUUAGAUGAUGAUAGUCAACAAACUGUUGGUCAACAAGACGGCAGUGAGGACAAUCAGACAACUACUAUUCAAACAAUUGUUGAGGUUCAACCUCAAUUAGAGAUGGAACUUACACCAGUUGUUCAGACUAUUGAAGUGAAUAGUUUUAGUGGUUAUUUAAAACUUACUGACAAUGUAUACAUUAAAAAUGCAGACAUUGUGGAAGAAGCUAAAAAGGUAAAACCAACAGUGGUUGUUAAUGCAGCCAAUGUUUACCUUAAACAUGGAGGAGGUGUUGCAGGAGCCUUAAAUAAGGCUACUAACAAUGCCAUGCAAGUUGAAUCUGAUGAUUACAUAGCUACUAAUGGACCACUUAAAGUGGGUGGUAGUUGUGUUUUAAGCGGACACAAUCUUGCUAAACACUGUCUUCAUGUUGUCGGCCCAAAUGUUAACAAAGGUGAAGACAUUCAACUUCUUAAGAGUGCUUAUGAAAAUUUUAAUCAGCACGAAGUUCUACUUGCACCAUUAUUAUCAGCUGGUAUUUUUGGUGCUGACCCUAUACAUUCUUUAAGAGUUUGUGUAGAUACUGUUCGCACAAAUGUCUACUUAGCUGUCUUUGAUAAAAAUCUCUAUGACAAACUUGUUUCAAGCUUUUUGGAAAUGAAGAGUGAAAAGCAAGUUGAACAAAAGAUCGCUGAGAUUCCUAAAGAGGAAGUUAAGCCAUUUAUAACUGAAAGUAAACCUUCAGUUGAACAGAGAAAACAAGAUGAUAAGAAAAUCAAAGCUUGUGUUGAAGAAGUUACAACAACUCUGGAAGAAACUAAGUUCCUCACAGAAAACUUGUUACUUUAUAUUGACAUUAAUGGCAAUCUUCAUCCAGAUUCUGCCACUCUUGUUAGUGACAUUGACAUCACUUUCUUAAAGAAAGAUGCUCCAUAUAUAGUGGGUGAUGUUGUUCAAGAGGGUGUUUUAACUGCUGUGGUUAUACCUACUAAAAAGGCUGGUGGCACUACUGAAAUGCUAGCGAAAGCUUUGAGAAAAGUGCCAACAGACAAUUAUAUAACCACUUACCCGGGUCAGGGUUUAAAUGGUUACACUGUAGAGGAGGCAAAGACAGUGCUUAAAAAGUGUAAAAGUGCCUUUUACAUUCUACCAUCUAUUAUCUCUAAUGAGAAGCAAGAAAUUCUUGGAACUGUUUCUUGGAAUUUGCGAGAAAUGCUUGCACAUGCAGAAGAAACACGCAAAUUAAUGCCUGUCUGUGUGGAAACUAAAGCCAUAGUUUCAACUAUACAGCGUAAAUAUAAGGGUAUUAAAAUACAAGAGGGUGUGGUUGAUUAUGGUGCUAGAUUUUACUUUUACACCAGUAAAACAACUGUAGCGUCACUUAUCAACACACUUAACGAUCUAAAUGAAACUCUUGUUACAAUGCCACUUGGCUAUGUAACACAUGGCUUAAAUUUGGAAGAAGCUGCUCGGUAUAUGAGAUCUCUCAAAGUGCCAGCUACAGUUUCUGUUUCUUCACCUGAUGCUGUUACAGCGUAUAAUGGUUAUCUUACUUCUUCUUCUAAAACACCUGAAGAACAUUUUAUUGAAACCAUCUCACUUGCUGGUUCCUAUAAAGAUUGGUCCUAUUCUGGACAAUCUACACAACUAGGUAUAGAAUUUCUUAAGAGAGGUGAUAAAAGUGUAUAUUACACUAGUAAUCCUACCACAUUCCACCUAGAUGGUGAAGUUAUCACCUUUGACAAUCUUAAGACACUUCUUUCUUUGAGAGAAGUGAGGACUAUUAAGGUGUUUACAACAGUAGACAACAUUAACCUCCACACGCAAGUUGUGGACAUGUCAAUGACAUAUGGACAACAGUUUGGUCCAACUUAUUUGGAUGGAGCUGAUGUUACUAAAAUAAAACCUCAUAAUUCACAUGAAGGUAAAACAUUUUAUGUUUUACCUAAUGAUGACACUCUACGUGUUGAGGCUUUUGAGUACUACCACACAACUGAUCCUAGUUUUCUGGGUAGGUACAUGUCAGCAUUAAAUCACACUAAAAAGUGGAAAUACCCACAAGUUAAUGGUUUAACUUCUAUUAAAUGGGCAGAUAACAACUGUUAUCUUGCCACUGCAUUGUUAACACUCCAACAAAUAGAGUUGAAGUUUAAUCCACCUGCUCUACAAGAUGCUUAUUACAGAGCAAGGGCUGGUGAAGCUGCUAACUUUUGUGCACUUAUCUUAGCCUACUGUAAUAAGACAGUAGGUGAGUUAGGUGAUGUUAGAGAAACAAUGAGUUACUUGUUUCAACAUGCCAAUUUAGAUUCUUGCAAAAGAGUCUUGAACGUGGUGUGUAAAACUUGUGGACAACAGCAGACAACCCUUAAGGGUGUAGAAGCUGUUAUGUACAUGGGCACACUUUCUUAUGAACAAUUUAAGAAAGGUGUUCAGAUACCUUGUACGUGUGGUAAACAAGCUACAAAAUAUCUAGUACAACAGGAGUCACCUUUUGUUAUGAUGUCAGCACCACCUGCUCAGUAUGAACUUAAGCAUGGUACAUUUACUUGUGCUAGUGAGUACACUGGUAAUUACCAGUGUGGUCACUAUAAACAUAUAACUUCUAAAGAAACUUUGUAUUGCAUAGACGGUGCUUUACUUACAAAGUCCUCAGAAUACAAAGGUCCUAUUACGGAUGUUUUCUACAAAGAAAACAGUUACACAACAACCAUAAAACCAGUUACUUAUAAAUUGGAUGGUGUUGUUUGUACAGAAAUUGACCCUAAGUUGGACAAUUAUUAUAAGAAAGACAAUUCUUAUUUCACAGAGCAACCAAUUGAUCUUGUACCAAACCAACCAUAUCCAAACGCAAGCUUCGAUAAUUUUAAGUUUGUAUGUGAUAAUAUCAAAUUUGCUGAUGAUUUAAACCAGUUAACUGGUUAUAAGAAACCUGCUUCAAGAGAGCUUAAAGUUACAUUUUUCCCUGACUUAAAUGGUGAUGUGGUGGCUAUUGAUUAUAAACACUACACACCCUCUUUUAAGAAAGGAGCUAAAUUGUUACAUAAACCUAUUGUUUGGCAUGUUAACAAUGCAACUAAUAAAGCCACGUAUAAACCAAAUACCUGGUGUAUACGUUGUCUUUGGAGCACAAAACCAGUUGAAACAUCAAAUUCGUUUGAUGUACUGAAGUCAGAGGACGCGCAGGGAAUGGAUAAUCUUGCCUGCGAAGAUCUAAAACCAGUCUCUGAAGAAGUAGUGGAAAAUCCUACCAUACAGAAAGACGUUCUUGAGUGUAAUGUGAAAACUACCGAAGUUGUAGGAGACAUUAUACUUAAACCAGCAAAUAAUAGUUUAAAAAUUACAGAAGAGGUUGGCCACACAGAUCUAAUGGCUGCUUAUGUAGACAAUUCUAGUCUUACUAUUAAGAAACCUAAUGAAUUAUCUAGAGUAUUAGGUUUGAAAACCCUUGCUACUCAUGGUUUAGCUGCUGUUAAUAGUGUCCCUUGGGAUACUAUAGCUAAUUAUGCUAAGCCUUUUCUUAACAAAGUUGUUAGUACAACUACUAACAUAGUUACACGGUGUUUAAACCGUGUUUGUACUAAUUAUAUGCCUUAUUUCUUUACUUUAUUGCUACAAUUGUGUACUUUUACUAGAAGUACAAAUUCUAGAAUUAAAGCAUCUAUGCCGACUACUAUAGCAAAGAAUACUGUUAAGAGUGUCGGUAAAUUUUGUCUAGAGGCUUCAUUUAAUUAUUUGAAGUCACCUAAUUUUUCUAAACUGAUAAAUAUUAUAAUUUGGUUUUUACUAUUAAGUGUUUGCCUAGGUUCUUUAAUCUACUCAACCGCUGCUUUAGGUGUUUUAAUGUCUAAUUUAGGCAUGCCUUCUUACUGUACUGGUUACAGAGAAGGCUAUUUGAACUCUACUAAUGUCACUAUUGCAACCUACUGUACUGGUUCUAUACCUUGUAGUGUUUGUCUUAGUGGUUUAGAUUCUUUAGACACCUAUCCUUCUUUAGAAACUAUACAAAUUACCAUUUCAUCUUUUAAAUGGGAUUUAACUGCUUUUGGCUUAGUUGCAGAGUGGUUUUUGGCAUAUAUUCUUUUCACUAGGUUUUUCUAUGUACUUGGAUUGGCUGCAAUCAUGCAAUUGUUUUUCAGCUAUUUUGCAGUACAUUUUAUUAGUAAUUCUUGGCUUAUGUGGUUAAUAAUUAAUCUUGUACAAAUGGCCCCGAUUUCAGCUAUGGUUAGAAUGUACAUCUUCUUUGCAUCAUUUUAUUAUGUAUGGAAAAGUUAUGUGCAUGUUGUAGACGGUUGUAAUUCAUCAACUUGUAUGAUGUGUUACAAACGUAAUAGAGCAACAAGAGUCGAAUGUACAACUAUUGUUAAUGGUGUUAGAAGGUCCUUUUAUGUCUAUGCUAAUGGAGGUAAAGGCUUUUGCAAACUACACAAUUGGAAUUGUGUUAAUUGUGAUACAUUCUGUGCUGGUAGUACAUUUAUUAGUGAUGAAGUUGCGAGAGACUUGUCACUACAGUUUAAAAGACCAAUAAAUCCUACUGACCAGUCUUCUUACAUCGUUGAUAGUGUUACAGUGAAGAAUGGUUCCAUCCAUCUUUACUUUGAUAAAGCUGGUCAAAAGACUUAUGAAAGACAUUCUCUCUCUCAUUUUGUUAACUUAGACAACCUGAGAGCUAAUAACACUAAAGGUUCAUUGCCUAUUAAUGUUAUAGUUUUUGAUGGUAAAUCAAAAUGUGAAGAAUCAUCUGCAAAAUCAGCGUCUGUUUACUACAGUCAGCUUAUGUGUCAACCUAUACUGUUACUAGAUCAGGCAUUAGUGUCUGAUGUUGGUGAUAGUGCGGAAGUUGCAGUUAAAAUGUUUGAUGCUUACGUUAAUACGUUUUCAUCAACUUUUAACGUACCAAUGGAAAAACUCAAAACACUAGUUGCAACUGCAGAAGCUGAACUUGCAAAGAAUGUGUCCUUAGACAAUGUCUUAUCUACUUUUAUUUCAGCAGCUCGGCAAGGGUUUGUUGAUUCAGAUGUAGAAACUAAAGAUGUUGUUGAAUGUCUUAAAUUGUCACAUCAAUCUGACAUAGAAGUUACUGGCGAUAGUUGUAAUAACUAUAUGCUCACCUAUAACAAAGUUGAAAACAUGACACCCCGUGACCUUGGUGCUUGUAUUGACUGUAGUGCGCGUCAUAUUAAUGCGCAGGUAGCAAAAAGUCACAACAUUGCUUUGAUAUGGAACGUUAAAGAUUUCAUGUCAUUGUCUGAACAACUACGAAAACAAAUACGUAGUGCUGCUAAAAAGAAUAACUUACCUUUUAAGUUGACAUGUGCAACUACUAGACAAGUUGUUAAUGUUGUAACAACAAAGAUAGCACUUAAGGGUGGUAAAAUUGUUAAUAAUUGGUUGAAGCAGUUAAUUAAAGUUACACUUGUGUUCCUUUUUGUUGCUGCUAUUUUCUAUUUAAUAACACCUGUUCAUGUCAUGUCUAAACAUACUGACUUUUCAAGUGAAAUCAUAGGAUACAAGGCUAUUGAUGGUGGUGUCACUCGUGACAUAGCAUCUACAGAUACUUGUUUUGCUAACAAACAUGCUGAUUUUGACACAUGGUUUAGCCAGCGUGGUGGUAGUUAUACUAAUGACAAAGCUUGCCCAUUGAUUGCUGCAGUCAUAACAAGAGAAGUGGGUUUUGUCGUGCCUGGUUUGCCUGGCACGAUAUUACGCACAACUAAUGGUGACUUUUUGCAUUUCUUACCUAGAGUUUUUAGUGCAGUUGGUAACAUCUGUUACACACCAUCAAAACUUAUAGAGUACACUGACUUUGCAACAUCAGCUUGUGUUUUGGCUGCUGAAUGUACAAUUUUUAAAGAUGCUUCUGGUAAGCCAGUACCAUAUUGUUAUGAUACCAAUGUACUAGAAGGUUCUGUUGCUUAUGAAAGUUUACGCCCUGACACACGUUAUGUGCUCAUGGAUGGCUCUAUUAUUCAAUUUCCUAACACCUACCUUGAAGGUUCUGUUAGAGUGGUAACAACUUUUGAUUCUGAGUACUGUAGGCACGGCACUUGUGAAAGAUCAGAAGCUGGUGUUUGUGUAUCUACUAGUGGUAGAUGGGUACUUAACAAUGAUUAUUACAGAUCUUUACCAGGAGUUUUCUGUGGUGUAGAUGCUGUAAAUUUACUUACUAAUAUGUUUACACCACUAAUUCAACCUAUUGGUGCUUUGGACAUAUCAGCAUCUAUAGUAGCUGGUGGUAUUGUAGCUAUCGUAGUAACAUGCCUUGCCUACUAUUUUAUGAGGUUUAGAAGAGCUUUUGGUGAAUACAGUCAUGUAGUUGCCUUUAAUACUUUACUAUUCCUUAUGUCAUUCACUGUACUCUGUUUAACACCAGUUUACUCAUUCUUACCUGGUGUUUAUUCUGUUAUUUACUUGUACUUGACAUUUUAUCUUACUAAUGAUGUUUCUUUUUUAGCACAUAUUCAGUGGAUGGUUAUGUUCACACCUUUAGUACCUUUCUGGAUAACAAUUGCUUAUAUCAUUUGUAUUUCCACAAAGCAUUUCUAUUGGUUCUUUAGUAAUUACCUAAAGAGACGUGUAGUCUUUAAUGGUGUUUCCUUUAGUACUUUUGAAGAAGCUGCGCUGUGCACCUUUUUGUUAAAUAAAGAAAUGUAUCUAAAGUUGCGUAGUGAUGUGCUAUUACCUCUUACGCAAUAUAAUAGAUACUUAGCUCUUUAUAAUAAGUACAAGUAUUUUAGUGGAGCAAUGGAUACAACUAGCUACAGAGAAGCUGCUUGUUGUCAUCUCGCAAAGGCUCUCAAUGACUUCAGUAACUCAGGUUCUGAUGUUCUUUACCAACCACCACAAACCUCUAUCACCUCAGCUGUUUUGCAGAGUGGUUUUAGAAAAAUGGCAUUCCCAUCUGGUAAAGUUGAGGGUUGUAUGGUACAAGUAACUUGUGGUACAACUACACUUAACGGUCUUUGGCUUGAUGACGUAGUUUACUGUCCAAGACAUGUGAUCUGCACCUCUGAAGACAUGCUUAACCCUAAUUAUGAAGAUUUACUCAUUCGUAAGUCUAAUCAUAAUUUCUUGGUACAGGCUGGUAAUGUUCAACUCAGGGUUAUUGGACAUUCUAUGCAAAAUUGUGUACUUAAGCUUAAGGUUGAUACAGCCAAUCCUAAGACACCUAAGUAUAAGUUUGUUCGCAUUCAACCAGGACAGACUUUUUCAGUGUUAGCUUGUUACAAUGGUUCACCAUCUGGUGUUUACCAAUGUGCUAUGAGGCCCAAUUUCACUAUUAAGGGUUCAUUCCUUAAUGGUUCAUGUGGUAGUGUUGGUUUUAACAUAGAUUAUGACUGUGUCUCUUUUUGUUACAUGCACCAUAUGGAAUUACCAACUGGAGUUCAUGCUGGCACAGACUUAGAAGGUAACUUUUAUGGACCUUUUGUUGACAGGCAAACAGCACAAGCAGCUGGUACGGACACAACUAUUACAGUUAAUGUUUUAGCUUGGUUGUACGCUGCUGUUAUAAAUGGAGACAGGUGGUUUCUCAAUCGAUUUACCACAACUCUUAAUGACUUUAACCUUGUGGCUAUGAAGUACAAUUAUGAACCUCUAACACAAGACCAUGUUGACAUACUAGGACCUCUUUCUGCUCAAACUGGAAUUGCCGUUUUAGAUAUGUGUGCUUCAUUAAAAGAAUUACUGCAAAAUGGUAUGAAUGGACGUACCAUAUUGGGUAGUGCUUUAUUAGAAGAUGAAUUUACACCUUUUGAUGUUGUUAGACAAUGCUCAGGUGUUACUUUCCAAAGUGCAGUGAAAAGAACAAUCAAGGGUACACACCACUGGUUGUUACUCACAAUUUUGACUUCACUUUUAGUUUUAGUCCAGAGUACUCAAUGGUCUUUGUUCUUUUUUUUGUAUGAAAAUGCCUUUUUACCUUUUGCUAUGGGUAUUAUUGCUAUGUCUGCUUUUGCAAUGAUGUUUGUCAAACAUAAGCAUGCAUUUCUCUGUUUGUUUUUGUUACCUUCUCUUGCCACUGUAGCUUAUUUUAAUAUGGUCUAUAUGCCUGCUAGUUGGGUGAUGCGUAUUAUGACAUGGUUGGAUAUGGUUGAUACUAGUUUGUCUGGUUUUAAGCUAAAAGACUGUGUUAUGUAUGCAUCAGCUGUAGUGUUACUAAUCCUUAUGACAGCAAGAACUGUGUAUGAUGAUGGUGCUAGGAGAGUGUGGACACUUAUGAAUGUCUUGACACUCGUUUAUAAAGUUUAUUAUGGUAAUGCUUUAGAUCAAGCCAUUUCCAUGUGGGCUCUUAUAAUCUCUGUUACUUCUAACUACUCAGGUGUAGUUACAACUGUCAUGUUUUUGGCCAGAGGUAUUGUUUUUAUGUGUGUUGAGUAUUGCCCUAUUUUCUUCAUAACUGGUAAUACACUUCAGUGUAUAAUGCUAGUUUAUUGUUUCUUAGGCUAUUUUUGUACUUGUUACUUUGGCCUCUUUUGUUUACUCAACCGCUACUUUAGACUGACUCUUGGUGUUUAUGAUUACUUAGUUUCUACACAGGAGUUUAGAUAUAUGAAUUCACAGGGACUACUCCCACCCAAGAAUAGCAUAGAUGCCUUCAAACUCAACAUUAAAUUGUUGGGUGUUGGUGGCAAACCUUGUAUCAAAGUAGCCACUGUACAGUCUAAAAUGUCAGAUGUAAAGUGCACAUCAGUAGUCUUACUCUCAGUUUUGCAACAACUCAGAGUAGAAUCAUCAUCUAAAUUGUGGGCUCAAUGUGUCCAGUUACACAAUGACAUUCUCUUAGCUAAAGAUACUACUGAAGCCUUUGAAAAAAUGGUUUCACUACUUUCUGUUUUGCUUUCCAUGCAGGGUGCUGUAGACAUAAACAAGCUUUGUGAAGAAAUGCUGGACAACAGGGCAACCUUACAAGCUAUAGCCUCAGAGUUUAGUUCCCUUCCAUCAUAUGCAGCUUUUGCUACUGCUCAAGAAGCUUAUGAGCAGGCUGUUGCUAAUGGUGAUUCUGAAGUUGUUCUUAAAAAGUUGAAGAAGUCUUUGAAUGUGGCUAAAUCUGAAUUUGACCGUGAUGCAGCCAUGCAACGUAAGUUGGAAAAGAUGGCUGAUCAAGCUAUGACCCAAAUGUAUAAACAGGCUAGAUCUGAGGACAAGAGGGCAAAAGUUACUAGUGCUAUGCAGACAAUGCUUUUCACUAUGCUUAGAAAGUUGGAUAAUGAUGCACUCAACAACAUUAUCAACAAUGCAAGAGAUGGUUGUGUUCCCUUGAACAUAAUACCUCUUACAACAGCAGCCAAACUAAUGGUUGUCAUACCAGACUAUAACACAUAUAAAAAUACGUGUGAUGGUACAACAUUUACUUAUGCAUCAGCAUUGUGGGAAAUCCAACAGGUUGUAGAUGCAGAUAGUAAAAUUGUUCAACUUAGUGAAAUUAGUAUGGACAAUUCACCUAAUUUAGCAUGGCCUCUUAUUGUAACAGCUUUAAGGGCCAAUUCUGCUGUCAAAUUACAGAAUAAUGAGCUUAGUCCUGUUGCACUACGACAGAUGUCUUGUGCUGCCGGUACUACACAAACUGCUUGCACUGAUGACAAUGCGUUAGCUUACUACAACACAACAAAGGGAGGUAGGUUUGUACUUGCACUGUUAUCCGAUUUACAGGAUUUGAAAUGGGCUAGAUUCCCUAAGAGUGAUGGAACUGGUACUAUCUAUACAGAACUGGAACCACCUUGUAGGUUUGUUACAGACACACCUAAAGGUCCUAAAGUGAAGUAUUUAUACUUUAUUAAAGGAUUAAACAACCUAAAUAGAGGUAUGGUACUUGGUAGUUUAGCUGCCACAGUACGUCUACAAGCUGGUAAUGCAACAGAAGUGCCUGCCAAUUCAACUGUAUUAUCUUUCUGUGCUUUUGCUGUAGAUGCUGCUAAAGCUUACAAAGAUUAUCUAGCUAGUGGGGGACAACCAAUCACUAAUUGUGUUAAGAUGUUGUGUACACACACUGGUACUGGUCAGGCAAUAACAGUUACACCGGAAGCCAAUAUGGAUCAAGAAUCCUUUGGUGGUGCAUCGUGUUGUCUGUACUGCCGUUGCCACAUAGAUCAUCCAAAUCCUAAAGGAUUUUGUGACUUAAAAGGUAAGUAUGUACAAAUACCUACAACUUGUGCUAAUGACCCUGUGGGUUUUACACUUAAAAACACAGUCUGUACCGUCUGCGGUAUGUGGAAAGGUUAUGGCUGUAGUUGUGAUCAACUCCGCGAACCCAUGCUUCAGUCAGCUGAUGCACAAUCGUUUUUAAACGGGUUUGCGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGGCACUAGUACUGAUGUCGUAUACAGGGCUUUUGACAUCUACAAUGAUAAAGUAGCUGGUUUUGCUAAAUUCCUAAAAACUAAUUGUUGUCGCUUCCAAGAAAAGGACGAAGAUGACAAUUUAAUUGAUUCUUACUUUGUAGUUAAGAGACACACUUUCUCUAACUACCAACAUGAAGAAACAAUUUAUAAUUUACUUAAGGAUUGUCCAGCUGUUGCUAAACAUGACUUCUUUAAGUUUAGAAUAGACGGUGACAUGGUACCACAUAUAUCACGUCAACGUCUUACUAAAUACACAAUGGCAGACCUCGUCUAUGCUUUAAGGCAUUUUGAUGAAGGUAAUUGUGACACAUUAAAAGAAAUACUUGUCACAUACAAUUGUUGUGAUGAUGAUUAUUUCAAUAAAAAGGACUGGUAUGAUUUUGUAGAAAACCCAGAUAUAUUACGCGUAUACGCCAACUUAGGUGAACGUGUACGCCAAGCUUUGUUAAAAACAGUACAAUUCUGUGAUGCCAUGCGAAAUGCUGGUAUUGUUGGUGUACUGACAUUAGAUAAUCAAGAUCUCAAUGGUAACUGGUAUGAUUUCGGUGAUUUCAUACAAACCACGCCAGGUAGUGGAGUUCCUGUUGUAGAUUCUUAUUAUUCAUUGUUAAUGCCUAUAUUAACCUUGACCAGGGCUUUAACUGCAGAGUCACAUGUUGACACUGACUUAACAAAGCCUUACAUUAAGUGGGAUUUGUUAAAAUAUGACUUCACGGAAGAGAGGUUAAAACUCUUUGACCGUUAUUUUAAAUAUUGGGAUCAGACAUACCACCCAAAUUGUGUUAACUGUUUGGAUGACAGAUGCAUUCUGCAUUGUGCAAACUUUAAUGUUUUAUUCUCUACAGUGUUCCCACCUACAAGUUUUGGACCACUAGUGAGAAAAAUAUUUGUUGAUGGUGUUCCAUUUGUAGUUUCAACUGGAUACCACUUCAGAGAGCUAGGUGUUGUACAUAAUCAGGAUGUAAACUUACAUAGCUCUAGACUUAGUUUUAAGGAAUUACUUGUGUAUGCUGCUGACCCUGCUAUGCACGCUGCUUCUGGUAAUCUAUUACUAGAUAAACGCACUACGUGCUUUUCAGUAGCUGCACUUACUAACAAUGUUGCUUUUCAAACUGUCAAACCCGGUAAUUUUAACAAAGACUUCUAUGACUUUGCUGUGUCUAAGGGUUUCUUUAAGGAAGGAAGUUCUGUUGAAUUAAAACACUUCUUCUUUGCUCAGGAUGGUAAUGCUGCUAUCAGCGAUUAUGACUACUAUCGUUAUAAUCUACCAACAAUGUGUGAUAUCAGACAACUACUAUUUGUAGUUGAAGUUGUUGAUAAGUACUUUGAUUGUUACGAUGGUGGCUGUAUUAAUGCUAACCAAGUCAUCGUCAACAACCUAGACAAAUCAGCUGGUUUUCCAUUUAAUAAAUGGGGUAAGGCUAGACUUUAUUAUGAUUCAAUGAGUUAUGAGGAUCAAGAUGCACUUUUCGCAUAUACAAAACGUAAUGUCAUCCCUACUAUAACUCAAAUGAAUCUUAAGUAUGCCAUUAGUGCAAAGAAUAGAGCUCGCACCGUAGCUGGUGUCUCUAUCUGUAGUACUAUGACCAAUAGACAGUUUCAUCAAAAAUUAUUGAAAUCAAUAGCCGCCACUAGAGGAGCUACUGUAGUAAUUGGAACAAGCAAAUUCUAUGGUGGUUGGCACAACAUGUUAAAAACUGUUUAUAGUGAUGUAGAAAACCCUCACCUUAUGGGUUGGGAUUAUCCUAAAUGUGAUAGAGCCAUGCCUAACAUGCUUAGAAUUAUGGCCUCACUUGUUCUUGCUCGCAAACAUACAACGUGUUGUAGCUUGUCACACCGUUUCUAUAGAUUAGCUAAUGAGUGUGCUCAAGUAUUGAGUGAAAUGGUCAUGUGUGGCGGUUCACUAUAUGUUAAACCAGGUGGAACCUCAUCAGGAGAUGCCACAACUGCUUAUGCUAAUAGUGUUUUUAACAUUUGUCAAGCUGUCACGGCCAAUGUUAAUGCACUUUUAUCUACUGAUGGUAACAAAAUUGCCGAUAAGUAUGUCCGCAAUUUACAACACAGACUUUAUGAGUGUCUCUAUAGAAAUAGAGAUGUUGACACAGACUUUGUGAAUGAGUUUUACGCAUAUUUGCGUAAACAUUUCUCAAUGAUGAUACUCUCUGACGAUGCUGUUGUGUGUUUCAAUAGCACUUAUGCAUCUCAAGGUCUAGUGGCUAGCAUAAAGAACUUUAAGUCAGUUCUUUAUUAUCAAAACAAUGUUUUUAUGUCUGAAGCAAAAUGUUGGACUGAGACUGACCUUACUAAAGGACCUCAUGAAUUUUGCUCUCAACAUACAAUGCUAGUUAAACAGGGUGAUGAUUAUGUGUACCUUCCUUACCCAGAUCCAUCAAGAAUCCUAGGGGCCGGCUGUUUUGUAGAUGAUAUCGUAAAAACAGAUGGUACACUUAUGAUUGAACGGUUCGUGUCUUUAGCUAUAGAUGCUUACCCACUUACUAAACAUCCUAAUCAGGAGUAUGCUGAUGUCUUUCAUUUGUACUUACAAUACAUAAGAAAGCUACAUGAUGAGUUAACAGGACACAUGUUAGACAUGUAUUCUGUUAUGCUUACUAAUGAUAACACUUCAAGGUAUUGGGAACCUGAGUUUUAUGAGGCUAUGUACACACCGCAUACAGUCUUACAGGCUGUUGGGGCUUGUGUUCUUUGCAAUUCACAGACUUCAUUAAGAUGUGGUGCUUGCAUACGUAGACCAUUCUUAUGUUGUAAAUGCUGUUACGACCAUGUCAUAUCAACAUCACAUAAAUUAGUCUUGUCUGUUAAUCCGUAUGUUUGCAAUGCUCCAGGUUGUGAUGUCACAGAUGUGACUCAACUUUACUUAGGAGGUAUGAGCUAUUAUUGUAAAUCACAUAAACCACCCAUUAGUUUUCCAUUGUGUGCUAAUGGACAAGUUUUUGGUUUAUAUAAAAAUACAUGUGUUGGUAGCGAUAAUGUUACUGACUUUAAUGCAAUUGCAACAUGUGACUGGACAAAUGCUGGUGAUUACAUUUUAGCUAACACCUGUACUGAAAGACUCAAGCUUUUUGCAGCAGAAACGCUCAAAGCUACUGAGGAGACAUUUAAACUGUCUUAUGGUAUUGCUACUGUACGUGAAGUGCUGUCUGACAGAGAAUUACAUCUUUCAUGGGAAGUUGGUAAACCUAGACCACCACUUAACCGAAAUUAUGUCUUUACUGGUUAUCGUGUAACUAAAAACAGUAAAGUACAAAUAGGAGAGUACACCUUUGAAAAAGGUGACUAUGGUGAUGCUGUUGUUUACCGAGGUACAACAACUUACAAAUUAAAUGUUGGUGAUUAUUUUGUGCUGACAUCACAUACAGUAAUGCCAUUAAGUGCACCUACACUAGUGCCACAAGAGCACUAUGUUAGAAUUACUGGCUUAUACCCAACACUCAAUAUCUCAGAUGAGUUUUCUAGCAAUGUUGCAAAUUAUCAAAAGGUUGGUAUGCAAAAGUAUUCUACACUCCAGGGACCACCUGGUACUGGUAAGAGUCAUUUUGCUAUUGGCCUAGCUCUCUACUACCCUUCUGCUCGCAUAGUGUAUACAGCUUGCUCUCAUGCCGCUGUUGAUGCACUAUGUGAGAAGGCAUUAAAAUAUUUGCCUAUAGAUAAAUGUAGUAGAAUUAUACCUGCACGUGCUCGUGUAGAGUGUUUUGAUAAAUUCAAAGUGAAUUCAACAUUAGAACAGUAUGUCUUUUGUACUGUAAAUGCAUUGCCUGAGACGACAGCAGAUAUAGUUGUCUUUGAUGAAAUUUCAAUGGCCACAAAUUAUGAUUUGAGUGUUGUCAAUGCCAGAUUACGUGCUAAGCACUAUGUGUACAUUGGCGACCCUGCUCAAUUACCUGCACCACGCACAUUGCUAACUAAGGGCACACUAGAACCAGAAUAUUUCAAUUCAGUGUGUAGACUUAUGAAAACUAUAGGUCCAGACAUGUUCCUCGGAACUUGUCGGCGUUGUCCUGCUGAAAUUGUUGACACUGUGAGUGCUUUGGUUUAUGAUAAUAAGCUUAAAGCACAUAAAGACAAAUCAGCUCAAUGCUUUAAAAUGUUUUAUAAGGGUGUUAUCACGCAUGAUGUUUCAUCUGCAAUUAACAGGCCACAAAUAGGCGUGGUAAGAGAAUUCCUUACACGUAACCCUGCUUGGAGAAAAGCUGUCUUUAUUUCACCUUAUAAUUCACAGAAUGCUGUAGCCUCAAAGAUUUUGGGACUACCAACUCAAACUGUUGAUUCAUCACAGGGCUCAGAAUAUGACUAUGUCAUAUUCACUCAAACCACUGAAACAGCUCACUCUUGUAAUGUAAACAGAUUUAAUGUUGCUAUUACCAGAGCAAAAGUAGGCAUACUUUGCAUAAUGUCUGAUAGAGACCUUUAUGACAAGUUGCAAUUUACAAGUCUUGAAAUUCCACGUAGGAAUGUGGCAACUUUACAAGCUGAAAAUGUAACAGGACUCUUUAAAGAUUGUAGUAAGGUAAUCACUGGGUUACAUCCUACACAGGCACCUACACACCUCAGUGUUGACACUAAAUUCAAAACUGAAGGUUUAUGUGUUGACAUACCUGGCAUACCUAAGGACAUGACCUAUAGAAGACUCAUCUCUAUGAUGGGUUUUAAAAUGAAUUAUCAAGUUAAUGGUUACCCUAACAUGUUUAUCACCCGCGAAGAAGCUAUAAGACAUGUACGUGCAUGGAUUGGCUUCGAUGUCGAGGGGUGUCAUGCUACUAGAGAAGCUGUUGGUACCAAUUUACCUUUACAGCUAGGUUUUUCUACAGGUGUUAACCUAGUUGCUGUACCUACAGGUUAUGUUGAUACACCUAAUAAUACAGAUUUUUCCAGAGUUAGUGCUAAACCACCGCCUGGAGAUCAAUUUAAACACCUCAUACCACUUAUGUACAAAGGACUUCCUUGGAAUGUAGUGCGUAUAAAGAUUGUACAAAUGUUAAGUGACACACUUAAAAAUCUCUCUGACAGAGUCGUAUUUGUCUUAUGGGCACAUGGCUUUGAGUUGACAUCUAUGAAGUAUUUUGUGAAAAUAGGACCUGAGCGCACCUGUUGUCUAUGUGAUAGACGUGCCACAUGCUUUUCCACUGCUUCAGACACUUAUGCCUGUUGGCAUCAUUCUAUUGGAUUUGAUUACGUCUAUAAUCCGUUUAUGAUUGAUGUUCAACAAUGGGGUUUUACAGGUAACCUACAAAGCAACCAUGAUCUGUAUUGUCAAGUCCAUGGUAAUGCACAUGUAGCUAGUUGUGAUGCAAUCAUGACUAGGUGUCUAGCUGUCCACGAGUGCUUUGUUAAGCGUGUUGACUGGACUAUUGAAUAUCCUAUAAUUGGUGAUGAACUGAAGAUUAAUGCGGCUUGUAGAAAGGUUCAACACAUGGUUGUUAAAGCUGCAUUAUUAGCAGACAAAUUCCCAGUUCUUCACGACAUUGGUAACCCUAAAGCUAUUAAGUGUGUACCUCAAGCUGAUGUAGAAUGGAAGUUCUAUGAUGCACAGCCUUGUAGUGACAAAGCUUAUAAAAUAGAAGAAUUAUUCUAUUCUUAUGCCACACAUUCUGACAAAUUCACAGAUGGUGUAUGCCUAUUUUGGAAUUGCAAUGUCGAUAGAUAUCCUGCUAAUUCCAUUGUUUGUAGAUUUGACACUAGAGUGCUAUCUAACCUUAACUUGCCUGGUUGUGAUGGUGGCAGUUUGUAUGUAAAUAAACAUGCAUUCCACACACCAGCUUUUGAUAAAAGUGCUUUUGUUAAUUUAAAACAAUUACCAUUUUUCUAUUACUCUGACAGUCCAUGUGAGUCUCAUGGAAAACAAGUAGUGUCAGAUAUAGAUUAUGUACCACUAAAGUCUGCUACGUGUAUAACACGUUGCAAUUUAGGUGGUGCUGUCUGUAGACAUCAUGCUAAUGAGUACAGAUUGUAUCUCGAUGCUUAUAACAUGAUGAUCUCAGCUGGCUUUAGCUUGUGGGUUUACAAACAAUUUGAUACUUAUAACCUCUGGAACACUUUUACAAGACUUCAGAGUUUAGAAAAUGUGGCUUUUAAUGUUGUAAAUAAGGGACACUUUGAUGGACAACAGGGUGAAGUACCAGUUUCUAUCAUUAAUAACACUGUUUACACAAAAGUUGAUGGUGUUGAUGUAGAAUUGUUUGAAAAUAAAACAACAUUACCUGUUAAUGUAGCAUUUGAGCUUUGGGCUAAGCGCAACAUUAAACCAGUACCAGAGGUGAAAAUACUCAAUAAUUUGGGUGUGGACAUUGCUGCUAAUACUGUGAUCUGGGACUACAAAAGAGAUGCUCCAGCACAUAUAUCUACUAUUGGUGUUUGUUCUAUGACUGACAUAGCCAAGAAACCAACUGAAACGAUUUGUGCACCACUCACUGUCUUUUUUGAUGGUAGAGUUGAUGGUCAAGUAGACUUAUUUAGAAAUGCCCGUAAUGGUGUUCUUAUUACAGAAGGUAGUGUUAAAGGUUUACAACCAUCUGUAGGUCCCAAACAAGCUAGUCUUAAUGGAGUCACAUUAAUUGGAGAAGCCGUAAAAACACAGUUCAAUUAUUAUAAGAAAGUUGAUGGUGUUGUCCAACAAUUACCUGAAACUUACUUUACUCAGAGUAGAAAUUUACAAGAAUUUAAACCCAGGAGUCAAAUGGAAAUUGAUUUCUUAGAAUUAGCUAUGGAUGAAUUCAUUGAACGGUAUAAAUUAGAAGGCUAUGCCUUCGAACAUAUCGUUUAUGGAGAUUUUAGUCAUAGUCAGUUAGGUGGUUUACAUCUACUGAUUGGACUAGCUAAACGUUUUAAGGAAUCACCUUUUGAAUUAGAAGAUUUUAUUCCUAUGGACAGUACAGUUAAAAACUAUUUCAUAACAGAUGCGCAAACAGGUUCAUCUAAGUGUGUGUGUUCUGUUAUUGAUUUAUUACUUGAUGAUUUUGUUGAAAUAAUAAAAUCCCAAGAUUUAUCUGUAGUUUCUAAGGUUGUCAAAGUGACUAUUGACUAUACAGAAAUUUCAUUUAUGCUUUGGUGUAAAGAUGGCCAUGUAGAAACAUUUUACCCAAAAUUACAAUCUAGUCAAGCGUGGCAACCGGGUGUUGCUAUGCCUAAUCUUUACAAAAUGCAAAGAAUGCUAUUAGAAAAGUGUGACCUUCAAAAUUAUGGUGAUAGUGCAACAUUACCUAAAGGCAUAAUGAUGAAUGUCGCAAAAUAUACUCAACUGUGUCAAUAUUUAAACACAUUAACAUUAGCUGUACCCUAUAAUAUGAGAGUUAUACAUUUUGGUGCUGGUUCUGAUAAAGGAGUUGCACCAGGUACAGCUGUUUUAAGACAGUGGUUGCCUACGGGUACGCUGCUUGUCGAUUCAGAUCUUAAUGACUUUGUCUCUGAUGCAGAUUCAACUUUGAUUGGUGAUUGUGCAACUGUACAUACAGCUAAUAAAUGGGAUCUCAUUAUUAGUGAUAUGUACGACCCUAAGACUAAAAAUGUUACAAAAGAAAAUGACUCUAAAGAGGGUUUUUUCACUUACAUUUGUGGGUUUAUACAACAAAAGCUAGCUCUUGGAGGUUCCGUGGCUAUAAAGAUAACAGAACAUUCUUGGAAUGCUGAUCUUUAUAAGCUCAUGGGACACUUCGCAUGGUGGACAGCCUUUGUUACUAAUGUGAAUGCGUCAUCAUCUGAAGCAUUUUUAAUUGGAUGUAAUUAUCUUGGCAAACCACGCGAACAAAUAGAUGGUUAUGUCAUGCAUGCAAAUUACAUAUUUUGGAGGAAUACAAAUCCAAUUCAGUUGUCUUCCUAUUCUUUAUUUGACAUGAGUAAAUUUCCCCUUAAAUUAAGGGGUACUGCUGUUAUGUCUUUAAAAGAAGGUCAAAUCAAUGAUAUGAUUUUAUCUCUUCUUAGUAAAGGUAGACUUAUAAUUAGAGAAAACAACAGAGUUGUUAUUUCUAGUGAUGUUCUUGUUAACAACUAAACGAACAAUGUUUGUUUUUCUUGUUUUAUUGCCACUAGUCUCUAGUCAGUGUGUUAAUCUUACAACCAGAACUCAAUUACCCCCUGCAUACACUAAUUCUUUCACACGUGGUGUUUAUUACCCUGACAAAGUUUUCAGAUCCUCAGUUUUACAUUCAACUCAGGACUUGUUCUUACCUUUCUUUUCCAAUGUUACUUGGUUCCAUGCUAUACAUGUCUCUGGGACCAAUGGUACUAAGAGGUUUGAUAACCCUGUCCUACCAUUUAAUGAUGGUGUUUAUUUUGCUUCCACUGAGAAGUCUAACAUAAUAAGAGGCUGGAUUUUUGGUACUACUUUAGAUUCGAAGACCCAGUCCCUACUUAUUGUUAAUAACGCUACUAAUGUUGUUAUUAAAGUCUGUGAAUUUCAAUUUUGUAAUGAUCCAUUUUUGGGUGUUUAUUACCACAAAAACAACAAAAGUUGGAUGGAAAGUGAGUUCAGAGUUUAUUCUAGUGCGAAUAAUUGCACUUUUGAAUAUGUCUCUCAGCCUUUUCUUAUGGACCUUGAAGGAAAACAGGGUAAUUUCAAAAAUCUUAGGGAAUUUGUGUUUAAGAAUAUUGAUGGUUAUUUUAAAAUAUAUUCUAAGCACACGCCUAUUAAUUUAGUGCGUGAUCUCCCUCAGGGUUUUUCGGCUUUAGAACCAUUGGUAGAUUUGCCAAUAGGUAUUAACAUCACUAGGUUUCAAACUUUACUUGCUUUACAUAGAAGUUAUUUGACUCCUGGUGAUUCUUCUUCAGGUUGGACAGCUGGUGCUGCAGCUUAUUAUGUGGGUUAUCUUCAACCUAGGACUUUUCUAUUAAAAUAUAAUGAAAAUGGAACCAUUACAGAUGCUGUAGACUGUGCACUUGACCCUCUCUCAGAAACAAAGUGUACGUUGAAAUCCUUCACUGUAGAAAAAGGAAUCUAUCAAACUUCUAACUUUAGAGUCCAACCAACAGAAUCUAUUGUUAGAUUUCCUAAUAUUACAAACUUGUGCCCUUUUGGUGAAGUUUUUAACGCCACCAGAUUUGCAUCUGUUUAUGCUUGGAACAGGAAGAGAAUCAGCAACUGUGUUGCUGAUUAUUCUGUCCUAUAUAAUUCCGCAUCAUUUUCCACUUUUAAGUGUUAUGGAGUGUCUCCUACUAAAUUAAAUGAUCUCUGCUUUACUAAUGUCUAUGCAGAUUCAUUUGUAAUUAGAGGUGAUGAAGUCAGACAAAUCGCUCCAGGGCAAACUGGAAAGAUUGCUGAUUAUAAUUAUAAAUUACCAGAUGAUUUUACAGGCUGCGUUAUAGCUUGGAAUUCUAACAAUCUUGAUUCUAAGGUUGGUGGUAAUUAUAAUUACCUGUAUAGAUUGUUUAGGAAGUCUAAUCUCAAACCUUUUGAGAGAGAUAUUUCAACUGAAAUCUAUCAGGCCGGUAGCACACCUUGUAAUGGUGUUGAAGGUUUUAAUUGUUACUUUCCUUUACAAUCAUAUGGUUUCCAACCCACUAAUGGUGUUGGUUACCAACCAUACAGAGUAGUAGUACUUUCUUUUGAACUUCUACAUGCACCAGCAACUGUUUGUGGACCUAAAAAGUCUACUAAUUUGGUUAAAAACAAAUGUGUCAAUUUCAACUUCAAUGGUUUAACAGGCACAGGUGUUCUUACUGAGUCUAACAAAAAGUUUCUGCCUUUCCAACAAUUUGGCAGAGACAUUGCUGACACUACUGAUGCUGUCCGUGAUCCACAGACACUUGAGAUUCUUGACAUUACACCAUGUUCUUUUGGUGGUGUCAGUGUUAUAACACCAGGAACAAAUACUUCUAACCAGGUUGCUGUUCUUUAUCAGGAUGUUAACUGCACAGAAGUCCCUGUUGCUAUUCAUGCAGAUCAACUUACUCCUACUUGGCGUGUUUAUUCUACAGGUUCUAAUGUUUUUCAAACACGUGCAGGCUGUUUAAUAGGGGCUGAACAUGUCAACAACUCAUAUGAGUGUGACAUACCCAUUGGUGCAGGUAUAUGCGCUAGUUAUCAGACUCAGACUAAUUCUCCUCGGCGGGCACGUAGUGUAGCUAGUCAAUCCAUCAUUGCCUACACUAUGUCACUUGGUGCAGAAAAUUCAGUUGCUUACUCUAAUAACUCUAUUGCCAUACCCACAAAUUUUACUAUUAGUGUUACCACAGAAAUUCUACCAGUGUCUAUGACCAAGACAUCAGUAGAUUGUACAAUGUACAUUUGUGGUGAUUCAACUGAAUGCAGCAAUCUUUUGUUGCAAUAUGGCAGUUUUUGUACACAAUUAAACCGUGCUUUAACUGGAAUAGCUGUUGAACAAGACAAAAACACCCAAGAAGUUUUUGCACAAGUCAAACAAAUUUACAAAACACCACCAAUUAAAGAUUUUGGUGGUUUUAAUUUUUCACAAAUAUUACCAGAUCCAUCAAAACCAAGCAAGAGGUCAUUUAUUGAAGAUCUACUUUUCAACAAAGUGACACUUGCAGAUGCUGGCUUCAUCAAACAAUAUGGUGAUUGCCUUGGUGAUAUUGCUGCUAGAGACCUCAUUUGUGCACAAAAGUUUAACGGCCUUACUGUUUUGCCACCUUUGCUCACAGAUGAAAUGAUUGCUCAAUACACUUCUGCACUGUUAGCGGGUACAAUCACUUCUGGUUGGACCUUUGGUGCAGGUGCUGCAUUACAAAUACCAUUUGCUAUGCAAAUGGCUUAUAGGUUUAAUGGUAUUGGAGUUACACAGAAUGUUCUCUAUGAGAACCAAAAAUUGAUUGCCAACCAAUUUAAUAGUGCUAUUGGCAAAAUUCAAGACUCACUUUCUUCCACAGCAAGUGCACUUGGAAAACUUCAAGAUGUGGUCAACCAAAAUGCACAAGCUUUAAACACGCUUGUUAAACAACUUAGCUCCAAUUUUGGUGCAAUUUCAAGUGUUUUAAAUGAUAUCCUUUCACGUCUUGACAAAGUUGAGGCUGAAGUGCAAAUUGAUAGGUUGAUCACAGGCAGACUUCAAAGUUUGCAGACAUAUGUGACUCAACAAUUAAUUAGAGCUGCAGAAAUCAGAGCUUCUGCUAAUCUUGCUGCUACUAAAAUGUCAGAGUGUGUACUUGGACAAUCAAAAAGAGUUGAUUUUUGUGGAAAGGGCUAUCAUCUUAUGUCCUUCCCUCAGUCAGCACCUCAUGGUGUAGUCUUCUUGCAUGUGACUUAUGUCCCUGCACAAGAAAAGAACUUCACAACUGCUCCUGCCAUUUGUCAUGAUGGAAAAGCACACUUUCCUCGUGAAGGUGUCUUUGUUUCAAAUGGCACACACUGGUUUGUAACACAAAGGAAUUUUUAUGAACCACAAAUCAUUACUACAGACAACACAUUUGUGUCUGGUAACUGUGAUGUUGUAAUAGGAAUUGUCAACAACACAGUUUAUGAUCCUUUGCAACCUGAAUUAGACUCAUUCAAGGAGGAGUUAGAUAAAUAUUUUAAGAAUCAUACAUCACCAGAUGUUGAUUUAGGUGACAUCUCUGGCAUUAAUGCUUCAGUUGUAAACAUUCAAAAAGAAAUUGACCGCCUCAAUGAGGUUGCCAAGAAUUUAAAUGAAUCUCUCAUCGAUCUCCAAGAACUUGGAAAGUAUGAGCAGUAUAUAAAAUGGCCAUGGUACAUUUGGCUAGGUUUUAUAGCUGGCUUGAUUGCCAUAGUAAUGGUGACAAUUAUGCUUUGCUGUAUGACCAGUUGCUGUAGUUGUCUCAAGGGCUGUUGUUCUUGUGGAUCCUGCUGCAAAUUUGAUGAAGACGACUCUGAGCCAGUGCUCAAAGGAGUCAAAUUACAUUACACAUAAACGAACUUAUGGAUUUGUUUAUGAGAAUCUUCACAAUUGGAACUGUAACUUUGAAGCAAGGUGAAAUCAAGGAUGCUACUCCUUCAGAUUUUGUUCGCGCUACUGCAACGAUACCGAUACAAGCCUCACUCCCUUUCGGAUGGCUUAUUGUUGGCGUUGCACUUCUUGCUGUUUUUCAGAGCGCUUCCAAAAUCAUAACCCUCAAAAAGAGAUGGCAACUAGCACUCUCCAAGGGUGUUCACUUUGUUUGCAACUUGCUGUUGUUGUUUGUAACAGUUUACUCACACCUUUUGCUCGUUGCUGCUGGCCUUGAAGCCCCUUUUCUCUAUCUUUAUGCUUUAGUCUACUUCUUGCAGAGUAUAAACUUUGUAAGAAUAAUAAUGAGGCUUUGGCUUUGCUGGAAAUGCCGUUCCAAAAACCCAUUACUUUAUGAUGCCAACUAUUUUCUUUGCUGGCAUACUAAUUGUUACGACUAUUGUAUACCUUACAAUAGUGUAACUUCUUCAAUUGUCAUUACUUCAGGUGAUGGCACAACAAGUCCUAUUUCUGAACAUGACUACCAGAUUGGUGGUUAUACUGAAAAAUGGGAAUCUGGAGUAAAAGACUGUGUUGUAUUACACAGUUACUUCACUUCAGACUAUUACCAGCUGUACUCAACUCAAUUGAGUACAGACACUGGUGUUGAACAUGUUACCUUCUUCAUCUACAAUAAAAUUGUUGAUGAGCCUGAAGAACAUGUCCAAAUUCACACAAUCGACGGUUCAUCCGGAGUUGUUAAUCCAGUAAUGGAACCAAUUUAUGAUGAACCGACGACGACUACUAGCGUGCCUUUGUAAGCACAAGCUGAUGAGUACGAACUUAUGUACUCAUUCGUUUCGGAAGAGACAGGUACGUUAAUAGUUAAUAGCGUACUUCUUUUUCUUGCUUUCGUGGUAUUCUUGCUAGUUACACUAGCCAUCCUUACUGCGCUUCGAUUGUGUGCGUACUGCUGCAAUAUUGUUAACGUGAGUCUUGUAAAACCUUCUUUUUACGUUUACUCUCGUGUUAAAAAUCUGAAUUCUUCUAGAGUUCCUGAUCUUCUGGUCUAAACGAACUAAAUAUUAUAUUAGUUUUUCUGUUUGGAACUUUAAUUUUAGCCAUGGCAGAUUCCAACGGUACUAUUACCGUUGAAGAGCUUAAAAAGCUCCUUGAACAAUGGAACCUAGUAAUAGGUUUCCUAUUCCUUACAUGGAUUUGUCUUCUACAAUUUGCCUAUGCCAACAGGAAUAGGUUUUUGUAUAUAAUUAAGUUAAUUUUCCUCUGGCUGUUAUGGCCAGUAACUUUAGCUUGUUUUGUGCUUGCUGCUGUUUACAGAAUAAAUUGGAUCACCGGUGGAAUUGCUAUCGCAAUGGCUUGUCUUGUAGGCUUGAUGUGGCUCAGCUACUUCAUUGCUUCUUUCAGACUGUUUGCGCGUACGCGUUCCAUGUGGUCAUUCAAUCCAGAAACUAACAUUCUUCUCAACGUGCCACUCCAUGGCACUAUUCUGACCAGACCGCUUCUAGAAAGUGAACUCGUAAUCGGAGCUGUGAUCCUUCGUGGACAUCUUCGUAUUGCUGGACACCAUCUAGGACGCUGUGACAUCAAGGACCUGCCUAAAGAAAUCACUGUUGCUACAUCACGAACGCUUUCUUAUUACAAAUUGGGAGCUUCGCAGCGUGUAGCAGGUGACUCAGGUUUUGCUGCAUACAGUCGCUACAGGAUUGGCAACUAUAAAUUAAACACAGACCAUUCCAGUAGCAGUGACAAUAUUGCUUUGCUUGUACAGUAAGUGACAACAGAUGUUUCAUCUCGUUGACUUUCAGGUUACUAUAGCAGAGAUAUUACUAAUUAUUAUGAGGACUUUUAAAGUUUCCAUUUGGAAUCUUGAUUACAUCAUAAACCUCAUAAUUAAAAAUUUAUCUAAGUCACUAACUGAGAAUAAAUAUUCUCAAUUAGAUGAAGAGCAACCAAUGGAGAUUGAUUAAACGAACAUGAAAAUUAUUCUUUUCUUGGCACUGAUAACACUCGCUACUUGUGAGCUUUAUCACUACCAAGAGUGUGUUAGAGGUACAACAGUACUUUUAAAAGAACCUUGCUCUUCUGGAACAUACGAGGGCAAUUCACCAUUUCAUCCUCUAGCUGAUAACAAAUUUGCACUGACUUGCUUUAGCACUCAAUUUGCUUUUGCUUGUCCUGACGGCGUAAAACACGUCUAUCAGUUACGUGCCAGAUCAGUUUCACCUAAACUGUUCAUCAGACAAGAGGAAGUUCAAGAACUUUACUCUCCAAUUUUUCUUAUUGUUGCGGCAAUAGUGUUUAUAACACUUUGCUUCACACUCAAAAGAAAGACAGAAUGAUUGAACUUUCAUUAAUUGACUUCUAUUUGUGCUUUUUAGCCUUUCUGCUAUUCCUUGUUUUAAUUAUGCUUAUUAUCUUUUGGUUCUCACUUGAACUGCAAGAUCAUAAUGAAACUUGUCACGCCUAAACGAACAUGAAAUUUCUUGUUUUCUUAGGAAUCAUCACAACUGUAGCUGCAUUUCACCAAGAAUGUAGUUUACAGUCAUGUACUCAACAUCAACCAUAUGUAGUUGAUGACCCGUGUCCUAUUCACUUCUAUUCUAAAUGGUAUAUUAGAGUAGGAGCUAGAAAAUCAGCACCUUUAAUUGAAUUGUGCGUGGAUGAGGCUGGUUCUAAAUCACCCAUUCAGUACAUCGAUAUCGGUAAUUAUACAGUUUCCUGUUUACCUUUUACAAUUAAUUGCCAGGAACCUAAAUUGGGUAGUCUUGUAGUGCGUUGUUCGUUCUAUGAAGACUUUUUAGAGUAUCAUGACGUUCGUGUUGUUUUAGAUUUCAUCUAAACGAACAAACUAAAAUGUCUGAUAAUGGACCCCAAAAUCAGCGAAAUGCACCCCGCAUUACGUUUGGUGGACCCUCAGAUUCAACUGGCAGUAACCAGAAUGGAGAACGCAGUGGGGCGCGAUCAAAACAACGUCGGCCCCAAGGUUUACCCAAUAAUACUGCGUCUUGGUUCACCGCUCUCACUCAACAUGGCAAGGAAGACCUUAAAUUCCCUCGAGGACAAGGCGUUCCAAUUAACACCAAUAGCAGUCCAGAUGACCAAAUUGGCUACUACCGAAGAGCUACCAGACGAAUUCGUGGUGGUGACGGUAAAAUGAAAGAUCUCAGUCCAAGAUGGUAUUUCUACUACCUAGGAACUGGGCCAGAAGCUGGACUUCCCUAUGGUGCUAACAAAGACGGCAUCAUAUGGGUUGCAACUGAGGGAGCCUUGAAUACACCAAAAGAUCACAUUGGCACCCGCAAUCCUGCUAACAAUGCUGCAAUCGUGCUACAACUUCCUCAAGGAACAACAUUGCCAAAAGGCUUCUACGCAGAAGGGAGCAGAGGCGGCAGUCAAGCCUCUUCUCGUUCCUCAUCACGUAGUCGCAACAGUUCAAGAAAUUCAACUCCAGGCAGCAGUAGGGGAACUUCUCCUGCUAGAAUGGCUGGCAAUGGCGGUGAUGCUGCUCUUGCUUUGCUGCUGCUUGACAGAUUGAACCAGCUUGAGAGCAAAAUGUCUGGUAAAGGCCAACAACAACAAGGCCAAACUGUCACUAAGAAAUCUGCUGCUGAGGCUUCUAAGAAGCCUCGGCAAAAACGUACUGCCACUAAAGCAUACAAUGUAACACAAGCUUUCGGCAGACGUGGUCCAGAACAAACCCAAGGAAAUUUUGGGGACCAGGAACUAAUCAGACAAGGAACUGAUUACAAACAUUGGCCGCAAAUUGCACAAUUUGCCCCCAGCGCUUCAGCGUUCUUCGGAAUGUCGCGCAUUGGCAUGGAAGUCACACCUUCGGGAACGUGGUUGACCUACACAGGUGCCAUCAAAUUGGAUGACAAAGAUCCAAAUUUCAAAGAUCAAGUCAUUUUGCUGAAUAAGCAUAUUGACGCAUACAAAACAUUCCCACCAACAGAGCCUAAAAAGGACAAAAAGAAGAAGGCUGAUGAAACUCAAGCCUUACCGCAGAGACAGAAGAAACAGCAAACUGUGACUCUUCUUCCUGCUGCAGAUUUGGAUGAUUUCUCCAAACAAUUGCAACAAUCCAUGAGCAGUGCUGACUCAACUCAGGCCUAAACUCAUGCAGACCACACAAGGCAGAUGGGCUAUAUAAACGUUUUCGCUUUUCCGUUUACGAUAUAUAGUCUACUCUUGUGCAGAAUGAAUUCUCGUAACUACAUAGCACAAGUAGAUGUAGUUAACUUUAAUCUCACAUAGCAAUCUUUAAUCAGUGUGUAACAUUAGGGAGGACUUGAAAGAGCCACCACAUUUUCACCGAGGCCACGCGGAGUACGAUCGAGUGUACAGUGAACAAUGCUAGGGAGAGCUGCCUAUAUGGAAGAGCCCUAAUGUGUAAAAUUAAUUUUAGUAGUGCUAUCCCCAUGUGAUUUUAAUAGCUUCUUAGGAGAAUGACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|protein_mutation:K375E
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKEADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,protein_mutation:K375E,419aa(1-419),P0DTC9,-,-,"[1-43],[73-102],[145-149],[152-160],[172-215],[235-271],[365-388],[409-419]",-,In vitro,5-20µM[SARS2-NP–VSV K375E];|200nM[SARS-CoV-2],"15 mM NaCl, 135 mM KCl, 5 mM phosphate, 1.5 mM MgCl2","20 mM Tris–HCl, pH 7.0",37˚C,-,other_molecular:1 mg ml−1 BSA,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"To test whether these viral mutations induce changes in the phase separation of SARS2-NP , we incubated fluorescently labelled K375N and K375E with viral RNA and compared the micrometre-sized liquid droplet formation with that of SARS2-NP WT. Both the K375N and K375E mutants seemed to have compromised LLPS ",29903
217,705,PMID: 34239064,RNAPS0000450,https://pubmed.ncbi.nlm.nih.gov/34239064,RNA + protein,-,-,SARS-CoV-2 virus RNA,29903nt(1-29903),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCUGAAAAGAGCUAUGAAUUGCAGACACCUUUUGAAAUUAAAUUGGCAAAGAAAUUUGACACCUUCAAUGGGGAAUGUCCAAAUUUUGUAUUUCCCUUAAAUUCCAUAAUCAAGACUAUUCAACCAAGGGUUGAAAAGAAAAAGCUUGAUGGCUUUAUGGGUAGAAUUCGAUCUGUCUAUCCAGUUGCGUCACCAAAUGAAUGCAACCAAAUGUGCCUUUCAACUCUCAUGAAGUGUGAUCAUUGUGGUGAAACUUCAUGGCAGACGGGCGAUUUUGUUAAAGCCACUUGCGAAUUUUGUGGCACUGAGAAUUUGACUAAAGAAGGUGCCACUACUUGUGGUUACUUACCCCAAAAUGCUGUUGUUAAAAUUUAUUGUCCAGCAUGUCACAAUUCAGAAGUAGGACCUGAGCAUAGUCUUGCCGAAUACCAUAAUGAAUCUGGCUUGAAAACCAUUCUUCGUAAGGGUGGUCGCACUAUUGCCUUUGGAGGCUGUGUGUUCUCUUAUGUUGGUUGCCAUAACAAGUGUGCCUAUUGGGUUCCACGUGCUAGCGCUAACAUAGGUUGUAACCAUACAGGUGUUGUUGGAGAAGGUUCCGAAGGUCUUAAUGACAACCUUCUUGAAAUACUCCAAAAAGAGAAAGUCAACAUCAAUAUUGUUGGUGACUUUAAACUUAAUGAAGAGAUCGCCAUUAUUUUGGCAUCUUUUUCUGCUUCCACAAGUGCUUUUGUGGAAACUGUGAAAGGUUUGGAUUAUAAAGCAUUCAAACAAAUUGUUGAAUCCUGUGGUAAUUUUAAAGUUACAAAAGGAAAAGCUAAAAAAGGUGCCUGGAAUAUUGGUGAACAGAAAUCAAUACUGAGUCCUCUUUAUGCAUUUGCAUCAGAGGCUGCUCGUGUUGUACGAUCAAUUUUCUCCCGCACUCUUGAAACUGCUCAAAAUUCUGUGCGUGUUUUACAGAAGGCCGCUAUAACAAUACUAGAUGGAAUUUCACAGUAUUCACUGAGACUCAUUGAUGCUAUGAUGUUCACAUCUGAUUUGGCUACUAACAAUCUAGUUGUAAUGGCCUACAUUACAGGUGGUGUUGUUCAGUUGACUUCGCAGUGGCUAACUAACAUCUUUGGCACUGUUUAUGAAAAACUCAAACCCGUCCUUGAUUGGCUUGAAGAGAAGUUUAAGGAAGGUGUAGAGUUUCUUAGAGACGGUUGGGAAAUUGUUAAAUUUAUCUCAACCUGUGCUUGUGAAAUUGUCGGUGGACAAAUUGUCACCUGUGCAAAGGAAAUUAAGGAGAGUGUUCAGACAUUCUUUAAGCUUGUAAAUAAAUUUUUGGCUUUGUGUGCUGACUCUAUCAUUAUUGGUGGAGCUAAACUUAAAGCCUUGAAUUUAGGUGAAACAUUUGUCACGCACUCAAAGGGAUUGUACAGAAAGUGUGUUAAAUCCAGAGAAGAAACUGGCCUACUCAUGCCUCUAAAAGCCCCAAAAGAAAUUAUCUUCUUAGAGGGAGAAACACUUCCCACAGAAGUGUUAACAGAGGAAGUUGUCUUGAAAACUGGUGAUUUACAACCAUUAGAACAACCUACUAGUGAAGCUGUUGAAGCUCCAUUGGUUGGUACACCAGUUUGUAUUAACGGGCUUAUGUUGCUCGAAAUCAAAGACACAGAAAAGUACUGUGCCCUUGCACCUAAUAUGAUGGUAACAAACAAUACCUUCACACUCAAAGGCGGUGCACCAACAAAGGUUACUUUUGGUGAUGACACUGUGAUAGAAGUGCAAGGUUACAAGAGUGUGAAUAUCACUUUUGAACUUGAUGAAAGGAUUGAUAAAGUACUUAAUGAGAAGUGCUCUGCCUAUACAGUUGAACUCGGUACAGAAGUAAAUGAGUUCGCCUGUGUUGUGGCAGAUGCUGUCAUAAAAACUUUGCAACCAGUAUCUGAAUUACUUACACCACUGGGCAUUGAUUUAGAUGAGUGGAGUAUGGCUACAUACUACUUAUUUGAUGAGUCUGGUGAGUUUAAAUUGGCUUCACAUAUGUAUUGUUCUUUCUACCCUCCAGAUGAGGAUGAAGAAGAAGGUGAUUGUGAAGAAGAAGAGUUUGAGCCAUCAACUCAAUAUGAGUAUGGUACUGAAGAUGAUUACCAAGGUAAACCUUUGGAAUUUGGUGCCACUUCUGCUGCUCUUCAACCUGAAGAAGAGCAAGAAGAAGAUUGGUUAGAUGAUGAUAGUCAACAAACUGUUGGUCAACAAGACGGCAGUGAGGACAAUCAGACAACUACUAUUCAAACAAUUGUUGAGGUUCAACCUCAAUUAGAGAUGGAACUUACACCAGUUGUUCAGACUAUUGAAGUGAAUAGUUUUAGUGGUUAUUUAAAACUUACUGACAAUGUAUACAUUAAAAAUGCAGACAUUGUGGAAGAAGCUAAAAAGGUAAAACCAACAGUGGUUGUUAAUGCAGCCAAUGUUUACCUUAAACAUGGAGGAGGUGUUGCAGGAGCCUUAAAUAAGGCUACUAACAAUGCCAUGCAAGUUGAAUCUGAUGAUUACAUAGCUACUAAUGGACCACUUAAAGUGGGUGGUAGUUGUGUUUUAAGCGGACACAAUCUUGCUAAACACUGUCUUCAUGUUGUCGGCCCAAAUGUUAACAAAGGUGAAGACAUUCAACUUCUUAAGAGUGCUUAUGAAAAUUUUAAUCAGCACGAAGUUCUACUUGCACCAUUAUUAUCAGCUGGUAUUUUUGGUGCUGACCCUAUACAUUCUUUAAGAGUUUGUGUAGAUACUGUUCGCACAAAUGUCUACUUAGCUGUCUUUGAUAAAAAUCUCUAUGACAAACUUGUUUCAAGCUUUUUGGAAAUGAAGAGUGAAAAGCAAGUUGAACAAAAGAUCGCUGAGAUUCCUAAAGAGGAAGUUAAGCCAUUUAUAACUGAAAGUAAACCUUCAGUUGAACAGAGAAAACAAGAUGAUAAGAAAAUCAAAGCUUGUGUUGAAGAAGUUACAACAACUCUGGAAGAAACUAAGUUCCUCACAGAAAACUUGUUACUUUAUAUUGACAUUAAUGGCAAUCUUCAUCCAGAUUCUGCCACUCUUGUUAGUGACAUUGACAUCACUUUCUUAAAGAAAGAUGCUCCAUAUAUAGUGGGUGAUGUUGUUCAAGAGGGUGUUUUAACUGCUGUGGUUAUACCUACUAAAAAGGCUGGUGGCACUACUGAAAUGCUAGCGAAAGCUUUGAGAAAAGUGCCAACAGACAAUUAUAUAACCACUUACCCGGGUCAGGGUUUAAAUGGUUACACUGUAGAGGAGGCAAAGACAGUGCUUAAAAAGUGUAAAAGUGCCUUUUACAUUCUACCAUCUAUUAUCUCUAAUGAGAAGCAAGAAAUUCUUGGAACUGUUUCUUGGAAUUUGCGAGAAAUGCUUGCACAUGCAGAAGAAACACGCAAAUUAAUGCCUGUCUGUGUGGAAACUAAAGCCAUAGUUUCAACUAUACAGCGUAAAUAUAAGGGUAUUAAAAUACAAGAGGGUGUGGUUGAUUAUGGUGCUAGAUUUUACUUUUACACCAGUAAAACAACUGUAGCGUCACUUAUCAACACACUUAACGAUCUAAAUGAAACUCUUGUUACAAUGCCACUUGGCUAUGUAACACAUGGCUUAAAUUUGGAAGAAGCUGCUCGGUAUAUGAGAUCUCUCAAAGUGCCAGCUACAGUUUCUGUUUCUUCACCUGAUGCUGUUACAGCGUAUAAUGGUUAUCUUACUUCUUCUUCUAAAACACCUGAAGAACAUUUUAUUGAAACCAUCUCACUUGCUGGUUCCUAUAAAGAUUGGUCCUAUUCUGGACAAUCUACACAACUAGGUAUAGAAUUUCUUAAGAGAGGUGAUAAAAGUGUAUAUUACACUAGUAAUCCUACCACAUUCCACCUAGAUGGUGAAGUUAUCACCUUUGACAAUCUUAAGACACUUCUUUCUUUGAGAGAAGUGAGGACUAUUAAGGUGUUUACAACAGUAGACAACAUUAACCUCCACACGCAAGUUGUGGACAUGUCAAUGACAUAUGGACAACAGUUUGGUCCAACUUAUUUGGAUGGAGCUGAUGUUACUAAAAUAAAACCUCAUAAUUCACAUGAAGGUAAAACAUUUUAUGUUUUACCUAAUGAUGACACUCUACGUGUUGAGGCUUUUGAGUACUACCACACAACUGAUCCUAGUUUUCUGGGUAGGUACAUGUCAGCAUUAAAUCACACUAAAAAGUGGAAAUACCCACAAGUUAAUGGUUUAACUUCUAUUAAAUGGGCAGAUAACAACUGUUAUCUUGCCACUGCAUUGUUAACACUCCAACAAAUAGAGUUGAAGUUUAAUCCACCUGCUCUACAAGAUGCUUAUUACAGAGCAAGGGCUGGUGAAGCUGCUAACUUUUGUGCACUUAUCUUAGCCUACUGUAAUAAGACAGUAGGUGAGUUAGGUGAUGUUAGAGAAACAAUGAGUUACUUGUUUCAACAUGCCAAUUUAGAUUCUUGCAAAAGAGUCUUGAACGUGGUGUGUAAAACUUGUGGACAACAGCAGACAACCCUUAAGGGUGUAGAAGCUGUUAUGUACAUGGGCACACUUUCUUAUGAACAAUUUAAGAAAGGUGUUCAGAUACCUUGUACGUGUGGUAAACAAGCUACAAAAUAUCUAGUACAACAGGAGUCACCUUUUGUUAUGAUGUCAGCACCACCUGCUCAGUAUGAACUUAAGCAUGGUACAUUUACUUGUGCUAGUGAGUACACUGGUAAUUACCAGUGUGGUCACUAUAAACAUAUAACUUCUAAAGAAACUUUGUAUUGCAUAGACGGUGCUUUACUUACAAAGUCCUCAGAAUACAAAGGUCCUAUUACGGAUGUUUUCUACAAAGAAAACAGUUACACAACAACCAUAAAACCAGUUACUUAUAAAUUGGAUGGUGUUGUUUGUACAGAAAUUGACCCUAAGUUGGACAAUUAUUAUAAGAAAGACAAUUCUUAUUUCACAGAGCAACCAAUUGAUCUUGUACCAAACCAACCAUAUCCAAACGCAAGCUUCGAUAAUUUUAAGUUUGUAUGUGAUAAUAUCAAAUUUGCUGAUGAUUUAAACCAGUUAACUGGUUAUAAGAAACCUGCUUCAAGAGAGCUUAAAGUUACAUUUUUCCCUGACUUAAAUGGUGAUGUGGUGGCUAUUGAUUAUAAACACUACACACCCUCUUUUAAGAAAGGAGCUAAAUUGUUACAUAAACCUAUUGUUUGGCAUGUUAACAAUGCAACUAAUAAAGCCACGUAUAAACCAAAUACCUGGUGUAUACGUUGUCUUUGGAGCACAAAACCAGUUGAAACAUCAAAUUCGUUUGAUGUACUGAAGUCAGAGGACGCGCAGGGAAUGGAUAAUCUUGCCUGCGAAGAUCUAAAACCAGUCUCUGAAGAAGUAGUGGAAAAUCCUACCAUACAGAAAGACGUUCUUGAGUGUAAUGUGAAAACUACCGAAGUUGUAGGAGACAUUAUACUUAAACCAGCAAAUAAUAGUUUAAAAAUUACAGAAGAGGUUGGCCACACAGAUCUAAUGGCUGCUUAUGUAGACAAUUCUAGUCUUACUAUUAAGAAACCUAAUGAAUUAUCUAGAGUAUUAGGUUUGAAAACCCUUGCUACUCAUGGUUUAGCUGCUGUUAAUAGUGUCCCUUGGGAUACUAUAGCUAAUUAUGCUAAGCCUUUUCUUAACAAAGUUGUUAGUACAACUACUAACAUAGUUACACGGUGUUUAAACCGUGUUUGUACUAAUUAUAUGCCUUAUUUCUUUACUUUAUUGCUACAAUUGUGUACUUUUACUAGAAGUACAAAUUCUAGAAUUAAAGCAUCUAUGCCGACUACUAUAGCAAAGAAUACUGUUAAGAGUGUCGGUAAAUUUUGUCUAGAGGCUUCAUUUAAUUAUUUGAAGUCACCUAAUUUUUCUAAACUGAUAAAUAUUAUAAUUUGGUUUUUACUAUUAAGUGUUUGCCUAGGUUCUUUAAUCUACUCAACCGCUGCUUUAGGUGUUUUAAUGUCUAAUUUAGGCAUGCCUUCUUACUGUACUGGUUACAGAGAAGGCUAUUUGAACUCUACUAAUGUCACUAUUGCAACCUACUGUACUGGUUCUAUACCUUGUAGUGUUUGUCUUAGUGGUUUAGAUUCUUUAGACACCUAUCCUUCUUUAGAAACUAUACAAAUUACCAUUUCAUCUUUUAAAUGGGAUUUAACUGCUUUUGGCUUAGUUGCAGAGUGGUUUUUGGCAUAUAUUCUUUUCACUAGGUUUUUCUAUGUACUUGGAUUGGCUGCAAUCAUGCAAUUGUUUUUCAGCUAUUUUGCAGUACAUUUUAUUAGUAAUUCUUGGCUUAUGUGGUUAAUAAUUAAUCUUGUACAAAUGGCCCCGAUUUCAGCUAUGGUUAGAAUGUACAUCUUCUUUGCAUCAUUUUAUUAUGUAUGGAAAAGUUAUGUGCAUGUUGUAGACGGUUGUAAUUCAUCAACUUGUAUGAUGUGUUACAAACGUAAUAGAGCAACAAGAGUCGAAUGUACAACUAUUGUUAAUGGUGUUAGAAGGUCCUUUUAUGUCUAUGCUAAUGGAGGUAAAGGCUUUUGCAAACUACACAAUUGGAAUUGUGUUAAUUGUGAUACAUUCUGUGCUGGUAGUACAUUUAUUAGUGAUGAAGUUGCGAGAGACUUGUCACUACAGUUUAAAAGACCAAUAAAUCCUACUGACCAGUCUUCUUACAUCGUUGAUAGUGUUACAGUGAAGAAUGGUUCCAUCCAUCUUUACUUUGAUAAAGCUGGUCAAAAGACUUAUGAAAGACAUUCUCUCUCUCAUUUUGUUAACUUAGACAACCUGAGAGCUAAUAACACUAAAGGUUCAUUGCCUAUUAAUGUUAUAGUUUUUGAUGGUAAAUCAAAAUGUGAAGAAUCAUCUGCAAAAUCAGCGUCUGUUUACUACAGUCAGCUUAUGUGUCAACCUAUACUGUUACUAGAUCAGGCAUUAGUGUCUGAUGUUGGUGAUAGUGCGGAAGUUGCAGUUAAAAUGUUUGAUGCUUACGUUAAUACGUUUUCAUCAACUUUUAACGUACCAAUGGAAAAACUCAAAACACUAGUUGCAACUGCAGAAGCUGAACUUGCAAAGAAUGUGUCCUUAGACAAUGUCUUAUCUACUUUUAUUUCAGCAGCUCGGCAAGGGUUUGUUGAUUCAGAUGUAGAAACUAAAGAUGUUGUUGAAUGUCUUAAAUUGUCACAUCAAUCUGACAUAGAAGUUACUGGCGAUAGUUGUAAUAACUAUAUGCUCACCUAUAACAAAGUUGAAAACAUGACACCCCGUGACCUUGGUGCUUGUAUUGACUGUAGUGCGCGUCAUAUUAAUGCGCAGGUAGCAAAAAGUCACAACAUUGCUUUGAUAUGGAACGUUAAAGAUUUCAUGUCAUUGUCUGAACAACUACGAAAACAAAUACGUAGUGCUGCUAAAAAGAAUAACUUACCUUUUAAGUUGACAUGUGCAACUACUAGACAAGUUGUUAAUGUUGUAACAACAAAGAUAGCACUUAAGGGUGGUAAAAUUGUUAAUAAUUGGUUGAAGCAGUUAAUUAAAGUUACACUUGUGUUCCUUUUUGUUGCUGCUAUUUUCUAUUUAAUAACACCUGUUCAUGUCAUGUCUAAACAUACUGACUUUUCAAGUGAAAUCAUAGGAUACAAGGCUAUUGAUGGUGGUGUCACUCGUGACAUAGCAUCUACAGAUACUUGUUUUGCUAACAAACAUGCUGAUUUUGACACAUGGUUUAGCCAGCGUGGUGGUAGUUAUACUAAUGACAAAGCUUGCCCAUUGAUUGCUGCAGUCAUAACAAGAGAAGUGGGUUUUGUCGUGCCUGGUUUGCCUGGCACGAUAUUACGCACAACUAAUGGUGACUUUUUGCAUUUCUUACCUAGAGUUUUUAGUGCAGUUGGUAACAUCUGUUACACACCAUCAAAACUUAUAGAGUACACUGACUUUGCAACAUCAGCUUGUGUUUUGGCUGCUGAAUGUACAAUUUUUAAAGAUGCUUCUGGUAAGCCAGUACCAUAUUGUUAUGAUACCAAUGUACUAGAAGGUUCUGUUGCUUAUGAAAGUUUACGCCCUGACACACGUUAUGUGCUCAUGGAUGGCUCUAUUAUUCAAUUUCCUAACACCUACCUUGAAGGUUCUGUUAGAGUGGUAACAACUUUUGAUUCUGAGUACUGUAGGCACGGCACUUGUGAAAGAUCAGAAGCUGGUGUUUGUGUAUCUACUAGUGGUAGAUGGGUACUUAACAAUGAUUAUUACAGAUCUUUACCAGGAGUUUUCUGUGGUGUAGAUGCUGUAAAUUUACUUACUAAUAUGUUUACACCACUAAUUCAACCUAUUGGUGCUUUGGACAUAUCAGCAUCUAUAGUAGCUGGUGGUAUUGUAGCUAUCGUAGUAACAUGCCUUGCCUACUAUUUUAUGAGGUUUAGAAGAGCUUUUGGUGAAUACAGUCAUGUAGUUGCCUUUAAUACUUUACUAUUCCUUAUGUCAUUCACUGUACUCUGUUUAACACCAGUUUACUCAUUCUUACCUGGUGUUUAUUCUGUUAUUUACUUGUACUUGACAUUUUAUCUUACUAAUGAUGUUUCUUUUUUAGCACAUAUUCAGUGGAUGGUUAUGUUCACACCUUUAGUACCUUUCUGGAUAACAAUUGCUUAUAUCAUUUGUAUUUCCACAAAGCAUUUCUAUUGGUUCUUUAGUAAUUACCUAAAGAGACGUGUAGUCUUUAAUGGUGUUUCCUUUAGUACUUUUGAAGAAGCUGCGCUGUGCACCUUUUUGUUAAAUAAAGAAAUGUAUCUAAAGUUGCGUAGUGAUGUGCUAUUACCUCUUACGCAAUAUAAUAGAUACUUAGCUCUUUAUAAUAAGUACAAGUAUUUUAGUGGAGCAAUGGAUACAACUAGCUACAGAGAAGCUGCUUGUUGUCAUCUCGCAAAGGCUCUCAAUGACUUCAGUAACUCAGGUUCUGAUGUUCUUUACCAACCACCACAAACCUCUAUCACCUCAGCUGUUUUGCAGAGUGGUUUUAGAAAAAUGGCAUUCCCAUCUGGUAAAGUUGAGGGUUGUAUGGUACAAGUAACUUGUGGUACAACUACACUUAACGGUCUUUGGCUUGAUGACGUAGUUUACUGUCCAAGACAUGUGAUCUGCACCUCUGAAGACAUGCUUAACCCUAAUUAUGAAGAUUUACUCAUUCGUAAGUCUAAUCAUAAUUUCUUGGUACAGGCUGGUAAUGUUCAACUCAGGGUUAUUGGACAUUCUAUGCAAAAUUGUGUACUUAAGCUUAAGGUUGAUACAGCCAAUCCUAAGACACCUAAGUAUAAGUUUGUUCGCAUUCAACCAGGACAGACUUUUUCAGUGUUAGCUUGUUACAAUGGUUCACCAUCUGGUGUUUACCAAUGUGCUAUGAGGCCCAAUUUCACUAUUAAGGGUUCAUUCCUUAAUGGUUCAUGUGGUAGUGUUGGUUUUAACAUAGAUUAUGACUGUGUCUCUUUUUGUUACAUGCACCAUAUGGAAUUACCAACUGGAGUUCAUGCUGGCACAGACUUAGAAGGUAACUUUUAUGGACCUUUUGUUGACAGGCAAACAGCACAAGCAGCUGGUACGGACACAACUAUUACAGUUAAUGUUUUAGCUUGGUUGUACGCUGCUGUUAUAAAUGGAGACAGGUGGUUUCUCAAUCGAUUUACCACAACUCUUAAUGACUUUAACCUUGUGGCUAUGAAGUACAAUUAUGAACCUCUAACACAAGACCAUGUUGACAUACUAGGACCUCUUUCUGCUCAAACUGGAAUUGCCGUUUUAGAUAUGUGUGCUUCAUUAAAAGAAUUACUGCAAAAUGGUAUGAAUGGACGUACCAUAUUGGGUAGUGCUUUAUUAGAAGAUGAAUUUACACCUUUUGAUGUUGUUAGACAAUGCUCAGGUGUUACUUUCCAAAGUGCAGUGAAAAGAACAAUCAAGGGUACACACCACUGGUUGUUACUCACAAUUUUGACUUCACUUUUAGUUUUAGUCCAGAGUACUCAAUGGUCUUUGUUCUUUUUUUUGUAUGAAAAUGCCUUUUUACCUUUUGCUAUGGGUAUUAUUGCUAUGUCUGCUUUUGCAAUGAUGUUUGUCAAACAUAAGCAUGCAUUUCUCUGUUUGUUUUUGUUACCUUCUCUUGCCACUGUAGCUUAUUUUAAUAUGGUCUAUAUGCCUGCUAGUUGGGUGAUGCGUAUUAUGACAUGGUUGGAUAUGGUUGAUACUAGUUUGUCUGGUUUUAAGCUAAAAGACUGUGUUAUGUAUGCAUCAGCUGUAGUGUUACUAAUCCUUAUGACAGCAAGAACUGUGUAUGAUGAUGGUGCUAGGAGAGUGUGGACACUUAUGAAUGUCUUGACACUCGUUUAUAAAGUUUAUUAUGGUAAUGCUUUAGAUCAAGCCAUUUCCAUGUGGGCUCUUAUAAUCUCUGUUACUUCUAACUACUCAGGUGUAGUUACAACUGUCAUGUUUUUGGCCAGAGGUAUUGUUUUUAUGUGUGUUGAGUAUUGCCCUAUUUUCUUCAUAACUGGUAAUACACUUCAGUGUAUAAUGCUAGUUUAUUGUUUCUUAGGCUAUUUUUGUACUUGUUACUUUGGCCUCUUUUGUUUACUCAACCGCUACUUUAGACUGACUCUUGGUGUUUAUGAUUACUUAGUUUCUACACAGGAGUUUAGAUAUAUGAAUUCACAGGGACUACUCCCACCCAAGAAUAGCAUAGAUGCCUUCAAACUCAACAUUAAAUUGUUGGGUGUUGGUGGCAAACCUUGUAUCAAAGUAGCCACUGUACAGUCUAAAAUGUCAGAUGUAAAGUGCACAUCAGUAGUCUUACUCUCAGUUUUGCAACAACUCAGAGUAGAAUCAUCAUCUAAAUUGUGGGCUCAAUGUGUCCAGUUACACAAUGACAUUCUCUUAGCUAAAGAUACUACUGAAGCCUUUGAAAAAAUGGUUUCACUACUUUCUGUUUUGCUUUCCAUGCAGGGUGCUGUAGACAUAAACAAGCUUUGUGAAGAAAUGCUGGACAACAGGGCAACCUUACAAGCUAUAGCCUCAGAGUUUAGUUCCCUUCCAUCAUAUGCAGCUUUUGCUACUGCUCAAGAAGCUUAUGAGCAGGCUGUUGCUAAUGGUGAUUCUGAAGUUGUUCUUAAAAAGUUGAAGAAGUCUUUGAAUGUGGCUAAAUCUGAAUUUGACCGUGAUGCAGCCAUGCAACGUAAGUUGGAAAAGAUGGCUGAUCAAGCUAUGACCCAAAUGUAUAAACAGGCUAGAUCUGAGGACAAGAGGGCAAAAGUUACUAGUGCUAUGCAGACAAUGCUUUUCACUAUGCUUAGAAAGUUGGAUAAUGAUGCACUCAACAACAUUAUCAACAAUGCAAGAGAUGGUUGUGUUCCCUUGAACAUAAUACCUCUUACAACAGCAGCCAAACUAAUGGUUGUCAUACCAGACUAUAACACAUAUAAAAAUACGUGUGAUGGUACAACAUUUACUUAUGCAUCAGCAUUGUGGGAAAUCCAACAGGUUGUAGAUGCAGAUAGUAAAAUUGUUCAACUUAGUGAAAUUAGUAUGGACAAUUCACCUAAUUUAGCAUGGCCUCUUAUUGUAACAGCUUUAAGGGCCAAUUCUGCUGUCAAAUUACAGAAUAAUGAGCUUAGUCCUGUUGCACUACGACAGAUGUCUUGUGCUGCCGGUACUACACAAACUGCUUGCACUGAUGACAAUGCGUUAGCUUACUACAACACAACAAAGGGAGGUAGGUUUGUACUUGCACUGUUAUCCGAUUUACAGGAUUUGAAAUGGGCUAGAUUCCCUAAGAGUGAUGGAACUGGUACUAUCUAUACAGAACUGGAACCACCUUGUAGGUUUGUUACAGACACACCUAAAGGUCCUAAAGUGAAGUAUUUAUACUUUAUUAAAGGAUUAAACAACCUAAAUAGAGGUAUGGUACUUGGUAGUUUAGCUGCCACAGUACGUCUACAAGCUGGUAAUGCAACAGAAGUGCCUGCCAAUUCAACUGUAUUAUCUUUCUGUGCUUUUGCUGUAGAUGCUGCUAAAGCUUACAAAGAUUAUCUAGCUAGUGGGGGACAACCAAUCACUAAUUGUGUUAAGAUGUUGUGUACACACACUGGUACUGGUCAGGCAAUAACAGUUACACCGGAAGCCAAUAUGGAUCAAGAAUCCUUUGGUGGUGCAUCGUGUUGUCUGUACUGCCGUUGCCACAUAGAUCAUCCAAAUCCUAAAGGAUUUUGUGACUUAAAAGGUAAGUAUGUACAAAUACCUACAACUUGUGCUAAUGACCCUGUGGGUUUUACACUUAAAAACACAGUCUGUACCGUCUGCGGUAUGUGGAAAGGUUAUGGCUGUAGUUGUGAUCAACUCCGCGAACCCAUGCUUCAGUCAGCUGAUGCACAAUCGUUUUUAAACGGGUUUGCGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGGCACUAGUACUGAUGUCGUAUACAGGGCUUUUGACAUCUACAAUGAUAAAGUAGCUGGUUUUGCUAAAUUCCUAAAAACUAAUUGUUGUCGCUUCCAAGAAAAGGACGAAGAUGACAAUUUAAUUGAUUCUUACUUUGUAGUUAAGAGACACACUUUCUCUAACUACCAACAUGAAGAAACAAUUUAUAAUUUACUUAAGGAUUGUCCAGCUGUUGCUAAACAUGACUUCUUUAAGUUUAGAAUAGACGGUGACAUGGUACCACAUAUAUCACGUCAACGUCUUACUAAAUACACAAUGGCAGACCUCGUCUAUGCUUUAAGGCAUUUUGAUGAAGGUAAUUGUGACACAUUAAAAGAAAUACUUGUCACAUACAAUUGUUGUGAUGAUGAUUAUUUCAAUAAAAAGGACUGGUAUGAUUUUGUAGAAAACCCAGAUAUAUUACGCGUAUACGCCAACUUAGGUGAACGUGUACGCCAAGCUUUGUUAAAAACAGUACAAUUCUGUGAUGCCAUGCGAAAUGCUGGUAUUGUUGGUGUACUGACAUUAGAUAAUCAAGAUCUCAAUGGUAACUGGUAUGAUUUCGGUGAUUUCAUACAAACCACGCCAGGUAGUGGAGUUCCUGUUGUAGAUUCUUAUUAUUCAUUGUUAAUGCCUAUAUUAACCUUGACCAGGGCUUUAACUGCAGAGUCACAUGUUGACACUGACUUAACAAAGCCUUACAUUAAGUGGGAUUUGUUAAAAUAUGACUUCACGGAAGAGAGGUUAAAACUCUUUGACCGUUAUUUUAAAUAUUGGGAUCAGACAUACCACCCAAAUUGUGUUAACUGUUUGGAUGACAGAUGCAUUCUGCAUUGUGCAAACUUUAAUGUUUUAUUCUCUACAGUGUUCCCACCUACAAGUUUUGGACCACUAGUGAGAAAAAUAUUUGUUGAUGGUGUUCCAUUUGUAGUUUCAACUGGAUACCACUUCAGAGAGCUAGGUGUUGUACAUAAUCAGGAUGUAAACUUACAUAGCUCUAGACUUAGUUUUAAGGAAUUACUUGUGUAUGCUGCUGACCCUGCUAUGCACGCUGCUUCUGGUAAUCUAUUACUAGAUAAACGCACUACGUGCUUUUCAGUAGCUGCACUUACUAACAAUGUUGCUUUUCAAACUGUCAAACCCGGUAAUUUUAACAAAGACUUCUAUGACUUUGCUGUGUCUAAGGGUUUCUUUAAGGAAGGAAGUUCUGUUGAAUUAAAACACUUCUUCUUUGCUCAGGAUGGUAAUGCUGCUAUCAGCGAUUAUGACUACUAUCGUUAUAAUCUACCAACAAUGUGUGAUAUCAGACAACUACUAUUUGUAGUUGAAGUUGUUGAUAAGUACUUUGAUUGUUACGAUGGUGGCUGUAUUAAUGCUAACCAAGUCAUCGUCAACAACCUAGACAAAUCAGCUGGUUUUCCAUUUAAUAAAUGGGGUAAGGCUAGACUUUAUUAUGAUUCAAUGAGUUAUGAGGAUCAAGAUGCACUUUUCGCAUAUACAAAACGUAAUGUCAUCCCUACUAUAACUCAAAUGAAUCUUAAGUAUGCCAUUAGUGCAAAGAAUAGAGCUCGCACCGUAGCUGGUGUCUCUAUCUGUAGUACUAUGACCAAUAGACAGUUUCAUCAAAAAUUAUUGAAAUCAAUAGCCGCCACUAGAGGAGCUACUGUAGUAAUUGGAACAAGCAAAUUCUAUGGUGGUUGGCACAACAUGUUAAAAACUGUUUAUAGUGAUGUAGAAAACCCUCACCUUAUGGGUUGGGAUUAUCCUAAAUGUGAUAGAGCCAUGCCUAACAUGCUUAGAAUUAUGGCCUCACUUGUUCUUGCUCGCAAACAUACAACGUGUUGUAGCUUGUCACACCGUUUCUAUAGAUUAGCUAAUGAGUGUGCUCAAGUAUUGAGUGAAAUGGUCAUGUGUGGCGGUUCACUAUAUGUUAAACCAGGUGGAACCUCAUCAGGAGAUGCCACAACUGCUUAUGCUAAUAGUGUUUUUAACAUUUGUCAAGCUGUCACGGCCAAUGUUAAUGCACUUUUAUCUACUGAUGGUAACAAAAUUGCCGAUAAGUAUGUCCGCAAUUUACAACACAGACUUUAUGAGUGUCUCUAUAGAAAUAGAGAUGUUGACACAGACUUUGUGAAUGAGUUUUACGCAUAUUUGCGUAAACAUUUCUCAAUGAUGAUACUCUCUGACGAUGCUGUUGUGUGUUUCAAUAGCACUUAUGCAUCUCAAGGUCUAGUGGCUAGCAUAAAGAACUUUAAGUCAGUUCUUUAUUAUCAAAACAAUGUUUUUAUGUCUGAAGCAAAAUGUUGGACUGAGACUGACCUUACUAAAGGACCUCAUGAAUUUUGCUCUCAACAUACAAUGCUAGUUAAACAGGGUGAUGAUUAUGUGUACCUUCCUUACCCAGAUCCAUCAAGAAUCCUAGGGGCCGGCUGUUUUGUAGAUGAUAUCGUAAAAACAGAUGGUACACUUAUGAUUGAACGGUUCGUGUCUUUAGCUAUAGAUGCUUACCCACUUACUAAACAUCCUAAUCAGGAGUAUGCUGAUGUCUUUCAUUUGUACUUACAAUACAUAAGAAAGCUACAUGAUGAGUUAACAGGACACAUGUUAGACAUGUAUUCUGUUAUGCUUACUAAUGAUAACACUUCAAGGUAUUGGGAACCUGAGUUUUAUGAGGCUAUGUACACACCGCAUACAGUCUUACAGGCUGUUGGGGCUUGUGUUCUUUGCAAUUCACAGACUUCAUUAAGAUGUGGUGCUUGCAUACGUAGACCAUUCUUAUGUUGUAAAUGCUGUUACGACCAUGUCAUAUCAACAUCACAUAAAUUAGUCUUGUCUGUUAAUCCGUAUGUUUGCAAUGCUCCAGGUUGUGAUGUCACAGAUGUGACUCAACUUUACUUAGGAGGUAUGAGCUAUUAUUGUAAAUCACAUAAACCACCCAUUAGUUUUCCAUUGUGUGCUAAUGGACAAGUUUUUGGUUUAUAUAAAAAUACAUGUGUUGGUAGCGAUAAUGUUACUGACUUUAAUGCAAUUGCAACAUGUGACUGGACAAAUGCUGGUGAUUACAUUUUAGCUAACACCUGUACUGAAAGACUCAAGCUUUUUGCAGCAGAAACGCUCAAAGCUACUGAGGAGACAUUUAAACUGUCUUAUGGUAUUGCUACUGUACGUGAAGUGCUGUCUGACAGAGAAUUACAUCUUUCAUGGGAAGUUGGUAAACCUAGACCACCACUUAACCGAAAUUAUGUCUUUACUGGUUAUCGUGUAACUAAAAACAGUAAAGUACAAAUAGGAGAGUACACCUUUGAAAAAGGUGACUAUGGUGAUGCUGUUGUUUACCGAGGUACAACAACUUACAAAUUAAAUGUUGGUGAUUAUUUUGUGCUGACAUCACAUACAGUAAUGCCAUUAAGUGCACCUACACUAGUGCCACAAGAGCACUAUGUUAGAAUUACUGGCUUAUACCCAACACUCAAUAUCUCAGAUGAGUUUUCUAGCAAUGUUGCAAAUUAUCAAAAGGUUGGUAUGCAAAAGUAUUCUACACUCCAGGGACCACCUGGUACUGGUAAGAGUCAUUUUGCUAUUGGCCUAGCUCUCUACUACCCUUCUGCUCGCAUAGUGUAUACAGCUUGCUCUCAUGCCGCUGUUGAUGCACUAUGUGAGAAGGCAUUAAAAUAUUUGCCUAUAGAUAAAUGUAGUAGAAUUAUACCUGCACGUGCUCGUGUAGAGUGUUUUGAUAAAUUCAAAGUGAAUUCAACAUUAGAACAGUAUGUCUUUUGUACUGUAAAUGCAUUGCCUGAGACGACAGCAGAUAUAGUUGUCUUUGAUGAAAUUUCAAUGGCCACAAAUUAUGAUUUGAGUGUUGUCAAUGCCAGAUUACGUGCUAAGCACUAUGUGUACAUUGGCGACCCUGCUCAAUUACCUGCACCACGCACAUUGCUAACUAAGGGCACACUAGAACCAGAAUAUUUCAAUUCAGUGUGUAGACUUAUGAAAACUAUAGGUCCAGACAUGUUCCUCGGAACUUGUCGGCGUUGUCCUGCUGAAAUUGUUGACACUGUGAGUGCUUUGGUUUAUGAUAAUAAGCUUAAAGCACAUAAAGACAAAUCAGCUCAAUGCUUUAAAAUGUUUUAUAAGGGUGUUAUCACGCAUGAUGUUUCAUCUGCAAUUAACAGGCCACAAAUAGGCGUGGUAAGAGAAUUCCUUACACGUAACCCUGCUUGGAGAAAAGCUGUCUUUAUUUCACCUUAUAAUUCACAGAAUGCUGUAGCCUCAAAGAUUUUGGGACUACCAACUCAAACUGUUGAUUCAUCACAGGGCUCAGAAUAUGACUAUGUCAUAUUCACUCAAACCACUGAAACAGCUCACUCUUGUAAUGUAAACAGAUUUAAUGUUGCUAUUACCAGAGCAAAAGUAGGCAUACUUUGCAUAAUGUCUGAUAGAGACCUUUAUGACAAGUUGCAAUUUACAAGUCUUGAAAUUCCACGUAGGAAUGUGGCAACUUUACAAGCUGAAAAUGUAACAGGACUCUUUAAAGAUUGUAGUAAGGUAAUCACUGGGUUACAUCCUACACAGGCACCUACACACCUCAGUGUUGACACUAAAUUCAAAACUGAAGGUUUAUGUGUUGACAUACCUGGCAUACCUAAGGACAUGACCUAUAGAAGACUCAUCUCUAUGAUGGGUUUUAAAAUGAAUUAUCAAGUUAAUGGUUACCCUAACAUGUUUAUCACCCGCGAAGAAGCUAUAAGACAUGUACGUGCAUGGAUUGGCUUCGAUGUCGAGGGGUGUCAUGCUACUAGAGAAGCUGUUGGUACCAAUUUACCUUUACAGCUAGGUUUUUCUACAGGUGUUAACCUAGUUGCUGUACCUACAGGUUAUGUUGAUACACCUAAUAAUACAGAUUUUUCCAGAGUUAGUGCUAAACCACCGCCUGGAGAUCAAUUUAAACACCUCAUACCACUUAUGUACAAAGGACUUCCUUGGAAUGUAGUGCGUAUAAAGAUUGUACAAAUGUUAAGUGACACACUUAAAAAUCUCUCUGACAGAGUCGUAUUUGUCUUAUGGGCACAUGGCUUUGAGUUGACAUCUAUGAAGUAUUUUGUGAAAAUAGGACCUGAGCGCACCUGUUGUCUAUGUGAUAGACGUGCCACAUGCUUUUCCACUGCUUCAGACACUUAUGCCUGUUGGCAUCAUUCUAUUGGAUUUGAUUACGUCUAUAAUCCGUUUAUGAUUGAUGUUCAACAAUGGGGUUUUACAGGUAACCUACAAAGCAACCAUGAUCUGUAUUGUCAAGUCCAUGGUAAUGCACAUGUAGCUAGUUGUGAUGCAAUCAUGACUAGGUGUCUAGCUGUCCACGAGUGCUUUGUUAAGCGUGUUGACUGGACUAUUGAAUAUCCUAUAAUUGGUGAUGAACUGAAGAUUAAUGCGGCUUGUAGAAAGGUUCAACACAUGGUUGUUAAAGCUGCAUUAUUAGCAGACAAAUUCCCAGUUCUUCACGACAUUGGUAACCCUAAAGCUAUUAAGUGUGUACCUCAAGCUGAUGUAGAAUGGAAGUUCUAUGAUGCACAGCCUUGUAGUGACAAAGCUUAUAAAAUAGAAGAAUUAUUCUAUUCUUAUGCCACACAUUCUGACAAAUUCACAGAUGGUGUAUGCCUAUUUUGGAAUUGCAAUGUCGAUAGAUAUCCUGCUAAUUCCAUUGUUUGUAGAUUUGACACUAGAGUGCUAUCUAACCUUAACUUGCCUGGUUGUGAUGGUGGCAGUUUGUAUGUAAAUAAACAUGCAUUCCACACACCAGCUUUUGAUAAAAGUGCUUUUGUUAAUUUAAAACAAUUACCAUUUUUCUAUUACUCUGACAGUCCAUGUGAGUCUCAUGGAAAACAAGUAGUGUCAGAUAUAGAUUAUGUACCACUAAAGUCUGCUACGUGUAUAACACGUUGCAAUUUAGGUGGUGCUGUCUGUAGACAUCAUGCUAAUGAGUACAGAUUGUAUCUCGAUGCUUAUAACAUGAUGAUCUCAGCUGGCUUUAGCUUGUGGGUUUACAAACAAUUUGAUACUUAUAACCUCUGGAACACUUUUACAAGACUUCAGAGUUUAGAAAAUGUGGCUUUUAAUGUUGUAAAUAAGGGACACUUUGAUGGACAACAGGGUGAAGUACCAGUUUCUAUCAUUAAUAACACUGUUUACACAAAAGUUGAUGGUGUUGAUGUAGAAUUGUUUGAAAAUAAAACAACAUUACCUGUUAAUGUAGCAUUUGAGCUUUGGGCUAAGCGCAACAUUAAACCAGUACCAGAGGUGAAAAUACUCAAUAAUUUGGGUGUGGACAUUGCUGCUAAUACUGUGAUCUGGGACUACAAAAGAGAUGCUCCAGCACAUAUAUCUACUAUUGGUGUUUGUUCUAUGACUGACAUAGCCAAGAAACCAACUGAAACGAUUUGUGCACCACUCACUGUCUUUUUUGAUGGUAGAGUUGAUGGUCAAGUAGACUUAUUUAGAAAUGCCCGUAAUGGUGUUCUUAUUACAGAAGGUAGUGUUAAAGGUUUACAACCAUCUGUAGGUCCCAAACAAGCUAGUCUUAAUGGAGUCACAUUAAUUGGAGAAGCCGUAAAAACACAGUUCAAUUAUUAUAAGAAAGUUGAUGGUGUUGUCCAACAAUUACCUGAAACUUACUUUACUCAGAGUAGAAAUUUACAAGAAUUUAAACCCAGGAGUCAAAUGGAAAUUGAUUUCUUAGAAUUAGCUAUGGAUGAAUUCAUUGAACGGUAUAAAUUAGAAGGCUAUGCCUUCGAACAUAUCGUUUAUGGAGAUUUUAGUCAUAGUCAGUUAGGUGGUUUACAUCUACUGAUUGGACUAGCUAAACGUUUUAAGGAAUCACCUUUUGAAUUAGAAGAUUUUAUUCCUAUGGACAGUACAGUUAAAAACUAUUUCAUAACAGAUGCGCAAACAGGUUCAUCUAAGUGUGUGUGUUCUGUUAUUGAUUUAUUACUUGAUGAUUUUGUUGAAAUAAUAAAAUCCCAAGAUUUAUCUGUAGUUUCUAAGGUUGUCAAAGUGACUAUUGACUAUACAGAAAUUUCAUUUAUGCUUUGGUGUAAAGAUGGCCAUGUAGAAACAUUUUACCCAAAAUUACAAUCUAGUCAAGCGUGGCAACCGGGUGUUGCUAUGCCUAAUCUUUACAAAAUGCAAAGAAUGCUAUUAGAAAAGUGUGACCUUCAAAAUUAUGGUGAUAGUGCAACAUUACCUAAAGGCAUAAUGAUGAAUGUCGCAAAAUAUACUCAACUGUGUCAAUAUUUAAACACAUUAACAUUAGCUGUACCCUAUAAUAUGAGAGUUAUACAUUUUGGUGCUGGUUCUGAUAAAGGAGUUGCACCAGGUACAGCUGUUUUAAGACAGUGGUUGCCUACGGGUACGCUGCUUGUCGAUUCAGAUCUUAAUGACUUUGUCUCUGAUGCAGAUUCAACUUUGAUUGGUGAUUGUGCAACUGUACAUACAGCUAAUAAAUGGGAUCUCAUUAUUAGUGAUAUGUACGACCCUAAGACUAAAAAUGUUACAAAAGAAAAUGACUCUAAAGAGGGUUUUUUCACUUACAUUUGUGGGUUUAUACAACAAAAGCUAGCUCUUGGAGGUUCCGUGGCUAUAAAGAUAACAGAACAUUCUUGGAAUGCUGAUCUUUAUAAGCUCAUGGGACACUUCGCAUGGUGGACAGCCUUUGUUACUAAUGUGAAUGCGUCAUCAUCUGAAGCAUUUUUAAUUGGAUGUAAUUAUCUUGGCAAACCACGCGAACAAAUAGAUGGUUAUGUCAUGCAUGCAAAUUACAUAUUUUGGAGGAAUACAAAUCCAAUUCAGUUGUCUUCCUAUUCUUUAUUUGACAUGAGUAAAUUUCCCCUUAAAUUAAGGGGUACUGCUGUUAUGUCUUUAAAAGAAGGUCAAAUCAAUGAUAUGAUUUUAUCUCUUCUUAGUAAAGGUAGACUUAUAAUUAGAGAAAACAACAGAGUUGUUAUUUCUAGUGAUGUUCUUGUUAACAACUAAACGAACAAUGUUUGUUUUUCUUGUUUUAUUGCCACUAGUCUCUAGUCAGUGUGUUAAUCUUACAACCAGAACUCAAUUACCCCCUGCAUACACUAAUUCUUUCACACGUGGUGUUUAUUACCCUGACAAAGUUUUCAGAUCCUCAGUUUUACAUUCAACUCAGGACUUGUUCUUACCUUUCUUUUCCAAUGUUACUUGGUUCCAUGCUAUACAUGUCUCUGGGACCAAUGGUACUAAGAGGUUUGAUAACCCUGUCCUACCAUUUAAUGAUGGUGUUUAUUUUGCUUCCACUGAGAAGUCUAACAUAAUAAGAGGCUGGAUUUUUGGUACUACUUUAGAUUCGAAGACCCAGUCCCUACUUAUUGUUAAUAACGCUACUAAUGUUGUUAUUAAAGUCUGUGAAUUUCAAUUUUGUAAUGAUCCAUUUUUGGGUGUUUAUUACCACAAAAACAACAAAAGUUGGAUGGAAAGUGAGUUCAGAGUUUAUUCUAGUGCGAAUAAUUGCACUUUUGAAUAUGUCUCUCAGCCUUUUCUUAUGGACCUUGAAGGAAAACAGGGUAAUUUCAAAAAUCUUAGGGAAUUUGUGUUUAAGAAUAUUGAUGGUUAUUUUAAAAUAUAUUCUAAGCACACGCCUAUUAAUUUAGUGCGUGAUCUCCCUCAGGGUUUUUCGGCUUUAGAACCAUUGGUAGAUUUGCCAAUAGGUAUUAACAUCACUAGGUUUCAAACUUUACUUGCUUUACAUAGAAGUUAUUUGACUCCUGGUGAUUCUUCUUCAGGUUGGACAGCUGGUGCUGCAGCUUAUUAUGUGGGUUAUCUUCAACCUAGGACUUUUCUAUUAAAAUAUAAUGAAAAUGGAACCAUUACAGAUGCUGUAGACUGUGCACUUGACCCUCUCUCAGAAACAAAGUGUACGUUGAAAUCCUUCACUGUAGAAAAAGGAAUCUAUCAAACUUCUAACUUUAGAGUCCAACCAACAGAAUCUAUUGUUAGAUUUCCUAAUAUUACAAACUUGUGCCCUUUUGGUGAAGUUUUUAACGCCACCAGAUUUGCAUCUGUUUAUGCUUGGAACAGGAAGAGAAUCAGCAACUGUGUUGCUGAUUAUUCUGUCCUAUAUAAUUCCGCAUCAUUUUCCACUUUUAAGUGUUAUGGAGUGUCUCCUACUAAAUUAAAUGAUCUCUGCUUUACUAAUGUCUAUGCAGAUUCAUUUGUAAUUAGAGGUGAUGAAGUCAGACAAAUCGCUCCAGGGCAAACUGGAAAGAUUGCUGAUUAUAAUUAUAAAUUACCAGAUGAUUUUACAGGCUGCGUUAUAGCUUGGAAUUCUAACAAUCUUGAUUCUAAGGUUGGUGGUAAUUAUAAUUACCUGUAUAGAUUGUUUAGGAAGUCUAAUCUCAAACCUUUUGAGAGAGAUAUUUCAACUGAAAUCUAUCAGGCCGGUAGCACACCUUGUAAUGGUGUUGAAGGUUUUAAUUGUUACUUUCCUUUACAAUCAUAUGGUUUCCAACCCACUAAUGGUGUUGGUUACCAACCAUACAGAGUAGUAGUACUUUCUUUUGAACUUCUACAUGCACCAGCAACUGUUUGUGGACCUAAAAAGUCUACUAAUUUGGUUAAAAACAAAUGUGUCAAUUUCAACUUCAAUGGUUUAACAGGCACAGGUGUUCUUACUGAGUCUAACAAAAAGUUUCUGCCUUUCCAACAAUUUGGCAGAGACAUUGCUGACACUACUGAUGCUGUCCGUGAUCCACAGACACUUGAGAUUCUUGACAUUACACCAUGUUCUUUUGGUGGUGUCAGUGUUAUAACACCAGGAACAAAUACUUCUAACCAGGUUGCUGUUCUUUAUCAGGAUGUUAACUGCACAGAAGUCCCUGUUGCUAUUCAUGCAGAUCAACUUACUCCUACUUGGCGUGUUUAUUCUACAGGUUCUAAUGUUUUUCAAACACGUGCAGGCUGUUUAAUAGGGGCUGAACAUGUCAACAACUCAUAUGAGUGUGACAUACCCAUUGGUGCAGGUAUAUGCGCUAGUUAUCAGACUCAGACUAAUUCUCCUCGGCGGGCACGUAGUGUAGCUAGUCAAUCCAUCAUUGCCUACACUAUGUCACUUGGUGCAGAAAAUUCAGUUGCUUACUCUAAUAACUCUAUUGCCAUACCCACAAAUUUUACUAUUAGUGUUACCACAGAAAUUCUACCAGUGUCUAUGACCAAGACAUCAGUAGAUUGUACAAUGUACAUUUGUGGUGAUUCAACUGAAUGCAGCAAUCUUUUGUUGCAAUAUGGCAGUUUUUGUACACAAUUAAACCGUGCUUUAACUGGAAUAGCUGUUGAACAAGACAAAAACACCCAAGAAGUUUUUGCACAAGUCAAACAAAUUUACAAAACACCACCAAUUAAAGAUUUUGGUGGUUUUAAUUUUUCACAAAUAUUACCAGAUCCAUCAAAACCAAGCAAGAGGUCAUUUAUUGAAGAUCUACUUUUCAACAAAGUGACACUUGCAGAUGCUGGCUUCAUCAAACAAUAUGGUGAUUGCCUUGGUGAUAUUGCUGCUAGAGACCUCAUUUGUGCACAAAAGUUUAACGGCCUUACUGUUUUGCCACCUUUGCUCACAGAUGAAAUGAUUGCUCAAUACACUUCUGCACUGUUAGCGGGUACAAUCACUUCUGGUUGGACCUUUGGUGCAGGUGCUGCAUUACAAAUACCAUUUGCUAUGCAAAUGGCUUAUAGGUUUAAUGGUAUUGGAGUUACACAGAAUGUUCUCUAUGAGAACCAAAAAUUGAUUGCCAACCAAUUUAAUAGUGCUAUUGGCAAAAUUCAAGACUCACUUUCUUCCACAGCAAGUGCACUUGGAAAACUUCAAGAUGUGGUCAACCAAAAUGCACAAGCUUUAAACACGCUUGUUAAACAACUUAGCUCCAAUUUUGGUGCAAUUUCAAGUGUUUUAAAUGAUAUCCUUUCACGUCUUGACAAAGUUGAGGCUGAAGUGCAAAUUGAUAGGUUGAUCACAGGCAGACUUCAAAGUUUGCAGACAUAUGUGACUCAACAAUUAAUUAGAGCUGCAGAAAUCAGAGCUUCUGCUAAUCUUGCUGCUACUAAAAUGUCAGAGUGUGUACUUGGACAAUCAAAAAGAGUUGAUUUUUGUGGAAAGGGCUAUCAUCUUAUGUCCUUCCCUCAGUCAGCACCUCAUGGUGUAGUCUUCUUGCAUGUGACUUAUGUCCCUGCACAAGAAAAGAACUUCACAACUGCUCCUGCCAUUUGUCAUGAUGGAAAAGCACACUUUCCUCGUGAAGGUGUCUUUGUUUCAAAUGGCACACACUGGUUUGUAACACAAAGGAAUUUUUAUGAACCACAAAUCAUUACUACAGACAACACAUUUGUGUCUGGUAACUGUGAUGUUGUAAUAGGAAUUGUCAACAACACAGUUUAUGAUCCUUUGCAACCUGAAUUAGACUCAUUCAAGGAGGAGUUAGAUAAAUAUUUUAAGAAUCAUACAUCACCAGAUGUUGAUUUAGGUGACAUCUCUGGCAUUAAUGCUUCAGUUGUAAACAUUCAAAAAGAAAUUGACCGCCUCAAUGAGGUUGCCAAGAAUUUAAAUGAAUCUCUCAUCGAUCUCCAAGAACUUGGAAAGUAUGAGCAGUAUAUAAAAUGGCCAUGGUACAUUUGGCUAGGUUUUAUAGCUGGCUUGAUUGCCAUAGUAAUGGUGACAAUUAUGCUUUGCUGUAUGACCAGUUGCUGUAGUUGUCUCAAGGGCUGUUGUUCUUGUGGAUCCUGCUGCAAAUUUGAUGAAGACGACUCUGAGCCAGUGCUCAAAGGAGUCAAAUUACAUUACACAUAAACGAACUUAUGGAUUUGUUUAUGAGAAUCUUCACAAUUGGAACUGUAACUUUGAAGCAAGGUGAAAUCAAGGAUGCUACUCCUUCAGAUUUUGUUCGCGCUACUGCAACGAUACCGAUACAAGCCUCACUCCCUUUCGGAUGGCUUAUUGUUGGCGUUGCACUUCUUGCUGUUUUUCAGAGCGCUUCCAAAAUCAUAACCCUCAAAAAGAGAUGGCAACUAGCACUCUCCAAGGGUGUUCACUUUGUUUGCAACUUGCUGUUGUUGUUUGUAACAGUUUACUCACACCUUUUGCUCGUUGCUGCUGGCCUUGAAGCCCCUUUUCUCUAUCUUUAUGCUUUAGUCUACUUCUUGCAGAGUAUAAACUUUGUAAGAAUAAUAAUGAGGCUUUGGCUUUGCUGGAAAUGCCGUUCCAAAAACCCAUUACUUUAUGAUGCCAACUAUUUUCUUUGCUGGCAUACUAAUUGUUACGACUAUUGUAUACCUUACAAUAGUGUAACUUCUUCAAUUGUCAUUACUUCAGGUGAUGGCACAACAAGUCCUAUUUCUGAACAUGACUACCAGAUUGGUGGUUAUACUGAAAAAUGGGAAUCUGGAGUAAAAGACUGUGUUGUAUUACACAGUUACUUCACUUCAGACUAUUACCAGCUGUACUCAACUCAAUUGAGUACAGACACUGGUGUUGAACAUGUUACCUUCUUCAUCUACAAUAAAAUUGUUGAUGAGCCUGAAGAACAUGUCCAAAUUCACACAAUCGACGGUUCAUCCGGAGUUGUUAAUCCAGUAAUGGAACCAAUUUAUGAUGAACCGACGACGACUACUAGCGUGCCUUUGUAAGCACAAGCUGAUGAGUACGAACUUAUGUACUCAUUCGUUUCGGAAGAGACAGGUACGUUAAUAGUUAAUAGCGUACUUCUUUUUCUUGCUUUCGUGGUAUUCUUGCUAGUUACACUAGCCAUCCUUACUGCGCUUCGAUUGUGUGCGUACUGCUGCAAUAUUGUUAACGUGAGUCUUGUAAAACCUUCUUUUUACGUUUACUCUCGUGUUAAAAAUCUGAAUUCUUCUAGAGUUCCUGAUCUUCUGGUCUAAACGAACUAAAUAUUAUAUUAGUUUUUCUGUUUGGAACUUUAAUUUUAGCCAUGGCAGAUUCCAACGGUACUAUUACCGUUGAAGAGCUUAAAAAGCUCCUUGAACAAUGGAACCUAGUAAUAGGUUUCCUAUUCCUUACAUGGAUUUGUCUUCUACAAUUUGCCUAUGCCAACAGGAAUAGGUUUUUGUAUAUAAUUAAGUUAAUUUUCCUCUGGCUGUUAUGGCCAGUAACUUUAGCUUGUUUUGUGCUUGCUGCUGUUUACAGAAUAAAUUGGAUCACCGGUGGAAUUGCUAUCGCAAUGGCUUGUCUUGUAGGCUUGAUGUGGCUCAGCUACUUCAUUGCUUCUUUCAGACUGUUUGCGCGUACGCGUUCCAUGUGGUCAUUCAAUCCAGAAACUAACAUUCUUCUCAACGUGCCACUCCAUGGCACUAUUCUGACCAGACCGCUUCUAGAAAGUGAACUCGUAAUCGGAGCUGUGAUCCUUCGUGGACAUCUUCGUAUUGCUGGACACCAUCUAGGACGCUGUGACAUCAAGGACCUGCCUAAAGAAAUCACUGUUGCUACAUCACGAACGCUUUCUUAUUACAAAUUGGGAGCUUCGCAGCGUGUAGCAGGUGACUCAGGUUUUGCUGCAUACAGUCGCUACAGGAUUGGCAACUAUAAAUUAAACACAGACCAUUCCAGUAGCAGUGACAAUAUUGCUUUGCUUGUACAGUAAGUGACAACAGAUGUUUCAUCUCGUUGACUUUCAGGUUACUAUAGCAGAGAUAUUACUAAUUAUUAUGAGGACUUUUAAAGUUUCCAUUUGGAAUCUUGAUUACAUCAUAAACCUCAUAAUUAAAAAUUUAUCUAAGUCACUAACUGAGAAUAAAUAUUCUCAAUUAGAUGAAGAGCAACCAAUGGAGAUUGAUUAAACGAACAUGAAAAUUAUUCUUUUCUUGGCACUGAUAACACUCGCUACUUGUGAGCUUUAUCACUACCAAGAGUGUGUUAGAGGUACAACAGUACUUUUAAAAGAACCUUGCUCUUCUGGAACAUACGAGGGCAAUUCACCAUUUCAUCCUCUAGCUGAUAACAAAUUUGCACUGACUUGCUUUAGCACUCAAUUUGCUUUUGCUUGUCCUGACGGCGUAAAACACGUCUAUCAGUUACGUGCCAGAUCAGUUUCACCUAAACUGUUCAUCAGACAAGAGGAAGUUCAAGAACUUUACUCUCCAAUUUUUCUUAUUGUUGCGGCAAUAGUGUUUAUAACACUUUGCUUCACACUCAAAAGAAAGACAGAAUGAUUGAACUUUCAUUAAUUGACUUCUAUUUGUGCUUUUUAGCCUUUCUGCUAUUCCUUGUUUUAAUUAUGCUUAUUAUCUUUUGGUUCUCACUUGAACUGCAAGAUCAUAAUGAAACUUGUCACGCCUAAACGAACAUGAAAUUUCUUGUUUUCUUAGGAAUCAUCACAACUGUAGCUGCAUUUCACCAAGAAUGUAGUUUACAGUCAUGUACUCAACAUCAACCAUAUGUAGUUGAUGACCCGUGUCCUAUUCACUUCUAUUCUAAAUGGUAUAUUAGAGUAGGAGCUAGAAAAUCAGCACCUUUAAUUGAAUUGUGCGUGGAUGAGGCUGGUUCUAAAUCACCCAUUCAGUACAUCGAUAUCGGUAAUUAUACAGUUUCCUGUUUACCUUUUACAAUUAAUUGCCAGGAACCUAAAUUGGGUAGUCUUGUAGUGCGUUGUUCGUUCUAUGAAGACUUUUUAGAGUAUCAUGACGUUCGUGUUGUUUUAGAUUUCAUCUAAACGAACAAACUAAAAUGUCUGAUAAUGGACCCCAAAAUCAGCGAAAUGCACCCCGCAUUACGUUUGGUGGACCCUCAGAUUCAACUGGCAGUAACCAGAAUGGAGAACGCAGUGGGGCGCGAUCAAAACAACGUCGGCCCCAAGGUUUACCCAAUAAUACUGCGUCUUGGUUCACCGCUCUCACUCAACAUGGCAAGGAAGACCUUAAAUUCCCUCGAGGACAAGGCGUUCCAAUUAACACCAAUAGCAGUCCAGAUGACCAAAUUGGCUACUACCGAAGAGCUACCAGACGAAUUCGUGGUGGUGACGGUAAAAUGAAAGAUCUCAGUCCAAGAUGGUAUUUCUACUACCUAGGAACUGGGCCAGAAGCUGGACUUCCCUAUGGUGCUAACAAAGACGGCAUCAUAUGGGUUGCAACUGAGGGAGCCUUGAAUACACCAAAAGAUCACAUUGGCACCCGCAAUCCUGCUAACAAUGCUGCAAUCGUGCUACAACUUCCUCAAGGAACAACAUUGCCAAAAGGCUUCUACGCAGAAGGGAGCAGAGGCGGCAGUCAAGCCUCUUCUCGUUCCUCAUCACGUAGUCGCAACAGUUCAAGAAAUUCAACUCCAGGCAGCAGUAGGGGAACUUCUCCUGCUAGAAUGGCUGGCAAUGGCGGUGAUGCUGCUCUUGCUUUGCUGCUGCUUGACAGAUUGAACCAGCUUGAGAGCAAAAUGUCUGGUAAAGGCCAACAACAACAAGGCCAAACUGUCACUAAGAAAUCUGCUGCUGAGGCUUCUAAGAAGCCUCGGCAAAAACGUACUGCCACUAAAGCAUACAAUGUAACACAAGCUUUCGGCAGACGUGGUCCAGAACAAACCCAAGGAAAUUUUGGGGACCAGGAACUAAUCAGACAAGGAACUGAUUACAAACAUUGGCCGCAAAUUGCACAAUUUGCCCCCAGCGCUUCAGCGUUCUUCGGAAUGUCGCGCAUUGGCAUGGAAGUCACACCUUCGGGAACGUGGUUGACCUACACAGGUGCCAUCAAAUUGGAUGACAAAGAUCCAAAUUUCAAAGAUCAAGUCAUUUUGCUGAAUAAGCAUAUUGACGCAUACAAAACAUUCCCACCAACAGAGCCUAAAAAGGACAAAAAGAAGAAGGCUGAUGAAACUCAAGCCUUACCGCAGAGACAGAAGAAACAGCAAACUGUGACUCUUCUUCCUGCUGCAGAUUUGGAUGAUUUCUCCAAACAAUUGCAACAAUCCAUGAGCAGUGCUGACUCAACUCAGGCCUAAACUCAUGCAGACCACACAAGGCAGAUGGGCUAUAUAAACGUUUUCGCUUUUCCGUUUACGAUAUAUAGUCUACUCUUGUGCAGAAUGAAUUCUCGUAACUACAUAGCACAAGUAGAUGUAGUUAACUUUAAUCUCACAUAGCAAUCUUUAAUCAGUGUGUAACAUUAGGGAGGACUUGAAAGAGCCACCACAUUUUCACCGAGGCCACGCGGAGUACGAUCGAGUGUACAGUGAACAAUGCUAGGGAGAGCUGCCUAUAUGGAAGAGCCCUAAUGUGUAAAAUUAAUUUUAGUAGUGCUAUCCCCAUGUGAUUUUAAUAGCUUCUUAGGAGAAUGACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|protein_mutation:K375Q
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKQADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,protein_mutation:K375Q,419aa(1-419),P0DTC9,-,-,"[1-43],[73-102],[145-149],[152-160],[172-215],[235-271],[365-387],[409-419]",-,In vitro,5-20µM[SARS2-NP–VSV K375Q];|200nM[SARS-CoV-2],"15 mM NaCl, 135 mM KCl, 5 mM phosphate, 1.5 mM MgCl2","20 mM Tris–HCl, pH 7.0",37˚C,-,other_molecular:1 mg ml−1 BSA,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"To test whether these viral mutations induce changes in the phase separation of SARS2-NP , we incubated fluorescently labelled K375N and K375E with viral RNA and compared the micrometre-sized liquid droplet formation with that of SARS2-NP WT. Both the K375N and K375E mutants seemed to have compromised LLPS ",29903
218,706,PMID: 34239064,RNAPS0000450,https://pubmed.ncbi.nlm.nih.gov/34239064,RNA + protein,-,-,SARS-CoV-2 virus RNA,29903nt(1-29903),AUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGCACCUCAUGGUCAUGUUAUGGUUGAGCUGGUAGCAGAACUCGAAGGCAUUCAGUACGGUCGUAGUGGUGAGACACUUGGUGUCCUUGUCCCUCAUGUGGGCGAAAUACCAGUGGCUUACCGCAAGGUUCUUCUUCGUAAGAACGGUAAUAAAGGAGCUGGUGGCCAUAGUUACGGCGCCGAUCUAAAGUCAUUUGACUUAGGCGACGAGCUUGGCACUGAUCCUUAUGAAGAUUUUCAAGAAAACUGGAACACUAAACAUAGCAGUGGUGUUACCCGUGAACUCAUGCGUGAGCUUAACGGAGGGGCAUACACUCGCUAUGUCGAUAACAACUUCUGUGGCCCUGAUGGCUACCCUCUUGAGUGCAUUAAAGACCUUCUAGCACGUGCUGGUAAAGCUUCAUGCACUUUGUCCGAACAACUGGACUUUAUUGACACUAAGAGGGGUGUAUACUGCUGCCGUGAACAUGAGCAUGAAAUUGCUUGGUACACGGAACGUUCUGAAAAGAGCUAUGAAUUGCAGACACCUUUUGAAAUUAAAUUGGCAAAGAAAUUUGACACCUUCAAUGGGGAAUGUCCAAAUUUUGUAUUUCCCUUAAAUUCCAUAAUCAAGACUAUUCAACCAAGGGUUGAAAAGAAAAAGCUUGAUGGCUUUAUGGGUAGAAUUCGAUCUGUCUAUCCAGUUGCGUCACCAAAUGAAUGCAACCAAAUGUGCCUUUCAACUCUCAUGAAGUGUGAUCAUUGUGGUGAAACUUCAUGGCAGACGGGCGAUUUUGUUAAAGCCACUUGCGAAUUUUGUGGCACUGAGAAUUUGACUAAAGAAGGUGCCACUACUUGUGGUUACUUACCCCAAAAUGCUGUUGUUAAAAUUUAUUGUCCAGCAUGUCACAAUUCAGAAGUAGGACCUGAGCAUAGUCUUGCCGAAUACCAUAAUGAAUCUGGCUUGAAAACCAUUCUUCGUAAGGGUGGUCGCACUAUUGCCUUUGGAGGCUGUGUGUUCUCUUAUGUUGGUUGCCAUAACAAGUGUGCCUAUUGGGUUCCACGUGCUAGCGCUAACAUAGGUUGUAACCAUACAGGUGUUGUUGGAGAAGGUUCCGAAGGUCUUAAUGACAACCUUCUUGAAAUACUCCAAAAAGAGAAAGUCAACAUCAAUAUUGUUGGUGACUUUAAACUUAAUGAAGAGAUCGCCAUUAUUUUGGCAUCUUUUUCUGCUUCCACAAGUGCUUUUGUGGAAACUGUGAAAGGUUUGGAUUAUAAAGCAUUCAAACAAAUUGUUGAAUCCUGUGGUAAUUUUAAAGUUACAAAAGGAAAAGCUAAAAAAGGUGCCUGGAAUAUUGGUGAACAGAAAUCAAUACUGAGUCCUCUUUAUGCAUUUGCAUCAGAGGCUGCUCGUGUUGUACGAUCAAUUUUCUCCCGCACUCUUGAAACUGCUCAAAAUUCUGUGCGUGUUUUACAGAAGGCCGCUAUAACAAUACUAGAUGGAAUUUCACAGUAUUCACUGAGACUCAUUGAUGCUAUGAUGUUCACAUCUGAUUUGGCUACUAACAAUCUAGUUGUAAUGGCCUACAUUACAGGUGGUGUUGUUCAGUUGACUUCGCAGUGGCUAACUAACAUCUUUGGCACUGUUUAUGAAAAACUCAAACCCGUCCUUGAUUGGCUUGAAGAGAAGUUUAAGGAAGGUGUAGAGUUUCUUAGAGACGGUUGGGAAAUUGUUAAAUUUAUCUCAACCUGUGCUUGUGAAAUUGUCGGUGGACAAAUUGUCACCUGUGCAAAGGAAAUUAAGGAGAGUGUUCAGACAUUCUUUAAGCUUGUAAAUAAAUUUUUGGCUUUGUGUGCUGACUCUAUCAUUAUUGGUGGAGCUAAACUUAAAGCCUUGAAUUUAGGUGAAACAUUUGUCACGCACUCAAAGGGAUUGUACAGAAAGUGUGUUAAAUCCAGAGAAGAAACUGGCCUACUCAUGCCUCUAAAAGCCCCAAAAGAAAUUAUCUUCUUAGAGGGAGAAACACUUCCCACAGAAGUGUUAACAGAGGAAGUUGUCUUGAAAACUGGUGAUUUACAACCAUUAGAACAACCUACUAGUGAAGCUGUUGAAGCUCCAUUGGUUGGUACACCAGUUUGUAUUAACGGGCUUAUGUUGCUCGAAAUCAAAGACACAGAAAAGUACUGUGCCCUUGCACCUAAUAUGAUGGUAACAAACAAUACCUUCACACUCAAAGGCGGUGCACCAACAAAGGUUACUUUUGGUGAUGACACUGUGAUAGAAGUGCAAGGUUACAAGAGUGUGAAUAUCACUUUUGAACUUGAUGAAAGGAUUGAUAAAGUACUUAAUGAGAAGUGCUCUGCCUAUACAGUUGAACUCGGUACAGAAGUAAAUGAGUUCGCCUGUGUUGUGGCAGAUGCUGUCAUAAAAACUUUGCAACCAGUAUCUGAAUUACUUACACCACUGGGCAUUGAUUUAGAUGAGUGGAGUAUGGCUACAUACUACUUAUUUGAUGAGUCUGGUGAGUUUAAAUUGGCUUCACAUAUGUAUUGUUCUUUCUACCCUCCAGAUGAGGAUGAAGAAGAAGGUGAUUGUGAAGAAGAAGAGUUUGAGCCAUCAACUCAAUAUGAGUAUGGUACUGAAGAUGAUUACCAAGGUAAACCUUUGGAAUUUGGUGCCACUUCUGCUGCUCUUCAACCUGAAGAAGAGCAAGAAGAAGAUUGGUUAGAUGAUGAUAGUCAACAAACUGUUGGUCAACAAGACGGCAGUGAGGACAAUCAGACAACUACUAUUCAAACAAUUGUUGAGGUUCAACCUCAAUUAGAGAUGGAACUUACACCAGUUGUUCAGACUAUUGAAGUGAAUAGUUUUAGUGGUUAUUUAAAACUUACUGACAAUGUAUACAUUAAAAAUGCAGACAUUGUGGAAGAAGCUAAAAAGGUAAAACCAACAGUGGUUGUUAAUGCAGCCAAUGUUUACCUUAAACAUGGAGGAGGUGUUGCAGGAGCCUUAAAUAAGGCUACUAACAAUGCCAUGCAAGUUGAAUCUGAUGAUUACAUAGCUACUAAUGGACCACUUAAAGUGGGUGGUAGUUGUGUUUUAAGCGGACACAAUCUUGCUAAACACUGUCUUCAUGUUGUCGGCCCAAAUGUUAACAAAGGUGAAGACAUUCAACUUCUUAAGAGUGCUUAUGAAAAUUUUAAUCAGCACGAAGUUCUACUUGCACCAUUAUUAUCAGCUGGUAUUUUUGGUGCUGACCCUAUACAUUCUUUAAGAGUUUGUGUAGAUACUGUUCGCACAAAUGUCUACUUAGCUGUCUUUGAUAAAAAUCUCUAUGACAAACUUGUUUCAAGCUUUUUGGAAAUGAAGAGUGAAAAGCAAGUUGAACAAAAGAUCGCUGAGAUUCCUAAAGAGGAAGUUAAGCCAUUUAUAACUGAAAGUAAACCUUCAGUUGAACAGAGAAAACAAGAUGAUAAGAAAAUCAAAGCUUGUGUUGAAGAAGUUACAACAACUCUGGAAGAAACUAAGUUCCUCACAGAAAACUUGUUACUUUAUAUUGACAUUAAUGGCAAUCUUCAUCCAGAUUCUGCCACUCUUGUUAGUGACAUUGACAUCACUUUCUUAAAGAAAGAUGCUCCAUAUAUAGUGGGUGAUGUUGUUCAAGAGGGUGUUUUAACUGCUGUGGUUAUACCUACUAAAAAGGCUGGUGGCACUACUGAAAUGCUAGCGAAAGCUUUGAGAAAAGUGCCAACAGACAAUUAUAUAACCACUUACCCGGGUCAGGGUUUAAAUGGUUACACUGUAGAGGAGGCAAAGACAGUGCUUAAAAAGUGUAAAAGUGCCUUUUACAUUCUACCAUCUAUUAUCUCUAAUGAGAAGCAAGAAAUUCUUGGAACUGUUUCUUGGAAUUUGCGAGAAAUGCUUGCACAUGCAGAAGAAACACGCAAAUUAAUGCCUGUCUGUGUGGAAACUAAAGCCAUAGUUUCAACUAUACAGCGUAAAUAUAAGGGUAUUAAAAUACAAGAGGGUGUGGUUGAUUAUGGUGCUAGAUUUUACUUUUACACCAGUAAAACAACUGUAGCGUCACUUAUCAACACACUUAACGAUCUAAAUGAAACUCUUGUUACAAUGCCACUUGGCUAUGUAACACAUGGCUUAAAUUUGGAAGAAGCUGCUCGGUAUAUGAGAUCUCUCAAAGUGCCAGCUACAGUUUCUGUUUCUUCACCUGAUGCUGUUACAGCGUAUAAUGGUUAUCUUACUUCUUCUUCUAAAACACCUGAAGAACAUUUUAUUGAAACCAUCUCACUUGCUGGUUCCUAUAAAGAUUGGUCCUAUUCUGGACAAUCUACACAACUAGGUAUAGAAUUUCUUAAGAGAGGUGAUAAAAGUGUAUAUUACACUAGUAAUCCUACCACAUUCCACCUAGAUGGUGAAGUUAUCACCUUUGACAAUCUUAAGACACUUCUUUCUUUGAGAGAAGUGAGGACUAUUAAGGUGUUUACAACAGUAGACAACAUUAACCUCCACACGCAAGUUGUGGACAUGUCAAUGACAUAUGGACAACAGUUUGGUCCAACUUAUUUGGAUGGAGCUGAUGUUACUAAAAUAAAACCUCAUAAUUCACAUGAAGGUAAAACAUUUUAUGUUUUACCUAAUGAUGACACUCUACGUGUUGAGGCUUUUGAGUACUACCACACAACUGAUCCUAGUUUUCUGGGUAGGUACAUGUCAGCAUUAAAUCACACUAAAAAGUGGAAAUACCCACAAGUUAAUGGUUUAACUUCUAUUAAAUGGGCAGAUAACAACUGUUAUCUUGCCACUGCAUUGUUAACACUCCAACAAAUAGAGUUGAAGUUUAAUCCACCUGCUCUACAAGAUGCUUAUUACAGAGCAAGGGCUGGUGAAGCUGCUAACUUUUGUGCACUUAUCUUAGCCUACUGUAAUAAGACAGUAGGUGAGUUAGGUGAUGUUAGAGAAACAAUGAGUUACUUGUUUCAACAUGCCAAUUUAGAUUCUUGCAAAAGAGUCUUGAACGUGGUGUGUAAAACUUGUGGACAACAGCAGACAACCCUUAAGGGUGUAGAAGCUGUUAUGUACAUGGGCACACUUUCUUAUGAACAAUUUAAGAAAGGUGUUCAGAUACCUUGUACGUGUGGUAAACAAGCUACAAAAUAUCUAGUACAACAGGAGUCACCUUUUGUUAUGAUGUCAGCACCACCUGCUCAGUAUGAACUUAAGCAUGGUACAUUUACUUGUGCUAGUGAGUACACUGGUAAUUACCAGUGUGGUCACUAUAAACAUAUAACUUCUAAAGAAACUUUGUAUUGCAUAGACGGUGCUUUACUUACAAAGUCCUCAGAAUACAAAGGUCCUAUUACGGAUGUUUUCUACAAAGAAAACAGUUACACAACAACCAUAAAACCAGUUACUUAUAAAUUGGAUGGUGUUGUUUGUACAGAAAUUGACCCUAAGUUGGACAAUUAUUAUAAGAAAGACAAUUCUUAUUUCACAGAGCAACCAAUUGAUCUUGUACCAAACCAACCAUAUCCAAACGCAAGCUUCGAUAAUUUUAAGUUUGUAUGUGAUAAUAUCAAAUUUGCUGAUGAUUUAAACCAGUUAACUGGUUAUAAGAAACCUGCUUCAAGAGAGCUUAAAGUUACAUUUUUCCCUGACUUAAAUGGUGAUGUGGUGGCUAUUGAUUAUAAACACUACACACCCUCUUUUAAGAAAGGAGCUAAAUUGUUACAUAAACCUAUUGUUUGGCAUGUUAACAAUGCAACUAAUAAAGCCACGUAUAAACCAAAUACCUGGUGUAUACGUUGUCUUUGGAGCACAAAACCAGUUGAAACAUCAAAUUCGUUUGAUGUACUGAAGUCAGAGGACGCGCAGGGAAUGGAUAAUCUUGCCUGCGAAGAUCUAAAACCAGUCUCUGAAGAAGUAGUGGAAAAUCCUACCAUACAGAAAGACGUUCUUGAGUGUAAUGUGAAAACUACCGAAGUUGUAGGAGACAUUAUACUUAAACCAGCAAAUAAUAGUUUAAAAAUUACAGAAGAGGUUGGCCACACAGAUCUAAUGGCUGCUUAUGUAGACAAUUCUAGUCUUACUAUUAAGAAACCUAAUGAAUUAUCUAGAGUAUUAGGUUUGAAAACCCUUGCUACUCAUGGUUUAGCUGCUGUUAAUAGUGUCCCUUGGGAUACUAUAGCUAAUUAUGCUAAGCCUUUUCUUAACAAAGUUGUUAGUACAACUACUAACAUAGUUACACGGUGUUUAAACCGUGUUUGUACUAAUUAUAUGCCUUAUUUCUUUACUUUAUUGCUACAAUUGUGUACUUUUACUAGAAGUACAAAUUCUAGAAUUAAAGCAUCUAUGCCGACUACUAUAGCAAAGAAUACUGUUAAGAGUGUCGGUAAAUUUUGUCUAGAGGCUUCAUUUAAUUAUUUGAAGUCACCUAAUUUUUCUAAACUGAUAAAUAUUAUAAUUUGGUUUUUACUAUUAAGUGUUUGCCUAGGUUCUUUAAUCUACUCAACCGCUGCUUUAGGUGUUUUAAUGUCUAAUUUAGGCAUGCCUUCUUACUGUACUGGUUACAGAGAAGGCUAUUUGAACUCUACUAAUGUCACUAUUGCAACCUACUGUACUGGUUCUAUACCUUGUAGUGUUUGUCUUAGUGGUUUAGAUUCUUUAGACACCUAUCCUUCUUUAGAAACUAUACAAAUUACCAUUUCAUCUUUUAAAUGGGAUUUAACUGCUUUUGGCUUAGUUGCAGAGUGGUUUUUGGCAUAUAUUCUUUUCACUAGGUUUUUCUAUGUACUUGGAUUGGCUGCAAUCAUGCAAUUGUUUUUCAGCUAUUUUGCAGUACAUUUUAUUAGUAAUUCUUGGCUUAUGUGGUUAAUAAUUAAUCUUGUACAAAUGGCCCCGAUUUCAGCUAUGGUUAGAAUGUACAUCUUCUUUGCAUCAUUUUAUUAUGUAUGGAAAAGUUAUGUGCAUGUUGUAGACGGUUGUAAUUCAUCAACUUGUAUGAUGUGUUACAAACGUAAUAGAGCAACAAGAGUCGAAUGUACAACUAUUGUUAAUGGUGUUAGAAGGUCCUUUUAUGUCUAUGCUAAUGGAGGUAAAGGCUUUUGCAAACUACACAAUUGGAAUUGUGUUAAUUGUGAUACAUUCUGUGCUGGUAGUACAUUUAUUAGUGAUGAAGUUGCGAGAGACUUGUCACUACAGUUUAAAAGACCAAUAAAUCCUACUGACCAGUCUUCUUACAUCGUUGAUAGUGUUACAGUGAAGAAUGGUUCCAUCCAUCUUUACUUUGAUAAAGCUGGUCAAAAGACUUAUGAAAGACAUUCUCUCUCUCAUUUUGUUAACUUAGACAACCUGAGAGCUAAUAACACUAAAGGUUCAUUGCCUAUUAAUGUUAUAGUUUUUGAUGGUAAAUCAAAAUGUGAAGAAUCAUCUGCAAAAUCAGCGUCUGUUUACUACAGUCAGCUUAUGUGUCAACCUAUACUGUUACUAGAUCAGGCAUUAGUGUCUGAUGUUGGUGAUAGUGCGGAAGUUGCAGUUAAAAUGUUUGAUGCUUACGUUAAUACGUUUUCAUCAACUUUUAACGUACCAAUGGAAAAACUCAAAACACUAGUUGCAACUGCAGAAGCUGAACUUGCAAAGAAUGUGUCCUUAGACAAUGUCUUAUCUACUUUUAUUUCAGCAGCUCGGCAAGGGUUUGUUGAUUCAGAUGUAGAAACUAAAGAUGUUGUUGAAUGUCUUAAAUUGUCACAUCAAUCUGACAUAGAAGUUACUGGCGAUAGUUGUAAUAACUAUAUGCUCACCUAUAACAAAGUUGAAAACAUGACACCCCGUGACCUUGGUGCUUGUAUUGACUGUAGUGCGCGUCAUAUUAAUGCGCAGGUAGCAAAAAGUCACAACAUUGCUUUGAUAUGGAACGUUAAAGAUUUCAUGUCAUUGUCUGAACAACUACGAAAACAAAUACGUAGUGCUGCUAAAAAGAAUAACUUACCUUUUAAGUUGACAUGUGCAACUACUAGACAAGUUGUUAAUGUUGUAACAACAAAGAUAGCACUUAAGGGUGGUAAAAUUGUUAAUAAUUGGUUGAAGCAGUUAAUUAAAGUUACACUUGUGUUCCUUUUUGUUGCUGCUAUUUUCUAUUUAAUAACACCUGUUCAUGUCAUGUCUAAACAUACUGACUUUUCAAGUGAAAUCAUAGGAUACAAGGCUAUUGAUGGUGGUGUCACUCGUGACAUAGCAUCUACAGAUACUUGUUUUGCUAACAAACAUGCUGAUUUUGACACAUGGUUUAGCCAGCGUGGUGGUAGUUAUACUAAUGACAAAGCUUGCCCAUUGAUUGCUGCAGUCAUAACAAGAGAAGUGGGUUUUGUCGUGCCUGGUUUGCCUGGCACGAUAUUACGCACAACUAAUGGUGACUUUUUGCAUUUCUUACCUAGAGUUUUUAGUGCAGUUGGUAACAUCUGUUACACACCAUCAAAACUUAUAGAGUACACUGACUUUGCAACAUCAGCUUGUGUUUUGGCUGCUGAAUGUACAAUUUUUAAAGAUGCUUCUGGUAAGCCAGUACCAUAUUGUUAUGAUACCAAUGUACUAGAAGGUUCUGUUGCUUAUGAAAGUUUACGCCCUGACACACGUUAUGUGCUCAUGGAUGGCUCUAUUAUUCAAUUUCCUAACACCUACCUUGAAGGUUCUGUUAGAGUGGUAACAACUUUUGAUUCUGAGUACUGUAGGCACGGCACUUGUGAAAGAUCAGAAGCUGGUGUUUGUGUAUCUACUAGUGGUAGAUGGGUACUUAACAAUGAUUAUUACAGAUCUUUACCAGGAGUUUUCUGUGGUGUAGAUGCUGUAAAUUUACUUACUAAUAUGUUUACACCACUAAUUCAACCUAUUGGUGCUUUGGACAUAUCAGCAUCUAUAGUAGCUGGUGGUAUUGUAGCUAUCGUAGUAACAUGCCUUGCCUACUAUUUUAUGAGGUUUAGAAGAGCUUUUGGUGAAUACAGUCAUGUAGUUGCCUUUAAUACUUUACUAUUCCUUAUGUCAUUCACUGUACUCUGUUUAACACCAGUUUACUCAUUCUUACCUGGUGUUUAUUCUGUUAUUUACUUGUACUUGACAUUUUAUCUUACUAAUGAUGUUUCUUUUUUAGCACAUAUUCAGUGGAUGGUUAUGUUCACACCUUUAGUACCUUUCUGGAUAACAAUUGCUUAUAUCAUUUGUAUUUCCACAAAGCAUUUCUAUUGGUUCUUUAGUAAUUACCUAAAGAGACGUGUAGUCUUUAAUGGUGUUUCCUUUAGUACUUUUGAAGAAGCUGCGCUGUGCACCUUUUUGUUAAAUAAAGAAAUGUAUCUAAAGUUGCGUAGUGAUGUGCUAUUACCUCUUACGCAAUAUAAUAGAUACUUAGCUCUUUAUAAUAAGUACAAGUAUUUUAGUGGAGCAAUGGAUACAACUAGCUACAGAGAAGCUGCUUGUUGUCAUCUCGCAAAGGCUCUCAAUGACUUCAGUAACUCAGGUUCUGAUGUUCUUUACCAACCACCACAAACCUCUAUCACCUCAGCUGUUUUGCAGAGUGGUUUUAGAAAAAUGGCAUUCCCAUCUGGUAAAGUUGAGGGUUGUAUGGUACAAGUAACUUGUGGUACAACUACACUUAACGGUCUUUGGCUUGAUGACGUAGUUUACUGUCCAAGACAUGUGAUCUGCACCUCUGAAGACAUGCUUAACCCUAAUUAUGAAGAUUUACUCAUUCGUAAGUCUAAUCAUAAUUUCUUGGUACAGGCUGGUAAUGUUCAACUCAGGGUUAUUGGACAUUCUAUGCAAAAUUGUGUACUUAAGCUUAAGGUUGAUACAGCCAAUCCUAAGACACCUAAGUAUAAGUUUGUUCGCAUUCAACCAGGACAGACUUUUUCAGUGUUAGCUUGUUACAAUGGUUCACCAUCUGGUGUUUACCAAUGUGCUAUGAGGCCCAAUUUCACUAUUAAGGGUUCAUUCCUUAAUGGUUCAUGUGGUAGUGUUGGUUUUAACAUAGAUUAUGACUGUGUCUCUUUUUGUUACAUGCACCAUAUGGAAUUACCAACUGGAGUUCAUGCUGGCACAGACUUAGAAGGUAACUUUUAUGGACCUUUUGUUGACAGGCAAACAGCACAAGCAGCUGGUACGGACACAACUAUUACAGUUAAUGUUUUAGCUUGGUUGUACGCUGCUGUUAUAAAUGGAGACAGGUGGUUUCUCAAUCGAUUUACCACAACUCUUAAUGACUUUAACCUUGUGGCUAUGAAGUACAAUUAUGAACCUCUAACACAAGACCAUGUUGACAUACUAGGACCUCUUUCUGCUCAAACUGGAAUUGCCGUUUUAGAUAUGUGUGCUUCAUUAAAAGAAUUACUGCAAAAUGGUAUGAAUGGACGUACCAUAUUGGGUAGUGCUUUAUUAGAAGAUGAAUUUACACCUUUUGAUGUUGUUAGACAAUGCUCAGGUGUUACUUUCCAAAGUGCAGUGAAAAGAACAAUCAAGGGUACACACCACUGGUUGUUACUCACAAUUUUGACUUCACUUUUAGUUUUAGUCCAGAGUACUCAAUGGUCUUUGUUCUUUUUUUUGUAUGAAAAUGCCUUUUUACCUUUUGCUAUGGGUAUUAUUGCUAUGUCUGCUUUUGCAAUGAUGUUUGUCAAACAUAAGCAUGCAUUUCUCUGUUUGUUUUUGUUACCUUCUCUUGCCACUGUAGCUUAUUUUAAUAUGGUCUAUAUGCCUGCUAGUUGGGUGAUGCGUAUUAUGACAUGGUUGGAUAUGGUUGAUACUAGUUUGUCUGGUUUUAAGCUAAAAGACUGUGUUAUGUAUGCAUCAGCUGUAGUGUUACUAAUCCUUAUGACAGCAAGAACUGUGUAUGAUGAUGGUGCUAGGAGAGUGUGGACACUUAUGAAUGUCUUGACACUCGUUUAUAAAGUUUAUUAUGGUAAUGCUUUAGAUCAAGCCAUUUCCAUGUGGGCUCUUAUAAUCUCUGUUACUUCUAACUACUCAGGUGUAGUUACAACUGUCAUGUUUUUGGCCAGAGGUAUUGUUUUUAUGUGUGUUGAGUAUUGCCCUAUUUUCUUCAUAACUGGUAAUACACUUCAGUGUAUAAUGCUAGUUUAUUGUUUCUUAGGCUAUUUUUGUACUUGUUACUUUGGCCUCUUUUGUUUACUCAACCGCUACUUUAGACUGACUCUUGGUGUUUAUGAUUACUUAGUUUCUACACAGGAGUUUAGAUAUAUGAAUUCACAGGGACUACUCCCACCCAAGAAUAGCAUAGAUGCCUUCAAACUCAACAUUAAAUUGUUGGGUGUUGGUGGCAAACCUUGUAUCAAAGUAGCCACUGUACAGUCUAAAAUGUCAGAUGUAAAGUGCACAUCAGUAGUCUUACUCUCAGUUUUGCAACAACUCAGAGUAGAAUCAUCAUCUAAAUUGUGGGCUCAAUGUGUCCAGUUACACAAUGACAUUCUCUUAGCUAAAGAUACUACUGAAGCCUUUGAAAAAAUGGUUUCACUACUUUCUGUUUUGCUUUCCAUGCAGGGUGCUGUAGACAUAAACAAGCUUUGUGAAGAAAUGCUGGACAACAGGGCAACCUUACAAGCUAUAGCCUCAGAGUUUAGUUCCCUUCCAUCAUAUGCAGCUUUUGCUACUGCUCAAGAAGCUUAUGAGCAGGCUGUUGCUAAUGGUGAUUCUGAAGUUGUUCUUAAAAAGUUGAAGAAGUCUUUGAAUGUGGCUAAAUCUGAAUUUGACCGUGAUGCAGCCAUGCAACGUAAGUUGGAAAAGAUGGCUGAUCAAGCUAUGACCCAAAUGUAUAAACAGGCUAGAUCUGAGGACAAGAGGGCAAAAGUUACUAGUGCUAUGCAGACAAUGCUUUUCACUAUGCUUAGAAAGUUGGAUAAUGAUGCACUCAACAACAUUAUCAACAAUGCAAGAGAUGGUUGUGUUCCCUUGAACAUAAUACCUCUUACAACAGCAGCCAAACUAAUGGUUGUCAUACCAGACUAUAACACAUAUAAAAAUACGUGUGAUGGUACAACAUUUACUUAUGCAUCAGCAUUGUGGGAAAUCCAACAGGUUGUAGAUGCAGAUAGUAAAAUUGUUCAACUUAGUGAAAUUAGUAUGGACAAUUCACCUAAUUUAGCAUGGCCUCUUAUUGUAACAGCUUUAAGGGCCAAUUCUGCUGUCAAAUUACAGAAUAAUGAGCUUAGUCCUGUUGCACUACGACAGAUGUCUUGUGCUGCCGGUACUACACAAACUGCUUGCACUGAUGACAAUGCGUUAGCUUACUACAACACAACAAAGGGAGGUAGGUUUGUACUUGCACUGUUAUCCGAUUUACAGGAUUUGAAAUGGGCUAGAUUCCCUAAGAGUGAUGGAACUGGUACUAUCUAUACAGAACUGGAACCACCUUGUAGGUUUGUUACAGACACACCUAAAGGUCCUAAAGUGAAGUAUUUAUACUUUAUUAAAGGAUUAAACAACCUAAAUAGAGGUAUGGUACUUGGUAGUUUAGCUGCCACAGUACGUCUACAAGCUGGUAAUGCAACAGAAGUGCCUGCCAAUUCAACUGUAUUAUCUUUCUGUGCUUUUGCUGUAGAUGCUGCUAAAGCUUACAAAGAUUAUCUAGCUAGUGGGGGACAACCAAUCACUAAUUGUGUUAAGAUGUUGUGUACACACACUGGUACUGGUCAGGCAAUAACAGUUACACCGGAAGCCAAUAUGGAUCAAGAAUCCUUUGGUGGUGCAUCGUGUUGUCUGUACUGCCGUUGCCACAUAGAUCAUCCAAAUCCUAAAGGAUUUUGUGACUUAAAAGGUAAGUAUGUACAAAUACCUACAACUUGUGCUAAUGACCCUGUGGGUUUUACACUUAAAAACACAGUCUGUACCGUCUGCGGUAUGUGGAAAGGUUAUGGCUGUAGUUGUGAUCAACUCCGCGAACCCAUGCUUCAGUCAGCUGAUGCACAAUCGUUUUUAAACGGGUUUGCGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGGCACUAGUACUGAUGUCGUAUACAGGGCUUUUGACAUCUACAAUGAUAAAGUAGCUGGUUUUGCUAAAUUCCUAAAAACUAAUUGUUGUCGCUUCCAAGAAAAGGACGAAGAUGACAAUUUAAUUGAUUCUUACUUUGUAGUUAAGAGACACACUUUCUCUAACUACCAACAUGAAGAAACAAUUUAUAAUUUACUUAAGGAUUGUCCAGCUGUUGCUAAACAUGACUUCUUUAAGUUUAGAAUAGACGGUGACAUGGUACCACAUAUAUCACGUCAACGUCUUACUAAAUACACAAUGGCAGACCUCGUCUAUGCUUUAAGGCAUUUUGAUGAAGGUAAUUGUGACACAUUAAAAGAAAUACUUGUCACAUACAAUUGUUGUGAUGAUGAUUAUUUCAAUAAAAAGGACUGGUAUGAUUUUGUAGAAAACCCAGAUAUAUUACGCGUAUACGCCAACUUAGGUGAACGUGUACGCCAAGCUUUGUUAAAAACAGUACAAUUCUGUGAUGCCAUGCGAAAUGCUGGUAUUGUUGGUGUACUGACAUUAGAUAAUCAAGAUCUCAAUGGUAACUGGUAUGAUUUCGGUGAUUUCAUACAAACCACGCCAGGUAGUGGAGUUCCUGUUGUAGAUUCUUAUUAUUCAUUGUUAAUGCCUAUAUUAACCUUGACCAGGGCUUUAACUGCAGAGUCACAUGUUGACACUGACUUAACAAAGCCUUACAUUAAGUGGGAUUUGUUAAAAUAUGACUUCACGGAAGAGAGGUUAAAACUCUUUGACCGUUAUUUUAAAUAUUGGGAUCAGACAUACCACCCAAAUUGUGUUAACUGUUUGGAUGACAGAUGCAUUCUGCAUUGUGCAAACUUUAAUGUUUUAUUCUCUACAGUGUUCCCACCUACAAGUUUUGGACCACUAGUGAGAAAAAUAUUUGUUGAUGGUGUUCCAUUUGUAGUUUCAACUGGAUACCACUUCAGAGAGCUAGGUGUUGUACAUAAUCAGGAUGUAAACUUACAUAGCUCUAGACUUAGUUUUAAGGAAUUACUUGUGUAUGCUGCUGACCCUGCUAUGCACGCUGCUUCUGGUAAUCUAUUACUAGAUAAACGCACUACGUGCUUUUCAGUAGCUGCACUUACUAACAAUGUUGCUUUUCAAACUGUCAAACCCGGUAAUUUUAACAAAGACUUCUAUGACUUUGCUGUGUCUAAGGGUUUCUUUAAGGAAGGAAGUUCUGUUGAAUUAAAACACUUCUUCUUUGCUCAGGAUGGUAAUGCUGCUAUCAGCGAUUAUGACUACUAUCGUUAUAAUCUACCAACAAUGUGUGAUAUCAGACAACUACUAUUUGUAGUUGAAGUUGUUGAUAAGUACUUUGAUUGUUACGAUGGUGGCUGUAUUAAUGCUAACCAAGUCAUCGUCAACAACCUAGACAAAUCAGCUGGUUUUCCAUUUAAUAAAUGGGGUAAGGCUAGACUUUAUUAUGAUUCAAUGAGUUAUGAGGAUCAAGAUGCACUUUUCGCAUAUACAAAACGUAAUGUCAUCCCUACUAUAACUCAAAUGAAUCUUAAGUAUGCCAUUAGUGCAAAGAAUAGAGCUCGCACCGUAGCUGGUGUCUCUAUCUGUAGUACUAUGACCAAUAGACAGUUUCAUCAAAAAUUAUUGAAAUCAAUAGCCGCCACUAGAGGAGCUACUGUAGUAAUUGGAACAAGCAAAUUCUAUGGUGGUUGGCACAACAUGUUAAAAACUGUUUAUAGUGAUGUAGAAAACCCUCACCUUAUGGGUUGGGAUUAUCCUAAAUGUGAUAGAGCCAUGCCUAACAUGCUUAGAAUUAUGGCCUCACUUGUUCUUGCUCGCAAACAUACAACGUGUUGUAGCUUGUCACACCGUUUCUAUAGAUUAGCUAAUGAGUGUGCUCAAGUAUUGAGUGAAAUGGUCAUGUGUGGCGGUUCACUAUAUGUUAAACCAGGUGGAACCUCAUCAGGAGAUGCCACAACUGCUUAUGCUAAUAGUGUUUUUAACAUUUGUCAAGCUGUCACGGCCAAUGUUAAUGCACUUUUAUCUACUGAUGGUAACAAAAUUGCCGAUAAGUAUGUCCGCAAUUUACAACACAGACUUUAUGAGUGUCUCUAUAGAAAUAGAGAUGUUGACACAGACUUUGUGAAUGAGUUUUACGCAUAUUUGCGUAAACAUUUCUCAAUGAUGAUACUCUCUGACGAUGCUGUUGUGUGUUUCAAUAGCACUUAUGCAUCUCAAGGUCUAGUGGCUAGCAUAAAGAACUUUAAGUCAGUUCUUUAUUAUCAAAACAAUGUUUUUAUGUCUGAAGCAAAAUGUUGGACUGAGACUGACCUUACUAAAGGACCUCAUGAAUUUUGCUCUCAACAUACAAUGCUAGUUAAACAGGGUGAUGAUUAUGUGUACCUUCCUUACCCAGAUCCAUCAAGAAUCCUAGGGGCCGGCUGUUUUGUAGAUGAUAUCGUAAAAACAGAUGGUACACUUAUGAUUGAACGGUUCGUGUCUUUAGCUAUAGAUGCUUACCCACUUACUAAACAUCCUAAUCAGGAGUAUGCUGAUGUCUUUCAUUUGUACUUACAAUACAUAAGAAAGCUACAUGAUGAGUUAACAGGACACAUGUUAGACAUGUAUUCUGUUAUGCUUACUAAUGAUAACACUUCAAGGUAUUGGGAACCUGAGUUUUAUGAGGCUAUGUACACACCGCAUACAGUCUUACAGGCUGUUGGGGCUUGUGUUCUUUGCAAUUCACAGACUUCAUUAAGAUGUGGUGCUUGCAUACGUAGACCAUUCUUAUGUUGUAAAUGCUGUUACGACCAUGUCAUAUCAACAUCACAUAAAUUAGUCUUGUCUGUUAAUCCGUAUGUUUGCAAUGCUCCAGGUUGUGAUGUCACAGAUGUGACUCAACUUUACUUAGGAGGUAUGAGCUAUUAUUGUAAAUCACAUAAACCACCCAUUAGUUUUCCAUUGUGUGCUAAUGGACAAGUUUUUGGUUUAUAUAAAAAUACAUGUGUUGGUAGCGAUAAUGUUACUGACUUUAAUGCAAUUGCAACAUGUGACUGGACAAAUGCUGGUGAUUACAUUUUAGCUAACACCUGUACUGAAAGACUCAAGCUUUUUGCAGCAGAAACGCUCAAAGCUACUGAGGAGACAUUUAAACUGUCUUAUGGUAUUGCUACUGUACGUGAAGUGCUGUCUGACAGAGAAUUACAUCUUUCAUGGGAAGUUGGUAAACCUAGACCACCACUUAACCGAAAUUAUGUCUUUACUGGUUAUCGUGUAACUAAAAACAGUAAAGUACAAAUAGGAGAGUACACCUUUGAAAAAGGUGACUAUGGUGAUGCUGUUGUUUACCGAGGUACAACAACUUACAAAUUAAAUGUUGGUGAUUAUUUUGUGCUGACAUCACAUACAGUAAUGCCAUUAAGUGCACCUACACUAGUGCCACAAGAGCACUAUGUUAGAAUUACUGGCUUAUACCCAACACUCAAUAUCUCAGAUGAGUUUUCUAGCAAUGUUGCAAAUUAUCAAAAGGUUGGUAUGCAAAAGUAUUCUACACUCCAGGGACCACCUGGUACUGGUAAGAGUCAUUUUGCUAUUGGCCUAGCUCUCUACUACCCUUCUGCUCGCAUAGUGUAUACAGCUUGCUCUCAUGCCGCUGUUGAUGCACUAUGUGAGAAGGCAUUAAAAUAUUUGCCUAUAGAUAAAUGUAGUAGAAUUAUACCUGCACGUGCUCGUGUAGAGUGUUUUGAUAAAUUCAAAGUGAAUUCAACAUUAGAACAGUAUGUCUUUUGUACUGUAAAUGCAUUGCCUGAGACGACAGCAGAUAUAGUUGUCUUUGAUGAAAUUUCAAUGGCCACAAAUUAUGAUUUGAGUGUUGUCAAUGCCAGAUUACGUGCUAAGCACUAUGUGUACAUUGGCGACCCUGCUCAAUUACCUGCACCACGCACAUUGCUAACUAAGGGCACACUAGAACCAGAAUAUUUCAAUUCAGUGUGUAGACUUAUGAAAACUAUAGGUCCAGACAUGUUCCUCGGAACUUGUCGGCGUUGUCCUGCUGAAAUUGUUGACACUGUGAGUGCUUUGGUUUAUGAUAAUAAGCUUAAAGCACAUAAAGACAAAUCAGCUCAAUGCUUUAAAAUGUUUUAUAAGGGUGUUAUCACGCAUGAUGUUUCAUCUGCAAUUAACAGGCCACAAAUAGGCGUGGUAAGAGAAUUCCUUACACGUAACCCUGCUUGGAGAAAAGCUGUCUUUAUUUCACCUUAUAAUUCACAGAAUGCUGUAGCCUCAAAGAUUUUGGGACUACCAACUCAAACUGUUGAUUCAUCACAGGGCUCAGAAUAUGACUAUGUCAUAUUCACUCAAACCACUGAAACAGCUCACUCUUGUAAUGUAAACAGAUUUAAUGUUGCUAUUACCAGAGCAAAAGUAGGCAUACUUUGCAUAAUGUCUGAUAGAGACCUUUAUGACAAGUUGCAAUUUACAAGUCUUGAAAUUCCACGUAGGAAUGUGGCAACUUUACAAGCUGAAAAUGUAACAGGACUCUUUAAAGAUUGUAGUAAGGUAAUCACUGGGUUACAUCCUACACAGGCACCUACACACCUCAGUGUUGACACUAAAUUCAAAACUGAAGGUUUAUGUGUUGACAUACCUGGCAUACCUAAGGACAUGACCUAUAGAAGACUCAUCUCUAUGAUGGGUUUUAAAAUGAAUUAUCAAGUUAAUGGUUACCCUAACAUGUUUAUCACCCGCGAAGAAGCUAUAAGACAUGUACGUGCAUGGAUUGGCUUCGAUGUCGAGGGGUGUCAUGCUACUAGAGAAGCUGUUGGUACCAAUUUACCUUUACAGCUAGGUUUUUCUACAGGUGUUAACCUAGUUGCUGUACCUACAGGUUAUGUUGAUACACCUAAUAAUACAGAUUUUUCCAGAGUUAGUGCUAAACCACCGCCUGGAGAUCAAUUUAAACACCUCAUACCACUUAUGUACAAAGGACUUCCUUGGAAUGUAGUGCGUAUAAAGAUUGUACAAAUGUUAAGUGACACACUUAAAAAUCUCUCUGACAGAGUCGUAUUUGUCUUAUGGGCACAUGGCUUUGAGUUGACAUCUAUGAAGUAUUUUGUGAAAAUAGGACCUGAGCGCACCUGUUGUCUAUGUGAUAGACGUGCCACAUGCUUUUCCACUGCUUCAGACACUUAUGCCUGUUGGCAUCAUUCUAUUGGAUUUGAUUACGUCUAUAAUCCGUUUAUGAUUGAUGUUCAACAAUGGGGUUUUACAGGUAACCUACAAAGCAACCAUGAUCUGUAUUGUCAAGUCCAUGGUAAUGCACAUGUAGCUAGUUGUGAUGCAAUCAUGACUAGGUGUCUAGCUGUCCACGAGUGCUUUGUUAAGCGUGUUGACUGGACUAUUGAAUAUCCUAUAAUUGGUGAUGAACUGAAGAUUAAUGCGGCUUGUAGAAAGGUUCAACACAUGGUUGUUAAAGCUGCAUUAUUAGCAGACAAAUUCCCAGUUCUUCACGACAUUGGUAACCCUAAAGCUAUUAAGUGUGUACCUCAAGCUGAUGUAGAAUGGAAGUUCUAUGAUGCACAGCCUUGUAGUGACAAAGCUUAUAAAAUAGAAGAAUUAUUCUAUUCUUAUGCCACACAUUCUGACAAAUUCACAGAUGGUGUAUGCCUAUUUUGGAAUUGCAAUGUCGAUAGAUAUCCUGCUAAUUCCAUUGUUUGUAGAUUUGACACUAGAGUGCUAUCUAACCUUAACUUGCCUGGUUGUGAUGGUGGCAGUUUGUAUGUAAAUAAACAUGCAUUCCACACACCAGCUUUUGAUAAAAGUGCUUUUGUUAAUUUAAAACAAUUACCAUUUUUCUAUUACUCUGACAGUCCAUGUGAGUCUCAUGGAAAACAAGUAGUGUCAGAUAUAGAUUAUGUACCACUAAAGUCUGCUACGUGUAUAACACGUUGCAAUUUAGGUGGUGCUGUCUGUAGACAUCAUGCUAAUGAGUACAGAUUGUAUCUCGAUGCUUAUAACAUGAUGAUCUCAGCUGGCUUUAGCUUGUGGGUUUACAAACAAUUUGAUACUUAUAACCUCUGGAACACUUUUACAAGACUUCAGAGUUUAGAAAAUGUGGCUUUUAAUGUUGUAAAUAAGGGACACUUUGAUGGACAACAGGGUGAAGUACCAGUUUCUAUCAUUAAUAACACUGUUUACACAAAAGUUGAUGGUGUUGAUGUAGAAUUGUUUGAAAAUAAAACAACAUUACCUGUUAAUGUAGCAUUUGAGCUUUGGGCUAAGCGCAACAUUAAACCAGUACCAGAGGUGAAAAUACUCAAUAAUUUGGGUGUGGACAUUGCUGCUAAUACUGUGAUCUGGGACUACAAAAGAGAUGCUCCAGCACAUAUAUCUACUAUUGGUGUUUGUUCUAUGACUGACAUAGCCAAGAAACCAACUGAAACGAUUUGUGCACCACUCACUGUCUUUUUUGAUGGUAGAGUUGAUGGUCAAGUAGACUUAUUUAGAAAUGCCCGUAAUGGUGUUCUUAUUACAGAAGGUAGUGUUAAAGGUUUACAACCAUCUGUAGGUCCCAAACAAGCUAGUCUUAAUGGAGUCACAUUAAUUGGAGAAGCCGUAAAAACACAGUUCAAUUAUUAUAAGAAAGUUGAUGGUGUUGUCCAACAAUUACCUGAAACUUACUUUACUCAGAGUAGAAAUUUACAAGAAUUUAAACCCAGGAGUCAAAUGGAAAUUGAUUUCUUAGAAUUAGCUAUGGAUGAAUUCAUUGAACGGUAUAAAUUAGAAGGCUAUGCCUUCGAACAUAUCGUUUAUGGAGAUUUUAGUCAUAGUCAGUUAGGUGGUUUACAUCUACUGAUUGGACUAGCUAAACGUUUUAAGGAAUCACCUUUUGAAUUAGAAGAUUUUAUUCCUAUGGACAGUACAGUUAAAAACUAUUUCAUAACAGAUGCGCAAACAGGUUCAUCUAAGUGUGUGUGUUCUGUUAUUGAUUUAUUACUUGAUGAUUUUGUUGAAAUAAUAAAAUCCCAAGAUUUAUCUGUAGUUUCUAAGGUUGUCAAAGUGACUAUUGACUAUACAGAAAUUUCAUUUAUGCUUUGGUGUAAAGAUGGCCAUGUAGAAACAUUUUACCCAAAAUUACAAUCUAGUCAAGCGUGGCAACCGGGUGUUGCUAUGCCUAAUCUUUACAAAAUGCAAAGAAUGCUAUUAGAAAAGUGUGACCUUCAAAAUUAUGGUGAUAGUGCAACAUUACCUAAAGGCAUAAUGAUGAAUGUCGCAAAAUAUACUCAACUGUGUCAAUAUUUAAACACAUUAACAUUAGCUGUACCCUAUAAUAUGAGAGUUAUACAUUUUGGUGCUGGUUCUGAUAAAGGAGUUGCACCAGGUACAGCUGUUUUAAGACAGUGGUUGCCUACGGGUACGCUGCUUGUCGAUUCAGAUCUUAAUGACUUUGUCUCUGAUGCAGAUUCAACUUUGAUUGGUGAUUGUGCAACUGUACAUACAGCUAAUAAAUGGGAUCUCAUUAUUAGUGAUAUGUACGACCCUAAGACUAAAAAUGUUACAAAAGAAAAUGACUCUAAAGAGGGUUUUUUCACUUACAUUUGUGGGUUUAUACAACAAAAGCUAGCUCUUGGAGGUUCCGUGGCUAUAAAGAUAACAGAACAUUCUUGGAAUGCUGAUCUUUAUAAGCUCAUGGGACACUUCGCAUGGUGGACAGCCUUUGUUACUAAUGUGAAUGCGUCAUCAUCUGAAGCAUUUUUAAUUGGAUGUAAUUAUCUUGGCAAACCACGCGAACAAAUAGAUGGUUAUGUCAUGCAUGCAAAUUACAUAUUUUGGAGGAAUACAAAUCCAAUUCAGUUGUCUUCCUAUUCUUUAUUUGACAUGAGUAAAUUUCCCCUUAAAUUAAGGGGUACUGCUGUUAUGUCUUUAAAAGAAGGUCAAAUCAAUGAUAUGAUUUUAUCUCUUCUUAGUAAAGGUAGACUUAUAAUUAGAGAAAACAACAGAGUUGUUAUUUCUAGUGAUGUUCUUGUUAACAACUAAACGAACAAUGUUUGUUUUUCUUGUUUUAUUGCCACUAGUCUCUAGUCAGUGUGUUAAUCUUACAACCAGAACUCAAUUACCCCCUGCAUACACUAAUUCUUUCACACGUGGUGUUUAUUACCCUGACAAAGUUUUCAGAUCCUCAGUUUUACAUUCAACUCAGGACUUGUUCUUACCUUUCUUUUCCAAUGUUACUUGGUUCCAUGCUAUACAUGUCUCUGGGACCAAUGGUACUAAGAGGUUUGAUAACCCUGUCCUACCAUUUAAUGAUGGUGUUUAUUUUGCUUCCACUGAGAAGUCUAACAUAAUAAGAGGCUGGAUUUUUGGUACUACUUUAGAUUCGAAGACCCAGUCCCUACUUAUUGUUAAUAACGCUACUAAUGUUGUUAUUAAAGUCUGUGAAUUUCAAUUUUGUAAUGAUCCAUUUUUGGGUGUUUAUUACCACAAAAACAACAAAAGUUGGAUGGAAAGUGAGUUCAGAGUUUAUUCUAGUGCGAAUAAUUGCACUUUUGAAUAUGUCUCUCAGCCUUUUCUUAUGGACCUUGAAGGAAAACAGGGUAAUUUCAAAAAUCUUAGGGAAUUUGUGUUUAAGAAUAUUGAUGGUUAUUUUAAAAUAUAUUCUAAGCACACGCCUAUUAAUUUAGUGCGUGAUCUCCCUCAGGGUUUUUCGGCUUUAGAACCAUUGGUAGAUUUGCCAAUAGGUAUUAACAUCACUAGGUUUCAAACUUUACUUGCUUUACAUAGAAGUUAUUUGACUCCUGGUGAUUCUUCUUCAGGUUGGACAGCUGGUGCUGCAGCUUAUUAUGUGGGUUAUCUUCAACCUAGGACUUUUCUAUUAAAAUAUAAUGAAAAUGGAACCAUUACAGAUGCUGUAGACUGUGCACUUGACCCUCUCUCAGAAACAAAGUGUACGUUGAAAUCCUUCACUGUAGAAAAAGGAAUCUAUCAAACUUCUAACUUUAGAGUCCAACCAACAGAAUCUAUUGUUAGAUUUCCUAAUAUUACAAACUUGUGCCCUUUUGGUGAAGUUUUUAACGCCACCAGAUUUGCAUCUGUUUAUGCUUGGAACAGGAAGAGAAUCAGCAACUGUGUUGCUGAUUAUUCUGUCCUAUAUAAUUCCGCAUCAUUUUCCACUUUUAAGUGUUAUGGAGUGUCUCCUACUAAAUUAAAUGAUCUCUGCUUUACUAAUGUCUAUGCAGAUUCAUUUGUAAUUAGAGGUGAUGAAGUCAGACAAAUCGCUCCAGGGCAAACUGGAAAGAUUGCUGAUUAUAAUUAUAAAUUACCAGAUGAUUUUACAGGCUGCGUUAUAGCUUGGAAUUCUAACAAUCUUGAUUCUAAGGUUGGUGGUAAUUAUAAUUACCUGUAUAGAUUGUUUAGGAAGUCUAAUCUCAAACCUUUUGAGAGAGAUAUUUCAACUGAAAUCUAUCAGGCCGGUAGCACACCUUGUAAUGGUGUUGAAGGUUUUAAUUGUUACUUUCCUUUACAAUCAUAUGGUUUCCAACCCACUAAUGGUGUUGGUUACCAACCAUACAGAGUAGUAGUACUUUCUUUUGAACUUCUACAUGCACCAGCAACUGUUUGUGGACCUAAAAAGUCUACUAAUUUGGUUAAAAACAAAUGUGUCAAUUUCAACUUCAAUGGUUUAACAGGCACAGGUGUUCUUACUGAGUCUAACAAAAAGUUUCUGCCUUUCCAACAAUUUGGCAGAGACAUUGCUGACACUACUGAUGCUGUCCGUGAUCCACAGACACUUGAGAUUCUUGACAUUACACCAUGUUCUUUUGGUGGUGUCAGUGUUAUAACACCAGGAACAAAUACUUCUAACCAGGUUGCUGUUCUUUAUCAGGAUGUUAACUGCACAGAAGUCCCUGUUGCUAUUCAUGCAGAUCAACUUACUCCUACUUGGCGUGUUUAUUCUACAGGUUCUAAUGUUUUUCAAACACGUGCAGGCUGUUUAAUAGGGGCUGAACAUGUCAACAACUCAUAUGAGUGUGACAUACCCAUUGGUGCAGGUAUAUGCGCUAGUUAUCAGACUCAGACUAAUUCUCCUCGGCGGGCACGUAGUGUAGCUAGUCAAUCCAUCAUUGCCUACACUAUGUCACUUGGUGCAGAAAAUUCAGUUGCUUACUCUAAUAACUCUAUUGCCAUACCCACAAAUUUUACUAUUAGUGUUACCACAGAAAUUCUACCAGUGUCUAUGACCAAGACAUCAGUAGAUUGUACAAUGUACAUUUGUGGUGAUUCAACUGAAUGCAGCAAUCUUUUGUUGCAAUAUGGCAGUUUUUGUACACAAUUAAACCGUGCUUUAACUGGAAUAGCUGUUGAACAAGACAAAAACACCCAAGAAGUUUUUGCACAAGUCAAACAAAUUUACAAAACACCACCAAUUAAAGAUUUUGGUGGUUUUAAUUUUUCACAAAUAUUACCAGAUCCAUCAAAACCAAGCAAGAGGUCAUUUAUUGAAGAUCUACUUUUCAACAAAGUGACACUUGCAGAUGCUGGCUUCAUCAAACAAUAUGGUGAUUGCCUUGGUGAUAUUGCUGCUAGAGACCUCAUUUGUGCACAAAAGUUUAACGGCCUUACUGUUUUGCCACCUUUGCUCACAGAUGAAAUGAUUGCUCAAUACACUUCUGCACUGUUAGCGGGUACAAUCACUUCUGGUUGGACCUUUGGUGCAGGUGCUGCAUUACAAAUACCAUUUGCUAUGCAAAUGGCUUAUAGGUUUAAUGGUAUUGGAGUUACACAGAAUGUUCUCUAUGAGAACCAAAAAUUGAUUGCCAACCAAUUUAAUAGUGCUAUUGGCAAAAUUCAAGACUCACUUUCUUCCACAGCAAGUGCACUUGGAAAACUUCAAGAUGUGGUCAACCAAAAUGCACAAGCUUUAAACACGCUUGUUAAACAACUUAGCUCCAAUUUUGGUGCAAUUUCAAGUGUUUUAAAUGAUAUCCUUUCACGUCUUGACAAAGUUGAGGCUGAAGUGCAAAUUGAUAGGUUGAUCACAGGCAGACUUCAAAGUUUGCAGACAUAUGUGACUCAACAAUUAAUUAGAGCUGCAGAAAUCAGAGCUUCUGCUAAUCUUGCUGCUACUAAAAUGUCAGAGUGUGUACUUGGACAAUCAAAAAGAGUUGAUUUUUGUGGAAAGGGCUAUCAUCUUAUGUCCUUCCCUCAGUCAGCACCUCAUGGUGUAGUCUUCUUGCAUGUGACUUAUGUCCCUGCACAAGAAAAGAACUUCACAACUGCUCCUGCCAUUUGUCAUGAUGGAAAAGCACACUUUCCUCGUGAAGGUGUCUUUGUUUCAAAUGGCACACACUGGUUUGUAACACAAAGGAAUUUUUAUGAACCACAAAUCAUUACUACAGACAACACAUUUGUGUCUGGUAACUGUGAUGUUGUAAUAGGAAUUGUCAACAACACAGUUUAUGAUCCUUUGCAACCUGAAUUAGACUCAUUCAAGGAGGAGUUAGAUAAAUAUUUUAAGAAUCAUACAUCACCAGAUGUUGAUUUAGGUGACAUCUCUGGCAUUAAUGCUUCAGUUGUAAACAUUCAAAAAGAAAUUGACCGCCUCAAUGAGGUUGCCAAGAAUUUAAAUGAAUCUCUCAUCGAUCUCCAAGAACUUGGAAAGUAUGAGCAGUAUAUAAAAUGGCCAUGGUACAUUUGGCUAGGUUUUAUAGCUGGCUUGAUUGCCAUAGUAAUGGUGACAAUUAUGCUUUGCUGUAUGACCAGUUGCUGUAGUUGUCUCAAGGGCUGUUGUUCUUGUGGAUCCUGCUGCAAAUUUGAUGAAGACGACUCUGAGCCAGUGCUCAAAGGAGUCAAAUUACAUUACACAUAAACGAACUUAUGGAUUUGUUUAUGAGAAUCUUCACAAUUGGAACUGUAACUUUGAAGCAAGGUGAAAUCAAGGAUGCUACUCCUUCAGAUUUUGUUCGCGCUACUGCAACGAUACCGAUACAAGCCUCACUCCCUUUCGGAUGGCUUAUUGUUGGCGUUGCACUUCUUGCUGUUUUUCAGAGCGCUUCCAAAAUCAUAACCCUCAAAAAGAGAUGGCAACUAGCACUCUCCAAGGGUGUUCACUUUGUUUGCAACUUGCUGUUGUUGUUUGUAACAGUUUACUCACACCUUUUGCUCGUUGCUGCUGGCCUUGAAGCCCCUUUUCUCUAUCUUUAUGCUUUAGUCUACUUCUUGCAGAGUAUAAACUUUGUAAGAAUAAUAAUGAGGCUUUGGCUUUGCUGGAAAUGCCGUUCCAAAAACCCAUUACUUUAUGAUGCCAACUAUUUUCUUUGCUGGCAUACUAAUUGUUACGACUAUUGUAUACCUUACAAUAGUGUAACUUCUUCAAUUGUCAUUACUUCAGGUGAUGGCACAACAAGUCCUAUUUCUGAACAUGACUACCAGAUUGGUGGUUAUACUGAAAAAUGGGAAUCUGGAGUAAAAGACUGUGUUGUAUUACACAGUUACUUCACUUCAGACUAUUACCAGCUGUACUCAACUCAAUUGAGUACAGACACUGGUGUUGAACAUGUUACCUUCUUCAUCUACAAUAAAAUUGUUGAUGAGCCUGAAGAACAUGUCCAAAUUCACACAAUCGACGGUUCAUCCGGAGUUGUUAAUCCAGUAAUGGAACCAAUUUAUGAUGAACCGACGACGACUACUAGCGUGCCUUUGUAAGCACAAGCUGAUGAGUACGAACUUAUGUACUCAUUCGUUUCGGAAGAGACAGGUACGUUAAUAGUUAAUAGCGUACUUCUUUUUCUUGCUUUCGUGGUAUUCUUGCUAGUUACACUAGCCAUCCUUACUGCGCUUCGAUUGUGUGCGUACUGCUGCAAUAUUGUUAACGUGAGUCUUGUAAAACCUUCUUUUUACGUUUACUCUCGUGUUAAAAAUCUGAAUUCUUCUAGAGUUCCUGAUCUUCUGGUCUAAACGAACUAAAUAUUAUAUUAGUUUUUCUGUUUGGAACUUUAAUUUUAGCCAUGGCAGAUUCCAACGGUACUAUUACCGUUGAAGAGCUUAAAAAGCUCCUUGAACAAUGGAACCUAGUAAUAGGUUUCCUAUUCCUUACAUGGAUUUGUCUUCUACAAUUUGCCUAUGCCAACAGGAAUAGGUUUUUGUAUAUAAUUAAGUUAAUUUUCCUCUGGCUGUUAUGGCCAGUAACUUUAGCUUGUUUUGUGCUUGCUGCUGUUUACAGAAUAAAUUGGAUCACCGGUGGAAUUGCUAUCGCAAUGGCUUGUCUUGUAGGCUUGAUGUGGCUCAGCUACUUCAUUGCUUCUUUCAGACUGUUUGCGCGUACGCGUUCCAUGUGGUCAUUCAAUCCAGAAACUAACAUUCUUCUCAACGUGCCACUCCAUGGCACUAUUCUGACCAGACCGCUUCUAGAAAGUGAACUCGUAAUCGGAGCUGUGAUCCUUCGUGGACAUCUUCGUAUUGCUGGACACCAUCUAGGACGCUGUGACAUCAAGGACCUGCCUAAAGAAAUCACUGUUGCUACAUCACGAACGCUUUCUUAUUACAAAUUGGGAGCUUCGCAGCGUGUAGCAGGUGACUCAGGUUUUGCUGCAUACAGUCGCUACAGGAUUGGCAACUAUAAAUUAAACACAGACCAUUCCAGUAGCAGUGACAAUAUUGCUUUGCUUGUACAGUAAGUGACAACAGAUGUUUCAUCUCGUUGACUUUCAGGUUACUAUAGCAGAGAUAUUACUAAUUAUUAUGAGGACUUUUAAAGUUUCCAUUUGGAAUCUUGAUUACAUCAUAAACCUCAUAAUUAAAAAUUUAUCUAAGUCACUAACUGAGAAUAAAUAUUCUCAAUUAGAUGAAGAGCAACCAAUGGAGAUUGAUUAAACGAACAUGAAAAUUAUUCUUUUCUUGGCACUGAUAACACUCGCUACUUGUGAGCUUUAUCACUACCAAGAGUGUGUUAGAGGUACAACAGUACUUUUAAAAGAACCUUGCUCUUCUGGAACAUACGAGGGCAAUUCACCAUUUCAUCCUCUAGCUGAUAACAAAUUUGCACUGACUUGCUUUAGCACUCAAUUUGCUUUUGCUUGUCCUGACGGCGUAAAACACGUCUAUCAGUUACGUGCCAGAUCAGUUUCACCUAAACUGUUCAUCAGACAAGAGGAAGUUCAAGAACUUUACUCUCCAAUUUUUCUUAUUGUUGCGGCAAUAGUGUUUAUAACACUUUGCUUCACACUCAAAAGAAAGACAGAAUGAUUGAACUUUCAUUAAUUGACUUCUAUUUGUGCUUUUUAGCCUUUCUGCUAUUCCUUGUUUUAAUUAUGCUUAUUAUCUUUUGGUUCUCACUUGAACUGCAAGAUCAUAAUGAAACUUGUCACGCCUAAACGAACAUGAAAUUUCUUGUUUUCUUAGGAAUCAUCACAACUGUAGCUGCAUUUCACCAAGAAUGUAGUUUACAGUCAUGUACUCAACAUCAACCAUAUGUAGUUGAUGACCCGUGUCCUAUUCACUUCUAUUCUAAAUGGUAUAUUAGAGUAGGAGCUAGAAAAUCAGCACCUUUAAUUGAAUUGUGCGUGGAUGAGGCUGGUUCUAAAUCACCCAUUCAGUACAUCGAUAUCGGUAAUUAUACAGUUUCCUGUUUACCUUUUACAAUUAAUUGCCAGGAACCUAAAUUGGGUAGUCUUGUAGUGCGUUGUUCGUUCUAUGAAGACUUUUUAGAGUAUCAUGACGUUCGUGUUGUUUUAGAUUUCAUCUAAACGAACAAACUAAAAUGUCUGAUAAUGGACCCCAAAAUCAGCGAAAUGCACCCCGCAUUACGUUUGGUGGACCCUCAGAUUCAACUGGCAGUAACCAGAAUGGAGAACGCAGUGGGGCGCGAUCAAAACAACGUCGGCCCCAAGGUUUACCCAAUAAUACUGCGUCUUGGUUCACCGCUCUCACUCAACAUGGCAAGGAAGACCUUAAAUUCCCUCGAGGACAAGGCGUUCCAAUUAACACCAAUAGCAGUCCAGAUGACCAAAUUGGCUACUACCGAAGAGCUACCAGACGAAUUCGUGGUGGUGACGGUAAAAUGAAAGAUCUCAGUCCAAGAUGGUAUUUCUACUACCUAGGAACUGGGCCAGAAGCUGGACUUCCCUAUGGUGCUAACAAAGACGGCAUCAUAUGGGUUGCAACUGAGGGAGCCUUGAAUACACCAAAAGAUCACAUUGGCACCCGCAAUCCUGCUAACAAUGCUGCAAUCGUGCUACAACUUCCUCAAGGAACAACAUUGCCAAAAGGCUUCUACGCAGAAGGGAGCAGAGGCGGCAGUCAAGCCUCUUCUCGUUCCUCAUCACGUAGUCGCAACAGUUCAAGAAAUUCAACUCCAGGCAGCAGUAGGGGAACUUCUCCUGCUAGAAUGGCUGGCAAUGGCGGUGAUGCUGCUCUUGCUUUGCUGCUGCUUGACAGAUUGAACCAGCUUGAGAGCAAAAUGUCUGGUAAAGGCCAACAACAACAAGGCCAAACUGUCACUAAGAAAUCUGCUGCUGAGGCUUCUAAGAAGCCUCGGCAAAAACGUACUGCCACUAAAGCAUACAAUGUAACACAAGCUUUCGGCAGACGUGGUCCAGAACAAACCCAAGGAAAUUUUGGGGACCAGGAACUAAUCAGACAAGGAACUGAUUACAAACAUUGGCCGCAAAUUGCACAAUUUGCCCCCAGCGCUUCAGCGUUCUUCGGAAUGUCGCGCAUUGGCAUGGAAGUCACACCUUCGGGAACGUGGUUGACCUACACAGGUGCCAUCAAAUUGGAUGACAAAGAUCCAAAUUUCAAAGAUCAAGUCAUUUUGCUGAAUAAGCAUAUUGACGCAUACAAAACAUUCCCACCAACAGAGCCUAAAAAGGACAAAAAGAAGAAGGCUGAUGAAACUCAAGCCUUACCGCAGAGACAGAAGAAACAGCAAACUGUGACUCUUCUUCCUGCUGCAGAUUUGGAUGAUUUCUCCAAACAAUUGCAACAAUCCAUGAGCAGUGCUGACUCAACUCAGGCCUAAACUCAUGCAGACCACACAAGGCAGAUGGGCUAUAUAAACGUUUUCGCUUUUCCGUUUACGAUAUAUAGUCUACUCUUGUGCAGAAUGAAUUCUCGUAACUACAUAGCACAAGUAGAUGUAGUUAACUUUAAUCUCACAUAGCAAUCUUUAAUCAGUGUGUAACAUUAGGGAGGACUUGAAAGAGCCACCACAUUUUCACCGAGGCCACGCGGAGUACGAUCGAGUGUACAGUGAACAAUGCUAGGGAGAGCUGCCUAUAUGGAAGAGCCCUAAUGUGUAAAAUUAAUUUUAGUAGUGCUAUCCCCAUGUGAUUUUAAUAGCUUCUUAGGAGAAUGACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5-20µM[SARS2-NP];|200nM[SARS-CoV-2],"15 mM NaCl, 135 mM KCl, 5 mM phosphate, 1.5 mM MgCl2","20 mM Tris–HCl, pH 7.0",37˚C,-,other_molecular:1 mg ml−1 BSA,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"To test whether these viral mutations induce changes in the phase separation of SARS2-NP , we incubated fluorescently labelled K375N and K375E with viral RNA and compared the micrometre-sized liquid droplet formation with that of SARS2-NP WT. Both the K375N and K375E mutants seemed to have compromised LLPS ",29903
